ONTOLOGY,ID,Description,Fold_Enrichment_Score,Count,pvalue,p.adjust,geneID
BP,GO:0016236,macroautophagy,3.2778715645891014,26,1.243942161579451e-7,5.060356713305207e-4,VMP1/NEDD4/CSNK2A2/RAB7A/SESN1/MTMR3/PRKAG2/STX12/PIK3CA/VPS4A/SNX14/MAP3K7/SNAPIN/PIP4K2A/TRAPPC8/PRKAA2/WDFY3/CDK5/GABARAP/MTM1/TOMM20/NUPR1/GBA/ATG9B/CSNK2B/LIX1L
BP,GO:0008654,phospholipid biosynthetic process,3.289993870671162,23,6.234584195442466e-7,0.0012681144253529975,PIGB/CSNK2A2/DDHD2/LPCAT2/MTMR3/DDHD1/PLEKHA1/PTPMT1/GNPAT/PIK3CA/LPGAT1/LPIN3/DPM2/MTMR6/MTMR12/PIP4K2A/CDS1/SGMS2/INPPL1/MTM1/FITM2/PIGN/CSNK2B
CC,GO:0010008,endosome membrane,2.57771204686868,32,1.1176208370599322e-6,3.1026130128877956e-4,STARD3NL/SNX1/AP5M1/RAB7A/KIF16B/SPG21/TAB1/EEA1/EHD4/SNX4/STX12/WDR83/VAMP7/RAP2A/MYO1B/YIPF2/RBSN/WDR44/VPS4A/SBF2/SNX14/MAP3K7/CD164/APPL2/ITM2B/KIF13A/RAB15/ZFYVE27/DTX3L/RAP2B/PRAF2/CHMP1B
CC,GO:0061695,"transferase complex, transferring phosphorus-containing groups",3.2775011522565336,22,1.1910222698225703e-6,3.1026130128877956e-4,CDK6/PRKAG2/TGFBR1/GTF2H1/CCND3/TBP/PRKAR2A/ACVR2B/CD3EAP/PIK3CA/CDKN1A/POLR3F/MAP3K7/CDK4/RTF1/CCNB3/NRBF2/PRKAA2/CDK5/POLR2J3/TADA3/POLR3C
BP,GO:0046474,glycerophospholipid biosynthetic process,3.427763599977968,20,1.7830963770344944e-6,0.0014806035590505767,PIGB/CSNK2A2/DDHD2/LPCAT2/MTMR3/DDHD1/PLEKHA1/PTPMT1/GNPAT/PIK3CA/LPIN3/DPM2/MTMR6/MTMR12/PIP4K2A/CDS1/INPPL1/MTM1/PIGN/CSNK2B
BP,GO:0006914,autophagy,2.4744168487340956,33,1.8198175504554776e-6,0.0014806035590505767,VMP1/NEDD4/CSNK2A2/RAB7A/SESN1/MTMR3/MET/PRKAG2/STX12/PIK3CA/ATG4D/VPS4A/SBF2/SNX14/MAP3K7/FNBP1L/ANXA7/MCL1/SNAPIN/NRBF2/PIP4K2A/TRAPPC8/PRKAA2/WDFY3/CDK5/GABARAP/MTM1/TOMM20/NUPR1/GBA/ATG9B/CSNK2B/LIX1L
BP,GO:0061919,process utilizing autophagic mechanism,2.4744168487340956,33,1.8198175504554776e-6,0.0014806035590505767,VMP1/NEDD4/CSNK2A2/RAB7A/SESN1/MTMR3/MET/PRKAG2/STX12/PIK3CA/ATG4D/VPS4A/SBF2/SNX14/MAP3K7/FNBP1L/ANXA7/MCL1/SNAPIN/NRBF2/PIP4K2A/TRAPPC8/PRKAA2/WDFY3/CDK5/GABARAP/MTM1/TOMM20/NUPR1/GBA/ATG9B/CSNK2B/LIX1L
BP,GO:0045017,glycerolipid biosynthetic process,3.111617275916255,21,4.633328535049572e-6,0.0031413967467636096,PIGB/CSNK2A2/DDHD2/LPCAT2/MTMR3/DDHD1/PLEKHA1/PTPMT1/GNPAT/PIK3CA/LPIN3/DPM2/MTMR6/MTMR12/PIP4K2A/CDS1/INPPL1/MTM1/FITM2/PIGN/CSNK2B
CC,GO:1902911,protein kinase complex,4.601895904773874,13,4.947457293887104e-6,8.592084167050603e-4,CDK6/PRKAG2/TGFBR1/GTF2H1/CCND3/PRKAR2A/ACVR2B/CDKN1A/MAP3K7/CDK4/CCNB3/PRKAA2/CDK5
BP,GO:0006650,glycerophospholipid metabolic process,2.798086650264147,24,6.210361928549533e-6,0.0036091074750484995,PIGB/CSNK2A2/DDHD2/LPCAT2/PLA2G3/MTMR3/DDHD1/IMPAD1/PLEKHA1/PTPMT1/PLCD4/GNPAT/PIK3CA/LPGAT1/LPIN3/DPM2/MTMR6/MTMR12/PIP4K2A/CDS1/INPPL1/MTM1/PIGN/CSNK2B
BP,GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",5.977162777461583,9,1.6835415544613988e-5,0.0070509126375979765,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,5.872300272593836,9,1.95216386103738e-5,0.0070509126375979765,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:1902400,intracellular signal transduction involved in G1 DNA damage checkpoint,5.872300272593836,9,1.95216386103738e-5,0.0070509126375979765,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:1902115,regulation of organelle assembly,3.2590257526594653,17,2.044287803626345e-5,0.0070509126375979765,MTMR3/CDKL1/STAG2/CNOT6/SDC1/WRAP73/G3BP2/PIP4K2A/HNRNPU/PRKAA2/TAPT1/MTM1/TRAPPC12/NUPR1/IL1RAP/NUP62/CHMP1B
MF,GO:0004674,protein serine/threonine kinase activity,2.338100227790433,29,2.19607428868532e-5,0.015262716306362974,CAMKK1/MAP4K5/PKN2/CSNK2A2/MAST2/TRPM7/MKNK2/CDKL1/DYRK1B/CDK6/PRKAG2/TGFBR1/GTF2H1/CCND3/ACVR2B/RPS6KA1/PIK3CA/STK26/TAOK3/MAP3K7/CDK4/ALPK3/BMP2K/PAK1/RPS6KA4/PRKAA2/CDK5/MAP4K2/CSNK2B
BP,GO:0009791,post-embryonic development,4.6489043824701195,11,2.3529073106753755e-5,0.0070509126375979765,RC3H2/BAX/IMPAD1/TGFBR1/PLEKHA1/C12orf57/ACVR2B/PLAGL2/PYGO2/INPPL1/TAPT1
BP,GO:0072413,signal transduction involved in mitotic cell cycle checkpoint,5.673239246404214,9,2.5998940404122332e-5,0.0070509126375979765,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:1902402,signal transduction involved in mitotic DNA damage checkpoint,5.673239246404214,9,2.5998940404122332e-5,0.0070509126375979765,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:1902403,signal transduction involved in mitotic DNA integrity checkpoint,5.673239246404214,9,2.5998940404122332e-5,0.0070509126375979765,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0071156,regulation of cell cycle arrest,4.13235945108455,12,3.361993744681096e-5,0.008429399315654156,BAX/CNOT6/CDKN1A/CDK4/CNOT11/CDK5/CRADD/TRIAP1/CRLF3/PIDD1/CNOT10/CNOT7
BP,GO:0007033,vacuole organization,3.422506293843033,15,3.522610333483792e-5,0.008429399315654156,VMP1/RAB7A/MTMR3/STX12/VPS4A/MBTPS1/SNAPIN/PIP4K2A/TRAPPC8/GABARAP/MTM1/NUPR1/GBA/ATG9B/TMEM199
BP,GO:0072331,signal transduction by p53 class mediator,2.785860304101944,20,3.884953213726708e-5,0.00877999426302236,USP28/CSNK2A2/BAX/RBBP7/PRKAG2/ING4/TBP/CNOT6/CDKN1A/CNOT11/PRKAA2/RBBP4/CDK5/CRADD/TRIAP1/NUPR1/PIDD1/CNOT10/CNOT7/CSNK2B
CC,GO:0001726,ruffle,3.364982023392345,15,4.354327543652073e-5,0.005671511625606826,ALS2/RASGRP2/TRPM7/CDK6/PLEKHA1/KLHL2/DIAPH1/APPL2/MTMR6/PAK1/CLASP2/MTM1/MYO5A/MYO1C/CYFIP1
BP,GO:0031571,mitotic G1 DNA damage checkpoint,5.313033579965851,9,4.452546279882082e-5,0.009056479133280155,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0044819,mitotic G1/S transition checkpoint,5.313033579965851,9,4.452546279882082e-5,0.009056479133280155,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0006354,"DNA-templated transcription, elongation",3.984775184974388,12,4.8330144995967035e-5,0.0090606230493319,ZMYND11/THOC5/HTATSF1/ELL/GTF2H1/TBP/CD3EAP/RTF1/EAF1/HNRNPU/RNF168/LDB1
BP,GO:0044783,G1 DNA damage checkpoint,5.230017430278885,9,5.059447084897562e-5,0.0090606230493319,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0032784,"regulation of DNA-templated transcription, elongation",5.950597609561753,8,5.1377362808898714e-5,0.0090606230493319,ZMYND11/THOC5/HTATSF1/ELL/RTF1/HNRNPU/RNF168/LDB1
BP,GO:1905037,autophagosome organization,4.261495683930943,11,5.345500324089616e-5,0.0090606230493319,VMP1/RAB7A/MTMR3/STX12/PIP4K2A/TRAPPC8/GABARAP/MTM1/NUPR1/GBA/ATG9B
CC,GO:0031252,cell leading edge,2.393618312752206,25,5.684327420600644e-5,0.005923069172265871,ALS2/SNX1/PKN2/RASGRP2/TRPM7/CDK6/PLEKHA1/ACTA2/KLHL2/PIK3CA/VAMP7/DIAPH1/APPL2/MTMR6/PAK1/CLASP2/CDK5/INPPL1/MTM1/NHS/MYO5A/PARVA/MYO1C/LDB1/CYFIP1
BP,GO:0046486,glycerolipid metabolic process,2.3356814288738765,26,6.0064703544597634e-5,0.009773728560776927,PIGB/CSNK2A2/DDHD2/LPCAT2/PLA2G3/MTMR3/DDHD1/IMPAD1/PLEKHA1/PTPMT1/PLCD4/GNPAT/PIK3CA/LPGAT1/LPIN3/DPM2/MTMR6/MTMR12/PIP4K2A/CDS1/INPPL1/MTM1/TBL1XR1/FITM2/PIGN/CSNK2B
BP,GO:0071158,positive regulation of cell cycle arrest,4.5355164707025555,10,6.82094512403152e-5,0.010292086143480369,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/CRLF3/PIDD1/CNOT10/CNOT7
BP,GO:0006661,phosphatidylinositol biosynthetic process,3.8473691441132023,12,6.831030626203785e-5,0.010292086143480369,PIGB/MTMR3/PLEKHA1/PIK3CA/DPM2/MTMR6/MTMR12/PIP4K2A/CDS1/INPPL1/MTM1/PIGN
BP,GO:0007050,cell cycle arrest,2.824650764032478,18,7.851192799555798e-5,0.01140666153878321,BAX/CDK6/PRKAG2/TGFBR1/ING4/CNOT6/CDKN1A/CDK4/CNOT11/PRKAA2/CDK5/CRADD/TRIAP1/CRLF3/PIDD1/CNOT10/CNOT7/KLLN
BP,GO:0034199,activation of protein kinase A activity,10.330898627711377,5,8.831104274624768e-5,0.012387907651439158,PRKAR2A/ADCY7/ADCY9/PRRC1/ADCY1
CC,GO:1902554,serine/threonine protein kinase complex,4.384673545632449,10,9.246742042775027e-5,0.008029254340476315,CDK6/TGFBR1/GTF2H1/CCND3/ACVR2B/CDKN1A/MAP3K7/CDK4/CCNB3/CDK5
BP,GO:0006644,phospholipid metabolic process,2.2487723524506626,26,1.1146761421152381e-4,0.015115008487082629,PIGB/CSNK2A2/DDHD2/LPCAT2/PLA2G3/MTMR3/DDHD1/IMPAD1/PLEKHA1/PTPMT1/PLCD4/GNPAT/PIK3CA/LPGAT1/LPIN3/DPM2/MTMR6/MTMR12/PIP4K2A/CDS1/SGMS2/INPPL1/MTM1/FITM2/PIGN/CSNK2B
BP,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,3.570358565737052,12,1.4071720847208717e-4,0.01775638437520782,BAX/CDK6/CNOT6/CDKN1A/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0072401,signal transduction involved in DNA integrity checkpoint,4.585220760792447,9,1.4404146617056493e-4,0.01775638437520782,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0072422,signal transduction involved in DNA damage checkpoint,4.585220760792447,9,1.4404146617056493e-4,0.01775638437520782,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0030104,water homeostasis,4.523258318079035,9,1.601440324091941e-4,0.018613312109731474,CYP26B1/MET/PRKAR2A/ADCY7/ANXA7/ADCY9/CLDN1/ADCY1/GBA
BP,GO:0072395,signal transduction involved in cell cycle checkpoint,4.523258318079035,9,1.601440324091941e-4,0.018613312109731474,BAX/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0048193,Golgi vesicle transport,2.3244521912350598,23,1.6978204178281622e-4,0.019185370721458234,SNX1/DDHD2/KIF16B/GOLGA3/ARFRP1/COPE/EXOC2/CAPZA1/TMED5/ARL1/VAMP7/MYO1B/RBSN/DCTN4/KIF13A/TEX261/NBAS/TRAPPC8/TRAPPC12/MCFD2/MYO18A/MYO5A/PDCD6
CC,GO:0031519,PcG protein complex,5.746721072573593,7,1.9306994007132445e-4,0.014369919825308577,CSNK2A2/RBBP7/ASXL2/RBBP4/RYBP/CBX6/CSNK2B
BP,GO:0000045,autophagosome assembly,3.9990575333076297,10,1.9803671556392234e-4,0.02177333402470368,VMP1/RAB7A/MTMR3/STX12/PIP4K2A/TRAPPC8/GABARAP/MTM1/NUPR1/ATG9B
BP,GO:1902807,negative regulation of cell cycle G1/S phase transition,3.406830692497187,12,2.1922510754733115e-4,0.023468624671119556,BAX/CDK6/CNOT6/CDKN1A/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0046058,cAMP metabolic process,8.452553422672946,5,2.4832921085411725e-4,0.025902646916783307,PDE8A/ADCY7/ADCY9/ADCY1/PDE4B
BP,GO:0046488,phosphatidylinositol metabolic process,2.9923982231991575,14,2.656855513625678e-4,0.027020220573573145,PIGB/MTMR3/IMPAD1/PLEKHA1/PLCD4/PIK3CA/DPM2/MTMR6/MTMR12/PIP4K2A/CDS1/INPPL1/MTM1/PIGN
BP,GO:0044773,mitotic DNA damage checkpoint,3.8341479443052533,10,2.8019807210215216e-4,0.027801116031989145,BAX/CNOT6/CDKN1A/TAOK3/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0016197,endosomal transport,2.6565167899829256,16,3.859902491975801e-4,0.03738591270799419,ALS2/SNX1/AP5M1/RAB7A/ARFRP1/EEA1/NDRG4/EHD4/ANKRD27/SNX4/VAMP4/ARL1/HEATR5A/RBSN/VPS4A/CHMP1B
BP,GO:0099518,vesicle cytoskeletal trafficking,5.006512411890898,7,4.573834951076724e-4,0.042428461697636526,VAMP7/KIF13A/FNBP1L/SNAPIN/BLOC1S5/MYO5A/MYO1C
BP,GO:0050891,multicellular organismal water homeostasis,4.375439418795406,8,4.637059609692202e-4,0.042428461697636526,CYP26B1/MET/PRKAR2A/ADCY7/ADCY9/CLDN1/ADCY1/GBA
BP,GO:2000045,regulation of G1/S transition of mitotic cell cycle,2.8297678849818118,14,4.6934139046058104e-4,0.042428461697636526,BAX/CDK6/CCND3/CNOT6/CDKN1A/INO80/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
MF,GO:0042393,histone binding,2.69497461928934,15,4.945821685317408e-4,0.17186730356477992,KDM7A/ZMYND11/CBX5/ING4/ASF1A/ATAD2B/INO80/RBBP4/PYGO2/DTX3L/RNF168/PHF8/TBL1XR1/SPTY2D1/RCC1
BP,GO:0000077,DNA damage checkpoint,3.077895315290562,12,5.568832238230247e-4,0.04924784683721879,USP28/BAX/THOC5/CNOT6/CDKN1A/TAOK3/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0044774,mitotic DNA integrity checkpoint,3.508607081109524,10,5.726997876001186e-4,0.049415345353687176,BAX/CNOT6/CDKN1A/TAOK3/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0000082,G1/S transition of mitotic cell cycle,2.399434519984578,18,5.830719215774298e-4,0.049415345353687176,BAX/CDK6/CCND3/CNOT6/CDKN1A/INO80/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/KLF11/PHF8/CRLF3/PIDD1/RCC1/CNOT10/CNOT7
BP,GO:0030330,"DNA damage response, signal transduction by p53 class mediator",3.475816360725323,10,6.168837464832428e-4,0.05121394042232309,BAX/ING4/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
CC,GO:0030014,CCR4-NOT complex,9.078853459191896,4,8.112336920320902e-4,0.052831594193589876,CNOT6/CNOT11/CNOT10/CNOT7
BP,GO:0034330,cell junction organization,2.3084214864679216,18,9.123382423791333e-4,0.07422783939996629,VMP1/PKN2/ITGA6/CDH20/TGFBR1/CAPZA1/GNPAT/RASSF8/MARVELD2/CLDN1/CLASP2/CLDN3/ACTG1/PKP3/APOD/MYO1C/LDB1/CLDN9
CC,GO:0005635,nuclear envelope,1.9957824414602874,24,0.0011188142259557243,0.054596522839498646,BAX/CBX5/HTATIP2/PLCD4/XPO4/CDK4/ANXA7/MTMR6/BNIP2/CMTM3/PSEN2/LBR/PAK1/EIF5A2/WDFY3/RNF180/NSMF/PHF8/AGFG1/BANF1/RCC1/KPNA5/MYO1C/NUP62
BP,GO:0031570,DNA integrity checkpoint,2.8426421701728115,12,0.001123721373361203,0.08806100855874348,USP28/BAX/THOC5/CNOT6/CDKN1A/TAOK3/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0034243,regulation of transcription elongation from RNA polymerase II promoter,6.198539176626826,5,0.0011256569432287762,0.08806100855874348,ZMYND11/ELL/RTF1/HNRNPU/RNF168
BP,GO:0006470,protein dephosphorylation,2.201350361792705,19,0.001167298094058993,0.08836133488466794,PHLPP2/TAB1/MTMR3/PTPMT1/PTPRB/MTMR6/SSH2/DUSP10/BOD1/PTPN14/NSMF/BTRC/PPP1R14A/SDHAF2/MTM1/GBA/PPP1CC/PTPN1/PPP1R14C
BP,GO:1902806,regulation of cell cycle G1/S phase transition,2.577610350676502,14,0.0011729380736902825,0.08836133488466794,BAX/CDK6/CCND3/CNOT6/CDKN1A/INO80/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
MF,GO:0004693,cyclin-dependent protein serine/threonine kinase activity,6.102413793103448,5,0.0011954331994288524,0.17912063546302023,CDKL1/CDK6/CCND3/CDK4/CDK5
BP,GO:0044843,cell cycle G1/S phase transition,2.246450439851333,18,0.0012418781169030542,0.09185382144657499,BAX/CDK6/CCND3/CNOT6/CDKN1A/INO80/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/KLF11/PHF8/CRLF3/PIDD1/RCC1/CNOT10/CNOT7
CC,GO:0043296,apical junction complex,2.968086707812735,11,0.0012701370154362022,0.054596522839498646,PKN2/TGFBR1/CYTH1/CDK4/TJAP1/MARVELD2/CLDN1/CLDN3/RAP2B/NHS/CLDN9
CC,GO:0000407,phagophore assembly site,6.0289261252446185,5,0.001294392747486536,0.054596522839498646,VMP1/RAB7A/STX12/TRAPPC8/ATG9B
BP,GO:0016050,vesicle organization,2.174256818878333,19,0.0013478941243907263,0.09791488032181205,ALS2/RAB7A/PLA2G3/EEA1/ANKRD27/SDC1/VAMP4/STX12/VAMP7/VPS4A/KIF13A/FNBP1L/SNAPIN/AGFG1/MCFD2/BLOC1S5/MYO18A/PDCD6/CHMP1B
CC,GO:0005923,bicellular tight junction,3.1370022115093947,10,0.0013759824167826503,0.054596522839498646,TGFBR1/CYTH1/CDK4/TJAP1/MARVELD2/CLDN1/CLDN3/RAP2B/NHS/CLDN9
MF,GO:0097472,cyclin-dependent protein kinase activity,5.899,5,0.0014016143086832667,0.17912063546302023,CDKL1/CDK6/CCND3/CDK4/CDK5
BP,GO:1990182,exosomal secretion,7.82973369679178,4,0.0014517446735670535,0.102968315004862,RAB7A/SDC1/COPS5/VPS4A
BP,GO:0045815,"positive regulation of gene expression, epigenetic",4.13235945108455,7,0.001468083153953293,0.102968315004862,ASF1A/TBP/CD3EAP/ATAD2B/ZMIZ2/PHF8/MYO1C
CC,GO:0030175,filopodium,3.339097546289327,9,0.0015289651956703224,0.054596522839498646,ITGA6/ACTA2/MYO1B/CDK5/INPPL1/MTM1/CBX6/MYO5A/CYFIP1
CC,GO:0030027,lamellipodium,2.598998205286799,13,0.0016241266284541252,0.054596522839498646,ALS2/SNX1/PKN2/ACTA2/KLHL2/PIK3CA/VAMP7/PAK1/CDK5/INPPL1/NHS/PARVA/CYFIP1
CC,GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,3.0623116826639327,10,0.0016499847927667378,0.054596522839498646,VMP1/DDHD2/TMED5/MTMR6/MGAT4B/TRAPPC12/MCFD2/P4HB/MYO18A/TMEM199
BP,GO:0035335,peptidyl-tyrosine dephosphorylation,3.2815795640965555,9,0.001713562907450909,0.11661545287210845,MTMR3/PTPMT1/PTPRB/MTMR6/SSH2/DUSP10/PTPN14/MTM1/PTPN1
BP,GO:0007093,mitotic cell cycle checkpoint,2.704817095255342,12,0.0017199919302670864,0.11661545287210845,CHFR/BAX/CNOT6/CDKN1A/VPS4A/TAOK3/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
MF,GO:0016646,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor",7.451368421052631,4,0.0017410060919643617,0.17912063546302023,MTHFD1L/ALDH1L1/QDPR/ALDH4A1
MF,GO:0016780,"phosphotransferase activity, for other substituted phosphate groups",7.451368421052631,4,0.0017410060919643617,0.17912063546302023,GNPTG/CDS1/SGMS2/PIGN
BP,GO:0097734,extracellular exosome biogenesis,7.438247011952191,4,0.0017764693243101759,0.11687028196404849,RAB7A/SDC1/COPS5/VPS4A
BP,GO:0032147,activation of protein kinase activity,2.122022420827202,19,0.0017812088204943476,0.11687028196404849,MAP4K5/TAB1/PRKAG2/TGFBR1/PRKAR2A/ACVR2B/MAPKAP1/ADCY7/PIK3CA/STK26/TAOK3/MAP3K7/PAK1/ADCY9/PRRC1/ADCY1/FRS2/MAP4K2/PTPN1
CC,GO:0016461,unconventional myosin complex,11.575538160469666,3,0.001812741303066762,0.054596522839498646,MYL6B/MYO5A/MYO1C
CC,GO:0070160,tight junction,3.0144630626223092,10,0.0018560471364578958,0.054596522839498646,TGFBR1/CYTH1/CDK4/TJAP1/MARVELD2/CLDN1/CLDN3/RAP2B/NHS/CLDN9
CC,GO:0005819,spindle,2.112730307866702,19,0.0018862522286199148,0.054596522839498646,CAPN6/KLHL42/NUBP2/CEP128/MAPRE1/STAG2/CBX1/INO80/CEP85/DIAPH1/VPS4A/DCTN4/MAPKBP1/BOD1/HNRNPU/CLASP2/TADA3/TBL1XR1/NUP62
BP,GO:0048284,organelle fusion,2.9992931499807223,10,0.0019133511455408656,0.12283056618744319,RAB7A/BAX/EEA1/ANKRD27/VAMP4/STX12/VAMP7/VPS4A/SNAPIN/OMA1
BP,GO:0010948,negative regulation of cell cycle process,2.060456235997837,20,0.0019324376194681328,0.12283056618744319,BAX/CBX5/STAG2/RBBP7/CDK6/CNOT6/CDKN1A/TERF2/VPS4A/TAOK3/CDK4/CNOT11/PRMT2/RBBP4/RYBP/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:0006171,cAMP biosynthetic process,11.157370517928287,3,0.002013767661345219,0.12603087455926695,ADCY7/ADCY9/ADCY1
MF,GO:0004725,protein tyrosine phosphatase activity,3.18546,9,0.0020867370114366025,0.17912063546302023,MTMR3/PTPMT1/PTPRB/MTMR6/SSH2/DUSP10/PTPN14/MTM1/PTPN1
CC,GO:0072686,mitotic spindle,3.1859279340742206,9,0.002118580388413728,0.05798387927391858,MAPRE1/STAG2/DIAPH1/MAPKBP1/HNRNPU/CLASP2/TADA3/TBL1XR1/NUP62
BP,GO:0000075,cell cycle checkpoint,2.4105430131326546,14,0.0022015795424671315,0.13485066654917394,USP28/CHFR/BAX/THOC5/CNOT6/CDKN1A/VPS4A/TAOK3/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
CC,GO:0000421,autophagosome membrane,5.3590454446618825,5,0.002225868686138909,0.05798387927391858,VMP1/RAB7A/WDFY3/GABARAP/ATG9B
BP,GO:0007041,lysosomal transport,3.157746372998572,9,0.002236454377268163,0.13485066654917394,NEDD4/RAB7A/VAMP7/RBSN/VPS4A/KIF13A/SNAPIN/DTX3L/MTM1
BP,GO:0032801,receptor catabolic process,5.313033579965851,5,0.0022966486621896196,0.13485066654917394,NEDD4/KIF16B/DTX3L/CDK5/PTPN1
BP,GO:0034329,cell junction assembly,2.31480716139591,15,0.0023077552822185028,0.13485066654917394,VMP1/PKN2/ITGA6/CDH20/CAPZA1/GNPAT/MARVELD2/CLDN1/CLASP2/CLDN3/ACTG1/PKP3/APOD/MYO1C/LDB1
MF,GO:0004016,adenylate cyclase activity,10.6182,3,0.002319547797362852,0.17912063546302023,ADCY7/ADCY9/ADCY1
MF,GO:0070513,death domain binding,10.6182,3,0.002319547797362852,0.17912063546302023,BAX/MCL1/CRADD
BP,GO:0016241,regulation of macroautophagy,2.6099112322639266,12,0.0023204391982404563,0.13485066654917394,NEDD4/SESN1/MTMR3/PRKAG2/PIK3CA/MAP3K7/PIP4K2A/PRKAA2/CDK5/MTM1/NUPR1/GBA
BP,GO:0045921,positive regulation of exocytosis,3.381021369069178,8,0.0025297557231403005,0.13800374233227092,RAB7A/SNX4/SDC1/VAMP7/VPS4A/RAB15/CLASP2/CDK5
BP,GO:0140112,extracellular vesicle biogenesis,6.762042738138356,4,0.002570512344235572,0.13800374233227092,RAB7A/SDC1/COPS5/VPS4A
BP,GO:0033762,response to glucagon,5.165449313855689,5,0.002609046953330895,0.13800374233227092,PRKAR2A/ADCY7/QDPR/ADCY9/ADCY1
BP,GO:1902373,negative regulation of mRNA catabolic process,4.291296353049341,6,0.002618502012972626,0.13800374233227092,CIRBP/DHX34/NBAS/HNRNPU/HNRNPA0/PKP3
BP,GO:0016311,dephosphorylation,1.8673423460967844,24,0.0026648914077188786,0.13800374233227092,PHLPP2/SMG6/TAB1/MTMR3/IMPAD1/ELL/PTPMT1/PTPRB/LPIN3/MTMR6/SSH2/DUSP10/BOD1/PTPN14/INPPL1/NSMF/BTRC/PPP1R14A/SDHAF2/MTM1/GBA/PPP1CC/PTPN1/PPP1R14C
BP,GO:0000185,activation of MAPKKK activity,10.143064107207534,3,0.002713937902306213,0.13800374233227092,MAP4K5/TAB1/MAP4K2
BP,GO:0006558,L-phenylalanine metabolic process,10.143064107207534,3,0.002713937902306213,0.13800374233227092,FAH/QDPR/PCBD1
BP,GO:0006559,L-phenylalanine catabolic process,10.143064107207534,3,0.002713937902306213,0.13800374233227092,FAH/QDPR/PCBD1
BP,GO:1902221,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,10.143064107207534,3,0.002713937902306213,0.13800374233227092,FAH/QDPR/PCBD1
BP,GO:1902222,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,10.143064107207534,3,0.002713937902306213,0.13800374233227092,FAH/QDPR/PCBD1
CC,GO:0005776,autophagosome,3.319150727016392,8,0.0028590424994293486,0.07093148296203289,VMP1/RAB7A/FTL/NRBF2/PIP4K2A/WDFY3/GABARAP/ATG9B
BP,GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,5.025842575643373,5,0.0029511213218096416,0.148211870828662,SAMD4A/CNOT6/CNOT11/CNOT10/CNOT7
CC,GO:0032587,ruffle membrane,3.2838406128991964,8,0.0030559056688324654,0.07236940243007793,RASGRP2/PLEKHA1/DIAPH1/APPL2/MTMR6/PAK1/CLASP2/MYO1C
BP,GO:0042770,signal transduction in response to DNA damage,2.7963334631399217,10,0.003197680765376049,0.1586361628481679,BAX/ING4/CNOT6/CDKN1A/CNOT11/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
CC,GO:0005802,trans-Golgi network,2.288948223821685,14,0.0035425391992274994,0.08024621403467509,AP4E1/ARFRP1/VAMP4/WDR11/ARL1/VAMP7/MYO1B/YIPF2/KIF13A/TJAP1/CLASP2/FAM91A1/GBA/MYO18A
BP,GO:0090161,Golgi ribbon formation,9.297808764940239,3,0.003546815735073057,0.17176721916996662,TMED5/VAMP4/MYO18A
BP,GO:1903894,regulation of IRE1-mediated unfolded protein response,9.297808764940239,3,0.003546815735073057,0.17176721916996662,BAX/COPS5/PTPN1
MF,GO:0034593,phosphatidylinositol bisphosphate phosphatase activity,6.155478260869565,4,0.003637684614347474,0.21014940241881616,MTMR3/PTPMT1/MTMR6/MTM1
BP,GO:0006906,vesicle fusion,3.1652114944477407,8,0.0038118398921691368,0.18243017272169468,RAB7A/EEA1/ANKRD27/VAMP4/STX12/VAMP7/VPS4A/SNAPIN
BP,GO:1902117,positive regulation of organelle assembly,3.471181938911023,7,0.00400020848016699,0.18921916392231763,CNOT6/SDC1/WRAP73/G3BP2/PIP4K2A/TAPT1/NUP62
MF,GO:0004438,phosphatidylinositol-3-phosphatase activity,8.848500000000001,3,0.00407708001243728,0.21014940241881616,MTMR3/MTMR6/MTM1
MF,GO:0017110,nucleoside-diphosphatase activity,8.848500000000001,3,0.00407708001243728,0.21014940241881616,NUDT15/ENTPD5/ENTPD6
BP,GO:0009187,cyclic nucleotide metabolic process,4.6489043824701195,5,0.004170963142208081,0.19066277783346725,PDE8A/ADCY7/ADCY9/ADCY1/PDE4B
BP,GO:0051310,metaphase plate congression,3.91486684839589,6,0.004170977030628139,0.19066277783346725,VPS4A/BOD1/HNRNPU/TRAPPC12/NUP62/CHMP1B
BP,GO:0046856,phosphatidylinositol dephosphorylation,5.950597609561753,4,0.004171334126641737,0.19066277783346725,MTMR3/MTMR6/INPPL1/MTM1
MF,GO:0003713,transcription coactivator activity,1.9971536050156737,18,0.004376306377691823,0.21014940241881616,SS18L2/DYRK1B/HTATIP2/VDR/ING4/COPS5/ZMIZ2/LPIN3/MED4/BCL10/ARNT/MED21/GABPA/PRMT2/PCBD1/TADA3/SCAND1/NUPR1
CC,GO:0000307,cyclin-dependent protein kinase holoenzyme complex,4.5934675239958995,5,0.004423671272676763,0.09603053054435805,CDK6/CCND3/CDKN1A/CDK4/CCNB3
BP,GO:0030948,negative regulation of vascular endothelial growth factor receptor signaling pathway,8.582592706098682,3,0.004519539193013656,0.2020383015074676,NEDD4/PTPN1/PDCD6
BP,GO:0035563,positive regulation of chromatin binding,8.582592706098682,3,0.004519539193013656,0.2020383015074676,HMBOX1/PYGO2/DTX3L
BP,GO:1902882,regulation of response to oxidative stress,3.0673183554442027,8,0.004616800332980611,0.204142866897447,PDE8A/SESN1/MET/LANCL1/MAPKAP1/STK26/MCL1/P4HB
BP,GO:0051403,stress-activated MAPK cascade,2.080628534811802,16,0.0047942084717654465,0.20528452378800463,MAP4K5/ZMYND11/TAB1/COPS5/RAP2A/SH2D3A/KLHDC10/TAOK3/MAP3K7/DUSP10/PAK1/BTRC/MAP4K2/TNIP2/CARD9/PTPN1
BP,GO:0033561,regulation of water loss via skin,5.7217284707324545,4,0.0048265487970504594,0.20528452378800463,CYP26B1/MET/CLDN1/GBA
BP,GO:0071377,cellular response to glucagon stimulus,5.7217284707324545,4,0.0048265487970504594,0.20528452378800463,PRKAR2A/ADCY7/ADCY9/ADCY1
BP,GO:0009411,response to UV,2.6376762453731173,10,0.004844472537770021,0.20528452378800463,SPRTN/USP28/NEDD4/BAX/CIRBP/CDKN1A/INO80/ERCC5/SCARA3/TRIAP1
BP,GO:0008333,endosome to lysosome transport,3.7821594976028092,6,0.0049515840255296316,0.20554126342708715,RAB7A/VAMP7/KIF13A/SNAPIN/DTX3L/MTM1
BP,GO:1902369,negative regulation of RNA catabolic process,3.7821594976028092,6,0.0049515840255296316,0.20554126342708715,CIRBP/DHX34/NBAS/HNRNPU/HNRNPA0/PKP3
BP,GO:0007030,Golgi organization,2.619101060546546,10,0.005090066716960618,0.20686828352347789,VMP1/TMED5/VAMP4/ARL1/RBSN/TJAP1/TRAPPC8/CLASP2/TRAPPC12/MYO18A
BP,GO:0007034,vacuolar transport,2.619101060546546,10,0.005090066716960618,0.20686828352347789,NEDD4/RAB7A/VAMP7/RBSN/VPS4A/KIF13A/SNAPIN/DTX3L/MTM1/CHMP1B
CC,GO:0031588,nucleotide-activated protein kinase complex,8.26824154319262,3,0.005090156501249674,0.1060788614860432,PRKAG2/PRKAR2A/PRKAA2
BP,GO:0009416,response to light stimulus,2.0135382038724083,17,0.00513611028413748,0.20686828352347789,SPRTN/CTNS/USP28/NEDD4/DDHD2/BAX/CIRBP/NDRG4/CDKN1A/INO80/ERCC5/NMT2/CDS1/CDK5/SCARA3/TRIAP1/PPP1CC
MF,GO:0032454,histone demethylase activity (H3-K9 specific),8.167846153846154,3,0.005189972604625361,0.21014940241881616,KDM7A/KDM3A/PHF8
MF,GO:0052744,phosphatidylinositol monophosphate phosphatase activity,8.167846153846154,3,0.005189972604625361,0.21014940241881616,MTMR3/MTMR6/MTM1
MF,GO:0019887,protein kinase regulator activity,2.3596000000000004,12,0.0052057161118355426,0.21014940241881616,ALS2/TAB1/PRKAG2/CCND3/PRKAR2A/PIK3CA/CDKN1A/TAOK3/CDK4/CCNB3/DUS2/CSNK2B
BP,GO:0031098,stress-activated protein kinase signaling cascade,2.0071460190982102,17,0.005298588639122997,0.21050188255573207,MAP4K5/ZMYND11/TAB1/COPS5/RAP2A/SH2D3A/KLHDC10/STK26/TAOK3/MAP3K7/DUSP10/PAK1/BTRC/MAP4K2/TNIP2/CARD9/PTPN1
BP,GO:0120193,tight junction organization,3.7191235059760954,6,0.005379761318731311,0.21050188255573207,TGFBR1/MARVELD2/CLDN1/CLDN3/MYO1C/CLDN9
BP,GO:0007254,JNK cascade,2.25928063447146,13,0.005381562385888923,0.21050188255573207,MAP4K5/ZMYND11/TAB1/COPS5/RAP2A/SH2D3A/TAOK3/MAP3K7/DUSP10/PAK1/MAP4K2/CARD9/PTPN1
BP,GO:0051650,establishment of vesicle localization,2.051930210193708,16,0.0054661382597316595,0.21177381371988943,STARD3NL/WDR11/VAMP7/KIF13A/FNBP1L/SNAPIN/CLASP2/ADCY1/CDK5/MAP4K2/FAM91A1/MCFD2/BLOC1S5/MYO5A/MYO1C/PDCD6
BP,GO:0090174,organelle membrane fusion,2.9752988047808766,8,0.005546238953360815,0.21285000058746978,RAB7A/EEA1/ANKRD27/VAMP4/STX12/VAMP7/VPS4A/SNAPIN
BP,GO:0033169,histone H3-K9 demethylation,7.969550369948776,3,0.005638374741653504,0.21436363036492012,KDM7A/KDM3A/PHF8
CC,GO:0005774,vacuolar membrane,1.873064427260464,20,0.005668327519482061,0.11213160943637418,STARD3NL/CTNS/AP5M1/VMP1/RAB7A/WDR11/SLC36A1/VAMP7/VPS4A/SBF2/SNX14/CD164/SNAPIN/WDFY3/DTX3L/GABARAP/GBA/ATG9B/GLMP/TMEM199
MF,GO:0004721,phosphoprotein phosphatase activity,2.3336703296703294,12,0.005676738041592147,0.21014940241881616,PHLPP2/TAB1/MTMR3/PTPMT1/PTPRB/MTMR6/SSH2/DUSP10/PTPN14/MTM1/PPP1CC/PTPN1
MF,GO:0003899,DNA-directed 5'-3' RNA polymerase activity,4.316341463414634,5,0.005716762610437221,0.21014940241881616,CD3EAP/POLR3F/MED21/POLR2J3/POLR3C
MF,GO:0030371,translation repressor activity,5.445230769230769,4,0.005745091576917276,0.21014940241881616,SAMD4A/CIRBP/PAIP2/CELF1
MF,GO:0019207,kinase regulator activity,2.2228115942028985,13,0.006111515059743778,0.2123751483260963,ALS2/TAB1/PRKAG2/CCND3/PRKAR2A/PIK3CA/CDKN1A/TAOK3/CDK4/BCL10/CCNB3/DUS2/CSNK2B
CC,GO:0000932,P-body,3.2154272667971298,7,0.006128631256169513,0.11213160943637418,SAMD4A/RC3H2/AGO4/CARHSP1/MEX3B/PNRC2/CNOT7
CC,GO:0017053,transcriptional repressor complex,3.2154272667971298,7,0.006128631256169513,0.11213160943637418,CBX5/RBBP7/CORO2A/RBBP4/RBPJ/TBL1XR1/C1D
CC,GO:0031083,BLOC-1 complex,7.717025440313112,3,0.006241490736381672,0.11213160943637418,STX12/SNAPIN/BLOC1S5
BP,GO:0007080,mitotic metaphase plate congression,4.226276711336473,5,0.006306757836800962,0.23755454518616956,VPS4A/BOD1/HNRNPU/NUP62/CHMP1B
MF,GO:0052866,phosphatidylinositol phosphate phosphatase activity,5.243555555555556,4,0.006596184395430139,0.2183022930868546,MTMR3/PTPMT1/MTMR6/MTM1
BP,GO:0031929,TOR signaling,2.677768924302789,9,0.006675252089727356,0.24912775689000813,SESN1/MAPKAP1/PIK3CA/PRKAA2/RHEBL1/MTM1/GBA/CARD11/PDCD6
CC,GO:0055029,nuclear DNA-directed RNA polymerase complex,2.884869323481537,8,0.006696407350527808,0.11629427432083293,GTF2H1/TBP/CD3EAP/POLR3F/RTF1/POLR2J3/TADA3/POLR3C
BP,GO:0019471,4-hydroxyproline metabolic process,7.438247011952191,3,0.006908769247411939,0.25093636873635505,EGLN3/ALDH4A1/P4HB
BP,GO:0042559,pteridine-containing compound biosynthetic process,7.438247011952191,3,0.006908769247411939,0.25093636873635505,MTHFD1L/QDPR/PCBD1
BP,GO:1903543,positive regulation of exosomal secretion,7.438247011952191,3,0.006908769247411939,0.25093636873635505,RAB7A/SDC1/VPS4A
BP,GO:0006892,post-Golgi vesicle-mediated transport,2.8608642353662272,8,0.0069994845396715915,0.25119832130146863,KIF16B/ARFRP1/EXOC2/VAMP7/MYO1B/RBSN/KIF13A/MYO5A
BP,GO:0090068,positive regulation of cell cycle process,1.9968448354234067,16,0.007039480980424638,0.25119832130146863,PKN2/BAX/CCND3/CNOT6/CDKN1A/INO80/CDK4/HNRNPU/CNOT11/CRADD/TRIAP1/CRLF3/PIDD1/CNOT10/CNOT7/NUP62
CC,GO:0000428,DNA-directed RNA polymerase complex,2.858157570486337,8,0.0070730683759475865,0.1188731814151191,GTF2H1/TBP/CD3EAP/POLR3F/RTF1/POLR2J3/TADA3/POLR3C
BP,GO:0006368,transcription elongation from RNA polymerase II promoter,3.099269588313413,7,0.007434439158353003,0.26121639131147595,ZMYND11/ELL/GTF2H1/RTF1/EAF1/HNRNPU/RNF168
BP,GO:1901991,negative regulation of mitotic cell cycle phase transition,2.0995052049865057,14,0.007448648326482598,0.26121639131147595,BAX/CDK6/CNOT6/CDKN1A/VPS4A/TAOK3/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
MF,GO:0016645,"oxidoreductase activity, acting on the CH-NH group of donors",5.056285714285714,4,0.007526787200935661,0.23021393498228662,MTHFD1L/ALDH1L1/QDPR/ALDH4A1
CC,GO:0016607,nuclear speck,1.8466433673293337,19,0.007980500811136474,0.1299325288313157,SPRTN/PPIE/TAB1/ELL/C12orf57/HP1BP3/MBD4/PNISR/BMP2K/DUSP10/EAF1/CCNB3/CWC15/HNRNPU/PRKAA2/RCHY1/INPPL1/PPP1CC/CNOT7
CC,GO:0005884,actin filament,2.7809100685813015,8,0.008299294818417962,0.13102826061805328,PLS3/MYO1B/PAK1/TPM4/YES1/ACTG1/MYO5A/MYO1C
BP,GO:0035372,protein localization to microtubule,6.973356573705179,3,0.008335399516460241,0.2814625589830805,MAPRE1/DIAPH1/HNRNPU
BP,GO:0048012,hepatocyte growth factor receptor signaling pathway,6.973356573705179,3,0.008335399516460241,0.2814625589830805,MET/PAK1/PTPN1
BP,GO:1903541,regulation of exosomal secretion,6.973356573705179,3,0.008335399516460241,0.2814625589830805,RAB7A/SDC1/VPS4A
BP,GO:1903580,positive regulation of ATP metabolic process,3.9565143680596764,5,0.008343194241289856,0.2814625589830805,ISCU/ARNT/PRKAA2/NUPR1/ENTPD5
BP,GO:0034404,nucleobase-containing small molecule biosynthetic process,2.1393188308712054,13,0.00837191977309556,0.2814625589830805,PDE8A/PGM1/PRKAG2/MBD4/NUDT15/ARNT/CMPK1/PRKAA2/TK2/NUPR1/PDE4B/ENTPD5/NUP62
MF,GO:0016706,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors",3.932666666666667,5,0.008502114651253452,0.23021393498228662,KDM7A/EGLN3/PHF8/P4HB/ASPH
MF,GO:0034062,5'-3' RNA polymerase activity,3.932666666666667,5,0.008502114651253452,0.23021393498228662,CD3EAP/POLR3F/MED21/POLR2J3/POLR3C
MF,GO:0097747,RNA polymerase activity,3.932666666666667,5,0.008502114651253452,0.23021393498228662,CD3EAP/POLR3F/MED21/POLR2J3/POLR3C
MF,GO:0016758,"transferase activity, transferring hexosyl groups",2.1301944444444443,13,0.008612319869840939,0.23021393498228662,B4GALT7/PIGB/PYGL/HAS3/DPM2/GALNT1/MGAT4B/WDFY3/RFNG/FUT1/GBA/OSTC/B3GNT9
CC,GO:0030880,RNA polymerase complex,2.7560805143975395,8,0.008741453646882735,0.13394992205958545,GTF2H1/TBP/CD3EAP/POLR3F/RTF1/POLR2J3/TADA3/POLR3C
BP,GO:0051648,vesicle localization,1.9446397416868473,16,0.008958403402579015,0.29871135280074945,STARD3NL/WDR11/VAMP7/KIF13A/FNBP1L/SNAPIN/CLASP2/ADCY1/CDK5/MAP4K2/FAM91A1/MCFD2/BLOC1S5/MYO5A/MYO1C/PDCD6
BP,GO:0043506,regulation of JUN kinase activity,2.9583936979355308,7,0.009514272692681286,0.3121295267244151,MAP4K5/TAOK3/MAP3K7/DUSP10/PAK1/MAP4K2/PTPN1
BP,GO:1900407,regulation of cellular response to oxidative stress,2.9583936979355308,7,0.009514272692681286,0.3121295267244151,PDE8A/MET/LANCL1/MAPKAP1/STK26/MCL1/P4HB
MF,GO:0050700,CARD domain binding,6.636375,3,0.009543029245789857,0.23687161877942683,BCL10/CARD9/CARD11
MF,GO:0070402,NADPH binding,6.636375,3,0.009543029245789857,0.23687161877942683,LBR/QDPR/DUS2
BP,GO:0045216,cell-cell junction organization,2.3840535294718563,10,0.009660320148904084,0.31438545892593445,PKN2/CDH20/TGFBR1/GNPAT/MARVELD2/CLDN1/CLDN3/PKP3/MYO1C/CLDN9
BP,GO:0016254,preassembly of GPI anchor in ER membrane,6.56315912819311,3,0.009922219503568143,0.31524767597835973,PIGB/DPM2/PIGN
BP,GO:0018904,ether metabolic process,6.56315912819311,3,0.009922219503568143,0.31524767597835973,AGPS/EPHX3/GNPAT
BP,GO:0048535,lymph node development,6.56315912819311,3,0.009922219503568143,0.31524767597835973,RC3H2/IL7R/TOX
BP,GO:0006402,mRNA catabolic process,1.8391270084497178,18,0.00999679208485949,0.31524767597835973,SAMD4A/SMG6/CIRBP/CNOT6/LSM7/AGO4/DHX34/NBAS/CARHSP1/HNRNPU/CNOT11/HNRNPA0/ZHX2/CNOT10/PKP3/YTHDF3/PNRC2/CNOT7
CC,GO:0045178,basal part of cell,3.7828556079966233,5,0.010107513927022766,0.14789173318628346,ITGA6/MET/DOCK7/CLASP2/MYO1C
CC,GO:0005769,early endosome,1.874134749790327,17,0.010219006515750874,0.14789173318628346,ALS2/SNX1/KIF16B/EEA1/EHD4/ANKRD27/SNX4/STX12/MYO1B/RBSN/VPS4A/APPL2/PSEN2/DIAPH2/DTX3L/PTPN1/MYO5A
BP,GO:0009166,nucleotide catabolic process,2.247821899216322,11,0.010388041461575601,0.3250657897360734,PDE8A/PGM1/PRKAG2/MBD4/NUDT15/ARNT/PRKAA2/NUPR1/PDE4B/ENTPD5/NUP62
BP,GO:0043467,regulation of generation of precursor metabolites and energy,2.3538756366937315,10,0.010509734526775248,0.3263633591978756,PRKAG2/PIK3CA/ISCU/ARNT/PRKAA2/NUPR1/DNAJC30/EPM2AIP1/ENTPD5/NUP62
CC,GO:0000922,spindle pole,2.3527516586320463,10,0.010587895292794218,0.14908901209583209,NUBP2/CEP128/STAG2/CEP85/VPS4A/DCTN4/MAPKBP1/BOD1/HNRNPU/NUP62
MF,GO:0017016,Ras GTPase binding,1.7325734265734267,21,0.010737415123553314,0.2573277072713639,ALS2/PKN2/TBC1D22B/KIF16B/ANKRD27/EXOC2/DOCK7/MAPKAP1/YIPF2/RBSN/DIAPH1/WDR44/SBF2/DIAPH2/PAK1/RIN1/DENND6A/RCC1/MYO5A/MYO1C/CYFIP1
BP,GO:0033059,cellular pigmentation,3.7191235059760954,5,0.010794999688608071,0.3326822631307396,ANKRD27/KIF13A/SNAPIN/BLOC1S5/MYO5A
BP,GO:0009896,positive regulation of catabolic process,1.758450830248745,20,0.010902723543039625,0.33347578476003903,SNX1/NEDD4/CHFR/RAB7A/SESN1/BAX/EDEM1/MAP3K7/ARNT/PIP4K2A/PRKAA2/RCHY1/DTX3L/RNF180/NUPR1/GBA/YTHDF3/ENTPD5/PTPN1/CNOT7
BP,GO:0048814,regulation of dendrite morphogenesis,2.8608642353662272,7,0.011332067700645595,0.3440212791509424,SS18L2/NEDD4/ANKRD27/VAMP7/RAP2A/CDK5/NSMF
BP,GO:0046328,regulation of JNK cascade,2.211370733283084,11,0.011643487671930687,0.35085709518084474,MAP4K5/ZMYND11/COPS5/RAP2A/TAOK3/MAP3K7/DUSP10/PAK1/MAP4K2/CARD9/PTPN1
MF,GO:0047485,protein N-terminus binding,2.597724770642202,8,0.012133361230530241,0.2810895351739506,CSNK2A2/EXOC2/DCTN4/ERCC5/RBPJ/BANF1/TBL1XR1/PPP1CC
BP,GO:0042558,pteridine-containing compound metabolic process,4.375439418795406,4,0.012650510212272625,0.3758265352005505,MTHFD1L/ALDH1L1/QDPR/PCBD1
BP,GO:0006903,vesicle targeting,2.799340273315341,7,0.01267579104373191,0.3758265352005505,STARD3NL/WDR11/CLASP2/MAP4K2/FAM91A1/MCFD2/PDCD6
BP,GO:0051169,nuclear transport,1.8273150173870987,17,0.012814038714791016,0.3758265352005505,NEDD4/SMG6/THOC5/HTATIP2/CDKN1A/XPO4/APPL2/WDR33/MBTPS1/PTPN14/CDK5/AGFG1/BANF1/PPP1CC/APOD/KPNA5/NUP62
BP,GO:0002532,production of molecular mediator involved in inflammatory response,3.099269588313413,6,0.012841663813391475,0.3758265352005505,SNX4/ADCY7/VAMP7/APPL2/DUSP10/APOD
BP,GO:1901292,nucleoside phosphate catabolic process,2.176082902432822,11,0.01301159192565769,0.37807968538268205,PDE8A/PGM1/PRKAG2/MBD4/NUDT15/ARNT/PRKAA2/NUPR1/PDE4B/ENTPD5/NUP62
BP,GO:0003159,morphogenesis of an endothelium,5.872300272593836,3,0.013588897902043933,0.37986307461876656,STARD13/RBPJ/CSNK2B
BP,GO:0034063,stress granule assembly,5.872300272593836,3,0.013588897902043933,0.37986307461876656,CIRBP/G3BP2/PRKAA2
BP,GO:0034312,diol biosynthetic process,5.872300272593836,3,0.013588897902043933,0.37986307461876656,QDPR/PCBD1/GBA
BP,GO:0035493,SNARE complex assembly,5.872300272593836,3,0.013588897902043933,0.37986307461876656,ANKRD27/VAMP4/VAMP7
BP,GO:0061154,endothelial tube morphogenesis,5.872300272593836,3,0.013588897902043933,0.37986307461876656,STARD13/RBPJ/CSNK2B
BP,GO:1901988,negative regulation of cell cycle phase transition,1.950102212871361,14,0.01363323719133233,0.37986307461876656,BAX/CDK6/CNOT6/CDKN1A/VPS4A/TAOK3/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
BP,GO:2000785,regulation of autophagosome assembly,4.250426863972681,4,0.013986492347767186,0.3857713705885452,MTMR3/PIP4K2A/MTM1/NUPR1
BP,GO:0018209,peptidyl-serine modification,1.8480116799881219,16,0.01403494661924894,0.3857713705885452,PKN2/CSNK2A2/MAST2/BAX/MKNK2/DYRK1B/TGFBR1/DOCK7/MAPKAP1/PIK3CA/SH2D3A/GALNT1/PAK1/RPS6KA4/PRKAA2/CDK5
CC,GO:0031082,BLOC complex,5.787769080234833,3,0.014209885321169057,0.18982949364946355,STX12/SNAPIN/BLOC1S5
CC,GO:0044232,organelle membrane contact site,5.787769080234833,3,0.014209885321169057,0.18982949364946355,STARD3NL/PDZD8/TOMM20
BP,GO:0070085,glycosylation,1.9356033116604214,14,0.014464649129875506,0.39103334734368983,B4GALT7/PIGB/DPM2/GALNT1/ST6GALNAC6/MGAT4B/RFNG/FUT1/GBA/MCFD2/POMK/ENTPD5/OSTC/B3GNT9
BP,GO:0043507,positive regulation of JUN kinase activity,3.0155055453860236,6,0.01456381177764535,0.39103334734368983,MAP4K5/TAOK3/MAP3K7/PAK1/MAP4K2/PTPN1
BP,GO:1900076,regulation of cellular response to insulin stimulus,3.0155055453860236,6,0.01456381177764535,0.39103334734368983,CCND3/CDK4/APPL2/PAK1/PTPN1/MYO1C
BP,GO:2001169,regulation of ATP biosynthetic process,2.7118608897742362,7,0.014900915361188682,0.39103334734368983,PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
MF,GO:0031267,small GTPase binding,1.677819413092551,21,0.014940776921713587,0.32630335426875995,ALS2/PKN2/TBC1D22B/KIF16B/ANKRD27/EXOC2/DOCK7/MAPKAP1/YIPF2/RBSN/DIAPH1/WDR44/SBF2/DIAPH2/PAK1/RIN1/DENND6A/RCC1/MYO5A/MYO1C/CYFIP1
CC,GO:0030496,midbody,2.230354173500899,10,0.014964825337418093,0.19032761766676937,PKN2/EXOC2/RAP2A/VPS4A/KIF13A/HNRNPU/PPP1CC/KLHL9/NUP62/CHMP1B
CC,GO:0031463,Cul3-RING ubiquitin ligase complex,4.1713651028719525,4,0.014977797167634442,0.19032761766676937,KLHL42/KLHL2/KLHL9/PDCD6
MF,GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",2.2260377358490566,10,0.015024039333237869,0.32630335426875995,CYP26B1/KDM7A/EGLN3/DOHH/MICAL2/PCBD1/PHF8/P4HB/AKR1C3/ASPH
BP,GO:0032886,regulation of microtubule-based process,2.0472239482437224,12,0.015211087912776748,0.39103334734368983,KLHL42/MAPRE1/STAG2/MET/CEP85/DIAPH1/PAK1/HNRNPU/PRKAA2/CLASP2/NUP62/CHMP1B
BP,GO:0003091,renal water homeostasis,4.13235945108455,4,0.01540867302207173,0.39103334734368983,PRKAR2A/ADCY7/ADCY9/ADCY1
BP,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,4.13235945108455,4,0.01540867302207173,0.39103334734368983,NEDD4/ARNT/PTPN1/PDCD6
BP,GO:0090313,regulation of protein targeting to membrane,4.13235945108455,4,0.01540867302207173,0.39103334734368983,VAMP7/PAK1/CDK5/MYO1C
BP,GO:0010256,endomembrane system organization,1.6982299114046098,20,0.015421610605204193,0.39103334734368983,ALS2/VMP1/RAB7A/PLA2G3/MOSPD3/TMED5/VAMP4/ARL1/RBSN/VPS4A/TJAP1/FNBP1L/TRAPPC8/ZFYVE27/CLASP2/TRAPPC12/AGFG1/BANF1/MYO18A/CHMP1B
BP,GO:0051303,establishment of chromosome localization,2.9752988047808766,6,0.015482385977426077,0.39103334734368983,VPS4A/BOD1/HNRNPU/TRAPPC12/NUP62/CHMP1B
BP,GO:1903201,regulation of oxidative stress-induced cell death,2.9752988047808766,6,0.015482385977426077,0.39103334734368983,PDE8A/MET/LANCL1/STK26/MCL1/P4HB
BP,GO:0050657,nucleic acid transport,2.119707697706583,11,0.01555846120246726,0.39103334734368983,SMG6/THOC5/TERF2/WDR33/G3BP2/HNRNPU/EIF5A2/TOMM20/AGFG1/MYO1C/NUP62
BP,GO:0050658,RNA transport,2.119707697706583,11,0.01555846120246726,0.39103334734368983,SMG6/THOC5/TERF2/WDR33/G3BP2/HNRNPU/EIF5A2/TOMM20/AGFG1/MYO1C/NUP62
BP,GO:0031936,negative regulation of chromatin silencing,5.578685258964144,3,0.01567344412164403,0.39103334734368983,ASF1A/ATAD2B/PHF8
BP,GO:1901673,regulation of mitotic spindle assembly,5.578685258964144,3,0.01567344412164403,0.39103334734368983,STAG2/HNRNPU/CHMP1B
CC,GO:0031901,early endosome membrane,2.330645267208658,9,0.01576421050773535,0.19555127796500282,SNX1/KIF16B/EEA1/EHD4/SNX4/STX12/RBSN/APPL2/DTX3L
BP,GO:0018105,peptidyl-serine phosphorylation,1.865781023064931,15,0.01576437290176134,0.39103334734368983,PKN2/CSNK2A2/MAST2/BAX/MKNK2/DYRK1B/TGFBR1/DOCK7/MAPKAP1/PIK3CA/SH2D3A/PAK1/RPS6KA4/PRKAA2/CDK5
MF,GO:0016779,nucleotidyltransferase activity,2.325153284671533,9,0.015855267381521085,0.3339215403077926,PAPOLA/UAP1/CD3EAP/TERF2/POLR3F/MED21/CDS1/POLR2J3/POLR3C
BP,GO:0046390,ribose phosphate biosynthetic process,1.859561752988048,15,0.01620013428834644,0.39940694718177766,PGM1/PYGL/PRKAG2/ADCY7/RFK/MPC2/ARNT/ADCY9/CMPK1/PRKAA2/ADCY1/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0050000,chromosome localization,2.936150136296918,6,0.01644032058591326,0.40248647571179574,VPS4A/BOD1/HNRNPU/TRAPPC12/NUP62/CHMP1B
BP,GO:0001824,blastocyst development,2.6565167899829256,7,0.016530682101884155,0.40248647571179574,TGFBR1/RTF1/CMTM3/MED21/GABPA/SMIM14/TBL1XR1
BP,GO:1901653,cellular response to peptide,1.738810989807006,18,0.016869826570558216,0.40248647571179574,CCND3/PRKAR2A/ADCY7/PIK3CA/LPIN3/CDK4/APPL2/CAPN10/PAK1/ADCY9/ADCY1/CDK5/KLF11/LDOC1/PTPN1/MYO5A/MYO1C/CYFIP1
BP,GO:0006623,protein targeting to vacuole,4.020674060514698,4,0.016918679288770173,0.40248647571179574,NEDD4/RAB7A/VAMP7/VPS4A
BP,GO:0046839,phospholipid dephosphorylation,4.020674060514698,4,0.016918679288770173,0.40248647571179574,MTMR3/MTMR6/INPPL1/MTM1
BP,GO:0060236,regulation of mitotic spindle organization,4.020674060514698,4,0.016918679288770173,0.40248647571179574,STAG2/HNRNPU/NUP62/CHMP1B
CC,GO:0000118,histone deacetylase complex,3.3263040691004786,5,0.017029740377206955,0.20633708689592614,CBX5/RBBP7/SUDS3/RBBP4/TBL1XR1
MF,GO:0042578,phosphoric ester hydrolase activity,1.7359455040871934,18,0.017049654212250423,0.3485149905151189,PHLPP2/PDE8A/TAB1/MTMR3/IMPAD1/PTPMT1/PRKAR2A/PLCD4/PTPRB/LPIN3/MTMR6/SSH2/DUSP10/PTPN14/MTM1/PDE4B/PPP1CC/PTPN1
BP,GO:0051236,establishment of RNA localization,2.087263192129442,11,0.01725636555069211,0.4067956822094706,SMG6/THOC5/TERF2/WDR33/G3BP2/HNRNPU/EIF5A2/TOMM20/AGFG1/MYO1C/NUP62
BP,GO:1903578,regulation of ATP metabolic process,2.4387695121154724,8,0.017299816377148086,0.4067956822094706,PRKAG2/ISCU/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.8980183163450097,6,0.017438362693525222,0.4076968933175897,SAMD4A/CNOT6/LSM7/CNOT11/CNOT10/CNOT7
BP,GO:1901990,regulation of mitotic cell cycle phase transition,1.6752808585477907,20,0.01759649991562835,0.4090432094672921,BAX/MAPRE1/CDK6/CCND3/CNOT6/CDKN1A/INO80/VPS4A/TAOK3/CDK4/CCNB3/CNOT11/PRMT2/BTRC/CRADD/TRIAP1/CDC26/PIDD1/CNOT10/CNOT7
MF,GO:0001091,RNA polymerase II basal transcription factor binding,5.3091,3,0.017872908965989108,0.3499598084665092,TBP/ZNHIT6/HNRNPU
CC,GO:0005798,Golgi-associated vesicle,2.1677037753688513,10,0.017914774395011563,0.21097575372674007,DDHD2/SPG21/COPE/TMED5/STK26/ITM2B/TEX261/MCFD2/TMEM199/PDCD6
BP,GO:0006622,protein targeting to lysosome,5.313033579965851,3,0.0179276352704055,0.4116460959222358,NEDD4/RAB7A/VPS4A
BP,GO:1900016,negative regulation of cytokine production involved in inflammatory response,5.313033579965851,3,0.0179276352704055,0.4116460959222358,ADCY7/APPL2/APOD
CC,GO:0005876,spindle microtubule,3.2699260340309793,5,0.018222473930332637,0.21097575372674007,CAPN6/MAPRE1/BOD1/HNRNPU/CLASP2
BP,GO:0045981,positive regulation of nucleotide metabolic process,3.2623890403299085,5,0.01832680733469709,0.4116460959222358,ISCU/ARNT/PRKAA2/NUPR1/ENTPD5
BP,GO:1900544,positive regulation of purine nucleotide metabolic process,3.2623890403299085,5,0.01832680733469709,0.4116460959222358,ISCU/ARNT/PRKAA2/NUPR1/ENTPD5
BP,GO:0006487,protein N-linked glycosylation,2.8608642353662272,6,0.018477239882709207,0.4116460959222358,B4GALT7/DPM2/MGAT4B/MCFD2/ENTPD5/OSTC
BP,GO:0006656,phosphatidylcholine biosynthetic process,3.91486684839589,4,0.018518002840159573,0.4116460959222358,CSNK2A2/LPIN3/CDS1/CSNK2B
BP,GO:0045022,early endosome to late endosome transport,3.91486684839589,4,0.018518002840159573,0.4116460959222358,RAB7A/KIF16B/EEA1/ANKRD27
BP,GO:0097352,autophagosome maturation,3.91486684839589,4,0.018518002840159573,0.4116460959222358,SNX14/SNAPIN/GABARAP/LIX1L
BP,GO:0031331,positive regulation of cellular catabolic process,1.7513878005981613,17,0.01865228491806503,0.41218117026701895,CHFR/SESN1/BAX/EDEM1/MAP3K7/ARNT/PIP4K2A/PRKAA2/RCHY1/DTX3L/RNF180/NUPR1/GBA/YTHDF3/ENTPD5/PTPN1/CNOT7
BP,GO:0051592,response to calcium ion,2.2616291590395177,9,0.01874471890349029,0.41218117026701895,RASGRP2/NEDD4/SDC1/ANXA7/PRKAA2/ADCY1/AKR1C3/ENTPD6/PDCD6
BP,GO:0007043,cell-cell junction assembly,2.399434519984578,8,0.018894440681876585,0.4132397026552363,PKN2/CDH20/GNPAT/MARVELD2/CLDN1/CLDN3/PKP3/MYO1C
MF,GO:0019208,phosphatase regulator activity,2.5808125000000004,7,0.019005913960936306,0.3499598084665092,SBF2/BMP2K/BOD1/MTMR12/FRS2/PPP1R14A/PPP1R14C
BP,GO:0009314,response to radiation,1.6603229937393285,20,0.019174673663766375,0.415582185113694,SPRTN/CTNS/USP28/NEDD4/DDHD2/BAX/CIRBP/NDRG4/CDKN1A/INO80/MBD4/ERCC5/INIP/NMT2/CDS1/RNF168/CDK5/SCARA3/TRIAP1/PPP1CC
BP,GO:1990542,mitochondrial transmembrane transport,2.577610350676502,7,0.019205863028853114,0.415582185113694,PRKAG2/MPC2/PSEN2/PRKAA2/TOMM20/UCP2/DNAJC30
BP,GO:0006110,regulation of glycolytic process,2.824650764032478,6,0.0195576594224192,0.41873978173895426,PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:1903312,negative regulation of mRNA metabolic process,2.824650764032478,6,0.0195576594224192,0.41873978173895426,CIRBP/DHX34/NBAS/HNRNPU/HNRNPA0/PKP3
BP,GO:0030522,intracellular receptor signaling pathway,1.8595617529880477,14,0.019755715971321617,0.4207657202687766,CYP26B1/NEDD4/TAB1/VDR/KDM3A/SAFB2/MAP3K7/ARNT/ASXL2/PAK1/PRMT2/TADA3/AKR1C3/ZCCHC3
BP,GO:0007289,spermatid nucleus differentiation,5.071532053603767,3,0.020352444153484958,0.42241705518559597,KDM3A/PYGO2/AGFG1
BP,GO:0009190,cyclic nucleotide biosynthetic process,5.071532053603767,3,0.020352444153484958,0.42241705518559597,ADCY7/ADCY9/ADCY1
BP,GO:0034311,diol metabolic process,5.071532053603767,3,0.020352444153484958,0.42241705518559597,QDPR/PCBD1/GBA
BP,GO:0042094,interleukin-2 biosynthetic process,5.071532053603767,3,0.020352444153484958,0.42241705518559597,CARD9/IL1RAP/CARD11
BP,GO:0052652,cyclic purine nucleotide metabolic process,5.071532053603767,3,0.020352444153484958,0.42241705518559597,ADCY7/ADCY9/ADCY1
MF,GO:0070530,K63-linked polyubiquitin modification-dependent protein binding,5.056285714285715,3,0.020423257833453733,0.3499598084665092,SPRTN/RNF168/TNIP2
MF,GO:0070063,RNA polymerase binding,2.794263157894737,6,0.02043256890899607,0.3499598084665092,PKN2/NEDD4/ERCC5/RTF1/HNRNPU/SPTY2D1
BP,GO:0002088,lens development in camera-type eye,2.789342629482072,6,0.020680307502726238,0.42704310112228594,CTNS/TGFBR1/CDK4/PYGO2/FRS2/NHS
BP,GO:0032386,regulation of intracellular transport,1.6705282887363078,19,0.020863326330094342,0.4286465227819383,NEDD4/CSNK2A2/NDRG4/SNX4/VAMP7/XPO4/EDEM1/CAPN10/SNAPIN/PAK1/PTPN14/ADCY1/CDK5/DNAJC30/PPP1CC/APOD/PTPN1/MYO1C/NUP62
BP,GO:0044264,cellular polysaccharide metabolic process,2.527559664255599,7,0.021149149134671363,0.43233537025046787,PGM1/PYGL/HAS3/PRKAG2/EPM2AIP1/PPP1CC/B3GNT9
MF,GO:0003779,actin binding,1.642412993039443,20,0.02116407208921527,0.3499598084665092,TRPM7/PLS3/CORO2A/KLHL2/CAPZA1/MYO1B/INO80/DIAPH1/MICAL2/SSH2/DIAPH2/HNRNPU/INPPL1/TPM4/MARCKSL1/MYO18A/MYO5A/PARVA/MYO1C/CYFIP1
MF,GO:0140030,modification-dependent protein binding,2.212125,9,0.021221993824416335,0.3499598084665092,KDM7A/SPRTN/ZMYND11/CBX5/ING4/ATAD2B/RNF168/TNIP2/PHF8
BP,GO:0016579,protein deubiquitination,1.8398490842284572,14,0.02142502302075993,0.435784968242257,USP28/TAB1/USP31/TGFBR1/USP46/SUDS3/COPS5/INO80/MAP3K7/ASXL2/TNIP2/OTUD3/TADA3/TOMM20
BP,GO:0016570,histone modification,1.638380399108412,20,0.021745574355715332,0.43765350889595295,KDM7A/ING4/SUDS3/KANSL3/KDM3A/MAP3K7/RTF1/PADI3/PRMT2/RPS6KA4/PRKAA2/PYGO2/RYBP/DTX3L/RNF168/CDK5/TADA3/PHF8/TBL1XR1/LDB1
MF,GO:0016791,phosphatase activity,1.8352444444444445,14,0.021749357958938523,0.3499598084665092,PHLPP2/TAB1/MTMR3/IMPAD1/PTPMT1/PTPRB/LPIN3/MTMR6/SSH2/DUSP10/PTPN14/MTM1/PPP1CC/PTPN1
BP,GO:0030811,regulation of nucleotide catabolic process,2.7549063007230337,6,0.021845848509866976,0.43765350889595295,PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0006403,RNA localization,1.940412263987528,12,0.022141097850098934,0.43765350889595295,SMG6/THOC5/ZNHIT6/TERF2/WDR33/G3BP2/HNRNPU/EIF5A2/TOMM20/AGFG1/MYO1C/NUP62
BP,GO:0046822,regulation of nucleocytoplasmic transport,2.503256205945449,7,0.02217025895080533,0.43765350889595295,NEDD4/XPO4/PTPN14/CDK5/PPP1CC/APOD/NUP62
CC,GO:0031227,intrinsic component of endoplasmic reticulum membrane,2.19788699249424,9,0.02218230891206167,0.2512387596344376,SEC62/EDEM1/DPM2/TEX261/ZFYVE27/SGMS2/RNF180/TAPT1/FITM2
BP,GO:0006401,RNA catabolic process,1.6862524712234188,18,0.02219050167688385,0.43765350889595295,SAMD4A/SMG6/CIRBP/CNOT6/LSM7/AGO4/DHX34/NBAS/CARHSP1/HNRNPU/CNOT11/HNRNPA0/ZHX2/CNOT10/PKP3/YTHDF3/PNRC2/CNOT7
MF,GO:0035091,phosphatidylinositol binding,1.8780489795918367,13,0.022385296554290772,0.3499598084665092,SNX1/SNX24/KIF16B/EEA1/PLEKHA1/SNX4/MAPKAP1/MYO1B/SBF2/SNX14/APPL2/WDFY3/MTM1
CC,GO:0036464,cytoplasmic ribonucleoprotein granule,2.0020584868736844,11,0.022775553928694892,0.2524694382308519,SAMD4A/RC3H2/CIRBP/AGO4/G3BP2/CARHSP1/HNRNPU/PRKAA2/MEX3B/PNRC2/CNOT7
BP,GO:1903320,regulation of protein modification by small protein conjugation or removal,1.9320122108966729,12,0.022809116538652873,0.43765350889595295,SPRTN/CHFR/TGFBR1/HMG20A/BCL10/ARNT/RCHY1/DTX3L/RNF180/CDK5/TRIM44/PDCD6
BP,GO:0006359,regulation of transcription by RNA polymerase III,4.851030659968821,3,0.022948360179917266,0.43765350889595295,ELL/POLR3F/POLR3C
BP,GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,4.851030659968821,3,0.022948360179917266,0.43765350889595295,CLDN1/CLDN3/CLDN9
BP,GO:0035561,regulation of chromatin binding,4.851030659968821,3,0.022948360179917266,0.43765350889595295,HMBOX1/PYGO2/DTX3L
BP,GO:0045821,positive regulation of glycolytic process,4.851030659968821,3,0.022948360179917266,0.43765350889595295,ARNT/PRKAA2/ENTPD5
BP,GO:0061436,establishment of skin barrier,4.851030659968821,3,0.022948360179917266,0.43765350889595295,CYP26B1/MET/CLDN1
BP,GO:0034644,cellular response to UV,2.7213098824215334,6,0.023054924341936595,0.43765350889595295,USP28/NEDD4/BAX/CDKN1A/INO80/TRIAP1
MF,GO:0000146,microfilament motor activity,4.8264545454545456,3,0.023162807466848092,0.3499598084665092,MYO1B/MYO5A/MYO1C
MF,GO:0005158,insulin receptor binding,4.8264545454545456,3,0.023162807466848092,0.3499598084665092,SNX1/SNX4/PTPN1
MF,GO:0009975,cyclase activity,4.8264545454545456,3,0.023162807466848092,0.3499598084665092,ADCY7/ADCY9/ADCY1
MF,GO:0016849,phosphorus-oxygen lyase activity,4.8264545454545456,3,0.023162807466848092,0.3499598084665092,ADCY7/ADCY9/ADCY1
CC,GO:0031902,late endosome membrane,2.3035896836755554,8,0.023559474919512907,0.255279533375907,STARD3NL/AP5M1/RAB7A/VAMP7/YIPF2/VPS4A/SNX14/CHMP1B
BP,GO:0061025,membrane fusion,2.1735137372587574,9,0.023566182932707302,0.43765350889595295,RAB7A/EEA1/ANKRD27/VAMP4/STX12/VAMP7/VPS4A/ANXA7/SNAPIN
MF,GO:0016627,"oxidoreductase activity, acting on the CH-CH group of donors",3.051206896551724,5,0.023705424520097915,0.35053766045676704,DHDH/LBR/DUS2/AKR1C3/ACAD11
BP,GO:0006913,nucleocytoplasmic transport,1.7348681077439512,16,0.02381046421745416,0.43765350889595295,NEDD4/SMG6/THOC5/HTATIP2/CDKN1A/XPO4/APPL2/WDR33/MBTPS1/PTPN14/CDK5/AGFG1/PPP1CC/APOD/KPNA5/NUP62
BP,GO:0070317,negative regulation of G0 to G1 transition,3.6284131765620447,4,0.023864770028186738,0.43765350889595295,CBX5/RBBP7/RBBP4/RYBP
BP,GO:0090224,regulation of spindle organization,3.6284131765620447,4,0.023864770028186738,0.43765350889595295,STAG2/HNRNPU/NUP62/CHMP1B
BP,GO:0098927,vesicle-mediated transport between endosomal compartments,3.6284131765620447,4,0.023864770028186738,0.43765350889595295,RAB7A/KIF16B/EEA1/ANKRD27
BP,GO:0007040,lysosome organization,3.0484618901443405,5,0.023883532683052756,0.43765350889595295,RAB7A/MBTPS1/SNAPIN/GBA/TMEM199
BP,GO:0080171,lytic vacuole organization,3.0484618901443405,5,0.023883532683052756,0.43765350889595295,RAB7A/MBTPS1/SNAPIN/GBA/TMEM199
BP,GO:1903902,positive regulation of viral life cycle,3.0484618901443405,5,0.023883532683052756,0.43765350889595295,PKN2/PPIE/VPS4A/P4HB/CNOT7
CC,GO:0031301,integral component of organelle membrane,1.9833476598935564,11,0.02419795847111424,0.255279533375907,VAMP4/STX12/UBIAD1/VAMP7/ITM2B/MPC2/LBR/TEX261/SGMS2/RFNG/TOMM20
BP,GO:0046470,phosphatidylcholine metabolic process,2.688523016368262,6,0.02430815376534057,0.43765350889595295,CSNK2A2/LPCAT2/PLA2G3/LPIN3/CDS1/CSNK2B
BP,GO:0048145,regulation of fibroblast proliferation,2.688523016368262,6,0.02430815376534057,0.43765350889595295,B4GALT7/BAX/CDK6/CDKN1A/CDK4/NUPR1
BP,GO:0007052,mitotic spindle organization,2.456024956776667,7,0.024313826383788657,0.43765350889595295,STAG2/WRAP73/HNRNPU/CLASP2/RCC1/NUP62/CHMP1B
CC,GO:0000776,kinetochore,2.2865260563890697,8,0.024498995525518905,0.255279533375907,CBX5/DCTN4/PSEN2/BOD1/HNRNPU/CLASP2/TRAPPC12/PPP1CC
BP,GO:0009108,coenzyme biosynthetic process,1.852436995313764,13,0.024793326442281036,0.43765350889595295,PGM1/PRKAG2/MTHFD1L/UBIAD1/RFK/MPC2/ARNT/QDPR/PRKAA2/PCBD1/NUPR1/ENTPD5/NUP62
BP,GO:0032623,interleukin-2 production,2.9992931499807223,5,0.025424503848170396,0.43765350889595295,MAP3K7/PDE4B/CARD9/IL1RAP/CARD11
BP,GO:0051898,negative regulation of protein kinase B signaling,2.9992931499807223,5,0.025424503848170396,0.43765350889595295,PHLPP2/PLEKHA1/OTUD3/MTM1/PDCD6
BP,GO:0009124,nucleoside monophosphate biosynthetic process,1.9668441618142816,11,0.025451746885231698,0.43765350889595295,PGM1/PRKAG2/RFK/ARNT/CMPK1/PRKAA2/TK2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0048144,fibroblast proliferation,2.6565167899829256,6,0.02560613181203193,0.43765350889595295,B4GALT7/BAX/CDK6/CDKN1A/CDK4/NUPR1
BP,GO:0009110,vitamin biosynthetic process,4.6489043824701195,3,0.025715422756297387,0.43765350889595295,VDR/UBIAD1/RFK
BP,GO:0010288,response to lead ion,4.6489043824701195,3,0.025715422756297387,0.43765350889595295,CDK4/QDPR/CLDN1
BP,GO:0018126,protein hydroxylation,4.6489043824701195,3,0.025715422756297387,0.43765350889595295,EGLN3/P4HB/ASPH
BP,GO:1902410,mitotic cytokinetic process,4.6489043824701195,3,0.025715422756297387,0.43765350889595295,VPS4A/NUP62/CHMP1B
BP,GO:1903421,regulation of synaptic vesicle recycling,4.6489043824701195,3,0.025715422756297387,0.43765350889595295,VAMP4/CDK5/CYFIP1
BP,GO:0044088,regulation of vacuole organization,3.5420223866439007,4,0.025833586439399047,0.43765350889595295,MTMR3/PIP4K2A/MTM1/NUPR1
BP,GO:1901031,regulation of response to reactive oxygen species,3.5420223866439007,4,0.025833586439399047,0.43765350889595295,PDE8A/SESN1/MET/STK26
CC,GO:0090575,RNA polymerase II transcription factor complex,2.1304671460987117,9,0.02646453636767228,0.2658813007951064,GTF2H1/VDR/TBP/MED4/ARNT/HNRNPU/PYGO2/TADA3/LDB1
BP,GO:0061136,regulation of proteasomal protein catabolic process,2.0323079267628934,10,0.026516136917655326,0.43765350889595295,CHFR/EDEM1/NUDT15/RYBP/RCHY1/RNF180/BTRC/MTM1/NUPR1/GBA
CC,GO:0016459,myosin complex,2.968086707812735,5,0.026537097200279334,0.2658813007951064,MYO1B/MYL6B/MYO18A/MYO5A/MYO1C
BP,GO:0051225,spindle assembly,2.4105430131326546,7,0.02659559989978788,0.43765350889595295,MAPRE1/STAG2/WRAP73/INO80/HNRNPU/RCC1/CHMP1B
BP,GO:0031330,negative regulation of cellular catabolic process,1.8313865749124714,13,0.02688300537628311,0.43765350889595295,CSNK2A2/CIRBP/MET/PIK3CA/DHX34/MCL1/NBAS/HNRNPU/RYBP/MTM1/NUPR1/HNRNPA0/PKP3
MF,GO:0045182,translation regulator activity,2.9495,5,0.027002989073434843,0.38575253848923663,SAMD4A/CIRBP/PAIP2/CELF1/CYFIP1
BP,GO:0032872,regulation of stress-activated MAPK cascade,1.883100509354985,12,0.02713328421365305,0.43765350889595295,MAP4K5/ZMYND11/COPS5/RAP2A/KLHDC10/TAOK3/MAP3K7/DUSP10/PAK1/MAP4K2/CARD9/PTPN1
BP,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,1.883100509354985,12,0.02713328421365305,0.43765350889595295,ZMYND11/TMEM101/MAP3K7/MAPKBP1/BCL10/LURAP1L/BTRC/TNIP2/PIDD1/CARD9/CARD11/NUP62
MF,GO:0017137,Rab GTPase binding,2.0225142857142857,10,0.027196941562550495,0.38575253848923663,ALS2/TBC1D22B/KIF16B/ANKRD27/YIPF2/RBSN/WDR44/SBF2/DENND6A/MYO5A
BP,GO:0009132,nucleoside diphosphate metabolic process,2.1184880730243583,9,0.02723536050755739,0.43765350889595295,PGM1/PRKAG2/ARNT/CMPK1/PRKAA2/NUPR1/ENTPD5/CARD11/NUP62
BP,GO:0016482,cytosolic transport,2.1184880730243583,9,0.02723536050755739,0.43765350889595295,SNX1/RAB7A/KIF16B/ARFRP1/EEA1/ANKRD27/ARL1/HEATR5A/RBSN
BP,GO:0071375,cellular response to peptide hormone stimulus,1.7379081803626617,15,0.027663154785411235,0.43765350889595295,CCND3/PRKAR2A/ADCY7/PIK3CA/LPIN3/CDK4/APPL2/CAPN10/PAK1/ADCY9/ADCY1/PTPN1/MYO5A/MYO1C/CYFIP1
BP,GO:0009260,ribonucleotide biosynthetic process,1.777055600125097,14,0.0277597227365421,0.43765350889595295,PGM1/PRKAG2/ADCY7/RFK/MPC2/ARNT/ADCY9/CMPK1/PRKAA2/ADCY1/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0060612,adipose tissue development,3.4596497730010194,4,0.02789716724205304,0.43765350889595295,DYRK1B/PIK3CA/CDK4/TBL1XR1
BP,GO:0030258,lipid modification,1.8751883223408885,12,0.02790825181421107,0.43765350889595295,MTMR3/IMPAD1/PRKAG2/PIK3CA/APPL2/MTMR6/PIP4K2A/INPPL1/MTM1/GBA/APOD/ACAD11
CC,GO:0005643,nuclear pore,2.6012445304426217,6,0.02811264981449866,0.27133311700790685,XPO4/EIF5A2/AGFG1/KPNA5/MYO1C/NUP62
CC,GO:0099023,tethering complex,2.9231156970882997,5,0.028122818269533528,0.27133311700790685,GOLGA3/EXOC2/NBAS/TRAPPC8/TRAPPC12
BP,GO:0034378,chylomicron assembly,7.438247011952191,2,0.02814412105400952,0.43765350889595295,PLAGL2/P4HB
BP,GO:0035646,endosome to melanosome transport,7.438247011952191,2,0.02814412105400952,0.43765350889595295,ANKRD27/BLOC1S5
BP,GO:0043485,endosome to pigment granule transport,7.438247011952191,2,0.02814412105400952,0.43765350889595295,ANKRD27/BLOC1S5
BP,GO:0046485,ether lipid metabolic process,7.438247011952191,2,0.02814412105400952,0.43765350889595295,AGPS/GNPAT
BP,GO:0048757,pigment granule maturation,7.438247011952191,2,0.02814412105400952,0.43765350889595295,ANKRD27/BLOC1S5
BP,GO:1903862,positive regulation of oxidative phosphorylation,7.438247011952191,2,0.02814412105400952,0.43765350889595295,ISCU/NUPR1
BP,GO:1904896,ESCRT complex disassembly,7.438247011952191,2,0.02814412105400952,0.43765350889595295,VPS4A/CHMP1B
BP,GO:1904903,ESCRT III complex disassembly,7.438247011952191,2,0.02814412105400952,0.43765350889595295,VPS4A/CHMP1B
BP,GO:2000644,regulation of receptor catabolic process,7.438247011952191,2,0.02814412105400952,0.43765350889595295,DTX3L/PTPN1
BP,GO:1902275,regulation of chromatin organization,2.010337030257349,10,0.028295762869124157,0.43765350889595295,ASF1A/KDM3A/ATAD2B/RTF1/HNRNPU/RPS6KA4/PYGO2/TADA3/PHF8/SPTY2D1
BP,GO:0006165,nucleoside diphosphate phosphorylation,2.2203722423737884,8,0.02846413314805727,0.43765350889595295,PGM1/PRKAG2/ARNT/CMPK1/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0006766,vitamin metabolic process,2.2203722423737884,8,0.02846413314805727,0.43765350889595295,CYP26B1/VDR/VNN2/MTHFD1L/UBIAD1/RFK/ALDH1L1/AKR1C3
MF,GO:0016757,"transferase activity, transferring glycosyl groups",1.7697,14,0.0285167624098857,0.39638299749741124,B4GALT7/PIGB/PYGL/HAS3/DPM2/GALNT1/ST6GALNAC6/MGAT4B/WDFY3/RFNG/FUT1/GBA/OSTC/B3GNT9
BP,GO:0030813,positive regulation of nucleotide catabolic process,4.462948207171315,3,0.028653253023977737,0.43765350889595295,ARNT/PRKAA2/ENTPD5
BP,GO:0032438,melanosome organization,4.462948207171315,3,0.028653253023977737,0.43765350889595295,KIF13A/SNAPIN/BLOC1S5
BP,GO:0033522,histone H2A ubiquitination,4.462948207171315,3,0.028653253023977737,0.43765350889595295,RYBP/DTX3L/RNF168
BP,GO:0051197,positive regulation of coenzyme metabolic process,4.462948207171315,3,0.028653253023977737,0.43765350889595295,ARNT/PRKAA2/ENTPD5
BP,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,4.462948207171315,3,0.028653253023977737,0.43765350889595295,BAX/COPS5/PTPN1
BP,GO:0036498,IRE1-mediated unfolded protein response,2.905565239043825,5,0.02869396975486332,0.43765350889595295,BAX/COPS5/EDEM1/TSPYL2/PTPN1
BP,GO:0043297,apical junction assembly,2.905565239043825,5,0.02869396975486332,0.43765350889595295,PKN2/MARVELD2/CLDN1/CLDN3/MYO1C
BP,GO:0070302,regulation of stress-activated protein kinase signaling cascade,1.8673423460967844,12,0.028699172686366084,0.43765350889595295,MAP4K5/ZMYND11/COPS5/RAP2A/KLHDC10/TAOK3/MAP3K7/DUSP10/PAK1/MAP4K2/CARD9/PTPN1
BP,GO:0006888,ER to Golgi vesicle-mediated transport,1.9297338946102385,11,0.028725045937861217,0.43765350889595295,DDHD2/COPE/CAPZA1/TMED5/VAMP7/DCTN4/TEX261/TRAPPC8/TRAPPC12/MCFD2/PDCD6
BP,GO:0006664,glycolipid metabolic process,2.3667149583484246,7,0.029019088247983594,0.4404837723611838,PIGB/BAX/DPM2/SUMF1/ST6GALNAC6/GBA/PIGN
BP,GO:0070507,regulation of microtubule cytoskeleton organization,1.9995287666538148,10,0.02921673192149809,0.4418351875712053,MAPRE1/STAG2/MET/CEP85/PAK1/HNRNPU/PRKAA2/CLASP2/NUP62/CHMP1B
CC,GO:0000775,"chromosome, centromeric region",1.999229388682153,10,0.029324880859769004,0.2777865986898118,CBX5/STAG2/CBX1/DCTN4/PSEN2/BOD1/HNRNPU/CLASP2/TRAPPC12/PPP1CC
BP,GO:1903509,liposaccharide metabolic process,2.3453932019669073,7,0.030285012473231142,0.44781488604837305,PIGB/BAX/DPM2/SUMF1/ST6GALNAC6/GBA/PIGN
BP,GO:0015931,nucleobase-containing compound transport,1.851845729116728,12,0.030329526688823407,0.44781488604837305,SMG6/THOC5/TERF2/WDR33/G3BP2/HNRNPU/EIF5A2/TOMM20/AGFG1/SLC35E3/MYO1C/NUP62
BP,GO:0038093,Fc receptor signaling pathway,1.851845729116728,12,0.030329526688823407,0.44781488604837305,TAB1/PIK3CA/MAP3K7/APPL2/BCL10/PAK1/BTRC/YES1/ACTG1/MYO1C/CARD11/CYFIP1
BP,GO:0072665,protein localization to vacuole,2.8608642353662272,5,0.030423793074634876,0.44781488604837305,NEDD4/RAB7A/VAMP7/VPS4A/TRAPPC8
BP,GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,1.9116989983989279,11,0.030470400378169706,0.44781488604837305,CSNK2A2/CHFR/EDEM1/NUDT15/RYBP/RCHY1/RNF180/BTRC/MTM1/NUPR1/GBA
BP,GO:0007249,I-kappaB kinase/NF-kappaB signaling,1.7973459322561056,13,0.030648832313132677,0.44781488604837305,ZMYND11/TMEM101/TAB1/MAP3K7/MAPKBP1/BCL10/LURAP1L/BTRC/TNIP2/PIDD1/CARD9/CARD11/NUP62
BP,GO:0046939,nucleotide phosphorylation,2.187719709397703,8,0.030717789370228454,0.44781488604837305,PGM1/PRKAG2/ARNT/CMPK1/PRKAA2/NUPR1/ENTPD5/NUP62
MF,GO:0051400,BH domain binding,7.078799999999999,2,0.030849785571421293,0.4204039406301529,BAX/MCL1
BP,GO:0051188,cofactor biosynthetic process,1.7112531469215164,15,0.03111152147652245,0.44781488604837305,GCLM/CTNS/PGM1/PRKAG2/MTHFD1L/UBIAD1/RFK/MPC2/ARNT/QDPR/PRKAA2/PCBD1/NUPR1/ENTPD5/NUP62
BP,GO:0042147,"retrograde transport, endosome to Golgi",2.5357660268018836,6,0.0312565698257609,0.44781488604837305,SNX1/RAB7A/ARFRP1/ARL1/HEATR5A/RBSN
BP,GO:0043470,regulation of carbohydrate catabolic process,2.5357660268018836,6,0.0312565698257609,0.44781488604837305,PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
CC,GO:0035770,ribonucleoprotein granule,1.9033022386422471,11,0.031406663079905486,0.28368523985461935,SAMD4A/RC3H2/CIRBP/AGO4/G3BP2/CARHSP1/HNRNPU/PRKAA2/MEX3B/PNRC2/CNOT7
CC,GO:0031932,TORC2 complex,7.015477673011919,2,0.03158108236385398,0.28368523985461935,SESN1/MAPKAP1
CC,GO:1990907,beta-catenin-TCF complex,7.015477673011919,2,0.03158108236385398,0.28368523985461935,PYGO2/LDB1
BP,GO:0001835,blastocyst hatching,4.291296353049341,3,0.03176108401009867,0.44781488604837305,CMTM3/SMIM14/TBL1XR1
BP,GO:0035188,hatching,4.291296353049341,3,0.03176108401009867,0.44781488604837305,CMTM3/SMIM14/TBL1XR1
BP,GO:0048753,pigment granule organization,4.291296353049341,3,0.03176108401009867,0.44781488604837305,KIF13A/SNAPIN/BLOC1S5
BP,GO:0071684,organism emergence from protective structure,4.291296353049341,3,0.03176108401009867,0.44781488604837305,CMTM3/SMIM14/TBL1XR1
BP,GO:0097066,response to thyroid hormone,4.291296353049341,3,0.03176108401009867,0.44781488604837305,GCLM/TOMM20/GBA
BP,GO:1904754,positive regulation of vascular associated smooth muscle cell migration,4.291296353049341,3,0.03176108401009867,0.44781488604837305,DOCK7/DOCK5/PAK1
BP,GO:0010506,regulation of autophagy,1.7060199568697687,15,0.03183744166526561,0.44781488604837305,NEDD4/CSNK2A2/SESN1/MTMR3/MET/PRKAG2/PIK3CA/MAP3K7/MCL1/PIP4K2A/PRKAA2/CDK5/MTM1/NUPR1/GBA
BP,GO:0070646,protein modification by small protein removal,1.7413956215272688,14,0.03216882460863617,0.44781488604837305,USP28/TAB1/USP31/TGFBR1/USP46/SUDS3/COPS5/INO80/MAP3K7/ASXL2/TNIP2/OTUD3/TADA3/TOMM20
BP,GO:1901617,organic hydroxy compound biosynthetic process,1.7840813866305993,13,0.032257533317718905,0.44781488604837305,CTNS/IMPAD1/PRKAG2/VDR/PLCD4/MBTPS1/LBR/QDPR/PRKAA2/PCBD1/GBA/AKR1C3/MYO5A
BP,GO:0016569,covalent chromatin modification,1.5692504244624874,20,0.03226198029262454,0.44781488604837305,KDM7A/ING4/SUDS3/KANSL3/KDM3A/MAP3K7/RTF1/PADI3/PRMT2/RPS6KA4/PRKAA2/PYGO2/RYBP/DTX3L/RNF168/CDK5/TADA3/PHF8/TBL1XR1/LDB1
BP,GO:0032869,cellular response to insulin stimulus,1.8939980817470858,11,0.032290225087044155,0.44781488604837305,CCND3/PIK3CA/LPIN3/CDK4/APPL2/CAPN10/PAK1/PTPN1/MYO5A/MYO1C/CYFIP1
BP,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,3.3058875608676406,4,0.03231127799513111,0.44781488604837305,USP28/CDKN1A/TRIAP1/NUPR1
BP,GO:0070316,regulation of G0 to G1 transition,3.3058875608676406,4,0.03231127799513111,0.44781488604837305,CBX5/RBBP7/RBBP4/RYBP
CC,GO:0032588,trans-Golgi network membrane,2.5164213392325365,6,0.03236825237326815,0.28582812688936793,AP4E1/ARFRP1/VAMP4/ARL1/MYO1B/KIF13A
MF,GO:0004860,protein kinase inhibitor activity,2.809047619047619,5,0.03247312585322195,0.421686420909148,PRKAG2/PRKAR2A/CDKN1A/TAOK3/DUS2
MF,GO:0004712,protein serine/threonine/tyrosine kinase activity,3.2924651162790695,4,0.03262427912975944,0.421686420909148,DYRK1B/ACVR2B/RPS6KA1/PRKAA2
BP,GO:0044282,small molecule catabolic process,1.5879403733381083,19,0.03274260475111933,0.44781488604837305,CYP26B1/HSD17B10/PGM1/ARG2/FAH/DHDH/IDUA/LPIN3/NUDT15/ALDH1L1/QDPR/ALDH4A1/AMDHD2/PCBD1/FUT1/ENTPD5/AKR1C3/ENTPD6/ACAD11
BP,GO:0006497,protein lipidation,2.50727427369175,6,0.03278634868656626,0.44781488604837305,PIGB/DPM2/NMT2/GBA/PIGN/ZDHHC18
BP,GO:0002223,stimulatory C-type lectin receptor signaling pathway,2.3038818178612983,7,0.0329271706108446,0.44781488604837305,TAB1/MAP3K7/BCL10/PAK1/BTRC/CARD9/CARD11
BP,GO:0032868,response to insulin,1.777522263885634,13,0.03308437170636176,0.44781488604837305,CCND3/PIK3CA/LPIN3/CDK4/APPL2/CAPN10/PAK1/INPPL1/EPM2AIP1/PTPN1/MYO5A/MYO1C/CYFIP1
BP,GO:0008584,male gonad development,2.156013626652809,8,0.03309091033592494,0.44781488604837305,BAX/TGFBR1/PLEKHA1/SDC1/SAFB2/AGO4/NUPR1/AKR1C3
BP,GO:0009135,purine nucleoside diphosphate metabolic process,2.156013626652809,8,0.03309091033592494,0.44781488604837305,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/CARD11/NUP62
BP,GO:0009179,purine ribonucleoside diphosphate metabolic process,2.156013626652809,8,0.03309091033592494,0.44781488604837305,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/CARD11/NUP62
BP,GO:0030048,actin filament-based movement,2.156013626652809,8,0.03309091033592494,0.44781488604837305,MYO1B/FNBP1L/TPM4/PDE4B/MYL6B/MYO5A/PARVA/MYO1C
BP,GO:0001821,histamine secretion,6.762042738138356,2,0.033795272865499146,0.44781488604837305,SNX4/VAMP7
BP,GO:0006048,UDP-N-acetylglucosamine biosynthetic process,6.762042738138356,2,0.033795272865499146,0.44781488604837305,UAP1/AMDHD2
BP,GO:0006853,carnitine shuttle,6.762042738138356,2,0.033795272865499146,0.44781488604837305,PRKAG2/PRKAA2
BP,GO:0035404,histone-serine phosphorylation,6.762042738138356,2,0.033795272865499146,0.44781488604837305,RPS6KA4/PRKAA2
BP,GO:0072537,fibroblast activation,6.762042738138356,2,0.033795272865499146,0.44781488604837305,GCLM/RPS6KA1
BP,GO:0090042,tubulin deacetylation,6.762042738138356,2,0.033795272865499146,0.44781488604837305,PRKAA2/TADA3
BP,GO:1905146,lysosomal protein catabolic process,6.762042738138356,2,0.033795272865499146,0.44781488604837305,GBA/TMEM199
BP,GO:0005976,polysaccharide metabolic process,2.283672328230936,7,0.034304140198200106,0.4518642718138635,PGM1/PYGL/HAS3/PRKAG2/EPM2AIP1/PPP1CC/B3GNT9
BP,GO:0046546,development of primary male sexual characteristics,2.140502737252429,8,0.03432302359648078,0.4518642718138635,BAX/TGFBR1/PLEKHA1/SDC1/SAFB2/AGO4/NUPR1/AKR1C3
BP,GO:0045787,positive regulation of cell cycle,1.6253238972132038,17,0.03477540587716142,0.45392906595504384,PKN2/BAX/THOC5/CCND3/CNOT6/CDKN1A/INO80/CDK4/HNRNPU/CNOT11/CRADD/TRIAP1/CRLF3/PIDD1/CNOT10/CNOT7/NUP62
MF,GO:0019209,kinase activator activity,2.4693488372093024,6,0.03484315101845278,0.421686420909148,ALS2/TAB1/PRKAG2/PIK3CA/CDKN1A/BCL10
BP,GO:0002021,response to dietary excess,4.13235945108455,3,0.03503778926005009,0.45392906595504384,APPL2/OMA1/TBL1XR1
BP,GO:0009651,response to salt stress,4.13235945108455,3,0.03503778926005009,0.45392906595504384,BAX/ANXA7/CLDN1
BP,GO:0046885,regulation of hormone biosynthetic process,4.13235945108455,3,0.03503778926005009,0.45392906595504384,VDR/ARNT/AKR1C3
BP,GO:0090169,regulation of spindle assembly,4.13235945108455,3,0.03503778926005009,0.45392906595504384,STAG2/HNRNPU/CHMP1B
CC,GO:0090543,Flemming body,4.13412077159631,3,0.035082883309476065,0.303060036597144,EXOC2/VPS4A/NUP62
BP,GO:1901136,carbohydrate derivative catabolic process,1.937043492695883,10,0.03519249582632572,0.4544859460999779,PDE8A/SDC1/IDUA/MBD4/EDEM1/NUDT15/NGLY1/AMDHD2/GBA/PDE4B
CC,GO:0005770,late endosome,1.8086778375733856,12,0.035483036914444877,0.303060036597144,STARD3NL/CTNS/AP5M1/RAB7A/ANKRD27/VAMP7/YIPF2/VPS4A/SNX14/MTM1/MYO5A/CHMP1B
BP,GO:0009185,ribonucleoside diphosphate metabolic process,2.1252134319863405,8,0.03558588866304808,0.45811200975088473,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/CARD11/NUP62
BP,GO:0006096,glycolytic process,2.2638143079854496,7,0.03571883537504405,0.45837294102737913,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
MF,GO:0016628,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",4.083923076923077,3,0.03600597929510817,0.421686420909148,DHDH/LBR/AKR1C3
MF,GO:0051019,mitogen-activated protein kinase binding,4.083923076923077,3,0.03600597929510817,0.421686420909148,TAB1/MICALCL/DUSP10
BP,GO:1901987,regulation of cell cycle phase transition,1.5496347941567066,20,0.03605782873411049,0.4612680732401304,BAX/MAPRE1/CDK6/CCND3/CNOT6/CDKN1A/INO80/VPS4A/TAOK3/CDK4/CCNB3/CNOT11/PRMT2/BTRC/CRADD/TRIAP1/CDC26/PIDD1/CNOT10/CNOT7
MF,GO:0035064,methylated histone binding,2.7226153846153847,5,0.03647697170749678,0.421686420909148,KDM7A/ZMYND11/CBX5/ING4/PHF8
MF,GO:0140034,methylation-dependent protein binding,2.7226153846153847,5,0.03647697170749678,0.421686420909148,KDM7A/ZMYND11/CBX5/ING4/PHF8
MF,GO:0004865,protein serine/threonine phosphatase inhibitor activity,6.435272727272728,2,0.03701132615173817,0.421686420909148,PPP1R14A/PPP1R14C
MF,GO:0005225,volume-sensitive anion channel activity,6.435272727272728,2,0.03701132615173817,0.421686420909148,PIDD1/LRRC8B
MF,GO:0016813,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines",6.435272727272728,2,0.03701132615173817,0.421686420909148,ARG2/PADI3
BP,GO:0045023,G0 to G1 transition,3.1652114944477407,4,0.0371111580327881,0.4644392972440263,CBX5/RBBP7/RBBP4/RYBP
BP,GO:0047496,vesicle transport along microtubule,3.1652114944477407,4,0.0371111580327881,0.4644392972440263,VAMP7/KIF13A/SNAPIN/BLOC1S5
BP,GO:0048066,developmental pigmentation,3.1652114944477407,4,0.0371111580327881,0.4644392972440263,BAX/ANKRD27/BLOC1S5/MYO5A
BP,GO:0070231,T cell apoptotic process,3.1652114944477407,4,0.0371111580327881,0.4644392972440263,ARG2/BAX/BCL10/IL7R
CC,GO:0044798,nuclear transcription factor complex,1.9196580697296297,10,0.03716518083181236,0.308116305465733,GTF2H1/VDR/TBP/CD3EAP/MED4/ARNT/HNRNPU/PYGO2/TADA3/LDB1
BP,GO:0002220,innate immune response activating cell surface receptor signaling pathway,2.244298667399368,7,0.03717158577135524,0.4644392972440263,TAB1/MAP3K7/BCL10/PAK1/BTRC/CARD9/CARD11
BP,GO:0006757,ATP generation from ADP,2.244298667399368,7,0.03717158577135524,0.4644392972440263,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
CC,GO:0030008,TRAPP complex,6.4308545335942595,2,0.0372578258048775,0.308116305465733,TRAPPC8/TRAPPC12
BP,GO:1900542,regulation of purine nucleotide metabolic process,2.095280848437237,8,0.03820496640016626,0.4644392972440263,PRKAG2/ISCU/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0001702,gastrulation with mouth forming second,3.984775184974388,3,0.0384819100163409,0.4644392972440263,ACVR2B/FRS2/LDB1
BP,GO:0009065,glutamine family amino acid catabolic process,3.984775184974388,3,0.0384819100163409,0.4644392972440263,ARG2/FAH/ALDH4A1
BP,GO:0009074,aromatic amino acid family catabolic process,3.984775184974388,3,0.0384819100163409,0.4644392972440263,FAH/QDPR/PCBD1
BP,GO:0033598,mammary gland epithelial cell proliferation,3.984775184974388,3,0.0384819100163409,0.4644392972440263,BAX/PYGO2/BTRC
BP,GO:0036296,response to increased oxygen levels,3.984775184974388,3,0.0384819100163409,0.4644392972440263,CDKN1A/CDK4/TMEM199
BP,GO:0070076,histone lysine demethylation,3.984775184974388,3,0.0384819100163409,0.4644392972440263,KDM7A/KDM3A/PHF8
BP,GO:1900371,regulation of purine nucleotide biosynthetic process,2.2251166275070657,7,0.03866270528060589,0.4644392972440263,PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0010639,negative regulation of organelle organization,1.6006354329517372,17,0.0392679390289455,0.4644392972440263,SMG6/RAB7A/MAPRE1/ANKRD27/MET/ASF1A/KDM3A/CAPZA1/ATAD2B/TERF2/HNRNPU/OMA1/CLASP2/TRIAP1/MTM1/PHF8/NUPR1
BP,GO:0036473,cell death in response to oxidative stress,2.399434519984578,6,0.039387399863672394,0.4644392972440263,PDE8A/MET/LANCL1/STK26/MCL1/P4HB
BP,GO:0048871,multicellular organismal homeostasis,1.5336591777221014,20,0.03946567511760174,0.4644392972440263,CYP26B1/BAX/MET/PRKAR2A/ACVR2B/KDM3A/DOCK7/ADCY7/PIK3CA/APPL2/ADCY9/PRKAA2/OMA1/CLDN1/ADCY1/RBPJ/UCP2/GBA/ACTG1/LDB1
BP,GO:0008542,visual learning,3.099269588313413,4,0.03965649221740297,0.4644392972440263,CTNS/DDHD2/NDRG4/CDK5
BP,GO:0072666,establishment of protein localization to vacuole,3.099269588313413,4,0.03965649221740297,0.4644392972440263,NEDD4/RAB7A/VAMP7/VPS4A
MF,GO:0032452,histone demethylase activity,3.932666666666667,3,0.03968220365756793,0.43701668656923215,KDM7A/KDM3A/PHF8
BP,GO:0002024,diet induced thermogenesis,6.198539176626826,2,0.03984496429158436,0.4644392972440263,APPL2/OMA1
BP,GO:0006527,arginine catabolic process,6.198539176626826,2,0.03984496429158436,0.4644392972440263,ARG2/FAH
BP,GO:0006662,glycerol ether metabolic process,6.198539176626826,2,0.03984496429158436,0.4644392972440263,AGPS/GNPAT
BP,GO:0010960,magnesium ion homeostasis,6.198539176626826,2,0.03984496429158436,0.4644392972440263,TRPM7/CNNM4
BP,GO:0034244,negative regulation of transcription elongation from RNA polymerase II promoter,6.198539176626826,2,0.03984496429158436,0.4644392972440263,HNRNPU/RNF168
BP,GO:0034497,protein localization to phagophore assembly site,6.198539176626826,2,0.03984496429158436,0.4644392972440263,TRAPPC8/ATG9B
BP,GO:0035751,regulation of lysosomal lumen pH,6.198539176626826,2,0.03984496429158436,0.4644392972440263,SNAPIN/TMEM199
BP,GO:0043476,pigment accumulation,6.198539176626826,2,0.03984496429158436,0.4644392972440263,ANKRD27/BLOC1S5
BP,GO:0043482,cellular pigment accumulation,6.198539176626826,2,0.03984496429158436,0.4644392972440263,ANKRD27/BLOC1S5
BP,GO:0051608,histamine transport,6.198539176626826,2,0.03984496429158436,0.4644392972440263,SNX4/VAMP7
BP,GO:0099640,axo-dendritic protein transport,6.198539176626826,2,0.03984496429158436,0.4644392972440263,TERF2/HNRNPU
BP,GO:1902337,regulation of apoptotic process involved in morphogenesis,6.198539176626826,2,0.03984496429158436,0.4644392972440263,BAX/VDR
BP,GO:0030808,regulation of nucleotide biosynthetic process,2.206259706934972,7,0.040192491834865895,0.46715159081209845,PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
CC,GO:0055037,recycling endosome,1.973103095534602,9,0.040261278871041264,0.3203024185355585,EEA1/EHD4/AVL9/STX12/RAP2A/ZFYVE27/DENND6A/RAP2B/MYO5A
BP,GO:0097191,extrinsic apoptotic signaling pathway,1.8263552931132614,11,0.040342397579374176,0.46755804374043913,ZMYND11/GCLM/BAX/ITGA6/MKNK2/TGFBR1/BCL10/MCL1/CRADD/GABARAP/PIDD1
CC,GO:0005795,Golgi stack,2.0716846819632515,8,0.04050829023489375,0.3203024185355585,B4GALT7/LPCAT2/GOLGA3/YIPF2/MBTPS1/GALNT1/MGAT4B/FUT1
BP,GO:0007051,spindle organization,1.9689477384579332,9,0.040620409095378035,0.46856253582165885,MAPRE1/STAG2/WRAP73/INO80/HNRNPU/CLASP2/RCC1/NUP62/CHMP1B
BP,GO:0045930,negative regulation of mitotic cell cycle,1.6504985973266697,15,0.0406594334181528,0.46856253582165885,CHFR/BAX/CDK6/CNOT6/CDKN1A/VPS4A/TAOK3/CDK4/CNOT11/PRMT2/CRADD/TRIAP1/PIDD1/CNOT10/CNOT7
MF,GO:0019210,kinase inhibitor activity,2.6413432835820894,5,0.040771446935356906,0.43701668656923215,PRKAG2/PRKAR2A/CDKN1A/TAOK3/DUS2
BP,GO:0009156,ribonucleoside monophosphate biosynthetic process,1.8878799522721297,10,0.04078397586386067,0.4686700955202972,PGM1/PRKAG2/RFK/ARNT/CMPK1/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0042158,lipoprotein biosynthetic process,2.3739086208358056,6,0.041160019228307025,0.47040922619159753,PIGB/DPM2/NMT2/GBA/PIGN/ZDHHC18
BP,GO:0033157,regulation of intracellular protein transport,1.8182381584772023,11,0.04143860296031503,0.47040922619159753,CSNK2A2/VAMP7/XPO4/EDEM1/PAK1/PTPN14/CDK5/APOD/PTPN1/MYO1C/NUP62
BP,GO:0000209,protein polyubiquitination,1.6796041639892043,14,0.04153978269626598,0.47040922619159753,RC3H2/NEDD4/CHFR/KLHL42/WSB1/FBXO30/FBXL12/DTX3L/RNF168/RNF180/BTRC/TRIM44/ZNF738/CDC26
BP,GO:0042866,pyruvate biosynthetic process,2.187719709397703,7,0.04176122719725101,0.47040922619159753,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0051193,regulation of cofactor metabolic process,2.187719709397703,7,0.04176122719725101,0.47040922619159753,CTNS/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
CC,GO:0030176,integral component of endoplasmic reticulum membrane,2.057873450750163,8,0.04186648896117952,0.3203024185355585,SEC62/EDEM1/DPM2/TEX261/ZFYVE27/SGMS2/TAPT1/FITM2
BP,GO:0010390,histone monoubiquitination,3.8473691441132023,3,0.042091681006327805,0.47040922619159753,RYBP/DTX3L/RNF168
BP,GO:0016577,histone demethylation,3.8473691441132023,3,0.042091681006327805,0.47040922619159753,KDM7A/KDM3A/PHF8
BP,GO:0031116,positive regulation of microtubule polymerization,3.8473691441132023,3,0.042091681006327805,0.47040922619159753,MAPRE1/MET/PAK1
BP,GO:0042219,cellular modified amino acid catabolic process,3.8473691441132023,3,0.042091681006327805,0.47040922619159753,GGACT/ALDH1L1/ALDH4A1
BP,GO:0070229,negative regulation of lymphocyte apoptotic process,3.8473691441132023,3,0.042091681006327805,0.47040922619159753,ARG2/BCL10/IL7R
CC,GO:0043292,contractile fiber,1.8138307658855601,11,0.042146692754908593,0.3203024185355585,ACTA2/DCTN4/PSEN2/PAK1/MTMR12/TPM4/MTM1/ACTG1/PDE4B/MYL6B/PARVA
BP,GO:0051196,regulation of coenzyme metabolic process,2.3489201090375342,6,0.04298223398806952,0.4786493826916011,PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0016052,carbohydrate catabolic process,1.868906284410098,10,0.04318198708156775,0.4786493826916011,PGM1/PYGL/DHDH/PRKAG2/ARNT/PRKAA2/FUT1/NUPR1/ENTPD5/NUP62
BP,GO:0061013,regulation of mRNA catabolic process,1.868906284410098,10,0.04318198708156775,0.4786493826916011,SAMD4A/CIRBP/DHX34/NBAS/CARHSP1/HNRNPU/HNRNPA0/PKP3/YTHDF3/CNOT7
CC,GO:0016580,Sin3 complex,5.93617341562547,2,0.043290670284251286,0.3203024185355585,SUDS3/RBBP4
CC,GO:0044233,Mitochondria-associated ER Membrane,5.93617341562547,2,0.043290670284251286,0.3203024185355585,PDZD8/TOMM20
MF,GO:0004114,"3',5'-cyclic-nucleotide phosphodiesterase activity",3.792214285714286,3,0.04354085363236385,0.43701668656923215,PDE8A/PRKAR2A/PDE4B
MF,GO:0080025,"phosphatidylinositol-3,5-bisphosphate binding",3.792214285714286,3,0.04354085363236385,0.43701668656923215,KIF16B/MAPKAP1/SNX14
MF,GO:0004115,"3',5'-cyclic-AMP phosphodiesterase activity",5.899000000000001,2,0.04359817537959832,0.43701668656923215,PDE8A/PDE4B
MF,GO:0030898,actin-dependent ATPase activity,5.899000000000001,2,0.04359817537959832,0.43701668656923215,MYO1B/MYO1C
MF,GO:0031543,peptidyl-proline dioxygenase activity,5.899000000000001,2,0.04359817537959832,0.43701668656923215,EGLN3/P4HB
MF,GO:0042975,peroxisome proliferator activated receptor binding,5.899000000000001,2,0.04359817537959832,0.43701668656923215,ASXL2/PRMT2
BP,GO:0006140,regulation of nucleotide metabolic process,2.037875893685532,8,0.043823598570180124,0.4838490583598476,PRKAG2/ISCU/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
CC,GO:0016605,PML body,2.3384925576706395,6,0.04386238774185834,0.3203024185355585,CHFR/CBX5/MKNK2/ELF4/HMBOX1/WDFY3
MF,GO:0051213,dioxygenase activity,2.3336703296703294,6,0.044016069150857914,0.43701668656923215,KDM7A/KDM3A/EGLN3/PHF8/P4HB/ASPH
BP,GO:0033044,regulation of chromosome organization,1.6311945201649543,15,0.044263757395173554,0.4838490583598476,SMG6/ASF1A/KDM3A/ATAD2B/TERF2/RTF1/HMBOX1/HNRNPU/RPS6KA4/PYGO2/TADA3/TRAPPC12/PHF8/CDC26/SPTY2D1
CC,GO:0019898,extrinsic component of membrane,1.7003615376961092,13,0.04468605304803067,0.3203024185355585,RAB7A/GOLGA3/MTMR3/CDH20/EEA1/CYTH1/PIK3CA/STAC/NRBF2/NMT2/WDFY3/YES1/GBA
BP,GO:0048010,vascular endothelial growth factor receptor signaling pathway,2.3244521912350598,6,0.044854321896528236,0.4838490583598476,NEDD4/PIK3CA/ARNT/PTPN1/PDCD6/CYFIP1
BP,GO:0030968,endoplasmic reticulum unfolded protein response,2.1515590530440223,7,0.045016589429664446,0.4838490583598476,BAX/COPS5/HERPUD2/EDEM1/MBTPS1/TSPYL2/PTPN1
BP,GO:0072698,protein localization to microtubule cytoskeleton,2.9752988047808766,4,0.04503837901810467,0.4838490583598476,MAPRE1/DIAPH1/HNRNPU/NUP62
CC,GO:0098858,actin-based cell projection,1.8550541923829593,10,0.04512597714771181,0.3203024185355585,ITGA6/ACTA2/MYO1B/CDK5/INPPL1/MTM1/CBX6/MYO5A/MYO1C/CYFIP1
CC,GO:0031300,intrinsic component of organelle membrane,1.790870882773085,11,0.04546832270987165,0.3203024185355585,VAMP4/STX12/UBIAD1/VAMP7/ITM2B/MPC2/LBR/TEX261/SGMS2/RFNG/TOMM20
CC,GO:1902555,endoribonuclease complex,3.7340445678934406,3,0.045494009542478564,0.3203024185355585,HSD17B10/AGO4/TSEN34
BP,GO:0001701,in utero embryonic development,1.5953344797752689,16,0.04567745366590943,0.4838490583598476,ALS2/TAB1/ELL/TGFBR1/RTF1/CMTM3/ARNT/MED21/GABPA/ADCY9/PYGO2/SMIM14/RBPJ/TAPT1/ARNT2/TBL1XR1
BP,GO:0001782,B cell homeostasis,3.7191235059760954,3,0.04586505489882265,0.4838490583598476,RC3H2/BAX/BCL10
BP,GO:0006362,transcription elongation from RNA polymerase I promoter,3.7191235059760954,3,0.04586505489882265,0.4838490583598476,GTF2H1/TBP/CD3EAP
BP,GO:0032743,positive regulation of interleukin-2 production,3.7191235059760954,3,0.04586505489882265,0.4838490583598476,MAP3K7/PDE4B/CARD11
BP,GO:0048147,negative regulation of fibroblast proliferation,3.7191235059760954,3,0.04586505489882265,0.4838490583598476,B4GALT7/BAX/NUPR1
BP,GO:0090314,positive regulation of protein targeting to membrane,3.7191235059760954,3,0.04586505489882265,0.4838490583598476,PAK1/CDK5/MYO1C
BP,GO:0097421,liver regeneration,3.7191235059760954,3,0.04586505489882265,0.4838490583598476,CSNK2A2/CLDN1/CSNK2B
BP,GO:1903205,regulation of hydrogen peroxide-induced cell death,3.7191235059760954,3,0.04586505489882265,0.4838490583598476,PDE8A/MET/STK26
BP,GO:0009650,UV protection,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,ERCC5/SCARA3
BP,GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,NDRG4/APOD
BP,GO:0019511,peptidyl-proline hydroxylation,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,EGLN3/P4HB
BP,GO:0030656,regulation of vitamin metabolic process,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,VDR/AKR1C3
BP,GO:0046349,amino sugar biosynthetic process,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,UAP1/AMDHD2
BP,GO:0050746,regulation of lipoprotein metabolic process,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,GBA/APOD
BP,GO:0051315,attachment of mitotic spindle microtubules to kinetochore,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,BOD1/HNRNPU
BP,GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,BAX/PTPN1
BP,GO:1902902,negative regulation of autophagosome assembly,5.7217284707324545,2,0.046267768854960846,0.4838490583598476,MTM1/NUPR1
BP,GO:0031100,animal organ regeneration,2.547344867106915,5,0.046611356546785776,0.486192303672627,CSNK2A2/CDKN1A/CDK4/CLDN1/CSNK2B
BP,GO:0006486,protein glycosylation,1.7298248865005097,12,0.046962631227714345,0.48735710161821927,B4GALT7/DPM2/GALNT1/ST6GALNAC6/MGAT4B/RFNG/FUT1/MCFD2/POMK/ENTPD5/OSTC/B3GNT9
BP,GO:0043413,macromolecule glycosylation,1.7298248865005097,12,0.046962631227714345,0.48735710161821927,B4GALT7/DPM2/GALNT1/ST6GALNAC6/MGAT4B/RFNG/FUT1/MCFD2/POMK/ENTPD5/OSTC/B3GNT9
BP,GO:0046165,alcohol biosynthetic process,1.9126920887877064,9,0.04732060552964686,0.48982245113130646,IMPAD1/VDR/PLCD4/MBTPS1/LBR/QDPR/PRKAA2/PCBD1/GBA
MF,GO:0004112,cyclic-nucleotide phosphodiesterase activity,3.661448275862069,3,0.04757943630057778,0.45298230450550075,PDE8A/PRKAR2A/PDE4B
MF,GO:0033764,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",3.661448275862069,3,0.04757943630057778,0.45298230450550075,HSD17B10/HSD17B14/AKR1C3
MF,GO:0046966,thyroid hormone receptor binding,3.661448275862069,3,0.04757943630057778,0.45298230450550075,MED4/PRMT2/NUP62
BP,GO:0032007,negative regulation of TOR signaling,2.9169596125302713,4,0.047874764146011696,0.49411044702960205,SESN1/PRKAA2/MTM1/PDCD6
BP,GO:0009267,cellular response to starvation,1.9968448354234067,8,0.048377647027142735,0.49411044702960205,SESN1/MTMR3/CDKN1A/STK26/PRKAA2/GABARAP/GBA/AKR1C3
BP,GO:0050773,regulation of dendrite development,1.9968448354234067,8,0.048377647027142735,0.49411044702960205,SS18L2/NEDD4/ANKRD27/VAMP7/RAP2A/CDK5/NSMF/CYFIP1
BP,GO:0051092,positive regulation of NF-kappaB transcription factor activity,1.9968448354234067,8,0.048377647027142735,0.49411044702960205,TAB1/MAP3K7/BCL10/RPS6KA4/RHEBL1/PIDD1/IL1RAP/CARD11
BP,GO:2001056,positive regulation of cysteine-type endopeptidase activity,1.9968448354234067,8,0.048377647027142735,0.49411044702960205,BAX/EGLN3/BCL10/CRADD/PIDD1/CARD9/ASPH/PDCD6
BP,GO:0043434,response to peptide hormone,1.5354179611827918,18,0.048472674548536786,0.49411044702960205,CCND3/PRKAR2A/ADCY7/PIK3CA/LPIN3/CDK4/APPL2/CAPN10/PAK1/QDPR/ADCY9/ADCY1/INPPL1/EPM2AIP1/PTPN1/MYO5A/MYO1C/CYFIP1
BP,GO:0043473,pigmentation,2.2770143914139362,6,0.048749088202074464,0.49411044702960205,BAX/ANKRD27/KIF13A/SNAPIN/BLOC1S5/MYO5A
BP,GO:0005977,glycogen metabolic process,2.5129212878216864,5,0.04893364239962206,0.49411044702960205,PGM1/PYGL/PRKAG2/EPM2AIP1/PPP1CC
MF,GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,2.8893061224489793,4,0.04916733974992124,0.453010398224904,CCND3/CDKN1A/CDK4/CCNB3
BP,GO:0072659,protein localization to plasma membrane,1.7165185412197363,12,0.04926436008404713,0.49411044702960205,ARFRP1/VAMP7/RAP2A/VPS4A/KIF13A/RAB15/STAC/ZFYVE27/CLASP2/CDK5/PKP3/MYO5A
CC,GO:1905348,endonuclease complex,3.6173556751467713,3,0.04926687725919095,0.33599372941453093,HSD17B10/AGO4/TSEN34
BP,GO:0031396,regulation of protein ubiquitination,1.8230997578314194,10,0.0495922345063739,0.49411044702960205,SPRTN/CHFR/TGFBR1/BCL10/RCHY1/DTX3L/RNF180/CDK5/TRIM44/PDCD6
CC,GO:0010369,chromocenter,5.512161028795079,2,0.049657422581418205,0.33599372941453093,CBX5/CBX1
CC,GO:0038201,TOR complex,5.512161028795079,2,0.049657422581418205,0.33599372941453093,SESN1/MAPKAP1
BP,GO:0002082,regulation of oxidative phosphorylation,3.5991517799768666,3,0.049799725487250944,0.49411044702960205,ISCU/NUPR1/DNAJC30
BP,GO:0006363,termination of RNA polymerase I transcription,3.5991517799768666,3,0.049799725487250944,0.49411044702960205,GTF2H1/TBP/CD3EAP
BP,GO:0006482,protein demethylation,3.5991517799768666,3,0.049799725487250944,0.49411044702960205,KDM7A/KDM3A/PHF8
BP,GO:0006506,GPI anchor biosynthetic process,3.5991517799768666,3,0.049799725487250944,0.49411044702960205,PIGB/DPM2/PIGN
BP,GO:0008214,protein dealkylation,3.5991517799768666,3,0.049799725487250944,0.49411044702960205,KDM7A/KDM3A/PHF8
BP,GO:0032786,"positive regulation of DNA-templated transcription, elongation",3.5991517799768666,3,0.049799725487250944,0.49411044702960205,THOC5/ELL/RTF1
BP,GO:0046471,phosphatidylglycerol metabolic process,3.5991517799768666,3,0.049799725487250944,0.49411044702960205,PLA2G3/PTPMT1/LPGAT1
MF,GO:0004535,poly(A)-specific ribonuclease activity,5.445230769230769,2,0.05058148497504792,0.453010398224904,CNOT6/CNOT7
MF,GO:0016208,AMP binding,5.445230769230769,2,0.05058148497504792,0.453010398224904,PYGL/PRKAG2
BP,GO:0097164,ammonium ion metabolic process,1.814206588281022,10,0.05094666289191411,0.5030892449343827,CSNK2A2/LPCAT2/PLA2G3/LPIN3/CDS1/SGMS2/RNF180/GBA/AKR1C3/CSNK2B
BP,GO:0006073,cellular glucan metabolic process,2.4794156706507304,5,0.05132301785835025,0.5030892449343827,PGM1/PYGL/PRKAG2/EPM2AIP1/PPP1CC
BP,GO:0006353,"DNA-templated transcription, termination",2.4794156706507304,5,0.05132301785835025,0.5030892449343827,PAPOLA/GTF2H1/TBP/CD3EAP/WDR33
BP,GO:0044042,glucan metabolic process,2.4794156706507304,5,0.05132301785835025,0.5030892449343827,PGM1/PYGL/PRKAG2/EPM2AIP1/PPP1CC
BP,GO:0046173,polyol biosynthetic process,2.4794156706507304,5,0.05132301785835025,0.5030892449343827,IMPAD1/PLCD4/QDPR/PCBD1/GBA
BP,GO:0016999,antibiotic metabolic process,1.970396559457534,8,0.051578586368904514,0.5043790609343836,CTNS/CS/IDH3G/KDM3A/MTHFD1L/AMDHD2/SDHAF2/AKR1C3
MF,GO:0030332,cyclin binding,3.5393999999999997,3,0.05179515290662236,0.453010398224904,CDK6/CDKN1A/CDK4
MF,GO:0043325,"phosphatidylinositol-3,4-bisphosphate binding",3.5393999999999997,3,0.05179515290662236,0.453010398224904,KIF16B/PLEKHA1/MAPKAP1
MF,GO:0003727,single-stranded RNA binding,2.2354105263157895,6,0.052347084381992745,0.453010398224904,PPIE/CIRBP/AGO4/HNRNPU/STRBP/CBX6
BP,GO:0007059,chromosome segregation,1.622047635005151,14,0.05270026613942998,0.5086713057903272,CSNK2A2/STAG2/INO80/CEP85/VPS4A/AGO4/BOD1/HNRNPU/TRAPPC12/BANF1/CDC26/RCC1/NUP62/CHMP1B
MF,GO:0001098,basal transcription machinery binding,2.4579166666666667,5,0.05279689533268666,0.453010398224904,TBP/ZNHIT6/ERCC5/RTF1/HNRNPU
MF,GO:0001099,basal RNA polymerase II transcription machinery binding,2.4579166666666667,5,0.05279689533268666,0.453010398224904,TBP/ZNHIT6/ERCC5/RTF1/HNRNPU
BP,GO:0070498,interleukin-1-mediated signaling pathway,2.2314741035856573,6,0.05284597956448862,0.5086713057903272,TAB1/MAP3K7/RPS6KA4/BTRC/TNIP2/IL1RAP
BP,GO:0007100,mitotic centrosome separation,5.313033579965851,2,0.0530393345405121,0.5086713057903272,CEP85/NUP62
BP,GO:0009214,cyclic nucleotide catabolic process,5.313033579965851,2,0.0530393345405121,0.5086713057903272,PDE8A/PDE4B
BP,GO:0032785,"negative regulation of DNA-templated transcription, elongation",5.313033579965851,2,0.0530393345405121,0.5086713057903272,HNRNPU/RNF168
BP,GO:1904748,regulation of apoptotic process involved in development,5.313033579965851,2,0.0530393345405121,0.5086713057903272,BAX/VDR
BP,GO:0051028,mRNA transport,1.957433424197945,8,0.053229039001359314,0.5086713057903272,SMG6/THOC5/WDR33/G3BP2/EIF5A2/AGFG1/MYO1C/NUP62
BP,GO:0046777,protein autophosphorylation,1.7408663219462575,11,0.05354808197656606,0.5086713057903272,TRPM7/MKNK2/DYRK1B/RAP2A/STK26/TAOK3/PAK1/CDK5/YES1/RAP2B/MEX3B
BP,GO:0000956,nuclear-transcribed mRNA catabolic process,1.7966780222106742,10,0.05372898777762057,0.5086713057903272,SAMD4A/SMG6/CNOT6/LSM7/DHX34/NBAS/CNOT11/CNOT10/PNRC2/CNOT7
BP,GO:0000186,activation of MAPKK activity,2.8068856648876195,4,0.053837187789791664,0.5086713057903272,TGFBR1/TAOK3/MAP3K7/FRS2
BP,GO:0007632,visual behavior,2.8068856648876195,4,0.053837187789791664,0.5086713057903272,CTNS/DDHD2/NDRG4/CDK5
BP,GO:0070228,regulation of lymphocyte apoptotic process,2.8068856648876195,4,0.053837187789791664,0.5086713057903272,ARG2/BAX/BCL10/IL7R
BP,GO:1903307,positive regulation of regulated secretory pathway,2.8068856648876195,4,0.053837187789791664,0.5086713057903272,SNX4/VAMP7/RAB15/CDK5
BP,GO:0046031,ADP metabolic process,2.066179725542275,7,0.053853133984193474,0.5086713057903272,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0006505,GPI anchor metabolic process,3.4866782868525896,3,0.053893149654776554,0.5086713057903272,PIGB/DPM2/PIGN
BP,GO:0140014,mitotic nuclear division,1.690510684534589,12,0.0540967904022777,0.5094114429547817,STAG2/WRAP73/INO80/CEP85/VPS4A/BOD1/HNRNPU/CLASP2/CDC26/RCC1/NUP62/CHMP1B
BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,1.4939396747049858,19,0.05435501252718869,0.5106609491007011,RC3H2/BAX/SPG21/TAB1/PLEKHA1/PIK3CA/MAP3K7/APPL2/CMTM3/BCL10/PAK1/BTRC/YES1/ACTG1/PDE4B/CARD9/MYO1C/CARD11/CYFIP1
BP,GO:0030705,cytoskeleton-dependent intracellular transport,1.859561752988048,9,0.054716961408919296,0.5116979287620315,VAMP7/TERF2/KIF13A/FNBP1L/SNAPIN/HNRNPU/BLOC1S5/MYO5A/MYO1C
BP,GO:1901796,regulation of signal transduction by p53 class mediator,1.859561752988048,9,0.054716961408919296,0.5116979287620315,CSNK2A2/RBBP7/PRKAG2/TBP/PRKAA2/RBBP4/CDK5/TRIAP1/CSNK2B
BP,GO:0031532,actin cytoskeleton reorganization,2.2093803005798587,6,0.0549706185035814,0.512891000166443,RAP2A/CAPN10/PAK1/CDK5/PTPN1/PARVA
MF,GO:0045309,protein phosphorylated amino acid binding,2.7760000000000002,4,0.05553744271011638,0.4653952932165256,NEDD4/RTF1/BTRC/YES1
BP,GO:0045727,positive regulation of translation,2.049910593845092,7,0.055741608108813186,0.5188944205644211,SAMD4A/CIRBP/CDK4/EIF5A2/TRUB2/NGRN/YTHDF3
CC,GO:0045335,phagocytic vesicle,2.04618098796181,7,0.056288647517813865,0.34508996604326675,RAB7A/KIF16B/STX12/VAMP7/APPL2/ACTG1/MYO1C
CC,GO:0005671,Ada2/Gcn5/Ada3 transcription activator complex,5.144683626875407,2,0.05633679671142382,0.34508996604326675,MAP3K7/TADA3
CC,GO:0016581,NuRD complex,5.144683626875407,2,0.05633679671142382,0.34508996604326675,RBBP7/RBBP4
CC,GO:0045120,pronucleus,5.144683626875407,2,0.05633679671142382,0.34508996604326675,CBX1/TBP
CC,GO:0090545,CHD-type complex,5.144683626875407,2,0.05633679671142382,0.34508996604326675,RBBP7/RBBP4
CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,5.144683626875407,2,0.05633679671142382,0.34508996604326675,EPM2AIP1/PTPN1
BP,GO:0051701,interaction with host,1.7794849310890408,10,0.05661008380321548,0.5197969038770394,NEDD4/RAB7A/THOC5/MET/EXOC2/VPS4A/CLDN1/P4HB/KPNA5/CLDN9
BP,GO:0006090,pyruvate metabolic process,1.932012210896673,8,0.05663064902882126,0.5197969038770394,PGM1/PRKAG2/MPC2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:1990845,adaptive thermogenesis,1.932012210896673,8,0.05663064902882126,0.5197969038770394,ACVR2B/KDM3A/DOCK7/APPL2/HNRNPU/OMA1/RBPJ/UCP2
BP,GO:0032210,regulation of telomere maintenance via telomerase,2.7549063007230337,4,0.05696242343604699,0.5197969038770394,SMG6/TERF2/HMBOX1/HNRNPU
BP,GO:0032663,regulation of interleukin-2 production,2.7549063007230337,4,0.05696242343604699,0.5197969038770394,MAP3K7/PDE4B/CARD9/CARD11
BP,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,2.187719709397703,6,0.0571462082825637,0.5197969038770394,GTF2H1/CCND3/CNPPD1/CDKN1A/CDK4/CCNB3
BP,GO:0006900,vesicle budding from membrane,2.187719709397703,6,0.0571462082825637,0.5197969038770394,RAB7A/VPS4A/FNBP1L/MCFD2/MYO18A/PDCD6
CC,GO:0009925,basal plasma membrane,3.4045700471969607,3,0.057253180974879324,0.34508996604326675,ITGA6/MET/MYO1C
CC,GO:0030285,integral component of synaptic vesicle membrane,3.4045700471969607,3,0.057253180974879324,0.34508996604326675,VAMP4/STX12/VAMP7
CC,GO:0042470,melanosome,2.1840638038622013,6,0.057625387803770065,0.34508996604326675,CTNS/RAB7A/ANKRD27/CALU/P4HB/MYO5A
CC,GO:0048770,pigment granule,2.1840638038622013,6,0.057625387803770065,0.34508996604326675,CTNS/RAB7A/ANKRD27/CALU/P4HB/MYO5A
MF,GO:0004065,arylsulfatase activity,5.056285714285714,2,0.05793369159871985,0.4653952932165256,ARSK/ARSJ
MF,GO:0048185,activin binding,5.056285714285714,2,0.05793369159871985,0.4653952932165256,TGFBR1/ACVR2B
BP,GO:0043523,regulation of neuron apoptotic process,1.7710111933219503,10,0.05808795439505465,0.5197969038770394,GCLM/BAX/LANCL1/PIK3CA/EGLN3/MCL1/FOXQ1/CDK5/NSMF/NUPR1
MF,GO:0019003,GDP binding,2.391486486486486,5,0.05812622547205222,0.4653952932165256,RAB7A/RAP2A/RIT1/RHEBL1/RAP2B
BP,GO:0016242,negative regulation of macroautophagy,3.381021369069178,3,0.058142568174631926,0.5197969038770394,PIK3CA/MTM1/NUPR1
BP,GO:0018279,protein N-linked glycosylation via asparagine,3.381021369069178,3,0.058142568174631926,0.5197969038770394,DPM2/MCFD2/OSTC
BP,GO:0031112,positive regulation of microtubule polymerization or depolymerization,3.381021369069178,3,0.058142568174631926,0.5197969038770394,MAPRE1/MET/PAK1
BP,GO:0043928,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,3.381021369069178,3,0.058142568174631926,0.5197969038770394,CNOT6/LSM7/CNOT7
BP,GO:0048011,neurotrophin TRK receptor signaling pathway,3.381021369069178,3,0.058142568174631926,0.5197969038770394,ZFYVE27/FRS2/CYFIP1
BP,GO:0051194,positive regulation of cofactor metabolic process,3.381021369069178,3,0.058142568174631926,0.5197969038770394,ARNT/PRKAA2/ENTPD5
BP,GO:2001038,regulation of cellular response to drug,3.381021369069178,3,0.058142568174631926,0.5197969038770394,PDE8A/MET/STK26
BP,GO:0009165,nucleotide biosynthetic process,1.5416055983320602,16,0.05859858879226985,0.5197969038770394,PGM1/PRKAG2/ADCY7/RFK/MPC2/ARNT/ADCY9/CMPK1/PRKAA2/CDS1/ADCY1/TK2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0008306,associative learning,2.3840535294718563,5,0.058894060973831146,0.5197969038770394,CTNS/DDHD2/NDRG4/CDK5/RIN1
BP,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,2.3840535294718563,5,0.058894060973831146,0.5197969038770394,USP28/BAX/CDKN1A/TRIAP1/NUPR1
CC,GO:0055038,recycling endosome membrane,2.3817979754052816,5,0.05918915072863256,0.35042667647292686,EHD4/STX12/RAP2A/ZFYVE27/RAP2B
BP,GO:0071482,cellular response to light stimulus,2.0181290342505944,7,0.05964086264406259,0.5197969038770394,USP28/NEDD4/BAX/CDKN1A/INO80/NMT2/TRIAP1
BP,GO:0007039,protein catabolic process in the vacuole,4.958831341301461,2,0.060136344585604386,0.5197969038770394,GBA/TMEM199
BP,GO:0032486,Rap protein signal transduction,4.958831341301461,2,0.060136344585604386,0.5197969038770394,RAP2A/RAP2B
BP,GO:0033008,positive regulation of mast cell activation involved in immune response,4.958831341301461,2,0.060136344585604386,0.5197969038770394,SNX4/VAMP7
BP,GO:0035635,entry of bacterium into host cell,4.958831341301461,2,0.060136344585604386,0.5197969038770394,MET/EXOC2
BP,GO:0042362,fat-soluble vitamin biosynthetic process,4.958831341301461,2,0.060136344585604386,0.5197969038770394,VDR/UBIAD1
BP,GO:0043306,positive regulation of mast cell degranulation,4.958831341301461,2,0.060136344585604386,0.5197969038770394,SNX4/VAMP7
BP,GO:0048070,regulation of developmental pigmentation,4.958831341301461,2,0.060136344585604386,0.5197969038770394,BAX/BLOC1S5
BP,GO:0051299,centrosome separation,4.958831341301461,2,0.060136344585604386,0.5197969038770394,CEP85/NUP62
BP,GO:0060339,negative regulation of type I interferon-mediated signaling pathway,4.958831341301461,2,0.060136344585604386,0.5197969038770394,YTHDF3/CNOT7
BP,GO:0090141,positive regulation of mitochondrial fission,4.958831341301461,2,0.060136344585604386,0.5197969038770394,DDHD2/DDHD1
BP,GO:0098840,protein transport along microtubule,4.958831341301461,2,0.060136344585604386,0.5197969038770394,TERF2/HNRNPU
BP,GO:0099118,microtubule-based protein transport,4.958831341301461,2,0.060136344585604386,0.5197969038770394,TERF2/HNRNPU
BP,GO:0006383,transcription by RNA polymerase III,2.704817095255342,4,0.06018297485891975,0.5197969038770394,ELL/TBP/POLR3F/POLR3C
BP,GO:0044380,protein localization to cytoskeleton,2.704817095255342,4,0.06018297485891975,0.5197969038770394,MAPRE1/DIAPH1/HNRNPU/NUP62
BP,GO:0070830,bicellular tight junction assembly,2.704817095255342,4,0.06018297485891975,0.5197969038770394,MARVELD2/CLDN1/CLDN3/MYO1C
MF,GO:0030291,protein serine/threonine kinase inhibitor activity,3.3181875,3,0.060745427811529765,0.4653952932165256,PRKAG2/PRKAR2A/CDKN1A
BP,GO:0019058,viral life cycle,1.5874307647458945,14,0.06079136369180174,0.5239391260556133,PKN2/RAB7A/PPIE/EEA1/HTATSF1/VPS4A/NMT2/CLDN1/BANF1/P4HB/CNOT7/NUP62/CLDN9/CHMP1B
MF,GO:0003725,double-stranded RNA binding,2.3596,5,0.060902175355471204,0.4653952932165256,RC3H2/AGO4/HNRNPU/STRBP/DUS2
BP,GO:0009100,glycoprotein metabolic process,1.508952257794597,17,0.061463560436459105,0.5268901846769518,B4GALT7/IMPAD1/IDUA/EDEM1/ITM2B/DPM2/GALNT1/NGLY1/ST6GALNAC6/MGAT4B/RFNG/FUT1/MCFD2/POMK/ENTPD5/OSTC/B3GNT9
BP,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,2.1456481765246704,6,0.06165053895996417,0.5268901846769518,USP28/BAX/CDKN1A/MCL1/TRIAP1/NUPR1
BP,GO:1901800,positive regulation of proteasomal protein catabolic process,2.1456481765246704,6,0.06165053895996417,0.5268901846769518,CHFR/EDEM1/RCHY1/RNF180/NUPR1/GBA
BP,GO:0042157,lipoprotein metabolic process,2.002604964756359,7,0.06165185051775542,0.5268901846769518,PIGB/DPM2/NMT2/GBA/APOD/PIGN/ZDHHC18
BP,GO:0032984,protein-containing complex disassembly,1.5826057472238706,14,0.06201202914224557,0.5278696334318772,MTRF1L/CAPZA1/VPS4A/MICAL2/SNX14/SNAPIN/CLASP2/EIF5A2/GABARAP/TRMT112/GBA/ASPH/CHMP1B/LIX1L
BP,GO:0006099,tricarboxylic acid cycle,3.281579564096555,3,0.06254502539679567,0.5278696334318772,CS/IDH3G/SDHAF2
BP,GO:0018196,peptidyl-asparagine modification,3.281579564096555,3,0.06254502539679567,0.5278696334318772,DPM2/MCFD2/OSTC
BP,GO:0036474,cell death in response to hydrogen peroxide,3.281579564096555,3,0.06254502539679567,0.5278696334318772,PDE8A/MET/STK26
BP,GO:0043276,anoikis,3.281579564096555,3,0.06254502539679567,0.5278696334318772,PIK3CA/MAP3K7/MCL1
BP,GO:0097009,energy homeostasis,3.281579564096555,3,0.06254502539679567,0.5278696334318772,PIK3CA/PRKAA2/OMA1
CC,GO:0044449,contractile fiber part,1.7459333575369032,10,0.0628132690129032,0.36010057190891287,ACTA2/DCTN4/PSEN2/PAK1/MTMR12/TPM4/MTM1/PDE4B/MYL6B/PARVA
BP,GO:0006979,response to oxidative stress,1.4843508449572,18,0.06291305417893762,0.5282113226515791,ALS2/GCLM/PDE8A/SESN1/MET/PLEKHA1/LANCL1/SDC1/MAPKAP1/STK26/NUDT15/MCL1/ARNT/PRKAA2/SCARA3/P4HB/APOD/AKR1C3
BP,GO:1901293,nucleoside phosphate biosynthetic process,1.5257942588619877,16,0.06303444382798887,0.5282113226515791,PGM1/PRKAG2/ADCY7/RFK/MPC2/ARNT/ADCY9/CMPK1/PRKAA2/CDS1/ADCY1/TK2/NUPR1/DNAJC30/ENTPD5/NUP62
CC,GO:0035098,ESC/E(Z) complex,4.823140900195694,2,0.06330838195714933,0.36010057190891287,RBBP7/RBBP4
CC,GO:0070822,Sin3-type complex,4.823140900195694,2,0.06330838195714933,0.36010057190891287,SUDS3/RBBP4
BP,GO:0031295,T cell costimulation,2.6565167899829256,4,0.0634981984761952,0.5282113226515791,PIK3CA/PAK1/YES1/CARD11
BP,GO:0090307,mitotic spindle assembly,2.6565167899829256,4,0.0634981984761952,0.5282113226515791,STAG2/WRAP73/HNRNPU/CHMP1B
BP,GO:0120192,tight junction assembly,2.6565167899829256,4,0.0634981984761952,0.5282113226515791,MARVELD2/CLDN1/CLDN3/MYO1C
CC,GO:0005925,focal adhesion,1.52435070425938,16,0.06358781692057579,0.36010057190891287,ITGA6/MAPRE1/PRKAR2A/DOCK7/DCTN4/PAK1/CLASP2/TPM4/KLF11/YES1/ACTG1/P4HB/PPP1CC/NHS/PARVA/CYFIP1
BP,GO:1902850,microtubule cytoskeleton organization involved in mitosis,1.9873179039566924,7,0.0637038548603722,0.5282113226515791,STAG2/WRAP73/HNRNPU/CLASP2/RCC1/NUP62/CHMP1B
MF,GO:0004722,protein serine/threonine phosphatase activity,2.3285526315789475,5,0.06375214764043426,0.4653952932165256,PHLPP2/TAB1/MTMR3/MTMR6/PPP1CC
BP,GO:0048515,spermatid differentiation,1.883100509354985,8,0.06384010397489097,0.5282113226515791,MAST2/BAX/PLA2G3/KDM3A/PYGO2/STRBP/AGFG1/OSBP2
BP,GO:0032006,regulation of TOR signaling,2.1252134319863405,6,0.06397935984064043,0.5282113226515791,SESN1/PIK3CA/PRKAA2/MTM1/GBA/PDCD6
CC,GO:0016591,"RNA polymerase II, holoenzyme",2.324405253106359,5,0.06438444979155815,0.3606913800150731,GTF2H1/TBP/RTF1/POLR2J3/TADA3
BP,GO:0043687,post-translational protein modification,1.545342176998378,15,0.06448751108077867,0.5282113226515791,KLHL42/RBBP7/WSB1/KLHL2/FBXO30/COPS5/FBXL12/CALU/MBTPS1/FN3KRP/SUMF1/BTRC/ASB8/P4HB/KLHL9
MF,GO:0005154,epidermal growth factor receptor binding,3.2176363636363634,3,0.06547310021241853,0.4653952932165256,SNX1/SNX4/YES1
MF,GO:0000900,"translation repressor activity, mRNA regulatory element binding",4.7192,2,0.06562846750947816,0.4653952932165256,PAIP2/CELF1
MF,GO:0001056,RNA polymerase III activity,4.7192,2,0.06562846750947816,0.4653952932165256,POLR3F/POLR3C
MF,GO:0003841,1-acylglycerol-3-phosphate O-acyltransferase activity,4.7192,2,0.06562846750947816,0.4653952932165256,LPCAT2/LPGAT1
MF,GO:0004029,aldehyde dehydrogenase (NAD) activity,4.7192,2,0.06562846750947816,0.4653952932165256,ALDH1L1/ALDH4A1
MF,GO:0005024,transforming growth factor beta-activated receptor activity,4.7192,2,0.06562846750947816,0.4653952932165256,TGFBR1/ACVR2B
MF,GO:0005545,1-phosphatidylinositol binding,4.7192,2,0.06562846750947816,0.4653952932165256,EEA1/WDFY3
MF,GO:0017160,Ral GTPase binding,4.7192,2,0.06562846750947816,0.4653952932165256,EXOC2/MYO1C
MF,GO:0042171,lysophosphatidic acid acyltransferase activity,4.7192,2,0.06562846750947816,0.4653952932165256,LPCAT2/LPGAT1
MF,GO:0042809,vitamin D receptor binding,4.7192,2,0.06562846750947816,0.4653952932165256,MED4/TOB2
BP,GO:0003158,endothelium development,1.9722624652903538,7,0.06579693603753224,0.5282113226515791,MET/ACVR2B/STARD13/MARVELD2/CLDN1/RBPJ/CSNK2B
BP,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,1.9722624652903538,7,0.06579693603753224,0.5282113226515791,BAX/EGLN3/BCL10/CRADD/PIDD1/CARD9/PDCD6
BP,GO:0032388,positive regulation of intracellular transport,1.7298248865005095,10,0.06585447530668606,0.5282113226515791,NEDD4/CSNK2A2/SNX4/VAMP7/XPO4/EDEM1/CAPN10/PAK1/CDK5/MYO1C
BP,GO:1904029,regulation of cyclin-dependent protein kinase activity,2.1051642486657145,6,0.06635929184805162,0.5282113226515791,GTF2H1/CCND3/CNPPD1/CDKN1A/CDK4/CCNB3
BP,GO:0018208,peptidyl-proline modification,2.6099112322639266,4,0.06690736007177987,0.5282113226515791,PPIE/FKBP9/EGLN3/P4HB
BP,GO:0031294,lymphocyte costimulation,2.6099112322639266,4,0.06690736007177987,0.5282113226515791,PIK3CA/PAK1/YES1/CARD11
BP,GO:0043525,positive regulation of neuron apoptotic process,2.6099112322639266,4,0.06690736007177987,0.5282113226515791,BAX/MCL1/CDK5/NUPR1
BP,GO:0048008,platelet-derived growth factor receptor signaling pathway,2.6099112322639266,4,0.06690736007177987,0.5282113226515791,NDRG4/PLEKHA1/APOD/PTPN1
BP,GO:0071398,cellular response to fatty acid,2.6099112322639266,4,0.06690736007177987,0.5282113226515791,CDK4/PRKAA2/CLDN1/AKR1C3
BP,GO:0045862,positive regulation of proteolysis,1.5368278950314445,15,0.06692735702236886,0.5282113226515791,CHFR/BAX/EGLN3/EDEM1/BCL10/RCHY1/RNF180/BTRC/CRADD/NUPR1/PIDD1/GBA/CARD9/ASPH/PDCD6
CC,GO:0005924,cell-substrate adherens junction,1.5131422431986492,16,0.06695096365040498,0.3710792772538404,ITGA6/MAPRE1/PRKAR2A/DOCK7/DCTN4/PAK1/CLASP2/TPM4/KLF11/YES1/ACTG1/P4HB/PPP1CC/NHS/PARVA/CYFIP1
MF,GO:0005506,iron ion binding,1.8628421052631579,8,0.06696335154194613,0.4653952932165256,CYP26B1/KDM7A/FTL/KDM3A/EGLN3/DOHH/ISCU/PHF8
MF,GO:0035257,nuclear hormone receptor binding,1.8628421052631579,8,0.06696335154194613,0.4653952932165256,VDR/KDM3A/MED4/PRMT2/TADA3/TOB2/C1D/NUP62
BP,GO:0006417,regulation of translation,1.4911580094715478,17,0.06699464783911156,0.5282113226515791,SAMD4A/CIRBP/MKNK2/CNOT6/RPS6KA1/PAIP2/AGO4/CDK4/CELF1/CNOT11/EIF5A2/TRUB2/NGRN/CNOT10/YTHDF3/CNOT7/CYFIP1
BP,GO:0110110,positive regulation of animal organ morphogenesis,2.2957552506025283,5,0.06706820392705477,0.5282113226515791,BAX/TGFBR1/VDR/FRS2/RBPJ
BP,GO:1903533,regulation of protein targeting,2.2957552506025283,5,0.06706820392705477,0.5282113226515791,CSNK2A2/VAMP7/PAK1/CDK5/MYO1C
BP,GO:0000291,"nuclear-transcribed mRNA catabolic process, exonucleolytic",3.1878201479795107,3,0.06709738787014209,0.5282113226515791,CNOT6/LSM7/CNOT7
BP,GO:0006101,citrate metabolic process,3.1878201479795107,3,0.06709738787014209,0.5282113226515791,CS/IDH3G/SDHAF2
BP,GO:0045070,positive regulation of viral genome replication,3.1878201479795107,3,0.06709738787014209,0.5282113226515791,PKN2/PPIE/CNOT7
BP,GO:0060338,regulation of type I interferon-mediated signaling pathway,3.1878201479795107,3,0.06709738787014209,0.5282113226515791,YTHDF3/PTPN1/CNOT7
BP,GO:0001946,lymphangiogenesis,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,ACVR2B/PTPN14
BP,GO:0003222,ventricular trabecula myocardium morphogenesis,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,TGFBR1/RBPJ
BP,GO:0006047,UDP-N-acetylglucosamine metabolic process,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,UAP1/AMDHD2
BP,GO:0022038,corpus callosum development,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,C12orf57/CDK5
BP,GO:0030033,microvillus assembly,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,RAP2A/STK26
BP,GO:0043981,histone H4-K5 acetylation,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,ING4/KANSL3
BP,GO:0043982,histone H4-K8 acetylation,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,ING4/KANSL3
BP,GO:0048385,regulation of retinoic acid receptor signaling pathway,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,CYP26B1/AKR1C3
BP,GO:0048820,hair follicle maturation,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,RBPJ/MYO5A
BP,GO:0090335,regulation of brown fat cell differentiation,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,DUSP10/HNRNPU
BP,GO:1902001,fatty acid transmembrane transport,4.6489043824701195,2,0.06753647959548216,0.5282113226515791,PRKAG2/PRKAA2
BP,GO:0006754,ATP biosynthetic process,1.8595617529880477,8,0.06764948355493429,0.5282113226515791,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0046661,male sex differentiation,1.8595617529880477,8,0.06764948355493429,0.5282113226515791,BAX/TGFBR1/PLEKHA1/SDC1/SAFB2/AGO4/NUPR1/AKR1C3
BP,GO:0006367,transcription initiation from RNA polymerase II promoter,1.7804314656268545,9,0.06804209498331062,0.529245205338638,BAX/GTF2H1/VDR/TBP/CDKN1A/CDK4/MED4/NRBF2/RBPJ
BP,GO:0009142,nucleoside triphosphate biosynthetic process,1.7804314656268545,9,0.06804209498331062,0.529245205338638,PGM1/PRKAG2/ARNT/CMPK1/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0048524,positive regulation of viral process,2.0854898164351936,6,0.06879030642755797,0.5326818931635434,PKN2/RAB7A/PPIE/VPS4A/P4HB/CNOT7
BP,GO:0016054,organic acid catabolic process,1.6228902571532053,12,0.06900424621389938,0.5326818931635434,CYP26B1/HSD17B10/ARG2/FAH/IDUA/LPIN3/ALDH1L1/QDPR/ALDH4A1/AMDHD2/PCBD1/ACAD11
BP,GO:0046395,carboxylic acid catabolic process,1.6228902571532053,12,0.06900424621389938,0.5326818931635434,CYP26B1/HSD17B10/ARG2/FAH/IDUA/LPIN3/ALDH1L1/QDPR/ALDH4A1/AMDHD2/PCBD1/ACAD11
BP,GO:0017157,regulation of exocytosis,1.713881799988984,10,0.06913865279998795,0.5326818931635434,RAB7A/SNX4/SDC1/VAMP7/VPS4A/RAB15/SNAPIN/CLASP2/ADCY1/CDK5
BP,GO:0043393,regulation of protein binding,1.713881799988984,10,0.06913865279998795,0.5326818931635434,BAX/MAPRE1/MET/TGFBR1/SNAPIN/DTX3L/CDK5/PCBD1/RFNG/LDOC1
CC,GO:0030173,integral component of Golgi membrane,2.5723418134377036,4,0.0699182175150962,0.3772295591175909,UBIAD1/TEX261/SGMS2/RFNG
BP,GO:0018210,peptidyl-threonine modification,1.942825712077065,7,0.07010648376294996,0.5391175348727418,CSNK2A2/DYRK1B/PRKAG2/TGFBR1/GALNT1/CDK5/CSNK2B
BP,GO:0051058,negative regulation of small GTPase mediated signal transduction,2.564912762742135,4,0.07040963829959065,0.5404271860428957,MET/MAPKAP1/ARHGAP12/NUP62
CC,GO:0005666,RNA polymerase III complex,4.539426729595948,2,0.07055261194403804,0.3772295591175909,POLR3F/POLR3C
CC,GO:0097440,apical dendrite,4.539426729595948,2,0.07055261194403804,0.3772295591175909,NSMF/OSBP2
BP,GO:1903362,regulation of cellular protein catabolic process,1.6562898204751844,11,0.07095095352307297,0.5435564574987963,CSNK2A2/CHFR/EDEM1/NUDT15/RYBP/RCHY1/RNF180/BTRC/MTM1/NUPR1/GBA
BP,GO:0018205,peptidyl-lysine modification,1.4988910855319277,16,0.0713362131405858,0.544902239554794,METTL22/ING4/KANSL3/KDM3A/ZMIZ2/DOHH/MAP3K7/RTF1/HMG20A/ARNT/RPS6KA4/PRKAA2/PYGO2/TADA3/LDB1/NUP62
CC,GO:0030055,cell-substrate junction,1.498451541808371,16,0.07161877863658958,0.3772295591175909,ITGA6/MAPRE1/PRKAR2A/DOCK7/DCTN4/PAK1/CLASP2/TPM4/KLF11/YES1/ACTG1/P4HB/PPP1CC/NHS/PARVA/CYFIP1
CC,GO:0098687,chromosomal region,1.5478274522117987,14,0.07168085672292034,0.3772295591175909,SMG6/CBX5/THOC5/STAG2/CBX1/TERF2/DCTN4/PSEN2/BOD1/HMBOX1/HNRNPU/CLASP2/TRAPPC12/PPP1CC
BP,GO:0006361,transcription initiation from RNA polymerase I promoter,3.099269588313413,3,0.07179636194723933,0.544902239554794,GTF2H1/TBP/CD3EAP
BP,GO:0032205,negative regulation of telomere maintenance,3.099269588313413,3,0.07179636194723933,0.544902239554794,SMG6/TERF2/HNRNPU
BP,GO:0050931,pigment cell differentiation,3.099269588313413,3,0.07179636194723933,0.544902239554794,ANKRD27/BLOC1S5/MYO5A
BP,GO:2001171,positive regulation of ATP biosynthetic process,3.099269588313413,3,0.07179636194723933,0.544902239554794,ARNT/PRKAA2/ENTPD5
BP,GO:0001889,liver development,1.9284344105061237,7,0.07232298456379982,0.5465213327489296,CSNK2A2/MET/RPS6KA1/PIK3CA/QDPR/CLDN1/CSNK2B
BP,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,1.9284344105061237,7,0.07232298456379982,0.5465213327489296,SPRTN/CHFR/BCL10/ARNT/RCHY1/RNF180/PDCD6
BP,GO:0043543,protein acylation,1.6496112324893974,11,0.07254707956844197,0.5465213327489296,ING4/KANSL3/MAP3K7/NMT2/RPS6KA4/PRKAA2/PYGO2/TADA3/NUPR1/LDB1/ZDHHC18
BP,GO:0046434,organophosphate catabolic process,1.6496112324893974,11,0.07254707956844197,0.5465213327489296,PDE8A/PGM1/PRKAG2/MBD4/NUDT15/ARNT/PRKAA2/NUPR1/PDE4B/ENTPD5/NUP62
BP,GO:0042594,response to starvation,1.7524665734965896,9,0.0735205143121752,0.552830780447188,SESN1/MTMR3/GNPAT/CDKN1A/STK26/PRKAA2/GABARAP/GBA/AKR1C3
MF,GO:0005521,lamin binding,4.42425,2,0.07364067297571944,0.49291379546481207,LBR/PPP1CC
MF,GO:0016307,phosphatidylinositol phosphate kinase activity,4.42425,2,0.07364067297571944,0.49291379546481207,PIK3CA/PIP4K2A
MF,GO:0071617,lysophospholipid acyltransferase activity,4.42425,2,0.07364067297571944,0.49291379546481207,LPCAT2/LPGAT1
BP,GO:0009895,negative regulation of catabolic process,1.569759921353547,13,0.0738434577522802,0.5533243646804269,CSNK2A2/CIRBP/MET/PIK3CA/DHX34/MCL1/NBAS/HNRNPU/RYBP/MTM1/NUPR1/HNRNPA0/PKP3
CC,GO:0030135,coated vesicle,1.6021506104456285,12,0.0744773416499549,0.3857249591990922,DDHD2/SPG21/COPE/TMED5/VAMP4/VAMP7/IDUA/TEX261/IL7R/MCFD2/TMEM199/PDCD6
BP,GO:0035690,cellular response to drug,1.5118388235675186,15,0.07461506344542106,0.5533243646804269,GCLM/PDE8A/MET/PLEKHA1/ADCY7/RAP2A/STK26/CDK4/QDPR/GABPA/PRKAA2/ADCY1/PPP1R14A/LDOC1/PDE4B
BP,GO:0001675,acrosome assembly,4.375439418795406,2,0.0752183809410708,0.5533243646804269,PLA2G3/AGFG1
BP,GO:0003198,epithelial to mesenchymal transition involved in endocardial cushion formation,4.375439418795406,2,0.0752183809410708,0.5533243646804269,TGFBR1/RBPJ
BP,GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",4.375439418795406,2,0.0752183809410708,0.5533243646804269,ING4/CDKN1A
BP,GO:0033262,regulation of nuclear cell cycle DNA replication,4.375439418795406,2,0.0752183809410708,0.5533243646804269,INO80/TERF2
BP,GO:0033599,regulation of mammary gland epithelial cell proliferation,4.375439418795406,2,0.0752183809410708,0.5533243646804269,BAX/PYGO2
BP,GO:0035518,histone H2A monoubiquitination,4.375439418795406,2,0.0752183809410708,0.5533243646804269,RYBP/RNF168
BP,GO:0035729,cellular response to hepatocyte growth factor stimulus,4.375439418795406,2,0.0752183809410708,0.5533243646804269,GCLM/APPL2
BP,GO:0061952,midbody abscission,4.375439418795406,2,0.0752183809410708,0.5533243646804269,VPS4A/CHMP1B
BP,GO:0070131,positive regulation of mitochondrial translation,4.375439418795406,2,0.0752183809410708,0.5533243646804269,TRUB2/NGRN
BP,GO:2000811,negative regulation of anoikis,4.375439418795406,2,0.0752183809410708,0.5533243646804269,PIK3CA/MCL1
BP,GO:0043112,receptor metabolic process,1.743339143426295,9,0.07540549882787269,0.5536995834508774,ALS2/SNX1/NEDD4/KIF16B/USP46/DTX3L/CDK5/PTPN1/CNPY2
MF,GO:0016229,steroid dehydrogenase activity,3.033771428571429,3,0.07541473107702064,0.49291379546481207,HSD17B10/HSD17B14/AKR1C3
MF,GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",3.033771428571429,3,0.07541473107702064,0.49291379546481207,ALDH1L1/ALDH4A1/AKR1C3
CC,GO:0031256,leading edge membrane,1.8157706918383791,8,0.07550354198750113,0.3857249591990922,RASGRP2/PLEKHA1/DIAPH1/APPL2/MTMR6/PAK1/CLASP2/MYO1C
CC,GO:0071013,catalytic step 2 spliceosome,2.2175360460669857,5,0.07551621082208716,0.3857249591990922,PPIE/WDR83/LSM7/CWC15/HNRNPU
MF,GO:0003714,transcription corepressor activity,1.635857142857143,11,0.07579992479987356,0.49291379546481207,ZMYND11/ZNF85/HNRNPU/RYBP/ZHX1/TBL1XR1/ZHX2/TOB2/C1D/LDB1/CNOT7
BP,GO:0010507,negative regulation of autophagy,2.213763991652438,5,0.07584058971464536,0.5548912211495994,MET/PIK3CA/MCL1/MTM1/NUPR1
BP,GO:1905897,regulation of response to endoplasmic reticulum stress,2.213763991652438,5,0.07584058971464536,0.5548912211495994,BAX/COPS5/EDEM1/NUPR1/PTPN1
MF,GO:0030295,protein kinase activator activity,2.212125,5,0.07588744764710056,0.49291379546481207,ALS2/TAB1/PRKAG2/PIK3CA/CDKN1A
BP,GO:0006605,protein targeting,1.4635439722591117,17,0.07652891312814447,0.5567240363871078,SEC62/AGPS/TOMM34/NEDD4/CSNK2A2/RAB7A/AP4E1/GNPAT/VAMP7/VPS4A/RTP4/PAK1/CDK5/GABARAP/TOMM20/MYO1C/ZDHHC18
BP,GO:0009152,purine ribonucleotide biosynthetic process,1.5939100739897554,12,0.07658497311458824,0.5567240363871078,PGM1/PRKAG2/ADCY7/MPC2/ARNT/ADCY9/PRKAA2/ADCY1/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0021587,cerebellum morphogenesis,3.0155055453860236,3,0.07663851041710432,0.5567240363871078,GNPAT/CDK5/LDB1
BP,GO:0031935,regulation of chromatin silencing,3.0155055453860236,3,0.07663851041710432,0.5567240363871078,ASF1A/ATAD2B/PHF8
BP,GO:0043966,histone H3 acetylation,2.4794156706507304,4,0.07768984473339967,0.5629587188621886,ING4/MAP3K7/TADA3/LDB1
BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,1.8032113968368946,8,0.07777354965598575,0.5629587188621886,BAX/PTPMT1/PLAGL2/MCL1/TRIAP1/NUPR1/P4HB/PTPN1
MF,GO:0008234,cysteine-type peptidase activity,1.731228260869565,9,0.07783602947137905,0.4946605905807372,USP28/CAPN6/USP31/USP46/COPS5/PGPEP1/ATG4D/CAPN10/OTUD3
CC,GO:0016327,apicolateral plasma membrane,4.287236355729506,2,0.07805073472491514,0.3872803123017218,NEDD4/CLDN3
CC,GO:0032433,filopodium tip,4.287236355729506,2,0.07805073472491514,0.3872803123017218,MYO5A/CYFIP1
CC,GO:0090723,growth cone part,4.287236355729506,2,0.07805073472491514,0.3872803123017218,ZFYVE27/CYFIP1
BP,GO:1990778,protein localization to cell periphery,1.5546175426909725,13,0.07827701959248416,0.5655966531123012,ARFRP1/VAMP7/RAP2A/VPS4A/KIF13A/RAB15/STAC/ZFYVE27/CLASP2/LZTFL1/CDK5/PKP3/MYO5A
BP,GO:0061008,hepaticobiliary system development,1.886511923321208,7,0.07921923951697696,0.5713898339628763,CSNK2A2/MET/RPS6KA1/PIK3CA/QDPR/CLDN1/CSNK2B
MF,GO:0019902,phosphatase binding,1.7218702702702702,9,0.07988924480411447,0.4946605905807372,MAST2/MTMR3/ELL/MET/SBF2/BOD1/CARHSP1/PPP1CC/PTPN1
MF,GO:0008378,galactosyltransferase activity,2.9495000000000005,3,0.08062064019135812,0.4946605905807372,B4GALT7/WDFY3/B3GNT9
MF,GO:0000287,magnesium ion binding,1.6616901408450704,10,0.08095109390855681,0.4946605905807372,IDH3G/PGM1/MAST2/PAPOLA/RPS6KA1/RAP2A/STK26/MAP3K7/RPS6KA4/PDCD6
BP,GO:0072522,purine-containing compound biosynthetic process,1.544683884271222,13,0.08132566108020803,0.5733922905734911,PGM1/PRKAG2/MTHFD1L/ADCY7/MPC2/ARNT/ADCY9/PRKAA2/ADCY1/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,2.4387695121154724,4,0.08146572628079247,0.5733922905734911,BAX/PLAGL2/MCL1/NUPR1
BP,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,1.8729398950958756,7,0.08160009945215482,0.5733922905734911,PIK3CA/APPL2/PAK1/YES1/ACTG1/MYO1C/CYFIP1
BP,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,1.8729398950958756,7,0.08160009945215482,0.5733922905734911,PIK3CA/APPL2/PAK1/YES1/ACTG1/MYO1C/CYFIP1
BP,GO:0007190,activation of adenylate cyclase activity,2.936150136296918,3,0.08162026820941388,0.5733922905734911,ADCY7/ADCY9/ADCY1
BP,GO:0016572,histone phosphorylation,2.936150136296918,3,0.08162026820941388,0.5733922905734911,RPS6KA4/PRKAA2/CDK5
BP,GO:0032350,regulation of hormone metabolic process,2.936150136296918,3,0.08162026820941388,0.5733922905734911,VDR/ARNT/AKR1C3
BP,GO:0046329,negative regulation of JNK cascade,2.936150136296918,3,0.08162026820941388,0.5733922905734911,ZMYND11/TAOK3/DUSP10
BP,GO:0046825,regulation of protein export from nucleus,2.936150136296918,3,0.08162026820941388,0.5733922905734911,XPO4/PTPN14/CDK5
BP,GO:0051590,positive regulation of neurotransmitter transport,2.936150136296918,3,0.08162026820941388,0.5733922905734911,SNX4/VAMP7/CDK5
BP,GO:1905898,positive regulation of response to endoplasmic reticulum stress,2.936150136296918,3,0.08162026820941388,0.5733922905734911,BAX/EDEM1/PTPN1
MF,GO:0004198,calcium-dependent cysteine-type endopeptidase activity,4.164000000000001,2,0.08194631038092944,0.4946605905807372,CAPN6/CAPN10
MF,GO:0004675,transmembrane receptor protein serine/threonine kinase activity,4.164000000000001,2,0.08194631038092944,0.4946605905807372,TGFBR1/ACVR2B
MF,GO:0008484,sulfuric ester hydrolase activity,4.164000000000001,2,0.08194631038092944,0.4946605905807372,ARSK/ARSJ
MF,GO:0051010,microtubule plus-end binding,4.164000000000001,2,0.08194631038092944,0.4946605905807372,MAPRE1/CLASP2
BP,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,2.162281108125637,5,0.08201713263747805,0.5733922905734911,BAX/EGLN3/CRADD/PIDD1/PDCD6
BP,GO:0034637,cellular carbohydrate biosynthetic process,2.162281108125637,5,0.08201713263747805,0.5733922905734911,PGM1/HAS3/IMPAD1/EPM2AIP1/B3GNT9
BP,GO:0042446,hormone biosynthetic process,2.162281108125637,5,0.08201713263747805,0.5733922905734911,STARD3NL/HSD17B14/VDR/ARNT/AKR1C3
BP,GO:0048013,ephrin receptor signaling pathway,2.162281108125637,5,0.08201713263747805,0.5733922905734911,PSEN2/PAK1/RBPJ/YES1/ACTG1
BP,GO:0070542,response to fatty acid,2.162281108125637,5,0.08201713263747805,0.5733922905734911,GNPAT/CDK4/PRKAA2/CLDN1/AKR1C3
BP,GO:0009123,nucleoside monophosphate metabolic process,1.4876494023904383,15,0.08286212953341525,0.5733922905734911,CTNS/PGM1/PRKAG2/RFK/ISCU/ARNT/CMPK1/PRKAA2/TK2/SDHAF2/NUPR1/DNAJC30/ENTPD5/CARD11/NUP62
MF,GO:0005085,guanyl-nucleotide exchange factor activity,1.65392523364486,10,0.0829010445021856,0.4946605905807372,ALS2/RASGRP2/ANKRD27/CYTH1/DOCK7/SH2D3A/SBF2/DOCK5/DENND6A/RCC1
BP,GO:0002902,regulation of B cell apoptotic process,4.13235945108455,2,0.08316161539782688,0.5733922905734911,BAX/BCL10
BP,GO:0031293,membrane protein intracellular domain proteolysis,4.13235945108455,2,0.08316161539782688,0.5733922905734911,MBTPS1/PSEN2
BP,GO:0031468,nuclear envelope reassembly,4.13235945108455,2,0.08316161539782688,0.5733922905734911,VPS4A/BANF1
BP,GO:0032968,positive regulation of transcription elongation from RNA polymerase II promoter,4.13235945108455,2,0.08316161539782688,0.5733922905734911,ELL/RTF1
BP,GO:0036148,phosphatidylglycerol acyl-chain remodeling,4.13235945108455,2,0.08316161539782688,0.5733922905734911,PLA2G3/LPGAT1
BP,GO:0042772,"DNA damage response, signal transduction resulting in transcription",4.13235945108455,2,0.08316161539782688,0.5733922905734911,ING4/CDKN1A
BP,GO:0051895,negative regulation of focal adhesion assembly,4.13235945108455,2,0.08316161539782688,0.5733922905734911,CLASP2/APOD
BP,GO:0070233,negative regulation of T cell apoptotic process,4.13235945108455,2,0.08316161539782688,0.5733922905734911,ARG2/IL7R
BP,GO:0071371,cellular response to gonadotropin stimulus,4.13235945108455,2,0.08316161539782688,0.5733922905734911,GCLM/NSMF
MF,GO:0043021,ribonucleoprotein complex binding,1.8628421052631579,7,0.08327379726323202,0.4946605905807372,SMG6/CBX5/MTRF1L/HNRNPU/EIF5A2/YTHDF3/CSNK2B
BP,GO:0034620,cellular response to unfolded protein,1.8595617529880477,7,0.08402190002000272,0.5773667048671809,BAX/COPS5/HERPUD2/EDEM1/MBTPS1/TSPYL2/PTPN1
BP,GO:0046330,positive regulation of JNK cascade,1.8595617529880477,7,0.08402190002000272,0.5773667048671809,MAP4K5/TAOK3/MAP3K7/PAK1/MAP4K2/CARD9/PTPN1
MF,GO:0008022,protein C-terminus binding,1.7034545454545456,9,0.08409356840266044,0.4952968647444831,MAPRE1/SDC1/PRRC2C/TERF2/VPS4A/BCL10/BANF1/PPP1CC/MYO1C
CC,GO:0005684,U2-type spliceosomal complex,2.143618177864753,5,0.08450500414656095,0.4153500675505496,PPIE/HTATSF1/LSM7/BUD13/CWC15
BP,GO:0051348,negative regulation of transferase activity,1.565946739358356,12,0.08467765300657899,0.5803454110825156,PRKAG2/PRKAR2A/CDKN1A/CEP85/TAOK3/DUSP10/HNRNPU/DTX3L/DUS2/GBA/PTPN1/NUP62
BP,GO:0006112,energy reserve metabolic process,2.1374273022851122,5,0.08520268094002076,0.5803454110825156,PGM1/PYGL/PRKAG2/EPM2AIP1/PPP1CC
BP,GO:1904356,regulation of telomere maintenance via telomere lengthening,2.399434519984578,4,0.0853306381726975,0.5803454110825156,SMG6/TERF2/HMBOX1/HNRNPU
BP,GO:1905268,negative regulation of chromatin organization,2.399434519984578,4,0.0853306381726975,0.5803454110825156,ASF1A/KDM3A/ATAD2B/PHF8
MF,GO:0032451,demethylase activity,2.8697837837837836,3,0.08597766158676506,0.49795395669001435,KDM7A/KDM3A/PHF8
MF,GO:0042162,telomeric DNA binding,2.8697837837837836,3,0.08597766158676506,0.49795395669001435,SMG6/TERF2/HMBOX1
BP,GO:0044262,cellular carbohydrate metabolic process,1.5604714011088514,12,0.08635796079995485,0.5803454110825156,PGM1/GNPTG/PYGL/HAS3/IMPAD1/PRKAG2/IDUA/NUPR1/EPM2AIP1/POMK/PPP1CC/B3GNT9
BP,GO:0018394,peptidyl-lysine acetylation,1.7605318371484475,8,0.08649149525344985,0.5803454110825156,ING4/KANSL3/MAP3K7/RPS6KA4/PRKAA2/PYGO2/TADA3/LDB1
BP,GO:0007257,activation of JUN kinase activity,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,MAP4K5/MAP4K2/PTPN1
BP,GO:0009072,aromatic amino acid family metabolic process,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,FAH/QDPR/PCBD1
BP,GO:0032506,cytokinetic process,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,VPS4A/NUP62/CHMP1B
BP,GO:0033574,response to testosterone,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,CDK4/GBA/CSNK2B
BP,GO:0038179,neurotrophin signaling pathway,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,ZFYVE27/FRS2/CYFIP1
BP,GO:0043001,Golgi to plasma membrane protein transport,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,ARFRP1/VAMP7/KIF13A
BP,GO:0050775,positive regulation of dendrite morphogenesis,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,SS18L2/ANKRD27/VAMP7
BP,GO:0060969,negative regulation of gene silencing,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,ASF1A/ATAD2B/PHF8
BP,GO:0072350,tricarboxylic acid metabolic process,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,CS/IDH3G/SDHAF2
BP,GO:0072595,maintenance of protein localization in organelle,2.8608642353662272,3,0.0867379572119394,0.5803454110825156,HNRNPU/CDK5/TAPT1
CC,GO:0030133,transport vesicle,1.476471704141539,15,0.08710530793924755,0.4241295835172708,SPG21/ANKRD27/COPE/VAMP4/STX12/COPS5/VAMP7/YIPF2/RAB15/SNAPIN/PSEN2/MCFD2/PDE4B/BLOC1S5/PDCD6
MF,GO:0045296,cadherin binding,1.4970271903323265,14,0.08792567481396626,0.5050276363281533,SNX1/PKN2/GOLGA3/ITGA6/MAPRE1/CDH20/EHD4/CAPZA1/PTPRB/MYO1B/FNBP1L/PKP3/PTPN1/PARVA
BP,GO:0033673,negative regulation of kinase activity,1.5918427457485234,11,0.08793959460888998,0.5874191639884474,PRKAG2/PRKAR2A/CDKN1A/CEP85/TAOK3/DUSP10/HNRNPU/DUS2/GBA/PTPN1/NUP62
CC,GO:0031228,intrinsic component of Golgi membrane,2.374469366250188,4,0.08800177264995214,0.42452706991319505,UBIAD1/TEX261/SGMS2/RFNG
BP,GO:1901888,regulation of cell junction assembly,2.1131383556682364,5,0.08845244666979542,0.5898763164798816,CLDN1/CLASP2/APOD/MYO1C/LDB1
BP,GO:0038094,Fc-gamma receptor signaling pathway,1.8333707423825825,7,0.08898793374073988,0.5924761284080684,PIK3CA/APPL2/PAK1/YES1/ACTG1/MYO1C/CYFIP1
BP,GO:0006893,Golgi to plasma membrane transport,2.3613482577626006,4,0.0892833761699036,0.5934718533646534,ARFRP1/EXOC2/VAMP7/KIF13A
CC,GO:0005911,cell-cell junction,1.4290787852431688,17,0.09038805592211917,0.4246945538534527,PKN2/ITGA6/CDH20/TGFBR1/CYTH1/CDK4/TJAP1/PAK1/MARVELD2/CLDN1/TMEM65/CLDN3/FRS2/RAP2B/PKP3/NHS/CLDN9
MF,GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activity",3.932666666666667,2,0.09052247996604448,0.509303443644751,PDE8A/PRKAR2A
BP,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,1.7399408215092844,8,0.09105616745057528,0.5949226890009435,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
MF,GO:0003774,motor activity,1.82175,7,0.0911413004661463,0.509303443644751,KIF16B/DNAL4/MYO1B/KIF13A/MYL6B/MYO5A/MYO1C
BP,GO:0035728,response to hepatocyte growth factor,3.91486684839589,2,0.09134664098556605,0.5949226890009435,GCLM/APPL2
BP,GO:0036303,lymph vessel morphogenesis,3.91486684839589,2,0.09134664098556605,0.5949226890009435,ACVR2B/PTPN14
BP,GO:0045076,regulation of interleukin-2 biosynthetic process,3.91486684839589,2,0.09134664098556605,0.5949226890009435,CARD9/CARD11
BP,GO:0046112,nucleobase biosynthetic process,3.91486684839589,2,0.09134664098556605,0.5949226890009435,MTHFD1L/CMPK1
BP,GO:0046653,tetrahydrofolate metabolic process,3.91486684839589,2,0.09134664098556605,0.5949226890009435,MTHFD1L/ALDH1L1
BP,GO:0048490,anterograde synaptic vesicle transport,3.91486684839589,2,0.09134664098556605,0.5949226890009435,SNAPIN/BLOC1S5
BP,GO:0099514,synaptic vesicle cytoskeletal transport,3.91486684839589,2,0.09134664098556605,0.5949226890009435,SNAPIN/BLOC1S5
BP,GO:0099517,synaptic vesicle transport along microtubule,3.91486684839589,2,0.09134664098556605,0.5949226890009435,SNAPIN/BLOC1S5
MF,GO:0017112,Rab guanyl-nucleotide exchange factor activity,2.794263157894737,3,0.09148142255383628,0.509303443644751,ALS2/SBF2/DENND6A
BP,GO:0048813,dendrite morphogenesis,1.8205499679603265,7,0.09153193104147396,0.5949226890009435,SS18L2/NEDD4/ANKRD27/VAMP7/RAP2A/CDK5/NSMF
BP,GO:0106106,cold-induced thermogenesis,1.8205499679603265,7,0.09153193104147396,0.5949226890009435,ACVR2B/KDM3A/DOCK7/APPL2/OMA1/RBPJ/UCP2
BP,GO:0120161,regulation of cold-induced thermogenesis,1.8205499679603265,7,0.09153193104147396,0.5949226890009435,ACVR2B/KDM3A/DOCK7/APPL2/OMA1/RBPJ/UCP2
MF,GO:0000149,SNARE binding,1.9305818181818182,6,0.09160133878502717,0.509303443644751,ANKRD27/STX12/VAMP7/CAPN10/SNAPIN/NBAS
BP,GO:0032465,regulation of cytokinesis,2.0893952280764583,5,0.09176590488308277,0.5949226890009435,PKN2/VPS4A/KIF13A/KLHL9/NUP62
BP,GO:0060021,roof of mouth development,2.0893952280764583,5,0.09176590488308277,0.5949226890009435,TGFBR1/PLEKHA1/ACVR2B/PYGO2/ASPH
BP,GO:0097306,cellular response to alcohol,2.0893952280764583,5,0.09176590488308277,0.5949226890009435,ADCY7/CDK4/PRKAA2/ADCY1/AKR1C3
BP,GO:0008156,negative regulation of DNA replication,2.789342629482072,3,0.09198780024129632,0.5949226890009435,STAG2/TERF2/TSPYL2
BP,GO:0061462,protein localization to lysosome,2.789342629482072,3,0.09198780024129632,0.5949226890009435,NEDD4/RAB7A/VPS4A
BP,GO:0006360,transcription by RNA polymerase I,2.3244521912350598,4,0.09332266993090628,0.6011224514030741,GTF2H1/TBP/CD3EAP/PHF8
BP,GO:0009145,purine nucleoside triphosphate biosynthetic process,1.7298248865005097,8,0.0933897220468886,0.6011224514030741,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0032874,positive regulation of stress-activated MAPK cascade,1.7298248865005097,8,0.0933897220468886,0.6011224514030741,MAP4K5/KLHDC10/TAOK3/MAP3K7/PAK1/MAP4K2/CARD9/PTPN1
MF,GO:0043175,RNA polymerase core enzyme binding,2.3209180327868855,4,0.09358065088559175,0.5161789870276688,ERCC5/RTF1/HNRNPU/SPTY2D1
CC,GO:0005721,pericentric heterochromatin,3.858512720156555,2,0.0937375503459531,0.4246945538534527,CBX5/CBX1
CC,GO:0030663,COPI-coated vesicle membrane,3.858512720156555,2,0.0937375503459531,0.4246945538534527,COPE/TMEM199
CC,GO:0030904,retromer complex,3.858512720156555,2,0.0937375503459531,0.4246945538534527,SNX1/RAB7A
CC,GO:0035371,microtubule plus-end,3.858512720156555,2,0.0937375503459531,0.4246945538534527,MAPRE1/MYO5A
CC,GO:0071782,endoplasmic reticulum tubular network,3.858512720156555,2,0.0937375503459531,0.4246945538534527,ZFYVE27/ASPH
CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,2.074469204385245,5,0.09403088407989767,0.4246945538534527,DDHD2/TMED5/TEX261/MCFD2/PDCD6
CC,GO:0005667,transcription factor complex,1.4799774817038844,14,0.09455771256621981,0.4246945538534527,GTF2H1/VDR/TBP/CD3EAP/CDK4/MED4/ARNT/HNRNPU/PYGO2/RBPJ/TADA3/ARNT2/NHLH2/LDB1
BP,GO:0051091,positive regulation of DNA-binding transcription factor activity,1.5674466883424159,11,0.0953768497879014,0.6129431673573189,TAB1/COPS5/MAP3K7/BCL10/RPS6KA4/ADCY1/RHEBL1/NHLH2/PIDD1/IL1RAP/CARD11
BP,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,1.7198258987172694,8,0.09575731314297695,0.6142663436664079,MAP4K5/KLHDC10/TAOK3/MAP3K7/PAK1/MAP4K2/CARD9/PTPN1
BP,GO:0031398,positive regulation of protein ubiquitination,1.907242823577485,6,0.09588474145235226,0.6142663436664079,SPRTN/CHFR/BCL10/RCHY1/RNF180/PDCD6
BP,GO:0002431,Fc receptor mediated stimulatory signaling pathway,1.7954389339194945,7,0.09674117494996554,0.6157851601089154,PIK3CA/APPL2/PAK1/YES1/ACTG1/MYO1C/CYFIP1
BP,GO:0071901,negative regulation of protein serine/threonine kinase activity,1.7954389339194945,7,0.09674117494996554,0.6157851601089154,PRKAG2/PRKAR2A/CDKN1A/DUSP10/GBA/PTPN1/NUP62
MF,GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate binding",2.7226153846153847,3,0.09712744305525076,0.5273716634640568,KIF16B/MAPKAP1/MYO1B
MF,GO:0016709,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",2.7226153846153847,3,0.09712744305525076,0.5273716634640568,CYP26B1/MICAL2/AKR1C3
BP,GO:0021575,hindbrain morphogenesis,2.7213098824215334,3,0.09736593420548909,0.6157851601089154,GNPAT/CDK5/LDB1
BP,GO:0050873,brown fat cell differentiation,2.7213098824215334,3,0.09736593420548909,0.6157851601089154,ITGA6/DUSP10/HNRNPU
BP,GO:0009247,glycolipid biosynthetic process,2.288691388292982,4,0.09744718644607164,0.6157851601089154,PIGB/DPM2/ST6GALNAC6/PIGN
MF,GO:0030145,manganese ion binding,2.283483870967742,4,0.09792559635941887,0.527583639300745,B4GALT7/ARG2/PAPOLA/GALNT1
BP,GO:0009161,ribonucleoside monophosphate metabolic process,1.4708398046233144,14,0.09798450288872848,0.6157851601089154,CTNS/PGM1/PRKAG2/RFK/ISCU/ARNT/CMPK1/PRKAA2/SDHAF2/NUPR1/DNAJC30/ENTPD5/CARD11/NUP62
BP,GO:0014909,smooth muscle cell migration,2.0434744538330194,5,0.09858160827185405,0.6157851601089154,NDRG4/DOCK7/DOCK5/PAK1/PARVA
BP,GO:0097305,response to alcohol,1.5961903459124873,10,0.0991156984399189,0.6157851601089154,TGFBR1/USP46/ADCY7/CDKN1A/CDK4/PRKAA2/CLDN1/ADCY1/CLDN3/AKR1C3
BP,GO:2001251,negative regulation of chromosome organization,1.7831414069748404,7,0.0994060888683721,0.6157851601089154,SMG6/ASF1A/KDM3A/ATAD2B/TERF2/HNRNPU/PHF8
BP,GO:1903311,regulation of mRNA metabolic process,1.4922409128916434,13,0.09943112687655067,0.6157851601089154,SAMD4A/PAPOLA/CIRBP/SAFB2/DHX34/CELF1/NBAS/CARHSP1/HNRNPU/HNRNPA0/PKP3/YTHDF3/CNOT7
BP,GO:0006525,arginine metabolic process,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,ARG2/FAH
BP,GO:0006677,glycosylceramide metabolic process,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,ST6GALNAC6/GBA
BP,GO:0009264,deoxyribonucleotide catabolic process,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,MBD4/NUDT15
BP,GO:0016137,glycoside metabolic process,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,GBA/AKR1C3
BP,GO:0032211,negative regulation of telomere maintenance via telomerase,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,TERF2/HNRNPU
BP,GO:0032495,response to muramyl dipeptide,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,LDOC1/CARD9
BP,GO:0032793,positive regulation of CREB transcription factor activity,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,RPS6KA4/ADCY1
BP,GO:0033005,positive regulation of mast cell activation,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,SNX4/VAMP7
BP,GO:0036065,fucosylation,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,RFNG/FUT1
BP,GO:0046655,folic acid metabolic process,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,MTHFD1L/ALDH1L1
BP,GO:0046823,negative regulation of nucleocytoplasmic transport,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,CDK5/APOD
BP,GO:0060008,Sertoli cell differentiation,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,SDC1/SAFB2
BP,GO:0070987,error-free translesion synthesis,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,SPRTN/RCHY1
BP,GO:1900424,regulation of defense response to bacterium,3.7191235059760954,2,0.09975477397044621,0.6157851601089154,ARG2/MAPKBP1
CC,GO:1902562,H4 histone acetyltransferase complex,2.691985618713876,3,0.09990441259817226,0.44487349541579274,KANSL3/MAP3K7/TADA3
BP,GO:0006473,protein acetylation,1.6407897820482777,9,0.10032423160046325,0.6183620820464917,ING4/KANSL3/MAP3K7/RPS6KA4/PRKAA2/PYGO2/TADA3/NUPR1/LDB1
BP,GO:0006513,protein monoubiquitination,2.2540142460461188,4,0.10165553343492002,0.6237325942884686,RYBP/DTX3L/RNF168/PDCD6
BP,GO:0006687,glycosphingolipid metabolic process,2.2540142460461188,4,0.10165553343492002,0.6237325942884686,BAX/SUMF1/ST6GALNAC6/GBA
BP,GO:0046626,regulation of insulin receptor signaling pathway,2.2540142460461188,4,0.10165553343492002,0.6237325942884686,CCND3/CDK4/PAK1/PTPN1
CC,GO:0005697,telomerase holoenzyme complex,3.6747740191967195,2,0.10189255571142726,0.44988153835299666,SMG6/HNRNPU
BP,GO:0019359,nicotinamide nucleotide biosynthetic process,1.7710111933219501,7,0.102110949367147,0.6246426195872993,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0019363,pyridine nucleotide biosynthetic process,1.7710111933219501,7,0.102110949367147,0.6246426195872993,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0006654,phosphatidic acid biosynthetic process,2.6565167899829256,3,0.10286842249518838,0.6264267578932113,DDHD2/DDHD1/GNPAT
BP,GO:0042149,cellular response to glucose starvation,2.6565167899829256,3,0.10286842249518838,0.6264267578932113,SESN1/MTMR3/PRKAA2
BP,GO:0009615,response to virus,1.4830860606653142,13,0.10296687419986812,0.6264267578932113,ZMYND11/CDK6/ACTA2/POLR3F/RTP4/DTX3L/TRIM44/VWCE/BANF1/POLR3C/CARD9/CNOT7/ZCCHC3
BP,GO:0006986,response to unfolded protein,1.690510684534589,8,0.10306328898246814,0.6264267578932113,BAX/COPS5/HERPUD2/EDEM1/MBTPS1/HSPA4L/TSPYL2/PTPN1
BP,GO:0006469,negative regulation of protein kinase activity,1.5826057472238704,10,0.10332653749910146,0.6264267578932113,PRKAG2/PRKAR2A/CDKN1A/CEP85/TAOK3/DUSP10/DUS2/GBA/PTPN1/NUP62
BP,GO:0009755,hormone-mediated signaling pathway,1.5826057472238704,10,0.10332653749910146,0.6264267578932113,NEDD4/VDR/KDM3A/SAFB2/APPL2/PAK1/PRMT2/TADA3/CSNK2B/NUP62
CC,GO:0030117,membrane coat,2.009642041748206,5,0.10408052192365037,0.45188293268518204,AP5M1/AP4E1/COPE/PDCD6/CHMP1B
CC,GO:0048475,coated membrane,2.009642041748206,5,0.10408052192365037,0.45188293268518204,AP5M1/AP4E1/COPE/PDCD6/CHMP1B
BP,GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,1.8595617529880477,6,0.1049810816227113,0.6286929810372619,CHFR/EDEM1/RCHY1/RNF180/NUPR1/GBA
BP,GO:0009201,ribonucleoside triphosphate biosynthetic process,1.6809597767123594,8,0.10556595383276336,0.6286929810372619,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0015807,L-amino acid transport,2.2203722423737884,4,0.10594626270144204,0.6286929810372619,CTNS/SLC36A1/SLC7A1/PRAF2
BP,GO:0019748,secondary metabolic process,2.2203722423737884,4,0.10594626270144204,0.6286929810372619,CTNS/ARL1/AKR1C3/MYO5A
CC,GO:0000784,"nuclear chromosome, telomeric region",1.8520861056751465,6,0.10660588684523425,0.45902204170551275,CBX5/THOC5/CBX1/TERF2/HMBOX1/PPP1CC
BP,GO:0002064,epithelial cell development,1.6170102199896068,9,0.1072133956080723,0.6286929810372619,CDK6/MET/ACTA2/SDC1/CDKN1A/MARVELD2/CLDN1/CLDN3/FRS2
BP,GO:0006733,oxidoreduction coenzyme metabolic process,1.6170102199896068,9,0.1072133956080723,0.6286929810372619,PGM1/PRKAG2/UBIAD1/MPC2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,1.747239230995481,7,0.10763967302007282,0.6286929810372619,CSNK2A2/CHFR/RYBP/RCHY1/RNF180/MTM1/GBA
BP,GO:0010950,positive regulation of endopeptidase activity,1.6715161824611666,8,0.10810206359809968,0.6286929810372619,BAX/EGLN3/BCL10/CRADD/PIDD1/CARD9/ASPH/PDCD6
BP,GO:0022406,membrane docking,1.6715161824611666,8,0.10810206359809968,0.6286929810372619,RAB7A/MAPRE1/NDRG4/MOSPD3/STX12/RAB15/PSEN2/PDZD8
BP,GO:0006293,"nucleotide-excision repair, preincision complex stabilization",3.5420223866439007,2,0.10836815699150319,0.6286929810372619,GTF2H1/ERCC5
BP,GO:0006295,"nucleotide-excision repair, DNA incision, 3'-to lesion",3.5420223866439007,2,0.10836815699150319,0.6286929810372619,GTF2H1/ERCC5
BP,GO:0006907,pinocytosis,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,EHD4/APPL2
BP,GO:0007035,vacuolar acidification,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,SNAPIN/TMEM199
BP,GO:0017000,antibiotic biosynthetic process,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,CTNS/KDM3A
BP,GO:0021697,cerebellar cortex formation,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,CDK5/LDB1
BP,GO:0032682,negative regulation of chemokine production,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,ARG2/APOD
BP,GO:0033962,cytoplasmic mRNA processing body assembly,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,CNOT6/CNOT7
BP,GO:0034389,lipid droplet organization,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,DDHD2/FITM2
BP,GO:0039702,viral budding via host ESCRT complex,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,VPS4A/CHMP1B
BP,GO:0042438,melanin biosynthetic process,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,CTNS/MYO5A
BP,GO:0046386,deoxyribose phosphate catabolic process,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,MBD4/NUDT15
BP,GO:0055093,response to hyperoxia,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,CDKN1A/CDK4
BP,GO:0070584,mitochondrion morphogenesis,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,BAX/MTM1
BP,GO:0071459,"protein localization to chromosome, centromeric region",3.5420223866439007,2,0.10836815699150319,0.6286929810372619,BOD1/TRAPPC12
BP,GO:1903392,negative regulation of adherens junction organization,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,CLASP2/APOD
BP,GO:2000810,regulation of bicellular tight junction assembly,3.5420223866439007,2,0.10836815699150319,0.6286929810372619,CLDN1/MYO1C
MF,GO:0008320,protein transmembrane transporter activity,3.5393999999999997,2,0.10840005139605456,0.5750995093149459,MCL1/TOMM20
MF,GO:0016922,nuclear receptor binding,3.5393999999999997,2,0.10840005139605456,0.5750995093149459,TADA3/C1D
BP,GO:0006775,fat-soluble vitamin metabolic process,2.5947373297507643,3,0.10849126663917352,0.6286929810372619,CYP26B1/VDR/UBIAD1
BP,GO:0032365,intracellular lipid transport,2.5947373297507643,3,0.10849126663917352,0.6286929810372619,PRKAG2/VPS4A/PRKAA2
BP,GO:0032924,activin receptor signaling pathway,2.5947373297507643,3,0.10849126663917352,0.6286929810372619,TGFBR1/ACVR2B/CSNK2B
BP,GO:0045773,positive regulation of axon extension,2.5947373297507643,3,0.10849126663917352,0.6286929810372619,PAK1/ZFYVE27/CYFIP1
BP,GO:0046473,phosphatidic acid metabolic process,2.5947373297507643,3,0.10849126663917352,0.6286929810372619,DDHD2/DDHD1/GNPAT
CC,GO:0005681,spliceosomal complex,1.668546041148781,8,0.10903678914387377,0.46564071429473963,PPIE/CIRBP/HTATSF1/WDR83/LSM7/BUD13/CWC15/HNRNPU
BP,GO:0031668,cellular response to extracellular stimulus,1.5265059166319797,11,0.10927343876665883,0.6323248206298266,SESN1/ITGA6/MTMR3/VDR/CDKN1A/STK26/NUDT15/PRKAA2/GABARAP/GBA/AKR1C3
MF,GO:0051015,actin filament binding,1.6088181818181817,9,0.10954023490743532,0.576745933792936,PLS3/CORO2A/CAPZA1/MYO1B/TPM4/MYO18A/MYO5A/MYO1C/CYFIP1
BP,GO:0016239,positive regulation of macroautophagy,2.187719709397703,4,0.11031787344283425,0.6373954724380397,SESN1/MAP3K7/PIP4K2A/PRKAA2
BP,GO:0072525,pyridine-containing compound biosynthetic process,1.7355909694555114,7,0.11046307966293462,0.6373954724380397,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0006611,protein export from nucleus,1.6621781032295397,8,0.11067146703636908,0.6376933823002117,SMG6/THOC5/XPO4/WDR33/PTPN14/CDK5/AGFG1/NUP62
BP,GO:0019079,viral genome replication,1.8290771340866043,6,0.11128583450354401,0.6394219982491766,PKN2/PPIE/EEA1/HTATSF1/BANF1/CNOT7
BP,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,1.8290771340866043,6,0.11128583450354401,0.6394219982491766,CHFR/RYBP/RCHY1/RNF180/MTM1/GBA
BP,GO:0071229,cellular response to acid chemical,1.601536437980137,9,0.11195079170573091,0.6402217160656003,CYP26B1/GCLM/SESN1/CDK4/PRKAA2/CLDN1/NSMF/YES1/AKR1C3
BP,GO:0006164,purine nucleotide biosynthetic process,1.4876494023904383,12,0.11204838134726593,0.6402217160656003,PGM1/PRKAG2/ADCY7/MPC2/ARNT/ADCY9/PRKAA2/ADCY1/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0051402,neuron apoptotic process,1.5561186217473202,10,0.11205453830843348,0.6402217160656003,GCLM/BAX/LANCL1/PIK3CA/EGLN3/MCL1/FOXQ1/CDK5/NSMF/NUPR1
BP,GO:2000116,regulation of cysteine-type endopeptidase activity,1.5561186217473202,10,0.11205453830843348,0.6402217160656003,BAX/RPS6KA1/EGLN3/BCL10/CRADD/TRIAP1/PIDD1/CARD9/ASPH/PDCD6
CC,GO:0033116,endoplasmic reticulum-Golgi intermediate compartment membrane,2.173809983186792,4,0.11234864144178758,0.4758832698469213,VMP1/TMED5/MCFD2/TMEM199
BP,GO:0000070,mitotic sister chromatid segregation,1.7240969895253422,7,0.11332552030917228,0.6465753388747726,INO80/VPS4A/BOD1/HNRNPU/CDC26/NUP62/CHMP1B
BP,GO:0006195,purine nucleotide catabolic process,2.5357660268018836,3,0.11423041725794875,0.6484985777196468,PDE8A/NUDT15/PDE4B
MF,GO:0005516,calmodulin binding,1.59273,9,0.11458459427913377,0.5957964338818668,CAMKK1/MKNK2/EEA1/MYO1B/RIT1/ADCY1/MARCKSL1/MYO5A/MYO1C
BP,GO:0008088,axo-dendritic transport,2.156013626652809,4,0.11476881550748173,0.6484985777196468,TERF2/SNAPIN/HNRNPU/BLOC1S5
BP,GO:0036465,synaptic vesicle recycling,2.156013626652809,4,0.11476881550748173,0.6484985777196468,VAMP4/CDK5/ACTG1/CYFIP1
BP,GO:0070227,lymphocyte apoptotic process,2.156013626652809,4,0.11476881550748173,0.6484985777196468,ARG2/BAX/BCL10/IL7R
MF,GO:0030544,Hsp70 protein binding,2.5281428571428575,3,0.1148729814966477,0.5957964338818668,BAX/DNAJC8/NUP62
BP,GO:0016042,lipid catabolic process,1.4519100774080855,13,0.11593093437320473,0.6484985777196468,CYP26B1/RAB7A/DDHD2/HSD17B14/PLA2G3/DDHD1/PLCD4/LPIN3/CDK4/TBL1XR1/GBA/AKR1C3/ACAD11
BP,GO:0098876,vesicle-mediated transport to the plasma membrane,1.937043492695883,5,0.1166916336809759,0.6484985777196468,ARFRP1/ANKRD27/EXOC2/VAMP7/KIF13A
BP,GO:0005980,glycogen catabolic process,3.381021369069178,2,0.11716972827530493,0.6484985777196468,PGM1/PYGL
BP,GO:0006582,melanin metabolic process,3.381021369069178,2,0.11716972827530493,0.6484985777196468,CTNS/MYO5A
BP,GO:0008053,mitochondrial fusion,3.381021369069178,2,0.11716972827530493,0.6484985777196468,BAX/OMA1
BP,GO:0010226,response to lithium ion,3.381021369069178,2,0.11716972827530493,0.6484985777196468,ADCY7/ADCY1
BP,GO:0016226,iron-sulfur cluster assembly,3.381021369069178,2,0.11716972827530493,0.6484985777196468,NUBP2/ISCU
BP,GO:0031163,metallo-sulfur cluster assembly,3.381021369069178,2,0.11716972827530493,0.6484985777196468,NUBP2/ISCU
BP,GO:0032402,melanosome transport,3.381021369069178,2,0.11716972827530493,0.6484985777196468,BLOC1S5/MYO5A
BP,GO:0032656,regulation of interleukin-13 production,3.381021369069178,2,0.11716972827530493,0.6484985777196468,ARG2/IL1RAP
BP,GO:0033233,regulation of protein sumoylation,3.381021369069178,2,0.11716972827530493,0.6484985777196468,HMG20A/ARNT
BP,GO:0043162,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,3.381021369069178,2,0.11716972827530493,0.6484985777196468,NEDD4/VPS4A
BP,GO:0043496,regulation of protein homodimerization activity,3.381021369069178,2,0.11716972827530493,0.6484985777196468,BAX/PCBD1
BP,GO:0045117,azole transport,3.381021369069178,2,0.11716972827530493,0.6484985777196468,SNX4/VAMP7
BP,GO:0051195,negative regulation of cofactor metabolic process,3.381021369069178,2,0.11716972827530493,0.6484985777196468,CTNS/NUPR1
BP,GO:0051457,maintenance of protein location in nucleus,3.381021369069178,2,0.11716972827530493,0.6484985777196468,HNRNPU/CDK5
BP,GO:0071379,cellular response to prostaglandin stimulus,3.381021369069178,2,0.11716972827530493,0.6484985777196468,PRKAA2/AKR1C3
BP,GO:2000773,negative regulation of cellular senescence,3.381021369069178,2,0.11716972827530493,0.6484985777196468,CDK6/TERF2
CC,GO:0031461,cullin-RING ubiquitin ligase complex,1.7094676608288537,7,0.11720203276049088,0.4895225450903636,KLHL42/KLHL2/FBXL12/BTRC/CDC26/KLHL9/PDCD6
CC,GO:0000151,ubiquitin ligase complex,1.505093614245465,11,0.11744782751688185,0.4895225450903636,NEDD4/KLHL42/KLHL2/FBXL12/MED21/RCHY1/RNF168/BTRC/CDC26/KLHL9/PDCD6
MF,GO:0016411,acylglycerol O-acyltransferase activity,3.370857142857143,2,0.11766076650790722,0.6012811229632024,LPCAT2/LPGAT1
MF,GO:0050750,low-density lipoprotein particle receptor binding,3.370857142857143,2,0.11766076650790722,0.6012811229632024,LANCL1/ANKRA2
BP,GO:0019751,polyol metabolic process,1.7995758899884333,6,0.11777924156843517,0.6509863514951009,IMPAD1/PLCD4/QDPR/INPPL1/PCBD1/GBA
BP,GO:0034250,positive regulation of cellular amide metabolic process,1.7015597739759913,7,0.11916642843159332,0.6567012177137285,SAMD4A/CIRBP/CDK4/EIF5A2/TRUB2/NGRN/YTHDF3
BP,GO:0062013,positive regulation of small molecule metabolic process,1.7015597739759913,7,0.11916642843159332,0.6567012177137285,LPGAT1/ISCU/ARNT/PRKAA2/NUPR1/EPM2AIP1/ENTPD5
BP,GO:0007004,telomere maintenance via telomerase,2.1252134319863405,4,0.1192974925984379,0.6567012177137285,SMG6/TERF2/HMBOX1/HNRNPU
BP,GO:0001974,blood vessel remodeling,2.4794156706507304,3,0.12008178434814987,0.6574598906167882,BAX/ACVR2B/RBPJ
BP,GO:0016574,histone ubiquitination,2.4794156706507304,3,0.12008178434814987,0.6574598906167882,RYBP/DTX3L/RNF168
BP,GO:0032456,endocytic recycling,2.4794156706507304,3,0.12008178434814987,0.6574598906167882,NDRG4/EHD4/SNX4
BP,GO:0048255,mRNA stabilization,2.4794156706507304,3,0.12008178434814987,0.6574598906167882,CIRBP/HNRNPU/HNRNPA0
MF,GO:0030374,nuclear receptor transcription coactivator activity,2.1130746268656715,4,0.12100319542832172,0.60545013371594,VDR/ZMIZ2/MED4/TADA3
MF,GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",2.4693488372093024,3,0.12104163417416439,0.60545013371594,ALDH1L1/ALDH4A1/AKR1C3
MF,GO:0031072,heat shock protein binding,1.7845714285714287,6,0.121090026743188,0.60545013371594,TOMM34/METTL22/BAX/DNAJC8/CDK5/NUP62
BP,GO:0009063,cellular amino acid catabolic process,1.785179282868526,6,0.12109557670106585,0.6604570625359371,HSD17B10/ARG2/FAH/QDPR/ALDH4A1/PCBD1
BP,GO:0009127,purine nucleoside monophosphate biosynthetic process,1.6258463414103148,8,0.12127861989044862,0.6604570625359371,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0009168,purine ribonucleoside monophosphate biosynthetic process,1.6258463414103148,8,0.12127861989044862,0.6604570625359371,PGM1/PRKAG2/ARNT/PRKAA2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,1.6258463414103148,8,0.12127861989044862,0.6604570625359371,TMEM101/MAP3K7/BCL10/LURAP1L/TNIP2/CARD9/CARD11/NUP62
CC,GO:0031201,SNARE complex,2.4628804596743974,3,0.12196309915839841,0.500336808358469,SNX4/STX12/VAMP7
CC,GO:0098563,intrinsic component of synaptic vesicle membrane,2.4628804596743974,3,0.12196309915839841,0.500336808358469,VAMP4/STX12/VAMP7
BP,GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1.690510684534589,7,0.12214432268886831,0.6642822255325084,SS18L2/ANKRD27/VAMP7/DOCK5/PAK1/ZFYVE27/CYFIP1
BP,GO:0007015,actin filament organization,1.394671314741036,15,0.12334561016992056,0.6664292268353017,PLS3/MET/TGFBR1/CAPZA1/MYO1B/DIAPH1/MICAL2/DIAPH2/PAK1/CLASP2/ARHGAP12/INPPL1/TPM4/MYO1C/CYFIP1
BP,GO:0051896,regulation of protein kinase B signaling,1.5242309450721703,10,0.12353273974836437,0.6664292268353017,PHLPP2/MET/TGFBR1/PLEKHA1/PIK3CA/FRS2/OTUD3/MTM1/AKR1C3/PDCD6
BP,GO:0033692,cellular polysaccharide biosynthetic process,2.095280848437237,4,0.12390226541903959,0.6664292268353017,PGM1/HAS3/EPM2AIP1/B3GNT9
BP,GO:0045732,positive regulation of protein catabolic process,1.5641173623263955,9,0.12429385808922175,0.6664292268353017,SNX1/NEDD4/CHFR/RAB7A/EDEM1/RCHY1/RNF180/NUPR1/GBA
CC,GO:0008021,synaptic vesicle,1.6161309822645258,8,0.1244118567575671,0.5041650871111265,VAMP4/STX12/COPS5/VAMP7/RAB15/SNAPIN/PSEN2/PDE4B
BP,GO:0018107,peptidyl-threonine phosphorylation,1.7710111933219503,6,0.1244576988369095,0.6664292268353017,CSNK2A2/DYRK1B/PRKAG2/TGFBR1/CDK5/CSNK2B
CC,GO:0005874,microtubule,1.3912906442872195,15,0.12527228503081483,0.5041650871111265,CAPN6/KIF16B/DNAL4/MAPRE1/INO80/KIF13A/BCL10/BOD1/HNRNPU/CLASP2/CDK5/GABARAP/TCP11L1/TUBAL3/MYO5A
CC,GO:0000781,"chromosome, telomeric region",1.6776142261550244,7,0.12583861463517096,0.5041650871111265,SMG6/CBX5/THOC5/CBX1/TERF2/HMBOX1/PPP1CC
BP,GO:0030810,positive regulation of nucleotide biosynthetic process,2.4255153299844103,3,0.12604124692903274,0.6664292268353017,ARNT/PRKAA2/ENTPD5
BP,GO:0060443,mammary gland morphogenesis,2.4255153299844103,3,0.12604124692903274,0.6664292268353017,BAX/VDR/BTRC
BP,GO:1900015,regulation of cytokine production involved in inflammatory response,2.4255153299844103,3,0.12604124692903274,0.6664292268353017,ADCY7/APPL2/APOD
BP,GO:1900373,positive regulation of purine nucleotide biosynthetic process,2.4255153299844103,3,0.12604124692903274,0.6664292268353017,ARNT/PRKAA2/ENTPD5
BP,GO:1904738,vascular associated smooth muscle cell migration,2.4255153299844103,3,0.12604124692903274,0.6664292268353017,DOCK7/DOCK5/PAK1
BP,GO:1904752,regulation of vascular associated smooth muscle cell migration,2.4255153299844103,3,0.12604124692903274,0.6664292268353017,DOCK7/DOCK5/PAK1
BP,GO:0009226,nucleotide-sugar biosynthetic process,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,UAP1/AMDHD2
BP,GO:0009251,glucan catabolic process,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,PGM1/PYGL
BP,GO:0032401,establishment of melanosome localization,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,BLOC1S5/MYO5A
BP,GO:0045109,intermediate filament organization,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,MTM1/AGFG1
BP,GO:0051904,pigment granule transport,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,BLOC1S5/MYO5A
BP,GO:0090140,regulation of mitochondrial fission,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,DDHD2/DDHD1
BP,GO:1901032,negative regulation of response to reactive oxygen species,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,PDE8A/MET
BP,GO:1901889,negative regulation of cell junction assembly,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,CLASP2/APOD
BP,GO:1903206,negative regulation of hydrogen peroxide-induced cell death,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,PDE8A/MET
BP,GO:2000726,negative regulation of cardiac muscle cell differentiation,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,PAK1/FRS2
BP,GO:2001039,negative regulation of cellular response to drug,3.2340204399792136,2,0.12614319190343715,0.6664292268353017,PDE8A/MET
BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,1.5568423978504586,9,0.12684703500690542,0.6692785193360457,BAX/RPS6KA1/EGLN3/BCL10/CRADD/TRIAP1/PIDD1/CARD9/PDCD6
MF,GO:0008565,protein transporter activity,3.217636363636364,2,0.12711056241201318,0.609155998065435,MCL1/TOMM20
MF,GO:0050145,nucleoside monophosphate kinase activity,3.217636363636364,2,0.12711056241201318,0.609155998065435,CMPK1/CARD11
MF,GO:0070034,telomerase RNA binding,3.217636363636364,2,0.12711056241201318,0.609155998065435,SMG6/HNRNPU
MF,GO:0004864,protein phosphatase inhibitor activity,2.4132272727272728,3,0.12732906393027654,0.609155998065435,BOD1/PPP1R14A/PPP1R14C
MF,GO:0016879,"ligase activity, forming carbon-nitrogen bonds",2.4132272727272728,3,0.12732906393027654,0.609155998065435,GCLM/MTHFD1L/GATC
MF,GO:0019205,nucleobase-containing compound kinase activity,2.4132272727272728,3,0.12732906393027654,0.609155998065435,CMPK1/TK2/CARD11
CC,GO:0000178,exosome (RNase complex),3.2154272667971298,2,0.12741663250251334,0.5041650871111265,CARHSP1/C1D
CC,GO:0031312,extrinsic component of organelle membrane,2.411570450097847,3,0.12773472456558294,0.5041650871111265,RAB7A/GOLGA3/WDFY3
BP,GO:0071496,cellular response to external stimulus,1.426212553914137,13,0.12776620510717002,0.6729046061345796,SESN1/ITGA6/MTMR3/VDR/CDKN1A/STK26/NUDT15/BCL10/PRKAA2/CRADD/GABARAP/GBA/AKR1C3
BP,GO:0043620,regulation of DNA-templated transcription in response to stress,1.7570662232957932,6,0.12786510829450098,0.6729046061345796,NEDD4/RPS6KA1/INO80/EGLN3/ARNT/RBPJ
BP,GO:0016573,histone acetylation,1.6688374706302993,7,0.12821345433443965,0.6738660623158921,ING4/KANSL3/MAP3K7/RPS6KA4/PYGO2/TADA3/LDB1
BP,GO:0061180,mammary gland epithelium development,2.066179725542275,4,0.12858145475767063,0.6749282038118763,BAX/VDR/PYGO2/BTRC
BP,GO:0006732,coenzyme metabolic process,1.3842891461449487,15,0.12886611554680127,0.6755507191293655,PGM1/PRKAG2/VNN2/MTHFD1L/UBIAD1/RFK/MPC2/ARNT/ALDH1L1/QDPR/PRKAA2/PCBD1/NUPR1/ENTPD5/NUP62
CC,GO:0030016,myofibril,1.5502952893486162,9,0.12931827755932346,0.506577613597049,DCTN4/PSEN2/PAK1/MTMR12/TPM4/MTM1/ACTG1/PDE4B/PARVA
MF,GO:0030971,receptor tyrosine kinase binding,2.0518260869565217,4,0.130831492899253,0.609155998065435,MAP3K7/PTPN14/FRS2/PTPN1
MF,GO:0048365,Rac GTPase binding,2.0518260869565217,4,0.130831492899253,0.609155998065435,ALS2/DOCK7/PAK1/CYFIP1
BP,GO:0051291,protein heterooligomerization,1.7433391434262948,6,0.13131728672562956,0.6869952269481635,BCL10/CLDN1/CLDN3/PCBD1/RCC1/NUP62
BP,GO:0014911,positive regulation of smooth muscle cell migration,2.3739086208358056,3,0.13210466208104946,0.6869952269481635,DOCK7/DOCK5/PAK1
BP,GO:0043303,mast cell degranulation,2.3739086208358056,3,0.13210466208104946,0.6869952269481635,PLA2G3/SNX4/VAMP7
BP,GO:0045646,regulation of erythrocyte differentiation,2.3739086208358056,3,0.13210466208104946,0.6869952269481635,CDK6/ARNT/LDB1
BP,GO:0120163,negative regulation of cold-induced thermogenesis,2.3739086208358056,3,0.13210466208104946,0.6869952269481635,ACVR2B/DOCK7/RBPJ
BP,GO:2000107,negative regulation of leukocyte apoptotic process,2.3739086208358056,3,0.13210466208104946,0.6869952269481635,ARG2/BCL10/IL7R
BP,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,1.8595617529880477,5,0.1322313821780757,0.6869952269481635,TGFBR1/WRAP73/FNBP1L/TAPT1/CYFIP1
CC,GO:0005765,lysosomal membrane,1.416967948080091,13,0.1324409409976579,0.5149382855207445,STARD3NL/CTNS/AP5M1/RAB7A/WDR11/SLC36A1/VAMP7/SNX14/CD164/SNAPIN/DTX3L/GBA/GLMP
BP,GO:0065004,protein-DNA complex assembly,1.4996465749903611,10,0.1331622479571027,0.687863149566542,RBBP7/GTF2H1/ASF1A/TBP/HP1BP3/ERCC5/RBBP4/TRAPPC12/SPTY2D1/TSPYL2
BP,GO:0006283,transcription-coupled nucleotide-excision repair,2.037875893685532,4,0.13333334450902662,0.687863149566542,PPIE/GTF2H1/COPS5/ERCC5
BP,GO:0044766,multi-organism transport,2.037875893685532,4,0.13333334450902662,0.687863149566542,RAB7A/THOC5/NMT2/NUP62
BP,GO:1902579,multi-organism localization,2.037875893685532,4,0.13333334450902662,0.687863149566542,RAB7A/THOC5/NMT2/NUP62
MF,GO:0140098,"catalytic activity, acting on RNA",1.3754145077720206,15,0.13359872290480354,0.609155998065435,SMG6/TRMT2A/CNOT6/CD3EAP/POLR3F/DHX34/MED21/DUS2/POLR2J3/TSEN34/TRMT112/POLR3C/TRMT2B/CNOT7/GATC
MF,GO:0008138,protein tyrosine/serine/threonine phosphatase activity,2.3596000000000004,3,0.13373045041445422,0.609155998065435,PTPMT1/SSH2/DUSP10
CC,GO:0098852,lytic vacuole membrane,1.4129764890714147,13,0.13444248227073155,0.5188483945411195,STARD3NL/CTNS/AP5M1/RAB7A/WDR11/SLC36A1/VAMP7/SNX14/CD164/SNAPIN/DTX3L/GBA/GLMP
BP,GO:2001233,regulation of apoptotic signaling pathway,1.374060408611858,15,0.13452640303234428,0.687863149566542,ZMYND11/GCLM/CSNK2A2/BAX/ITGA6/TGFBR1/PTPMT1/PLAGL2/BCL10/MCL1/CRADD/TRIAP1/NUPR1/P4HB/PTPN1
BP,GO:0001783,B cell apoptotic process,3.099269588313413,2,0.13527298909863167,0.687863149566542,BAX/BCL10
BP,GO:0003272,endocardial cushion formation,3.099269588313413,2,0.13527298909863167,0.687863149566542,TGFBR1/RBPJ
BP,GO:0007097,nuclear migration,3.099269588313413,2,0.13527298909863167,0.687863149566542,DOCK7/DCTN4
BP,GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,3.099269588313413,2,0.13527298909863167,0.687863149566542,NDRG4/APOD
BP,GO:0014850,response to muscle activity,3.099269588313413,2,0.13527298909863167,0.687863149566542,PRKAA2/TOMM20
BP,GO:0032528,microvillus organization,3.099269588313413,2,0.13527298909863167,0.687863149566542,RAP2A/STK26
BP,GO:0032925,regulation of activin receptor signaling pathway,3.099269588313413,2,0.13527298909863167,0.687863149566542,ACVR2B/CSNK2B
BP,GO:0043302,positive regulation of leukocyte degranulation,3.099269588313413,2,0.13527298909863167,0.687863149566542,SNX4/VAMP7
BP,GO:0046835,carbohydrate phosphorylation,3.099269588313413,2,0.13527298909863167,0.687863149566542,GNPTG/POMK
BP,GO:0051905,establishment of pigment granule localization,3.099269588313413,2,0.13527298909863167,0.687863149566542,BLOC1S5/MYO5A
BP,GO:1900078,positive regulation of cellular response to insulin stimulus,3.099269588313413,2,0.13527298909863167,0.687863149566542,PAK1/MYO1C
BP,GO:2000209,regulation of anoikis,3.099269588313413,2,0.13527298909863167,0.687863149566542,PIK3CA/MCL1
MF,GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",1.7265365853658536,6,0.1355339465265546,0.609155998065435,ARG2/SUDS3/VNN2/PADI3/NGLY1/AMDHD2
BP,GO:0006352,"DNA-templated transcription, initiation",1.4936238979823677,10,0.13563071268889462,0.6888211475885435,BAX/GTF2H1/VDR/TBP/CD3EAP/CDKN1A/CDK4/MED4/NRBF2/RBPJ
CC,GO:1905354,exoribonuclease complex,3.086810176125245,2,0.13622951839341893,0.521879257963024,CARHSP1/C1D
MF,GO:0008194,UDP-glycosyltransferase activity,1.6407814569536425,7,0.13639024542747732,0.609155998065435,B4GALT7/HAS3/GALNT1/MGAT4B/WDFY3/RFNG/B3GNT9
MF,GO:0022884,macromolecule transmembrane transporter activity,3.0777391304347823,2,0.13673141827080265,0.609155998065435,MCL1/TOMM20
MF,GO:0030159,receptor signaling complex scaffold activity,3.0777391304347823,2,0.13673141827080265,0.609155998065435,G3BP2/NUP62
MF,GO:0030552,cAMP binding,3.0777391304347823,2,0.13673141827080265,0.609155998065435,PRKAR2A/PDE4B
MF,GO:0035250,UDP-galactosyltransferase activity,3.0777391304347823,2,0.13673141827080265,0.609155998065435,B4GALT7/WDFY3
MF,GO:0140103,"catalytic activity, acting on a glycoprotein",3.0777391304347823,2,0.13673141827080265,0.609155998065435,B4GALT7/MGAT4B
BP,GO:0000819,sister chromatid segregation,1.5742321718417334,8,0.13815587515610717,0.6931320266684515,STAG2/INO80/VPS4A/BOD1/HNRNPU/CDC26/NUP62/CHMP1B
BP,GO:0019362,pyridine nucleotide metabolic process,1.5742321718417334,8,0.13815587515610717,0.6931320266684515,PGM1/PRKAG2/MPC2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0046496,nicotinamide nucleotide metabolic process,1.5742321718417334,8,0.13815587515610717,0.6931320266684515,PGM1/PRKAG2/MPC2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:0009064,glutamine family amino acid metabolic process,2.010337030257349,4,0.13815618462956383,0.6931320266684515,GCLM/ARG2/FAH/ALDH4A1
BP,GO:0032418,lysosome localization,2.010337030257349,4,0.13815618462956383,0.6931320266684515,PLA2G3/SNX4/VAMP7/SNAPIN
BP,GO:1900006,positive regulation of dendrite development,2.010337030257349,4,0.13815618462956383,0.6931320266684515,SS18L2/ANKRD27/VAMP7/CYFIP1
BP,GO:0002279,mast cell activation involved in immune response,2.3244521912350598,3,0.13826787340529245,0.6931320266684515,PLA2G3/SNX4/VAMP7
BP,GO:0008089,anterograde axonal transport,2.3244521912350598,3,0.13826787340529245,0.6931320266684515,TERF2/SNAPIN/BLOC1S5
BP,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,2.3244521912350598,3,0.13826787340529245,0.6931320266684515,CSNK2A2/RYBP/MTM1
BP,GO:0006997,nucleus organization,1.7165185412197363,6,0.1383537870341157,0.6931320266684515,KDM3A/VPS4A/PYGO2/AGFG1/BANF1/CHMP1B
BP,GO:0008033,tRNA processing,1.7165185412197363,6,0.1383537870341157,0.6931320266684515,HSD17B10/DUS2/TSEN34/TRMT112/SEPHS2/TRMT2B
CC,GO:0060076,excitatory synapse,2.3151076320939334,3,0.13956043503620127,0.5307371288602983,SRPX2/PDE4B/CYFIP1
MF,GO:0008307,structural constituent of muscle,2.3083043478260867,3,0.14024095891618915,0.6208118881958691,TPM4/MYL6B/ASPH
BP,GO:0046887,positive regulation of hormone secretion,1.7034153462485935,6,0.14193698377845546,0.7084410751559854,SNX4/VAMP7/ANO1/CAPN10/MPC2/RASL10B
BP,GO:0018393,internal peptidyl-lysine acetylation,1.6170102199896066,7,0.14403155144702492,0.7084410751559854,ING4/KANSL3/MAP3K7/RPS6KA4/PYGO2/TADA3/LDB1
BP,GO:0035967,cellular response to topologically incorrect protein,1.6170102199896066,7,0.14403155144702492,0.7084410751559854,BAX/COPS5/HERPUD2/EDEM1/MBTPS1/TSPYL2/PTPN1
BP,GO:0002448,mast cell mediated immunity,2.2770143914139362,3,0.14452671893139343,0.7084410751559854,PLA2G3/SNX4/VAMP7
BP,GO:0002534,cytokine production involved in inflammatory response,2.2770143914139362,3,0.14452671893139343,0.7084410751559854,ADCY7/APPL2/APOD
BP,GO:0097300,programmed necrotic cell death,2.2770143914139362,3,0.14452671893139343,0.7084410751559854,BAX/TRPM7/PYGL
BP,GO:0001945,lymph vessel development,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,ACVR2B/PTPN14
BP,GO:0014829,vascular smooth muscle contraction,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,ACTA2/DOCK5
BP,GO:0032400,melanosome localization,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,BLOC1S5/MYO5A
BP,GO:0032616,interleukin-13 production,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,ARG2/IL1RAP
BP,GO:0044247,cellular polysaccharide catabolic process,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,PGM1/PYGL
BP,GO:0045724,positive regulation of cilium assembly,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,WRAP73/TAPT1
BP,GO:0046755,viral budding,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,VPS4A/CHMP1B
BP,GO:0060444,branching involved in mammary gland duct morphogenesis,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,VDR/BTRC
BP,GO:0060561,apoptotic process involved in morphogenesis,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,BAX/VDR
BP,GO:0070129,regulation of mitochondrial translation,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,TRUB2/NGRN
BP,GO:0097186,amelogenesis,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,ITGA6/CNNM4
BP,GO:2000104,negative regulation of DNA-dependent DNA replication,2.9752988047808766,2,0.1445442704964277,0.7084410751559854,STAG2/TERF2
BP,GO:0031647,regulation of protein stability,1.4405055833006006,11,0.14516669224659892,0.7100108692723518,USP28/CHFR/STX12/CDKN1A/DPM2/BTRC/TRIM44/TNIP2/OTUD3/TADA3/ASPH
CC,GO:0070971,endoplasmic reticulum exit site,2.968086707812735,2,0.1451723203585381,0.5480781080202779,TMED5/PDCD6
BP,GO:1901605,alpha-amino acid metabolic process,1.507752772693012,9,0.14548871962078844,0.7100108692723518,GCLM/ARG2/FAH/EGLN3/QDPR/ALDH4A1/PCBD1/SEPHS2/P4HB
BP,GO:0030518,intracellular steroid hormone receptor signaling pathway,1.690510684534589,6,0.14556270033754706,0.7100108692723518,NEDD4/KDM3A/SAFB2/PAK1/PRMT2/TADA3
BP,GO:0042476,odontogenesis,1.690510684534589,6,0.14556270033754706,0.7100108692723518,BAX/ITGA6/ACVR2B/SDC1/CNNM4/MYO5A
BP,GO:0050851,antigen receptor-mediated signaling pathway,1.412325382016239,12,0.14628515391421448,0.7126802468539216,RC3H2/BAX/SPG21/PLEKHA1/PIK3CA/MAP3K7/CMTM3/BCL10/PAK1/BTRC/PDE4B/CARD11
MF,GO:0008143,poly(A) binding,2.9495000000000005,2,0.14650617694379717,0.6339425248709528,PPIE/HNRNPU
MF,GO:0008198,ferrous iron binding,2.9495000000000005,2,0.14650617694379717,0.6339425248709528,FTL/ISCU
BP,GO:0009101,glycoprotein biosynthetic process,1.389327746485323,13,0.14674604423453963,0.7140704640503674,B4GALT7/ITM2B/DPM2/GALNT1/ST6GALNAC6/MGAT4B/RFNG/FUT1/MCFD2/POMK/ENTPD5/OSTC/B3GNT9
MF,GO:0008374,O-acyltransferase activity,2.259191489361702,3,0.14685575036578907,0.6339425248709528,LPCAT2/GNPAT/LPGAT1
MF,GO:0019212,phosphatase inhibitor activity,2.259191489361702,3,0.14685575036578907,0.6339425248709528,BOD1/PPP1R14A/PPP1R14C
BP,GO:0034976,response to endoplasmic reticulum stress,1.4354511777451597,11,0.1475950843328772,0.7167794854584685,BAX/COPS5/HERPUD2/EDEM1/TMX1/MBTPS1/NRBF2/NUPR1/TSPYL2/P4HB/PTPN1
BP,GO:0000422,autophagy of mitochondrion,1.957433424197945,4,0.1480075633690053,0.7167794854584685,CSNK2A2/GABARAP/GBA/ATG9B
BP,GO:0046785,microtubule polymerization,1.957433424197945,4,0.1480075633690053,0.7167794854584685,MAPRE1/MET/PAK1/CLASP2
BP,GO:0061726,mitochondrion disassembly,1.957433424197945,4,0.1480075633690053,0.7167794854584685,CSNK2A2/GABARAP/GBA/ATG9B
CC,GO:0031965,nuclear membrane,1.4339067541122335,11,0.14848104674905752,0.5538766793982106,PLCD4/CDK4/CMTM3/PSEN2/LBR/PAK1/WDFY3/NSMF/PHF8/RCC1/NUP62
MF,GO:0004497,monooxygenase activity,1.7875757575757576,5,0.14862330259368317,0.6376123166827765,CYP26B1/DOHH/MICAL2/PCBD1/AKR1C3
BP,GO:0014812,muscle cell migration,1.788040147103892,5,0.14864629040993643,0.7173353548533623,NDRG4/DOCK7/DOCK5/PAK1/PARVA
BP,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,1.788040147103892,5,0.14864629040993643,0.7173353548533623,ZMYND11/GCLM/ITGA6/TGFBR1/MCL1
BP,GO:0042176,regulation of protein catabolic process,1.3666070625633948,14,0.14879994228459223,0.7173353548533623,SNX1/NEDD4/CSNK2A2/CHFR/RAB7A/EDEM1/NUDT15/RYBP/RCHY1/RNF180/BTRC/MTM1/NUPR1/GBA
CC,GO:0042641,actomyosin,1.953677326661547,4,0.14883442440642894,0.5538766793982106,DCTN4/TPM4/MYO18A/MYO5A
BP,GO:1901654,response to ketone,1.5416055983320602,8,0.15002953406629477,0.7173353548533623,CDKN1A/CDK4/PRKAA2/CLDN1/ADCY1/GBA/AKR1C3/CSNK2B
MF,GO:0001085,RNA polymerase II transcription factor binding,1.5984387096774193,7,0.15003311544687759,0.6397117499115332,TBP/ZNHIT6/ZMIZ2/HNRNPU/RBPJ/NHLH2/LDB1
BP,GO:0009451,RNA modification,1.597169603793415,7,0.15060907897519518,0.7173353548533623,HSD17B10/TRMT2A/TRUB2/DUS2/TRMT112/SEPHS2/TRMT2B
BP,GO:0051170,import into nucleus,1.597169603793415,7,0.15060907897519518,0.7173353548533623,HTATIP2/CDKN1A/APPL2/MBTPS1/APOD/KPNA5/NUP62
BP,GO:0009409,response to cold,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,CIRBP/APPL2/UCP2
BP,GO:0010171,body morphogenesis,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,PLEKHA1/CLASP2/ASPH
BP,GO:0031113,regulation of microtubule polymerization,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,MAPRE1/MET/PAK1
BP,GO:0032873,negative regulation of stress-activated MAPK cascade,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,ZMYND11/TAOK3/DUSP10
BP,GO:0034656,nucleobase-containing small molecule catabolic process,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,NUDT15/ENTPD5/ENTPD6
BP,GO:0043489,RNA stabilization,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,CIRBP/HNRNPU/HNRNPA0
BP,GO:0046854,phosphatidylinositol phosphorylation,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,IMPAD1/PIK3CA/PIP4K2A
BP,GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,ZMYND11/TAOK3/DUSP10
BP,GO:2000725,regulation of cardiac muscle cell differentiation,2.2314741035856573,3,0.15087703850032672,0.7173353548533623,PAK1/FRS2/RBPJ
BP,GO:0022409,positive regulation of cell-cell adhesion,1.4584798062651354,10,0.15094372265350986,0.7173353548533623,ITGA6/PIK3CA/BCL10/DUSP10/PAK1/FAM49B/IL7R/DENND6A/YES1/CARD11
MF,GO:0016811,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",1.9393972602739729,4,0.15142503583835132,0.6417097555344767,SUDS3/VNN2/NGLY1/AMDHD2
BP,GO:0033138,positive regulation of peptidyl-serine phosphorylation,1.7710111933219503,5,0.1528796369384013,0.7198483427510385,DOCK7/MAPKAP1/PIK3CA/SH2D3A/PAK1
BP,GO:0006278,RNA-dependent DNA biosynthetic process,1.932012210896673,4,0.15303245784900482,0.7198483427510385,SMG6/TERF2/HMBOX1/HNRNPU
BP,GO:0051168,nuclear export,1.5336591777221014,8,0.15307321641653723,0.7198483427510385,SMG6/THOC5/XPO4/WDR33/PTPN14/CDK5/AGFG1/NUP62
CC,GO:0016363,nuclear matrix,1.7699599633745668,5,0.15324925662065175,0.5580214710736586,STAG2/KIN/HNRNPU/NSMF/CSNK2B
BP,GO:0051260,protein homooligomerization,1.3774531503615168,13,0.15339227083746482,0.7198483427510385,HSD17B10/BAX/EHD4/ATXN10/APPL2/G3BP2/LNX2/BCL10/KCTD18/CLDN1/CLDN3/PCBD1/GBA
BP,GO:0006839,mitochondrial transport,1.4527826195219125,10,0.1535781151722495,0.7198483427510385,TOMM34/CSNK2A2/BAX/PRKAG2/MPC2/PSEN2/PRKAA2/TOMM20/UCP2/DNAJC30
BP,GO:0002230,positive regulation of defense response to virus by host,2.8608642353662272,2,0.1539428693702886,0.7198483427510385,DTX3L/TRIM44
BP,GO:0006516,glycoprotein catabolic process,2.8608642353662272,2,0.1539428693702886,0.7198483427510385,EDEM1/NGLY1
BP,GO:0021591,ventricular system development,2.8608642353662272,2,0.1539428693702886,0.7198483427510385,CDK6/C12orf57
BP,GO:0031954,positive regulation of protein autophosphorylation,2.8608642353662272,2,0.1539428693702886,0.7198483427510385,RAP2A/RAP2B
BP,GO:0051497,negative regulation of stress fiber assembly,2.8608642353662272,2,0.1539428693702886,0.7198483427510385,MET/CLASP2
BP,GO:0051875,pigment granule localization,2.8608642353662272,2,0.1539428693702886,0.7198483427510385,BLOC1S5/MYO5A
BP,GO:1903203,regulation of oxidative stress-induced neuron death,2.8608642353662272,2,0.1539428693702886,0.7198483427510385,LANCL1/MCL1
BP,GO:1904353,regulation of telomere capping,2.8608642353662272,2,0.1539428693702886,0.7198483427510385,SMG6/TERF2
BP,GO:0007088,regulation of mitotic nuclear division,1.5874307647458945,7,0.15394986681253772,0.7198483427510385,STAG2/CEP85/HNRNPU/CDC26/RCC1/NUP62/CHMP1B
MF,GO:0051427,hormone receptor binding,1.5305513513513516,8,0.15413180328811116,0.649221838092347,VDR/KDM3A/MED4/PRMT2/TADA3/TOB2/C1D/NUP62
CC,GO:0005942,phosphatidylinositol 3-kinase complex,2.858157570486337,2,0.15423242194742198,0.5580214710736586,PIK3CA/NRBF2
CC,GO:0030137,COPI-coated vesicle,2.858157570486337,2,0.15423242194742198,0.5580214710736586,COPE/TMEM199
CC,GO:0097431,mitotic spindle pole,2.858157570486337,2,0.15423242194742198,0.5580214710736586,STAG2/MAPKBP1
BP,GO:0071824,protein-DNA complex subunit organization,1.4204985613103145,11,0.15500627507238782,0.7239558289259169,RBBP7/GTF2H1/ASF1A/TBP/HP1BP3/INO80/ERCC5/RBBP4/TRAPPC12/SPTY2D1/TSPYL2
BP,GO:0048285,organelle fission,1.325300135759856,16,0.15528381938594002,0.7244203867683533,CYP26B1/DDHD2/DDHD1/STAG2/WRAP73/INO80/CEP85/VPS4A/AGO4/BOD1/HNRNPU/CLASP2/CDC26/RCC1/NUP62/CHMP1B
BP,GO:0072524,pyridine-containing compound metabolic process,1.5257942588619877,8,0.1561464069664628,0.7268206878172926,PGM1/PRKAG2/MPC2/ARNT/PRKAA2/NUPR1/ENTPD5/NUP62
BP,GO:1903825,organic acid transmembrane transport,1.6529437804338203,6,0.15668885806951868,0.7268206878172926,PRKAG2/SLC36A1/SLC7A1/MPC2/PRKAA2/PRAF2
BP,GO:1905039,carboxylic acid transmembrane transport,1.6529437804338203,6,0.15668885806951868,0.7268206878172926,PRKAG2/SLC36A1/SLC7A1/MPC2/PRKAA2/PRAF2
CC,GO:0030426,growth cone,1.579508131058239,7,0.15683929302674451,0.563539804599544,ALS2/DOCK7/ZFYVE27/CDK5/CBX6/MYO5A/CYFIP1
BP,GO:1901606,alpha-amino acid catabolic process,1.754303540554762,5,0.1571628223389137,0.7268206878172926,ARG2/FAH/QDPR/ALDH4A1/PCBD1
BP,GO:0048146,positive regulation of fibroblast proliferation,2.187719709397703,3,0.15731468064747128,0.7268206878172926,CDK6/CDKN1A/CDK4
BP,GO:0051452,intracellular pH reduction,2.187719709397703,3,0.15731468064747128,0.7268206878172926,RAB7A/SNAPIN/TMEM199
BP,GO:0072523,purine-containing compound catabolic process,2.187719709397703,3,0.15731468064747128,0.7268206878172926,PDE8A/NUDT15/PDE4B
BP,GO:0048545,response to steroid hormone,1.3524085476276713,14,0.1573570782407469,0.7268206878172926,NEDD4/RBBP7/VDR/KDM3A/SDC1/CDKN1A/SAFB2/PAK1/HNRNPU/PRMT2/CLDN1/TADA3/GBA/AKR1C3
BP,GO:0034248,regulation of cellular amide metabolic process,1.3090082733249198,17,0.15774454007596753,0.7268206878172926,SAMD4A/CIRBP/MKNK2/CNOT6/RPS6KA1/PAIP2/AGO4/CDK4/CELF1/CNOT11/EIF5A2/TRUB2/NGRN/CNOT10/YTHDF3/CNOT7/CYFIP1
BP,GO:0000271,polysaccharide biosynthetic process,1.907242823577485,4,0.1581210198422576,0.7268206878172926,PGM1/HAS3/EPM2AIP1/B3GNT9
BP,GO:0010827,regulation of glucose transmembrane transport,1.907242823577485,4,0.1581210198422576,0.7268206878172926,PRKAG2/APPL2/CAPN10/YES1
BP,GO:0043407,negative regulation of MAP kinase activity,1.907242823577485,4,0.1581210198422576,0.7268206878172926,DUSP10/GBA/PTPN1/NUP62
BP,GO:0090398,cellular senescence,1.907242823577485,4,0.1581210198422576,0.7268206878172926,ARG2/CDK6/CDKN1A/TERF2
BP,GO:0006694,steroid biosynthetic process,1.5180095942759575,8,0.15924879163212696,0.7303540973613218,STARD3NL/HSD17B14/PRKAG2/VDR/MBTPS1/LBR/PRKAA2/AKR1C3
BP,GO:0071897,DNA biosynthetic process,1.5180095942759575,8,0.15924879163212696,0.7303540973613218,SPRTN/SMG6/CDKN1A/TERF2/HMBOX1/HNRNPU/RCHY1/TK2
BP,GO:0006457,protein folding,1.474542359197571,9,0.15960313998746406,0.7307122904680216,CSNK2A2/PPIE/FKBP9/NGLY1/HSPA4L/RIC3/P4HB/ENTPD5/CSNK2B
BP,GO:0022604,regulation of cell morphogenesis,1.3063037107767277,17,0.1596861421401355,0.7307122904680216,SS18L2/NEDD4/ANKRD27/VAMP7/RAP2A/DIAPH1/AGO4/ANXA7/DOCK5/PAK1/ZFYVE27/CDK5/PDZD8/NSMF/FITM2/PARVA/CYFIP1
MF,GO:0015485,cholesterol binding,2.1669795918367347,3,0.16037885917061284,0.6714657055637103,STARD3NL/OSBP2/APOD
BP,GO:0006475,internal protein amino acid acetylation,1.5683050928814861,7,0.16073333812751092,0.7315947866669551,ING4/KANSL3/MAP3K7/RPS6KA4/PYGO2/TADA3/LDB1
BP,GO:0045088,regulation of innate immune response,1.3165038959207418,16,0.16131308904015626,0.7315947866669551,TAB1/POLR3F/MAP3K7/APPL2/BCL10/DUSP10/PAK1/BTRC/TNIP2/YTHDF3/POLR3C/CARD9/PTPN1/CARD11/CNOT7/ZCCHC3
CC,GO:0030017,sarcomere,1.5131422431986492,8,0.16133968407244356,0.5757395575461856,DCTN4/PSEN2/PAK1/MTMR12/TPM4/MTM1/PDE4B/PARVA
BP,GO:0010952,positive regulation of peptidase activity,1.5103039618177037,8,0.16238004824518884,0.7315947866669551,BAX/EGLN3/BCL10/CRADD/PIDD1/CARD9/ASPH/PDCD6
BP,GO:0007032,endosome organization,1.883100509354985,4,0.16327137151685667,0.7315947866669551,ALS2/RAB7A/VPS4A/CHMP1B
BP,GO:0031110,regulation of microtubule polymerization or depolymerization,1.883100509354985,4,0.16327137151685667,0.7315947866669551,MAPRE1/MET/PAK1/CLASP2
BP,GO:0000272,polysaccharide catabolic process,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,PGM1/PYGL
BP,GO:0000460,maturation of 5.8S rRNA,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,FCF1/C1D
BP,GO:0006730,one-carbon metabolic process,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,MTHFD1L/ALDH1L1
BP,GO:0018195,peptidyl-arginine modification,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,PADI3/PRMT2
BP,GO:0034067,protein localization to Golgi apparatus,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,ARFRP1/ARL1
BP,GO:0036151,phosphatidylcholine acyl-chain remodeling,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,LPCAT2/PLA2G3
BP,GO:0036475,neuron death in response to oxidative stress,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,LANCL1/MCL1
BP,GO:0048643,positive regulation of skeletal muscle tissue development,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,CYP26B1/MTM1
BP,GO:0051569,regulation of histone H3-K4 methylation,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,RTF1/PYGO2
BP,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,MCL1/P4HB
BP,GO:1904357,negative regulation of telomere maintenance via telomere lengthening,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,TERF2/HNRNPU
BP,GO:1905208,negative regulation of cardiocyte differentiation,2.7549063007230337,2,0.16345527577910748,0.7315947866669551,PAK1/FRS2
BP,GO:0006301,postreplication repair,2.1456481765246704,3,0.1638355090102252,0.7315947866669551,SPRTN/WDR33/RCHY1
BP,GO:0031529,ruffle organization,2.1456481765246704,3,0.1638355090102252,0.7315947866669551,PLEKHA1/INPPL1/CYFIP1
BP,GO:0046580,negative regulation of Ras protein signal transduction,2.1456481765246704,3,0.1638355090102252,0.7315947866669551,MET/MAPKAP1/NUP62
BP,GO:0072132,mesenchyme morphogenesis,2.1456481765246704,3,0.1638355090102252,0.7315947866669551,TGFBR1/ACTA2/RBPJ
BP,GO:2000772,regulation of cellular senescence,2.1456481765246704,3,0.1638355090102252,0.7315947866669551,ARG2/CDK6/TERF2
BP,GO:0034605,cellular response to heat,1.6288132142961003,6,0.16430743367999784,0.732897631809464,RBBP7/CDKN1A/ANO1/STAC/NUP62/PDCD6
BP,GO:0046890,regulation of lipid biosynthetic process,1.5026761640307458,8,0.16553984673952307,0.7375860860201312,PRKAG2/VDR/LPGAT1/CDK4/MBTPS1/PRKAA2/AKR1C3/FITM2
BP,GO:2000278,regulation of DNA biosynthetic process,1.721816437951896,5,0.1658745395015913,0.7382687381755727,SMG6/CDKN1A/TERF2/HMBOX1/HNRNPU
MF,GO:0004709,MAP kinase kinase kinase activity,2.7226153846153847,2,0.16645288834937794,0.680498572957751,TAOK3/MAP3K7
MF,GO:0008574,"ATP-dependent microtubule motor activity, plus-end-directed",2.7226153846153847,2,0.16645288834937794,0.680498572957751,KIF16B/DNAL4
MF,GO:0042974,retinoic acid receptor binding,2.7226153846153847,2,0.16645288834937794,0.680498572957751,VDR/PRMT2
MF,GO:0070325,lipoprotein particle receptor binding,2.7226153846153847,2,0.16645288834937794,0.680498572957751,LANCL1/ANKRA2
BP,GO:0022412,cellular process involved in reproduction in multicellular organism,1.3543026772461975,13,0.1671497858453377,0.7431315069058293,CYP26B1/MAST2/BAX/PLA2G3/TGFBR1/KDM3A/AGO4/DIAPH2/CELF1/PYGO2/STRBP/AGFG1/OSBP2
MF,GO:0043130,ubiquitin binding,1.8628421052631579,4,0.16762355015984093,0.6812770021116342,SPRTN/NEDD4/RNF168/NUP62
BP,GO:2001234,negative regulation of apoptotic signaling pathway,1.4553091979906463,9,0.16837796675085986,0.7468823624765099,ZMYND11/GCLM/CSNK2A2/BAX/ITGA6/TGFBR1/MCL1/TRIAP1/PTPN1
BP,GO:0140029,exocytic process,1.8595617529880477,4,0.16848161735952064,0.7468823624765099,SNX4/VAMP7/RAB15/SNAPIN
BP,GO:0031032,actomyosin structure organization,1.4951250275280785,8,0.16872784934019483,0.7468823624765099,TRPM7/MET/TGFBR1/VPS4A/PAK1/CLASP2/ACTG1/MYO18A
BP,GO:0035966,response to topologically incorrect protein,1.4951250275280785,8,0.16872784934019483,0.7468823624765099,BAX/COPS5/HERPUD2/EDEM1/MBTPS1/HSPA4L/TSPYL2/PTPN1
BP,GO:0098813,nuclear chromosome segregation,1.4195127885404946,10,0.16986169029374962,0.7510840827336668,STAG2/INO80/VPS4A/AGO4/BOD1/HNRNPU/TRAPPC12/CDC26/NUP62/CHMP1B
BP,GO:0051261,protein depolymerization,1.7060199568697687,5,0.1703009436049204,0.7519861614935784,CAPZA1/VPS4A/MICAL2/CLASP2/ASPH
BP,GO:0045851,pH reduction,2.1051642486657145,3,0.17043540828345116,0.7519861614935784,RAB7A/SNAPIN/TMEM199
CC,GO:0070382,exocytic vesicle,1.4912126454711325,8,0.17052132470396603,0.5975722898972263,VAMP4/STX12/COPS5/VAMP7/RAB15/SNAPIN/PSEN2/PDE4B
BP,GO:0038095,Fc-epsilon receptor signaling pathway,1.5404653575048914,7,0.17115651233892076,0.7535332166609628,TAB1/PIK3CA/MAP3K7/BCL10/PAK1/BTRC/CARD11
BP,GO:0140056,organelle localization by membrane tethering,1.5404653575048914,7,0.17115651233892076,0.7535332166609628,MAPRE1/NDRG4/MOSPD3/STX12/RAB15/PSEN2/PDZD8
BP,GO:0033135,regulation of peptidyl-serine phosphorylation,1.6053770529393219,6,0.1720807170384175,0.7543376479036427,BAX/DOCK7/MAPKAP1/PIK3CA/SH2D3A/PAK1
CC,GO:0090568,nuclear transcriptional repressor complex,2.661043255280383,2,0.17265685933030273,0.5975722898972263,RBBP7/RBBP4
CC,GO:1990752,microtubule end,2.661043255280383,2,0.17265685933030273,0.5975722898972263,MAPRE1/MYO5A
BP,GO:0001958,endochondral ossification,2.6565167899829256,2,0.17306861160701267,0.7543376479036427,IMPAD1/INPPL1
BP,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,2.6565167899829256,2,0.17306861160701267,0.7543376479036427,NGLY1/OMA1
BP,GO:0006760,folic acid-containing compound metabolic process,2.6565167899829256,2,0.17306861160701267,0.7543376479036427,MTHFD1L/ALDH1L1
BP,GO:0034377,plasma lipoprotein particle assembly,2.6565167899829256,2,0.17306861160701267,0.7543376479036427,PLAGL2/P4HB
BP,GO:0034698,response to gonadotropin,2.6565167899829256,2,0.17306861160701267,0.7543376479036427,GCLM/NSMF
BP,GO:0036075,replacement ossification,2.6565167899829256,2,0.17306861160701267,0.7543376479036427,IMPAD1/INPPL1
BP,GO:0051647,nucleus localization,2.6565167899829256,2,0.17306861160701267,0.7543376479036427,DOCK7/DCTN4
BP,GO:0090344,negative regulation of cell aging,2.6565167899829256,2,0.17306861160701267,0.7543376479036427,CDK6/TERF2
CC,GO:0030427,site of polarized growth,1.5346357409713571,7,0.17353624331404757,0.5975722898972263,ALS2/DOCK7/ZFYVE27/CDK5/CBX6/MYO5A/CYFIP1
CC,GO:0120111,neuron projection cytoplasm,1.8373870095983598,4,0.1736560731918542,0.5975722898972263,TERF2/SNAPIN/HNRNPU/BLOC1S5
BP,GO:0001510,RNA methylation,1.8366042004820224,4,0.17374984662873974,0.7543376479036427,HSD17B10/TRMT2A/TRMT112/TRMT2B
BP,GO:0016126,sterol biosynthetic process,1.8366042004820224,4,0.17374984662873974,0.7543376479036427,PRKAG2/MBTPS1/LBR/PRKAA2
BP,GO:0032204,regulation of telomere maintenance,1.8366042004820224,4,0.17374984662873974,0.7543376479036427,SMG6/TERF2/HMBOX1/HNRNPU
BP,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,1.8366042004820224,4,0.17374984662873974,0.7543376479036427,CHFR/RCHY1/RNF180/GBA
MF,GO:0031593,polyubiquitin modification-dependent protein binding,2.0820000000000003,3,0.17426131414565507,0.7041372868094783,SPRTN/RNF168/TNIP2
CC,GO:0030660,Golgi-associated vesicle membrane,1.6923301404195419,5,0.17433970837692592,0.5975722898972263,COPE/ITM2B/MCFD2/TMEM199/PDCD6
BP,GO:0000302,response to reactive oxygen species,1.4427634290424511,9,0.17435124644141503,0.756141653010316,PDE8A/SESN1/MET/PLEKHA1/SDC1/STK26/NUDT15/APOD/AKR1C3
BP,GO:0042737,drug catabolic process,1.5939100739897554,6,0.17602364914371949,0.7617704305496286,FAH/IDUA/NUDT15/QDPR/AMDHD2/PCBD1
BP,GO:1903364,positive regulation of cellular protein catabolic process,1.5939100739897554,6,0.17602364914371949,0.7617704305496286,CHFR/EDEM1/RCHY1/RNF180/NUPR1/GBA
MF,GO:0016866,intramolecular transferase activity,2.621777777777778,2,0.17659454312472275,0.7053632613315076,PGM1/TRUB2
MF,GO:0046875,ephrin receptor binding,2.621777777777778,2,0.17659454312472275,0.7053632613315076,CDK5/PTPN1
BP,GO:0006336,DNA replication-independent nucleosome assembly,2.066179725542275,3,0.17711028974506288,0.7621722726387863,RBBP7/ASF1A/RBBP4
BP,GO:0051353,positive regulation of oxidoreductase activity,2.066179725542275,3,0.17711028974506288,0.7621722726387863,VDR/TERF2/RFK
BP,GO:0090329,regulation of DNA-dependent DNA replication,2.066179725542275,3,0.17711028974506288,0.7621722726387863,STAG2/INO80/TERF2
BP,GO:0050867,positive regulation of cell activation,1.3215159665904908,14,0.17752864265600948,0.7621722726387863,SNX4/RPS6KA1/PIK3CA/VAMP7/CDKN1A/BCL10/DUSP10/PAK1/FAM49B/IL7R/TNIP2/YES1/CARD11/TOX
BP,GO:0006575,cellular modified amino acid metabolic process,1.4729202003865725,8,0.1784575924272135,0.7621722726387863,GCLM/CTNS/VNN2/MTHFD1L/EGLN3/ALDH1L1/ALDH4A1/P4HB
BP,GO:0050852,T cell receptor signaling pathway,1.4729202003865725,8,0.1784575924272135,0.7621722726387863,RC3H2/PIK3CA/MAP3K7/BCL10/PAK1/BTRC/PDE4B/CARD11
BP,GO:0050870,positive regulation of T cell activation,1.4729202003865725,8,0.1784575924272135,0.7621722726387863,PIK3CA/BCL10/DUSP10/PAK1/FAM49B/IL7R/YES1/CARD11
CC,GO:0000123,histone acetyltransferase complex,1.8157706918383791,4,0.1787834151231321,0.6013669162593464,ING4/KANSL3/MAP3K7/TADA3
BP,GO:0010833,telomere maintenance via telomere lengthening,1.8142065882810223,4,0.1790741357330382,0.7621722726387863,SMG6/TERF2/HMBOX1/HNRNPU
BP,GO:0016925,protein sumoylation,1.8142065882810223,4,0.1790741357330382,0.7621722726387863,ZMIZ2/HMG20A/ARNT/NUP62
BP,GO:0009141,nucleoside triphosphate metabolic process,1.3355968391626862,13,0.17907449722527824,0.7621722726387863,CTNS/PGM1/PRKAG2/ISCU/NUDT15/ARNT/CMPK1/PRKAA2/SDHAF2/NUPR1/DNAJC30/ENTPD5/NUP62
MF,GO:0019787,ubiquitin-like protein transferase activity,1.3044471744471744,15,0.17926655087452198,0.7093548555614949,RC3H2/NEDD4/CHFR/KLHL42/FBXO30/ZMIZ2/FBXL12/MED21/RCHY1/DTX3L/RNF168/RNF180/BTRC/ZNF738/KLHL9
BP,GO:0006406,mRNA export from nucleus,1.6752808585477907,5,0.1792894077803572,0.7621722726387863,SMG6/THOC5/WDR33/AGFG1/NUP62
BP,GO:0071427,mRNA-containing ribonucleoprotein complex export from nucleus,1.6752808585477907,5,0.1792894077803572,0.7621722726387863,SMG6/THOC5/WDR33/AGFG1/NUP62
MF,GO:0004843,thiol-dependent ubiquitin-specific protease activity,1.6695283018867926,5,0.18090431287707598,0.7093548555614949,USP28/USP31/USP46/COPS5/OTUD3
MF,GO:0050661,NADP binding,2.0419615384615386,3,0.18132539644186155,0.7093548555614949,LBR/QDPR/DUS2
CC,GO:0005719,nuclear euchromatin,2.5723418134377036,2,0.18199870199857987,0.6013669162593464,TBP/NSMF
CC,GO:0071007,U2-type catalytic step 2 spliceosome,2.5723418134377036,2,0.18199870199857987,0.6013669162593464,PPIE/CWC15
CC,GO:0000790,nuclear chromatin,1.3305216276401917,13,0.1825779751634878,0.6013669162593464,CBX5/RBBP7/CBX1/SUDS3/ASF1A/TBP/INO80/ASXL2/GABPA/RBBP4/NSMF/RCC1/LDB1
BP,GO:0006294,"nucleotide-excision repair, preincision complex assembly",2.564912762742135,2,0.18277060646632273,0.7621722726387863,GTF2H1/ERCC5
BP,GO:0032232,negative regulation of actin filament bundle assembly,2.564912762742135,2,0.18277060646632273,0.7621722726387863,MET/CLASP2
BP,GO:0042226,interleukin-6 biosynthetic process,2.564912762742135,2,0.18277060646632273,0.7621722726387863,BCL10/CARD9
BP,GO:0044550,secondary metabolite biosynthetic process,2.564912762742135,2,0.18277060646632273,0.7621722726387863,CTNS/MYO5A
BP,GO:0046134,pyrimidine nucleoside biosynthetic process,2.564912762742135,2,0.18277060646632273,0.7621722726387863,CMPK1/TK2
BP,GO:0060765,regulation of androgen receptor signaling pathway,2.564912762742135,2,0.18277060646632273,0.7621722726387863,SAFB2/PRMT2
BP,GO:0090162,establishment of epithelial cell polarity,2.564912762742135,2,0.18277060646632273,0.7621722726387863,CYTH1/MYO18A
BP,GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",2.564912762742135,2,0.18277060646632273,0.7621722726387863,RC3H2/ARG2
CC,GO:0031985,Golgi cisterna,1.6631520345502393,5,0.18307234884581877,0.6013669162593464,B4GALT7/GOLGA3/YIPF2/GALNT1/FUT1
CC,GO:0016328,lateral plasma membrane,2.0307961685034503,3,0.18352656369527076,0.6013669162593464,CLDN1/CLDN3/MYO1C
CC,GO:1904115,axon cytoplasm,2.0307961685034503,3,0.18352656369527076,0.6013669162593464,TERF2/SNAPIN/BLOC1S5
BP,GO:0003279,cardiac septum development,1.6603229937393285,5,0.18384925204034525,0.7621722726387863,TAB1/TGFBR1/FRS2/RBPJ/PARVA
BP,GO:0098693,regulation of synaptic vesicle cycle,1.6603229937393285,5,0.18384925204034525,0.7621722726387863,VAMP4/SNAPIN/ADCY1/CDK5/CYFIP1
BP,GO:0034724,DNA replication-independent nucleosome organization,2.0286128214415067,3,0.18385609637310968,0.7621722726387863,RBBP7/ASF1A/RBBP4
BP,GO:0042304,regulation of fatty acid biosynthetic process,2.0286128214415067,3,0.18385609637310968,0.7621722726387863,PRKAG2/LPGAT1/PRKAA2
BP,GO:0010038,response to metal ion,1.3282583949914628,13,0.18395795483208163,0.7621722726387863,RASGRP2/NEDD4/SDC1/ADCY7/CDK4/ANXA7/QDPR/PRKAA2/CLDN1/ADCY1/AKR1C3/ENTPD6/PDCD6
BP,GO:0046467,membrane lipid biosynthetic process,1.5714606363279278,6,0.18401854258751338,0.7621722726387863,PIGB/DPM2/ST6GALNAC6/SGMS2/GBA/PIGN
MF,GO:0050660,flavin adenine dinucleotide binding,1.7921012658227846,4,0.18440210510987146,0.7093548555614949,AGPS/MICAL2/DUS2/ACAD11
BP,GO:0045913,positive regulation of carbohydrate metabolic process,1.7923486775788413,4,0.1844525505341583,0.7621722726387863,ARNT/PRKAA2/EPM2AIP1/ENTPD5
BP,GO:0071277,cellular response to calcium ion,1.7923486775788413,4,0.1844525505341583,0.7621722726387863,RASGRP2/PRKAA2/ADCY1/AKR1C3
BP,GO:2000106,regulation of leukocyte apoptotic process,1.7923486775788413,4,0.1844525505341583,0.7621722726387863,ARG2/BAX/BCL10/IL7R
BP,GO:0001659,temperature homeostasis,1.5048476613776107,7,0.18549696816303377,0.7621722726387863,ACVR2B/KDM3A/DOCK7/APPL2/OMA1/RBPJ/UCP2
MF,GO:0004683,calmodulin-dependent protein kinase activity,2.528142857142857,2,0.1868294423164427,0.7093548555614949,CAMKK1/MKNK2
MF,GO:0005227,calcium activated cation channel activity,2.528142857142857,2,0.1868294423164427,0.7093548555614949,ANO1/MTMR6
MF,GO:0090079,"translation regulator activity, nucleic acid binding",2.528142857142857,2,0.1868294423164427,0.7093548555614949,PAIP2/CELF1
BP,GO:0031334,positive regulation of protein complex assembly,1.3877326514836177,10,0.18693197949998694,0.7621722726387863,BAX/MAPRE1/MET/GTF2H1/CNOT6/ERCC5/G3BP2/PAK1/MYO1C/CYFIP1
CC,GO:0031253,cell projection membrane,1.3420913809240194,12,0.18695073029925682,0.608758315536955,PHLPP2/RASGRP2/MAPRE1/NDRG4/PLEKHA1/DIAPH1/APPL2/MTMR6/PAK1/CLASP2/PCDHB13/MYO1C
BP,GO:0006606,protein import into nucleus,1.5604714011088514,6,0.18806905112237648,0.7621722726387863,CDKN1A/APPL2/MBTPS1/APOD/KPNA5/NUP62
BP,GO:0043244,regulation of protein complex disassembly,1.6456298699009273,5,0.1884513398312352,0.7621722726387863,CAPZA1/CLASP2/EIF5A2/GBA/ASPH
BP,GO:0048640,negative regulation of developmental growth,1.6456298699009273,5,0.1884513398312352,0.7621722726387863,CDKN1A/DUSP10/PAK1/WWC2/CDK5
MF,GO:0000993,RNA polymerase II complex binding,2.003433962264151,3,0.188465111859485,0.7093548555614949,ERCC5/RTF1/HNRNPU
BP,GO:0051090,regulation of DNA-binding transcription factor activity,1.2913623284639222,15,0.18921189104562836,0.7621722726387863,TAB1/COPS5/MAP3K7/G3BP2/BCL10/PRMT2/RPS6KA4/ADCY1/BTRC/RHEBL1/NUPR1/NHLH2/PIDD1/IL1RAP/CARD11
BP,GO:0010769,regulation of cell morphogenesis involved in differentiation,1.3591481251075435,11,0.18921651246635,0.7621722726387863,SS18L2/NEDD4/ANKRD27/VAMP7/RAP2A/DOCK5/PAK1/ZFYVE27/CDK5/NSMF/CYFIP1
BP,GO:1903532,positive regulation of secretion by cell,1.3049556161319633,14,0.1892640980917407,0.7621722726387863,RAB7A/SNX4/SDC1/VAMP7/ANO1/VPS4A/RAB15/CAPN10/MPC2/CLASP2/CDK5/IL1RAP/MYO18A/RASL10B
BP,GO:0031669,cellular response to nutrient levels,1.412325382016239,9,0.18970041398878712,0.7621722726387863,SESN1/MTMR3/VDR/CDKN1A/STK26/PRKAA2/GABARAP/GBA/AKR1C3
BP,GO:0043491,protein kinase B signaling,1.3825737940431582,10,0.1898502128809772,0.7621722726387863,PHLPP2/MET/TGFBR1/PLEKHA1/PIK3CA/FRS2/OTUD3/MTM1/AKR1C3/PDCD6
BP,GO:0014910,regulation of smooth muscle cell migration,1.7710111933219503,4,0.18988314857513378,0.7621722726387863,NDRG4/DOCK7/DOCK5/PAK1
BP,GO:0051492,regulation of stress fiber assembly,1.7710111933219503,4,0.18988314857513378,0.7621722726387863,MET/TGFBR1/PAK1/CLASP2
CC,GO:0008023,transcription elongation factor complex,1.9957824414602874,3,0.19008556751467504,0.6151216191002837,ELL/RTF1/EAF1
BP,GO:0034508,centromere complex assembly,1.992387592487194,3,0.1906688075748219,0.7621722726387863,RBBP7/RBBP4/TRAPPC12
BP,GO:0046148,pigment biosynthetic process,1.992387592487194,3,0.1906688075748219,0.7621722726387863,CTNS/MTHFD1L/MYO5A
BP,GO:0048488,synaptic vesicle endocytosis,1.992387592487194,3,0.1906688075748219,0.7621722726387863,VAMP4/CDK5/ACTG1
BP,GO:0072528,pyrimidine-containing compound biosynthetic process,1.992387592487194,3,0.1906688075748219,0.7621722726387863,CMPK1/CDS1/TK2
BP,GO:0140238,presynaptic endocytosis,1.992387592487194,3,0.1906688075748219,0.7621722726387863,VAMP4/CDK5/ACTG1
BP,GO:1902017,regulation of cilium assembly,1.992387592487194,3,0.1906688075748219,0.7621722726387863,CDKL1/WRAP73/TAPT1
BP,GO:0034599,cellular response to oxidative stress,1.3546476346270546,11,0.1919823685889397,0.7621722726387863,PDE8A/MET/PLEKHA1/LANCL1/MAPKAP1/STK26/MCL1/ARNT/PRKAA2/P4HB/AKR1C3
BP,GO:0006517,protein deglycosylation,2.4794156706507304,2,0.1925495744354299,0.7621722726387863,EDEM1/NGLY1
BP,GO:0010586,miRNA metabolic process,2.4794156706507304,2,0.1925495744354299,0.7621722726387863,RC3H2/AGO4
BP,GO:0021696,cerebellar cortex morphogenesis,2.4794156706507304,2,0.1925495744354299,0.7621722726387863,CDK5/LDB1
BP,GO:0032728,positive regulation of interferon-beta production,2.4794156706507304,2,0.1925495744354299,0.7621722726387863,POLR3F/POLR3C
BP,GO:0036258,multivesicular body assembly,2.4794156706507304,2,0.1925495744354299,0.7621722726387863,VPS4A/CHMP1B
BP,GO:0046320,regulation of fatty acid oxidation,2.4794156706507304,2,0.1925495744354299,0.7621722726387863,PRKAG2/APPL2
BP,GO:0048384,retinoic acid receptor signaling pathway,2.4794156706507304,2,0.1925495744354299,0.7621722726387863,CYP26B1/AKR1C3
BP,GO:0051491,positive regulation of filopodium assembly,2.4794156706507304,2,0.1925495744354299,0.7621722726387863,TGFBR1/FNBP1L
BP,GO:0051607,defense response to virus,1.4063912417556665,9,0.19283925253491568,0.7621722726387863,ZMYND11/POLR3F/RTP4/DTX3L/TRIM44/POLR3C/CARD9/CNOT7/ZCCHC3
BP,GO:0045446,endothelial cell differentiation,1.6311945201649543,5,0.19309453376032565,0.7621722726387863,MET/ACVR2B/MARVELD2/CLDN1/RBPJ
BP,GO:0043254,regulation of protein complex assembly,1.2742179035464138,16,0.19325910285583364,0.7621722726387863,BAX/MAPRE1/ANKRD27/MET/GTF2H1/CNOT6/CAPZA1/ERCC5/G3BP2/PAK1/PRKAA2/ANKRA2/TRAPPC12/GBA/MYO1C/CYFIP1
CC,GO:0030662,coated vesicle membrane,1.4840433539063675,7,0.19453100448887423,0.625621316905577,COPE/VAMP4/VAMP7/IL7R/MCFD2/TMEM199/PDCD6
MF,GO:0004842,ubiquitin-protein transferase activity,1.2971623036649214,14,0.19486887943501796,0.7093548555614949,RC3H2/NEDD4/CHFR/KLHL42/FBXO30/FBXL12/MED21/RCHY1/DTX3L/RNF168/RNF180/BTRC/ZNF738/KLHL9
BP,GO:0006643,membrane lipid metabolic process,1.4373424177685392,8,0.1952042942146581,0.7621722726387863,PIGB/BAX/DPM2/SUMF1/ST6GALNAC6/SGMS2/GBA/PIGN
BP,GO:0099003,vesicle-mediated transport in synapse,1.4373424177685392,8,0.1952042942146581,0.7621722726387863,EEA1/USP46/VAMP4/SNAPIN/ADCY1/CDK5/ACTG1/BLOC1S5
BP,GO:0072384,organelle transport along microtubule,1.7501757675181626,4,0.19536398123337648,0.7621722726387863,VAMP7/KIF13A/SNAPIN/BLOC1S5
MF,GO:0015179,L-amino acid transmembrane transporter activity,1.9663333333333335,3,0.19567581628613812,0.7093548555614949,CTNS/SLC36A1/SLC7A1
BP,GO:0031348,negative regulation of defense response,1.4005067595725884,9,0.19600039352638715,0.7621722726387863,ARG2/ADCY7/APPL2/MAPKBP1/DUSP10/GBA/YTHDF3/APOD/CNOT7
BP,GO:0006334,nucleosome assembly,1.538947657645281,6,0.19627248611625517,0.7621722726387863,RBBP7/ASF1A/HP1BP3/RBBP4/SPTY2D1/TSPYL2
MF,GO:0000030,mannosyltransferase activity,2.4409655172413793,2,0.19714425757687723,0.7093548555614949,PIGB/DPM2
MF,GO:0032947,protein-containing complex scaffold activity,2.4409655172413793,2,0.19714425757687723,0.7093548555614949,G3BP2/NUP62
BP,GO:0008380,RNA splicing,1.2687841384993077,16,0.1977362609806683,0.7621722726387863,PPIE/PAPOLA/CIRBP/THOC5/HTATSF1/WDR83/DNAJC8/LSM7/WDR33/BUD13/CELF1/CWC15/HNRNPU/RP9/TSEN34/HNRNPA0
BP,GO:0010927,cellular component assembly involved in morphogenesis,1.6170102199896068,5,0.19777768650918437,0.7621722726387863,PLA2G3/GNPAT/CLASP2/AGFG1/ACTG1
BP,GO:0043405,regulation of MAP kinase activity,1.3243169754217552,12,0.19858274442852528,0.7621722726387863,MAP4K5/TAB1/TGFBR1/TAOK3/MAP3K7/DUSP10/PAK1/FRS2/MAP4K2/GBA/PTPN1/NUP62
BP,GO:0046034,ATP metabolic process,1.34132323166351,11,0.20038865731775948,0.7621722726387863,CTNS/PGM1/PRKAG2/ISCU/ARNT/PRKAA2/SDHAF2/NUPR1/DNAJC30/ENTPD5/NUP62
MF,GO:1902936,phosphatidylinositol bisphosphate binding,1.6088181818181817,5,0.2004236464592647,0.7093548555614949,KIF16B/PLEKHA1/MAPKAP1/MYO1B/SNX14
BP,GO:0035264,multicellular organism growth,1.5284069202641488,6,0.2004239031411645,0.7621722726387863,RC3H2/PLEKHA1/WDR11/PIK3CA/CDK4/TBL1XR1
CC,GO:0031941,filamentous actin,2.411570450097847,2,0.20088921481705682,0.6363257601124978,ACTG1/MYO1C
BP,GO:0001776,leukocyte homeostasis,1.7298248865005097,4,0.20089309579903014,0.7621722726387863,RC3H2/BAX/BCL10/PDE4B
BP,GO:0001942,hair follicle development,1.7298248865005097,4,0.20089309579903014,0.7621722726387863,FOXQ1/RBPJ/MYO5A/LDB1
BP,GO:0006400,tRNA modification,1.7298248865005097,4,0.20089309579903014,0.7621722726387863,HSD17B10/DUS2/TRMT112/SEPHS2
BP,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,1.7298248865005097,4,0.20089309579903014,0.7621722726387863,BAX/CRADD/GABARAP/PIDD1
CC,GO:0044448,cell cortex part,1.4679124478856462,7,0.20174582188932158,0.6363257601124978,MAPRE1/EXOC2/CAPZA1/CLASP2/NSMF/TPM4/ASPH
BP,GO:0017148,negative regulation of translation,1.4235879448712327,8,0.20207966712953854,0.7621722726387863,SAMD4A/CIRBP/PAIP2/AGO4/CELF1/CNOT10/YTHDF3/CNOT7
BP,GO:0035303,regulation of dephosphorylation,1.4235879448712327,8,0.20207966712953854,0.7621722726387863,SMG6/MTMR3/ELL/BOD1/NSMF/PPP1R14A/GBA/PPP1R14C
BP,GO:0002888,positive regulation of myeloid leukocyte mediated immunity,2.399434519984578,2,0.20239439160426992,0.7621722726387863,SNX4/VAMP7
BP,GO:0009154,purine ribonucleotide catabolic process,2.399434519984578,2,0.20239439160426992,0.7621722726387863,PDE8A/PDE4B
BP,GO:0009394,2'-deoxyribonucleotide metabolic process,2.399434519984578,2,0.20239439160426992,0.7621722726387863,MBD4/NUDT15
BP,GO:0010762,regulation of fibroblast migration,2.399434519984578,2,0.20239439160426992,0.7621722726387863,APPL2/PAK1
BP,GO:0034694,response to prostaglandin,2.399434519984578,2,0.20239439160426992,0.7621722726387863,PRKAA2/AKR1C3
BP,GO:0036257,multivesicular body organization,2.399434519984578,2,0.20239439160426992,0.7621722726387863,VPS4A/CHMP1B
BP,GO:0043304,regulation of mast cell degranulation,2.399434519984578,2,0.20239439160426992,0.7621722726387863,SNX4/VAMP7
BP,GO:0043457,regulation of cellular respiration,2.399434519984578,2,0.20239439160426992,0.7621722726387863,PIK3CA/ISCU
BP,GO:0007569,cell aging,1.6030704767138344,5,0.2024996418447813,0.7621722726387863,ARG2/CDK6/CDKN1A/TERF2/NUP62
CC,GO:0005875,microtubule associated complex,1.5230971263775877,6,0.20264494084273726,0.6363257601124978,KIF16B/DNAL4/SNX4/DCTN4/KIF13A/GABARAP
CC,GO:0016323,basolateral plasma membrane,1.4224931687213107,8,0.2027448679053256,0.6363257601124978,ITGA6/NDRG4/MET/MARVELD2/CNNM4/CLDN1/MAP4K2/MYO1C
MF,GO:0008375,acetylglucosaminyltransferase activity,1.9305818181818182,3,0.20295291883865108,0.7093548555614949,MGAT4B/RFNG/B3GNT9
BP,GO:0046605,regulation of centrosome cycle,1.9236845720566011,3,0.20447906928799284,0.7621722726387863,CEP85/NUP62/CHMP1B
BP,GO:0061951,establishment of protein localization to plasma membrane,1.9236845720566011,3,0.20447906928799284,0.7621722726387863,ARFRP1/VAMP7/KIF13A
BP,GO:0098930,axonal transport,1.9236845720566011,3,0.20447906928799284,0.7621722726387863,TERF2/SNAPIN/BLOC1S5
BP,GO:0010212,response to ionizing radiation,1.5180095942759573,6,0.20460743308899487,0.7621722726387863,USP28/BAX/CDKN1A/INO80/INIP/RNF168
BP,GO:0071236,cellular response to antibiotic,1.5180095942759573,6,0.20460743308899487,0.7621722726387863,PDE8A/MET/PLEKHA1/ADCY7/STK26/ADCY1
MF,GO:0042826,histone deacetylase binding,1.5943243243243244,5,0.20541229824743182,0.7093548555614949,PKN2/CBX5/SUDS3/RBBP4/ANKRA2
BP,GO:0007163,establishment or maintenance of cell polarity,1.4168089546575602,8,0.20555361194494462,0.7621722726387863,CYP26B1/CYTH1/DOCK7/MAPKAP1/PAK1/CLASP2/MYO18A/PARVA
BP,GO:0009167,purine ribonucleoside monophosphate metabolic process,1.312631825638622,12,0.206674045052728,0.7621722726387863,CTNS/PGM1/PRKAG2/ISCU/ARNT/PRKAA2/SDHAF2/NUPR1/DNAJC30/ENTPD5/CARD11/NUP62
BP,GO:0051098,regulation of binding,1.2962092648174062,13,0.20670189599190433,0.7621722726387863,BAX/MAPRE1/MET/TGFBR1/SNAPIN/HMBOX1/PYGO2/DTX3L/CDK5/PCBD1/RFNG/LDOC1/CSNK2B
BP,GO:0010508,positive regulation of autophagy,1.5893690196479042,5,0.20725923561230059,0.7621722726387863,SESN1/MAP3K7/PIP4K2A/PRKAA2/GBA
BP,GO:0010822,positive regulation of mitochondrion organization,1.5893690196479042,5,0.20725923561230059,0.7621722726387863,CSNK2A2/DDHD2/BAX/DDHD1/GBA
MF,GO:0070717,poly-purine tract binding,2.3596,2,0.20752633648189536,0.7093548555614949,PPIE/HNRNPU
MF,GO:0051219,phosphoprotein binding,1.7057349397590362,4,0.20757093413442954,0.7093548555614949,NEDD4/RTF1/BTRC/YES1
BP,GO:0008361,regulation of cell size,1.4544058403258473,7,0.20789061324798974,0.7621722726387863,CDK4/ANXA7/PAK1/ZFYVE27/CDK5/IL7R/CYFIP1
BP,GO:0048736,appendage development,1.4544058403258473,7,0.20789061324798974,0.7621722726387863,CYP26B1/RC3H2/BAX/ITGA6/IMPAD1/ASPH/SMOC1
BP,GO:0051099,positive regulation of binding,1.4544058403258473,7,0.20789061324798974,0.7621722726387863,MAPRE1/MET/HMBOX1/PYGO2/DTX3L/CDK5/RFNG
BP,GO:0060173,limb development,1.4544058403258473,7,0.20789061324798974,0.7621722726387863,CYP26B1/RC3H2/BAX/ITGA6/IMPAD1/ASPH/SMOC1
BP,GO:2001235,positive regulation of apoptotic signaling pathway,1.4544058403258473,7,0.20789061324798974,0.7621722726387863,BAX/TGFBR1/PLAGL2/BCL10/MCL1/CRADD/NUPR1
BP,GO:0000280,nuclear division,1.2793053828910401,14,0.20878439099896723,0.7621722726387863,CYP26B1/STAG2/WRAP73/INO80/CEP85/VPS4A/AGO4/BOD1/HNRNPU/CLASP2/CDC26/RCC1/NUP62/CHMP1B
BP,GO:0009266,response to temperature stimulus,1.377453150361517,9,0.2088617217267621,0.7621722726387863,CIRBP/RBBP7/CDKN1A/ANO1/APPL2/STAC/UCP2/NUP62/PDCD6
BP,GO:0009126,purine nucleoside monophosphate metabolic process,1.3087824654461335,12,0.20940290248165092,0.7621722726387863,CTNS/PGM1/PRKAG2/ISCU/ARNT/PRKAA2/SDHAF2/NUPR1/DNAJC30/ENTPD5/CARD11/NUP62
MF,GO:0032934,sterol binding,1.896107142857143,3,0.2102918867170373,0.7093548555614949,STARD3NL/OSBP2/APOD
MF,GO:0043621,protein self-association,1.896107142857143,3,0.2102918867170373,0.7093548555614949,BCL10/ZFYVE27/LDB1
BP,GO:0001885,endothelial cell development,1.8910797488014046,3,0.21146879827474327,0.7621722726387863,MET/MARVELD2/CLDN1
BP,GO:0045824,negative regulation of innate immune response,1.8910797488014046,3,0.21146879827474327,0.7621722726387863,DUSP10/YTHDF3/CNOT7
BP,GO:0046847,filopodium assembly,1.8910797488014046,3,0.21146879827474327,0.7621722726387863,ITGA6/TGFBR1/FNBP1L
BP,GO:2000756,regulation of peptidyl-lysine acetylation,1.8910797488014046,3,0.21146879827474327,0.7621722726387863,RPS6KA4/PRKAA2/PYGO2
BP,GO:0006767,water-soluble vitamin metabolic process,1.690510684534589,4,0.21208835132703907,0.7621722726387863,VNN2/MTHFD1L/RFK/ALDH1L1
BP,GO:0022404,molting cycle process,1.690510684534589,4,0.21208835132703907,0.7621722726387863,FOXQ1/RBPJ/MYO5A/LDB1
BP,GO:0022405,hair cycle process,1.690510684534589,4,0.21208835132703907,0.7621722726387863,FOXQ1/RBPJ/MYO5A/LDB1
BP,GO:0043044,ATP-dependent chromatin remodeling,1.690510684534589,4,0.21208835132703907,0.7621722726387863,RBBP7/INO80/RBBP4/SPTY2D1
BP,GO:0098773,skin epidermis development,1.690510684534589,4,0.21208835132703907,0.7621722726387863,FOXQ1/RBPJ/MYO5A/LDB1
BP,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,1.690510684534589,4,0.21208835132703907,0.7621722726387863,HMG20A/DTX3L/CDK5/TRIM44
BP,GO:1904035,regulation of epithelial cell apoptotic process,1.690510684534589,4,0.21208835132703907,0.7621722726387863,CAPN10/TNIP2/NUPR1/AKR1C3
BP,GO:0009144,purine nucleoside triphosphate metabolic process,1.3049556161319633,12,0.21214733792623075,0.7621722726387863,CTNS/PGM1/PRKAG2/ISCU/NUDT15/ARNT/PRKAA2/SDHAF2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0006335,DNA replication-dependent nucleosome assembly,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,ASF1A/RBBP4
BP,GO:0007616,long-term memory,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,CTNS/ADCY1
BP,GO:0008210,estrogen metabolic process,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,HSD17B14/PLEKHA1
BP,GO:0008608,attachment of spindle microtubules to kinetochore,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,BOD1/HNRNPU
BP,GO:0009261,ribonucleotide catabolic process,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,PDE8A/PDE4B
BP,GO:0033006,regulation of mast cell activation involved in immune response,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,SNX4/VAMP7
BP,GO:0034723,DNA replication-dependent nucleosome organization,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,ASF1A/RBBP4
BP,GO:0042573,retinoic acid metabolic process,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,CYP26B1/AKR1C3
BP,GO:0046685,response to arsenic-containing substance,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,MKNK2/CDKN1A
BP,GO:0060317,cardiac epithelial to mesenchymal transition,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,TGFBR1/RBPJ
BP,GO:0060325,face morphogenesis,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,PLEKHA1/ASPH
BP,GO:0061384,heart trabecula morphogenesis,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,TGFBR1/RBPJ
BP,GO:0065005,protein-lipid complex assembly,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,PLAGL2/P4HB
BP,GO:1901661,quinone metabolic process,2.3244521912350598,2,0.2122944744009025,0.7621722726387863,UBIAD1/AKR1C3
BP,GO:1903900,regulation of viral life cycle,1.4976336265675552,6,0.21306772631129592,0.7621722726387863,PKN2/PPIE/VPS4A/BANF1/P4HB/CNOT7
MF,GO:0003697,single-stranded DNA binding,1.5661061946902657,5,0.21551071028867266,0.7093548555614949,TERF2/ERCC5/RTF1/HNRNPU/POLR3C
CC,GO:0032580,Golgi cisterna membrane,1.6776142261550242,4,0.21598643068294063,0.6582806492273909,B4GALT7/GOLGA3/GALNT1/FUT1
BP,GO:0050777,negative regulation of immune response,1.4876494023904383,6,0.21734291992164406,0.7621722726387863,RC3H2/ARG2/DUSP10/IL7R/YTHDF3/CNOT7
MF,GO:0043022,ribosome binding,1.862842105263158,3,0.21768824962708813,0.7093548555614949,MTRF1L/EIF5A2/YTHDF3
MF,GO:0005484,SNAP receptor activity,2.283483870967742,2,0.21796367510388837,0.7093548555614949,STX12/VAMP7
MF,GO:0140142,nucleocytoplasmic carrier activity,2.283483870967742,2,0.21796367510388837,0.7093548555614949,XPO4/KPNA5
BP,GO:0032515,negative regulation of phosphoprotein phosphatase activity,1.8595617529880477,3,0.21850979582955088,0.7621722726387863,BOD1/PPP1R14A/PPP1R14C
BP,GO:0043486,histone exchange,1.8595617529880477,3,0.21850979582955088,0.7621722726387863,RBBP7/RBBP4/SPTY2D1
BP,GO:0045576,mast cell activation,1.8595617529880477,3,0.21850979582955088,0.7621722726387863,PLA2G3/SNX4/VAMP7
BP,GO:0046324,regulation of glucose import,1.8595617529880477,3,0.21850979582955088,0.7621722726387863,PRKAG2/APPL2/CAPN10
BP,GO:0051893,regulation of focal adhesion assembly,1.8595617529880477,3,0.21850979582955088,0.7621722726387863,CLASP2/APOD/LDB1
BP,GO:0090109,regulation of cell-substrate junction assembly,1.8595617529880477,3,0.21850979582955088,0.7621722726387863,CLASP2/APOD/LDB1
BP,GO:0090342,regulation of cell aging,1.8595617529880477,3,0.21850979582955088,0.7621722726387863,ARG2/CDK6/TERF2
BP,GO:0048872,homeostasis of number of cells,1.360654941210767,9,0.2187262743943282,0.7621722726387863,RC3H2/BAX/CDK6/BCL10/ARNT/IL7R/PDE4B/CARD11/LDB1
BP,GO:0010821,regulation of mitochondrion organization,1.4304321176831136,7,0.21945326443070232,0.7621722726387863,CSNK2A2/DDHD2/BAX/DDHD1/OMA1/TRIAP1/GBA
MF,GO:0031491,nucleosome binding,1.6656,4,0.2194562668952459,0.7093548555614949,HP1BP3/RBBP4/RNF168/RCC1
CC,GO:1904813,ficolin-1-rich granule lumen,1.5558519032889337,5,0.2194958227793985,0.6582806492273909,PGM1/PPIE/PYGL/CALML5/CSNK2B
CC,GO:0005790,smooth endoplasmic reticulum,2.269713364797974,2,0.21999118713530405,0.6582806492273909,GABARAP/MYO5A
CC,GO:0051233,spindle midzone,2.269713364797974,2,0.21999118713530405,0.6582806492273909,MAPRE1/HNRNPU
CC,GO:0098686,hippocampal mossy fiber to CA3 synapse,2.269713364797974,2,0.21999118713530405,0.6582806492273909,VAMP7/ADCY1
MF,GO:0009055,electron transfer activity,1.5523684210526316,5,0.22061773165527696,0.7093548555614949,DHDH/QDPR/ALDH4A1/C15orf48/ASPH
MF,GO:0036459,thiol-dependent ubiquitinyl hydrolase activity,1.5523684210526316,5,0.22061773165527696,0.7093548555614949,USP28/USP31/USP46/COPS5/OTUD3
MF,GO:0101005,ubiquitinyl hydrolase activity,1.5523684210526316,5,0.22061773165527696,0.7093548555614949,USP28/USP31/USP46/COPS5/OTUD3
BP,GO:1903169,regulation of calcium ion transmembrane transport,1.4777974195931505,6,0.22164708818147047,0.7621722726387863,BAX/DIAPH1/PSEN2/STAC/PDE4B/MYO5A
BP,GO:0003014,renal system process,1.5496347941567066,5,0.22175210744873006,0.7621722726387863,PRKAR2A/ADCY7/ADCY9/ADCY1/AKR1C3
BP,GO:0022612,gland morphogenesis,1.5496347941567066,5,0.22175210744873006,0.7621722726387863,BAX/VDR/RPS6KA1/BTRC/FRS2
BP,GO:0001914,regulation of T cell mediated cytotoxicity,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,FAM49B/IL7R
BP,GO:0006891,intra-Golgi vesicle-mediated transport,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,GOLGA3/COPE
BP,GO:0010092,specification of animal organ identity,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,FRS2/RBPJ
BP,GO:0019692,deoxyribose phosphate metabolic process,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,MBD4/NUDT15
BP,GO:0032633,interleukin-4 production,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,RBPJ/IL1RAP
BP,GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,ANO1/MPC2
BP,GO:0046633,alpha-beta T cell proliferation,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,ARG2/ELF4
BP,GO:0060603,mammary gland duct morphogenesis,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,VDR/BTRC
BP,GO:0070232,regulation of T cell apoptotic process,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,ARG2/IL7R
BP,GO:1901186,positive regulation of ERBB signaling pathway,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,RBPJ/NUP62
BP,GO:2000758,positive regulation of peptidyl-lysine acetylation,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,RPS6KA4/PRKAA2
BP,GO:2001024,negative regulation of response to drug,2.2540142460461188,2,0.22223975867356552,0.7621722726387863,PDE8A/MET
BP,GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",1.2756888015221437,13,0.2225260341476441,0.7621722726387863,PPIE/PAPOLA/CIRBP/HTATSF1/WDR83/DNAJC8/LSM7/WDR33/BUD13/CELF1/CWC15/HNRNPU/HNRNPA0
BP,GO:0000398,"mRNA splicing, via spliceosome",1.2756888015221437,13,0.2225260341476441,0.7621722726387863,PPIE/PAPOLA/CIRBP/HTATSF1/WDR83/DNAJC8/LSM7/WDR33/BUD13/CELF1/CWC15/HNRNPU/HNRNPA0
BP,GO:0043487,regulation of RNA stability,1.4226155487340255,7,0.22335793779309915,0.7621722726387863,SAMD4A/SMG6/CIRBP/CARHSP1/HNRNPU/HNRNPA0/YTHDF3
BP,GO:0042475,odontogenesis of dentin-containing tooth,1.6529437804338203,4,0.2234532860464591,0.7621722726387863,BAX/ITGA6/ACVR2B/CNNM4
BP,GO:1901214,regulation of neuron death,1.3070402097679572,11,0.22356588375319975,0.7621722726387863,GCLM/BAX/LANCL1/PIK3CA/EGLN3/MCL1/FOXQ1/CDK5/NSMF/NUPR1/GBA
MF,GO:0016667,"oxidoreductase activity, acting on a sulfur group of donors",1.8307241379310344,3,0.22513760379521713,0.7093548555614949,TMX1/SUMF1/P4HB
MF,GO:0016765,"transferase activity, transferring alkyl or aryl (other than methyl) groups",1.8307241379310344,3,0.22513760379521713,0.7093548555614949,AGPS/LANCL1/UBIAD1
BP,GO:0002696,positive regulation of leukocyte activation,1.2723317257286644,13,0.2252119389071254,0.7621722726387863,SNX4/PIK3CA/VAMP7/CDKN1A/BCL10/DUSP10/PAK1/FAM49B/IL7R/TNIP2/YES1/CARD11/TOX
BP,GO:0006879,cellular iron ion homeostasis,1.8290771340866043,3,0.2255982821855211,0.7621722726387863,FTL/ISCU/TMEM199
BP,GO:0030521,androgen receptor signaling pathway,1.8290771340866043,3,0.2255982821855211,0.7621722726387863,KDM3A/SAFB2/PRMT2
BP,GO:0046513,ceramide biosynthetic process,1.8290771340866043,3,0.2255982821855211,0.7621722726387863,ST6GALNAC6/SGMS2/GBA
BP,GO:0000187,activation of MAPK activity,1.468075068148459,6,0.225979431678588,0.7621722726387863,MAP4K5/TAB1/MAP3K7/FRS2/MAP4K2/PTPN1
BP,GO:0007286,spermatid development,1.468075068148459,6,0.225979431678588,0.7621722726387863,PLA2G3/KDM3A/PYGO2/STRBP/AGFG1/OSBP2
BP,GO:0016202,regulation of striated muscle tissue development,1.468075068148459,6,0.225979431678588,0.7621722726387863,CYP26B1/TGFBR1/PAK1/FRS2/RBPJ/MTM1
BP,GO:0048638,regulation of developmental growth,1.2861522210868341,12,0.2260966526327923,0.7621722726387863,TGFBR1/PIK3CA/CDKN1A/CDK4/DUSP10/PAK1/WWC2/ZFYVE27/CDK5/RBPJ/MTM1/CYFIP1
BP,GO:0050863,regulation of T cell activation,1.3028776613292055,11,0.22653686693669348,0.7621722726387863,CYP26B1/RC3H2/ARG2/PIK3CA/BCL10/DUSP10/PAK1/FAM49B/IL7R/YES1/CARD11
BP,GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,1.5368278950314445,5,0.2266504886394473,0.7621722726387863,NEDD4/INO80/EGLN3/ARNT/RBPJ
BP,GO:0002699,positive regulation of immune effector process,1.3774531503615168,8,0.22687844948510727,0.7621722726387863,SNX4/VAMP7/MAP3K7/APPL2/BCL10/FAM49B/MYO18A/ZCCHC3
BP,GO:0034728,nucleosome organization,1.4148839424909059,7,0.2272868790383994,0.7621722726387863,RBBP7/ASF1A/HP1BP3/INO80/RBBP4/SPTY2D1/TSPYL2
BP,GO:0043401,steroid hormone mediated signaling pathway,1.4148839424909059,7,0.2272868790383994,0.7621722726387863,NEDD4/VDR/KDM3A/SAFB2/PAK1/PRMT2/TADA3
BP,GO:0007265,Ras protein signal transduction,1.2452422453044965,15,0.22746982983733124,0.7621722726387863,ALS2/USP28/RASGRP2/RAB7A/MET/CYTH1/MAPKAP1/CDKN1A/RAP2A/G3BP2/RAB15/RIT1/RAP2B/NUP62/CYFIP1
MF,GO:0051721,protein phosphatase 2A binding,2.212125,2,0.22844489159004558,0.7093548555614949,BOD1/PTPN1
MF,GO:0071949,FAD binding,2.212125,2,0.22844489159004558,0.7093548555614949,AGPS/MICAL2
MF,GO:1904680,peptide transmembrane transporter activity,2.212125,2,0.22844489159004558,0.7093548555614949,MCL1/TOMM20
BP,GO:0045926,negative regulation of growth,1.344261508184131,9,0.2287681276643596,0.7621722726387863,RBBP7/ING4/CDKN1A/DUSP10/PAK1/WWC2/CDK5/CRLF3/TSPYL2
MF,GO:0005543,phospholipid binding,1.2433489461358314,15,0.22903299064858257,0.7093548555614949,SNX1/SNX24/KIF16B/EEA1/PLEKHA1/SNX4/MAPKAP1/MYO1B/SBF2/SNX14/APPL2/ANXA7/WDFY3/MTM1/NUP62
BP,GO:0045638,negative regulation of myeloid cell differentiation,1.6347795630664157,4,0.22919451261080828,0.7621722726387863,CDK6/GABPA/TOB2/LDB1
CC,GO:0005720,nuclear heterochromatin,2.204864411518032,2,0.2295990429534149,0.6582806492273909,CBX5/CBX1
BP,GO:0051017,actin filament bundle assembly,1.4584798062651354,6,0.2303391460968325,0.7621722726387863,PLS3/MET/TGFBR1/MYO1B/PAK1/CLASP2
BP,GO:0090316,positive regulation of intracellular protein transport,1.4584798062651354,6,0.2303391460968325,0.7621722726387863,CSNK2A2/XPO4/EDEM1/PAK1/CDK5/MYO1C
BP,GO:0008406,gonad development,1.3711054399911873,8,0.23050875490070352,0.7621722726387863,BAX/TGFBR1/PLEKHA1/SDC1/SAFB2/AGO4/NUPR1/AKR1C3
BP,GO:0043624,cellular protein complex disassembly,1.3711054399911873,8,0.23050875490070352,0.7621722726387863,MTRF1L/CAPZA1/VPS4A/MICAL2/CLASP2/EIF5A2/TRMT112/ASPH
BP,GO:0000375,"RNA splicing, via transesterification reactions",1.2656703030808703,13,0.2306238755940795,0.7621722726387863,PPIE/PAPOLA/CIRBP/HTATSF1/WDR83/DNAJC8/LSM7/WDR33/BUD13/CELF1/CWC15/HNRNPU/HNRNPA0
CC,GO:0000164,protein phosphatase type 1 complex,3.858512720156555,1,0.23098554983053798,0.6582806492273909,PPP1CC
CC,GO:0000815,ESCRT III complex,3.858512720156555,1,0.23098554983053798,0.6582806492273909,CHMP1B
CC,GO:0002177,manchette,3.858512720156555,1,0.23098554983053798,0.6582806492273909,STRBP
CC,GO:0031010,ISWI-type complex,3.858512720156555,1,0.23098554983053798,0.6582806492273909,RBBP4
BP,GO:0007369,gastrulation,1.4072359211801442,7,0.23123950491796957,0.7621722726387863,KIF16B/ARFRP1/ACVR2B/RTF1/CLASP2/FRS2/LDB1
BP,GO:0071383,cellular response to steroid hormone stimulus,1.3388844621513944,9,0.23215320260501557,0.7621722726387863,NEDD4/VDR/KDM3A/SAFB2/PAK1/HNRNPU/PRMT2/TADA3/AKR1C3
BP,GO:0003382,epithelial cell morphogenesis,2.187719709397703,2,0.23222067950336336,0.7621722726387863,MET/CLDN3
BP,GO:0006536,glutamate metabolic process,2.187719709397703,2,0.23222067950336336,0.7621722726387863,GCLM/ALDH4A1
BP,GO:0016601,Rac protein signal transduction,2.187719709397703,2,0.23222067950336336,0.7621722726387863,ALS2/CYFIP1
BP,GO:0071868,cellular response to monoamine stimulus,2.187719709397703,2,0.23222067950336336,0.7621722726387863,GABPA/PDE4B
BP,GO:0071870,cellular response to catecholamine stimulus,2.187719709397703,2,0.23222067950336336,0.7621722726387863,GABPA/PDE4B
CC,GO:0031248,protein acetyltransferase complex,1.6246369348027603,4,0.23253726600605018,0.6582806492273909,ING4/KANSL3/MAP3K7/TADA3
CC,GO:1902493,acetyltransferase complex,1.6246369348027603,4,0.23253726600605018,0.6582806492273909,ING4/KANSL3/MAP3K7/TADA3
BP,GO:0002260,lymphocyte homeostasis,1.7995758899884333,3,0.23273053527091897,0.7621722726387863,RC3H2/BAX/BCL10
BP,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,1.7995758899884333,3,0.23273053527091897,0.7621722726387863,TAB1/MAP3K7/ZCCHC3
BP,GO:0006220,pyrimidine nucleotide metabolic process,1.7995758899884333,3,0.23273053527091897,0.7621722726387863,MBD4/CMPK1/CDS1
BP,GO:0070265,necrotic cell death,1.7995758899884333,3,0.23273053527091897,0.7621722726387863,BAX/TRPM7/PYGL
BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,1.364815965495815,8,0.23415964509691245,0.7621722726387863,PIK3CA/BCL10/DUSP10/PAK1/FAM49B/IL7R/YES1/CARD11
MF,GO:0017048,Rho GTPase binding,1.3997627118644067,7,0.23505681521052735,0.7093548555614949,ALS2/PKN2/DOCK7/DIAPH1/DIAPH2/PAK1/CYFIP1
BP,GO:0022900,electron transport chain,1.3996701366576705,7,0.2352152278946528,0.7621722726387863,DHDH/ISCU/QDPR/ALDH4A1/C15orf48/SDHAF2/ASPH
BP,GO:0042089,cytokine biosynthetic process,1.5118388235675186,5,0.23654125579901952,0.7621722726387863,MAST2/BCL10/CARD9/IL1RAP/CARD11
BP,GO:0000012,single strand break repair,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,TERF2
BP,GO:0000290,deadenylation-dependent decapping of nuclear-transcribed mRNA,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CNOT7
BP,GO:0000338,protein deneddylation,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,COPS5
BP,GO:0001768,establishment of T cell polarity,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CYP26B1
BP,GO:0001787,natural killer cell proliferation,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,ELF4
BP,GO:0002934,desmosome organization,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,PKP3
BP,GO:0006222,UMP biosynthetic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CMPK1
BP,GO:0006285,"base-excision repair, AP site formation",3.7191235059760954,1,0.23862414660769404,0.7621722726387863,MBD4
BP,GO:0006560,proline metabolic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,ALDH4A1
BP,GO:0006570,tyrosine metabolic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,FAH
BP,GO:0007084,mitotic nuclear envelope reassembly,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,BANF1
BP,GO:0007220,Notch receptor processing,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,PSEN2
BP,GO:0007440,foregut morphogenesis,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,ACVR2B
BP,GO:0008343,adult feeding behavior,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,USP46
BP,GO:0009157,deoxyribonucleoside monophosphate biosynthetic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,TK2
BP,GO:0009173,pyrimidine ribonucleoside monophosphate metabolic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CMPK1
BP,GO:0009174,pyrimidine ribonucleoside monophosphate biosynthetic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CMPK1
BP,GO:0009396,folic acid-containing compound biosynthetic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,MTHFD1L
BP,GO:0010603,regulation of cytoplasmic mRNA processing body assembly,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CNOT6
BP,GO:0010918,positive regulation of mitochondrial membrane potential,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CTNS
BP,GO:0015809,arginine transport,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,SLC7A1
BP,GO:0016102,diterpenoid biosynthetic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,AKR1C3
BP,GO:0018065,protein-cofactor linkage,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,SDHAF2
BP,GO:0018242,protein O-linked glycosylation via serine,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,GALNT1
BP,GO:0021694,cerebellar Purkinje cell layer formation,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,LDB1
BP,GO:0030311,poly-N-acetyllactosamine biosynthetic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,B3GNT9
BP,GO:0030647,aminoglycoside antibiotic metabolic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,AKR1C3
BP,GO:0031848,protection from non-homologous end joining at telomere,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,TERF2
BP,GO:0032328,alanine transport,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,SLC36A1
BP,GO:0032463,negative regulation of protein homooligomerization,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,GBA
BP,GO:0032875,regulation of DNA endoreduplication,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,STAG2
BP,GO:0034058,endosomal vesicle fusion,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,VPS4A
BP,GO:0034350,regulation of glial cell apoptotic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CDK5
BP,GO:0035247,peptidyl-arginine omega-N-methylation,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,PRMT2
BP,GO:0035871,protein K11-linked deubiquitination,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,OTUD3
BP,GO:0035878,nail development,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,ITGA6
BP,GO:0035999,tetrahydrofolate interconversion,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,MTHFD1L
BP,GO:0036500,ATF6-mediated unfolded protein response,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,MBTPS1
BP,GO:0042428,serotonin metabolic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,RNF180
BP,GO:0043653,mitochondrial fragmentation involved in apoptotic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,BAX
BP,GO:0044351,macropinocytosis,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,APPL2
BP,GO:0045713,low-density lipoprotein particle receptor biosynthetic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CNPY2
BP,GO:0045945,positive regulation of transcription by RNA polymerase III,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,ELL
BP,GO:0046049,UMP metabolic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CMPK1
BP,GO:0046322,negative regulation of fatty acid oxidation,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,APPL2
BP,GO:0046642,negative regulation of alpha-beta T cell proliferation,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,ARG2
BP,GO:0046710,GDP metabolic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CARD11
BP,GO:0048149,behavioral response to ethanol,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,USP46
BP,GO:0048382,mesendoderm development,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,LDB1
BP,GO:0048703,embryonic viscerocranium morphogenesis,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,MTHFD1L
BP,GO:0050861,positive regulation of B cell receptor signaling pathway,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CMTM3
BP,GO:0051409,response to nitrosative stress,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,GCLM
BP,GO:0060068,vagina development,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,BAX
BP,GO:0060923,cardiac muscle cell fate commitment,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,RBPJ
BP,GO:0070816,phosphorylation of RNA polymerase II C-terminal domain,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,GTF2H1
BP,GO:0071233,cellular response to leucine,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,SESN1
BP,GO:0071609,chemokine (C-C motif) ligand 5 production,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,ARG2
BP,GO:0071670,smooth muscle cell chemotaxis,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,PARVA
BP,GO:0090336,positive regulation of brown fat cell differentiation,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,HNRNPU
BP,GO:0090557,establishment of endothelial intestinal barrier,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CLDN1
BP,GO:0097050,type B pancreatic cell apoptotic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,CAPN10
BP,GO:0098722,asymmetric stem cell division,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,DOCK7
BP,GO:1902915,negative regulation of protein polyubiquitination,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,TRIM44
BP,GO:1903897,regulation of PERK-mediated unfolded protein response,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,PTPN1
BP,GO:1904350,regulation of protein catabolic process in the vacuole,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,GBA
BP,GO:1904526,regulation of microtubule binding,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,MAPRE1
BP,GO:1904779,regulation of protein localization to centrosome,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,NUP62
BP,GO:1990253,cellular response to leucine starvation,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,SESN1
BP,GO:1990822,basic amino acid transmembrane transport,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,SLC7A1
BP,GO:2000049,positive regulation of cell-cell adhesion mediated by cadherin,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,DENND6A
BP,GO:2000317,negative regulation of T-helper 17 type immune response,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,RC3H2
BP,GO:2000480,negative regulation of cAMP-dependent protein kinase activity,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,PRKAR2A
BP,GO:2000574,regulation of microtubule motor activity,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,DNAL4
BP,GO:2000628,regulation of miRNA metabolic process,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,RC3H2
BP,GO:2000665,regulation of interleukin-13 secretion,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,ARG2
BP,GO:2001135,regulation of endocytic recycling,3.7191235059760954,1,0.23862414660769404,0.7621722726387863,NDRG4
MF,GO:0008187,poly-pyrimidine tract binding,2.145090909090909,2,0.2389592007111828,0.7093548555614949,CIRBP/HNRNPU
BP,GO:0015980,energy derivation by oxidation of organic compounds,1.3049556161319633,10,0.23912715881684324,0.7621722726387863,CS/IDH3G/PGM1/PYGL/PRKAG2/PIK3CA/ISCU/SDHAF2/EPM2AIP1/PPP1CC
BP,GO:1901861,regulation of muscle tissue development,1.4396607119907465,6,0.23913744893770578,0.7621722726387863,CYP26B1/TGFBR1/PAK1/FRS2/RBPJ/MTM1
BP,GO:2001236,regulation of extrinsic apoptotic signaling pathway,1.4396607119907465,6,0.23913744893770578,0.7621722726387863,ZMYND11/GCLM/ITGA6/TGFBR1/BCL10/MCL1
BP,GO:1905475,regulation of protein localization to membrane,1.39218526961672,7,0.23921345645169975,0.7621722726387863,VAMP7/VPS4A/STAC/PAK1/LZTFL1/CDK5/MYO1C
CC,GO:0001772,immunological synapse,2.143618177864753,2,0.23923370419363818,0.6582806492273909,BCL10/CARD11
CC,GO:0008180,COP9 signalosome,2.143618177864753,2,0.23923370419363818,0.6582806492273909,DOCK7/COPS5
BP,GO:0006476,protein deacetylation,1.5996230133230518,4,0.24078479717058185,0.7621722726387863,SUDS3/PRKAA2/TADA3/TBL1XR1
BP,GO:0032092,positive regulation of protein binding,1.5996230133230518,4,0.24078479717058185,0.7621722726387863,MAPRE1/DTX3L/CDK5/RFNG
BP,GO:1901655,cellular response to ketone,1.5996230133230518,4,0.24078479717058185,0.7621722726387863,CDK4/PRKAA2/ADCY1/AKR1C3
BP,GO:0042107,cytokine metabolic process,1.4996465749903611,5,0.24153125639694312,0.7621722726387863,MAST2/BCL10/CARD9/IL1RAP/CARD11
BP,GO:0000266,mitochondrial fission,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,DDHD2/DDHD1
BP,GO:0000462,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",2.1252134319863405,2,0.24222815172355872,0.7621722726387863,FCF1/BTRC
BP,GO:0001881,receptor recycling,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,ALS2/KIF16B
BP,GO:0001893,maternal placenta development,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,VDR/LDOC1
BP,GO:0003203,endocardial cushion morphogenesis,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,TGFBR1/RBPJ
BP,GO:0006369,termination of RNA polymerase II transcription,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,PAPOLA/WDR33
BP,GO:0009262,deoxyribonucleotide metabolic process,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,MBD4/NUDT15
BP,GO:0019076,viral release from host cell,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,RAB7A/VPS4A
BP,GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,RYBP/MTM1
BP,GO:0033363,secretory granule organization,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,PLA2G3/AGFG1
BP,GO:0035890,exit from host,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,RAB7A/VPS4A
BP,GO:0035891,exit from host cell,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,RAB7A/VPS4A
BP,GO:0052126,movement in host environment,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,RAB7A/VPS4A
BP,GO:0052192,movement in environment of other organism involved in symbiotic interaction,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,RAB7A/VPS4A
BP,GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,TAB1/MAP3K7
BP,GO:1901385,regulation of voltage-gated calcium channel activity,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,STAC/PDE4B
BP,GO:1904031,positive regulation of cyclin-dependent protein kinase activity,2.1252134319863405,2,0.24222815172355872,0.7621722726387863,CCND3/CDKN1A
BP,GO:0043902,positive regulation of multi-organism process,1.3847800288208867,7,0.2432335953991928,0.7621722726387863,PKN2/RAB7A/PPIE/VPS4A/P4HB/CNOT7/ZCCHC3
BP,GO:0051783,regulation of nuclear division,1.3847800288208867,7,0.2432335953991928,0.7621722726387863,STAG2/CEP85/HNRNPU/CDC26/RCC1/NUP62/CHMP1B
BP,GO:0048634,regulation of muscle organ development,1.4304321176831136,6,0.24357440872183622,0.7621722726387863,CYP26B1/TGFBR1/PAK1/FRS2/RBPJ/MTM1
MF,GO:0005253,anion channel activity,1.590741573033708,4,0.24373815013319447,0.7093548555614949,CLCC1/ANO1/PIDD1/LRRC8B
CC,GO:0010494,cytoplasmic stress granule,1.7538694182529797,3,0.24438074227767492,0.6582806492273909,CIRBP/G3BP2/PRKAA2
BP,GO:1901216,positive regulation of neuron death,1.5826057472238704,4,0.24663000649407504,0.7621722726387863,BAX/MCL1/CDK5/NUPR1
MF,GO:0016616,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",1.4871428571428573,5,0.24667577008115305,0.7093548555614949,IDH3G/HSD17B10/HSD17B14/DHDH/AKR1C3
BP,GO:0046834,lipid phosphorylation,1.7433391434262948,3,0.24711175666671054,0.7621722726387863,IMPAD1/PIK3CA/PIP4K2A
BP,GO:0048278,vesicle docking,1.7433391434262948,3,0.24711175666671054,0.7621722726387863,NDRG4/STX12/RAB15
BP,GO:0060135,maternal process involved in female pregnancy,1.7433391434262948,3,0.24711175666671054,0.7621722726387863,VDR/ADCY7/LDOC1
MF,GO:0048306,calcium-dependent protein binding,1.740688524590164,3,0.2477606476188181,0.7093548555614949,ANXA7/NSMF/PDCD6
BP,GO:0019827,stem cell population maintenance,1.4213210850864058,6,0.24803548312513823,0.7621722726387863,KDM3A/RTF1/MED21/RBPJ/ZHX2/LDB1
BP,GO:0061572,actin filament bundle organization,1.4213210850864058,6,0.24803548312513823,0.7621722726387863,PLS3/MET/TGFBR1/MYO1B/PAK1/CLASP2
BP,GO:0098656,anion transmembrane transport,1.2913623284639222,10,0.24885680091355109,0.7621722726387863,PRKAG2/CLCC1/SLC36A1/ANO1/SLC7A1/MPC2/PRKAA2/PIDD1/LRRC8B/PRAF2
CC,GO:0016592,mediator complex,2.0856825514359763,2,0.24888734564726933,0.6582806492273909,MED4/MED21
BP,GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",1.3402246868382326,8,0.24896000130552348,0.7621722726387863,PKN2/RAB7A/PPIE/EXOC2/VPS4A/BANF1/P4HB/CNOT7
MF,GO:0000182,rDNA binding,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,TSPYL2
MF,GO:0002162,dystroglycan binding,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,CLASP2
MF,GO:0004322,ferroxidase activity,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,FTL
MF,GO:0004576,oligosaccharyl transferase activity,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,OSTC
MF,GO:0005165,neurotrophin receptor binding,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,FRS2
MF,GO:0010857,calcium-dependent protein kinase activity,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,MKNK2
MF,GO:0015924,mannosyl-oligosaccharide mannosidase activity,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,EDEM1
MF,GO:0016303,1-phosphatidylinositol-3-kinase activity,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,PIK3CA
MF,GO:0016724,"oxidoreductase activity, oxidizing metal ions, oxygen as acceptor",3.5393999999999997,1,0.24924491231303414,0.7093548555614949,FTL
MF,GO:0016803,ether hydrolase activity,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,EPHX3
MF,GO:0016884,"carbon-nitrogen ligase activity, with glutamine as amido-N-donor",3.5393999999999997,1,0.24924491231303414,0.7093548555614949,GATC
MF,GO:0043995,histone acetyltransferase activity (H4-K5 specific),3.5393999999999997,1,0.24924491231303414,0.7093548555614949,KANSL3
MF,GO:0043996,histone acetyltransferase activity (H4-K8 specific),3.5393999999999997,1,0.24924491231303414,0.7093548555614949,KANSL3
MF,GO:0045294,alpha-catenin binding,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,PKP3
MF,GO:0046972,histone acetyltransferase activity (H4-K16 specific),3.5393999999999997,1,0.24924491231303414,0.7093548555614949,KANSL3
MF,GO:0098505,G-rich strand telomeric DNA binding,3.5393999999999997,1,0.24924491231303414,0.7093548555614949,TERF2
MF,GO:0000175,3'-5'-exoribonuclease activity,2.0820000000000003,2,0.24949638934753976,0.7093548555614949,CNOT6/CNOT7
MF,GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,2.0820000000000003,2,0.24949638934753976,0.7093548555614949,TBP/KDM3A
BP,GO:0060562,epithelial tube morphogenesis,1.2705080299918339,11,0.2508478785119766,0.7621722726387863,NDRG4/MET/VDR/MTHFD1L/STARD13/MICAL2/BCL10/PAK1/BTRC/RBPJ/CSNK2B
CC,GO:0000235,astral microtubule,3.5077388365059594,1,0.2509259965772065,0.6582806492273909,MAPRE1
CC,GO:0005818,aster,3.5077388365059594,1,0.2509259965772065,0.6582806492273909,MAPRE1
CC,GO:0034663,endoplasmic reticulum chaperone complex,3.5077388365059594,1,0.2509259965772065,0.6582806492273909,P4HB
CC,GO:0043220,Schmidt-Lanterman incisure,3.5077388365059594,1,0.2509259965772065,0.6582806492273909,MARVELD2
BP,GO:0097193,intrinsic apoptotic signaling pathway,1.2868939467045313,10,0.25213058539591354,0.7621722726387863,USP28/BAX/PTPMT1/CDKN1A/PLAGL2/MCL1/TRIAP1/NUPR1/P4HB/PTPN1
BP,GO:0002755,MyD88-dependent toll-like receptor signaling pathway,2.066179725542275,2,0.2522535511221656,0.7621722726387863,TAB1/MAP3K7
BP,GO:0009112,nucleobase metabolic process,2.066179725542275,2,0.2522535511221656,0.7621722726387863,MTHFD1L/CMPK1
BP,GO:0030224,monocyte differentiation,2.066179725542275,2,0.2522535511221656,0.7621722726387863,THOC5/CDK6
BP,GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",2.066179725542275,2,0.2522535511221656,0.7621722726387863,TAB1/MAP3K7
BP,GO:0051031,tRNA transport,2.066179725542275,2,0.2522535511221656,0.7621722726387863,TOMM20/NUP62
BP,GO:1903131,mononuclear cell differentiation,2.066179725542275,2,0.2522535511221656,0.7621722726387863,THOC5/CDK6
BP,GO:0042100,B cell proliferation,1.5659467393583562,4,0.2525060460311537,0.7621722726387863,BAX/CDKN1A/IL7R/CARD11
BP,GO:0045069,regulation of viral genome replication,1.5659467393583562,4,0.2525060460311537,0.7621722726387863,PKN2/PPIE/BANF1/CNOT7
BP,GO:0051651,maintenance of location in cell,1.5659467393583562,4,0.2525060460311537,0.7621722726387863,FTL/HNRNPU/CDK5/TAPT1
BP,GO:0110020,regulation of actomyosin structure organization,1.5659467393583562,4,0.2525060460311537,0.7621722726387863,MET/TGFBR1/PAK1/CLASP2
BP,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,1.5659467393583562,4,0.2525060460311537,0.7621722726387863,CHFR/RCHY1/RNF180/GBA
BP,GO:0045137,development of primary sexual characteristics,1.33421471066407,8,0.25270699779873185,0.7621722726387863,BAX/TGFBR1/PLEKHA1/SDC1/SAFB2/AGO4/NUPR1/AKR1C3
CC,GO:0034399,nuclear periphery,1.4727147786857082,5,0.253014676248216,0.6582806492273909,STAG2/KIN/HNRNPU/NSMF/CSNK2B
BP,GO:0014823,response to activity,1.7165185412197363,3,0.25435359070964453,0.7621722726387863,GCLM/PRKAA2/TOMM20
BP,GO:0031060,regulation of histone methylation,1.7165185412197363,3,0.25435359070964453,0.7621722726387863,KDM3A/RTF1/PYGO2
BP,GO:0035308,negative regulation of protein dephosphorylation,1.7165185412197363,3,0.25435359070964453,0.7621722726387863,BOD1/PPP1R14A/PPP1R14C
BP,GO:0071806,protein transmembrane transport,1.7165185412197363,3,0.25435359070964453,0.7621722726387863,SEC62/MCL1/TOMM20
BP,GO:0071478,cellular response to radiation,1.363029557164014,7,0.255419473945815,0.7621722726387863,USP28/NEDD4/BAX/CDKN1A/INO80/NMT2/TRIAP1
MF,GO:0003730,mRNA 3'-UTR binding,1.5557802197802197,4,0.2560988218608252,0.7093548555614949,CIRBP/CARHSP1/HNRNPU/HNRNPA0
BP,GO:0071426,ribonucleoprotein complex export from nucleus,1.4642218527464943,5,0.25666539933758997,0.7621722726387863,SMG6/THOC5/WDR33/AGFG1/NUP62
BP,GO:0098727,maintenance of cell number,1.4034428324438095,6,0.2570266882177334,0.7621722726387863,KDM3A/RTF1/MED21/RBPJ/ZHX2/LDB1
BP,GO:1903829,positive regulation of cellular protein localization,1.2626653878313905,11,0.25706754812459276,0.7621722726387863,CSNK2A2/XPO4/EDEM1/STAC/PAK1/PRKAA2/DTX3L/CDK5/TRAPPC12/MYO1C/NUP62
CC,GO:0001650,fibrillar center,1.4615578485441498,5,0.2579060066839715,0.6582806492273909,SAMD4A/SESN1/CD3EAP/WDR33/B3GNT9
BP,GO:0019217,regulation of fatty acid metabolic process,1.5496347941567066,4,0.2584110204811616,0.7621722726387863,PRKAG2/LPGAT1/APPL2/PRKAA2
BP,GO:0030516,regulation of axon extension,1.5496347941567066,4,0.2584110204811616,0.7621722726387863,PAK1/ZFYVE27/CDK5/CYFIP1
BP,GO:0090277,positive regulation of peptide hormone secretion,1.5496347941567066,4,0.2584110204811616,0.7621722726387863,ANO1/CAPN10/MPC2/RASL10B
CC,GO:0000791,euchromatin,2.0307961685034503,2,0.2585525281949489,0.6582806492273909,TBP/NSMF
CC,GO:0032040,small-subunit processome,2.0307961685034503,2,0.2585525281949489,0.6582806492273909,FCF1/BTRC
BP,GO:0000050,urea cycle,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ARG2
BP,GO:0000478,endonucleolytic cleavage involved in rRNA processing,3.381021369069178,1,0.2591070339819139,0.7621722726387863,FCF1
BP,GO:0000479,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",3.381021369069178,1,0.2591070339819139,0.7621722726387863,FCF1
BP,GO:0000491,small nucleolar ribonucleoprotein complex assembly,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ZNHIT6
BP,GO:0001574,ganglioside biosynthetic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ST6GALNAC6
BP,GO:0001767,establishment of lymphocyte polarity,3.381021369069178,1,0.2591070339819139,0.7621722726387863,CYP26B1
BP,GO:0005984,disaccharide metabolic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,IDUA
BP,GO:0006054,N-acetylneuraminate metabolic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,AMDHD2
BP,GO:0006620,posttranslational protein targeting to endoplasmic reticulum membrane,3.381021369069178,1,0.2591070339819139,0.7621722726387863,SEC62
BP,GO:0008655,pyrimidine-containing compound salvage,3.381021369069178,1,0.2591070339819139,0.7621722726387863,TK2
BP,GO:0009113,purine nucleobase biosynthetic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,MTHFD1L
BP,GO:0009151,purine deoxyribonucleotide metabolic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,NUDT15
BP,GO:0010172,embryonic body morphogenesis,3.381021369069178,1,0.2591070339819139,0.7621722726387863,CLASP2
BP,GO:0014883,transition between fast and slow fiber,3.381021369069178,1,0.2591070339819139,0.7621722726387863,GTF2IRD2
BP,GO:0019042,viral latency,3.381021369069178,1,0.2591070339819139,0.7621722726387863,BANF1
BP,GO:0019371,cyclooxygenase pathway,3.381021369069178,1,0.2591070339819139,0.7621722726387863,AKR1C3
BP,GO:0021670,lateral ventricle development,3.381021369069178,1,0.2591070339819139,0.7621722726387863,CDK6
BP,GO:0030309,poly-N-acetyllactosamine metabolic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,B3GNT9
BP,GO:0031987,locomotion involved in locomotory behavior,3.381021369069178,1,0.2591070339819139,0.7621722726387863,MYO5A
BP,GO:0032351,negative regulation of hormone metabolic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,AKR1C3
BP,GO:0032494,response to peptidoglycan,3.381021369069178,1,0.2591070339819139,0.7621722726387863,CARD9
BP,GO:0033089,positive regulation of T cell differentiation in thymus,3.381021369069178,1,0.2591070339819139,0.7621722726387863,IL7R
BP,GO:0033148,positive regulation of intracellular estrogen receptor signaling pathway,3.381021369069178,1,0.2591070339819139,0.7621722726387863,PAK1
BP,GO:0033234,negative regulation of protein sumoylation,3.381021369069178,1,0.2591070339819139,0.7621722726387863,HMG20A
BP,GO:0033235,positive regulation of protein sumoylation,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ARNT
BP,GO:0033327,Leydig cell differentiation,3.381021369069178,1,0.2591070339819139,0.7621722726387863,PLEKHA1
BP,GO:0033539,fatty acid beta-oxidation using acyl-CoA dehydrogenase,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ACAD11
BP,GO:0033860,regulation of NAD(P)H oxidase activity,3.381021369069178,1,0.2591070339819139,0.7621722726387863,RFK
BP,GO:0034379,very-low-density lipoprotein particle assembly,3.381021369069178,1,0.2591070339819139,0.7621722726387863,P4HB
BP,GO:0034776,response to histamine,3.381021369069178,1,0.2591070339819139,0.7621722726387863,DIAPH1
BP,GO:0035246,peptidyl-arginine N-methylation,3.381021369069178,1,0.2591070339819139,0.7621722726387863,PRMT2
BP,GO:0035542,regulation of SNARE complex assembly,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ANKRD27
BP,GO:0035739,"CD4-positive, alpha-beta T cell proliferation",3.381021369069178,1,0.2591070339819139,0.7621722726387863,ARG2
BP,GO:0036444,calcium import into the mitochondrion,3.381021369069178,1,0.2591070339819139,0.7621722726387863,PSEN2
BP,GO:0042023,DNA endoreduplication,3.381021369069178,1,0.2591070339819139,0.7621722726387863,STAG2
BP,GO:0043097,pyrimidine nucleoside salvage,3.381021369069178,1,0.2591070339819139,0.7621722726387863,TK2
BP,GO:0043619,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ARNT
BP,GO:0045793,positive regulation of cell size,3.381021369069178,1,0.2591070339819139,0.7621722726387863,CDK4
BP,GO:0046348,amino sugar catabolic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,AMDHD2
BP,GO:0046512,sphingosine biosynthetic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,GBA
BP,GO:0046607,positive regulation of centrosome cycle,3.381021369069178,1,0.2591070339819139,0.7621722726387863,NUP62
BP,GO:0046886,positive regulation of hormone biosynthetic process,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ARNT
BP,GO:0048096,chromatin-mediated maintenance of transcription,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ZMIZ2
BP,GO:0048548,regulation of pinocytosis,3.381021369069178,1,0.2591070339819139,0.7621722726387863,APPL2
BP,GO:0051573,negative regulation of histone H3-K9 methylation,3.381021369069178,1,0.2591070339819139,0.7621722726387863,KDM3A
BP,GO:0060379,cardiac muscle cell myoblast differentiation,3.381021369069178,1,0.2591070339819139,0.7621722726387863,RBPJ
BP,GO:0060525,prostate glandular acinus development,3.381021369069178,1,0.2591070339819139,0.7621722726387863,FRS2
BP,GO:0060837,blood vessel endothelial cell differentiation,3.381021369069178,1,0.2591070339819139,0.7621722726387863,RBPJ
BP,GO:0061314,Notch signaling involved in heart development,3.381021369069178,1,0.2591070339819139,0.7621722726387863,RBPJ
BP,GO:0070475,rRNA base methylation,3.381021369069178,1,0.2591070339819139,0.7621722726387863,TRMT112
BP,GO:0070673,response to interleukin-18,3.381021369069178,1,0.2591070339819139,0.7621722726387863,CLDN1
BP,GO:0071372,cellular response to follicle-stimulating hormone stimulus,3.381021369069178,1,0.2591070339819139,0.7621722726387863,GCLM
BP,GO:0072611,interleukin-13 secretion,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ARG2
BP,GO:0090657,telomeric loop disassembly,3.381021369069178,1,0.2591070339819139,0.7621722726387863,TERF2
BP,GO:0098883,synapse pruning,3.381021369069178,1,0.2591070339819139,0.7621722726387863,CDK5
BP,GO:0099149,regulation of postsynaptic neurotransmitter receptor internalization,3.381021369069178,1,0.2591070339819139,0.7621722726387863,USP46
BP,GO:0099151,regulation of postsynaptic density assembly,3.381021369069178,1,0.2591070339819139,0.7621722726387863,IL1RAP
BP,GO:1900102,negative regulation of endoplasmic reticulum unfolded protein response,3.381021369069178,1,0.2591070339819139,0.7621722726387863,PTPN1
BP,GO:1901077,regulation of relaxation of muscle,3.381021369069178,1,0.2591070339819139,0.7621722726387863,PDE4B
BP,GO:1902805,positive regulation of synaptic vesicle transport,3.381021369069178,1,0.2591070339819139,0.7621722726387863,CDK5
BP,GO:1902946,protein localization to early endosome,3.381021369069178,1,0.2591070339819139,0.7621722726387863,DTX3L
BP,GO:1903441,protein localization to ciliary membrane,3.381021369069178,1,0.2591070339819139,0.7621722726387863,LZTFL1
BP,GO:1904321,response to forskolin,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ADCY1
BP,GO:1904322,cellular response to forskolin,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ADCY1
BP,GO:1904468,negative regulation of tumor necrosis factor secretion,3.381021369069178,1,0.2591070339819139,0.7621722726387863,ARG2
BP,GO:1905383,protein localization to presynapse,3.381021369069178,1,0.2591070339819139,0.7621722726387863,TERF2
BP,GO:1905668,positive regulation of protein localization to endosome,3.381021369069178,1,0.2591070339819139,0.7621722726387863,DTX3L
BP,GO:2000561,"regulation of CD4-positive, alpha-beta T cell proliferation",3.381021369069178,1,0.2591070339819139,0.7621722726387863,ARG2
BP,GO:2000786,positive regulation of autophagosome assembly,3.381021369069178,1,0.2591070339819139,0.7621722726387863,PIP4K2A
BP,GO:2001269,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,3.381021369069178,1,0.2591070339819139,0.7621722726387863,BAX
BP,GO:0043406,positive regulation of MAP kinase activity,1.2973686648753824,9,0.2598625947888006,0.7621722726387863,MAP4K5/TAB1/TGFBR1/TAOK3/MAP3K7/PAK1/FRS2/MAP4K2/PTPN1
MF,GO:0001103,RNA polymerase II repressing transcription factor binding,2.0225142857142857,2,0.2600467928790864,0.7093548555614949,TBP/RBPJ
BP,GO:0002819,regulation of adaptive immune response,1.394671314741036,6,0.2615551706294696,0.7621722726387863,RC3H2/ADCY7/MAP3K7/DUSP10/FAM49B/IL7R
BP,GO:1903305,regulation of regulated secretory pathway,1.394671314741036,6,0.2615551706294696,0.7621722726387863,SNX4/VAMP7/RAB15/SNAPIN/ADCY1/CDK5
BP,GO:1905207,regulation of cardiocyte differentiation,1.690510684534589,3,0.2616249267703458,0.7621722726387863,PAK1/FRS2/RBPJ
BP,GO:0071166,ribonucleoprotein complex localization,1.4527826195219125,5,0.26176085106978353,0.7621722726387863,SMG6/THOC5/WDR33/AGFG1/NUP62
BP,GO:0001662,behavioral fear response,2.010337030257349,2,0.2622886963053117,0.7621722726387863,ALS2/USP46
BP,GO:0006296,"nucleotide-excision repair, DNA incision, 5'-to lesion",2.010337030257349,2,0.2622886963053117,0.7621722726387863,GTF2H1/ERCC5
BP,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,2.010337030257349,2,0.2622886963053117,0.7621722726387863,BAX/CAPN10
BP,GO:0031111,negative regulation of microtubule polymerization or depolymerization,2.010337030257349,2,0.2622886963053117,0.7621722726387863,MAPRE1/CLASP2
BP,GO:0043029,T cell homeostasis,2.010337030257349,2,0.2622886963053117,0.7621722726387863,RC3H2/BAX
BP,GO:0043243,positive regulation of protein complex disassembly,2.010337030257349,2,0.2622886963053117,0.7621722726387863,EIF5A2/GBA
BP,GO:0050691,regulation of defense response to virus by host,2.010337030257349,2,0.2622886963053117,0.7621722726387863,DTX3L/TRIM44
BP,GO:0060323,head morphogenesis,2.010337030257349,2,0.2622886963053117,0.7621722726387863,PLEKHA1/ASPH
BP,GO:0006399,tRNA metabolic process,1.3489048985405527,7,0.2636418952489805,0.7621722726387863,HSD17B10/DUS2/TSEN34/TRMT112/SEPHS2/TRMT2B/GATC
BP,GO:0051047,positive regulation of secretion,1.216535726253863,14,0.26391920765794,0.7621722726387863,RAB7A/SNX4/SDC1/VAMP7/ANO1/VPS4A/RAB15/CAPN10/MPC2/CLASP2/CDK5/IL1RAP/MYO18A/RASL10B
BP,GO:0090130,tissue migration,1.2397078353253652,12,0.263989838268747,0.7621722726387863,PKN2/SRPX2/MET/TGFBR1/ACTA2/PIK3CA/STARD13/DUSP10/DOCK5/CLASP2/CSNK2B/PDCD6
BP,GO:0051495,positive regulation of cytoskeleton organization,1.3165038959207418,8,0.26405313048458356,0.7621722726387863,MAPRE1/MET/TGFBR1/PAK1/CDK5/MYO1C/NUP62/CYFIP1
BP,GO:0070482,response to oxygen levels,1.2271219689768844,13,0.26414557951383,0.7621722726387863,CDKN1A/HP1BP3/EGLN3/CDK4/ARNT/PSEN2/PAK1/CLDN3/RBPJ/ARNT2/UCP2/P4HB/TMEM199
BP,GO:0007044,cell-substrate junction assembly,1.5336591777221014,4,0.26434304856944796,0.7621722726387863,ITGA6/CLASP2/APOD/LDB1
BP,GO:0032231,regulation of actin filament bundle assembly,1.5336591777221014,4,0.26434304856944796,0.7621722726387863,MET/TGFBR1/PAK1/CLASP2
BP,GO:0120162,positive regulation of cold-induced thermogenesis,1.5336591777221014,4,0.26434304856944796,0.7621722726387863,KDM3A/APPL2/OMA1/UCP2
CC,GO:0005881,cytoplasmic microtubule,1.6776142261550242,3,0.26535687657570184,0.6582806492273909,MAPRE1/BCL10/CLASP2
BP,GO:0010970,transport along microtubule,1.3860087599910913,6,0.2661044720171772,0.7621722726387863,VAMP7/TERF2/KIF13A/SNAPIN/HNRNPU/BLOC1S5
BP,GO:0099111,microtubule-based transport,1.3860087599910913,6,0.2661044720171772,0.7621722726387863,VAMP7/TERF2/KIF13A/SNAPIN/HNRNPU/BLOC1S5
BP,GO:0034754,cellular hormone metabolic process,1.4415207387504247,5,0.2668796879009667,0.7621722726387863,CYP26B1/STARD3NL/HSD17B14/PLEKHA1/AKR1C3
BP,GO:0099504,synaptic vesicle cycle,1.3419517805068386,7,0.26778082975072925,0.7621722726387863,EEA1/VAMP4/SNAPIN/ADCY1/CDK5/ACTG1/CYFIP1
MF,GO:0019783,ubiquitin-like protein-specific protease activity,1.438780487804878,5,0.26806651887236155,0.7093548555614949,USP28/USP31/USP46/COPS5/OTUD3
MF,GO:1990782,protein tyrosine kinase binding,1.5223225806451612,4,0.2685824134257766,0.7093548555614949,MAP3K7/PTPN14/FRS2/PTPN1
BP,GO:0042110,T cell activation,1.2023028575353758,15,0.2686885069723723,0.7621722726387863,CYP26B1/RC3H2/ARG2/BAX/ELF4/CDK6/CCND3/PIK3CA/BCL10/DUSP10/PAK1/FAM49B/IL7R/YES1/CARD11
BP,GO:0043967,histone H4 acetylation,1.6652791817803414,3,0.2689223641485755,0.7621722726387863,ING4/KANSL3/TADA3
BP,GO:0046365,monosaccharide catabolic process,1.6652791817803414,3,0.2689223641485755,0.7621722726387863,PGM1/DHDH/FUT1
BP,GO:0048662,negative regulation of smooth muscle cell proliferation,1.6652791817803414,3,0.2689223641485755,0.7621722726387863,NDRG4/CDKN1A/APOD
BP,GO:0060038,cardiac muscle cell proliferation,1.6652791817803414,3,0.2689223641485755,0.7621722726387863,NDRG4/TGFBR1/RBPJ
BP,GO:1903391,regulation of adherens junction organization,1.6652791817803414,3,0.2689223641485755,0.7621722726387863,CLASP2/APOD/LDB1
BP,GO:0031667,response to nutrient levels,1.1925045309742992,16,0.2702951702416677,0.7621722726387863,CYP26B1/GCLM/SESN1/MTMR3/VDR/GNPAT/CDKN1A/STK26/APPL2/BCL10/PRKAA2/OMA1/GABARAP/TBL1XR1/GBA/AKR1C3
BP,GO:0030038,contractile actin filament bundle assembly,1.5180095942759575,4,0.27030026428666404,0.7621722726387863,MET/TGFBR1/PAK1/CLASP2
BP,GO:0043149,stress fiber assembly,1.5180095942759575,4,0.27030026428666404,0.7621722726387863,MET/TGFBR1/PAK1/CLASP2
CC,GO:0000109,nucleotide-excision repair complex,3.2154272667971298,1,0.27035037573832776,0.6582806492273909,ERCC5
CC,GO:0005751,mitochondrial respiratory chain complex IV,3.2154272667971298,1,0.27035037573832776,0.6582806492273909,C15orf48
CC,GO:0005845,mRNA cap binding complex,3.2154272667971298,1,0.27035037573832776,0.6582806492273909,CYFIP1
CC,GO:0017119,Golgi transport complex,3.2154272667971298,1,0.27035037573832776,0.6582806492273909,GOLGA3
CC,GO:0030914,STAGA complex,3.2154272667971298,1,0.27035037573832776,0.6582806492273909,TADA3
CC,GO:0032009,early phagosome,3.2154272667971298,1,0.27035037573832776,0.6582806492273909,APPL2
CC,GO:0061700,GATOR2 complex,3.2154272667971298,1,0.27035037573832776,0.6582806492273909,SESN1
CC,GO:0090576,RNA polymerase III transcription factor complex,3.2154272667971298,1,0.27035037573832776,0.6582806492273909,TBP
MF,GO:0001016,RNA polymerase III regulatory region DNA binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,TBP
MF,GO:0001055,RNA polymerase II activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,POLR2J3
MF,GO:0001094,TFIID-class transcription factor complex binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,ZNHIT6
MF,GO:0003995,acyl-CoA dehydrogenase activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,ACAD11
MF,GO:0004303,estradiol 17-beta-dehydrogenase activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,HSD17B14
MF,GO:0005049,nuclear export signal receptor activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,XPO4
MF,GO:0005247,voltage-gated chloride channel activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,ANO1
MF,GO:0005522,profilin binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,ACTG1
MF,GO:0005536,glucose binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,PYGL
MF,GO:0008199,ferric iron binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,FTL
MF,GO:0016273,arginine N-methyltransferase activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,PRMT2
MF,GO:0016274,protein-arginine N-methyltransferase activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,PRMT2
MF,GO:0016801,"hydrolase activity, acting on ether bonds",3.217636363636364,1,0.27046827092916326,0.7093548555614949,EPHX3
MF,GO:0016868,"intramolecular transferase activity, phosphotransferases",3.217636363636364,1,0.27046827092916326,0.7093548555614949,PGM1
MF,GO:0030546,receptor activator activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,CDK5
MF,GO:0034713,type I transforming growth factor beta receptor binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,ACVR2B
MF,GO:0035004,phosphatidylinositol 3-kinase activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,PIK3CA
MF,GO:0043295,glutathione binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,LANCL1
MF,GO:0043422,protein kinase B binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,BCL10
MF,GO:0043560,insulin receptor substrate binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,PIK3CA
MF,GO:0047429,nucleoside-triphosphate diphosphatase activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,NUDT15
MF,GO:0052650,NADP-retinol dehydrogenase activity,3.217636363636364,1,0.27046827092916326,0.7093548555614949,AKR1C3
MF,GO:0070181,small ribosomal subunit rRNA binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,CIRBP
MF,GO:0070411,I-SMAD binding,3.217636363636364,1,0.27046827092916326,0.7093548555614949,TGFBR1
MF,GO:0099186,structural constituent of postsynapse,3.217636363636364,1,0.27046827092916326,0.7093548555614949,ACTG1
MF,GO:0016896,"exoribonuclease activity, producing 5'-phosphomonoesters",1.9663333333333335,2,0.2706012724489528,0.7093548555614949,CNOT6/CNOT7
MF,GO:0030551,cyclic nucleotide binding,1.9663333333333335,2,0.2706012724489528,0.7093548555614949,PRKAR2A/PDE4B
MF,GO:0042169,SH2 domain binding,1.9663333333333335,2,0.2706012724489528,0.7093548555614949,INPPL1/NUP62
BP,GO:0031960,response to corticosteroid,1.3774531503615168,6,0.27067376578742247,0.7621722726387863,SDC1/CDKN1A/HNRNPU/CLDN1/GBA/AKR1C3
MF,GO:0033293,monocarboxylic acid binding,1.65909375,3,0.270709156219255,0.7093548555614949,CYP26B1/PYGL/VDR
BP,GO:0002209,behavioral defense response,1.957433424197945,2,0.27232583119952725,0.7621722726387863,ALS2/USP46
BP,GO:0006040,amino sugar metabolic process,1.957433424197945,2,0.27232583119952725,0.7621722726387863,UAP1/AMDHD2
BP,GO:0007223,"Wnt signaling pathway, calcium modulating pathway",1.957433424197945,2,0.27232583119952725,0.7621722726387863,AGO4/MAP3K7
BP,GO:0009225,nucleotide-sugar metabolic process,1.957433424197945,2,0.27232583119952725,0.7621722726387863,UAP1/AMDHD2
BP,GO:0015804,neutral amino acid transport,1.957433424197945,2,0.27232583119952725,0.7621722726387863,CTNS/SLC36A1
BP,GO:0019068,virion assembly,1.957433424197945,2,0.27232583119952725,0.7621722726387863,VPS4A/CHMP1B
BP,GO:0046636,negative regulation of alpha-beta T cell activation,1.957433424197945,2,0.27232583119952725,0.7621722726387863,RC3H2/ARG2
BP,GO:0071867,response to monoamine,1.957433424197945,2,0.27232583119952725,0.7621722726387863,GABPA/PDE4B
BP,GO:0071869,response to catecholamine,1.957433424197945,2,0.27232583119952725,0.7621722726387863,GABPA/PDE4B
BP,GO:0097502,mannosylation,1.957433424197945,2,0.27232583119952725,0.7621722726387863,PIGB/DPM2
BP,GO:1900077,negative regulation of cellular response to insulin stimulus,1.957433424197945,2,0.27232583119952725,0.7621722726387863,APPL2/PTPN1
BP,GO:1902742,apoptotic process involved in development,1.957433424197945,2,0.27232583119952725,0.7621722726387863,BAX/VDR
BP,GO:1904037,positive regulation of epithelial cell apoptotic process,1.957433424197945,2,0.27232583119952725,0.7621722726387863,CAPN10/AKR1C3
BP,GO:2000279,negative regulation of DNA biosynthetic process,1.957433424197945,2,0.27232583119952725,0.7621722726387863,TERF2/HNRNPU
BP,GO:0007281,germ cell development,1.2775615096864452,9,0.27409819547753606,0.7621722726387863,BAX/PLA2G3/KDM3A/DIAPH2/CELF1/PYGO2/STRBP/AGFG1/OSBP2
BP,GO:0034504,protein localization to nucleus,1.2775615096864452,9,0.27409819547753606,0.7621722726387863,CDKN1A/APPL2/MBTPS1/HNRNPU/DTX3L/CDK5/APOD/KPNA5/NUP62
MF,GO:0008081,phosphoric diester hydrolase activity,1.5061276595744681,4,0.27486487656739234,0.7093548555614949,PDE8A/PRKAR2A/PLCD4/PDE4B
BP,GO:0050890,cognition,1.2564606439108432,10,0.2754438384999129,0.7621722726387863,CTNS/DDHD2/NDRG4/C12orf57/RP9/ADCY1/CDK5/RIN1/POMK/CYFIP1
BP,GO:0034249,negative regulation of cellular amide metabolic process,1.299257119991649,8,0.2755470835051456,0.7621722726387863,SAMD4A/CIRBP/PAIP2/AGO4/CELF1/CNOT10/YTHDF3/CNOT7
BP,GO:0006066,alcohol metabolic process,1.2260846722998118,12,0.2760692658610618,0.7621722726387863,IMPAD1/VDR/PLCD4/DPM2/MBTPS1/LBR/QDPR/PRKAA2/INPPL1/PCBD1/GBA/AKR1C3
BP,GO:0046323,glucose import,1.6407897820482775,3,0.2762425714119175,0.7621722726387863,PRKAG2/APPL2/CAPN10
BP,GO:0071230,cellular response to amino acid stimulus,1.6407897820482775,3,0.2762425714119175,0.7621722726387863,GCLM/SESN1/NSMF
BP,GO:0043648,dicarboxylic acid metabolic process,1.5026761640307458,4,0.2762808180651596,0.7621722726387863,GCLM/MTHFD1L/ALDH1L1/ALDH4A1
BP,GO:0070301,cellular response to hydrogen peroxide,1.5026761640307458,4,0.2762808180651596,0.7621722726387863,PDE8A/MET/PLEKHA1/STK26
BP,GO:0072527,pyrimidine-containing compound metabolic process,1.5026761640307458,4,0.2762808180651596,0.7621722726387863,MBD4/CMPK1/CDS1/TK2
CC,GO:0005938,cell cortex,1.2527638701806998,10,0.27848284117093264,0.6582806492273909,NEDD4/MAPRE1/EXOC2/CAPZA1/DCTN4/FNBP1L/CLASP2/NSMF/TPM4/ASPH
BP,GO:0002903,negative regulation of B cell apoptotic process,3.099269588313413,1,0.27903994940830745,0.7621722726387863,BCL10
BP,GO:0006020,inositol metabolic process,3.099269588313413,1,0.27903994940830745,0.7621722726387863,IMPAD1
BP,GO:0007288,sperm axoneme assembly,3.099269588313413,1,0.27903994940830745,0.7621722726387863,PLA2G3
BP,GO:0008228,opsonization,3.099269588313413,1,0.27903994940830745,0.7621722726387863,MYO18A
BP,GO:0009111,vitamin catabolic process,3.099269588313413,1,0.27903994940830745,0.7621722726387863,CYP26B1
BP,GO:0009886,post-embryonic animal morphogenesis,3.099269588313413,1,0.27903994940830745,0.7621722726387863,BAX
BP,GO:0010623,programmed cell death involved in cell development,3.099269588313413,1,0.27903994940830745,0.7621722726387863,BAX
BP,GO:0010889,regulation of sequestering of triglyceride,3.099269588313413,1,0.27903994940830745,0.7621722726387863,FITM2
BP,GO:0014029,neural crest formation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,PDCD6
BP,GO:0015816,glycine transport,3.099269588313413,1,0.27903994940830745,0.7621722726387863,SLC36A1
BP,GO:0016188,synaptic vesicle maturation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,SNAPIN
BP,GO:0019336,phenol-containing compound catabolic process,3.099269588313413,1,0.27903994940830745,0.7621722726387863,FAH
BP,GO:0021819,layer formation in cerebral cortex,3.099269588313413,1,0.27903994940830745,0.7621722726387863,CDK5
BP,GO:0030259,lipid glycosylation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,GBA
BP,GO:0030950,establishment or maintenance of actin cytoskeleton polarity,3.099269588313413,1,0.27903994940830745,0.7621722726387863,MAPKAP1
BP,GO:0031581,hemidesmosome assembly,3.099269588313413,1,0.27903994940830745,0.7621722726387863,ITGA6
BP,GO:0032252,secretory granule localization,3.099269588313413,1,0.27903994940830745,0.7621722726387863,MYO5A
BP,GO:0033523,histone H2B ubiquitination,3.099269588313413,1,0.27903994940830745,0.7621722726387863,DTX3L
BP,GO:0035330,regulation of hippo signaling,3.099269588313413,1,0.27903994940830745,0.7621722726387863,WWC2
BP,GO:0035437,maintenance of protein localization in endoplasmic reticulum,3.099269588313413,1,0.27903994940830745,0.7621722726387863,TAPT1
BP,GO:0038003,opioid receptor signaling pathway,3.099269588313413,1,0.27903994940830745,0.7621722726387863,NPBWR1
BP,GO:0042118,endothelial cell activation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,TGFBR1
BP,GO:0042308,negative regulation of protein import into nucleus,3.099269588313413,1,0.27903994940830745,0.7621722726387863,APOD
BP,GO:0042368,vitamin D biosynthetic process,3.099269588313413,1,0.27903994940830745,0.7621722726387863,VDR
BP,GO:0043696,dedifferentiation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,CDK6
BP,GO:0043697,cell dedifferentiation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,CDK6
BP,GO:0045416,positive regulation of interleukin-8 biosynthetic process,3.099269588313413,1,0.27903994940830745,0.7621722726387863,BCL10
BP,GO:0045472,response to ether,3.099269588313413,1,0.27903994940830745,0.7621722726387863,CDK4
BP,GO:0045760,positive regulation of action potential,3.099269588313413,1,0.27903994940830745,0.7621722726387863,GBA
BP,GO:0046520,sphingoid biosynthetic process,3.099269588313413,1,0.27903994940830745,0.7621722726387863,GBA
BP,GO:0051132,NK T cell activation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,ELF4
BP,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,3.099269588313413,1,0.27903994940830745,0.7621722726387863,HNRNPU
BP,GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,3.099269588313413,1,0.27903994940830745,0.7621722726387863,CNOT7
BP,GO:0060368,regulation of Fc receptor mediated stimulatory signaling pathway,3.099269588313413,1,0.27903994940830745,0.7621722726387863,APPL2
BP,GO:0060391,positive regulation of SMAD protein signal transduction,3.099269588313413,1,0.27903994940830745,0.7621722726387863,TGFBR1
BP,GO:0060442,branching involved in prostate gland morphogenesis,3.099269588313413,1,0.27903994940830745,0.7621722726387863,FRS2
BP,GO:0060788,ectodermal placode formation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,FRS2
BP,GO:0060900,embryonic camera-type eye formation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,FRS2
BP,GO:0070493,thrombin-activated receptor signaling pathway,3.099269588313413,1,0.27903994940830745,0.7621722726387863,MET
BP,GO:0070601,centromeric sister chromatid cohesion,3.099269588313413,1,0.27903994940830745,0.7621722726387863,BOD1
BP,GO:0071257,cellular response to electrical stimulus,3.099269588313413,1,0.27903994940830745,0.7621722726387863,NSMF
BP,GO:0071697,ectodermal placode morphogenesis,3.099269588313413,1,0.27903994940830745,0.7621722726387863,FRS2
BP,GO:0098885,modification of postsynaptic actin cytoskeleton,3.099269588313413,1,0.27903994940830745,0.7621722726387863,CYFIP1
BP,GO:0098974,postsynaptic actin cytoskeleton organization,3.099269588313413,1,0.27903994940830745,0.7621722726387863,ACTG1
BP,GO:0099150,regulation of postsynaptic specialization assembly,3.099269588313413,1,0.27903994940830745,0.7621722726387863,IL1RAP
BP,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,3.099269588313413,1,0.27903994940830745,0.7621722726387863,MYO5A
BP,GO:0150052,regulation of postsynapse assembly,3.099269588313413,1,0.27903994940830745,0.7621722726387863,IL1RAP
BP,GO:1901298,regulation of hydrogen peroxide-mediated programmed cell death,3.099269588313413,1,0.27903994940830745,0.7621722726387863,MET
BP,GO:1901387,positive regulation of voltage-gated calcium channel activity,3.099269588313413,1,0.27903994940830745,0.7621722726387863,STAC
BP,GO:1902510,regulation of apoptotic DNA fragmentation,3.099269588313413,1,0.27903994940830745,0.7621722726387863,BAX
BP,GO:1904424,regulation of GTP binding,3.099269588313413,1,0.27903994940830745,0.7621722726387863,MET
BP,GO:1904590,negative regulation of protein import,3.099269588313413,1,0.27903994940830745,0.7621722726387863,APOD
BP,GO:1905244,regulation of modification of synaptic structure,3.099269588313413,1,0.27903994940830745,0.7621722726387863,CYFIP1
BP,GO:1905666,regulation of protein localization to endosome,3.099269588313413,1,0.27903994940830745,0.7621722726387863,DTX3L
BP,GO:2000105,positive regulation of DNA-dependent DNA replication,3.099269588313413,1,0.27903994940830745,0.7621722726387863,INO80
BP,GO:2000232,regulation of rRNA processing,3.099269588313413,1,0.27903994940830745,0.7621722726387863,TRMT112
BP,GO:2000650,negative regulation of sodium ion transmembrane transporter activity,3.099269588313413,1,0.27903994940830745,0.7621722726387863,NEDD4
BP,GO:0008202,steroid metabolic process,1.2359624944331435,11,0.27923819449361265,0.7621722726387863,CYP26B1/STARD3NL/HSD17B14/PRKAG2/PLEKHA1/VDR/MBTPS1/LBR/PRKAA2/GBA/AKR1C3
CC,GO:0016529,sarcoplasmic reticulum,1.630357487390094,3,0.2794592171100702,0.6582806492273909,CALU/MTMR12/ASPH
CC,GO:0044291,cell-cell contact zone,1.630357487390094,3,0.2794592171100702,0.6582806492273909,PAK1/TMEM65/RAP2B
BP,GO:0048732,gland development,1.1997172599922887,14,0.2805653999071188,0.7621722726387863,CSNK2A2/BAX/MET/TGFBR1/VDR/RPS6KA1/PIK3CA/QDPR/CLDN1/PYGO2/BTRC/FRS2/RBPJ/CSNK2B
MF,GO:0005496,steroid binding,1.4902736842105264,4,0.28117159695944555,0.7093548555614949,STARD3NL/VDR/OSBP2/APOD
BP,GO:0006520,cellular amino acid metabolic process,1.2193847560577362,12,0.2821747449270682,0.7621722726387863,GCLM/CTNS/HSD17B10/ARG2/FAH/EGLN3/QDPR/ALDH4A1/PCBD1/SEPHS2/P4HB/GATC
BP,GO:0002758,innate immune response-activating signal transduction,1.2480280221396294,10,0.28222298792876516,0.7621722726387863,TAB1/MAP3K7/APPL2/BCL10/PAK1/BTRC/TNIP2/CARD9/CARD11/ZCCHC3
BP,GO:0055024,regulation of cardiac muscle tissue development,1.4876494023904383,4,0.2822828778937879,0.7621722726387863,TGFBR1/PAK1/FRS2/RBPJ
BP,GO:0060840,artery development,1.4876494023904383,4,0.2822828778937879,0.7621722726387863,TAB1/TGFBR1/ACVR2B/RBPJ
BP,GO:0008207,C21-steroid hormone metabolic process,1.907242823577485,2,0.28235760817183,0.7621722726387863,STARD3NL/AKR1C3
BP,GO:0010761,fibroblast migration,1.907242823577485,2,0.28235760817183,0.7621722726387863,APPL2/PAK1
BP,GO:0030049,muscle filament sliding,1.907242823577485,2,0.28235760817183,0.7621722726387863,TPM4/MYL6B
BP,GO:0030204,chondroitin sulfate metabolic process,1.907242823577485,2,0.28235760817183,0.7621722726387863,IMPAD1/IDUA
BP,GO:0030488,tRNA methylation,1.907242823577485,2,0.28235760817183,0.7621722726387863,HSD17B10/TRMT112
BP,GO:0033275,actin-myosin filament sliding,1.907242823577485,2,0.28235760817183,0.7621722726387863,TPM4/MYL6B
BP,GO:0033683,"nucleotide-excision repair, DNA incision",1.907242823577485,2,0.28235760817183,0.7621722726387863,GTF2H1/ERCC5
BP,GO:1902116,negative regulation of organelle assembly,1.907242823577485,2,0.28235760817183,0.7621722726387863,MTM1/NUPR1
BP,GO:2000826,regulation of heart morphogenesis,1.907242823577485,2,0.28235760817183,0.7621722726387863,TGFBR1/RBPJ
BP,GO:0055007,cardiac muscle cell differentiation,1.4087589037788242,5,0.2823646699030541,0.7621722726387863,ALPK3/PAK1/HNRNPU/FRS2/RBPJ
BP,GO:0072329,monocarboxylic acid catabolic process,1.4087589037788242,5,0.2823646699030541,0.7621722726387863,CYP26B1/FAH/IDUA/LPIN3/ACAD11
BP,GO:0015909,long-chain fatty acid transport,1.6170102199896068,3,0.28358228758939186,0.7621722726387863,PLA2G3/PRKAG2/PRKAA2
CC,GO:0044309,neuron spine,1.3538641123356334,6,0.28373024274019576,0.6582806492273909,ALS2/NEDD4/EEA1/PDE4B/PPP1CC/CYFIP1
CC,GO:0030672,synaptic vesicle membrane,1.4840433539063675,4,0.2837835802788608,0.6582806492273909,VAMP4/STX12/VAMP7/SNAPIN
CC,GO:0099501,exocytic vesicle membrane,1.4840433539063675,4,0.2837835802788608,0.6582806492273909,VAMP4/STX12/VAMP7/SNAPIN
BP,GO:0031497,chromatin assembly,1.352408547627671,6,0.28449333514526015,0.7621722726387863,RBBP7/ASF1A/HP1BP3/RBBP4/SPTY2D1/TSPYL2
BP,GO:0031099,regeneration,1.3148416435269026,7,0.28450708722358514,0.7621722726387863,CSNK2A2/CDKN1A/CDK4/DUSP10/CLDN1/APOD/CSNK2B
MF,GO:0002039,p53 binding,1.6088181818181817,3,0.28613617583956014,0.7093548555614949,RCHY1/CDK5/TRIAP1
MF,GO:0008173,RNA methyltransferase activity,1.6088181818181817,3,0.28613617583956014,0.7093548555614949,TRMT2A/TRMT112/TRMT2B
MF,GO:0032182,ubiquitin-like protein binding,1.4747500000000002,4,0.2875004615817426,0.7093548555614949,SPRTN/NEDD4/RNF168/NUP62
CC,GO:0043596,nuclear replication fork,1.882201326905637,2,0.28754841754072635,0.6582806492273909,ZMIZ2/ERCC5
BP,GO:0071333,cellular response to glucose stimulus,1.3981667315699609,5,0.28756522992868383,0.7621722726387863,GCLM/PIK3CA/ANO1/MPC2/PRKAA2
BP,GO:0034440,lipid oxidation,1.4729202003865725,4,0.2883046303724547,0.7621722726387863,PRKAG2/APPL2/APOD/ACAD11
BP,GO:1903008,organelle disassembly,1.4729202003865725,4,0.2883046303724547,0.7621722726387863,CSNK2A2/GABARAP/GBA/ATG9B
BP,GO:0017038,protein import,1.3082343990870686,7,0.2887282052714168,0.7621722726387863,CDKN1A/APPL2/MBTPS1/TOMM20/APOD/KPNA5/NUP62
BP,GO:0051251,positive regulation of lymphocyte activation,1.224861034902307,11,0.2889155157761626,0.7621722726387863,PIK3CA/CDKN1A/BCL10/DUSP10/PAK1/FAM49B/IL7R/TNIP2/YES1/CARD11/TOX
BP,GO:0071902,positive regulation of protein serine/threonine kinase activity,1.224861034902307,11,0.2889155157761626,0.7621722726387863,ALS2/MAP4K5/TAB1/TGFBR1/CCND3/TAOK3/MAP3K7/PAK1/FRS2/MAP4K2/PTPN1
CC,GO:0033267,axon part,1.2120982366983943,12,0.2890268293123061,0.6582806492273909,ALS2/EEA1/DOCK7/TERF2/SNAPIN/ZFYVE27/CDK5/CBX6/ACTG1/BLOC1S5/MYO5A/CYFIP1
BP,GO:0016125,sterol metabolic process,1.344261508184131,6,0.2891343350334262,0.7621722726387863,CYP26B1/PRKAG2/MBTPS1/LBR/PRKAA2/GBA
CC,GO:0000782,telomere cap complex,2.968086707812735,1,0.28927201785950063,0.6582806492273909,TERF2
CC,GO:0000783,nuclear telomere cap complex,2.968086707812735,1,0.28927201785950063,0.6582806492273909,TERF2
CC,GO:0005675,transcription factor TFIIH holo complex,2.968086707812735,1,0.28927201785950063,0.6582806492273909,GTF2H1
CC,GO:0005688,U6 snRNP,2.968086707812735,1,0.28927201785950063,0.6582806492273909,LSM7
CC,GO:0005736,RNA polymerase I complex,2.968086707812735,1,0.28927201785950063,0.6582806492273909,CD3EAP
CC,GO:0005952,cAMP-dependent protein kinase complex,2.968086707812735,1,0.28927201785950063,0.6582806492273909,PRKAR2A
CC,GO:0008250,oligosaccharyltransferase complex,2.968086707812735,1,0.28927201785950063,0.6582806492273909,OSTC
CC,GO:0044292,dendrite terminus,2.968086707812735,1,0.28927201785950063,0.6582806492273909,CYFIP1
CC,GO:0071203,WASH complex,2.968086707812735,1,0.28927201785950063,0.6582806492273909,CAPZA1
CC,GO:0098845,postsynaptic endosome,2.968086707812735,1,0.28927201785950063,0.6582806492273909,STX12
CC,GO:1990023,mitotic spindle midzone,2.968086707812735,1,0.28927201785950063,0.6582806492273909,HNRNPU
CC,GO:0000777,condensed chromosome kinetochore,1.4699096076786877,4,0.28958879456361725,0.6582806492273909,BOD1/HNRNPU/CLASP2/PPP1CC
MF,GO:0004519,endonuclease activity,1.393464566929134,5,0.28984527041121955,0.7093548555614949,SMG6/MBD4/ERCC5/TSEN34/PGBD5
BP,GO:0045785,positive regulation of cell adhesion,1.199717259992289,13,0.29033444269005726,0.7621722726387863,ITGA6/CDK6/PIK3CA/BCL10/DUSP10/DOCK5/PAK1/FAM49B/IL7R/DENND6A/YES1/CARD11/LDB1
BP,GO:0002709,regulation of T cell mediated immunity,1.5939100739897554,3,0.2909383231860017,0.7621722726387863,MAP3K7/FAM49B/IL7R
BP,GO:0033077,T cell differentiation in thymus,1.5939100739897554,3,0.2909383231860017,0.7621722726387863,CDK6/IL7R/CARD11
BP,GO:0070988,demethylation,1.5939100739897554,3,0.2909383231860017,0.7621722726387863,KDM7A/KDM3A/PHF8
BP,GO:0016358,dendrite development,1.27695227672999,8,0.2910800803223859,0.7621722726387863,SS18L2/NEDD4/ANKRD27/VAMP7/RAP2A/CDK5/NSMF/CYFIP1
MF,GO:0000340,RNA 7-methylguanosine cap binding,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,CYFIP1
MF,GO:0001054,RNA polymerase I activity,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,CD3EAP
MF,GO:0003964,RNA-directed DNA polymerase activity,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,TERF2
MF,GO:0004861,cyclin-dependent protein serine/threonine kinase inhibitor activity,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,CDKN1A
MF,GO:0015174,basic amino acid transmembrane transporter activity,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,SLC7A1
MF,GO:0017154,semaphorin receptor activity,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,MET
MF,GO:0019992,diacylglycerol binding,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,RASGRP2
MF,GO:0031994,insulin-like growth factor I binding,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,ITGA6
MF,GO:0033130,acetylcholine receptor binding,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,RIC3
MF,GO:0034595,phosphatidylinositol phosphate 5-phosphatase activity,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,PTPMT1
MF,GO:0043047,single-stranded telomeric DNA binding,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,TERF2
MF,GO:1900750,oligopeptide binding,2.9495000000000005,1,0.2910928250700324,0.7093548555614949,LANCL1
BP,GO:0006909,phagocytosis,1.209471058854015,12,0.2914100530038495,0.7621722726387863,RAB7A/MET/PIK3CA/VAMP7/APPL2/PAK1/ARHGAP12/YES1/ACTG1/MYO18A/MYO1C/CYFIP1
MF,GO:0004532,exoribonuclease activity,1.8628421052631579,2,0.29168840254275064,0.7093548555614949,CNOT6/CNOT7
MF,GO:0043531,ADP binding,1.8628421052631579,2,0.29168840254275064,0.7093548555614949,PRKAG2/MYO18A
BP,GO:0009205,purine ribonucleoside triphosphate metabolic process,1.2212047333055838,11,0.2921627504534811,0.7621722726387863,CTNS/PGM1/PRKAG2/ISCU/ARNT/PRKAA2/SDHAF2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0001709,cell fate determination,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,CYP26B1/MCL1
BP,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,RC3H2/IL7R
BP,GO:0032467,positive regulation of cytokinesis,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,PKN2/NUP62
BP,GO:0042596,fear response,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,ALS2/USP46
BP,GO:0046621,negative regulation of organ growth,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,PAK1/WWC2
BP,GO:0071548,response to dexamethasone,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,CLDN1/GBA
BP,GO:0090207,regulation of triglyceride metabolic process,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,TBL1XR1/FITM2
BP,GO:0098760,response to interleukin-7,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,IL7R/P4HB
BP,GO:0098761,cellular response to interleukin-7,1.8595617529880477,2,0.2923770717471209,0.7621722726387863,IL7R/P4HB
BP,GO:0030260,entry into host cell,1.3877326514836177,5,0.292783290635552,0.7621722726387863,MET/EXOC2/CLDN1/P4HB/CLDN9
BP,GO:0032273,positive regulation of protein polymerization,1.3877326514836177,5,0.292783290635552,0.7621722726387863,MAPRE1/MET/PAK1/MYO1C/CYFIP1
BP,GO:0044409,entry into host,1.3877326514836177,5,0.292783290635552,0.7621722726387863,MET/EXOC2/CLDN1/P4HB/CLDN9
BP,GO:0051806,entry into cell of other organism involved in symbiotic interaction,1.3877326514836177,5,0.292783290635552,0.7621722726387863,MET/EXOC2/CLDN1/P4HB/CLDN9
BP,GO:0051828,entry into other organism involved in symbiotic interaction,1.3877326514836177,5,0.292783290635552,0.7621722726387863,MET/EXOC2/CLDN1/P4HB/CLDN9
CC,GO:0018995,host,1.5856901589684473,3,0.29362879316361185,0.6582806492273909,NMT2/CNOT7/NUP62
CC,GO:0043657,host cell,1.5856901589684473,3,0.29362879316361185,0.6582806492273909,NMT2/CNOT7/NUP62
CC,GO:0090734,site of DNA damage,1.5856901589684473,3,0.29362879316361185,0.6582806492273909,CBX5/CBX1/RNF168
BP,GO:0021549,cerebellum development,1.4584798062651356,4,0.29434428170776133,0.7621722726387863,GNPAT/PAK1/CDK5/LDB1
CC,GO:0032838,plasma membrane bounded cell projection cytoplasm,1.2985379346680717,7,0.2950867434544112,0.6582806492273909,PRKAR2A/WDR11/TERF2/SNAPIN/HNRNPU/GABARAP/BLOC1S5
MF,GO:0016614,"oxidoreductase activity, acting on CH-OH group of donors",1.382578125,5,0.29534032479300715,0.7093548555614949,IDH3G/HSD17B10/HSD17B14/DHDH/AKR1C3
BP,GO:0090305,nucleic acid phosphodiester bond hydrolysis,1.2314978496609588,10,0.29592248852760694,0.7621722726387863,SMG6/BAX/GTF2H1/CNOT6/FCF1/ERCC5/TSEN34/PGBD5/PNRC2/CNOT7
BP,GO:0043547,positive regulation of GTPase activity,1.1937927303133147,13,0.2962598353828127,0.7621722726387863,ALS2/TBC1D22B/RASGRP2/ITGA6/RGS17/ANKRD27/DOCK7/STARD13/BNIP2/DOCK5/ARHGAP12/AGFG1/RIN1
BP,GO:0043900,regulation of multi-organism process,1.1937927303133147,13,0.2962598353828127,0.7621722726387863,PKN2/RAB7A/ARG2/PPIE/EXOC2/VPS4A/MAPKBP1/DTX3L/TRIM44/BANF1/P4HB/CNOT7/ZCCHC3
BP,GO:0006405,RNA export from nucleus,1.3774531503615168,5,0.2980176918880914,0.7621722726387863,SMG6/THOC5/WDR33/AGFG1/NUP62
BP,GO:0030010,establishment of cell polarity,1.3774531503615168,5,0.2980176918880914,0.7621722726387863,CYP26B1/CYTH1/DOCK7/PAK1/MYO18A
BP,GO:0071331,cellular response to hexose stimulus,1.3774531503615168,5,0.2980176918880914,0.7621722726387863,GCLM/PIK3CA/ANO1/MPC2/PRKAA2
BP,GO:0042440,pigment metabolic process,1.5714606363279278,3,0.29830756102866196,0.7621722726387863,CTNS/MTHFD1L/MYO5A
BP,GO:0044786,cell cycle DNA replication,1.5714606363279278,3,0.29830756102866196,0.7621722726387863,STAG2/INO80/TERF2
BP,GO:0000722,telomere maintenance via recombination,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,TERF2
BP,GO:0001845,phagolysosome assembly,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,RAB7A
BP,GO:0001867,"complement activation, lectin pathway",2.8608642353662272,1,0.2984376311210868,0.7621722726387863,SCARA3
BP,GO:0001886,endothelial cell morphogenesis,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,MET
BP,GO:0002679,respiratory burst involved in defense response,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,DUSP10
BP,GO:0002829,negative regulation of type 2 immune response,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,ARG2
BP,GO:0003157,endocardium development,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,RBPJ
BP,GO:0003306,Wnt signaling pathway involved in heart development,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,RBPJ
BP,GO:0006012,galactose metabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,PGM1
BP,GO:0006384,transcription initiation from RNA polymerase III promoter,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,TBP
BP,GO:0006670,sphingosine metabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,GBA
BP,GO:0006703,estrogen biosynthetic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,HSD17B14
BP,GO:0006995,cellular response to nitrogen starvation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,GABARAP
BP,GO:0009143,nucleoside triphosphate catabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,NUDT15
BP,GO:0009162,deoxyribonucleoside monophosphate metabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,TK2
BP,GO:0009223,pyrimidine deoxyribonucleotide catabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,MBD4
BP,GO:0010763,positive regulation of fibroblast migration,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,PAK1
BP,GO:0010839,negative regulation of keratinocyte proliferation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,VDR
BP,GO:0010870,positive regulation of receptor biosynthetic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,CNPY2
BP,GO:0016024,CDP-diacylglycerol biosynthetic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,CDS1
BP,GO:0019627,urea metabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,ARG2
BP,GO:0030205,dermatan sulfate metabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,IDUA
BP,GO:0031115,negative regulation of microtubule polymerization,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,MAPRE1
BP,GO:0032754,positive regulation of interleukin-5 production,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,IL1RAP
BP,GO:0032823,regulation of natural killer cell differentiation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,TOX
BP,GO:0033127,regulation of histone phosphorylation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,RPS6KA4
BP,GO:0034969,histone arginine methylation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,PRMT2
BP,GO:0034982,mitochondrial protein processing,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,OMA1
BP,GO:0042415,norepinephrine metabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,RNF180
BP,GO:0042538,hyperosmotic salinity response,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,CLDN1
BP,GO:0043201,response to leucine,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,SESN1
BP,GO:0043247,telomere maintenance in response to DNA damage,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,TERF2
BP,GO:0043248,proteasome assembly,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,PSMG4
BP,GO:0043562,cellular response to nitrogen levels,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,GABARAP
BP,GO:0045086,positive regulation of interleukin-2 biosynthetic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,CARD11
BP,GO:0045820,negative regulation of glycolytic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,NUPR1
BP,GO:0048505,regulation of timing of cell differentiation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,RBPJ
BP,GO:0048715,negative regulation of oligodendrocyte differentiation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,DUSP10
BP,GO:0050872,white fat cell differentiation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,TBL1XR1
BP,GO:0051386,regulation of neurotrophin TRK receptor signaling pathway,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,CYFIP1
BP,GO:0060100,"positive regulation of phagocytosis, engulfment",2.8608642353662272,1,0.2984376311210868,0.7621722726387863,APPL2
BP,GO:0060576,intestinal epithelial cell development,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,CDKN1A
BP,GO:0061052,negative regulation of cell growth involved in cardiac muscle cell development,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,PAK1
BP,GO:0061469,regulation of type B pancreatic cell proliferation,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,NUPR1
BP,GO:0061478,response to platelet aggregation inhibitor,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,ADCY1
BP,GO:0070071,proton-transporting two-sector ATPase complex assembly,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,TMEM199
BP,GO:0070208,protein heterotrimerization,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,NUP62
BP,GO:0070831,basement membrane assembly,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,CLASP2
BP,GO:0070914,UV-damage excision repair,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,INO80
BP,GO:0071285,cellular response to lithium ion,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,ADCY7
BP,GO:0071696,ectodermal placode development,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,FRS2
BP,GO:0071872,cellular response to epinephrine stimulus,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,PDE4B
BP,GO:0090399,replicative senescence,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,CDKN1A
BP,GO:0090646,mitochondrial tRNA processing,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,HSD17B10
BP,GO:1901160,primary amino compound metabolic process,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,RNF180
BP,GO:1902306,negative regulation of sodium ion transmembrane transport,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,NEDD4
BP,GO:1902855,regulation of non-motile cilium assembly,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,WRAP73
BP,GO:1904925,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,GBA
BP,GO:1905155,positive regulation of membrane invagination,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,APPL2
BP,GO:2000194,regulation of female gonad development,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,NUPR1
BP,GO:2001034,positive regulation of double-strand break repair via nonhomologous end joining,2.8608642353662272,1,0.2984376311210868,0.7621722726387863,DTX3L
BP,GO:0018958,phenol-containing compound metabolic process,1.4443198081460566,4,0.3004000586511271,0.7621722726387863,CTNS/FAH/RNF180/MYO5A
BP,GO:0035601,protein deacylation,1.4443198081460566,4,0.3004000586511271,0.7621722726387863,SUDS3/PRKAA2/TADA3/TBL1XR1
BP,GO:0006612,protein targeting to membrane,1.288805175338251,7,0.3014766277809239,0.7621722726387863,SEC62/VAMP7/RTP4/PAK1/CDK5/MYO1C/ZDHHC18
MF,GO:0016776,"phosphotransferase activity, phosphate group as acceptor",1.8150769230769233,2,0.3022052111636966,0.7093548555614949,CMPK1/CARD11
MF,GO:0032266,phosphatidylinositol-3-phosphate binding,1.8150769230769233,2,0.3022052111636966,0.7093548555614949,SNX24/KIF16B
BP,GO:0019432,triglyceride biosynthetic process,1.8142065882810223,2,0.30237764290310265,0.7621722726387863,LPIN3/FITM2
BP,GO:0019985,translesion synthesis,1.8142065882810223,2,0.30237764290310265,0.7621722726387863,SPRTN/RCHY1
BP,GO:0030890,positive regulation of B cell proliferation,1.8142065882810223,2,0.30237764290310265,0.7621722726387863,CDKN1A/CARD11
BP,GO:0061028,establishment of endothelial barrier,1.8142065882810223,2,0.30237764290310265,0.7621722726387863,MARVELD2/CLDN1
BP,GO:0090317,negative regulation of intracellular protein transport,1.8142065882810223,2,0.30237764290310265,0.7621722726387863,CDK5/APOD
BP,GO:0097178,ruffle assembly,1.8142065882810223,2,0.30237764290310265,0.7621722726387863,INPPL1/CYFIP1
BP,GO:1903037,regulation of leukocyte cell-cell adhesion,1.2233958901237156,10,0.30283771032682066,0.7621722726387863,RC3H2/ARG2/PIK3CA/BCL10/DUSP10/PAK1/FAM49B/IL7R/YES1/CARD11
BP,GO:0030307,positive regulation of cell growth,1.3203988778613356,6,0.30314924046437697,0.7621722726387863,TGFBR1/RPS6KA1/INO80/PAK1/ZFYVE27/CYFIP1
BP,GO:0045619,regulation of lymphocyte differentiation,1.3203988778613356,6,0.30314924046437697,0.7621722726387863,CYP26B1/RC3H2/DUSP10/IL7R/CARD11/TOX
BP,GO:0045814,"negative regulation of gene expression, epigenetic",1.3673248183735647,5,0.30326728056480484,0.7621722726387863,RBBP7/ASF1A/ATAD2B/RBBP4/PHF8
BP,GO:0071326,cellular response to monosaccharide stimulus,1.3673248183735647,5,0.30326728056480484,0.7621722726387863,GCLM/PIK3CA/ANO1/MPC2/PRKAA2
MF,GO:1901981,phosphatidylinositol phosphate binding,1.3190310559006213,6,0.30391266778170384,0.7093548555614949,SNX24/KIF16B/PLEKHA1/MAPKAP1/MYO1B/SNX14
BP,GO:0010498,proteasomal protein catabolic process,1.169535693703175,15,0.30396794272228306,0.7621722726387863,NEDD4/CHFR/KLHL42/FBXL12/EDEM1/NUDT15/RYBP/RCHY1/RNF180/BTRC/MTM1/NUPR1/CDC26/TBL1XR1/GBA
BP,GO:0032024,positive regulation of insulin secretion,1.5496347941567066,3,0.30568695695348774,0.7621722726387863,ANO1/CAPN10/MPC2
BP,GO:0035019,somatic stem cell population maintenance,1.5496347941567066,3,0.30568695695348774,0.7621722726387863,RBPJ/ZHX2/LDB1
BP,GO:0038034,signal transduction in absence of ligand,1.5496347941567066,3,0.30568695695348774,0.7621722726387863,BAX/MKNK2/MCL1
BP,GO:0051881,regulation of mitochondrial membrane potential,1.5496347941567066,3,0.30568695695348774,0.7621722726387863,GCLM/CTNS/BAX
BP,GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,1.5496347941567066,3,0.30568695695348774,0.7621722726387863,BAX/MKNK2/MCL1
BP,GO:1903051,negative regulation of proteolysis involved in cellular protein catabolic process,1.5496347941567066,3,0.30568695695348774,0.7621722726387863,CSNK2A2/RYBP/MTM1
BP,GO:0010923,negative regulation of phosphatase activity,1.4304321176831136,4,0.3064702093807751,0.7621722726387863,ELL/BOD1/PPP1R14A/PPP1R14C
BP,GO:0071887,leukocyte apoptotic process,1.4304321176831136,4,0.3064702093807751,0.7621722726387863,ARG2/BAX/BCL10/IL7R
BP,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1.4304321176831136,4,0.3064702093807751,0.7621722726387863,TGFBR1/ACVR2B/RBPJ/CSNK2B
BP,GO:0098732,macromolecule deacylation,1.4304321176831136,4,0.3064702093807751,0.7621722726387863,SUDS3/PRKAA2/TADA3/TBL1XR1
CC,GO:0000177,cytoplasmic exosome (RNase complex),2.7560805143975395,1,0.30770390980396867,0.6582806492273909,CARHSP1
CC,GO:0000346,transcription export complex,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,THOC5
CC,GO:0000940,condensed chromosome outer kinetochore,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,BOD1
CC,GO:0005767,secondary lysosome,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,FTL
CC,GO:0030677,ribonuclease P complex,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,HSD17B10
CC,GO:0033162,melanosome membrane,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,RAB7A
CC,GO:0033276,transcription factor TFTC complex,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,TADA3
CC,GO:0033646,host intracellular part,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,CNOT7
CC,GO:0034518,RNA cap binding complex,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,CYFIP1
CC,GO:0043218,compact myelin,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,MARVELD2
CC,GO:0043656,intracellular region of host,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,CNOT7
CC,GO:0045009,chitosome,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,RAB7A
CC,GO:0090741,pigment granule membrane,2.7560805143975395,1,0.30770390980396867,0.6582806492273909,RAB7A
CC,GO:0032432,actin filament bundle,1.5434050880626222,3,0.30784325913804234,0.6582806492273909,PLS3/DCTN4/TPM4
BP,GO:0006022,aminoglycan metabolic process,1.312631825638622,6,0.30784878024515167,0.7621722726387863,B4GALT7/HAS3/IMPAD1/SDC1/IDUA/B3GNT9
BP,GO:0050684,regulation of mRNA processing,1.3573443452467502,5,0.30853091112862313,0.7621722726387863,PAPOLA/CIRBP/SAFB2/CELF1/HNRNPU
MF,GO:0008094,DNA-dependent ATPase activity,1.5388695652173912,3,0.3093942363644386,0.7093548555614949,GTF2H1/INO80/RBBP4
CC,GO:0043025,neuronal cell body,1.1645410624214956,15,0.30972903209369274,0.6582806492273909,ALS2/ATXN10/PSEN2/CNNM4/PRKAA2/WDFY3/CDK5/NSMF/RIC3/AGFG1/RIN1/CBX6/APOD/MYO5A/CYFIP1
MF,GO:0003924,GTPase activity,1.201648148148148,11,0.30996110535363597,0.7093548555614949,RAB7A/RGS17/ARFRP1/ARL1/RAP2A/RAB15/RIT1/RHEBL1/TUBAL3/RAP2B/RASL10B
BP,GO:0035265,organ growth,1.2761698304819935,7,0.3100403064196437,0.7621722726387863,NDRG4/TGFBR1/ACVR2B/PAK1/WWC2/SCARA3/RBPJ
MF,GO:0004032,alditol:NADP+ 1-oxidoreductase activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,AKR1C3
MF,GO:0004652,polynucleotide adenylyltransferase activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,PAPOLA
MF,GO:0005068,transmembrane receptor protein tyrosine kinase adaptor activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,FRS2
MF,GO:0008195,phosphatidate phosphatase activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,LPIN3
MF,GO:0008417,fucosyltransferase activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,FUT1
MF,GO:0009982,pseudouridine synthase activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,TRUB2
MF,GO:0016251,RNA polymerase II general transcription initiation factor activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,TBP
MF,GO:0016840,carbon-nitrogen lyase activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,GGACT
MF,GO:0017017,MAP kinase tyrosine/serine/threonine phosphatase activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,DUSP10
MF,GO:0017070,U6 snRNA binding,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,LSM7
MF,GO:0030548,acetylcholine receptor regulator activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,CDK5
MF,GO:0034236,protein kinase A catalytic subunit binding,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,PRKAR2A
MF,GO:0043495,protein membrane anchor,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,PDCD6
MF,GO:0099602,neurotransmitter receptor regulator activity,2.7226153846153847,1,0.3111354367446152,0.7093548555614949,CDK5
MF,GO:0106019,"phosphatidylinositol-4,5-bisphosphate phosphatase activity",2.7226153846153847,1,0.3111354367446152,0.7093548555614949,PTPMT1
BP,GO:0019216,regulation of lipid metabolic process,1.1792342823826645,13,0.31122263409515344,0.7621722726387863,MTMR3/PRKAG2/VDR/LPGAT1/CDK4/APPL2/MBTPS1/NRBF2/PRKAA2/TBL1XR1/APOD/AKR1C3/FITM2
BP,GO:0009199,ribonucleoside triphosphate metabolic process,1.1997172599922892,11,0.31185250994338,0.7621722726387863,CTNS/PGM1/PRKAG2/ISCU/ARNT/PRKAA2/SDHAF2/NUPR1/DNAJC30/ENTPD5/NUP62
BP,GO:0033003,regulation of mast cell activation,1.7710111933219503,2,0.312353103923498,0.7621722726387863,SNX4/VAMP7
BP,GO:0042181,ketone biosynthetic process,1.7710111933219503,2,0.312353103923498,0.7621722726387863,UBIAD1/AKR1C3
BP,GO:0051154,negative regulation of striated muscle cell differentiation,1.7710111933219503,2,0.312353103923498,0.7621722726387863,PAK1/FRS2
BP,GO:0090503,"RNA phosphodiester bond hydrolysis, exonucleolytic",1.7710111933219503,2,0.312353103923498,0.7621722726387863,CNOT6/CNOT7
BP,GO:1903146,regulation of autophagy of mitochondrion,1.7710111933219503,2,0.312353103923498,0.7621722726387863,CSNK2A2/GBA
BP,GO:0006641,triglyceride metabolic process,1.4168089546575602,4,0.3125530043289879,0.7621722726387863,DDHD2/LPIN3/TBL1XR1/FITM2
BP,GO:0045185,maintenance of protein location,1.4168089546575602,4,0.3125530043289879,0.7621722726387863,G3BP2/HNRNPU/CDK5/TAPT1
BP,GO:0055017,cardiac muscle tissue growth,1.4168089546575602,4,0.3125530043289879,0.7621722726387863,NDRG4/TGFBR1/PAK1/RBPJ
BP,GO:0000910,cytokinesis,1.3049556161319633,6,0.31256091371483813,0.7621722726387863,PKN2/VPS4A/KIF13A/KLHL9/NUP62/CHMP1B
BP,GO:0003205,cardiac chamber development,1.3049556161319633,6,0.31256091371483813,0.7621722726387863,TAB1/TGFBR1/TMEM65/FRS2/RBPJ/PARVA
MF,GO:0015036,disulfide oxidoreductase activity,1.7696999999999998,2,0.31269437218431884,0.7093548555614949,TMX1/P4HB
CC,GO:0031674,I band,1.3491303217330615,5,0.31296584796428356,0.6582806492273909,PSEN2/PAK1/MTM1/PDE4B/PARVA
BP,GO:0000281,mitotic cytokinesis,1.5284069202641488,3,0.31307354034396434,0.7621722726387863,VPS4A/NUP62/CHMP1B
BP,GO:0050688,regulation of defense response to virus,1.5284069202641488,3,0.31307354034396434,0.7621722726387863,DTX3L/TRIM44/ZCCHC3
BP,GO:0060350,endochondral bone morphogenesis,1.5284069202641488,3,0.31307354034396434,0.7621722726387863,IMPAD1/INPPL1/SCARA3
BP,GO:1901983,regulation of protein acetylation,1.5284069202641488,3,0.31307354034396434,0.7621722726387863,RPS6KA4/PRKAA2/PYGO2
BP,GO:0061448,connective tissue development,1.2260846722998118,9,0.314314986932237,0.7621722726387863,IMPAD1/DYRK1B/TGFBR1/ACTA2/PIK3CA/CDK4/SCARA3/TAPT1/TBL1XR1
BP,GO:0048705,skeletal system morphogenesis,1.2448948973978562,8,0.31476221729995424,0.7621722726387863,CYP26B1/IMPAD1/TGFBR1/PLEKHA1/ACVR2B/MTHFD1L/INPPL1/SCARA3
CC,GO:0030670,phagocytic vesicle membrane,1.5230971263775877,3,0.3149606182262142,0.6582806492273909,RAB7A/VAMP7/APPL2
CC,GO:0070603,SWI/SNF superfamily-type complex,1.5230971263775877,3,0.3149606182262142,0.6582806492273909,RBBP7/INO80/RBBP4
CC,GO:0044452,nucleolar part,1.3006222652213109,6,0.3152923760716675,0.6582806492273909,SAMD4A/SESN1/CD3EAP/WDR33/BTRC/B3GNT9
CC,GO:0098562,cytoplasmic side of membrane,1.3006222652213109,6,0.3152923760716675,0.6582806492273909,CYTH1/STAC/YES1/EPM2AIP1/CBX6/PTPN1
BP,GO:0051262,protein tetramerization,1.2973686648753822,6,0.31728483045672895,0.7621722726387863,HSD17B10/TRPM7/SBF2/APPL2/PCBD1/RCC1
BP,GO:0000463,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",2.6565167899829256,1,0.31731442316574654,0.7621722726387863,ZNHIT6
BP,GO:0003128,heart field specification,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,RBPJ
BP,GO:0003214,cardiac left ventricle morphogenesis,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,RBPJ
BP,GO:0006244,pyrimidine nucleotide catabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,MBD4
BP,GO:0006684,sphingomyelin metabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,SGMS2
BP,GO:0006896,Golgi to vacuole transport,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,RBSN
BP,GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,BAX
BP,GO:0010421,hydrogen peroxide-mediated programmed cell death,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,MET
BP,GO:0010917,negative regulation of mitochondrial membrane potential,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,BAX
BP,GO:0014819,regulation of skeletal muscle contraction,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,C12orf57
BP,GO:0020027,hemoglobin metabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,LDB1
BP,GO:0021692,cerebellar Purkinje cell layer morphogenesis,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,LDB1
BP,GO:0030207,chondroitin sulfate catabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,IDUA
BP,GO:0030213,hyaluronan biosynthetic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,HAS3
BP,GO:0032048,cardiolipin metabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,PTPMT1
BP,GO:0034331,cell junction maintenance,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,RASSF8
BP,GO:0035020,regulation of Rac protein signal transduction,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,ALS2
BP,GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,ASXL2
BP,GO:0035791,platelet-derived growth factor receptor-beta signaling pathway,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,PTPN1
BP,GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,PIK3CA
BP,GO:0036295,cellular response to increased oxygen levels,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,TMEM199
BP,GO:0040034,"regulation of development, heterochronic",2.6565167899829256,1,0.31731442316574654,0.7621722726387863,RBPJ
BP,GO:0042574,retinal metabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,AKR1C3
BP,GO:0044090,positive regulation of vacuole organization,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,PIP4K2A
BP,GO:0045591,positive regulation of regulatory T cell differentiation,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,DUSP10
BP,GO:0046037,GMP metabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,CARD11
BP,GO:0046341,CDP-diacylglycerol metabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,CDS1
BP,GO:0046479,glycosphingolipid catabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,GBA
BP,GO:0046940,nucleoside monophosphate phosphorylation,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,CMPK1
BP,GO:0060009,Sertoli cell development,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,SDC1
BP,GO:0060211,regulation of nuclear-transcribed mRNA poly(A) tail shortening,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,CNOT7
BP,GO:0060397,JAK-STAT cascade involved in growth hormone signaling pathway,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,PTPN1
BP,GO:0060911,cardiac cell fate commitment,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,RBPJ
BP,GO:0070307,lens fiber cell development,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,FRS2
BP,GO:0071361,cellular response to ethanol,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,ADCY7
BP,GO:0071941,nitrogen cycle metabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,ARG2
BP,GO:0090069,regulation of ribosome biogenesis,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,TRMT112
BP,GO:0097202,activation of cysteine-type endopeptidase activity,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,ASPH
BP,GO:0097468,programmed cell death in response to reactive oxygen species,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,MET
BP,GO:0099171,presynaptic modulation of chemical synaptic transmission,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,CDK5
BP,GO:0099188,postsynaptic cytoskeleton organization,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,ACTG1
BP,GO:1901213,regulation of transcription from RNA polymerase II promoter involved in heart development,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,RBPJ
BP,GO:1903351,cellular response to dopamine,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,GABPA
BP,GO:1903624,regulation of DNA catabolic process,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,BAX
BP,GO:1904152,"regulation of retrograde protein transport, ER to cytosol",2.6565167899829256,1,0.31731442316574654,0.7621722726387863,EDEM1
BP,GO:1904889,regulation of excitatory synapse assembly,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,IL1RAP
BP,GO:1904923,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,2.6565167899829256,1,0.31731442316574654,0.7621722726387863,GBA
BP,GO:0001101,response to acid chemical,1.1927218240739665,11,0.3184878028399211,0.7621722726387863,CYP26B1/GCLM/SESN1/GNPAT/CDK4/PRKAA2/CLDN1/NSMF/TOMM20/YES1/AKR1C3
BP,GO:0006109,regulation of carbohydrate metabolic process,1.2637798321277995,7,0.31865003331087544,0.7621722726387863,PRKAG2/ARNT/PRKAA2/NUPR1/EPM2AIP1/ENTPD5/NUP62
BP,GO:0002831,regulation of response to biotic stimulus,1.3378142107827682,5,0.31909575696468323,0.7621722726387863,ARG2/MAPKBP1/DTX3L/TRIM44/ZCCHC3
BP,GO:0035304,regulation of protein dephosphorylation,1.3378142107827682,5,0.31909575696468323,0.7621722726387863,BOD1/NSMF/PPP1R14A/GBA/PPP1R14C
BP,GO:0045580,regulation of T cell differentiation,1.3378142107827682,5,0.31909575696468323,0.7621722726387863,CYP26B1/RC3H2/DUSP10/IL7R/CARD11
BP,GO:0051588,regulation of neurotransmitter transport,1.3378142107827682,5,0.31909575696468323,0.7621722726387863,SNX4/VAMP7/SNAPIN/ADCY1/CDK5
BP,GO:0043414,macromolecule methylation,1.2035998401217138,10,0.32029597050221476,0.7621722726387863,METTL22/HSD17B10/TRMT2A/KDM3A/PIK3CA/RTF1/PRMT2/PYGO2/TRMT112/TRMT2B
BP,GO:0006081,cellular aldehyde metabolic process,1.5077527726930118,3,0.3204644145290799,0.7621722726387863,KDM3A/ALDH4A1/AKR1C3
BP,GO:0032507,maintenance of protein location in cell,1.5077527726930118,3,0.3204644145290799,0.7621722726387863,HNRNPU/CDK5/TAPT1
CC,GO:0015030,Cajal body,1.5033166442168397,3,0.32208127784266954,0.6582806492273909,ELL/EAF1/HMBOX1
CC,GO:0044215,other organism,1.5033166442168397,3,0.32208127784266954,0.6582806492273909,NMT2/CNOT7/NUP62
CC,GO:0044216,other organism cell,1.5033166442168397,3,0.32208127784266954,0.6582806492273909,NMT2/CNOT7/NUP62
CC,GO:0044217,other organism part,1.5033166442168397,3,0.32208127784266954,0.6582806492273909,NMT2/CNOT7/NUP62
BP,GO:0000413,protein peptidyl-prolyl isomerization,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,PPIE/FKBP9
BP,GO:0001953,negative regulation of cell-matrix adhesion,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,CLASP2/APOD
BP,GO:0003009,skeletal muscle contraction,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,C12orf57/STAC
BP,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,MCL1/P4HB
BP,GO:0009163,nucleoside biosynthetic process,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,CMPK1/TK2
BP,GO:0010824,regulation of centrosome duplication,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,NUP62/CHMP1B
BP,GO:0021762,substantia nigra development,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,SUDS3/MAPKAP1
BP,GO:0030866,cortical actin cytoskeleton organization,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,VPS4A/CDK5
BP,GO:0032459,regulation of protein oligomerization,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,BAX/GBA
BP,GO:0034198,cellular response to amino acid starvation,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,SESN1/CDKN1A
BP,GO:0038202,TORC1 signaling,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,SESN1/CARD11
BP,GO:0046460,neutral lipid biosynthetic process,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,LPIN3/FITM2
BP,GO:0046463,acylglycerol biosynthetic process,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,LPIN3/FITM2
BP,GO:0051602,response to electrical stimulus,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,NSMF/CYFIP1
BP,GO:0055026,negative regulation of cardiac muscle tissue development,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,PAK1/FRS2
BP,GO:1901985,positive regulation of protein acetylation,1.7298248865005097,2,0.3222975837910259,0.7621722726387863,RPS6KA4/PRKAA2
MF,GO:0003755,peptidyl-prolyl cis-trans isomerase activity,1.7265365853658536,2,0.3231490630066043,0.7093548555614949,PPIE/FKBP9
MF,GO:0004520,endodeoxyribonuclease activity,1.7265365853658536,2,0.3231490630066043,0.7093548555614949,MBD4/ERCC5
MF,GO:0051539,"4 iron, 4 sulfur cluster binding",1.7265365853658536,2,0.3231490630066043,0.7093548555614949,NUBP2/ISCU
MF,GO:0051879,Hsp90 protein binding,1.7265365853658536,2,0.3231490630066043,0.7093548555614949,CDK5/NUP62
BP,GO:0001837,epithelial to mesenchymal transition,1.3282583949914628,5,0.3243947239210153,0.7621722726387863,TGFBR1/CLASP2/SDHAF2/RBPJ/PDCD6
MF,GO:0070491,repressing transcription factor binding,1.4955211267605635,3,0.32493709946506644,0.7093548555614949,CBX5/TBP/RBPJ
MF,GO:0061659,ubiquitin-like protein ligase activity,1.231095652173913,8,0.325403619755104,0.7093548555614949,NEDD4/CHFR/FBXO30/ZMIZ2/FBXL12/MED21/RNF180/BTRC
CC,GO:0000124,SAGA complex,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,TADA3
CC,GO:0005639,integral component of nuclear inner membrane,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,LBR
CC,GO:0005662,DNA replication factor A complex,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,ERCC5
CC,GO:0005665,"RNA polymerase II, core complex",2.5723418134377036,1,0.32565870359629356,0.6582806492273909,POLR2J3
CC,GO:0030126,COPI vesicle coat,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,COPE
CC,GO:0030127,COPII vesicle coat,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,PDCD6
CC,GO:0031011,Ino80 complex,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,INO80
CC,GO:0031229,intrinsic component of nuclear inner membrane,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,LBR
CC,GO:0031616,spindle pole centrosome,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,NUBP2
CC,GO:0033202,DNA helicase complex,2.5723418134377036,1,0.32565870359629356,0.6582806492273909,INO80
MF,GO:0004620,phospholipase activity,1.3880000000000001,4,0.32582348840210335,0.7093548555614949,DDHD2/PLA2G3/DDHD1/PLCD4
CC,GO:0030119,AP-type membrane coat adaptor complex,1.7148945422918027,2,0.3259815882930266,0.6582806492273909,AP5M1/AP4E1
BP,GO:0050792,regulation of viral process,1.2516281029727245,7,0.32730091344838624,0.7621722726387863,PKN2/RAB7A/PPIE/VPS4A/BANF1/P4HB/CNOT7
BP,GO:0003281,ventricular septum development,1.4876494023904383,3,0.32785675705007755,0.7621722726387863,TGFBR1/FRS2/RBPJ
BP,GO:0006695,cholesterol biosynthetic process,1.4876494023904383,3,0.32785675705007755,0.7621722726387863,MBTPS1/LBR/PRKAA2
MF,GO:0070851,growth factor receptor binding,1.3206716417910447,5,0.3286305683972464,0.7093548555614949,SNX1/SNX4/FRS2/YES1/IL1RAP
BP,GO:0045089,positive regulation of innate immune response,1.1713774821971956,12,0.3291576811565592,0.7621722726387863,TAB1/POLR3F/MAP3K7/APPL2/BCL10/PAK1/BTRC/TNIP2/POLR3C/CARD9/CARD11/ZCCHC3
CC,GO:0000792,heterochromatin,1.4840433539063675,3,0.3292027302549003,0.6602633055694179,CBX5/CBX1/CBX6
BP,GO:0022618,ribonucleoprotein complex assembly,1.2083794784759878,9,0.3292541197662321,0.7621722726387863,CIRBP/CNOT6/ZNHIT6/AGO4/RSL24D1/G3BP2/CELF1/PRKAA2/CNOT7
BP,GO:0008286,insulin receptor signaling pathway,1.3188381226865586,5,0.329703237125872,0.7621722726387863,CCND3/PIK3CA/CDK4/PAK1/PTPN1
MF,GO:0005338,nucleotide-sugar transmembrane transporter activity,2.528142857142857,1,0.3306124940635301,0.7093548555614949,SLC35E3
MF,GO:0015926,glucosidase activity,2.528142857142857,1,0.3306124940635301,0.7093548555614949,GBA
MF,GO:0016290,palmitoyl-CoA hydrolase activity,2.528142857142857,1,0.3306124940635301,0.7093548555614949,GNPAT
MF,GO:0019104,DNA N-glycosylase activity,2.528142857142857,1,0.3306124940635301,0.7093548555614949,MBD4
MF,GO:0052745,inositol phosphate phosphatase activity,2.528142857142857,1,0.3306124940635301,0.7093548555614949,IMPAD1
MF,GO:0098847,sequence-specific single stranded DNA binding,2.528142857142857,1,0.3306124940635301,0.7093548555614949,TERF2
BP,GO:0006275,regulation of DNA replication,1.3774531503615168,4,0.3308603085096188,0.7621722726387863,STAG2/INO80/TERF2/TSPYL2
BP,GO:1904659,glucose transmembrane transport,1.3774531503615168,4,0.3308603085096188,0.7621722726387863,PRKAG2/APPL2/CAPN10/YES1
BP,GO:0120032,regulation of plasma membrane bounded cell projection assembly,1.2751280591918042,6,0.33151923302033465,0.7621722726387863,CDKL1/TGFBR1/WRAP73/FNBP1L/TAPT1/CYFIP1
BP,GO:0003197,endocardial cushion development,1.690510684534589,2,0.33220554410212566,0.7621722726387863,TGFBR1/RBPJ
BP,GO:0006378,mRNA polyadenylation,1.690510684534589,2,0.33220554410212566,0.7621722726387863,PAPOLA/WDR33
BP,GO:0034080,CENP-A containing nucleosome assembly,1.690510684534589,2,0.33220554410212566,0.7621722726387863,RBBP7/RBBP4
BP,GO:0034105,positive regulation of tissue remodeling,1.690510684534589,2,0.33220554410212566,0.7621722726387863,BAX/VDR
BP,GO:0035307,positive regulation of protein dephosphorylation,1.690510684534589,2,0.33220554410212566,0.7621722726387863,NSMF/GBA
BP,GO:0044331,cell-cell adhesion mediated by cadherin,1.690510684534589,2,0.33220554410212566,0.7621722726387863,CDH20/DENND6A
BP,GO:0046189,phenol-containing compound biosynthetic process,1.690510684534589,2,0.33220554410212566,0.7621722726387863,CTNS/MYO5A
BP,GO:0050654,chondroitin sulfate proteoglycan metabolic process,1.690510684534589,2,0.33220554410212566,0.7621722726387863,IMPAD1/IDUA
BP,GO:0051489,regulation of filopodium assembly,1.690510684534589,2,0.33220554410212566,0.7621722726387863,TGFBR1/FNBP1L
BP,GO:0060412,ventricular septum morphogenesis,1.690510684534589,2,0.33220554410212566,0.7621722726387863,TGFBR1/RBPJ
BP,GO:0061641,CENP-A containing chromatin organization,1.690510684534589,2,0.33220554410212566,0.7621722726387863,RBBP7/RBBP4
BP,GO:0070266,necroptotic process,1.690510684534589,2,0.33220554410212566,0.7621722726387863,TRPM7/PYGL
BP,GO:0090311,regulation of protein deacetylation,1.690510684534589,2,0.33220554410212566,0.7621722726387863,PRKAA2/TADA3
BP,GO:0034332,adherens junction organization,1.309550530273273,5,0.33502019678055683,0.7621722726387863,CDH20/RASSF8/CLASP2/APOD/LDB1
BP,GO:0038127,ERBB signaling pathway,1.309550530273273,5,0.33502019678055683,0.7621722726387863,RAB7A/KIF16B/PIK3CA/RBPJ/NUP62
BP,GO:0070997,neuron death,1.175585016256812,11,0.3352127051553707,0.7621722726387863,GCLM/BAX/LANCL1/PIK3CA/EGLN3/MCL1/FOXQ1/CDK5/NSMF/NUPR1/GBA
BP,GO:0007492,endoderm development,1.468075068148459,3,0.3352478198040947,0.7621722726387863,KIF16B/RTF1/LDB1
BP,GO:0060411,cardiac septum morphogenesis,1.468075068148459,3,0.3352478198040947,0.7621722726387863,TGFBR1/RBPJ/PARVA
BP,GO:0061045,negative regulation of wound healing,1.468075068148459,3,0.3352478198040947,0.7621722726387863,CDKN1A/DUSP10/CLASP2
BP,GO:1902653,secondary alcohol biosynthetic process,1.468075068148459,3,0.3352478198040947,0.7621722726387863,MBTPS1/LBR/PRKAA2
BP,GO:0031346,positive regulation of cell projection organization,1.1652606285042597,12,0.3355556515438572,0.7621722726387863,SS18L2/ITGA6/NDRG4/ANKRD27/TGFBR1/WRAP73/VAMP7/FNBP1L/PAK1/ZFYVE27/TAPT1/CYFIP1
BP,GO:0001325,formation of extrachromosomal circular DNA,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,TERF2
BP,GO:0001711,endodermal cell fate commitment,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,RTF1
BP,GO:0006388,"tRNA splicing, via endonucleolytic cleavage and ligation",2.4794156706507304,1,0.33568428592147037,0.7621722726387863,TSEN34
BP,GO:0006491,N-glycan processing,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,MGAT4B
BP,GO:0006646,phosphatidylethanolamine biosynthetic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,LPIN3
BP,GO:0007351,tripartite regional subdivision,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,FRS2
BP,GO:0007638,mechanosensory behavior,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,STRBP
BP,GO:0008595,"anterior/posterior axis specification, embryo",2.4794156706507304,1,0.33568428592147037,0.7621722726387863,FRS2
BP,GO:0009109,coenzyme catabolic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,ALDH1L1
BP,GO:0010455,positive regulation of cell fate commitment,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,RBPJ
BP,GO:0010561,negative regulation of glycoprotein biosynthetic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,ITM2B
BP,GO:0015802,basic amino acid transport,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,SLC7A1
BP,GO:0018158,protein oxidation,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,SUMF1
BP,GO:0018216,peptidyl-arginine methylation,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,PRMT2
BP,GO:0019321,pentose metabolic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,DHDH
BP,GO:0030730,sequestering of triglyceride,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,FITM2
BP,GO:0030812,negative regulation of nucleotide catabolic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,NUPR1
BP,GO:0031054,pre-miRNA processing,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,AGO4
BP,GO:0032352,positive regulation of hormone metabolic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,ARNT
BP,GO:0032736,positive regulation of interleukin-13 production,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,IL1RAP
BP,GO:0034134,toll-like receptor 2 signaling pathway,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,TNIP2
BP,GO:0034310,primary alcohol catabolic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,AKR1C3
BP,GO:0034349,glial cell apoptotic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,CDK5
BP,GO:0036445,neuronal stem cell division,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,DOCK7
BP,GO:0042921,glucocorticoid receptor signaling pathway,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,NEDD4
BP,GO:0042983,amyloid precursor protein biosynthetic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,ITM2B
BP,GO:0042984,regulation of amyloid precursor protein biosynthetic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,ITM2B
BP,GO:0043508,negative regulation of JUN kinase activity,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,DUSP10
BP,GO:0043650,dicarboxylic acid biosynthetic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,MTHFD1L
BP,GO:0045837,negative regulation of membrane potential,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,BAX
BP,GO:0045838,positive regulation of membrane potential,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,CTNS
BP,GO:0046184,aldehyde biosynthetic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,KDM3A
BP,GO:0048569,post-embryonic animal organ development,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,BAX
BP,GO:0050961,detection of temperature stimulus involved in sensory perception,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,ANO1
BP,GO:0050965,detection of temperature stimulus involved in sensory perception of pain,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,ANO1
BP,GO:0051127,positive regulation of actin nucleation,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,CYFIP1
BP,GO:0051198,negative regulation of coenzyme metabolic process,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,NUPR1
BP,GO:0055057,neuroblast division,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,DOCK7
BP,GO:0055089,fatty acid homeostasis,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,PRKAA2
BP,GO:0060099,"regulation of phagocytosis, engulfment",2.4794156706507304,1,0.33568428592147037,0.7621722726387863,APPL2
BP,GO:0060841,venous blood vessel development,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,ACVR2B
BP,GO:0072148,epithelial cell fate commitment,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,RBPJ
BP,GO:0090656,t-circle formation,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,TERF2
BP,GO:0090737,telomere maintenance via telomere trimming,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,TERF2
BP,GO:1900029,positive regulation of ruffle assembly,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,CYFIP1
BP,GO:1900119,positive regulation of execution phase of apoptosis,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,BAX
BP,GO:1901841,regulation of high voltage-gated calcium channel activity,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,PDE4B
BP,GO:1902188,positive regulation of viral release from host cell,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,VPS4A
BP,GO:1903350,response to dopamine,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,GABPA
BP,GO:1903358,regulation of Golgi organization,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,RBSN
BP,GO:1905874,regulation of postsynaptic density organization,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,IL1RAP
BP,GO:2000402,negative regulation of lymphocyte migration,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,APOD
BP,GO:2001028,positive regulation of endothelial cell chemotaxis,2.4794156706507304,1,0.33568428592147037,0.7621722726387863,MET
BP,GO:0006323,DNA packaging,1.2397078353253652,7,0.3359880791415674,0.7621722726387863,RBBP7/ASF1A/HP1BP3/RBBP4/BANF1/SPTY2D1/TSPYL2
BP,GO:0009408,response to heat,1.2678830134009418,6,0.3362822568033925,0.7621722726387863,RBBP7/CDKN1A/ANO1/STAC/NUP62/PDCD6
BP,GO:0006289,nucleotide-excision repair,1.364815965495815,4,0.3369768557440837,0.7621722726387863,PPIE/GTF2H1/COPS5/ERCC5
BP,GO:0006493,protein O-linked glycosylation,1.364815965495815,4,0.3369768557440837,0.7621722726387863,DPM2/GALNT1/RFNG/POMK
BP,GO:0021761,limbic system development,1.364815965495815,4,0.3369768557440837,0.7621722726387863,PHLPP2/BAX/CDK6/CDK5
MF,GO:0050839,cell adhesion molecule binding,1.134877755511022,16,0.3377508754604691,0.7093548555614949,SNX1/PKN2/GOLGA3/ITGA6/MAPRE1/CDH20/EHD4/CAPZA1/PTPRB/MYO1B/FNBP1L/ANXA7/PKP3/P4HB/PTPN1/PARVA
BP,GO:0043010,camera-type eye development,1.184434237572005,10,0.3379648259650783,0.7621722726387863,CTNS/BAX/TGFBR1/C12orf57/ACVR2B/CDK4/PYGO2/FRS2/ZHX2/NHS
BP,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,1.1539046677252802,13,0.3386240924371214,0.7621722726387863,NEDD4/CHFR/KLHL42/FBXL12/EDEM1/RYBP/RCHY1/RNF180/BTRC/MTM1/CDC26/TBL1XR1/GBA
BP,GO:0034470,ncRNA processing,1.1622260956175299,12,0.3387642797037976,0.7621722726387863,HSD17B10/ZNHIT6/FCF1/WDR55/AGO4/BTRC/DUS2/TSEN34/TRMT112/SEPHS2/TRMT2B/C1D
BP,GO:0031056,regulation of histone modification,1.300392834257376,5,0.34034451365222956,0.7621722726387863,KDM3A/RTF1/RPS6KA4/PYGO2/TADA3
BP,GO:0043488,regulation of mRNA stability,1.2607198325342697,6,0.3410530731833387,0.7621722726387863,SAMD4A/CIRBP/CARHSP1/HNRNPU/HNRNPA0/YTHDF3
BP,GO:0060491,regulation of cell projection assembly,1.2607198325342697,6,0.3410530731833387,0.7621722726387863,CDKL1/TGFBR1/WRAP73/FNBP1L/TAPT1/CYFIP1
BP,GO:0002820,negative regulation of adaptive immune response,1.6529437804338203,2,0.34207176548603113,0.7621722726387863,RC3H2/IL7R
BP,GO:0044275,cellular carbohydrate catabolic process,1.6529437804338203,2,0.34207176548603113,0.7621722726387863,PGM1/PYGL
BP,GO:0048701,embryonic cranial skeleton morphogenesis,1.6529437804338203,2,0.34207176548603113,0.7621722726387863,TGFBR1/MTHFD1L
BP,GO:0071827,plasma lipoprotein particle organization,1.6529437804338203,2,0.34207176548603113,0.7621722726387863,PLAGL2/P4HB
BP,GO:0016575,histone deacetylation,1.4490091581725049,3,0.3426349290725439,0.7621722726387863,SUDS3/TADA3/TBL1XR1
BP,GO:0031397,negative regulation of protein ubiquitination,1.4490091581725049,3,0.3426349290725439,0.7621722726387863,DTX3L/CDK5/TRIM44
BP,GO:0032481,positive regulation of type I interferon production,1.4490091581725049,3,0.3426349290725439,0.7621722726387863,POLR3F/POLR3C/ZCCHC3
BP,GO:0061418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,1.4490091581725049,3,0.3426349290725439,0.7621722726387863,EGLN3/ARNT/RBPJ
BP,GO:0090502,"RNA phosphodiester bond hydrolysis, endonucleolytic",1.4490091581725049,3,0.3426349290725439,0.7621722726387863,SMG6/FCF1/TSEN34
BP,GO:1901224,positive regulation of NIK/NF-kappaB signaling,1.4490091581725049,3,0.3426349290725439,0.7621722726387863,RC3H2/MAP3K7/TRIM44
BP,GO:0061387,regulation of extent of cell growth,1.352408547627671,4,0.3430977584706765,0.7621722726387863,PAK1/ZFYVE27/CDK5/CYFIP1
CC,GO:0005852,eukaryotic translation initiation factor 3 complex,2.411570450097847,1,0.3431487250389026,0.6602633055694179,COPS5
CC,GO:0008278,cohesin complex,2.411570450097847,1,0.3431487250389026,0.6602633055694179,STAG2
CC,GO:0030479,actin cortical patch,2.411570450097847,1,0.3431487250389026,0.6602633055694179,CAPZA1
CC,GO:0033643,host cell part,2.411570450097847,1,0.3431487250389026,0.6602633055694179,CNOT7
CC,GO:0034045,phagophore assembly site membrane,2.411570450097847,1,0.3431487250389026,0.6602633055694179,RAB7A
CC,GO:0044453,nuclear membrane part,2.411570450097847,1,0.3431487250389026,0.6602633055694179,LBR
CC,GO:0061645,endocytic patch,2.411570450097847,1,0.3431487250389026,0.6602633055694179,CAPZA1
CC,GO:0071004,U2-type prespliceosome,2.411570450097847,1,0.3431487250389026,0.6602633055694179,LSM7
CC,GO:0071010,prespliceosome,2.411570450097847,1,0.3431487250389026,0.6602633055694179,LSM7
CC,GO:0071437,invadopodium,2.411570450097847,1,0.3431487250389026,0.6602633055694179,PAK1
CC,GO:0098799,outer mitochondrial membrane protein complex,2.411570450097847,1,0.3431487250389026,0.6602633055694179,TOMM20
CC,GO:0016528,sarcoplasm,1.4469422700587082,3,0.34343830289695254,0.6602633055694179,CALU/MTMR12/ASPH
BP,GO:0031503,protein-containing complex localization,1.1911783471097817,9,0.34432152220888856,0.7621722726387863,SMG6/THOC5/USP46/TERF2/WDR33/SNAPIN/HNRNPU/AGFG1/NUP62
BP,GO:0010631,epithelial cell migration,1.1655372810751297,11,0.3453302742441633,0.7621722726387863,PKN2/SRPX2/MET/TGFBR1/PIK3CA/STARD13/DUSP10/DOCK5/CLASP2/CSNK2B/PDCD6
BP,GO:0071322,cellular response to carbohydrate stimulus,1.2913623284639222,5,0.34567510949934277,0.7621722726387863,GCLM/PIK3CA/ANO1/MPC2/PRKAA2
BP,GO:0000086,G2/M transition of mitotic cell cycle,1.204574414891043,8,0.34689065210629766,0.7621722726387863,MAPRE1/CDKN1A/FBXL12/VPS4A/TAOK3/CDK4/CCNB3/BTRC
CC,GO:0044450,microtubule organizing center part,1.2514095308615856,6,0.347369517848832,0.6607637206969009,NUBP2/PLA2G3/CEP128/WRAP73/CEP85/PDE4B
CC,GO:0101002,ficolin-1-rich granule,1.2514095308615856,6,0.347369517848832,0.6607637206969009,PGM1/PPIE/PYGL/DIAPH1/CALML5/CSNK2B
MF,GO:0015171,amino acid transmembrane transporter activity,1.4348918918918918,3,0.3482420923537378,0.7093548555614949,CTNS/SLC36A1/SLC7A1
MF,GO:0030674,"protein binding, bridging",1.2491999999999999,6,0.3488271876602689,0.7093548555614949,CBX5/SH2D3A/TEX261/FRS2/CRADD/PDCD6
BP,GO:0022037,metencephalon development,1.3402246868382326,4,0.349221435131997,0.7621722726387863,GNPAT/PAK1/CDK5/LDB1
BP,GO:0035305,negative regulation of dephosphorylation,1.3402246868382326,4,0.349221435131997,0.7621722726387863,ELL/BOD1/PPP1R14A/PPP1R14C
BP,GO:1904019,epithelial cell apoptotic process,1.3402246868382326,4,0.349221435131997,0.7621722726387863,CAPN10/TNIP2/NUPR1/AKR1C3
MF,GO:0004559,alpha-mannosidase activity,2.3596,1,0.3495399245316766,0.7093548555614949,EDEM1
MF,GO:0004659,prenyltransferase activity,2.3596,1,0.3495399245316766,0.7093548555614949,UBIAD1
MF,GO:0008242,omega peptidase activity,2.3596,1,0.3495399245316766,0.7093548555614949,PGPEP1
MF,GO:0008252,nucleotidase activity,2.3596,1,0.3495399245316766,0.7093548555614949,IMPAD1
MF,GO:0015037,peptide disulfide oxidoreductase activity,2.3596,1,0.3495399245316766,0.7093548555614949,P4HB
MF,GO:0015269,calcium-activated potassium channel activity,2.3596,1,0.3495399245316766,0.7093548555614949,MTMR6
MF,GO:0016805,dipeptidase activity,2.3596,1,0.3495399245316766,0.7093548555614949,PM20D2
MF,GO:0019215,intermediate filament binding,2.3596,1,0.3495399245316766,0.7093548555614949,MTM1
MF,GO:0033549,MAP kinase phosphatase activity,2.3596,1,0.3495399245316766,0.7093548555614949,DUSP10
MF,GO:0072349,modified amino acid transmembrane transporter activity,2.3596,1,0.3495399245316766,0.7093548555614949,CTNS
BP,GO:0031016,pancreas development,1.4304321176831136,3,0.3500154854417553,0.7621722726387863,CDK6/MET/ACVR2B
BP,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,1.4304321176831136,3,0.3500154854417553,0.7621722726387863,SAFB2/PAK1/PRMT2
BP,GO:0042246,tissue regeneration,1.4304321176831136,3,0.3500154854417553,0.7621722726387863,CDKN1A/DUSP10/APOD
BP,GO:0055021,regulation of cardiac muscle tissue growth,1.4304321176831136,3,0.3500154854417553,0.7621722726387863,TGFBR1/PAK1/RBPJ
BP,GO:1903313,positive regulation of mRNA metabolic process,1.4304321176831136,3,0.3500154854417553,0.7621722726387863,CIRBP/YTHDF3/CNOT7
BP,GO:2000300,regulation of synaptic vesicle exocytosis,1.4304321176831136,3,0.3500154854417553,0.7621722726387863,SNAPIN/ADCY1/CDK5
CC,GO:0005811,lipid droplet,1.4290787852431688,3,0.35054772795059674,0.6607637206969009,RAB7A/LPCAT2/STARD13
BP,GO:0006479,protein methylation,1.2466335774221549,6,0.3506149546447158,0.7621722726387863,METTL22/KDM3A/RTF1/PRMT2/PYGO2/TRMT112
BP,GO:0008213,protein alkylation,1.2466335774221549,6,0.3506149546447158,0.7621722726387863,METTL22/KDM3A/RTF1/PRMT2/PYGO2/TRMT112
BP,GO:0071347,cellular response to interleukin-1,1.2466335774221549,6,0.3506149546447158,0.7621722726387863,TAB1/MAP3K7/RPS6KA4/BTRC/TNIP2/IL1RAP
BP,GO:0007612,learning,1.2824563813710674,5,0.3510109174773103,0.7621722726387863,CTNS/DDHD2/NDRG4/CDK5/RIN1
BP,GO:0005978,glycogen biosynthetic process,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,PGM1/EPM2AIP1
BP,GO:0006221,pyrimidine nucleotide biosynthetic process,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,CMPK1/CDS1
BP,GO:0006984,ER-nucleus signaling pathway,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,MBTPS1/PTPN1
BP,GO:0009250,glucan biosynthetic process,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,PGM1/EPM2AIP1
BP,GO:0030490,maturation of SSU-rRNA,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,FCF1/BTRC
BP,GO:0031648,protein destabilization,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,CHFR/BTRC
BP,GO:0043300,regulation of leukocyte degranulation,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,SNX4/VAMP7
BP,GO:0043330,response to exogenous dsRNA,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,CARD9/ZCCHC3
BP,GO:0043631,RNA polyadenylation,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,PAPOLA/WDR33
BP,GO:0099172,presynapse organization,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,SNAPIN/IL1RAP
BP,GO:1904036,negative regulation of epithelial cell apoptotic process,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,TNIP2/NUPR1
BP,GO:1990928,response to amino acid starvation,1.6170102199896068,2,0.35189133451134913,0.7621722726387863,SESN1/CDKN1A
BP,GO:0062012,regulation of small molecule metabolic process,1.134373182650661,14,0.35305606051691857,0.7621722726387863,PRKAG2/VDR/LPGAT1/ISCU/APPL2/MBTPS1/ARNT/PRKAA2/NUPR1/DNAJC30/EPM2AIP1/ENTPD5/AKR1C3/NUP62
BP,GO:0000394,"RNA splicing, via endonucleolytic cleavage and ligation",2.3244521912350598,1,0.3535608063432031,0.7621722726387863,TSEN34
BP,GO:0001780,neutrophil homeostasis,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,PDE4B
BP,GO:0002070,epithelial cell maturation,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,CDKN1A
BP,GO:0006004,fucose metabolic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,FUT1
BP,GO:0006086,acetyl-CoA biosynthetic process from pyruvate,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,MPC2
BP,GO:0006206,pyrimidine nucleobase metabolic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,CMPK1
BP,GO:0007567,parturition,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,LDOC1
BP,GO:0009130,pyrimidine nucleoside monophosphate biosynthetic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,CMPK1
BP,GO:0010225,response to UV-C,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,ERCC5
BP,GO:0010566,regulation of ketone biosynthetic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,AKR1C3
BP,GO:0015074,DNA integration,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,BANF1
BP,GO:0016114,terpenoid biosynthetic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,AKR1C3
BP,GO:0016540,protein autoprocessing,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,PIDD1
BP,GO:0019372,lipoxygenase pathway,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,PLA2G3
BP,GO:0019377,glycolipid catabolic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,GBA
BP,GO:0021542,dentate gyrus development,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,CDK6
BP,GO:0030952,establishment or maintenance of cytoskeleton polarity,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,MAPKAP1
BP,GO:0031958,corticosteroid receptor signaling pathway,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,NEDD4
BP,GO:0032354,response to follicle-stimulating hormone,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,GCLM
BP,GO:0034315,regulation of Arp2/3 complex-mediated actin nucleation,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,CYFIP1
BP,GO:0035970,peptidyl-threonine dephosphorylation,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,DUSP10
BP,GO:0042448,progesterone metabolic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,AKR1C3
BP,GO:0043174,nucleoside salvage,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,TK2
BP,GO:0045618,positive regulation of keratinocyte differentiation,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,VDR
BP,GO:0045623,negative regulation of T-helper cell differentiation,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,RC3H2
BP,GO:0045986,negative regulation of smooth muscle contraction,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,DOCK5
BP,GO:0046325,negative regulation of glucose import,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,APPL2
BP,GO:0046519,sphingoid metabolic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,GBA
BP,GO:0050655,dermatan sulfate proteoglycan metabolic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,IDUA
BP,GO:0051238,sequestering of metal ion,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,FTL
BP,GO:0051382,kinetochore assembly,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,TRAPPC12
BP,GO:0051444,negative regulation of ubiquitin-protein transferase activity,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,DTX3L
BP,GO:0051571,positive regulation of histone H3-K4 methylation,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,RTF1
BP,GO:0055119,relaxation of cardiac muscle,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,PDE4B
BP,GO:0070293,renal absorption,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,AKR1C3
BP,GO:0070863,positive regulation of protein exit from endoplasmic reticulum,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,EDEM1
BP,GO:0071380,cellular response to prostaglandin E stimulus,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,PRKAA2
BP,GO:0071786,endoplasmic reticulum tubular network organization,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,ZFYVE27
BP,GO:0071871,response to epinephrine,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,PDE4B
BP,GO:0072109,glomerular mesangium development,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,ACTA2
BP,GO:0080182,histone H3-K4 trimethylation,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,RTF1
BP,GO:0097067,cellular response to thyroid hormone stimulus,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,GCLM
BP,GO:0099116,tRNA 5'-end processing,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,HSD17B10
BP,GO:0099170,postsynaptic modulation of chemical synaptic transmission,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,CYFIP1
BP,GO:1900242,regulation of synaptic vesicle endocytosis,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,VAMP4
BP,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,TRIAP1
BP,GO:1903830,magnesium ion transmembrane transport,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,CNNM4
BP,GO:1904294,positive regulation of ERAD pathway,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,EDEM1
BP,GO:1905153,regulation of membrane invagination,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,APPL2
BP,GO:2001170,negative regulation of ATP biosynthetic process,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,NUPR1
BP,GO:2001224,positive regulation of neuron migration,2.3244521912350598,1,0.3535608063432031,0.7621722726387863,NSMF
CC,GO:0030863,cortical cytoskeleton,1.3305216276401914,4,0.3541806390834553,0.6607637206969009,MAPRE1/CAPZA1/NSMF/TPM4
MF,GO:0019213,deacetylase activity,1.608818181818182,2,0.35424407518567236,0.7093548555614949,SUDS3/AMDHD2
MF,GO:0050681,androgen receptor binding,1.608818181818182,2,0.35424407518567236,0.7093548555614949,KDM3A/PRMT2
MF,GO:1990939,ATP-dependent microtubule motor activity,1.608818181818182,2,0.35424407518567236,0.7093548555614949,KIF16B/DNAL4
MF,GO:0060090,molecular adaptor activity,1.1947341772151898,8,0.355099296984294,0.7093548555614949,CBX5/SH2D3A/ISCU/TEX261/WWC2/FRS2/CRADD/PDCD6
BP,GO:0008645,hexose transmembrane transport,1.3282583949914628,4,0.3553463308020579,0.7621722726387863,PRKAG2/APPL2/CAPN10/YES1
BP,GO:0031109,microtubule polymerization or depolymerization,1.3282583949914628,4,0.3553463308020579,0.7621722726387863,MAPRE1/MET/PAK1/CLASP2
BP,GO:0042303,molting cycle,1.3282583949914628,4,0.3553463308020579,0.7621722726387863,FOXQ1/RBPJ/MYO5A/LDB1
BP,GO:0042633,hair cycle,1.3282583949914628,4,0.3553463308020579,0.7621722726387863,FOXQ1/RBPJ/MYO5A/LDB1
BP,GO:0048593,camera-type eye morphogenesis,1.3282583949914628,4,0.3553463308020579,0.7621722726387863,BAX/C12orf57/FRS2/ZHX2
BP,GO:0060419,heart growth,1.3282583949914628,4,0.3553463308020579,0.7621722726387863,NDRG4/TGFBR1/PAK1/RBPJ
BP,GO:0090132,epithelium migration,1.1556598464897472,11,0.3555006563667909,0.7621722726387863,PKN2/SRPX2/MET/TGFBR1/PIK3CA/STARD13/DUSP10/DOCK5/CLASP2/CSNK2B/PDCD6
BP,GO:0002218,activation of innate immune response,1.1658694376100613,10,0.35580350167202063,0.7621722726387863,TAB1/MAP3K7/APPL2/BCL10/PAK1/BTRC/TNIP2/CARD9/CARD11/ZCCHC3
MF,GO:0048029,monosaccharide binding,1.41576,3,0.35599565310857006,0.7093548555614949,PYGL/EGLN3/SCARA3
BP,GO:0002224,toll-like receptor signaling pathway,1.2736724335534575,5,0.3563508825246918,0.7621722726387863,TAB1/MAP3K7/APPL2/BCL10/TNIP2
BP,GO:0042542,response to hydrogen peroxide,1.2736724335534575,5,0.3563508825246918,0.7621722726387863,PDE8A/MET/PLEKHA1/SDC1/STK26
BP,GO:0051384,response to glucocorticoid,1.2736724335534575,5,0.3563508825246918,0.7621722726387863,SDC1/CDKN1A/HNRNPU/CLDN1/GBA
BP,GO:0055072,iron ion homeostasis,1.412325382016239,3,0.3573869636230014,0.7621722726387863,FTL/ISCU/TMEM199
CC,GO:0000793,condensed chromosome,1.21119233368143,7,0.35761186240039894,0.6607637206969009,STAG2/BOD1/HNRNPU/CLASP2/BANF1/RCC1/PPP1CC
CC,GO:0098685,Schaffer collateral - CA1 synapse,1.4116509951792278,3,0.35764855520698824,0.6607637206969009,ADCY1/CDK5/ACTG1
BP,GO:0014706,striated muscle tissue development,1.144345694146491,12,0.3581359389174171,0.7621722726387863,CYP26B1/NDRG4/TGFBR1/ALPK3/PAK1/HNRNPU/CDK5/FRS2/RBPJ/MTM1/NUPR1/MYL6B
MF,GO:0004518,nuclease activity,1.2085756097560976,7,0.3596014343351341,0.7093548555614949,SMG6/CNOT6/MBD4/ERCC5/TSEN34/PGBD5/CNOT7
CC,GO:0005913,cell-cell adherens junction,1.319149647916771,4,0.3600809009787036,0.6607637206969009,ITGA6/CDH20/FRS2/PKP3
CC,GO:0000176,nuclear exosome (RNase complex),2.269713364797974,1,0.36018598210733177,0.6607637206969009,C1D
CC,GO:0005847,mRNA cleavage and polyadenylation specificity factor complex,2.269713364797974,1,0.36018598210733177,0.6607637206969009,WDR33
CC,GO:0016471,vacuolar proton-transporting V-type ATPase complex,2.269713364797974,1,0.36018598210733177,0.6607637206969009,TMEM199
CC,GO:0031143,pseudopodium,2.269713364797974,1,0.36018598210733177,0.6607637206969009,VAMP7
CC,GO:0035859,Seh1-associated complex,2.269713364797974,1,0.36018598210733177,0.6607637206969009,SESN1
CC,GO:0042622,photoreceptor outer segment membrane,2.269713364797974,1,0.36018598210733177,0.6607637206969009,PHLPP2
BP,GO:0043200,response to amino acid,1.3165038959207418,4,0.3614709176266747,0.7621722726387863,GCLM/SESN1/NSMF/TOMM20
BP,GO:0046620,regulation of organ growth,1.3165038959207418,4,0.3614709176266747,0.7621722726387863,TGFBR1/PAK1/WWC2/RBPJ
BP,GO:0002832,negative regulation of response to biotic stimulus,1.5826057472238704,2,0.3616596310638067,0.7621722726387863,ARG2/MAPKBP1
BP,GO:0021695,cerebellar cortex development,1.5826057472238704,2,0.3616596310638067,0.7621722726387863,CDK5/LDB1
BP,GO:0031952,regulation of protein autophosphorylation,1.5826057472238704,2,0.3616596310638067,0.7621722726387863,RAP2A/RAP2B
BP,GO:0035722,interleukin-12-mediated signaling pathway,1.5826057472238704,2,0.3616596310638067,0.7621722726387863,CAPZA1/P4HB
BP,GO:0061383,trabecula morphogenesis,1.5826057472238704,2,0.3616596310638067,0.7621722726387863,TGFBR1/RBPJ
BP,GO:1901659,glycosyl compound biosynthetic process,1.5826057472238704,2,0.3616596310638067,0.7621722726387863,CMPK1/TK2
BP,GO:0002262,myeloid cell homeostasis,1.2650079952299644,5,0.361693961730174,0.7621722726387863,BAX/CDK6/ARNT/PDE4B/LDB1
BP,GO:1901657,glycosyl compound metabolic process,1.2650079952299644,5,0.361693961730174,0.7621722726387863,CMPK1/TK2/GBA/AKR1C3/CARD11
MF,GO:0019903,protein phosphatase binding,1.2640714285714285,5,0.3622672124869804,0.7093548555614949,MTMR3/MET/BOD1/PPP1CC/PTPN1
MF,GO:0001046,core promoter sequence-specific DNA binding,1.5730666666666668,2,0.3645005228494499,0.7093548555614949,TBP/KDM3A
MF,GO:0016859,cis-trans isomerase activity,1.5730666666666668,2,0.3645005228494499,0.7093548555614949,PPIE/FKBP9
BP,GO:0048194,Golgi vesicle budding,1.394671314741036,3,0.36474691217872135,0.7621722726387863,MCFD2/MYO18A/PDCD6
BP,GO:0006338,chromatin remodeling,1.2260846722998118,6,0.3649968150838998,0.7621722726387863,RBBP7/ZMIZ2/INO80/PAK1/RBBP4/SPTY2D1
CC,GO:0000779,"condensed chromosome, centromeric region",1.3079704136123915,4,0.3659797923781034,0.6690367432596206,BOD1/HNRNPU/CLASP2/PPP1CC
MF,GO:0005096,GTPase activator activity,1.1668351648351647,9,0.3665515041896535,0.7093548555614949,TBC1D22B/RGS17/ANKRD27/STARD13/BNIP2/DOCK5/ARHGAP12/AGFG1/RIN1
BP,GO:0060348,bone development,1.1997172599922887,7,0.3666095160939253,0.7621722726387863,CYP26B1/PLS3/IMPAD1/PIP4K2A/INPPL1/SCARA3/TAPT1
BP,GO:0014065,phosphatidylinositol 3-kinase signaling,1.2564606439108432,5,0.36703912468065064,0.7621722726387863,NEDD4/PLEKHA1/PIK3CA/PIP4K2A/ENTPD5
BP,GO:0015749,monosaccharide transmembrane transport,1.3049556161319633,4,0.3675936952218154,0.7621722726387863,PRKAG2/APPL2/CAPN10/YES1
BP,GO:0042035,regulation of cytokine biosynthetic process,1.3049556161319633,4,0.3675936952218154,0.7621722726387863,MAST2/BCL10/CARD9/CARD11
BP,GO:0042752,regulation of circadian rhythm,1.3049556161319633,4,0.3675936952218154,0.7621722726387863,PRKAA2/ADCY1/BTRC/PPP1CC
BP,GO:0060349,bone morphogenesis,1.3049556161319633,4,0.3675936952218154,0.7621722726387863,CYP26B1/IMPAD1/INPPL1/SCARA3
MF,GO:0005525,GTP binding,1.1356363636363638,12,0.3678167209148687,0.7093548555614949,RAB7A/ARFRP1/EHD4/ARL1/RAP2A/RAB15/RIT1/IRGQ/RHEBL1/TUBAL3/RAP2B/RASL10B
MF,GO:0003756,protein disulfide isomerase activity,2.212125,1,0.36793320796873996,0.7093548555614949,P4HB
MF,GO:0004697,protein kinase C activity,2.212125,1,0.36793320796873996,0.7093548555614949,PKN2
MF,GO:0005149,interleukin-1 receptor binding,2.212125,1,0.36793320796873996,0.7093548555614949,IL1RAP
MF,GO:0005229,intracellular calcium activated chloride channel activity,2.212125,1,0.36793320796873996,0.7093548555614949,ANO1
MF,GO:0010181,FMN binding,2.212125,1,0.36793320796873996,0.7093548555614949,DUS2
MF,GO:0015095,magnesium ion transmembrane transporter activity,2.212125,1,0.36793320796873996,0.7093548555614949,CNNM4
MF,GO:0015923,mannosidase activity,2.212125,1,0.36793320796873996,0.7093548555614949,EDEM1
MF,GO:0016864,"intramolecular oxidoreductase activity, transposing S-S bonds",2.212125,1,0.36793320796873996,0.7093548555614949,P4HB
MF,GO:0016881,acid-amino acid ligase activity,2.212125,1,0.36793320796873996,0.7093548555614949,GCLM
MF,GO:0019211,phosphatase activator activity,2.212125,1,0.36793320796873996,0.7093548555614949,FRS2
MF,GO:0047498,calcium-dependent phospholipase A2 activity,2.212125,1,0.36793320796873996,0.7093548555614949,PLA2G3
MF,GO:0052742,phosphatidylinositol kinase activity,2.212125,1,0.36793320796873996,0.7093548555614949,PIK3CA
MF,GO:0061778,intracellular chloride channel activity,2.212125,1,0.36793320796873996,0.7093548555614949,ANO1
BP,GO:0051052,regulation of DNA metabolic process,1.1270071230230594,13,0.36961795265289654,0.7621722726387863,SMG6/BAX/STAG2/PIK3CA/CDKN1A/INO80/TERF2/HMBOX1/HNRNPU/DTX3L/RNF168/IL7R/TSPYL2
BP,GO:0000963,mitochondrial RNA processing,2.187719709397703,1,0.37095720793083675,0.7621722726387863,HSD17B10
BP,GO:0001522,pseudouridine synthesis,2.187719709397703,1,0.37095720793083675,0.7621722726387863,TRUB2
BP,GO:0006744,ubiquinone biosynthetic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,UBIAD1
BP,GO:0006750,glutathione biosynthetic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,GCLM
BP,GO:0006895,Golgi to endosome transport,2.187719709397703,1,0.37095720793083675,0.7621722726387863,KIF16B
BP,GO:0009070,serine family amino acid biosynthetic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,SEPHS2
BP,GO:0009129,pyrimidine nucleoside monophosphate metabolic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CMPK1
BP,GO:0010224,response to UV-B,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CDKN1A
BP,GO:0010715,regulation of extracellular matrix disassembly,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CLASP2
BP,GO:0014733,regulation of skeletal muscle adaptation,2.187719709397703,1,0.37095720793083675,0.7621722726387863,GTF2IRD2
BP,GO:0015693,magnesium ion transport,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CNNM4
BP,GO:0016246,RNA interference,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CELF1
BP,GO:0018027,peptidyl-lysine dimethylation,2.187719709397703,1,0.37095720793083675,0.7621722726387863,KDM3A
BP,GO:0030540,female genitalia development,2.187719709397703,1,0.37095720793083675,0.7621722726387863,BAX
BP,GO:0032460,negative regulation of protein oligomerization,2.187719709397703,1,0.37095720793083675,0.7621722726387863,GBA
BP,GO:0033145,positive regulation of intracellular steroid hormone receptor signaling pathway,2.187719709397703,1,0.37095720793083675,0.7621722726387863,PAK1
BP,GO:0034501,protein localization to kinetochore,2.187719709397703,1,0.37095720793083675,0.7621722726387863,TRAPPC12
BP,GO:0035313,"wound healing, spreading of epidermal cells",2.187719709397703,1,0.37095720793083675,0.7621722726387863,CLASP2
BP,GO:0035855,megakaryocyte development,2.187719709397703,1,0.37095720793083675,0.7621722726387863,PIP4K2A
BP,GO:0042753,positive regulation of circadian rhythm,2.187719709397703,1,0.37095720793083675,0.7621722726387863,BTRC
BP,GO:0042790,nucleolar large rRNA transcription by RNA polymerase I,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CD3EAP
BP,GO:0042994,cytoplasmic sequestering of transcription factor,2.187719709397703,1,0.37095720793083675,0.7621722726387863,G3BP2
BP,GO:0043649,dicarboxylic acid catabolic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,ALDH1L1
BP,GO:0045324,late endosome to vacuole transport,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CHMP1B
BP,GO:0045725,positive regulation of glycogen biosynthetic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,EPM2AIP1
BP,GO:0048311,mitochondrion distribution,2.187719709397703,1,0.37095720793083675,0.7621722726387863,MTM1
BP,GO:0050665,hydrogen peroxide biosynthetic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CTNS
BP,GO:0051969,regulation of transmission of nerve impulse,2.187719709397703,1,0.37095720793083675,0.7621722726387863,GBA
BP,GO:0060263,regulation of respiratory burst,2.187719709397703,1,0.37095720793083675,0.7621722726387863,DUSP10
BP,GO:0061298,retina vasculature development in camera-type eye,2.187719709397703,1,0.37095720793083675,0.7621722726387863,ACVR2B
BP,GO:0061323,cell proliferation involved in heart morphogenesis,2.187719709397703,1,0.37095720793083675,0.7621722726387863,RBPJ
BP,GO:0062033,positive regulation of mitotic sister chromatid segregation,2.187719709397703,1,0.37095720793083675,0.7621722726387863,HNRNPU
BP,GO:0070166,enamel mineralization,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CNNM4
BP,GO:0070242,thymocyte apoptotic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,BAX
BP,GO:0070525,tRNA threonylcarbamoyladenosine metabolic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,HSD17B10
BP,GO:0071360,cellular response to exogenous dsRNA,2.187719709397703,1,0.37095720793083675,0.7621722726387863,ZCCHC3
BP,GO:0071850,mitotic cell cycle arrest,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CDKN1A
BP,GO:0072673,lamellipodium morphogenesis,2.187719709397703,1,0.37095720793083675,0.7621722726387863,SNX1
BP,GO:0097107,postsynaptic density assembly,2.187719709397703,1,0.37095720793083675,0.7621722726387863,IL1RAP
BP,GO:0098884,postsynaptic neurotransmitter receptor internalization,2.187719709397703,1,0.37095720793083675,0.7621722726387863,USP46
BP,GO:0099010,modification of postsynaptic structure,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CYFIP1
BP,GO:0099509,regulation of presynaptic cytosolic calcium ion concentration,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CDK5
BP,GO:0140239,postsynaptic endocytosis,2.187719709397703,1,0.37095720793083675,0.7621722726387863,USP46
BP,GO:1901663,quinone biosynthetic process,2.187719709397703,1,0.37095720793083675,0.7621722726387863,UBIAD1
BP,GO:1903209,positive regulation of oxidative stress-induced cell death,2.187719709397703,1,0.37095720793083675,0.7621722726387863,MCL1
BP,GO:1904380,endoplasmic reticulum mannose trimming,2.187719709397703,1,0.37095720793083675,0.7621722726387863,EDEM1
BP,GO:1905331,negative regulation of morphogenesis of an epithelium,2.187719709397703,1,0.37095720793083675,0.7621722726387863,CLASP2
BP,GO:2000001,regulation of DNA damage checkpoint,2.187719709397703,1,0.37095720793083675,0.7621722726387863,THOC5
BP,GO:2000136,regulation of cell proliferation involved in heart morphogenesis,2.187719709397703,1,0.37095720793083675,0.7621722726387863,RBPJ
BP,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,2.187719709397703,1,0.37095720793083675,0.7621722726387863,BAX
BP,GO:0002063,chondrocyte development,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,IMPAD1/SCARA3
BP,GO:0002711,positive regulation of T cell mediated immunity,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,MAP3K7/FAM49B
BP,GO:0002762,negative regulation of myeloid leukocyte differentiation,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,CDK6/TOB2
BP,GO:0007140,male meiotic nuclear division,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,CYP26B1/AGO4
BP,GO:0007528,neuromuscular junction development,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,ALS2/NEDD4
BP,GO:0009069,serine family amino acid metabolic process,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,GCLM/SEPHS2
BP,GO:0009311,oligosaccharide metabolic process,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,IDUA/ST6GALNAC6
BP,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,TGFBR1/CSNK2B
BP,GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,CDH20/PCDHB13
BP,GO:0030865,cortical cytoskeleton organization,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,VPS4A/CDK5
BP,GO:0031055,chromatin remodeling at centromere,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,RBBP7/RBBP4
BP,GO:0032648,regulation of interferon-beta production,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,POLR3F/POLR3C
BP,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,RAB7A/NUP62
BP,GO:0051972,regulation of telomerase activity,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,SMG6/HMBOX1
BP,GO:0055010,ventricular cardiac muscle tissue morphogenesis,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,TGFBR1/RBPJ
BP,GO:0060324,face development,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,PLEKHA1/ASPH
BP,GO:0061014,positive regulation of mRNA catabolic process,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,YTHDF3/CNOT7
BP,GO:0090199,regulation of release of cytochrome c from mitochondria,1.5496347941567066,2,0.37137231617939437,0.7621722726387863,BAX/TRIAP1
BP,GO:0007045,cell-substrate adherens junction assembly,1.3774531503615168,3,0.37209295316141333,0.7621722726387863,CLASP2/APOD/LDB1
BP,GO:0014855,striated muscle cell proliferation,1.3774531503615168,3,0.37209295316141333,0.7621722726387863,NDRG4/TGFBR1/RBPJ
BP,GO:0021766,hippocampus development,1.3774531503615168,3,0.37209295316141333,0.7621722726387863,PHLPP2/CDK6/CDK5
BP,GO:0048041,focal adhesion assembly,1.3774531503615168,3,0.37209295316141333,0.7621722726387863,CLASP2/APOD/LDB1
BP,GO:2001021,negative regulation of response to DNA damage stimulus,1.3774531503615168,3,0.37209295316141333,0.7621722726387863,THOC5/TERF2/TRIAP1
CC,GO:0014704,intercalated disc,1.5434050880626224,2,0.37319375588304793,0.6751178708856527,PAK1/TMEM65
CC,GO:0034707,chloride channel complex,1.5434050880626224,2,0.37319375588304793,0.6751178708856527,CLCC1/ANO1
CC,GO:0071005,U2-type precatalytic spliceosome,1.5434050880626224,2,0.37319375588304793,0.6751178708856527,LSM7/BUD13
BP,GO:0006023,aminoglycan biosynthetic process,1.2936081759916855,4,0.3737131910312791,0.7647209562953942,B4GALT7/HAS3/SDC1/B3GNT9
BP,GO:1904375,regulation of protein localization to cell periphery,1.2936081759916855,4,0.3737131910312791,0.7647209562953942,VPS4A/STAC/LZTFL1/CDK5
BP,GO:0042098,T cell proliferation,1.2127576649922052,6,0.3746018830902912,0.7657690755835701,RC3H2/ARG2/BAX/ELF4/CCND3/CARD11
BP,GO:0043409,negative regulation of MAPK cascade,1.2127576649922052,6,0.3746018830902912,0.7657690755835701,ZMYND11/TAOK3/DUSP10/GBA/PTPN1/NUP62
MF,GO:0005048,signal sequence binding,1.5388695652173912,2,0.3746941393918707,0.7093548555614949,TOMM20/KPNA5
BP,GO:0048608,reproductive structure development,1.121777391593718,13,0.3758682855393928,0.7679719666369913,BAX/TGFBR1/PLEKHA1/VDR/SDC1/SAFB2/AGO4/ARNT/FRS2/RBPJ/NUPR1/LDOC1/AKR1C3
CC,GO:0005859,muscle myosin complex,2.143618177864753,1,0.37678217312982665,0.6792509072686495,MYL6B
MF,GO:0016407,acetyltransferase activity,1.2870545454545455,4,0.3773095718594537,0.7093548555614949,LPCAT2/KANSL3/GNPAT/TADA3
BP,GO:0034502,protein localization to chromosome,1.3606549412107667,3,0.37942278167135157,0.7697179093856313,TERF2/BOD1/TRAPPC12
BP,GO:0051279,regulation of release of sequestered calcium ion into cytosol,1.3606549412107667,3,0.37942278167135157,0.7697179093856313,BAX/DIAPH1/MYO5A
BP,GO:0034219,carbohydrate transmembrane transport,1.2824563813710674,4,0.3798279606450824,0.7697179093856313,PRKAG2/APPL2/CAPN10/YES1
BP,GO:0070252,actin-mediated cell contraction,1.2824563813710674,4,0.3798279606450824,0.7697179093856313,TPM4/PDE4B/MYL6B/PARVA
BP,GO:2000736,regulation of stem cell differentiation,1.2824563813710674,4,0.3798279606450824,0.7697179093856313,CDK6/KDM3A/HNRNPU/LDB1
BP,GO:0042326,negative regulation of phosphorylation,1.1125583137535329,14,0.3800178143654511,0.7697179093856313,ZMYND11/BAX/PRKAG2/PRKAR2A/CDKN1A/CEP85/TAOK3/DUSP10/HNRNPU/DUS2/NUPR1/GBA/PTPN1/NUP62
BP,GO:0001913,T cell mediated cytotoxicity,1.5180095942759575,2,0.38102532031760716,0.7697179093856313,FAM49B/IL7R
BP,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,1.5180095942759575,2,0.38102532031760716,0.7697179093856313,ZMYND11/MAPKBP1
BP,GO:0051205,protein insertion into membrane,1.5180095942759575,2,0.38102532031760716,0.7697179093856313,BAX/RTP4
BP,GO:0061912,selective autophagy,1.5180095942759575,2,0.38102532031760716,0.7697179093856313,RAB7A/WDFY3
BP,GO:0071349,cellular response to interleukin-12,1.5180095942759575,2,0.38102532031760716,0.7697179093856313,CAPZA1/P4HB
BP,GO:0071825,protein-lipid complex subunit organization,1.5180095942759575,2,0.38102532031760716,0.7697179093856313,PLAGL2/P4HB
MF,GO:0032550,purine ribonucleoside binding,1.1236190476190475,12,0.3815480731475404,0.7093548555614949,RAB7A/ARFRP1/EHD4/ARL1/RAP2A/RAB15/RIT1/IRGQ/RHEBL1/TUBAL3/RAP2B/RASL10B
BP,GO:0071826,ribonucleoprotein complex subunit organization,1.150244383291576,9,0.38238789824632774,0.7697179093856313,CIRBP/CNOT6/ZNHIT6/AGO4/RSL24D1/G3BP2/CELF1/PRKAA2/CNOT7
CC,GO:0005782,peroxisomal matrix,1.5131422431986492,2,0.38248300797275814,0.6801148367024129,AGPS/GNPAT
CC,GO:0030286,dynein complex,1.5131422431986492,2,0.38248300797275814,0.6801148367024129,DNAL4/SNX4
CC,GO:0031907,microbody lumen,1.5131422431986492,2,0.38248300797275814,0.6801148367024129,AGPS/GNPAT
CC,GO:0071011,precatalytic spliceosome,1.5131422431986492,2,0.38248300797275814,0.6801148367024129,LSM7/BUD13
BP,GO:0001654,eye development,1.1301204023684268,11,0.3828230764082301,0.7697179093856313,CTNS/BAX/TGFBR1/C12orf57/ACVR2B/CDK4/PYGO2/FRS2/ZHX2/NHS/SMOC1
BP,GO:0030308,negative regulation of cell growth,1.199717259992289,6,0.38421372920203534,0.7697179093856313,RBBP7/CDKN1A/PAK1/CDK5/CRLF3/TSPYL2
BP,GO:0001503,ossification,1.121343770646059,12,0.38421743155303006,0.7697179093856313,IMPAD1/CDK6/ASF1A/ACVR2B/BMP2K/HNRNPU/INPPL1/TPM4/RBPJ/TAPT1/TOB2/SMOC1
BP,GO:0046677,response to antibiotic,1.1373466379131791,10,0.38459734019463504,0.7697179093856313,PDE8A/MET/PLEKHA1/USP46/SDC1/ADCY7/STK26/CLDN1/ADCY1/CLDN3
BP,GO:0071103,DNA conformation change,1.1373466379131791,10,0.38459734019463504,0.7697179093856313,RBBP7/GTF2H1/ASF1A/HP1BP3/INO80/RBBP4/RAD54L2/BANF1/SPTY2D1/TSPYL2
MF,GO:0004879,nuclear receptor activity,1.5061276595744681,2,0.3848202900152522,0.7093548555614949,VDR/ARNT
MF,GO:0008376,acetylgalactosaminyltransferase activity,1.5061276595744681,2,0.3848202900152522,0.7093548555614949,GALNT1/B3GNT9
MF,GO:0017069,snRNA binding,1.5061276595744681,2,0.3848202900152522,0.7093548555614949,LSM7/HNRNPU
MF,GO:0042887,amide transmembrane transporter activity,1.5061276595744681,2,0.3848202900152522,0.7093548555614949,MCL1/TOMM20
MF,GO:0098531,"transcription factor activity, direct ligand regulated sequence-specific DNA binding",1.5061276595744681,2,0.3848202900152522,0.7093548555614949,VDR/ARNT
BP,GO:0061458,reproductive system development,1.1140231699928398,13,0.38526814797963815,0.7697179093856313,BAX/TGFBR1/PLEKHA1/VDR/SDC1/SAFB2/AGO4/ARNT/FRS2/RBPJ/NUPR1/LDOC1/AKR1C3
MF,GO:0004549,tRNA-specific ribonuclease activity,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,TSEN34
MF,GO:0004551,nucleotide diphosphatase activity,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,NUDT15
MF,GO:0004724,magnesium-dependent protein serine/threonine phosphatase activity,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,TAB1
MF,GO:0005001,transmembrane receptor protein tyrosine phosphatase activity,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,PTPRB
MF,GO:0005123,death receptor binding,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,PIDD1
MF,GO:0008308,voltage-gated anion channel activity,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,ANO1
MF,GO:0010314,phosphatidylinositol-5-phosphate binding,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,SNX24
MF,GO:0019198,transmembrane receptor protein phosphatase activity,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,PTPRB
MF,GO:0030676,Rac guanyl-nucleotide exchange factor activity,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,ALS2
MF,GO:0035173,histone kinase activity,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,PRKAA2
MF,GO:0046965,retinoid X receptor binding,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,VDR
MF,GO:0050664,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor",2.0820000000000003,1,0.3858073890679785,0.7093548555614949,MICAL2
MF,GO:0050811,GABA receptor binding,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,GABARAP
MF,GO:0098918,structural constituent of synapse,2.0820000000000003,1,0.3858073890679785,0.7093548555614949,ACTG1
CC,GO:0035097,histone methyltransferase complex,1.345992809356938,3,0.3859230703345343,0.6838976858649402,CBX5/RBBP7/RBBP4
BP,GO:0051153,regulation of striated muscle cell differentiation,1.2714952157183232,4,0.38593658807987163,0.7697179093856313,CYP26B1/PAK1/FRS2/RBPJ
BP,GO:0006970,response to osmotic stress,1.344261508184131,3,0.38673416533899596,0.7697179093856313,BAX/ANXA7/CLDN1
BP,GO:1901879,regulation of protein depolymerization,1.344261508184131,3,0.38673416533899596,0.7697179093856313,CAPZA1/CLASP2/ASPH
MF,GO:0019199,transmembrane receptor protein kinase activity,1.3440759493670884,3,0.3868601412402428,0.709413715466936,MET/TGFBR1/ACVR2B
BP,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,2.066179725542275,1,0.3878863604327788,0.7697179093856313,IL7R
BP,GO:0003414,chondrocyte morphogenesis involved in endochondral bone morphogenesis,2.066179725542275,1,0.3878863604327788,0.7697179093856313,SCARA3
BP,GO:0003429,growth plate cartilage chondrocyte morphogenesis,2.066179725542275,1,0.3878863604327788,0.7697179093856313,SCARA3
BP,GO:0006607,NLS-bearing protein import into nucleus,2.066179725542275,1,0.3878863604327788,0.7697179093856313,KPNA5
BP,GO:0006743,ubiquinone metabolic process,2.066179725542275,1,0.3878863604327788,0.7697179093856313,UBIAD1
BP,GO:0007221,positive regulation of transcription of Notch receptor target,2.066179725542275,1,0.3878863604327788,0.7697179093856313,RBPJ
BP,GO:0007250,activation of NF-kappaB-inducing kinase activity,2.066179725542275,1,0.3878863604327788,0.7697179093856313,MAP3K7
BP,GO:0007252,I-kappaB phosphorylation,2.066179725542275,1,0.3878863604327788,0.7697179093856313,MAP3K7
BP,GO:0008090,retrograde axonal transport,2.066179725542275,1,0.3878863604327788,0.7697179093856313,SNAPIN
BP,GO:0009048,dosage compensation by inactivation of X chromosome,2.066179725542275,1,0.3878863604327788,0.7697179093856313,HNRNPU
BP,GO:0009200,deoxyribonucleoside triphosphate metabolic process,2.066179725542275,1,0.3878863604327788,0.7697179093856313,NUDT15
BP,GO:0009312,oligosaccharide biosynthetic process,2.066179725542275,1,0.3878863604327788,0.7697179093856313,ST6GALNAC6
BP,GO:0010766,negative regulation of sodium ion transport,2.066179725542275,1,0.3878863604327788,0.7697179093856313,NEDD4
BP,GO:0030809,negative regulation of nucleotide biosynthetic process,2.066179725542275,1,0.3878863604327788,0.7697179093856313,NUPR1
BP,GO:0039535,regulation of RIG-I signaling pathway,2.066179725542275,1,0.3878863604327788,0.7697179093856313,ZCCHC3
BP,GO:0043011,myeloid dendritic cell differentiation,2.066179725542275,1,0.3878863604327788,0.7697179093856313,RBPJ
BP,GO:0043555,regulation of translation in response to stress,2.066179725542275,1,0.3878863604327788,0.7697179093856313,RPS6KA1
BP,GO:0045653,negative regulation of megakaryocyte differentiation,2.066179725542275,1,0.3878863604327788,0.7697179093856313,GABPA
BP,GO:0051782,negative regulation of cell division,2.066179725542275,1,0.3878863604327788,0.7697179093856313,VPS4A
BP,GO:0060977,coronary vasculature morphogenesis,2.066179725542275,1,0.3878863604327788,0.7697179093856313,TGFBR1
BP,GO:0070230,positive regulation of lymphocyte apoptotic process,2.066179725542275,1,0.3878863604327788,0.7697179093856313,BAX
BP,GO:0070875,positive regulation of glycogen metabolic process,2.066179725542275,1,0.3878863604327788,0.7697179093856313,EPM2AIP1
BP,GO:0071605,monocyte chemotactic protein-1 production,2.066179725542275,1,0.3878863604327788,0.7697179093856313,APOD
BP,GO:0071625,vocalization behavior,2.066179725542275,1,0.3878863604327788,0.7697179093856313,SRPX2
BP,GO:0071637,regulation of monocyte chemotactic protein-1 production,2.066179725542275,1,0.3878863604327788,0.7697179093856313,APOD
BP,GO:0072574,hepatocyte proliferation,2.066179725542275,1,0.3878863604327788,0.7697179093856313,RPS6KA1
BP,GO:0072575,epithelial cell proliferation involved in liver morphogenesis,2.066179725542275,1,0.3878863604327788,0.7697179093856313,RPS6KA1
BP,GO:0090171,chondrocyte morphogenesis,2.066179725542275,1,0.3878863604327788,0.7697179093856313,SCARA3
BP,GO:0150078,positive regulation of neuroinflammatory response,2.066179725542275,1,0.3878863604327788,0.7697179093856313,NUPR1
BP,GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.066179725542275,1,0.3878863604327788,0.7697179093856313,CNOT7
BP,GO:1900372,negative regulation of purine nucleotide biosynthetic process,2.066179725542275,1,0.3878863604327788,0.7697179093856313,NUPR1
BP,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2.066179725542275,1,0.3878863604327788,0.7697179093856313,TRIAP1
BP,GO:1903019,negative regulation of glycoprotein metabolic process,2.066179725542275,1,0.3878863604327788,0.7697179093856313,ITM2B
BP,GO:1904262,negative regulation of TORC1 signaling,2.066179725542275,1,0.3878863604327788,0.7697179093856313,SESN1
BP,GO:2000047,regulation of cell-cell adhesion mediated by cadherin,2.066179725542275,1,0.3878863604327788,0.7697179093856313,DENND6A
BP,GO:2000319,regulation of T-helper 17 cell differentiation,2.066179725542275,1,0.3878863604327788,0.7697179093856313,RC3H2
BP,GO:2000479,regulation of cAMP-dependent protein kinase activity,2.066179725542275,1,0.3878863604327788,0.7697179093856313,PRKAR2A
BP,GO:0001678,cellular glucose homeostasis,1.2233958901237156,5,0.3884204610489189,0.7704019675997085,GCLM/PIK3CA/ANO1/MPC2/PRKAA2
BP,GO:0051146,striated muscle cell differentiation,1.1423928857947052,9,0.3900448214821017,0.7713694838932309,CYP26B1/DYRK1B/SDC1/ALPK3/PAK1/HNRNPU/FRS2/RBPJ/ACTG1
BP,GO:0072001,renal system development,1.1423928857947052,9,0.3900448214821017,0.7713694838932309,CYP26B1/ARG2/BAX/ITGA6/TGFBR1/ACTA2/ACVR2B/SDC1/PYGO2
BP,GO:0009948,anterior/posterior axis specification,1.4876494023904383,2,0.39061483205999403,0.7713694838932309,FRS2/LDB1
BP,GO:0032608,interferon-beta production,1.4876494023904383,2,0.39061483205999403,0.7713694838932309,POLR3F/POLR3C
BP,GO:0042398,cellular modified amino acid biosynthetic process,1.4876494023904383,2,0.39061483205999403,0.7713694838932309,GCLM/MTHFD1L
BP,GO:0045104,intermediate filament cytoskeleton organization,1.4876494023904383,2,0.39061483205999403,0.7713694838932309,MTM1/AGFG1
BP,GO:0060976,coronary vasculature development,1.4876494023904383,2,0.39061483205999403,0.7713694838932309,TAB1/TGFBR1
BP,GO:0070534,protein K63-linked ubiquitination,1.4876494023904383,2,0.39061483205999403,0.7713694838932309,NEDD4/RNF168
BP,GO:0070671,response to interleukin-12,1.4876494023904383,2,0.39061483205999403,0.7713694838932309,CAPZA1/P4HB
MF,GO:0001883,purine nucleoside binding,1.1147716535433072,12,0.39188189472593654,0.712656902291597,RAB7A/ARFRP1/EHD4/ARL1/RAP2A/RAB15/RIT1/IRGQ/RHEBL1/TUBAL3/RAP2B/RASL10B
CC,GO:0000145,exocyst,2.0307961685034503,1,0.3929486947568467,0.6939873558248038,EXOC2
MF,GO:0008017,microtubule binding,1.1510243902439026,8,0.3936835980366344,0.712656902291597,CAPN6/MAST2/KIF16B/MAPRE1/KIF13A/CLASP2/STRBP/GABARAP
BP,GO:0051453,regulation of intracellular pH,1.3282583949914628,3,0.39402494373765784,0.774585934090976,RAB7A/SNAPIN/TMEM199
BP,GO:0060420,regulation of heart growth,1.3282583949914628,3,0.39402494373765784,0.774585934090976,TGFBR1/PAK1/RBPJ
BP,GO:1902803,regulation of synaptic vesicle transport,1.3282583949914628,3,0.39402494373765784,0.774585934090976,SNAPIN/ADCY1/CDK5
MF,GO:0032549,ribonucleoside binding,1.1118534031413612,12,0.39533176127390524,0.712656902291597,RAB7A/ARFRP1/EHD4/ARL1/RAP2A/RAB15/RIT1/IRGQ/RHEBL1/TUBAL3/RAP2B/RASL10B
BP,GO:0001655,urogenital system development,1.1270071230230592,10,0.39544674170009375,0.774585934090976,CYP26B1/ARG2/BAX/ITGA6/TGFBR1/ACTA2/ACVR2B/SDC1/PYGO2/FRS2
BP,GO:0150063,visual system development,1.1177693597195917,11,0.3965612087936605,0.774585934090976,CTNS/BAX/TGFBR1/C12orf57/ACVR2B/CDK4/PYGO2/FRS2/ZHX2/NHS/SMOC1
BP,GO:0048511,rhythmic process,1.1346478492808427,9,0.3977092546060331,0.774585934090976,PLEKHA1/CDK4/HNRNPU/PRKAA2/ADCY1/CDK5/BTRC/NHLH2/PPP1CC
BP,GO:0001952,regulation of cell-matrix adhesion,1.250125548227259,4,0.3981298960395193,0.774585934090976,CDK6/CLASP2/APOD/LDB1
BP,GO:0007173,epidermal growth factor receptor signaling pathway,1.250125548227259,4,0.3981298960395193,0.774585934090976,RAB7A/KIF16B/PIK3CA/NUP62
BP,GO:0071214,cellular response to abiotic stimulus,1.123602267666494,10,0.39906694566291256,0.774585934090976,USP28/NEDD4/BAX/CDKN1A/INO80/BCL10/NMT2/NSMF/CRADD/TRIAP1
BP,GO:0104004,cellular response to environmental stimulus,1.123602267666494,10,0.39906694566291256,0.774585934090976,USP28/NEDD4/BAX/CDKN1A/INO80/BCL10/NMT2/NSMF/CRADD/TRIAP1
BP,GO:0090501,RNA phosphodiester bond hydrolysis,1.2075076318104208,5,0.3990978118958002,0.774585934090976,SMG6/CNOT6/FCF1/TSEN34/CNOT7
CC,GO:0001750,photoreceptor outer segment,1.3154020636897348,3,0.39995483677774823,0.7004307714051412,PHLPP2/PCDHB13/MYO5A
BP,GO:0000731,DNA synthesis involved in DNA repair,1.4584798062651356,2,0.40013728721968955,0.774585934090976,SPRTN/RCHY1
BP,GO:0006213,pyrimidine nucleoside metabolic process,1.4584798062651356,2,0.40013728721968955,0.774585934090976,CMPK1/TK2
BP,GO:0045103,intermediate filament-based process,1.4584798062651356,2,0.40013728721968955,0.774585934090976,MTM1/AGFG1
BP,GO:0048641,regulation of skeletal muscle tissue development,1.4584798062651356,2,0.40013728721968955,0.774585934090976,CYP26B1/MTM1
BP,GO:0051496,positive regulation of stress fiber assembly,1.4584798062651356,2,0.40013728721968955,0.774585934090976,TGFBR1/PAK1
BP,GO:0022407,regulation of cell-cell adhesion,1.1074313169159589,12,0.40061593591839384,0.774585934090976,RC3H2/ARG2/ITGA6/PIK3CA/BCL10/DUSP10/PAK1/FAM49B/IL7R/DENND6A/YES1/CARD11
BP,GO:0050772,positive regulation of axonogenesis,1.312631825638622,3,0.4012930277317175,0.774585934090976,PAK1/ZFYVE27/CYFIP1
BP,GO:0007160,cell-matrix adhesion,1.1570606463036741,7,0.40181843841191867,0.774585934090976,ITGA6/TRPM7/CDK6/CLASP2/CDK5/APOD/LDB1
BP,GO:0090150,establishment of protein localization to membrane,1.1202179234867757,10,0.4026884977401279,0.774585934090976,SEC62/BAX/ARFRP1/VAMP7/RTP4/KIF13A/PAK1/CDK5/MYO1C/ZDHHC18
MF,GO:0004540,ribonuclease activity,1.2418947368421054,4,0.4029608593464238,0.712656902291597,SMG6/CNOT6/TSEN34/CNOT7
MF,GO:0005416,amino acid:cation symporter activity,1.9663333333333335,1,0.40317708960338616,0.712656902291597,SLC36A1
MF,GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,1.9663333333333335,1,0.40317708960338616,0.712656902291597,GTF2H1
MF,GO:0031435,mitogen-activated protein kinase kinase kinase binding,1.9663333333333335,1,0.40317708960338616,0.712656902291597,MAP4K2
MF,GO:0035613,RNA stem-loop binding,1.9663333333333335,1,0.40317708960338616,0.712656902291597,RC3H2
MF,GO:0046527,glucosyltransferase activity,1.9663333333333335,1,0.40317708960338616,0.712656902291597,GBA
MF,GO:0070064,proline-rich region binding,1.9663333333333335,1,0.40317708960338616,0.712656902291597,NEDD4
BP,GO:0071248,cellular response to metal ion,1.1744600545187671,6,0.40343456645536,0.774585934090976,RASGRP2/ADCY7/PRKAA2/CLDN1/ADCY1/AKR1C3
BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.2397078353253652,4,0.40421188874954617,0.774585934090976,SMG6/DHX34/NBAS/PNRC2
BP,GO:0001573,ganglioside metabolic process,1.957433424197945,1,0.4043607892909571,0.774585934090976,ST6GALNAC6
BP,GO:0001832,blastocyst growth,1.957433424197945,1,0.4043607892909571,0.774585934090976,RTF1
BP,GO:0002710,negative regulation of T cell mediated immunity,1.957433424197945,1,0.4043607892909571,0.774585934090976,IL7R
BP,GO:0002726,positive regulation of T cell cytokine production,1.957433424197945,1,0.4043607892909571,0.774585934090976,MAP3K7
BP,GO:0003422,growth plate cartilage morphogenesis,1.957433424197945,1,0.4043607892909571,0.774585934090976,SCARA3
BP,GO:0006044,N-acetylglucosamine metabolic process,1.957433424197945,1,0.4043607892909571,0.774585934090976,AMDHD2
BP,GO:0006448,regulation of translational elongation,1.957433424197945,1,0.4043607892909571,0.774585934090976,EIF5A2
BP,GO:0006534,cysteine metabolic process,1.957433424197945,1,0.4043607892909571,0.774585934090976,GCLM
BP,GO:0007350,blastoderm segmentation,1.957433424197945,1,0.4043607892909571,0.774585934090976,FRS2
BP,GO:0007625,grooming behavior,1.957433424197945,1,0.4043607892909571,0.774585934090976,CTNS
BP,GO:0016048,detection of temperature stimulus,1.957433424197945,1,0.4043607892909571,0.774585934090976,ANO1
BP,GO:0019184,nonribosomal peptide biosynthetic process,1.957433424197945,1,0.4043607892909571,0.774585934090976,GCLM
BP,GO:0021533,cell differentiation in hindbrain,1.957433424197945,1,0.4043607892909571,0.774585934090976,LDB1
BP,GO:0030150,protein import into mitochondrial matrix,1.957433424197945,1,0.4043607892909571,0.774585934090976,TOMM20
BP,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,1.957433424197945,1,0.4043607892909571,0.774585934090976,ARNT
BP,GO:0032011,ARF protein signal transduction,1.957433424197945,1,0.4043607892909571,0.774585934090976,CYTH1
BP,GO:0032012,regulation of ARF protein signal transduction,1.957433424197945,1,0.4043607892909571,0.774585934090976,CYTH1
BP,GO:0032026,response to magnesium ion,1.957433424197945,1,0.4043607892909571,0.774585934090976,ENTPD6
BP,GO:0032288,myelin assembly,1.957433424197945,1,0.4043607892909571,0.774585934090976,GNPAT
BP,GO:0032700,negative regulation of interleukin-17 production,1.957433424197945,1,0.4043607892909571,0.774585934090976,ARG2
BP,GO:0033189,response to vitamin A,1.957433424197945,1,0.4043607892909571,0.774585934090976,CYP26B1
BP,GO:0034138,toll-like receptor 3 signaling pathway,1.957433424197945,1,0.4043607892909571,0.774585934090976,TNIP2
BP,GO:0034471,ncRNA 5'-end processing,1.957433424197945,1,0.4043607892909571,0.774585934090976,HSD17B10
BP,GO:0034755,iron ion transmembrane transport,1.957433424197945,1,0.4043607892909571,0.774585934090976,ISCU
BP,GO:0035269,protein O-linked mannosylation,1.957433424197945,1,0.4043607892909571,0.774585934090976,DPM2
BP,GO:0042693,muscle cell fate commitment,1.957433424197945,1,0.4043607892909571,0.774585934090976,RBPJ
BP,GO:0042789,mRNA transcription by RNA polymerase II,1.957433424197945,1,0.4043607892909571,0.774585934090976,ARNT
BP,GO:0045414,regulation of interleukin-8 biosynthetic process,1.957433424197945,1,0.4043607892909571,0.774585934090976,BCL10
BP,GO:0045947,negative regulation of translational initiation,1.957433424197945,1,0.4043607892909571,0.774585934090976,PAIP2
BP,GO:0060004,reflex,1.957433424197945,1,0.4043607892909571,0.774585934090976,USP46
BP,GO:0060252,positive regulation of glial cell proliferation,1.957433424197945,1,0.4043607892909571,0.774585934090976,PPP1CC
BP,GO:0060716,labyrinthine layer blood vessel development,1.957433424197945,1,0.4043607892909571,0.774585934090976,RBPJ
BP,GO:0060973,cell migration involved in heart development,1.957433424197945,1,0.4043607892909571,0.774585934090976,NDRG4
BP,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,1.957433424197945,1,0.4043607892909571,0.774585934090976,BCL10
BP,GO:0071243,cellular response to arsenic-containing substance,1.957433424197945,1,0.4043607892909571,0.774585934090976,MKNK2
BP,GO:0072576,liver morphogenesis,1.957433424197945,1,0.4043607892909571,0.774585934090976,RPS6KA1
BP,GO:0090201,negative regulation of release of cytochrome c from mitochondria,1.957433424197945,1,0.4043607892909571,0.774585934090976,TRIAP1
BP,GO:1900409,positive regulation of cellular response to oxidative stress,1.957433424197945,1,0.4043607892909571,0.774585934090976,MCL1
BP,GO:1902644,tertiary alcohol metabolic process,1.957433424197945,1,0.4043607892909571,0.774585934090976,AKR1C3
BP,GO:1905939,regulation of gonad development,1.957433424197945,1,0.4043607892909571,0.774585934090976,NUPR1
BP,GO:2000251,positive regulation of actin cytoskeleton reorganization,1.957433424197945,1,0.4043607892909571,0.774585934090976,CDK5
BP,GO:1903707,negative regulation of hemopoiesis,1.1997172599922887,5,0.4044298239944034,0.774585934090976,RC3H2/CDK6/GABPA/TOB2/LDB1
BP,GO:0006333,chromatin assembly or disassembly,1.1683110489977262,6,0.4082350559421565,0.7809802961361664,RBBP7/ASF1A/HP1BP3/RBBP4/SPTY2D1/TSPYL2
BP,GO:0003333,amino acid transmembrane transport,1.2973686648753822,3,0.40853639876542824,0.7809802961361664,SLC36A1/SLC7A1/PRAF2
BP,GO:0030101,natural killer cell activation,1.2973686648753822,3,0.40853639876542824,0.7809802961361664,ELF4/VAMP7/TOX
BP,GO:1903363,negative regulation of cellular protein catabolic process,1.2973686648753822,3,0.40853639876542824,0.7809802961361664,CSNK2A2/RYBP/MTM1
CC,GO:0005849,mRNA cleavage factor complex,1.9292563600782775,1,0.4086966497258405,0.7004307714051412,WDR33
CC,GO:0005868,cytoplasmic dynein complex,1.9292563600782775,1,0.4086966497258405,0.7004307714051412,SNX4
CC,GO:0031307,integral component of mitochondrial outer membrane,1.9292563600782775,1,0.4086966497258405,0.7004307714051412,TOMM20
CC,GO:0035145,exon-exon junction complex,1.9292563600782775,1,0.4086966497258405,0.7004307714051412,SMG6
CC,GO:0043186,P granule,1.9292563600782775,1,0.4086966497258405,0.7004307714051412,CARHSP1
CC,GO:0045277,respiratory chain complex IV,1.9292563600782775,1,0.4086966497258405,0.7004307714051412,C15orf48
CC,GO:0045495,pole plasm,1.9292563600782775,1,0.4086966497258405,0.7004307714051412,CARHSP1
CC,GO:0060293,germ plasm,1.9292563600782775,1,0.4086966497258405,0.7004307714051412,CARHSP1
BP,GO:0006998,nuclear envelope organization,1.4304321176831136,2,0.40958935834806753,0.7822093233349344,VPS4A/BANF1
BP,GO:0009620,response to fungus,1.4304321176831136,2,0.40958935834806753,0.7822093233349344,BCL10/CARD9
BP,GO:0051053,negative regulation of DNA metabolic process,1.1920267647359282,5,0.40975616224846245,0.7822093233349344,SMG6/STAG2/TERF2/HNRNPU/TSPYL2
MF,GO:0019888,protein phosphatase regulator activity,1.2949024390243902,3,0.40977843020791394,0.712656902291597,BOD1/PPP1R14A/PPP1R14C
BP,GO:0048675,axon extension,1.2294623160251557,4,0.4102823639669856,0.78256553793218,PAK1/ZFYVE27/CDK5/CYFIP1
BP,GO:0032535,regulation of cellular component size,1.105685366641542,11,0.4103275055086873,0.78256553793218,ALS2/CAPZA1/HP1BP3/CDK4/ANXA7/PAK1/ZFYVE27/CDK5/IL7R/MYO1C/CYFIP1
BP,GO:0043087,regulation of GTPase activity,1.0870089579053306,14,0.41328724188376076,0.7873653047446084,ALS2/TBC1D22B/RASGRP2/ITGA6/RGS17/ANKRD27/DOCK7/STARD13/SBF2/BNIP2/DOCK5/ARHGAP12/AGFG1/RIN1
BP,GO:0048880,sensory system development,1.102705082634422,11,0.4137714795194927,0.7873653047446084,CTNS/BAX/TGFBR1/C12orf57/ACVR2B/CDK4/PYGO2/FRS2/ZHX2/NHS/SMOC1
MF,GO:0051018,protein kinase A binding,1.4157600000000001,2,0.4147521801092806,0.712656902291597,PRKAR2A/PRRC1
MF,GO:0004197,cysteine-type endopeptidase activity,1.2204827586206897,4,0.41571806281015256,0.712656902291597,USP28/CAPN6/USP46/CAPN10
BP,GO:0009060,aerobic respiration,1.2824563813710674,3,0.4157531080970871,0.7873653047446084,CS/IDH3G/SDHAF2
BP,GO:0045844,positive regulation of striated muscle tissue development,1.2824563813710674,3,0.4157531080970871,0.7873653047446084,CYP26B1/RBPJ/MTM1
BP,GO:0048636,positive regulation of muscle organ development,1.2824563813710674,3,0.4157531080970871,0.7873653047446084,CYP26B1/RBPJ/MTM1
BP,GO:1905477,positive regulation of protein localization to membrane,1.2193847560577362,4,0.4163400508111532,0.7873653047446084,STAC/PAK1/CDK5/MYO1C
BP,GO:0060537,muscle tissue development,1.0938598546988516,12,0.4170542292079614,0.7873653047446084,CYP26B1/NDRG4/TGFBR1/ALPK3/PAK1/HNRNPU/CDK5/FRS2/RBPJ/MTM1/NUPR1/MYL6B
BP,GO:0035065,regulation of histone acetylation,1.4034428324438097,2,0.4189679446251112,0.7873653047446084,RPS6KA4/PYGO2
BP,GO:0043331,response to dsRNA,1.4034428324438097,2,0.4189679446251112,0.7873653047446084,CARD9/ZCCHC3
BP,GO:0045840,positive regulation of mitotic nuclear division,1.4034428324438097,2,0.4189679446251112,0.7873653047446084,HNRNPU/NUP62
BP,GO:1901185,negative regulation of ERBB signaling pathway,1.4034428324438097,2,0.4189679446251112,0.7873653047446084,RAB7A/NUP62
BP,GO:1902475,L-alpha-amino acid transmembrane transport,1.4034428324438097,2,0.4189679446251112,0.7873653047446084,SLC7A1/PRAF2
CC,GO:0005871,kinesin complex,1.403095534602384,2,0.4190149440997525,0.7013434957340902,KIF16B/KIF13A
CC,GO:0032154,cleavage furrow,1.403095534602384,2,0.4190149440997525,0.7013434957340902,PKN2/PPP1CC
CC,GO:1904724,tertiary granule lumen,1.403095534602384,2,0.4190149440997525,0.7013434957340902,PGM1/CYFIP1
MF,GO:0001882,nucleoside binding,1.0918457583547558,12,0.4195265619900701,0.712656902291597,RAB7A/ARFRP1/EHD4/ARL1/RAP2A/RAB15/RIT1/IRGQ/RHEBL1/TUBAL3/RAP2B/RASL10B
MF,GO:0000339,RNA cap binding,1.8628421052631579,1,0.4200565202950719,0.712656902291597,CYFIP1
MF,GO:0001972,retinoic acid binding,1.8628421052631579,1,0.4200565202950719,0.712656902291597,CYP26B1
MF,GO:0004550,nucleoside diphosphate kinase activity,1.8628421052631579,1,0.4200565202950719,0.712656902291597,CMPK1
MF,GO:0004653,polypeptide N-acetylgalactosaminyltransferase activity,1.8628421052631579,1,0.4200565202950719,0.712656902291597,GALNT1
MF,GO:0005086,ARF guanyl-nucleotide exchange factor activity,1.8628421052631579,1,0.4200565202950719,0.712656902291597,CYTH1
MF,GO:0016722,"oxidoreductase activity, oxidizing metal ions",1.8628421052631579,1,0.4200565202950719,0.712656902291597,FTL
MF,GO:0031690,adrenergic receptor binding,1.8628421052631579,1,0.4200565202950719,0.712656902291597,NEDD4
MF,GO:0034458,3'-5' RNA helicase activity,1.8628421052631579,1,0.4200565202950719,0.712656902291597,DHX34
MF,GO:0070182,DNA polymerase binding,1.8628421052631579,1,0.4200565202950719,0.712656902291597,SMG6
MF,GO:0070300,phosphatidic acid binding,1.8628421052631579,1,0.4200565202950719,0.712656902291597,MAPKAP1
MF,GO:0070577,lysine-acetylated histone binding,1.8628421052631579,1,0.4200565202950719,0.712656902291597,ATAD2B
MF,GO:0098641,cadherin binding involved in cell-cell adhesion,1.8628421052631579,1,0.4200565202950719,0.712656902291597,PKP3
MF,GO:0140033,acetylation-dependent protein binding,1.8628421052631579,1,0.4200565202950719,0.712656902291597,ATAD2B
MF,GO:0140223,general transcription initiation factor activity,1.8628421052631579,1,0.4200565202950719,0.712656902291597,TBP
BP,GO:0003323,type B pancreatic cell development,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,CDK6
BP,GO:0007095,mitotic G2 DNA damage checkpoint,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,TAOK3
BP,GO:0007130,synaptonemal complex assembly,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,AGO4
BP,GO:0007549,dosage compensation,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,HNRNPU
BP,GO:0008356,asymmetric cell division,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,DOCK7
BP,GO:0009219,pyrimidine deoxyribonucleotide metabolic process,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,MBD4
BP,GO:0010002,cardioblast differentiation,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,RBPJ
BP,GO:0031061,negative regulation of histone methylation,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,KDM3A
BP,GO:0032462,regulation of protein homooligomerization,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,GBA
BP,GO:0032816,positive regulation of natural killer cell activation,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,TOX
BP,GO:0034143,regulation of toll-like receptor 4 signaling pathway,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,APPL2
BP,GO:0039529,RIG-I signaling pathway,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,ZCCHC3
BP,GO:0042228,interleukin-8 biosynthetic process,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,BCL10
BP,GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",1.8595617529880477,1,0.42039268483414194,0.7873653047446084,RC3H2
BP,GO:0043586,tongue development,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,CYP26B1
BP,GO:0045655,regulation of monocyte differentiation,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,CDK6
BP,GO:0046514,ceramide catabolic process,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,GBA
BP,GO:0048148,behavioral response to cocaine,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,CDK5
BP,GO:0051016,barbed-end actin filament capping,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,CAPZA1
BP,GO:0070828,heterochromatin organization,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,HP1BP3
BP,GO:0097503,sialylation,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,ST6GALNAC6
BP,GO:0098698,postsynaptic specialization assembly,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,IL1RAP
BP,GO:0098780,response to mitochondrial depolarisation,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,GBA
BP,GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",1.8595617529880477,1,0.42039268483414194,0.7873653047446084,CNOT7
BP,GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,PTPN1
BP,GO:1903599,positive regulation of autophagy of mitochondrion,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,GBA
BP,GO:2000774,positive regulation of cellular senescence,1.8595617529880477,1,0.42039268483414194,0.7873653047446084,ARG2
CC,GO:0070820,tertiary granule,1.1763758293160231,5,0.4207625637887198,0.7013434957340902,PGM1/PTPRB/DIAPH1/RAP2B/CYFIP1
BP,GO:0007159,leukocyte cell-cell adhesion,1.1035974795181294,10,0.42080568955801145,0.7877761367335439,RC3H2/ARG2/PIK3CA/BCL10/DUSP10/PAK1/FAM49B/IL7R/YES1/CARD11
CC,GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,1.2720371604911722,3,0.4208287451372982,0.7013434957340902,CYTH1/STAC/YES1
MF,GO:0016798,"hydrolase activity, acting on glycosyl bonds",1.210051282051282,4,0.42207433014524265,0.712656902291597,IDUA/MBD4/EDEM1/GBA
BP,GO:1901863,positive regulation of muscle tissue development,1.2678830134009418,3,0.4229412759830893,0.7914098945258543,CYP26B1/RBPJ/MTM1
CC,GO:0000242,pericentriolar material,1.8373870095983598,1,0.42403685442656125,0.7013434957340902,CEP85
CC,GO:0000930,gamma-tubulin complex,1.8373870095983598,1,0.42403685442656125,0.7013434957340902,PDE4B
CC,GO:0005680,anaphase-promoting complex,1.8373870095983598,1,0.42403685442656125,0.7013434957340902,CDC26
CC,GO:0031306,intrinsic component of mitochondrial outer membrane,1.8373870095983598,1,0.42403685442656125,0.7013434957340902,TOMM20
CC,GO:0032806,carboxy-terminal domain protein kinase complex,1.8373870095983598,1,0.42403685442656125,0.7013434957340902,GTF2H1
CC,GO:0099091,"postsynaptic specialization, intracellular component",1.8373870095983598,1,0.42403685442656125,0.7013434957340902,YES1
BP,GO:0044839,cell cycle G2/M phase transition,1.1185333852559687,8,0.4243908248281041,0.7927496144282777,MAPRE1/CDKN1A/FBXL12/VPS4A/TAOK3/CDK4/CCNB3/BTRC
MF,GO:0005160,transforming growth factor beta receptor binding,1.3880000000000001,2,0.4245681338220815,0.712656902291597,TGFBR1/ACVR2B
MF,GO:0003777,microtubule motor activity,1.2640714285714287,3,0.42491198147755216,0.712656902291597,KIF16B/DNAL4/KIF13A
BP,GO:0006665,sphingolipid metabolic process,1.1695356937031747,5,0.42569215687698314,0.7927496144282777,BAX/SUMF1/ST6GALNAC6/SGMS2/GBA
CC,GO:0019897,extrinsic component of plasma membrane,1.16924627883532,5,0.42587150857756906,0.70214891129403,CDH20/EEA1/CYTH1/STAC/YES1
BP,GO:0002720,positive regulation of cytokine production involved in immune response,1.3774531503615168,2,0.4282701621204976,0.7927496144282777,MAP3K7/BCL10
BP,GO:0030042,actin filament depolymerization,1.3774531503615168,2,0.4282701621204976,0.7927496144282777,CAPZA1/MICAL2
BP,GO:0030199,collagen fibril organization,1.3774531503615168,2,0.4282701621204976,0.7927496144282777,TGFBR1/ADAMTS14
BP,GO:0045747,positive regulation of Notch signaling pathway,1.3774531503615168,2,0.4282701621204976,0.7927496144282777,RBPJ/RFNG
BP,GO:0070206,protein trimerization,1.3774531503615168,2,0.4282701621204976,0.7927496144282777,ATXN10/NUP62
BP,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,1.199717259992289,4,0.42841212283266406,0.7927496144282777,NEDD4/PIK3CA/PIP4K2A/ENTPD5
BP,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,1.253637136845875,3,0.43009909081618936,0.7927496144282777,ADCY7/ADCY9/ADCY1
BP,GO:0055013,cardiac muscle cell development,1.253637136845875,3,0.43009909081618936,0.7927496144282777,ALPK3/PAK1/HNRNPU
BP,GO:1901019,regulation of calcium ion transmembrane transporter activity,1.253637136845875,3,0.43009909081618936,0.7927496144282777,STAC/PDE4B/MYO5A
BP,GO:0007519,skeletal muscle tissue development,1.1622260956175299,5,0.4309868983688385,0.7927496144282777,CYP26B1/CDK5/MTM1/NUPR1/MYL6B
BP,GO:0030203,glycosaminoglycan metabolic process,1.1622260956175299,5,0.4309868983688385,0.7927496144282777,B4GALT7/HAS3/IMPAD1/SDC1/IDUA
BP,GO:0051249,regulation of lymphocyte activation,1.073561424405471,14,0.4314996170029246,0.7927496144282777,CYP26B1/RC3H2/ARG2/PIK3CA/CDKN1A/BCL10/DUSP10/PAK1/FAM49B/IL7R/TNIP2/YES1/CARD11/TOX
MF,GO:0008135,"translation factor activity, RNA binding",1.2491999999999999,3,0.4324286539622709,0.712656902291597,MTRF1L/COPS5/EIF5A2
MF,GO:0033613,activating transcription factor binding,1.2491999999999999,3,0.4324286539622709,0.712656902291597,GABPA/NHLH2/LDB1
MF,GO:0043178,alcohol binding,1.2491999999999999,3,0.4324286539622709,0.712656902291597,STARD3NL/OSBP2/APOD
BP,GO:0042445,hormone metabolic process,1.122149333699684,7,0.4325966257636048,0.7927496144282777,CYP26B1/STARD3NL/HSD17B14/PLEKHA1/VDR/ARNT/AKR1C3
MF,GO:0061630,ubiquitin protein ligase activity,1.121076923076923,7,0.43359619501156244,0.712656902291597,NEDD4/CHFR/FBXO30/FBXL12/MED21/RNF180/BTRC
BP,GO:0006805,xenobiotic metabolic process,1.1901195219123506,4,0.43442411334886444,0.7927496144282777,CYP26B1/ARNT/CMBL/ARNT2
BP,GO:0045471,response to ethanol,1.1901195219123506,4,0.43442411334886444,0.7927496144282777,USP46/ADCY7/CLDN1/CLDN3
MF,GO:0016829,lyase activity,1.1356363636363638,6,0.4345736939296515,0.712656902291597,ADCY7/GGACT/ADCY9/ADCY1/PCBD1/TSEN34
MF,GO:0031490,chromatin DNA binding,1.1897142857142857,4,0.4347351366171328,0.712656902291597,KDM3A/HNRNPU/RBBP4/RCC1
BP,GO:0000470,maturation of LSU-rRNA,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,ZNHIT6
BP,GO:0000966,RNA 5'-end processing,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,HSD17B10
BP,GO:0001779,natural killer cell differentiation,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,TOX
BP,GO:0001956,positive regulation of neurotransmitter secretion,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CDK5
BP,GO:0003177,pulmonary valve development,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,RBPJ
BP,GO:0006144,purine nucleobase metabolic process,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,MTHFD1L
BP,GO:0006450,regulation of translational fidelity,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,GATC
BP,GO:0009081,branched-chain amino acid metabolic process,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,HSD17B10
BP,GO:0009083,branched-chain amino acid catabolic process,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,HSD17B10
BP,GO:0010310,regulation of hydrogen peroxide metabolic process,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CTNS
BP,GO:0010829,negative regulation of glucose transmembrane transport,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,APPL2
BP,GO:0010988,regulation of low-density lipoprotein particle clearance,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CNPY2
BP,GO:0032674,regulation of interleukin-5 production,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,IL1RAP
BP,GO:0035162,embryonic hemopoiesis,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,THOC5
BP,GO:0035357,peroxisome proliferator activated receptor signaling pathway,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,ASXL2
BP,GO:0036120,cellular response to platelet-derived growth factor stimulus,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,YES1
BP,GO:0036499,PERK-mediated unfolded protein response,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,PTPN1
BP,GO:0036507,protein demannosylation,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,EDEM1
BP,GO:0036508,"protein alpha-1,2-demannosylation",1.7710111933219503,1,0.43599391122627373,0.7927496144282777,EDEM1
BP,GO:0039531,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,ZCCHC3
BP,GO:0043153,entrainment of circadian clock by photoperiod,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,PPP1CC
BP,GO:0043984,histone H4-K16 acetylation,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,KANSL3
BP,GO:0045061,thymic T cell selection,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CARD11
BP,GO:0046132,pyrimidine ribonucleoside biosynthetic process,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CMPK1
BP,GO:0046716,muscle cell cellular homeostasis,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,MTM1
BP,GO:0046827,positive regulation of protein export from nucleus,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,XPO4
BP,GO:0048026,"positive regulation of mRNA splicing, via spliceosome",1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CIRBP
BP,GO:0050951,sensory perception of temperature stimulus,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,ANO1
BP,GO:0051383,kinetochore organization,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,TRAPPC12
BP,GO:0051412,response to corticosterone,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CDKN1A
BP,GO:0051900,regulation of mitochondrial depolarization,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,GCLM
BP,GO:1900273,positive regulation of long-term synaptic potentiation,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,ADCY1
BP,GO:1902884,positive regulation of response to oxidative stress,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,MCL1
BP,GO:1903055,positive regulation of extracellular matrix organization,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CLASP2
BP,GO:2000269,regulation of fibroblast apoptotic process,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,PIK3CA
BP,GO:2000316,regulation of T-helper 17 type immune response,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,RC3H2
BP,GO:2000737,negative regulation of stem cell differentiation,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,HNRNPU
BP,GO:2001014,regulation of skeletal muscle cell differentiation,1.7710111933219503,1,0.43599391122627373,0.7927496144282777,CYP26B1
MF,GO:0003746,translation elongation factor activity,1.7696999999999998,1,0.4364594923423881,0.712656902291597,EIF5A2
MF,GO:0004745,retinol dehydrogenase activity,1.7696999999999998,1,0.4364594923423881,0.712656902291597,AKR1C3
MF,GO:0008157,protein phosphatase 1 binding,1.7696999999999998,1,0.4364594923423881,0.712656902291597,PPP1CC
MF,GO:0008373,sialyltransferase activity,1.7696999999999998,1,0.4364594923423881,0.712656902291597,ST6GALNAC6
MF,GO:0031418,L-ascorbic acid binding,1.7696999999999998,1,0.4364594923423881,0.712656902291597,EGLN3
MF,GO:0043138,3'-5' DNA helicase activity,1.7696999999999998,1,0.4364594923423881,0.712656902291597,INO80
MF,GO:0047617,acyl-CoA hydrolase activity,1.7696999999999998,1,0.4364594923423881,0.712656902291597,GNPAT
MF,GO:0061608,nuclear import signal receptor activity,1.7696999999999998,1,0.4364594923423881,0.712656902291597,KPNA5
MF,GO:0019001,guanyl nucleotide binding,1.0779898477157361,12,0.4368227919082307,0.712656902291597,RAB7A/ARFRP1/EHD4/ARL1/RAP2A/RAB15/RIT1/IRGQ/RHEBL1/TUBAL3/RAP2B/RASL10B
MF,GO:0032561,guanyl ribonucleotide binding,1.0779898477157361,12,0.4368227919082307,0.712656902291597,RAB7A/ARFRP1/EHD4/ARL1/RAP2A/RAB15/RIT1/IRGQ/RHEBL1/TUBAL3/RAP2B/RASL10B
BP,GO:0002221,pattern recognition receptor signaling pathway,1.1327279713632779,6,0.4369459778971946,0.7927496144282777,TAB1/MAP3K7/APPL2/BCL10/TNIP2/ZCCHC3
BP,GO:0009749,response to glucose,1.1327279713632779,6,0.4369459778971946,0.7927496144282777,GCLM/ACVR2B/PIK3CA/ANO1/MPC2/PRKAA2
BP,GO:0048738,cardiac muscle tissue development,1.1173332421387412,7,0.43697988159585543,0.7927496144282777,NDRG4/TGFBR1/ALPK3/PAK1/HNRNPU/FRS2/RBPJ
BP,GO:0010717,regulation of epithelial to mesenchymal transition,1.2397078353253652,3,0.43722480822204235,0.7927496144282777,TGFBR1/CLASP2/SDHAF2
BP,GO:0030641,regulation of cellular pH,1.2397078353253652,3,0.43722480822204235,0.7927496144282777,RAB7A/SNAPIN/TMEM199
BP,GO:0030901,midbrain development,1.2397078353253652,3,0.43722480822204235,0.7927496144282777,KDM7A/SUDS3/MAPKAP1
BP,GO:0034333,adherens junction assembly,1.2397078353253652,3,0.43722480822204235,0.7927496144282777,CLASP2/APOD/LDB1
BP,GO:1903035,negative regulation of response to wounding,1.2397078353253652,3,0.43722480822204235,0.7927496144282777,CDKN1A/DUSP10/CLASP2
BP,GO:0002011,morphogenesis of an epithelial sheet,1.352408547627671,2,0.43749333441285243,0.7927496144282777,CLASP2/ARHGAP12
BP,GO:0002886,regulation of myeloid leukocyte mediated immunity,1.352408547627671,2,0.43749333441285243,0.7927496144282777,SNX4/VAMP7
BP,GO:0003229,ventricular cardiac muscle tissue development,1.352408547627671,2,0.43749333441285243,0.7927496144282777,TGFBR1/RBPJ
BP,GO:0010823,negative regulation of mitochondrion organization,1.352408547627671,2,0.43749333441285243,0.7927496144282777,OMA1/TRIAP1
BP,GO:0016233,telomere capping,1.352408547627671,2,0.43749333441285243,0.7927496144282777,SMG6/TERF2
BP,GO:0032781,positive regulation of ATPase activity,1.352408547627671,2,0.43749333441285243,0.7927496144282777,DNAL4/HNRNPU
BP,GO:0042306,regulation of protein import into nucleus,1.352408547627671,2,0.43749333441285243,0.7927496144282777,APOD/NUP62
BP,GO:0043030,regulation of macrophage activation,1.352408547627671,2,0.43749333441285243,0.7927496144282777,TNIP2/MYO18A
CC,GO:0016460,myosin II complex,1.7538694182529797,1,0.4389798462720135,0.7147140622116219,MYL6B
CC,GO:0042629,mast cell granule,1.7538694182529797,1,0.4389798462720135,0.7147140622116219,PLA2G3
CC,GO:0097038,perinuclear endoplasmic reticulum,1.7538694182529797,1,0.4389798462720135,0.7147140622116219,OSBP2
CC,GO:0097225,sperm midpiece,1.7538694182529797,1,0.4389798462720135,0.7147140622116219,GABARAP
MF,GO:0050662,coenzyme binding,1.094659793814433,9,0.4390328104229545,0.7145850193066824,AGPS/IDH3G/PYGL/EGLN3/MICAL2/LBR/QDPR/DUS2/ACAD11
BP,GO:0007548,sex differentiation,1.1019625202892136,8,0.4407056764682624,0.7973020406435657,BAX/TGFBR1/PLEKHA1/SDC1/SAFB2/AGO4/NUPR1/AKR1C3
BP,GO:0045927,positive regulation of growth,1.1019625202892136,8,0.4407056764682624,0.7973020406435657,TGFBR1/RPS6KA1/INO80/PAK1/ZFYVE27/RBPJ/MTM1/CYFIP1
BP,GO:0140053,mitochondrial gene expression,1.1478776253012641,5,0.44154540762730465,0.7973020406435657,HSD17B10/MTRF1L/TRUB2/NGRN/GATC
BP,GO:0072330,monocarboxylic acid biosynthetic process,1.0842925673399695,10,0.44252712504031033,0.7973020406435657,PGM1/PRKAG2/LPGAT1/ARNT/PRKAA2/NUPR1/ENTPD5/AKR1C3/MYO5A/NUP62
BP,GO:0001558,regulation of cell growth,1.0728240882623352,12,0.44336654354390104,0.7973020406435657,RASGRP2/RBBP7/TGFBR1/RPS6KA1/CDKN1A/INO80/PAK1/ZFYVE27/CDK5/CRLF3/TSPYL2/CYFIP1
MF,GO:0001102,RNA polymerase II activating transcription factor binding,1.335622641509434,2,0.44393834259014575,0.7148207815870432,NHLH2/LDB1
CC,GO:0005637,nuclear inner membrane,1.3305216276401914,2,0.4456800793177078,0.7186053882538008,PSEN2/LBR
CC,GO:0030120,vesicle coat,1.3305216276401914,2,0.4456800793177078,0.7186053882538008,COPE/PDCD6
CC,GO:0043197,dendritic spine,1.1415718106972057,5,0.4462140839210338,0.7186053882538008,ALS2/NEDD4/PDE4B/PPP1CC/CYFIP1
BP,GO:0006749,glutathione metabolic process,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,GCLM/CTNS
BP,GO:0010332,response to gamma radiation,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,BAX/CDKN1A
BP,GO:0050879,multicellular organismal movement,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,C12orf57/STAC
BP,GO:0050881,musculoskeletal movement,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,C12orf57/STAC
BP,GO:0051568,histone H3-K4 methylation,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,RTF1/PYGO2
BP,GO:0065002,intracellular protein transmembrane transport,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,SEC62/TOMM20
BP,GO:0070936,protein K48-linked ubiquitination,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,DTX3L/TRIM44
BP,GO:0098586,cellular response to virus,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,VWCE/ZCCHC3
BP,GO:1903202,negative regulation of oxidative stress-induced cell death,1.3282583949914628,2,0.44663498355500164,0.7973020406435657,PDE8A/MET
BP,GO:0045931,positive regulation of mitotic cell cycle,1.1408354312810107,5,0.44680753365487624,0.7973020406435657,PKN2/CCND3/CDK4/HNRNPU/NUP62
MF,GO:0008276,protein methyltransferase activity,1.2204827586206897,3,0.44735176708809166,0.7148207815870432,METTL22/PRMT2/TRMT112
CC,GO:0030018,Z disc,1.16924627883532,4,0.44772453982405147,0.7186053882538008,PSEN2/PAK1/PDE4B/PARVA
CC,GO:0043202,lysosomal lumen,1.2184777011020702,3,0.44826631704891606,0.7186053882538008,SDC1/IDUA/GBA
BP,GO:0046651,lymphocyte proliferation,1.0938598546988516,8,0.44884160595444855,0.7973020406435657,RC3H2/ARG2/BAX/ELF4/CCND3/CDKN1A/IL7R/CARD11
BP,GO:1902105,regulation of leukocyte differentiation,1.0938598546988516,8,0.44884160595444855,0.7973020406435657,CYP26B1/RC3H2/CDK6/DUSP10/IL7R/TOB2/CARD11/TOX
BP,GO:0000466,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",1.690510684534589,1,0.4511760151763201,0.7973020406435657,FCF1
BP,GO:0000469,cleavage involved in rRNA processing,1.690510684534589,1,0.4511760151763201,0.7973020406435657,FCF1
BP,GO:0000717,"nucleotide-excision repair, DNA duplex unwinding",1.690510684534589,1,0.4511760151763201,0.7973020406435657,GTF2H1
BP,GO:0001759,organ induction,1.690510684534589,1,0.4511760151763201,0.7973020406435657,FRS2
BP,GO:0006085,acetyl-CoA biosynthetic process,1.690510684534589,1,0.4511760151763201,0.7973020406435657,MPC2
BP,GO:0006312,mitotic recombination,1.690510684534589,1,0.4511760151763201,0.7973020406435657,TERF2
BP,GO:0007398,ectoderm development,1.690510684534589,1,0.4511760151763201,0.7973020406435657,ITGA6
BP,GO:0009220,pyrimidine ribonucleotide biosynthetic process,1.690510684534589,1,0.4511760151763201,0.7973020406435657,CMPK1
BP,GO:0010155,regulation of proton transport,1.690510684534589,1,0.4511760151763201,0.7973020406435657,DNAJC30
BP,GO:0010866,regulation of triglyceride biosynthetic process,1.690510684534589,1,0.4511760151763201,0.7973020406435657,FITM2
BP,GO:0010869,regulation of receptor biosynthetic process,1.690510684534589,1,0.4511760151763201,0.7973020406435657,CNPY2
BP,GO:0010884,positive regulation of lipid storage,1.690510684534589,1,0.4511760151763201,0.7973020406435657,FITM2
BP,GO:0018230,peptidyl-L-cysteine S-palmitoylation,1.690510684534589,1,0.4511760151763201,0.7973020406435657,ZDHHC18
BP,GO:0018231,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,1.690510684534589,1,0.4511760151763201,0.7973020406435657,ZDHHC18
BP,GO:0021801,cerebral cortex radial glia guided migration,1.690510684534589,1,0.4511760151763201,0.7973020406435657,CDK5
BP,GO:0021854,hypothalamus development,1.690510684534589,1,0.4511760151763201,0.7973020406435657,BAX
BP,GO:0022030,telencephalon glial cell migration,1.690510684534589,1,0.4511760151763201,0.7973020406435657,CDK5
BP,GO:0031342,negative regulation of cell killing,1.690510684534589,1,0.4511760151763201,0.7973020406435657,IL7R
BP,GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,1.690510684534589,1,0.4511760151763201,0.7973020406435657,SNAPIN
BP,GO:0032069,regulation of nuclease activity,1.690510684534589,1,0.4511760151763201,0.7973020406435657,TERF2
BP,GO:0032469,endoplasmic reticulum calcium ion homeostasis,1.690510684534589,1,0.4511760151763201,0.7973020406435657,BAX
BP,GO:0032634,interleukin-5 production,1.690510684534589,1,0.4511760151763201,0.7973020406435657,IL1RAP
BP,GO:0035024,negative regulation of Rho protein signal transduction,1.690510684534589,1,0.4511760151763201,0.7973020406435657,MET
BP,GO:0036119,response to platelet-derived growth factor,1.690510684534589,1,0.4511760151763201,0.7973020406435657,YES1
BP,GO:0042359,vitamin D metabolic process,1.690510684534589,1,0.4511760151763201,0.7973020406435657,VDR
BP,GO:0044342,type B pancreatic cell proliferation,1.690510684534589,1,0.4511760151763201,0.7973020406435657,NUPR1
BP,GO:0045723,positive regulation of fatty acid biosynthetic process,1.690510684534589,1,0.4511760151763201,0.7973020406435657,LPGAT1
BP,GO:0045943,positive regulation of transcription by RNA polymerase I,1.690510684534589,1,0.4511760151763201,0.7973020406435657,PHF8
BP,GO:0046599,regulation of centriole replication,1.690510684534589,1,0.4511760151763201,0.7973020406435657,NUP62
BP,GO:0046628,positive regulation of insulin receptor signaling pathway,1.690510684534589,1,0.4511760151763201,0.7973020406435657,PAK1
BP,GO:0051000,positive regulation of nitric-oxide synthase activity,1.690510684534589,1,0.4511760151763201,0.7973020406435657,TERF2
BP,GO:0060390,regulation of SMAD protein signal transduction,1.690510684534589,1,0.4511760151763201,0.7973020406435657,TGFBR1
BP,GO:0060487,lung epithelial cell differentiation,1.690510684534589,1,0.4511760151763201,0.7973020406435657,RBPJ
BP,GO:0060575,intestinal epithelial cell differentiation,1.690510684534589,1,0.4511760151763201,0.7973020406435657,CDKN1A
BP,GO:0070935,3'-UTR-mediated mRNA stabilization,1.690510684534589,1,0.4511760151763201,0.7973020406435657,HNRNPA0
BP,GO:0071359,cellular response to dsRNA,1.690510684534589,1,0.4511760151763201,0.7973020406435657,ZCCHC3
BP,GO:0097320,plasma membrane tubulation,1.690510684534589,1,0.4511760151763201,0.7973020406435657,FNBP1L
BP,GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,1.690510684534589,1,0.4511760151763201,0.7973020406435657,RBPJ
BP,GO:2001032,regulation of double-strand break repair via nonhomologous end joining,1.690510684534589,1,0.4511760151763201,0.7973020406435657,DTX3L
BP,GO:0006672,ceramide metabolic process,1.2127576649922052,3,0.4513733037370039,0.7973020406435657,ST6GALNAC6/SGMS2/GBA
BP,GO:0045833,negative regulation of lipid metabolic process,1.2127576649922052,3,0.4513733037370039,0.7973020406435657,APPL2/APOD/AKR1C3
BP,GO:0006633,fatty acid biosynthetic process,1.1338791176756389,5,0.4520571723366601,0.7981634449069155,PRKAG2/LPGAT1/PRKAA2/AKR1C3/MYO5A
MF,GO:0004806,triglyceride lipase activity,1.6854285714285715,1,0.4523994286341124,0.7148207815870432,DDHD2
MF,GO:0008106,alcohol dehydrogenase (NADP+) activity,1.6854285714285715,1,0.4523994286341124,0.7148207815870432,AKR1C3
MF,GO:0010485,H4 histone acetyltransferase activity,1.6854285714285715,1,0.4523994286341124,0.7148207815870432,KANSL3
MF,GO:0016018,cyclosporin A binding,1.6854285714285715,1,0.4523994286341124,0.7148207815870432,PPIE
MF,GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",1.6854285714285715,1,0.4523994286341124,0.7148207815870432,MBD4
MF,GO:0016894,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters",1.6854285714285715,1,0.4523994286341124,0.7148207815870432,TSEN34
MF,GO:0017049,GTP-Rho binding,1.6854285714285715,1,0.4523994286341124,0.7148207815870432,PKN2
MF,GO:0019200,carbohydrate kinase activity,1.6854285714285715,1,0.4523994286341124,0.7148207815870432,POMK
MF,GO:0019789,SUMO transferase activity,1.6854285714285715,1,0.4523994286341124,0.7148207815870432,ZMIZ2
MF,GO:0034237,protein kinase A regulatory subunit binding,1.6854285714285715,1,0.4523994286341124,0.7148207815870432,PRRC1
BP,GO:0043588,skin development,1.065142770207951,12,0.45321742233502904,0.7998648477478951,CYP26B1/ITGA6/MET/VDR/CLDN1/FOXQ1/RBPJ/GBA/PKP3/AKR1C3/MYO5A/LDB1
CC,GO:0030658,transport vesicle membrane,1.1130325154297755,6,0.4534782333370049,0.7196072703332175,VAMP4/STX12/VAMP7/SNAPIN/MCFD2/PDCD6
MF,GO:0140104,molecular carrier activity,1.310888888888889,2,0.45348690129414593,0.7148207815870432,XPO4/KPNA5
CC,GO:0046930,pore complex,1.6776142261550242,1,0.4535358908800363,0.7196072703332175,BAX
CC,GO:0097381,photoreceptor disc membrane,1.6776142261550242,1,0.4535358908800363,0.7196072703332175,PCDHB13
MF,GO:0140101,"catalytic activity, acting on a tRNA",1.1604590163934427,4,0.45357692759695833,0.7148207815870432,DUS2/TSEN34/TRMT2B/GATC
CC,GO:0045171,intercellular bridge,1.3079704136123915,2,0.4544161073697285,0.7196072703332175,DNAJC8/EAF1
BP,GO:0002066,columnar/cuboidal epithelial cell development,1.3049556161319633,2,0.4556928213734668,0.801451965995358,CDK6/CDKN1A
BP,GO:0007029,endoplasmic reticulum organization,1.3049556161319633,2,0.4556928213734668,0.801451965995358,MOSPD3/ZFYVE27
BP,GO:0019320,hexose catabolic process,1.3049556161319633,2,0.4556928213734668,0.801451965995358,PGM1/FUT1
BP,GO:0060043,regulation of cardiac muscle cell proliferation,1.3049556161319633,2,0.4556928213734668,0.801451965995358,TGFBR1/RBPJ
BP,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,1.3049556161319633,2,0.4556928213734668,0.801451965995358,ANO1/MPC2
BP,GO:0075733,intracellular transport of virus,1.3049556161319633,2,0.4556928213734668,0.801451965995358,NMT2/NUP62
BP,GO:1900408,negative regulation of cellular response to oxidative stress,1.3049556161319633,2,0.4556928213734668,0.801451965995358,PDE8A/MET
BP,GO:1901799,negative regulation of proteasomal protein catabolic process,1.3049556161319633,2,0.4556928213734668,0.801451965995358,RYBP/MTM1
BP,GO:0006260,DNA replication,1.0858754761974,8,0.45695891960002666,0.8029843995390533,STAG2/RBBP7/ING4/INO80/TERF2/KIN/RBBP4/TSPYL2
BP,GO:0032943,mononuclear cell proliferation,1.0858754761974,8,0.45695891960002666,0.8029843995390533,RC3H2/ARG2/BAX/ELF4/CCND3/CDKN1A/IL7R/CARD11
BP,GO:0050680,negative regulation of epithelial cell proliferation,1.1270071230230592,5,0.4572935422488916,0.8032254446755143,CDK6/TGFBR1/VDR/DUSP10/NUPR1
BP,GO:0006639,acylglycerol metabolic process,1.1532165910003398,4,0.45828520822002516,0.80411487757332345,DDHD2/LPIN3/TBL1XR1/FITM2
BP,GO:0018022,peptidyl-lysine methylation,1.1532165910003398,4,0.45828520822002516,0.80411487757332345,METTL22/KDM3A/RTF1/PYGO2
BP,GO:1901184,regulation of ERBB signaling pathway,1.199717259992289,3,0.4583929206225509,0.80411487757332345,RAB7A/RBPJ/NUP62
CC,GO:0005777,peroxisome,1.1517948418377777,4,0.45917195081113815,0.7201816540944912,AGPS/GNPAT/MYO5A/ACAD11
CC,GO:0042579,microbody,1.1517948418377777,4,0.45917195081113815,0.7201816540944912,AGPS/GNPAT/MYO5A/ACAD11
CC,GO:0150034,distal axon,1.0830912898685068,8,0.45977824491409847,0.7201816540944912,ALS2/DOCK7/ZFYVE27/CDK5/CBX6/ACTG1/MYO5A/CYFIP1
BP,GO:0009746,response to hexose,1.1046901502899293,6,0.46068033763203475,0.8041941254154751,GCLM/ACVR2B/PIK3CA/ANO1/MPC2/PRKAA2
BP,GO:0002697,regulation of immune effector process,1.055646409993215,13,0.46087576710956213,0.8041941254154751,RC3H2/SNX4/VAMP7/MAP3K7/APPL2/BCL10/DUSP10/FAM49B/DTX3L/TRIM44/IL7R/MYO18A/ZCCHC3
CC,GO:0005775,vacuolar lumen,1.1216606744641149,5,0.46135278091010556,0.7201816540944912,FTL/SDC1/IDUA/GBA/C6orf120
BP,GO:0042692,muscle cell differentiation,1.0626067159931702,11,0.4619154398722207,0.8041941254154751,CYP26B1/DYRK1B/ASF1A/SDC1/ALPK3/BNIP2/PAK1/HNRNPU/FRS2/RBPJ/ACTG1
MF,GO:0016853,isomerase activity,1.1200632911392405,5,0.46269775780589417,0.7162623686741377,PGM1/PPIE/FKBP9/TRUB2/P4HB
MF,GO:0001047,core promoter binding,1.2870545454545455,2,0.46294101383963615,0.7162623686741377,TBP/KDM3A
MF,GO:0008408,3'-5' exonuclease activity,1.2870545454545455,2,0.46294101383963615,0.7162623686741377,CNOT6/CNOT7
MF,GO:0031492,nucleosomal DNA binding,1.2870545454545455,2,0.46294101383963615,0.7162623686741377,RBBP4/RCC1
CC,GO:0005778,peroxisomal membrane,1.2861709067188518,2,0.46307265666344444,0.7201816540944912,AGPS/GNPAT
CC,GO:0031903,microbody membrane,1.2861709067188518,2,0.46307265666344444,0.7201816540944912,AGPS/GNPAT
BP,GO:0003231,cardiac ventricle development,1.144345694146491,4,0.464198366451275,0.8041941254154751,TGFBR1/TMEM65/FRS2/RBPJ
BP,GO:0006638,neutral lipid metabolic process,1.144345694146491,4,0.464198366451275,0.8041941254154751,DDHD2/LPIN3/TBL1XR1/FITM2
BP,GO:0017001,antibiotic catabolic process,1.2824563813710674,2,0.46466474109080513,0.8041941254154751,AMDHD2/AKR1C3
BP,GO:0030520,intracellular estrogen receptor signaling pathway,1.2824563813710674,2,0.46466474109080513,0.8041941254154751,PAK1/TADA3
BP,GO:0035306,positive regulation of dephosphorylation,1.2824563813710674,2,0.46466474109080513,0.8041941254154751,NSMF/GBA
BP,GO:0035904,aorta development,1.2824563813710674,2,0.46466474109080513,0.8041941254154751,TAB1/RBPJ
BP,GO:1904589,regulation of protein import,1.2824563813710674,2,0.46466474109080513,0.8041941254154751,APOD/NUP62
BP,GO:0006029,proteoglycan metabolic process,1.1869543104179028,3,0.46537411559381947,0.8041941254154751,B4GALT7/IMPAD1/IDUA
BP,GO:0045621,positive regulation of lymphocyte differentiation,1.1869543104179028,3,0.46537411559381947,0.8041941254154751,DUSP10/IL7R/TOX
BP,GO:0051289,protein homotetramerization,1.1869543104179028,3,0.46537411559381947,0.8041941254154751,HSD17B10/APPL2/PCBD1
BP,GO:0030278,regulation of ossification,1.0992483268894864,6,0.46539895489198047,0.8041941254154751,CDK6/ACVR2B/BMP2K/RBPJ/TOB2/SMOC1
BP,GO:0000715,"nucleotide-excision repair, DNA damage recognition",1.6170102199896068,1,0.4659502344159967,0.8041941254154751,COPS5
BP,GO:0007064,mitotic sister chromatid cohesion,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,BOD1
BP,GO:0007617,mating behavior,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,NHLH2
BP,GO:0015813,L-glutamate transmembrane transport,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,PRAF2
BP,GO:0032331,negative regulation of chondrocyte differentiation,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,TGFBR1
BP,GO:0032717,negative regulation of interleukin-8 production,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,MAPKBP1
BP,GO:0032799,low-density lipoprotein receptor particle metabolic process,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,CNPY2
BP,GO:0032959,inositol trisphosphate biosynthetic process,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,PLCD4
BP,GO:0034695,response to prostaglandin E,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,PRKAA2
BP,GO:0042776,mitochondrial ATP synthesis coupled proton transport,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,DNAJC30
BP,GO:0046337,phosphatidylethanolamine metabolic process,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,LPIN3
BP,GO:0051349,positive regulation of lyase activity,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,ISCU
BP,GO:0051570,regulation of histone H3-K9 methylation,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,KDM3A
BP,GO:0051882,mitochondrial depolarization,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,GCLM
BP,GO:0060479,lung cell differentiation,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,RBPJ
BP,GO:0070193,synaptonemal complex organization,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,AGO4
BP,GO:0071157,negative regulation of cell cycle arrest,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,CDK4
BP,GO:0071305,cellular response to vitamin D,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,VDR
BP,GO:0072337,modified amino acid transport,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,CTNS
BP,GO:0089718,amino acid import across plasma membrane,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,SLC7A1
BP,GO:0090343,positive regulation of cell aging,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,ARG2
BP,GO:0099500,vesicle fusion to plasma membrane,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,SNAPIN
BP,GO:1900746,regulation of vascular endothelial growth factor signaling pathway,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,MYO1C
BP,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1.6170102199896068,1,0.4659502344159967,0.8041941254154751,TRIAP1
MF,GO:0044325,ion channel binding,1.141741935483871,4,0.46602371511084584,0.7162623686741377,DIAPH1/STAC/YES1/PDE4B
CC,GO:0043601,nuclear replisome,1.6077136333985649,1,0.46771498907036324,0.7209452938037256,ERCC5
CC,GO:0044305,calyx of Held,1.6077136333985649,1,0.46771498907036324,0.7209452938037256,ACTG1
CC,GO:0044322,endoplasmic reticulum quality control compartment,1.6077136333985649,1,0.46771498907036324,0.7209452938037256,EDEM1
BP,GO:0035051,cardiocyte differentiation,1.1135100317293698,5,0.4677234296672692,0.8069121763725408,ALPK3/PAK1/HNRNPU/FRS2/RBPJ
MF,GO:0005537,mannose binding,1.608818181818182,1,0.4678893746446885,0.7162623686741377,SCARA3
MF,GO:0008649,rRNA methyltransferase activity,1.608818181818182,1,0.4678893746446885,0.7162623686741377,TRMT112
MF,GO:0016289,CoA hydrolase activity,1.608818181818182,1,0.4678893746446885,0.7162623686741377,GNPAT
MF,GO:0030742,GTP-dependent protein binding,1.608818181818182,1,0.4678893746446885,0.7162623686741377,EEA1
MF,GO:0050321,tau-protein kinase activity,1.608818181818182,1,0.4678893746446885,0.7162623686741377,CDK5
MF,GO:0050431,transforming growth factor beta binding,1.608818181818182,1,0.4678893746446885,0.7162623686741377,TGFBR1
MF,GO:0051537,"2 iron, 2 sulfur cluster binding",1.608818181818182,1,0.4678893746446885,0.7162623686741377,ISCU
MF,GO:0140102,"catalytic activity, acting on a rRNA",1.608818181818182,1,0.4678893746446885,0.7162623686741377,TRMT112
BP,GO:1902905,positive regulation of supramolecular fiber organization,1.0938598546988516,6,0.4701067927244754,0.8094334275935547,MAPRE1/MET/TGFBR1/PAK1/MYO1C/CYFIP1
BP,GO:0001667,ameboidal-type cell migration,1.0487766936592027,13,0.470296906071742,0.8094334275935547,PKN2/SRPX2/MET/TGFBR1/PIK3CA/STARD13/APPL2/DUSP10/DOCK5/PAK1/CLASP2/CSNK2B/PDCD6
MF,GO:0016746,"transferase activity, transferring acyl groups",1.0725454545454545,8,0.4707763150617085,0.7190978878415107,CS/LPCAT2/KANSL3/GNPAT/LPGAT1/NMT2/TADA3/ZDHHC18
BP,GO:0042593,glucose homeostasis,1.080243341984758,7,0.47182743712284936,0.8094334275935547,GCLM/PYGL/PIK3CA/ANO1/APPL2/MPC2/PRKAA2
MF,GO:0051287,NAD binding,1.2640714285714285,2,0.47229838891825093,0.7198407462679483,IDH3G/QDPR
BP,GO:0050810,regulation of steroid biosynthetic process,1.1744600545187671,3,0.4723154656882541,0.8094334275935547,VDR/MBTPS1/AKR1C3
BP,GO:0055006,cardiac cell development,1.1744600545187671,3,0.4723154656882541,0.8094334275935547,ALPK3/PAK1/HNRNPU
BP,GO:0060337,type I interferon signaling pathway,1.1744600545187671,3,0.4723154656882541,0.8094334275935547,YTHDF3/PTPN1/CNOT7
BP,GO:0071357,cellular response to type I interferon,1.1744600545187671,3,0.4723154656882541,0.8094334275935547,YTHDF3/PTPN1/CNOT7
BP,GO:1903076,regulation of protein localization to plasma membrane,1.1744600545187671,3,0.4723154656882541,0.8094334275935547,VPS4A/STAC/CDK5
BP,GO:0034614,cellular response to reactive oxygen species,1.106881995826219,5,0.47291546407102336,0.8094334275935547,PDE8A/MET/PLEKHA1/STK26/AKR1C3
BP,GO:0051302,regulation of cell division,1.106881995826219,5,0.47291546407102336,0.8094334275935547,PKN2/VPS4A/KIF13A/KLHL9/NUP62
BP,GO:0001822,kidney development,1.0702513686262145,8,0.47312525796128224,0.8094334275935547,CYP26B1/ARG2/BAX/TGFBR1/ACTA2/ACVR2B/SDC1/PYGO2
BP,GO:0046394,carboxylic acid biosynthetic process,1.0465066142356978,13,0.47343222008112973,0.8094334275935547,PGM1/HAS3/PRKAG2/MTHFD1L/LPGAT1/ARNT/PRKAA2/NUPR1/SEPHS2/ENTPD5/AKR1C3/MYO5A/NUP62
BP,GO:0001836,release of cytochrome c from mitochondria,1.2607198325342697,2,0.4735488092597895,0.8094334275935547,BAX/TRIAP1
BP,GO:0007602,phototransduction,1.2607198325342697,2,0.4735488092597895,0.8094334275935547,NMT2/CDS1
BP,GO:0033619,membrane protein proteolysis,1.2607198325342697,2,0.4735488092597895,0.8094334275935547,MBTPS1/PSEN2
BP,GO:0045843,negative regulation of striated muscle tissue development,1.2607198325342697,2,0.4735488092597895,0.8094334275935547,PAK1/FRS2
BP,GO:0070527,platelet aggregation,1.2607198325342697,2,0.4735488092597895,0.8094334275935547,RAP2B/ACTG1
BP,GO:1902883,negative regulation of response to oxidative stress,1.2607198325342697,2,0.4735488092597895,0.8094334275935547,PDE8A/MET
BP,GO:2000351,regulation of endothelial cell apoptotic process,1.2607198325342697,2,0.4735488092597895,0.8094334275935547,TNIP2/AKR1C3
BP,GO:0033500,carbohydrate homeostasis,1.0757795265220111,7,0.4761489746678764,0.8094334275935547,GCLM/PYGL/PIK3CA/ANO1/APPL2/MPC2/PRKAA2
BP,GO:0016053,organic acid biosynthetic process,1.044246340770826,13,0.47656469403235224,0.8094334275935547,PGM1/HAS3/PRKAG2/MTHFD1L/LPGAT1/ARNT/PRKAA2/NUPR1/SEPHS2/ENTPD5/AKR1C3/MYO5A/NUP62
BP,GO:0050728,negative regulation of inflammatory response,1.1003323982177797,5,0.4780912635712259,0.8094334275935547,ADCY7/APPL2/DUSP10/GBA/APOD
BP,GO:0060538,skeletal muscle organ development,1.1003323982177797,5,0.4780912635712259,0.8094334275935547,CYP26B1/CDK5/MTM1/NUPR1/MYL6B
CC,GO:0098589,membrane region,1.0587382463844208,9,0.4784455373337394,0.7314154705488963,TGFBR1/PRKAR2A/STX12/BCL10/ADCY1/RAP2B/MYO1C/CARD11/NUP62
MF,GO:0015631,tubulin binding,1.0533928571428572,10,0.4787853081094634,0.7272712800909189,CAPN6/MAST2/KIF16B/MAPRE1/INO80/KIF13A/CLASP2/STRBP/GABARAP/PDE4B
BP,GO:0008585,female gonad development,1.1622260956175299,3,0.47921560908203176,0.8094334275935547,BAX/PLEKHA1/NUPR1
BP,GO:0030219,megakaryocyte differentiation,1.1622260956175299,3,0.47921560908203176,0.8094334275935547,AGO4/PIP4K2A/GABPA
BP,GO:0097327,response to antineoplastic agent,1.1622260956175299,3,0.47921560908203176,0.8094334275935547,CDK4/CLDN1/GBA
BP,GO:1990823,response to leukemia inhibitory factor,1.1622260956175299,3,0.47921560908203176,0.8094334275935547,GCLM/KDM3A/HNRNPU
BP,GO:1990830,cellular response to leukemia inhibitory factor,1.1622260956175299,3,0.47921560908203176,0.8094334275935547,GCLM/KDM3A/HNRNPU
CC,GO:0012507,ER to Golgi transport vesicle membrane,1.244681522631147,2,0.480140452007191,0.7314154705488963,MCFD2/PDCD6
BP,GO:0001919,regulation of receptor recycling,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,KIF16B
BP,GO:0003418,growth plate cartilage chondrocyte differentiation,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,SCARA3
BP,GO:0003433,chondrocyte development involved in endochondral bone morphogenesis,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,SCARA3
BP,GO:0009218,pyrimidine ribonucleotide metabolic process,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,CMPK1
BP,GO:0033081,regulation of T cell differentiation in thymus,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,IL7R
BP,GO:0034162,toll-like receptor 9 signaling pathway,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,TNIP2
BP,GO:0034505,tooth mineralization,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,CNNM4
BP,GO:0034629,cellular protein-containing complex localization,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,SNAPIN
BP,GO:0036010,protein localization to endosome,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,DTX3L
BP,GO:0042430,indole-containing compound metabolic process,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,RNF180
BP,GO:0042738,exogenous drug catabolic process,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,NUDT15
BP,GO:0044346,fibroblast apoptotic process,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,PIK3CA
BP,GO:0045606,positive regulation of epidermal cell differentiation,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,VDR
BP,GO:0046639,negative regulation of alpha-beta T cell differentiation,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,RC3H2
BP,GO:0046697,decidualization,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,VDR
BP,GO:0050427,3'-phosphoadenosine 5'-phosphosulfate metabolic process,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,IMPAD1
BP,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,CMTM3
BP,GO:0051220,cytoplasmic sequestering of protein,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,G3BP2
BP,GO:0060396,growth hormone receptor signaling pathway,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,PTPN1
BP,GO:0099563,modification of synaptic structure,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,CYFIP1
BP,GO:0099590,neurotransmitter receptor internalization,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,USP46
BP,GO:1901071,glucosamine-containing compound metabolic process,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,AMDHD2
BP,GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,MYO1C
BP,GO:1902914,regulation of protein polyubiquitination,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,TRIM44
BP,GO:1903010,regulation of bone development,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,TAPT1
BP,GO:1904376,negative regulation of protein localization to cell periphery,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,LZTFL1
BP,GO:2000178,negative regulation of neural precursor cell proliferation,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,APPL2
BP,GO:2001026,regulation of endothelial cell chemotaxis,1.5496347941567066,1,0.4803275059515342,0.8094334275935547,MET
CC,GO:0030057,desmosome,1.5434050880626224,1,0.481526883681903,0.7314154705488963,PKP3
CC,GO:0035327,transcriptionally active chromatin,1.5434050880626224,1,0.481526883681903,0.7314154705488963,ELL
CC,GO:0097346,INO80-type complex,1.5434050880626224,1,0.481526883681903,0.7314154705488963,INO80
MF,GO:0016796,"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",1.2418947368421054,2,0.48155693943792954,0.7272712800909189,CNOT6/CNOT7
MF,GO:0050840,extracellular matrix binding,1.2418947368421054,2,0.48155693943792954,0.7272712800909189,ITGA6/SMOC1
BP,GO:0002705,positive regulation of leukocyte mediated immunity,1.1185333852559687,4,0.48179653780662235,0.8111502164278503,SNX4/VAMP7/MAP3K7/FAM49B
BP,GO:0031023,microtubule organizing center organization,1.1185333852559687,4,0.48179653780662235,0.8111502164278503,CEP85/CLASP2/NUP62/CHMP1B
BP,GO:0033260,nuclear DNA replication,1.2397078353253652,2,0.48234325799876354,0.8111502164278503,INO80/TERF2
BP,GO:0046794,transport of virus,1.2397078353253652,2,0.48234325799876354,0.8111502164278503,NMT2/NUP62
BP,GO:0048635,negative regulation of muscle organ development,1.2397078353253652,2,0.48234325799876354,0.8111502164278503,PAK1/FRS2
MF,GO:0001223,transcription coactivator binding,1.5388695652173912,1,0.4829420090253197,0.7272712800909189,VGLL4
MF,GO:0044183,protein binding involved in protein folding,1.5388695652173912,1,0.4829420090253197,0.7272712800909189,RIC3
MF,GO:0016747,"transferase activity, transferring acyl groups other than amino-acyl groups",1.0679224137931034,7,0.48388255868210495,0.7272712800909189,LPCAT2/KANSL3/GNPAT/LPGAT1/NMT2/TADA3/ZDHHC18
BP,GO:0034284,response to monosaccharide,1.0780068133264045,6,0.4841600417320595,0.8131368995634778,GCLM/ACVR2B/PIK3CA/ANO1/MPC2/PRKAA2
BP,GO:0070555,response to interleukin-1,1.0780068133264045,6,0.4841600417320595,0.8131368995634778,TAB1/MAP3K7/RPS6KA4/BTRC/TNIP2/IL1RAP
MF,GO:0016298,lipase activity,1.114771653543307,4,0.4844987088951014,0.7272712800909189,DDHD2/PLA2G3/DDHD1/PLCD4
BP,GO:0010976,positive regulation of neuron projection development,1.0588251974309169,8,0.4851784018320797,0.8131368995634778,SS18L2/ITGA6/NDRG4/ANKRD27/VAMP7/PAK1/ZFYVE27/CYFIP1
BP,GO:0001933,negative regulation of protein phosphorylation,1.040314267405901,12,0.4858914042188247,0.8131368995634778,ZMYND11/BAX/PRKAG2/PRKAR2A/CDKN1A/CEP85/TAOK3/DUSP10/DUS2/GBA/PTPN1/NUP62
BP,GO:0015908,fatty acid transport,1.150244383291576,3,0.4860732439920079,0.8131368995634778,PLA2G3/PRKAG2/PRKAA2
CC,GO:0005814,centriole,1.1103633727069224,4,0.48741705211139064,0.7347154857490886,NUBP2/PLA2G3/CEP128/WRAP73
CC,GO:1904949,ATPase complex,1.1460928871752145,3,0.48838896584122315,0.7347154857490886,RBBP7/INO80/RBBP4
BP,GO:0010634,positive regulation of epithelial cell migration,1.0874630134433028,5,0.4883913680573635,0.8131368995634778,SRPX2/MET/DOCK5/CLASP2/PDCD6
CC,GO:0032155,cell division site part,1.2249246730655732,2,0.4885486177824593,0.7347154857490886,PKN2/PPP1CC
BP,GO:0007623,circadian rhythm,1.0728240882623352,6,0.4888192237602873,0.8131368995634778,CDK4/HNRNPU/PRKAA2/ADCY1/BTRC/PPP1CC
BP,GO:1901215,negative regulation of neuron death,1.0728240882623352,6,0.4888192237602873,0.8131368995634778,GCLM/BAX/PIK3CA/FOXQ1/CDK5/GBA
MF,GO:0030695,GTPase regulator activity,1.0478486842105261,9,0.49093003179089545,0.7353370088247249,TBC1D22B/RGS17/ANKRD27/STARD13/BNIP2/DOCK5/ARHGAP12/AGFG1/RIN1
BP,GO:0001947,heart looping,1.2193847560577362,2,0.49104647751785657,0.8131368995634778,NDRG4/MICAL2
BP,GO:0006027,glycosaminoglycan catabolic process,1.2193847560577362,2,0.49104647751785657,0.8131368995634778,SDC1/IDUA
BP,GO:0007405,neuroblast proliferation,1.2193847560577362,2,0.49104647751785657,0.8131368995634778,DOCK7/FRS2
BP,GO:0030888,regulation of B cell proliferation,1.2193847560577362,2,0.49104647751785657,0.8131368995634778,CDKN1A/CARD11
BP,GO:0032233,positive regulation of actin filament bundle assembly,1.2193847560577362,2,0.49104647751785657,0.8131368995634778,TGFBR1/PAK1
BP,GO:0042733,embryonic digit morphogenesis,1.2193847560577362,2,0.49104647751785657,0.8131368995634778,BAX/IMPAD1
BP,GO:0048645,animal organ formation,1.2193847560577362,2,0.49104647751785657,0.8131368995634778,FRS2/RBPJ
BP,GO:0071384,cellular response to corticosteroid stimulus,1.2193847560577362,2,0.49104647751785657,0.8131368995634778,HNRNPU/AKR1C3
BP,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",1.2193847560577362,2,0.49104647751785657,0.8131368995634778,RC3H2/ARG2
CC,GO:0005741,mitochondrial outer membrane,1.0838518876844256,5,0.4912466153942545,0.7347154857490886,TOMM34/BAX/MCL1/TOMM20/PPP1CC
BP,GO:0006626,protein targeting to mitochondrion,1.1385071957069681,3,0.4928871275616499,0.8131368995634778,TOMM34/CSNK2A2/TOMM20
BP,GO:0006885,regulation of pH,1.1385071957069681,3,0.4928871275616499,0.8131368995634778,RAB7A/SNAPIN/TMEM199
BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,1.1385071957069681,3,0.4928871275616499,0.8131368995634778,RAB7A/CAPZA1/DCTN4
BP,GO:0031124,mRNA 3'-end processing,1.1385071957069681,3,0.4928871275616499,0.8131368995634778,PAPOLA/THOC5/WDR33
BP,GO:0048024,"regulation of mRNA splicing, via spliceosome",1.1385071957069681,3,0.4928871275616499,0.8131368995634778,CIRBP/CELF1/HNRNPU
BP,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,1.1385071957069681,3,0.4928871275616499,0.8131368995634778,MCL1/TRIAP1/PTPN1
BP,GO:0007018,microtubule-based movement,1.0513423338448327,8,0.4931742766815703,0.8131368995634778,KIF16B/DNAL4/VAMP7/TERF2/KIF13A/SNAPIN/HNRNPU/BLOC1S5
BP,GO:0051258,protein polymerization,1.0513423338448327,8,0.4931742766815703,0.8131368995634778,MAPRE1/MET/CAPZA1/DIAPH1/PAK1/CLASP2/MYO1C/CYFIP1
BP,GO:0010324,membrane invagination,1.1019625202892136,4,0.4934014792834295,0.8131368995634778,VAMP7/APPL2/FNBP1L/ARHGAP12
BP,GO:0032543,mitochondrial translation,1.1019625202892136,4,0.4934014792834295,0.8131368995634778,MTRF1L/TRUB2/NGRN/GATC
BP,GO:0006006,glucose metabolic process,1.0676909586534244,6,0.4934649073127588,0.8131368995634778,PGM1/PIK3CA/OMA1/INPPL1/EPM2AIP1/APOD
BP,GO:0021543,pallium development,1.0811405540628185,5,0.493514318284928,0.8131368995634778,PHLPP2/CSNK2A2/BAX/CDK6/CDK5
BP,GO:0002068,glandular epithelial cell development,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,CDK6
BP,GO:0003309,type B pancreatic cell differentiation,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,CDK6
BP,GO:0006688,glycosphingolipid biosynthetic process,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,ST6GALNAC6
BP,GO:0006851,mitochondrial calcium ion transmembrane transport,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,PSEN2
BP,GO:0007026,negative regulation of microtubule depolymerization,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,CLASP2
BP,GO:0009299,mRNA transcription,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,ARNT
BP,GO:0009404,toxin metabolic process,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,ARL1
BP,GO:0009648,photoperiodism,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,PPP1CC
BP,GO:0019054,modulation by virus of host process,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,KPNA5
BP,GO:0021680,cerebellar Purkinje cell layer development,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,LDB1
BP,GO:0021952,central nervous system projection neuron axonogenesis,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,C12orf57
BP,GO:0031069,hair follicle morphogenesis,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,FOXQ1
BP,GO:0032461,positive regulation of protein oligomerization,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,BAX
BP,GO:0032509,endosome transport via multivesicular body sorting pathway,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,CHMP1B
BP,GO:0034035,purine ribonucleoside bisphosphate metabolic process,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,IMPAD1
BP,GO:0035459,cargo loading into vesicle,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,KIF13A
BP,GO:0045956,positive regulation of calcium ion-dependent exocytosis,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,CDK5
BP,GO:0048103,somatic stem cell division,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,DOCK7
BP,GO:0051560,mitochondrial calcium ion homeostasis,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,PDZD8
BP,GO:0061050,regulation of cell growth involved in cardiac muscle cell development,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,PAK1
BP,GO:0071378,cellular response to growth hormone stimulus,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,PTPN1
BP,GO:0072012,glomerulus vasculature development,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,ACTA2
BP,GO:1904861,excitatory synapse assembly,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,IL1RAP
BP,GO:2000353,positive regulation of endothelial cell apoptotic process,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,AKR1C3
BP,GO:2000482,regulation of interleukin-8 secretion,1.4876494023904383,1,0.4943184740954967,0.8131368995634778,MAPKBP1
CC,GO:0030867,rough endoplasmic reticulum membrane,1.4840433539063675,1,0.49498106621483706,0.7347154857490886,RP9
CC,GO:0030894,replisome,1.4840433539063675,1,0.49498106621483706,0.7347154857490886,ERCC5
CC,GO:0033176,proton-transporting V-type ATPase complex,1.4840433539063675,1,0.49498106621483706,0.7347154857490886,TMEM199
CC,GO:0036452,ESCRT complex,1.4840433539063675,1,0.49498106621483706,0.7347154857490886,CHMP1B
CC,GO:0019005,SCF ubiquitin ligase complex,1.2057852250489236,2,0.49687113197751154,0.7354257379553509,FBXL12/BTRC
MF,GO:0000217,DNA secondary structure binding,1.4747500000000002,1,0.49756965389842933,0.7399069832978173,ERCC5
MF,GO:0015295,solute:proton symporter activity,1.4747500000000002,1,0.49756965389842933,0.7399069832978173,SLC36A1
MF,GO:0042923,neuropeptide binding,1.4747500000000002,1,0.49756965389842933,0.7399069832978173,NPBWR1
BP,GO:0097237,cellular response to toxic substance,1.0540026130296627,7,0.49761056368405576,0.8182214119105654,PDE8A/SESN1/MET/PLEKHA1/UBIAD1/ADCY7/STK26
MF,GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",1.129595744680851,3,0.4982395225660122,0.7399069832978173,IDUA/EDEM1/GBA
BP,GO:0055002,striated muscle cell development,1.0748911866982935,5,0.4986183240757651,0.8182788696905495,SDC1/ALPK3/PAK1/HNRNPU/ACTG1
BP,GO:0019395,fatty acid oxidation,1.1270071230230594,3,0.49965607473341533,0.8182788696905495,PRKAG2/APPL2/ACAD11
BP,GO:0034340,response to type I interferon,1.1270071230230594,3,0.49965607473341533,0.8182788696905495,YTHDF3/PTPN1/CNOT7
BP,GO:0032922,circadian regulation of gene expression,1.199717259992289,2,0.4996570089260878,0.8182788696905495,HNRNPU/PPP1CC
BP,GO:0046824,positive regulation of nucleocytoplasmic transport,1.199717259992289,2,0.4996570089260878,0.8182788696905495,NEDD4/XPO4
BP,GO:0048857,neural nucleus development,1.199717259992289,2,0.4996570089260878,0.8182788696905495,SUDS3/MAPKAP1
BP,GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,1.199717259992289,2,0.4996570089260878,0.8182788696905495,TGFBR1/CSNK2B
BP,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1.199717259992289,2,0.4996570089260878,0.8182788696905495,BAX/PTPN1
BP,GO:1901862,negative regulation of muscle tissue development,1.199717259992289,2,0.4996570089260878,0.8182788696905495,PAK1/FRS2
BP,GO:1905818,regulation of chromosome separation,1.199717259992289,2,0.4996570089260878,0.8182788696905495,CSNK2A2/CDC26
MF,GO:0004536,deoxyribonuclease activity,1.1997966101694917,2,0.499770181880254,0.7405976042788412,MBD4/ERCC5
BP,GO:0001666,response to hypoxia,1.0359675504111687,10,0.49989223501870084,0.8183346527388632,HP1BP3/EGLN3/ARNT/PSEN2/PAK1/CLDN3/RBPJ/ARNT2/UCP2/P4HB
BP,GO:0050673,epithelial cell proliferation,1.0283290799933904,12,0.5020883226123841,0.8193618508822239,BAX/CDK6/TGFBR1/VDR/RPS6KA1/ARNT/DUSP10/PYGO2/BTRC/FRS2/NUPR1/PDCD6
BP,GO:0006936,muscle contraction,1.0330898627711376,10,0.5034328713198621,0.8193618508822239,ARG2/ACTA2/C12orf57/PIK3CA/STAC/DOCK5/TPM4/PDE4B/MYL6B/ASPH
BP,GO:0006941,striated muscle contraction,1.0687136511425561,5,0.5037027481396279,0.8193618508822239,ARG2/C12orf57/PIK3CA/STAC/PDE4B
BP,GO:0072655,establishment of protein localization to mitochondrion,1.0858754761974,4,0.5048964212339613,0.8193618508822239,TOMM34/CSNK2A2/BAX/TOMM20
BP,GO:0019318,hexose metabolic process,1.0455367285876573,7,0.5061191439944002,0.8193618508822239,PGM1/PIK3CA/OMA1/INPPL1/FUT1/EPM2AIP1/APOD
BP,GO:0071560,cellular response to transforming growth factor beta stimulus,1.0455367285876573,7,0.5061191439944002,0.8193618508822239,TAB1/TGFBR1/ACVR2B/MAP3K7/APPL2/CLDN1/YES1
BP,GO:0061640,cytoskeleton-dependent cytokinesis,1.1157370517928287,3,0.506378957109899,0.8193618508822239,VPS4A/NUP62/CHMP1B
BP,GO:2001023,regulation of response to drug,1.1157370517928287,3,0.506378957109899,0.8193618508822239,PDE8A/MET/STK26
BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,FAM49B
BP,GO:0006309,apoptotic DNA fragmentation,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,BAX
BP,GO:0006700,C21-steroid hormone biosynthetic process,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,STARD3NL
BP,GO:0007020,microtubule nucleation,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,CLASP2
BP,GO:0015985,"energy coupled proton transport, down electrochemical gradient",1.4304321176831136,1,0.5079334982845052,0.8193618508822239,DNAJC30
BP,GO:0015986,ATP synthesis coupled proton transport,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,DNAJC30
BP,GO:0022400,regulation of rhodopsin mediated signaling pathway,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,NMT2
BP,GO:0030318,melanocyte differentiation,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,MYO5A
BP,GO:0032366,intracellular sterol transport,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,VPS4A
BP,GO:0032367,intracellular cholesterol transport,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,VPS4A
BP,GO:0032800,receptor biosynthetic process,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,CNPY2
BP,GO:0032957,inositol trisphosphate metabolic process,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,PLCD4
BP,GO:0034453,microtubule anchoring,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,CLASP2
BP,GO:0035268,protein mannosylation,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,DPM2
BP,GO:0036152,phosphatidylethanolamine acyl-chain remodeling,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,PLA2G3
BP,GO:0043090,amino acid import,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,SLC7A1
BP,GO:0048596,embryonic camera-type eye morphogenesis,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,FRS2
BP,GO:0051125,regulation of actin nucleation,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,CYFIP1
BP,GO:0060037,pharyngeal system development,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,TGFBR1
BP,GO:0060740,prostate gland epithelium morphogenesis,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,FRS2
BP,GO:0060914,heart formation,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,RBPJ
BP,GO:0070911,global genome nucleotide-excision repair,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,GTF2H1
BP,GO:0071711,basement membrane organization,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,CLASP2
BP,GO:0072539,T-helper 17 cell differentiation,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,RC3H2
BP,GO:0099560,synaptic membrane adhesion,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,IL1RAP
BP,GO:1900120,regulation of receptor binding,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,LDOC1
BP,GO:1903579,negative regulation of ATP metabolic process,1.4304321176831136,1,0.5079334982845052,0.8193618508822239,NUPR1
CC,GO:0001891,phagocytic cup,1.4290787852431686,1,0.5080867833020455,0.7441044936873293,ARHGAP12
CC,GO:0005686,U2 snRNP,1.4290787852431686,1,0.5080867833020455,0.7441044936873293,HTATSF1
CC,GO:0005689,U12-type spliceosomal complex,1.4290787852431686,1,0.5080867833020455,0.7441044936873293,LSM7
BP,GO:0007062,sister chromatid cohesion,1.1806741288813003,2,0.5081735373096978,0.8193618508822239,STAG2/BOD1
BP,GO:0035418,protein localization to synapse,1.1806741288813003,2,0.5081735373096978,0.8193618508822239,TERF2/CDK5
BP,GO:0042982,amyloid precursor protein metabolic process,1.1806741288813003,2,0.5081735373096978,0.8193618508822239,ITM2B/PSEN2
CC,GO:0098793,presynapse,1.0216021458662978,13,0.5084476002930696,0.7441044936873293,VAMP4/STX12/COPS5/VAMP7/PNISR/RAB15/SNAPIN/PSEN2/CDK5/ACTG1/PDE4B/PPP1CC/CYFIP1
MF,GO:0004190,aspartic-type endopeptidase activity,1.4157600000000001,1,0.5117842848637881,0.7472480629838923,PSEN2
MF,GO:0005104,fibroblast growth factor receptor binding,1.4157600000000001,1,0.5117842848637881,0.7472480629838923,FRS2
MF,GO:0008139,nuclear localization sequence binding,1.4157600000000001,1,0.5117842848637881,0.7472480629838923,KPNA5
MF,GO:0023023,MHC protein complex binding,1.4157600000000001,1,0.5117842848637881,0.7472480629838923,FAM49B
MF,GO:0043027,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,1.4157600000000001,1,0.5117842848637881,0.7472480629838923,RPS6KA1
MF,GO:0102567,"phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)",1.4157600000000001,1,0.5117842848637881,0.7472480629838923,PLA2G3
MF,GO:0102568,"phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)",1.4157600000000001,1,0.5117842848637881,0.7472480629838923,PLA2G3
BP,GO:0010876,lipid localization,1.0227589641434265,11,0.5128158619248842,0.8259226461996748,PLA2G3/PRKAG2/STX12/VAMP7/VPS4A/PRKAA2/PDZD8/TRIAP1/OSBP2/APOD/FITM2
BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,1.1046901502899293,3,0.5130547018059435,0.8259226461996748,RAB7A/CAPZA1/DCTN4
BP,GO:0046545,development of primary female sexual characteristics,1.1046901502899293,3,0.5130547018059435,0.8259226461996748,BAX/PLEKHA1/NUPR1
BP,GO:0097006,regulation of plasma lipoprotein particle levels,1.1046901502899293,3,0.5130547018059435,0.8259226461996748,PLAGL2/P4HB/CNPY2
CC,GO:0035869,ciliary transition zone,1.16924627883532,2,0.5132544691328293,0.7490352336644371,CDKL1/PCDHB13
BP,GO:0051897,positive regulation of protein kinase B signaling,1.0565691778341182,5,0.5138103818149218,0.8268119593445814,MET/TGFBR1/PIK3CA/FRS2/AKR1C3
BP,GO:0006720,isoprenoid metabolic process,1.0702513686262145,4,0.5162747864180732,0.8278684356427399,CYP26B1/SDC1/DPM2/AKR1C3
BP,GO:0016571,histone methylation,1.0702513686262145,4,0.5162747864180732,0.8278684356427399,KDM3A/RTF1/PRMT2/PYGO2
BP,GO:0031333,negative regulation of protein complex assembly,1.0702513686262145,4,0.5162747864180732,0.8278684356427399,MAPRE1/ANKRD27/CAPZA1/GBA
BP,GO:0006364,rRNA processing,1.0427449082175968,6,0.5164732249367289,0.8278684356427399,ZNHIT6/FCF1/WDR55/BTRC/TRMT112/C1D
BP,GO:0016051,carbohydrate biosynthetic process,1.0427449082175968,6,0.5164732249367289,0.8278684356427399,PGM1/HAS3/IMPAD1/ST6GALNAC6/EPM2AIP1/B3GNT9
BP,GO:2001020,regulation of response to DNA damage stimulus,1.0427449082175968,6,0.5164732249367289,0.8278684356427399,THOC5/TERF2/MCL1/DTX3L/RNF168/TRIAP1
BP,GO:0006826,iron ion transport,1.1622260956175299,2,0.5165948850723754,0.8278684356427399,FTL/ISCU
BP,GO:0032768,regulation of monooxygenase activity,1.1622260956175299,2,0.5165948850723754,0.8278684356427399,VDR/TERF2
BP,GO:0035773,insulin secretion involved in cellular response to glucose stimulus,1.1622260956175299,2,0.5165948850723754,0.8278684356427399,ANO1/MPC2
BP,GO:0045600,positive regulation of fat cell differentiation,1.1622260956175299,2,0.5165948850723754,0.8278684356427399,ASXL2/HNRNPU
BP,GO:0007416,synapse assembly,1.0505998604452247,5,0.5188323966007233,0.8278684356427399,SRPX2/GNPAT/CDK5/PCDHB13/IL1RAP
BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,1.0938598546988516,3,0.519682290293767,0.8278684356427399,RAB7A/CAPZA1/DCTN4
BP,GO:0010522,regulation of calcium ion transport into cytosol,1.0938598546988516,3,0.519682290293767,0.8278684356427399,BAX/DIAPH1/MYO5A
BP,GO:0030148,sphingolipid biosynthetic process,1.0938598546988516,3,0.519682290293767,0.8278684356427399,ST6GALNAC6/SGMS2/GBA
CC,GO:0044295,axonal growth cone,1.3780402571987698,1,0.5208530430142166,0.7523661688790885,CYFIP1
CC,GO:0070461,SAGA-type complex,1.3780402571987698,1,0.5208530430142166,0.7523661688790885,TADA3
BP,GO:0010810,regulation of cell-substrate adhesion,1.0378949319003057,6,0.5210274861179589,0.8278684356427399,ITGA6/CDK6/DOCK5/CLASP2/APOD/LDB1
BP,GO:0006869,lipid transport,1.018937946842766,10,0.5210293487010944,0.8278684356427399,PLA2G3/PRKAG2/STX12/VAMP7/VPS4A/PRKAA2/PDZD8/TRIAP1/OSBP2/APOD
BP,GO:0000188,inactivation of MAPK activity,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,DUSP10
BP,GO:0003148,outflow tract septum morphogenesis,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,PARVA
BP,GO:0006706,steroid catabolic process,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,HSD17B14
BP,GO:0006884,cell volume homeostasis,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,ANXA7
BP,GO:0009649,entrainment of circadian clock,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,PPP1CC
BP,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,CDK4
BP,GO:0031167,rRNA methylation,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,TRMT112
BP,GO:0032201,telomere maintenance via semi-conservative replication,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,TERF2
BP,GO:0035883,enteroendocrine cell differentiation,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,CDK6
BP,GO:0039528,cytoplasmic pattern recognition receptor signaling pathway in response to virus,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,ZCCHC3
BP,GO:0042501,serine phosphorylation of STAT protein,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,CDK5
BP,GO:0043032,positive regulation of macrophage activation,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,TNIP2
BP,GO:0045671,negative regulation of osteoclast differentiation,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,TOB2
BP,GO:0045932,negative regulation of muscle contraction,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,DOCK5
BP,GO:0061437,renal system vasculature development,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,ACTA2
BP,GO:0061440,kidney vasculature development,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,ACTA2
BP,GO:0071514,genetic imprinting,1.3774531503615168,1,0.5211826606885588,0.8278684356427399,PIK3CA
CC,GO:0001725,stress fiber,1.1517948418377777,2,0.5213132187434759,0.7523661688790885,DCTN4/TPM4
CC,GO:0097517,contractile actin filament bundle,1.1517948418377777,2,0.5213132187434759,0.7523661688790885,DCTN4/TPM4
BP,GO:0016072,rRNA metabolic process,1.0290065036297498,7,0.522988267594821,0.8292443691129816,ZNHIT6/CD3EAP/FCF1/WDR55/BTRC/TRMT112/C1D
BP,GO:0050821,protein stabilization,1.0446976140382291,5,0.5238324398981862,0.8292443691129816,STX12/CDKN1A/TRIM44/TNIP2/OTUD3
BP,GO:0032259,methylation,1.0161539633814467,10,0.52452564476591,0.8292443691129816,METTL22/HSD17B10/TRMT2A/KDM3A/PIK3CA/RTF1/PRMT2/PYGO2/TRMT112/TRMT2B
BP,GO:0060271,cilium assembly,1.0161539633814467,10,0.52452564476591,0.8292443691129816,PLA2G3/CDKL1/MAPRE1/WRAP73/WDR11/ATXN10/FNBP1L/TAPT1/TTC36/PARVA
BP,GO:0010632,regulation of epithelial cell migration,1.0224394518147342,8,0.524781869787331,0.8292443691129816,SRPX2/MET/STARD13/DUSP10/DOCK5/CLASP2/CSNK2B/PDCD6
BP,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",1.144345694146491,2,0.5249200055283347,0.8292443691129816,CELF1/HNRNPU
BP,GO:0006026,aminoglycan catabolic process,1.144345694146491,2,0.5249200055283347,0.8292443691129816,SDC1/IDUA
BP,GO:0032729,positive regulation of interferon-gamma production,1.144345694146491,2,0.5249200055283347,0.8292443691129816,FAM49B/PDE4B
BP,GO:0045739,positive regulation of DNA repair,1.144345694146491,2,0.5249200055283347,0.8292443691129816,DTX3L/RNF168
BP,GO:0048663,neuron fate commitment,1.144345694146491,2,0.5249200055283347,0.8292443691129816,TGFBR1/RBPJ
BP,GO:0050854,regulation of antigen receptor-mediated signaling pathway,1.144345694146491,2,0.5249200055283347,0.8292443691129816,CMTM3/BCL10
BP,GO:0051148,negative regulation of muscle cell differentiation,1.144345694146491,2,0.5249200055283347,0.8292443691129816,PAK1/FRS2
BP,GO:0060389,pathway-restricted SMAD protein phosphorylation,1.144345694146491,2,0.5249200055283347,0.8292443691129816,TGFBR1/CSNK2B
BP,GO:0072577,endothelial cell apoptotic process,1.144345694146491,2,0.5249200055283347,0.8292443691129816,TNIP2/AKR1C3
MF,GO:0004033,aldo-keto reductase (NADP) activity,1.3613076923076923,1,0.5255975407243647,0.7578636738660446,AKR1C3
MF,GO:0004435,phosphatidylinositol phospholipase C activity,1.3613076923076923,1,0.5255975407243647,0.7578636738660446,PLCD4
MF,GO:0035925,mRNA 3'-UTR AU-rich region binding,1.3613076923076923,1,0.5255975407243647,0.7578636738660446,HNRNPA0
MF,GO:0043015,gamma-tubulin binding,1.3613076923076923,1,0.5255975407243647,0.7578636738660446,PDE4B
MF,GO:0051787,misfolded protein binding,1.3613076923076923,1,0.5255975407243647,0.7578636738660446,EDEM1
MF,GO:0070001,aspartic-type peptidase activity,1.3613076923076923,1,0.5255975407243647,0.7578636738660446,PSEN2
BP,GO:0051983,regulation of chromosome segregation,1.0832398561095424,3,0.5262607572430462,0.8292443691129816,CSNK2A2/HNRNPU/CDC26
BP,GO:1902106,negative regulation of leukocyte differentiation,1.0832398561095424,3,0.5262607572430462,0.8292443691129816,RC3H2/CDK6/TOB2
BP,GO:0070585,protein localization to mitochondrion,1.055070498149247,4,0.5275304368079019,0.8292443691129816,TOMM34/CSNK2A2/BAX/TOMM20
BP,GO:0005996,monosaccharide metabolic process,1.018937946842766,8,0.5286851552746883,0.8292443691129816,PGM1/DHDH/PIK3CA/OMA1/INPPL1/FUT1/EPM2AIP1/APOD
BP,GO:0009410,response to xenobiotic stimulus,1.018937946842766,8,0.5286851552746883,0.8292443691129816,CYP26B1/RGS17/ARNT/CLDN1/CMBL/CDK5/ARNT2/GBA
BP,GO:0090287,regulation of cellular response to growth factor stimulus,1.018937946842766,8,0.5286851552746883,0.8292443691129816,NEDD4/TGFBR1/ARNT/RBPJ/PTPN1/MYO1C/PDCD6/CYFIP1
CC,GO:0030139,endocytic vesicle,1.018749233044635,8,0.5288193512184045,0.7596584162462984,RAB7A/KIF16B/STX12/VAMP7/HEATR5A/APPL2/ACTG1/MYO1C
CC,GO:0032153,cell division site,1.134856682398987,2,0.5292821594959815,0.7596584162462984,PKN2/PPP1CC
BP,GO:0044242,cellular lipid catabolic process,1.0283290799933904,6,0.5300849239688208,0.8292443691129816,CYP26B1/DDHD2/LPIN3/GBA/AKR1C3/ACAD11
BP,GO:0071241,cellular response to inorganic substance,1.0283290799933904,6,0.5300849239688208,0.8292443691129816,RASGRP2/ADCY7/PRKAA2/CLDN1/ADCY1/AKR1C3
BP,GO:0051235,maintenance of location,1.0143064107207533,9,0.530121266402113,0.8292443691129816,FTL/BAX/DIAPH1/G3BP2/HNRNPU/CDK5/TAPT1/FITM2/MYO5A
BP,GO:0071559,response to transforming growth factor beta,1.0209358643855948,7,0.53134275275979,0.8292443691129816,TAB1/TGFBR1/ACVR2B/MAP3K7/APPL2/CLDN1/YES1
BP,GO:0001523,retinoid metabolic process,1.0728240882623352,3,0.5327891893577668,0.8292443691129816,CYP26B1/SDC1/AKR1C3
BP,GO:0006415,translational termination,1.0728240882623352,3,0.5327891893577668,0.8292443691129816,MTRF1L/EIF5A2/TRMT112
BP,GO:0019233,sensory perception of pain,1.0728240882623352,3,0.5327891893577668,0.8292443691129816,ANO1/CDK5/POMK
BP,GO:0046928,regulation of neurotransmitter secretion,1.0728240882623352,3,0.5327891893577668,0.8292443691129816,SNAPIN/ADCY1/CDK5
BP,GO:1902904,negative regulation of supramolecular fiber organization,1.0476404242186186,4,0.5331104437652165,0.8292443691129816,MAPRE1/MET/CAPZA1/CLASP2
BP,GO:0040014,regulation of multicellular organism growth,1.1270071230230594,2,0.533147976739522,0.8292443691129816,PIK3CA/CDK4
BP,GO:0048207,"vesicle targeting, rough ER to cis-Golgi",1.1270071230230594,2,0.533147976739522,0.8292443691129816,MCFD2/PDCD6
BP,GO:0048208,COPII vesicle coating,1.1270071230230594,2,0.533147976739522,0.8292443691129816,MCFD2/PDCD6
BP,GO:0051785,positive regulation of nuclear division,1.1270071230230594,2,0.533147976739522,0.8292443691129816,HNRNPU/NUP62
BP,GO:1901880,negative regulation of protein depolymerization,1.1270071230230594,2,0.533147976739522,0.8292443691129816,CAPZA1/CLASP2
BP,GO:1904888,cranial skeletal system development,1.1270071230230594,2,0.533147976739522,0.8292443691129816,TGFBR1/MTHFD1L
CC,GO:0016342,catenin complex,1.3305216276401914,1,0.5332886210029278,0.7633059657761687,CDH20
BP,GO:0001516,prostaglandin biosynthetic process,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,AKR1C3
BP,GO:0001773,myeloid dendritic cell activation,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,RBPJ
BP,GO:0006972,hyperosmotic response,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,CLDN1
BP,GO:0008045,motor neuron axon guidance,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,CDK5
BP,GO:0008209,androgen metabolic process,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,PLEKHA1
BP,GO:0021846,cell proliferation in forebrain,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,DOCK7
BP,GO:0031440,regulation of mRNA 3'-end processing,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,PAPOLA
BP,GO:0032196,transposition,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,PGBD5
BP,GO:0032770,positive regulation of monooxygenase activity,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,TERF2
BP,GO:0033137,negative regulation of peptidyl-serine phosphorylation,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,BAX
BP,GO:0043501,skeletal muscle adaptation,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,GTF2IRD2
BP,GO:0045408,regulation of interleukin-6 biosynthetic process,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,CARD9
BP,GO:0045577,regulation of B cell differentiation,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,CARD11
BP,GO:0045686,negative regulation of glial cell differentiation,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,DUSP10
BP,GO:0046457,prostanoid biosynthetic process,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,AKR1C3
BP,GO:0051123,RNA polymerase II preinitiation complex assembly,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,TBP
BP,GO:0051984,positive regulation of chromosome segregation,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,HNRNPU
BP,GO:0060512,prostate gland morphogenesis,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,FRS2
BP,GO:0070198,"protein localization to chromosome, telomeric region",1.3282583949914628,1,0.5340757736175054,0.8292443691129816,TERF2
BP,GO:0070861,regulation of protein exit from endoplasmic reticulum,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,EDEM1
BP,GO:0085029,extracellular matrix assembly,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,HAS3
BP,GO:0090383,phagosome acidification,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,RAB7A
BP,GO:1900543,negative regulation of purine nucleotide metabolic process,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,NUPR1
BP,GO:2000108,positive regulation of leukocyte apoptotic process,1.3282583949914628,1,0.5340757736175054,0.8292443691129816,BAX
BP,GO:0032271,regulation of protein polymerization,1.0236119741218612,6,0.53458722594029,0.8297217989794351,MAPRE1/MET/CAPZA1/PAK1/MYO1C/CYFIP1
MF,GO:0019843,rRNA binding,1.1236190476190475,2,0.5349394227784592,0.7636083858931199,CIRBP/NGRN
MF,GO:0036002,pre-mRNA binding,1.1236190476190475,2,0.5349394227784592,0.7636083858931199,CELF1/HNRNPU
MF,GO:0051536,iron-sulfur cluster binding,1.1236190476190475,2,0.5349394227784592,0.7636083858931199,NUBP2/ISCU
MF,GO:0051540,metal cluster binding,1.1236190476190475,2,0.5349394227784592,0.7636083858931199,NUBP2/ISCU
BP,GO:0007611,learning or memory,1.0169478336653386,7,0.5354987063646888,0.8308195032385789,CTNS/DDHD2/NDRG4/ADCY1/CDK5/RIN1/POMK
BP,GO:0036293,response to decreased oxygen levels,1.0051685151286744,10,0.5384265388374363,0.8315855905825849,HP1BP3/EGLN3/ARNT/PSEN2/PAK1/CLDN3/RBPJ/ARNT2/UCP2/P4HB
BP,GO:0030879,mammary gland development,1.040314267405901,4,0.5386576647756621,0.8315855905825849,BAX/VDR/PYGO2/BTRC
BP,GO:0010565,regulation of cellular ketone metabolic process,1.027382183971297,5,0.5386952405832027,0.8315855905825849,PRKAG2/LPGAT1/APPL2/PRKAA2/AKR1C3
BP,GO:0048015,phosphatidylinositol-mediated signaling,1.027382183971297,5,0.5386952405832027,0.8315855905825849,NEDD4/PLEKHA1/PIK3CA/PIP4K2A/ENTPD5
BP,GO:0051147,regulation of muscle cell differentiation,1.027382183971297,5,0.5386952405832027,0.8315855905825849,CYP26B1/BNIP2/PAK1/FRS2/RBPJ
MF,GO:0004364,glutathione transferase activity,1.310888888888889,1,0.5390207329397354,0.7636083858931199,LANCL1
BP,GO:0048762,mesenchymal cell differentiation,1.018937946842766,6,0.5390713504281206,0.8315855905825849,TGFBR1/CLASP2/SDHAF2/RBPJ/TAPT1/PDCD6
BP,GO:0050808,synapse organization,1.0027048668072807,11,0.5394165560591155,0.8315855905825849,ALS2/NEDD4/SRPX2/GNPAT/SNAPIN/CDK5/ACTG1/PCDHB13/IL1RAP/MYO5A/CYFIP1
BP,GO:0048863,stem cell differentiation,1.0129908382036057,7,0.5396400024127881,0.8315855905825849,CDK6/KDM3A/HNRNPU/RBPJ/TAPT1/LDB1/PDCD6
BP,GO:0003143,embryonic heart tube morphogenesis,1.1101861211868942,2,0.5412779955884741,0.8315855905825849,NDRG4/MICAL2
BP,GO:0032387,negative regulation of intracellular transport,1.1101861211868942,2,0.5412779955884741,0.8315855905825849,CDK5/APOD
BP,GO:0042108,positive regulation of cytokine biosynthetic process,1.1101861211868942,2,0.5412779955884741,0.8315855905825849,BCL10/CARD11
BP,GO:0042274,ribosomal small subunit biogenesis,1.1101861211868942,2,0.5412779955884741,0.8315855905825849,FCF1/BTRC
BP,GO:0051298,centrosome duplication,1.1101861211868942,2,0.5412779955884741,0.8315855905825849,NUP62/CHMP1B
BP,GO:0061371,determination of heart left/right asymmetry,1.1101861211868942,2,0.5412779955884741,0.8315855905825849,NDRG4/MICAL2
BP,GO:0016049,cell growth,0.998938131770439,13,0.5413799442606206,0.8315855905825849,RASGRP2/RBBP7/TGFBR1/RPS6KA1/CDKN1A/INO80/PAK1/ZFYVE27/PRMT2/CDK5/CRLF3/TSPYL2/CYFIP1
MF,GO:0004402,histone acetyltransferase activity,1.1060625,2,0.5434629797642396,0.7636083858931199,KANSL3/TADA3
MF,GO:0004521,endoribonuclease activity,1.1060625,2,0.5434629797642396,0.7636083858931199,SMG6/TSEN34
BP,GO:0061138,morphogenesis of a branching epithelium,1.0217372269165097,5,0.5436019757667985,0.8315855905825849,MET/VDR/PAK1/BTRC/FRS2
MF,GO:0005088,Ras guanyl-nucleotide exchange factor activity,1.0334014598540147,4,0.5440582143360806,0.7636083858931199,ALS2/SBF2/DENND6A/RCC1
MF,GO:0019838,growth factor binding,1.0334014598540147,4,0.5440582143360806,0.7636083858931199,ITGA6/SRPX2/TGFBR1/ACVR2B
BP,GO:0030534,adult behavior,1.0330898627711376,4,0.5441714520692713,0.8315855905825849,CTNS/USP46/RNF180/CDK5
BP,GO:0043312,neutrophil degranulation,0.996878465519366,13,0.5444063092062779,0.8315855905825849,RAB7A/PGM1/PPIE/FTL/PYGL/VAMP7/PTPRB/DIAPH1/CALML5/RAP2B/C6orf120/CSNK2B/CYFIP1
BP,GO:0030336,negative regulation of cell migration,1.002159028556433,9,0.5447111979893506,0.8315855905825849,NDRG4/RAP2A/STARD13/STK26/DUSP10/CLASP2/RAP2B/APOD/CSNK2B
CC,GO:0005657,replication fork,1.102432205759016,2,0.5449476531879579,0.7742628791256696,ZMIZ2/ERCC5
CC,GO:0000803,sex chromosome,1.2861709067188518,1,0.5454020664858363,0.7742628791256696,HNRNPU
CC,GO:0002102,podosome,1.2861709067188518,1,0.5454020664858363,0.7742628791256696,TPM4
BP,GO:0002456,T cell mediated immunity,1.0525821243328572,3,0.5456925490830744,0.8315855905825849,MAP3K7/FAM49B/IL7R
BP,GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,KLF11
BP,GO:0005979,regulation of glycogen biosynthetic process,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,EPM2AIP1
BP,GO:0007271,"synaptic transmission, cholinergic",1.2824563813710674,1,0.5466223867300471,0.8315855905825849,RIC3
BP,GO:0007628,adult walking behavior,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,CTNS
BP,GO:0008299,isoprenoid biosynthetic process,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,AKR1C3
BP,GO:0010575,positive regulation of vascular endothelial growth factor production,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,ARNT
BP,GO:0010669,epithelial structure maintenance,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,LDB1
BP,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,PRKAG2
BP,GO:0010962,regulation of glucan biosynthetic process,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,EPM2AIP1
BP,GO:0014044,Schwann cell development,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,CDK5
BP,GO:0015949,nucleobase-containing small molecule interconversion,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,CMPK1
BP,GO:0016056,rhodopsin mediated signaling pathway,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,NMT2
BP,GO:0021799,cerebral cortex radially oriented cell migration,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,CDK5
BP,GO:0030970,"retrograde protein transport, ER to cytosol",1.2824563813710674,1,0.5466223867300471,0.8315855905825849,EDEM1
BP,GO:0031063,regulation of histone deacetylation,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,TADA3
BP,GO:0031114,regulation of microtubule depolymerization,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,CLASP2
BP,GO:0031365,N-terminal protein amino acid modification,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,NMT2
BP,GO:0044030,regulation of DNA methylation,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,PIK3CA
BP,GO:0044068,modulation by symbiont of host cellular process,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,KPNA5
BP,GO:0045980,negative regulation of nucleotide metabolic process,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,NUPR1
BP,GO:0048730,epidermis morphogenesis,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,FOXQ1
BP,GO:0050855,regulation of B cell receptor signaling pathway,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,CMTM3
BP,GO:0060536,cartilage morphogenesis,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,SCARA3
BP,GO:0070723,response to cholesterol,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,TGFBR1
BP,GO:0072538,T-helper 17 type immune response,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,RC3H2
BP,GO:0072606,interleukin-8 secretion,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,MAPKBP1
BP,GO:1900027,regulation of ruffle assembly,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,CYFIP1
BP,GO:1900181,negative regulation of protein localization to nucleus,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,APOD
BP,GO:1903513,endoplasmic reticulum to cytosol transport,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,EDEM1
BP,GO:1990126,"retrograde transport, endosome to plasma membrane",1.2824563813710674,1,0.5466223867300471,0.8315855905825849,ANKRD27
BP,GO:2000036,regulation of stem cell population maintenance,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,KDM3A
BP,GO:2000727,positive regulation of cardiac muscle cell differentiation,1.2824563813710674,1,0.5466223867300471,0.8315855905825849,RBPJ
BP,GO:0006625,protein targeting to peroxisome,1.0938598546988516,2,0.5493093720786726,0.8327676032288378,AGPS/GNPAT
BP,GO:0010812,negative regulation of cell-substrate adhesion,1.0938598546988516,2,0.5493093720786726,0.8327676032288378,CLASP2/APOD
BP,GO:0033047,regulation of mitotic sister chromatid segregation,1.0938598546988516,2,0.5493093720786726,0.8327676032288378,HNRNPU/CDC26
BP,GO:0035914,skeletal muscle cell differentiation,1.0938598546988516,2,0.5493093720786726,0.8327676032288378,CYP26B1/NUPR1
BP,GO:0051965,positive regulation of synapse assembly,1.0938598546988516,2,0.5493093720786726,0.8327676032288378,SRPX2/IL1RAP
BP,GO:0071242,cellular response to ammonium ion,1.0938598546988516,2,0.5493093720786726,0.8327676032288378,DIAPH1/GABPA
BP,GO:0072662,protein localization to peroxisome,1.0938598546988516,2,0.5493093720786726,0.8327676032288378,AGPS/GNPAT
BP,GO:0072663,establishment of protein localization to peroxisome,1.0938598546988516,2,0.5493093720786726,0.8327676032288378,AGPS/GNPAT
BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1.025965105096854,4,0.5496511835470574,0.8327676032288378,RC3H2/MAP3K7/FAM49B/IL7R
BP,GO:0006119,oxidative phosphorylation,1.025965105096854,4,0.5496511835470574,0.8327676032288378,ISCU/SDHAF2/NUPR1/DNAJC30
BP,GO:0006865,amino acid transport,1.025965105096854,4,0.5496511835470574,0.8327676032288378,CTNS/SLC36A1/SLC7A1/PRAF2
BP,GO:0070661,leukocyte proliferation,0.9984224177117034,8,0.5518505076844968,0.8342487112651903,RC3H2/ARG2/BAX/ELF4/CCND3/CDKN1A/IL7R/CARD11
MF,GO:0004129,cytochrome-c oxidase activity,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,C15orf48
MF,GO:0004407,histone deacetylase activity,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,SUDS3
MF,GO:0004629,phospholipase C activity,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,PLCD4
MF,GO:0005520,insulin-like growth factor binding,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,ITGA6
MF,GO:0015002,heme-copper terminal oxidase activity,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,C15orf48
MF,GO:0016676,"oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor",1.2640714285714285,1,0.5520648548146718,0.7636083858931199,C15orf48
MF,GO:0017056,structural constituent of nuclear pore,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,NUP62
MF,GO:0017091,AU-rich element binding,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,HNRNPA0
MF,GO:0019706,protein-cysteine S-palmitoyltransferase activity,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,ZDHHC18
MF,GO:0019707,protein-cysteine S-acyltransferase activity,1.2640714285714285,1,0.5520648548146718,0.7636083858931199,ZDHHC18
BP,GO:0001909,leukocyte mediated cytotoxicity,1.0427449082175968,3,0.5520658997930008,0.8342487112651903,VAMP7/FAM49B/IL7R
BP,GO:0051341,regulation of oxidoreductase activity,1.0427449082175968,3,0.5520658997930008,0.8342487112651903,VDR/TERF2/RFK
BP,GO:0062014,negative regulation of small molecule metabolic process,1.0427449082175968,3,0.5520658997930008,0.8342487112651903,APPL2/NUPR1/AKR1C3
BP,GO:0098781,ncRNA transcription,1.0427449082175968,3,0.5520658997930008,0.8342487112651903,ELL/TBP/CD3EAP
BP,GO:0048017,inositol lipid-mediated signaling,1.0106313874935042,5,0.55334115152055,0.8342487112651903,NEDD4/PLEKHA1/PIK3CA/PIP4K2A/ENTPD5
BP,GO:0048639,positive regulation of developmental growth,1.0106313874935042,5,0.55334115152055,0.8342487112651903,PAK1/ZFYVE27/RBPJ/MTM1/CYFIP1
BP,GO:0002283,neutrophil activation involved in immune response,0.9907501142969108,13,0.5534448232542848,0.8342487112651903,RAB7A/PGM1/PPIE/FTL/PYGL/VAMP7/PTPRB/DIAPH1/CALML5/RAP2B/C6orf120/CSNK2B/CYFIP1
MF,GO:0042623,"ATPase activity, coupled",0.9970140845070423,8,0.553562618237957,0.7636083858931199,KIF16B/DNAL4/GTF2H1/MYO1B/INO80/VPS4A/RBBP4/MYO1C
BP,GO:1904892,regulation of STAT cascade,1.018937946842766,4,0.5550962624490963,0.8342487112651903,CDK5/IL7R/CRLF3/CNOT7
BP,GO:0110053,regulation of actin filament organization,0.9974660743997191,7,0.5560519206410739,0.8342487112651903,MET/TGFBR1/CAPZA1/PAK1/CLASP2/MYO1C/CYFIP1
CC,GO:0005865,striated muscle thin filament,1.244681522631147,1,0.5572017080780415,0.7817689672446526,TPM4
CC,GO:0008305,integrin complex,1.244681522631147,1,0.5572017080780415,0.7817689672446526,ITGA6
CC,GO:0030140,trans-Golgi network transport vesicle,1.244681522631147,1,0.5572017080780415,0.7817689672446526,SPG21
CC,GO:0030686,90S preribosome,1.244681522631147,1,0.5572017080780415,0.7817689672446526,BTRC
BP,GO:0042698,ovulation cycle,1.0780068133264045,2,0.5572415238544725,0.8342487112651903,PLEKHA1/NHLH2
BP,GO:0043574,peroxisomal transport,1.0780068133264045,2,0.5572415238544725,0.8342487112651903,AGPS/GNPAT
BP,GO:0055008,cardiac muscle tissue morphogenesis,1.0780068133264045,2,0.5572415238544725,0.8342487112651903,TGFBR1/RBPJ
BP,GO:0071300,cellular response to retinoic acid,1.0780068133264045,2,0.5572415238544725,0.8342487112651903,CYP26B1/YES1
BP,GO:0030004,cellular monovalent inorganic cation homeostasis,1.0330898627711376,3,0.5583860595439546,0.8342487112651903,RAB7A/SNAPIN/TMEM199
BP,GO:0046916,cellular transition metal ion homeostasis,1.0330898627711376,3,0.5583860595439546,0.8342487112651903,FTL/ISCU/TMEM199
BP,GO:0000027,ribosomal large subunit assembly,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,RSL24D1
BP,GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,BAX
BP,GO:0002828,regulation of type 2 immune response,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,ARG2
BP,GO:0003413,chondrocyte differentiation involved in endochondral bone morphogenesis,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,SCARA3
BP,GO:0035066,positive regulation of histone acetylation,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,RPS6KA4
BP,GO:0038111,interleukin-7-mediated signaling pathway,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,IL7R
BP,GO:0042759,long-chain fatty acid biosynthetic process,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,MYO5A
BP,GO:0044818,mitotic G2/M transition checkpoint,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,TAOK3
BP,GO:0045948,positive regulation of translational initiation,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,YTHDF3
BP,GO:0046596,regulation of viral entry into host cell,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,P4HB
BP,GO:0046640,regulation of alpha-beta T cell proliferation,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,ARG2
BP,GO:0048873,homeostasis of number of cells within a tissue,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,BAX
BP,GO:0061037,negative regulation of cartilage development,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,TGFBR1
BP,GO:0061082,myeloid leukocyte cytokine production,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,BCL10
BP,GO:0061157,mRNA destabilization,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,YTHDF3
BP,GO:0070979,protein K11-linked ubiquitination,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,CDC26
BP,GO:0071480,cellular response to gamma radiation,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,CDKN1A
BP,GO:0090200,positive regulation of release of cytochrome c from mitochondria,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,BAX
BP,GO:0099068,postsynapse assembly,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,IL1RAP
BP,GO:1902751,positive regulation of cell cycle G2/M phase transition,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,CDK4
BP,GO:1904292,regulation of ERAD pathway,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,EDEM1
BP,GO:1904837,beta-catenin-TCF complex assembly,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,PYGO2
BP,GO:1905476,negative regulation of protein localization to membrane,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,LZTFL1
BP,GO:1905606,regulation of presynapse assembly,1.2397078353253652,1,0.5588317940505515,0.8342487112651903,IL1RAP
CC,GO:0005759,mitochondrial matrix,0.987252721575238,12,0.5592743013751562,0.7817689672446526,CS/IDH3G/HSD17B10/ARG2/MTRF1L/MTHFD1L/ATG4D/ISCU/ALDH4A1/TK2/TRUB2/SDHAF2
MF,GO:0004222,metalloendopeptidase activity,1.030893203883495,3,0.5599824169170011,0.7636083858931199,COPS5/ADAMTS14/OMA1
MF,GO:0061733,peptide-lysine-N-acetyltransferase activity,1.0725454545454545,2,0.5601816933123146,0.7636083858931199,KANSL3/TADA3
BP,GO:0043524,negative regulation of neuron apoptotic process,1.0120063961839716,4,0.5605061170146599,0.8364412633953179,GCLM/BAX/PIK3CA/FOXQ1
MF,GO:0140097,"catalytic activity, acting on DNA",0.9970140845070422,6,0.560516287766477,0.7636083858931199,INO80/MBD4/TERF2/ERCC5/RAD54L2/PGBD5
BP,GO:0055001,muscle cell development,0.9997643833269074,5,0.5629781416335673,0.8383665845952104,SDC1/ALPK3/PAK1/HNRNPU/ACTG1
CC,GO:0034708,methyltransferase complex,1.0243839080061652,3,0.5640228281134959,0.7817689672446526,CBX5/RBBP7/RBBP4
CC,GO:0097733,photoreceptor cell cilium,1.0243839080061652,3,0.5640228281134959,0.7817689672446526,PHLPP2/PCDHB13/MYO5A
BP,GO:0051149,positive regulation of muscle cell differentiation,1.0236119741218612,3,0.5646523577647055,0.8383665845952104,CYP26B1/BNIP2/RBPJ
MF,GO:0016675,"oxidoreductase activity, acting on a heme group of donors",1.2204827586206897,1,0.5647405904303073,0.7636083858931199,C15orf48
MF,GO:0033558,protein deacetylase activity,1.2204827586206897,1,0.5647405904303073,0.7636083858931199,SUDS3
MF,GO:0043236,laminin binding,1.2204827586206897,1,0.5647405904303073,0.7636083858931199,ITGA6
MF,GO:0043539,protein serine/threonine kinase activator activity,1.2204827586206897,1,0.5647405904303073,0.7636083858931199,ALS2
MF,GO:0045505,dynein intermediate chain binding,1.2204827586206897,1,0.5647405904303073,0.7636083858931199,DNAL4
MF,GO:0051059,NF-kappaB binding,1.2204827586206897,1,0.5647405904303073,0.7636083858931199,BCL10
MF,GO:0051959,dynein light intermediate chain binding,1.2204827586206897,1,0.5647405904303073,0.7636083858931199,DNAL4
MF,GO:0070566,adenylyltransferase activity,1.2204827586206897,1,0.5647405904303073,0.7636083858931199,PAPOLA
MF,GO:0071889,14-3-3 protein binding,1.2204827586206897,1,0.5647405904303073,0.7636083858931199,TBC1D22B
BP,GO:0006901,vesicle coating,1.0626067159931702,2,0.5650739709329569,0.8383665845952104,MCFD2/PDCD6
BP,GO:0050766,positive regulation of phagocytosis,1.0626067159931702,2,0.5650739709329569,0.8383665845952104,APPL2/MYO18A
BP,GO:0001649,osteoblast differentiation,0.9917662682602921,6,0.5655720079088788,0.8383665845952104,CDK6/ASF1A/ACVR2B/HNRNPU/TPM4/SMOC1
BP,GO:0050678,regulation of epithelial cell proliferation,0.9838951074010834,10,0.565779005007806,0.8383665845952104,BAX/CDK6/TGFBR1/VDR/ARNT/DUSP10/PYGO2/FRS2/NUPR1/PDCD6
BP,GO:0008643,carbohydrate transport,1.0051685151286744,4,0.5658802001350498,0.8383665845952104,PRKAG2/APPL2/CAPN10/YES1
BP,GO:0035107,appendage morphogenesis,1.0051685151286744,4,0.5658802001350498,0.8383665845952104,CYP26B1/BAX/IMPAD1/ASPH
BP,GO:0035108,limb morphogenesis,1.0051685151286744,4,0.5658802001350498,0.8383665845952104,CYP26B1/BAX/IMPAD1/ASPH
BP,GO:0051494,negative regulation of cytoskeleton organization,1.0051685151286744,4,0.5658802001350498,0.8383665845952104,MAPRE1/MET/CAPZA1/CLASP2
CC,GO:0032592,integral component of mitochondrial membrane,1.0571267726456317,2,0.5677563410807223,0.7817689672446526,MPC2/TOMM20
CC,GO:0070821,tertiary granule membrane,1.0571267726456317,2,0.5677563410807223,0.7817689672446526,PTPRB/RAP2B
CC,GO:0009898,cytoplasmic side of plasma membrane,1.0022110961445598,4,0.5681057155243723,0.7817689672446526,CYTH1/STAC/YES1/CBX6
CC,GO:0032839,dendrite cytoplasm,1.2057852250489236,1,0.5686956594735573,0.7817689672446526,HNRNPU
CC,GO:0036379,myofilament,1.2057852250489236,1,0.5686956594735573,0.7817689672446526,TPM4
BP,GO:0001963,"synaptic transmission, dopaminergic",1.199717259992289,1,0.5707130407987605,0.8383665845952104,CDK5
BP,GO:0002724,regulation of T cell cytokine production,1.199717259992289,1,0.5707130407987605,0.8383665845952104,MAP3K7
BP,GO:0009954,proximal/distal pattern formation,1.199717259992289,1,0.5707130407987605,0.8383665845952104,CYP26B1
BP,GO:0010165,response to X-ray,1.199717259992289,1,0.5707130407987605,0.8383665845952104,CDKN1A
BP,GO:0010458,exit from mitosis,1.199717259992289,1,0.5707130407987605,0.8383665845952104,CLASP2
BP,GO:0010719,negative regulation of epithelial to mesenchymal transition,1.199717259992289,1,0.5707130407987605,0.8383665845952104,SDHAF2
BP,GO:0019098,reproductive behavior,1.199717259992289,1,0.5707130407987605,0.8383665845952104,NHLH2
BP,GO:0030149,sphingolipid catabolic process,1.199717259992289,1,0.5707130407987605,0.8383665845952104,GBA
BP,GO:0031338,regulation of vesicle fusion,1.199717259992289,1,0.5707130407987605,0.8383665845952104,ANKRD27
BP,GO:0031572,G2 DNA damage checkpoint,1.199717259992289,1,0.5707130407987605,0.8383665845952104,TAOK3
BP,GO:0035767,endothelial cell chemotaxis,1.199717259992289,1,0.5707130407987605,0.8383665845952104,MET
BP,GO:0044319,"wound healing, spreading of cells",1.199717259992289,1,0.5707130407987605,0.8383665845952104,CLASP2
BP,GO:0045648,positive regulation of erythrocyte differentiation,1.199717259992289,1,0.5707130407987605,0.8383665845952104,ARNT
BP,GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,1.199717259992289,1,0.5707130407987605,0.8383665845952104,CCND3
BP,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,1.199717259992289,1,0.5707130407987605,0.8383665845952104,NUP62
BP,GO:0045879,negative regulation of smoothened signaling pathway,1.199717259992289,1,0.5707130407987605,0.8383665845952104,BTRC
BP,GO:0050482,arachidonic acid secretion,1.199717259992289,1,0.5707130407987605,0.8383665845952104,PLA2G3
BP,GO:0050685,positive regulation of mRNA processing,1.199717259992289,1,0.5707130407987605,0.8383665845952104,CIRBP
BP,GO:0070306,lens fiber cell differentiation,1.199717259992289,1,0.5707130407987605,0.8383665845952104,FRS2
BP,GO:0071539,protein localization to centrosome,1.199717259992289,1,0.5707130407987605,0.8383665845952104,NUP62
BP,GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,1.199717259992289,1,0.5707130407987605,0.8383665845952104,ADCY9
BP,GO:0090075,relaxation of muscle,1.199717259992289,1,0.5707130407987605,0.8383665845952104,PDE4B
BP,GO:0090505,epiboly involved in wound healing,1.199717259992289,1,0.5707130407987605,0.8383665845952104,CLASP2
BP,GO:0090659,walking behavior,1.199717259992289,1,0.5707130407987605,0.8383665845952104,CTNS
BP,GO:0097106,postsynaptic density organization,1.199717259992289,1,0.5707130407987605,0.8383665845952104,IL1RAP
BP,GO:0099174,regulation of presynapse organization,1.199717259992289,1,0.5707130407987605,0.8383665845952104,IL1RAP
BP,GO:1902186,regulation of viral release from host cell,1.199717259992289,1,0.5707130407987605,0.8383665845952104,VPS4A
BP,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1.199717259992289,1,0.5707130407987605,0.8383665845952104,TRIAP1
BP,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1.199717259992289,1,0.5707130407987605,0.8383665845952104,TRIAP1
BP,GO:1903963,arachidonate transport,1.199717259992289,1,0.5707130407987605,0.8383665845952104,PLA2G3
BP,GO:2000781,positive regulation of double-strand break repair,1.199717259992289,1,0.5707130407987605,0.8383665845952104,DTX3L
BP,GO:0006024,glycosaminoglycan biosynthetic process,1.0143064107207533,3,0.5708641689598655,0.8383665845952104,B4GALT7/HAS3/SDC1
BP,GO:0016101,diterpenoid metabolic process,1.0143064107207533,3,0.5708641689598655,0.8383665845952104,CYP26B1/SDC1/AKR1C3
BP,GO:0032508,DNA duplex unwinding,1.0143064107207533,3,0.5708641689598655,0.8383665845952104,GTF2H1/INO80/RAD54L2
BP,GO:0048592,eye morphogenesis,0.9984224177117034,4,0.5712179889997211,0.8385834641829178,BAX/C12orf57/FRS2/ZHX2
BP,GO:0051222,positive regulation of protein transport,0.9787167120989725,11,0.5719343051653587,0.8390983626376858,CSNK2A2/ANO1/XPO4/EDEM1/CAPN10/MPC2/PAK1/CDK5/IL1RAP/MYO18A/MYO1C
BP,GO:0042273,ribosomal large subunit biogenesis,1.0476404242186186,2,0.5728063306403278,0.8390983626376858,ZNHIT6/RSL24D1
BP,GO:0042795,snRNA transcription by RNA polymerase II,1.0476404242186186,2,0.5728063306403278,0.8390983626376858,ELL/TBP
BP,GO:0043647,inositol phosphate metabolic process,1.0476404242186186,2,0.5728063306403278,0.8390983626376858,PLCD4/INPPL1
BP,GO:0071479,cellular response to ionizing radiation,1.0476404242186186,2,0.5728063306403278,0.8390983626376858,CDKN1A/INO80
BP,GO:1904427,positive regulation of calcium ion transmembrane transport,1.0476404242186186,2,0.5728063306403278,0.8390983626376858,BAX/STAC
CC,GO:0045121,membrane raft,0.9799397384524585,8,0.5730152297988751,0.7823339820388389,TGFBR1/PRKAR2A/STX12/BCL10/ADCY1/RAP2B/MYO1C/CARD11
BP,GO:1904062,regulation of cation transmembrane transport,0.9787167120989725,9,0.5733523405320606,0.8395958679929527,NEDD4/BAX/DIAPH1/ISCU/PSEN2/STAC/DNAJC30/PDE4B/MYO5A
CC,GO:0098573,intrinsic component of mitochondrial membrane,1.0428412757179881,2,0.5751736902138953,0.7823339820388389,MPC2/TOMM20
CC,GO:0030665,clathrin-coated vesicle membrane,1.0065685356930145,3,0.5759524076007939,0.7823339820388389,VAMP4/VAMP7/IL7R
CC,GO:0097731,9+0 non-motile cilium,1.0065685356930145,3,0.5759524076007939,0.7823339820388389,PHLPP2/PCDHB13/MYO5A
BP,GO:0008203,cholesterol metabolic process,0.9917662682602921,4,0.5765189847363223,0.8396957474158817,MBTPS1/LBR/PRKAA2/GBA
BP,GO:0008360,regulation of cell shape,0.9917662682602921,4,0.5765189847363223,0.8396957474158817,DIAPH1/ANXA7/PARVA/CYFIP1
BP,GO:0031123,RNA 3'-end processing,0.9917662682602921,4,0.5765189847363223,0.8396957474158817,HSD17B10/PAPOLA/THOC5/WDR33
BP,GO:0048754,branching morphogenesis of an epithelial tube,0.9917662682602921,4,0.5765189847363223,0.8396957474158817,MET/VDR/PAK1/BTRC
CC,GO:0098857,membrane microdomain,0.9768386633307735,8,0.5766146815794897,0.7823339820388389,TGFBR1/PRKAR2A/STX12/BCL10/ADCY1/RAP2B/MYO1C/CARD11
BP,GO:0002237,response to molecule of bacterial origin,0.9758633106059726,9,0.5768775708896225,0.8396957474158817,CDK4/BCL10/DUSP10/CLDN1/TNIP2/HNRNPA0/LDOC1/PDE4B/CARD9
BP,GO:0031623,receptor internalization,1.0051685151286744,3,0.5770209115661951,0.8396957474158817,SNX1/NEDD4/USP46
MF,GO:0008266,poly(U) RNA binding,1.1798,1,0.5770583233250806,0.7772394083545174,CIRBP
MF,GO:0070273,phosphatidylinositol-4-phosphate binding,1.1798,1,0.5770583233250806,0.7772394083545174,SNX24
BP,GO:0009301,snRNA transcription,1.0330898627711376,2,0.580438312745666,0.8396957474158817,ELL/TBP
BP,GO:0032272,negative regulation of protein polymerization,1.0330898627711376,2,0.580438312745666,0.8396957474158817,MAPRE1/CAPZA1
BP,GO:0051155,positive regulation of striated muscle cell differentiation,1.0330898627711376,2,0.580438312745666,0.8396957474158817,CYP26B1/RBPJ
BP,GO:0061035,regulation of cartilage development,1.0330898627711376,2,0.580438312745666,0.8396957474158817,TGFBR1/TAPT1
BP,GO:0090114,COPII-coated vesicle budding,1.0330898627711376,2,0.580438312745666,0.8396957474158817,MCFD2/PDCD6
BP,GO:1902036,regulation of hematopoietic stem cell differentiation,1.0330898627711376,2,0.580438312745666,0.8396957474158817,CDK6/LDB1
BP,GO:0001975,response to amphetamine,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,RGS17
BP,GO:0002323,natural killer cell activation involved in immune response,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,VAMP7
BP,GO:0003176,aortic valve development,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,RBPJ
BP,GO:0006356,regulation of transcription by RNA polymerase I,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,PHF8
BP,GO:0032228,"regulation of synaptic transmission, GABAergic",1.1622260956175299,1,0.5822749300374013,0.8396957474158817,USP46
BP,GO:0032814,regulation of natural killer cell activation,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,TOX
BP,GO:0038128,ERBB2 signaling pathway,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,PIK3CA
BP,GO:0039694,viral RNA genome replication,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,EEA1
BP,GO:0042491,inner ear auditory receptor cell differentiation,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,RBPJ
BP,GO:0045589,regulation of regulatory T cell differentiation,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,DUSP10
BP,GO:0045922,negative regulation of fatty acid metabolic process,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,APPL2
BP,GO:0050779,RNA destabilization,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,YTHDF3
BP,GO:0051385,response to mineralocorticoid,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,CDKN1A
BP,GO:0055022,negative regulation of cardiac muscle tissue growth,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,PAK1
BP,GO:0060674,placenta blood vessel development,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,RBPJ
BP,GO:0061117,negative regulation of heart growth,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,PAK1
BP,GO:0061311,cell surface receptor signaling pathway involved in heart development,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,RBPJ
BP,GO:0070207,protein homotrimerization,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,ATXN10
BP,GO:0071295,cellular response to vitamin,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,VDR
BP,GO:0071353,cellular response to interleukin-4,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,CDK4
BP,GO:0090504,epiboly,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,CLASP2
BP,GO:1901976,regulation of cell cycle checkpoint,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,THOC5
BP,GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,PTPN1
BP,GO:1903955,positive regulation of protein targeting to mitochondrion,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,CSNK2A2
BP,GO:1904467,regulation of tumor necrosis factor secretion,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,ARG2
BP,GO:1905508,protein localization to microtubule organizing center,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,NUP62
BP,GO:2000778,positive regulation of interleukin-6 secretion,1.1622260956175299,1,0.5822749300374013,0.8396957474158817,IL1RAP
BP,GO:0006631,fatty acid metabolic process,0.9710505237535497,10,0.5825330494509773,0.8396957474158817,PLA2G3/PRKAG2/GNPAT/LPGAT1/LPIN3/APPL2/PRKAA2/AKR1C3/MYO5A/ACAD11
BP,GO:0042119,neutrophil activation,0.970855533688539,13,0.5830906462423762,0.8396957474158817,RAB7A/PGM1/PPIE/FTL/PYGL/VAMP7/PTPRB/DIAPH1/CALML5/RAP2B/C6orf120/CSNK2B/CYFIP1
BP,GO:0001938,positive regulation of endothelial cell proliferation,0.996193796243597,3,0.5831220468165845,0.8396957474158817,TGFBR1/ARNT/PDCD6
BP,GO:0002065,columnar/cuboidal epithelial cell differentiation,0.996193796243597,3,0.5831220468165845,0.8396957474158817,CDK6/CDKN1A/RBPJ
BP,GO:0015918,sterol transport,0.996193796243597,3,0.5831220468165845,0.8396957474158817,STX12/VPS4A/OSBP2
BP,GO:0017158,regulation of calcium ion-dependent exocytosis,0.996193796243597,3,0.5831220468165845,0.8396957474158817,SNAPIN/ADCY1/CDK5
BP,GO:1903510,mucopolysaccharide metabolic process,0.996193796243597,3,0.5831220468165845,0.8396957474158817,HAS3/IMPAD1/IDUA
BP,GO:1903828,negative regulation of cellular protein localization,0.996193796243597,3,0.5831220468165845,0.8396957474158817,LZTFL1/CDK5/APOD
BP,GO:0044782,cilium organization,0.9685217463479415,10,0.5858497436895607,0.8429605650061844,PLA2G3/CDKL1/MAPRE1/WRAP73/WDR11/ATXN10/FNBP1L/TAPT1/TTC36/PARVA
MF,GO:0016651,"oxidoreductase activity, acting on NAD(P)H",0.992355140186916,3,0.5859101030654845,0.7857705723537157,DHDH/MICAL2/AKR1C3
BP,GO:0002446,neutrophil mediated immunity,0.9689099314166182,13,0.5860109335883701,0.8429605650061844,RAB7A/PGM1/PPIE/FTL/PYGL/VAMP7/PTPRB/DIAPH1/CALML5/RAP2B/C6orf120/CSNK2B/CYFIP1
BP,GO:0010975,regulation of neuron projection development,0.9689099314166182,13,0.5860109335883701,0.8429605650061844,SS18L2/NEDD4/ITGA6/NDRG4/ANKRD27/VAMP7/RAP2A/SNAPIN/PAK1/ZFYVE27/CDK5/NSMF/CYFIP1
BP,GO:0001890,placenta development,0.9787167120989725,4,0.5870087188288733,0.8430170851613172,VDR/ARNT/RBPJ/LDOC1
BP,GO:0030902,hindbrain development,0.9787167120989725,4,0.5870087188288733,0.8430170851613172,GNPAT/PAK1/CDK5/LDB1
BP,GO:0048489,synaptic vesicle transport,0.9787167120989725,4,0.5870087188288733,0.8430170851613172,SNAPIN/ADCY1/CDK5/BLOC1S5
BP,GO:0097480,establishment of synaptic vesicle localization,0.9787167120989725,4,0.5870087188288733,0.8430170851613172,SNAPIN/ADCY1/CDK5/BLOC1S5
BP,GO:0009743,response to carbohydrate,0.970206131993764,6,0.5870863820703077,0.8430170851613172,GCLM/ACVR2B/PIK3CA/ANO1/MPC2/PRKAA2
BP,GO:0003208,cardiac ventricle morphogenesis,1.018937946842766,2,0.5879697147851503,0.8432469963366348,TGFBR1/RBPJ
BP,GO:0033555,multicellular organismal response to stress,1.018937946842766,2,0.5879697147851503,0.8432469963366348,ALS2/USP46
BP,GO:1903779,regulation of cardiac conduction,1.018937946842766,2,0.5879697147851503,0.8432469963366348,TMEM65/ASPH
BP,GO:0006836,neurotransmitter transport,0.9678016558302107,7,0.5880756461669205,0.8432469963366348,SNX4/SLC36A1/VAMP7/SNAPIN/ADCY1/CDK5/PRAF2
MF,GO:0015175,neutral amino acid transmembrane transporter activity,1.141741935483871,1,0.5890281449324535,0.7857705723537157,SLC36A1
MF,GO:0015248,sterol transporter activity,1.141741935483871,1,0.5890281449324535,0.7857705723537157,OSBP2
MF,GO:0035198,miRNA binding,1.141741935483871,1,0.5890281449324535,0.7857705723537157,AGO4
MF,GO:0016874,ligase activity,0.9763862068965518,4,0.5890452779802675,0.7857705723537157,GCLM/MTHFD1L/BTRC/GATC
CC,GO:0030684,preribosome,1.0153980842517252,2,0.5897285465696398,0.7933136816003936,FCF1/BTRC
CC,GO:0031904,endosome lumen,1.134856682398987,1,0.5907979049154564,0.7933136816003936,AP4E1
CC,GO:0070069,cytochrome complex,1.134856682398987,1,0.5907979049154564,0.7933136816003936,C15orf48
CC,GO:0098636,protein complex involved in cell adhesion,1.134856682398987,1,0.5907979049154564,0.7933136816003936,ITGA6
BP,GO:0002683,negative regulation of immune system process,0.9639196991730701,12,0.5928461697352088,0.8450182070034435,RC3H2/ARG2/CDK6/BCL10/DUSP10/GABPA/IL7R/TOB2/YTHDF3/APOD/LDB1/CNOT7
BP,GO:0006370,7-methylguanosine mRNA capping,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,GTF2H1
BP,GO:0009303,rRNA transcription,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,CD3EAP
BP,GO:0010837,regulation of keratinocyte proliferation,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,VDR
BP,GO:0019934,cGMP-mediated signaling,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,PRKAR2A
BP,GO:0030513,positive regulation of BMP signaling pathway,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,RBPJ
BP,GO:0030851,granulocyte differentiation,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,LBR
BP,GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,RBPJ
BP,GO:0036314,response to sterol,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,TGFBR1
BP,GO:0042407,cristae formation,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,OMA1
BP,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,CDKN1A
BP,GO:0048536,spleen development,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,RC3H2
BP,GO:0051204,protein insertion into mitochondrial membrane,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,BAX
BP,GO:0061036,positive regulation of cartilage development,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,TAPT1
BP,GO:0071985,multivesicular body sorting pathway,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,CHMP1B
BP,GO:0099084,postsynaptic specialization organization,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,IL1RAP
BP,GO:1901797,negative regulation of signal transduction by p53 class mediator,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,TRIAP1
BP,GO:1901890,positive regulation of cell junction assembly,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,CLDN1
BP,GO:2000352,negative regulation of endothelial cell apoptotic process,1.1270071230230594,1,0.5935260291425211,0.8450182070034435,TNIP2
MF,GO:0015103,inorganic anion transmembrane transporter activity,0.9696986301369864,4,0.5944836205325118,0.7915059698660837,CLCC1/ANO1/PIDD1/LRRC8B
BP,GO:0010633,negative regulation of epithelial cell migration,0.9787167120989725,3,0.5951555474070207,0.8450182070034435,STARD13/DUSP10/CSNK2B
BP,GO:0030218,erythrocyte differentiation,0.9787167120989725,3,0.5951555474070207,0.8450182070034435,CDK6/ARNT/LDB1
BP,GO:0034968,histone lysine methylation,0.9787167120989725,3,0.5951555474070207,0.8450182070034435,KDM3A/RTF1/PYGO2
BP,GO:0009583,detection of light stimulus,1.0051685151286744,2,0.5954004175700416,0.8450182070034435,NMT2/CDS1
BP,GO:0032677,regulation of interleukin-8 production,1.0051685151286744,2,0.5954004175700416,0.8450182070034435,MAPKBP1/BCL10
BP,GO:0048199,"vesicle targeting, to, from or within Golgi",1.0051685151286744,2,0.5954004175700416,0.8450182070034435,MCFD2/PDCD6
BP,GO:0050710,negative regulation of cytokine secretion,1.0051685151286744,2,0.5954004175700416,0.8450182070034435,ARG2/MAPKBP1
BP,GO:0070373,negative regulation of ERK1 and ERK2 cascade,1.0051685151286744,2,0.5954004175700416,0.8450182070034435,DUSP10/PTPN1
BP,GO:1901616,organic hydroxy compound catabolic process,1.0051685151286744,2,0.5954004175700416,0.8450182070034435,FAH/AKR1C3
BP,GO:0007219,Notch signaling pathway,0.9635034989575376,5,0.5958539094073438,0.8450182070034435,CDK6/PSEN2/DTX3L/RBPJ/RFNG
BP,GO:0045333,cellular respiration,0.9635034989575376,5,0.5958539094073438,0.8450182070034435,CS/IDH3G/PIK3CA/ISCU/SDHAF2
BP,GO:0017156,calcium ion regulated exocytosis,0.9660061054483365,4,0.5973458761884427,0.8450182070034435,VAMP7/SNAPIN/ADCY1/CDK5
BP,GO:2000146,negative regulation of cell motility,0.9590862909393945,9,0.597750964524842,0.8450182070034435,NDRG4/RAP2A/STARD13/STK26/DUSP10/CLASP2/RAP2B/APOD/CSNK2B
BP,GO:0003012,muscle system process,0.9597738079938312,12,0.5988443729910928,0.8450182070034435,ARG2/ACTA2/C12orf57/PIK3CA/STAC/DOCK5/PAK1/TPM4/PDE4B/GTF2IRD2/MYL6B/ASPH
CC,GO:0031968,organelle outer membrane,0.9598290348648149,5,0.5991232625143215,0.8024247294857622,TOMM34/BAX/MCL1/TOMM20/PPP1CC
MF,GO:0016417,S-acyltransferase activity,1.1060625,1,0.6006598627822086,0.7966767264000667,ZDHHC18
MF,GO:0031624,ubiquitin conjugating enzyme binding,1.1060625,1,0.6006598627822086,0.7966767264000667,RNF180
BP,GO:0046660,female sex differentiation,0.970206131993764,3,0.6010870390956563,0.8450182070034435,BAX/PLEKHA1/NUPR1
CC,GO:0097546,ciliary base,1.102432205759016,1,0.6014214008555165,0.8034373072967285,PRKAR2A
BP,GO:0060968,regulation of gene silencing,0.959773807993831,4,0.6024562351869601,0.8450182070034435,ASF1A/ATAD2B/PHF8/NUP62
BP,GO:1902652,secondary alcohol metabolic process,0.959773807993831,4,0.6024562351869601,0.8450182070034435,MBTPS1/LBR/PRKAA2/GBA
BP,GO:0001960,negative regulation of cytokine-mediated signaling pathway,0.9917662682602921,2,0.602730380871958,0.8450182070034435,YTHDF3/CNOT7
BP,GO:0007422,peripheral nervous system development,0.9917662682602921,2,0.602730380871958,0.8450182070034435,CLDN1/CDK5
BP,GO:0021536,diencephalon development,0.9917662682602921,2,0.602730380871958,0.8450182070034435,BAX/RBPJ
BP,GO:0032482,Rab protein signal transduction,0.9917662682602921,2,0.602730380871958,0.8450182070034435,RAB7A/RAB15
BP,GO:0043242,negative regulation of protein complex disassembly,0.9917662682602921,2,0.602730380871958,0.8450182070034435,CAPZA1/CLASP2
BP,GO:0150076,neuroinflammatory response,0.9917662682602921,2,0.602730380871958,0.8450182070034435,ADCY1/NUPR1
CC,GO:0032993,protein-DNA complex,0.9550774059793455,5,0.6035184312546977,0.8041767332063875,TBP/HP1BP3/TERF2/ERCC5/NUPR1
BP,GO:0043542,endothelial cell migration,0.9536214117887424,7,0.6036516215946872,0.8450182070034435,SRPX2/MET/TGFBR1/PIK3CA/STARD13/CSNK2B/PDCD6
BP,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,0.9536214117887424,7,0.6036516215946872,0.8450182070034435,CDH20/CD164/CLDN1/CLDN3/PCDHB13/IL1RAP/CLDN9
BP,GO:0071453,cellular response to oxygen levels,0.9536214117887425,6,0.603895658126146,0.8450182070034435,HP1BP3/EGLN3/ARNT/RBPJ/P4HB/TMEM199
BP,GO:0046879,hormone secretion,0.9536214117887425,8,0.6039460740418505,0.8450182070034435,SNX4/ACVR2B/VAMP7/ANO1/CAPN10/MPC2/MYO5A/RASL10B
BP,GO:0000737,"DNA catabolic process, endonucleolytic",1.0938598546988516,1,0.6044746761012834,0.8450182070034435,BAX
BP,GO:0006409,tRNA export from nucleus,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,NUP62
BP,GO:0007603,"phototransduction, visible light",1.0938598546988516,1,0.6044746761012834,0.8450182070034435,NMT2
BP,GO:0009452,7-methylguanosine RNA capping,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,GTF2H1
BP,GO:0010574,regulation of vascular endothelial growth factor production,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,ARNT
BP,GO:0010984,regulation of lipoprotein particle clearance,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,CNPY2
BP,GO:0018345,protein palmitoylation,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,ZDHHC18
BP,GO:0019228,neuronal action potential,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,GBA
BP,GO:0031128,developmental induction,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,FRS2
BP,GO:0032148,activation of protein kinase B activity,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,MAPKAP1
BP,GO:0032212,positive regulation of telomere maintenance via telomerase,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,HMBOX1
BP,GO:0032660,regulation of interleukin-17 production,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,ARG2
BP,GO:0033120,positive regulation of RNA splicing,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,CIRBP
BP,GO:0036260,RNA capping,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,GTF2H1
BP,GO:0042533,tumor necrosis factor biosynthetic process,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,CARD9
BP,GO:0042534,regulation of tumor necrosis factor biosynthetic process,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,CARD9
BP,GO:0043094,cellular metabolic compound salvage,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,TK2
BP,GO:0045066,regulatory T cell differentiation,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,DUSP10
BP,GO:0045738,negative regulation of DNA repair,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,TERF2
BP,GO:0045920,negative regulation of exocytosis,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,RAB7A
BP,GO:0048048,embryonic eye morphogenesis,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,FRS2
BP,GO:0060795,cell fate commitment involved in formation of primary germ layer,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,RTF1
BP,GO:0070050,neuron cellular homeostasis,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,CDK5
BP,GO:0070670,response to interleukin-4,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,CDK4
BP,GO:0071431,tRNA-containing ribonucleoprotein complex export from nucleus,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,NUP62
BP,GO:0071875,adrenergic receptor signaling pathway,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,ADCY9
BP,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,1.0938598546988516,1,0.6044746761012834,0.8450182070034435,CDKN1A
BP,GO:0021987,cerebral cortex development,0.9618422860283006,3,0.6069611739217778,0.8479114201627034,CSNK2A2/BAX/CDK5
BP,GO:1900180,regulation of protein localization to nucleus,0.9618422860283006,3,0.6069611739217778,0.8479114201627034,DTX3L/APOD/NUP62
CC,GO:0019867,outer membrane,0.9503725911715655,5,0.6078861277022213,0.8079302870736156,TOMM34/BAX/MCL1/TOMM20/PPP1CC
BP,GO:0001763,morphogenesis of a branching structure,0.9487559964224733,5,0.6095146055461502,0.8500568045864256,MET/VDR/PAK1/BTRC/FRS2
BP,GO:0010389,regulation of G2/M transition of mitotic cell cycle,0.9487559964224733,5,0.6095146055461502,0.8500568045864256,MAPRE1/VPS4A/TAOK3/CDK4/CCNB3
BP,GO:0000380,"alternative mRNA splicing, via spliceosome",0.9787167120989725,2,0.6099596392791977,0.8500568045864256,CELF1/HNRNPU
BP,GO:0030500,regulation of bone mineralization,0.9787167120989725,2,0.6099596392791977,0.8500568045864256,ACVR2B/BMP2K
BP,GO:0042310,vasoconstriction,0.9787167120989725,2,0.6099596392791977,0.8500568045864256,ACTA2/DOCK5
BP,GO:0045454,cell redox homeostasis,0.9787167120989725,2,0.6099596392791977,0.8500568045864256,TMX1/P4HB
BP,GO:0048844,artery morphogenesis,0.9787167120989725,2,0.6099596392791977,0.8500568045864256,TGFBR1/RBPJ
BP,GO:0030098,lymphocyte differentiation,0.9482184576143021,9,0.6113880330121473,0.8505590460879886,CYP26B1/RC3H2/BAX/CDK6/DUSP10/RBPJ/IL7R/CARD11/TOX
MF,GO:0004623,phospholipase A2 activity,1.0725454545454545,1,0.6119630084719281,0.8085823020684221,PLA2G3
MF,GO:0097718,disordered domain specific binding,1.0725454545454545,1,0.6119630084719281,0.8085823020684221,MYO5A
BP,GO:0001764,neuron migration,0.9475473900576039,4,0.6125586980597466,0.8505590460879886,BAX/CDK5/NSMF/POMK
BP,GO:0007613,memory,0.9536214117887425,3,0.6127776103913015,0.8505590460879886,CTNS/ADCY1/RIN1
BP,GO:0043666,regulation of phosphoprotein phosphatase activity,0.9536214117887425,3,0.6127776103913015,0.8505590460879886,BOD1/PPP1R14A/PPP1R14C
BP,GO:1901222,regulation of NIK/NF-kappaB signaling,0.9536214117887425,3,0.6127776103913015,0.8505590460879886,RC3H2/MAP3K7/TRIM44
BP,GO:0031589,cell-substrate adhesion,0.9455398744007023,9,0.6147608723434028,0.8505590460879886,ITGA6/TRPM7/CDK6/DOCK5/CLASP2/CDK5/APOD/PARVA/LDB1
BP,GO:0019433,triglyceride catabolic process,1.0626067159931702,1,0.615128985641805,0.8505590460879886,DDHD2
BP,GO:0021955,central nervous system neuron axonogenesis,1.0626067159931702,1,0.615128985641805,0.8505590460879886,C12orf57
BP,GO:0030262,apoptotic nuclear changes,1.0626067159931702,1,0.615128985641805,0.8505590460879886,BAX
BP,GO:0034142,toll-like receptor 4 signaling pathway,1.0626067159931702,1,0.615128985641805,0.8505590460879886,APPL2
BP,GO:0035909,aorta morphogenesis,1.0626067159931702,1,0.615128985641805,0.8505590460879886,RBPJ
BP,GO:0042092,type 2 immune response,1.0626067159931702,1,0.615128985641805,0.8505590460879886,ARG2
BP,GO:0042455,ribonucleoside biosynthetic process,1.0626067159931702,1,0.615128985641805,0.8505590460879886,CMPK1
BP,GO:0045622,regulation of T-helper cell differentiation,1.0626067159931702,1,0.615128985641805,0.8505590460879886,RC3H2
BP,GO:0046131,pyrimidine ribonucleoside metabolic process,1.0626067159931702,1,0.615128985641805,0.8505590460879886,CMPK1
BP,GO:0046466,membrane lipid catabolic process,1.0626067159931702,1,0.615128985641805,0.8505590460879886,GBA
BP,GO:0060251,regulation of glial cell proliferation,1.0626067159931702,1,0.615128985641805,0.8505590460879886,PPP1CC
BP,GO:0070873,regulation of glycogen metabolic process,1.0626067159931702,1,0.615128985641805,0.8505590460879886,EPM2AIP1
BP,GO:0071108,protein K48-linked deubiquitination,1.0626067159931702,1,0.615128985641805,0.8505590460879886,OTUD3
BP,GO:0097484,dendrite extension,1.0626067159931702,1,0.615128985641805,0.8505590460879886,CYFIP1
BP,GO:0098751,bone cell development,1.0626067159931702,1,0.615128985641805,0.8505590460879886,PIP4K2A
BP,GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1.0626067159931702,1,0.615128985641805,0.8505590460879886,BAX
BP,GO:1990774,tumor necrosis factor secretion,1.0626067159931702,1,0.615128985641805,0.8505590460879886,ARG2
BP,GO:0035050,embryonic heart tube development,0.9660061054483365,2,0.6170882982180417,0.8526885859887886,NDRG4/MICAL2
BP,GO:0048678,response to axon injury,0.9660061054483365,2,0.6170882982180417,0.8526885859887886,BAX/APOD
MF,GO:0016741,"transferase activity, transferring one-carbon groups",0.9396637168141594,6,0.6183469310595135,0.813812138277234,METTL22/TRMT2A/ALDH1L1/PRMT2/TRMT112/TRMT2B
BP,GO:0006911,"phagocytosis, engulfment",0.9455398744007023,3,0.6185360432009168,0.854398853562421,VAMP7/APPL2/ARHGAP12
MF,GO:0004857,enzyme inhibitor activity,0.94384,10,0.6186131584495522,0.813812138277234,PRKAG2/PRKAR2A/RPS6KA1/CDKN1A/TAOK3/BOD1/DTX3L/DUS2/PPP1R14A/PPP1R14C
CC,GO:0044445,cytosolic part,0.9372905393092847,6,0.6205133047098639,0.8219344614009729,STX12/MAP3K7/RSL24D1/SNAPIN/BLOC1S5/APOD
CC,GO:0005930,axoneme,0.9411006634528184,3,0.6215780763761676,0.8219344614009729,PRKAR2A/WDR11/GABARAP
MF,GO:0001618,virus receptor activity,0.9565945945945945,2,0.6226216128003359,0.813812138277234,CLDN1/CLDN9
MF,GO:0104005,hijacked molecular function,0.9565945945945945,2,0.6226216128003359,0.813812138277234,CLDN1/CLDN9
BP,GO:0060485,mesenchyme development,0.9364699475479378,7,0.6226818880021354,0.857896563368713,TGFBR1/ACTA2/CLASP2/SDHAF2/RBPJ/TAPT1/PDCD6
BP,GO:0007179,transforming growth factor beta receptor signaling pathway,0.934453142205049,5,0.62290544401033765,0.857896563368713,TAB1/TGFBR1/ACVR2B/MAP3K7/APPL2
MF,GO:0016410,N-acyltransferase activity,0.9396637168141594,3,0.6229260556370524,0.813812138277234,KANSL3/NMT2/TADA3
MF,GO:0008175,tRNA methyltransferase activity,1.0410000000000001,1,0.6229468454150913,0.813812138277234,TRMT2B
BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,0.9536214117887425,2,0.6241165301332071,0.857896563368713,FAM49B/IL7R
BP,GO:0008589,regulation of smoothened signaling pathway,0.9536214117887425,2,0.6241165301332071,0.857896563368713,WDR11/BTRC
BP,GO:0021954,central nervous system neuron development,0.9536214117887425,2,0.6241165301332071,0.857896563368713,C12orf57/CDK5
BP,GO:0007368,determination of left/right symmetry,0.9375941611704443,3,0.6242362021792291,0.857896563368713,NDRG4/ACVR2B/MICAL2
BP,GO:0016079,synaptic vesicle exocytosis,0.9375941611704443,3,0.6242362021792291,0.857896563368713,SNAPIN/ADCY1/CDK5
BP,GO:0032392,DNA geometric change,0.9375941611704443,3,0.6242362021792291,0.857896563368713,GTF2H1/INO80/RAD54L2
BP,GO:0033002,muscle cell proliferation,0.9336711730483922,6,0.6243751599110434,0.857896563368713,NDRG4/TGFBR1/CDKN1A/PAK1/RBPJ/APOD
BP,GO:0000154,rRNA modification,1.0330898627711376,1,0.625496855199509,0.857896563368713,TRMT112
BP,GO:0000578,embryonic axis specification,1.0330898627711376,1,0.625496855199509,0.857896563368713,FRS2
BP,GO:0003417,growth plate cartilage development,1.0330898627711376,1,0.625496855199509,0.857896563368713,SCARA3
BP,GO:0010453,regulation of cell fate commitment,1.0330898627711376,1,0.625496855199509,0.857896563368713,RBPJ
BP,GO:0010573,vascular endothelial growth factor production,1.0330898627711376,1,0.625496855199509,0.857896563368713,ARNT
BP,GO:0034314,Arp2/3 complex-mediated actin nucleation,1.0330898627711376,1,0.625496855199509,0.857896563368713,CYFIP1
BP,GO:0045740,positive regulation of DNA replication,1.0330898627711376,1,0.625496855199509,0.857896563368713,INO80
BP,GO:0046627,negative regulation of insulin receptor signaling pathway,1.0330898627711376,1,0.625496855199509,0.857896563368713,PTPN1
BP,GO:0051973,positive regulation of telomerase activity,1.0330898627711376,1,0.625496855199509,0.857896563368713,HMBOX1
BP,GO:0060428,lung epithelium development,1.0330898627711376,1,0.625496855199509,0.857896563368713,RBPJ
BP,GO:1901099,negative regulation of signal transduction in absence of ligand,1.0330898627711376,1,0.625496855199509,0.857896563368713,MCL1
BP,GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,1.0330898627711376,1,0.625496855199509,0.857896563368713,MCL1
CC,GO:0097014,ciliary plasm,0.9335111419733602,3,0.6270402105208841,0.8270581004591914,PRKAR2A/WDR11/GABARAP
BP,GO:1903706,regulation of hemopoiesis,0.9395680436150136,12,0.6282161879485011,0.860658462556625,CYP26B1/RC3H2/CDK6/AGO4/ARNT/DUSP10/GABPA/IL7R/TOB2/CARD11/LDB1/TOX
BP,GO:0030217,T cell differentiation,0.9297808764940239,6,0.6283976722241313,0.860658462556625,CYP26B1/RC3H2/CDK6/DUSP10/IL7R/CARD11
BP,GO:0002698,negative regulation of immune effector process,0.9297808764940239,3,0.6298778512415286,0.860658462556625,RC3H2/DUSP10/IL7R
BP,GO:0006342,chromatin silencing,0.9297808764940239,3,0.6298778512415286,0.860658462556625,ASF1A/ATAD2B/PHF8
BP,GO:0006721,terpenoid metabolic process,0.9297808764940239,3,0.6298778512415286,0.860658462556625,CYP26B1/SDC1/AKR1C3
BP,GO:0072089,stem cell proliferation,0.9297808764940239,3,0.6298778512415286,0.860658462556625,DOCK7/HNRNPU/FRS2
MF,GO:0005254,chloride channel activity,0.94384,2,0.6299264336138088,0.8170058656374076,CLCC1/ANO1
MF,GO:0005546,"phosphatidylinositol-4,5-bisphosphate binding",0.94384,2,0.6299264336138088,0.8170058656374076,MAPKAP1/MYO1B
MF,GO:0034212,peptide N-acetyltransferase activity,0.94384,2,0.6299264336138088,0.8170058656374076,KANSL3/TADA3
BP,GO:0003151,outflow tract morphogenesis,0.9415502546774925,2,0.6310445708217842,0.860658462556625,RBPJ/PARVA
BP,GO:0006446,regulation of translational initiation,0.9415502546774925,2,0.6310445708217842,0.860658462556625,PAIP2/YTHDF3
BP,GO:0043537,negative regulation of blood vessel endothelial cell migration,0.9415502546774925,2,0.6310445708217842,0.860658462556625,STARD13/CSNK2B
BP,GO:0045652,regulation of megakaryocyte differentiation,0.9415502546774925,2,0.6310445708217842,0.860658462556625,AGO4/GABPA
BP,GO:0071260,cellular response to mechanical stimulus,0.9415502546774925,2,0.6310445708217842,0.860658462556625,BCL10/CRADD
CC,GO:0016234,inclusion body,0.9411006634528185,2,0.631151425553417,0.8303785169528543,EDEM1/WDFY3
MF,GO:0005342,organic acid transmembrane transporter activity,0.9253333333333332,4,0.6313303847048913,0.8170058656374076,CTNS/SLC36A1/SLC7A1/MPC2
MF,GO:0046943,carboxylic acid transmembrane transporter activity,0.9253333333333332,4,0.6313303847048913,0.8170058656374076,CTNS/SLC36A1/SLC7A1/MPC2
BP,GO:0002703,regulation of leukocyte mediated immunity,0.9251551009890785,5,0.631679146730836,0.860658462556625,SNX4/VAMP7/MAP3K7/FAM49B/IL7R
BP,GO:0032635,interleukin-6 production,0.9240058399940609,4,0.6322817568004249,0.860658462556625,BCL10/GBA/CARD9/IL1RAP
MF,GO:0005501,retinoid binding,1.0112571428571429,1,0.6336203763720327,0.8170058656374076,CYP26B1
MF,GO:1901682,sulfur compound transmembrane transporter activity,1.0112571428571429,1,0.6336203763720327,0.8170058656374076,CTNS
BP,GO:0010811,positive regulation of cell-substrate adhesion,0.9220967370188667,3,0.6354607873586778,0.860658462556625,ITGA6/CDK6/DOCK5
BP,GO:0046718,viral entry into host cell,0.9220967370188667,3,0.6354607873586778,0.860658462556625,CLDN1/P4HB/CLDN9
BP,GO:0003156,regulation of animal organ formation,1.0051685151286744,1,0.635585970724348,0.860658462556625,FRS2
BP,GO:0007099,centriole replication,1.0051685151286744,1,0.635585970724348,0.860658462556625,NUP62
BP,GO:0010614,negative regulation of cardiac muscle hypertrophy,1.0051685151286744,1,0.635585970724348,0.860658462556625,PAK1
BP,GO:0014037,Schwann cell differentiation,1.0051685151286744,1,0.635585970724348,0.860658462556625,CDK5
BP,GO:0014912,negative regulation of smooth muscle cell migration,1.0051685151286744,1,0.635585970724348,0.860658462556625,NDRG4
BP,GO:0030212,hyaluronan metabolic process,1.0051685151286744,1,0.635585970724348,0.860658462556625,HAS3
BP,GO:0031076,embryonic camera-type eye development,1.0051685151286744,1,0.635585970724348,0.860658462556625,FRS2
BP,GO:0032885,regulation of polysaccharide biosynthetic process,1.0051685151286744,1,0.635585970724348,0.860658462556625,EPM2AIP1
BP,GO:0033280,response to vitamin D,1.0051685151286744,1,0.635585970724348,0.860658462556625,VDR
BP,GO:0038083,peptidyl-tyrosine autophosphorylation,1.0051685151286744,1,0.635585970724348,0.860658462556625,YES1
BP,GO:0043114,regulation of vascular permeability,1.0051685151286744,1,0.635585970724348,0.860658462556625,YES1
BP,GO:0045730,respiratory burst,1.0051685151286744,1,0.635585970724348,0.860658462556625,DUSP10
BP,GO:0045923,positive regulation of fatty acid metabolic process,1.0051685151286744,1,0.635585970724348,0.860658462556625,LPGAT1
BP,GO:0051084,'de novo' posttranslational protein folding,1.0051685151286744,1,0.635585970724348,0.860658462556625,ENTPD5
BP,GO:0051567,histone H3-K9 methylation,1.0051685151286744,1,0.635585970724348,0.860658462556625,KDM3A
BP,GO:0071276,cellular response to cadmium ion,1.0051685151286744,1,0.635585970724348,0.860658462556625,AKR1C3
BP,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,1.0051685151286744,1,0.635585970724348,0.860658462556625,SRPX2
BP,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,1.0051685151286744,1,0.635585970724348,0.860658462556625,DOCK5
BP,GO:1903427,negative regulation of reactive oxygen species biosynthetic process,1.0051685151286744,1,0.635585970724348,0.860658462556625,CTNS
BP,GO:1903432,regulation of TORC1 signaling,1.0051685151286744,1,0.635585970724348,0.860658462556625,SESN1
BP,GO:1904358,positive regulation of telomere maintenance via telomere lengthening,1.0051685151286744,1,0.635585970724348,0.860658462556625,HMBOX1
BP,GO:1905314,semi-lunar valve development,1.0051685151286744,1,0.635585970724348,0.860658462556625,RBPJ
BP,GO:2000249,regulation of actin cytoskeleton reorganization,1.0051685151286744,1,0.635585970724348,0.860658462556625,CDK5
BP,GO:0007568,aging,0.9268843628600862,8,0.6357617207430329,0.860658462556625,GCLM/ARG2/CDK6/CDKN1A/TERF2/CLDN1/APOD/NUP62
CC,GO:0045111,intermediate filament cytoskeleton,0.9223536382844355,6,0.6359664097623499,0.8346057921566354,CTNS/PKN2/ING4/INO80/VMAC/MYO5A
BP,GO:0000723,telomere maintenance,0.9183021002410112,4,0.6371105251339213,0.8619107470052517,SMG6/TERF2/HMBOX1/HNRNPU
BP,GO:0015718,monocarboxylic acid transport,0.9183021002410112,4,0.6371105251339213,0.8619107470052517,PLA2G3/PRKAG2/MPC2/PRKAA2
BP,GO:0033045,regulation of sister chromatid segregation,0.9297808764940239,2,0.6378727159151958,0.8620817967916999,HNRNPU/CDC26
BP,GO:0043462,regulation of ATPase activity,0.9297808764940239,2,0.6378727159151958,0.8620817967916999,DNAL4/HNRNPU
BP,GO:0070509,calcium ion import,0.9297808764940239,2,0.6378727159151958,0.8620817967916999,PSEN2/CDK5
BP,GO:0009914,hormone transport,0.9240058399940609,8,0.6392083461610945,0.8630843880904533,SNX4/ACVR2B/VAMP7/ANO1/CAPN10/MPC2/MYO5A/RASL10B
MF,GO:0060589,nucleoside-triphosphatase regulator activity,0.9260058139534882,9,0.6396181504425931,0.8217125149228797,TBC1D22B/RGS17/ANKRD27/STARD13/BNIP2/DOCK5/ARHGAP12/AGFG1/RIN1
MF,GO:0031406,carboxylic acid binding,0.9169430051813472,5,0.6396352094579538,0.8217125149228797,CYP26B1/SESN1/PYGL/VDR/EGLN3
BP,GO:0006282,regulation of DNA repair,0.9145385670433022,3,0.6409848395405484,0.8630843880904533,TERF2/DTX3L/RNF168
BP,GO:0034101,erythrocyte homeostasis,0.9145385670433022,3,0.6409848395405484,0.8630843880904533,CDK6/ARNT/LDB1
CC,GO:0005669,transcription factor TFIID complex,0.9893622359375783,1,0.6412329034234876,0.8352058567090926,TBP
CC,GO:0032391,photoreceptor connecting cilium,0.9893622359375783,1,0.6412329034234876,0.8352058567090926,PCDHB13
CC,GO:0033017,sarcoplasmic reticulum membrane,0.9893622359375783,1,0.6412329034234876,0.8352058567090926,ASPH
MF,GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,0.9133935483870967,4,0.6414547786355426,0.8225296515714061,METTL22/PRMT2/TRMT112/TRMT2B
BP,GO:0097479,synaptic vesicle localization,0.9126683450248086,4,0.6418980217749034,0.8630843880904533,SNAPIN/ADCY1/CDK5/BLOC1S5
BP,GO:1902600,proton transmembrane transport,0.9126683450248086,4,0.6418980217749034,0.8630843880904533,SLC36A1/C15orf48/UCP2/DNAJC30
MF,GO:0017080,sodium channel regulator activity,0.9831666666666667,1,0.6439923507698351,0.8227475804871974,NEDD4
MF,GO:0019840,isoprenoid binding,0.9831666666666667,1,0.6439923507698351,0.8227475804871974,CYP26B1
BP,GO:0007031,peroxisome organization,0.9183021002410112,2,0.6446013175038994,0.8630843880904533,AGPS/GNPAT
BP,GO:0014032,neural crest cell development,0.9183021002410112,2,0.6446013175038994,0.8630843880904533,TAPT1/PDCD6
BP,GO:0034109,homotypic cell-cell adhesion,0.9183021002410112,2,0.6446013175038994,0.8630843880904533,RAP2B/ACTG1
BP,GO:0060761,negative regulation of response to cytokine stimulus,0.9183021002410112,2,0.6446013175038994,0.8630843880904533,YTHDF3/CNOT7
BP,GO:1902930,regulation of alcohol biosynthetic process,0.9183021002410112,2,0.6446013175038994,0.8630843880904533,VDR/MBTPS1
BP,GO:0002573,myeloid leukocyte differentiation,0.9115498789157097,5,0.6446047205263323,0.8630843880904533,THOC5/CDK6/LBR/RBPJ/TOB2
BP,GO:0001825,blastocyst formation,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,GABPA
BP,GO:0002707,negative regulation of lymphocyte mediated immunity,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,IL7R
BP,GO:0003298,physiological muscle hypertrophy,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,PAK1
BP,GO:0003301,physiological cardiac muscle hypertrophy,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,PAK1
BP,GO:0006084,acetyl-CoA metabolic process,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,MPC2
BP,GO:0007340,acrosome reaction,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,PLCD4
BP,GO:0010667,negative regulation of cardiac muscle cell apoptotic process,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,NUPR1
BP,GO:0010831,positive regulation of myotube differentiation,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,CYP26B1
BP,GO:0032094,response to food,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,BCL10
BP,GO:0032620,interleukin-17 production,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,ARG2
BP,GO:0035329,hippo signaling,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,WWC2
BP,GO:0046326,positive regulation of glucose import,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,CAPN10
BP,GO:0050892,intestinal absorption,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,VDR
BP,GO:0051693,actin filament capping,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,CAPZA1
BP,GO:0060045,positive regulation of cardiac muscle cell proliferation,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,RBPJ
BP,GO:0060416,response to growth hormone,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,PTPN1
BP,GO:0061049,cell growth involved in cardiac muscle cell development,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,PAK1
BP,GO:0097064,ncRNA export from nucleus,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,NUP62
BP,GO:1901021,positive regulation of calcium ion transmembrane transporter activity,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,STAC
BP,GO:1903523,negative regulation of blood circulation,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,DOCK5
BP,GO:1904706,negative regulation of vascular smooth muscle cell proliferation,0.9787167120989725,1,0.6454038123331266,0.8630843880904533,CDKN1A
BP,GO:0002062,chondrocyte differentiation,0.9071032941405112,3,0.6464498678344031,0.8639152635842153,IMPAD1/TGFBR1/SCARA3
BP,GO:0009116,nucleoside metabolic process,0.9071032941405112,3,0.6464498678344031,0.8639152635842153,CMPK1/TK2/CARD11
MF,GO:0016887,ATPase activity,0.92171875,10,0.6481307630024422,0.8265082434779242,KIF16B/DNAL4/GTF2H1/ATAD2B/MYO1B/INO80/VPS4A/KIF13A/RBBP4/MYO1C
BP,GO:0071222,cellular response to lipopolysaccharide,0.907103294140511,5,0.6488497563552498,0.8668377040568658,CDK4/BCL10/TNIP2/LDOC1/PDE4B
CC,GO:0005791,rough endoplasmic reticulum,0.9078853459191896,2,0.6506088931540726,0.8453048212799795,SEC62/RP9
BP,GO:0032102,negative regulation of response to external stimulus,0.9170441521584894,9,0.6508461833186387,0.8671514850207118,ARG2/ADCY7/CDKN1A/APPL2/MAPKBP1/DUSP10/CLASP2/GBA/APOD
BP,GO:0006855,drug transmembrane transport,0.9071032941405112,2,0.6512307808997133,0.8671514850207118,SLC7A1/PRAF2
BP,GO:0030279,negative regulation of ossification,0.9071032941405112,2,0.6512307808997133,0.8671514850207118,CDK6/RBPJ
BP,GO:0032637,interleukin-8 production,0.9071032941405112,2,0.6512307808997133,0.8671514850207118,MAPKBP1/BCL10
BP,GO:0032642,regulation of chemokine production,0.9071032941405112,2,0.6512307808997133,0.8671514850207118,ARG2/APOD
BP,GO:0060415,muscle tissue morphogenesis,0.9071032941405112,2,0.6512307808997133,0.8671514850207118,TGFBR1/RBPJ
BP,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,0.9071032941405112,2,0.6512307808997133,0.8671514850207118,SRPX2/STARD13
BP,GO:0097581,lamellipodium organization,0.9071032941405112,2,0.6512307808997133,0.8671514850207118,SNX1/CYFIP1
BP,GO:1905954,positive regulation of lipid localization,0.9071032941405112,2,0.6512307808997133,0.8671514850207118,TRIAP1/FITM2
BP,GO:0007098,centrosome cycle,0.8997879449942167,3,0.6518557623385783,0.8671514850207118,CEP85/NUP62/CHMP1B
BP,GO:0008637,apoptotic mitochondrial changes,0.8997879449942167,3,0.6518557623385783,0.8671514850207118,GCLM/BAX/TRIAP1
BP,GO:0019218,regulation of steroid metabolic process,0.8997879449942167,3,0.6518557623385783,0.8671514850207118,VDR/MBTPS1/AKR1C3
BP,GO:0051209,release of sequestered calcium ion into cytosol,0.8997879449942167,3,0.6518557623385783,0.8671514850207118,BAX/DIAPH1/MYO5A
MF,GO:0008200,ion channel inhibitor activity,0.9565945945945945,1,0.6540712718170623,0.8265082434779242,NEDD4
MF,GO:0016790,thiolester hydrolase activity,0.9565945945945945,1,0.6540712718170623,0.8265082434779242,GNPAT
MF,GO:0017147,Wnt-protein binding,0.9565945945945945,1,0.6540712718170623,0.8265082434779242,MET
MF,GO:0043014,alpha-tubulin binding,0.9565945945945945,1,0.6540712718170623,0.8265082434779242,INO80
MF,GO:0044390,ubiquitin-like protein conjugating enzyme binding,0.9565945945945945,1,0.6540712718170623,0.8265082434779242,RNF180
BP,GO:0014741,negative regulation of muscle hypertrophy,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,PAK1
BP,GO:0019048,modulation by virus of host morphology or physiology,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,KPNA5
BP,GO:0030501,positive regulation of bone mineralization,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,ACVR2B
BP,GO:0031062,positive regulation of histone methylation,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,RTF1
BP,GO:0033146,regulation of intracellular estrogen receptor signaling pathway,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,PAK1
BP,GO:0045684,positive regulation of epidermis development,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,VDR
BP,GO:0048713,regulation of oligodendrocyte differentiation,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,DUSP10
BP,GO:0050856,regulation of T cell receptor signaling pathway,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,BCL10
BP,GO:0055090,acylglycerol homeostasis,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,FITM2
BP,GO:0070328,triglyceride homeostasis,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,FITM2
BP,GO:0072529,pyrimidine-containing compound catabolic process,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,MBD4
BP,GO:1901998,toxin transport,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,MTMR12
BP,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,TRIAP1
BP,GO:2000648,positive regulation of stem cell proliferation,0.9536214117887425,1,0.6549576598110555,0.8673072135779211,HNRNPU
BP,GO:0090288,negative regulation of cellular response to growth factor stimulus,0.8961743387894207,4,0.6560109347696335,0.8681367868063985,NEDD4/TGFBR1/PTPN1/PDCD6
BP,GO:0097696,STAT cascade,0.8961743387894207,4,0.6560109347696335,0.8681367868063985,IL7R/CRLF3/PTPN1/CNOT7
BP,GO:0030326,embryonic limb morphogenesis,0.892589641434263,3,0.6572024422317679,0.8686376056023783,CYP26B1/BAX/IMPAD1
BP,GO:0035113,embryonic appendage morphogenesis,0.892589641434263,3,0.6572024422317679,0.8686376056023783,CYP26B1/BAX/IMPAD1
BP,GO:0030073,insulin secretion,0.8983390111053371,5,0.6572434980442774,0.8686376056023783,ACVR2B/ANO1/CAPN10/MPC2/MYO5A
BP,GO:0071456,cellular response to hypoxia,0.8983390111053371,5,0.6572434980442774,0.8686376056023783,HP1BP3/EGLN3/ARNT/RBPJ/P4HB
BP,GO:0045582,positive regulation of T cell differentiation,0.8961743387894207,2,0.6577615615308421,0.8687578026972291,DUSP10/IL7R
BP,GO:0060218,hematopoietic stem cell differentiation,0.8961743387894207,2,0.6577615615308421,0.8687578026972291,CDK6/LDB1
BP,GO:0042180,cellular ketone metabolic process,0.8997879449942167,6,0.6596628400104299,0.8709861840838782,PRKAG2/UBIAD1/LPGAT1/APPL2/PRKAA2/AKR1C3
BP,GO:0032479,regulation of type I interferon production,0.8855055966609752,3,0.6624898548181871,0.8713923587642336,POLR3F/POLR3C/ZCCHC3
BP,GO:0045667,regulation of osteoblast differentiation,0.8855055966609752,3,0.6624898548181871,0.8713923587642336,CDK6/ACVR2B/SMOC1
BP,GO:0048706,embryonic skeletal system development,0.8855055966609752,3,0.6624898548181871,0.8713923587642336,TGFBR1/MTHFD1L/TAPT1
BP,GO:0051283,negative regulation of sequestering of calcium ion,0.8855055966609752,3,0.6624898548181871,0.8713923587642336,BAX/DIAPH1/MYO5A
CC,GO:0005581,collagen trimer,0.8870144184267943,2,0.6631217975011903,0.8556999029338496,WDR33/SCARA3
MF,GO:0016248,channel inhibitor activity,0.9314210526315789,1,0.6638654034190706,0.8314410637603318,NEDD4
MF,GO:0034061,DNA polymerase activity,0.9314210526315789,1,0.6638654034190706,0.8314410637603318,TERF2
MF,GO:0048487,beta-tubulin binding,0.9314210526315789,1,0.6638654034190706,0.8314410637603318,GABARAP
BP,GO:0002718,regulation of cytokine production involved in immune response,0.8855055966609752,2,0.664194161964822,0.8713923587642336,MAP3K7/BCL10
BP,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.8855055966609752,2,0.664194161964822,0.8713923587642336,RPS6KA1/TRIAP1
BP,GO:0045445,myoblast differentiation,0.8855055966609752,2,0.664194161964822,0.8713923587642336,SDC1/RBPJ
BP,GO:0097756,negative regulation of blood vessel diameter,0.8855055966609752,2,0.664194161964822,0.8713923587642336,ACTA2/DOCK5
BP,GO:0000183,chromatin silencing at rDNA,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,PHF8
BP,GO:0001990,regulation of systemic arterial blood pressure by hormone,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,RASL10B
BP,GO:0002369,T cell cytokine production,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,MAP3K7
BP,GO:0007618,mating,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,NHLH2
BP,GO:0009268,response to pH,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,GBA
BP,GO:0032008,positive regulation of TOR signaling,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,PIK3CA
BP,GO:0035315,hair cell differentiation,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,RBPJ
BP,GO:0042026,protein refolding,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,PPIE
BP,GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,BAX
BP,GO:0071526,semaphorin-plexin signaling pathway,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,MET
BP,GO:0072583,clathrin-dependent endocytosis,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,FNBP1L
BP,GO:0098534,centriole assembly,0.9297808764940239,1,0.6642545979665408,0.8713923587642336,NUP62
MF,GO:0035591,signaling adaptor activity,0.8848499999999999,2,0.6648018412828021,0.8314410637603318,SH2D3A/FRS2
MF,GO:0046332,SMAD binding,0.8848499999999999,2,0.6648018412828021,0.8314410637603318,TGFBR1/ACVR2B
MF,GO:0004175,endopeptidase activity,0.9117892271662763,11,0.6651528510082654,0.8314410637603318,USP28/CAPN6/USP46/COPS5/ADAMTS14/MBTPS1/CAPN10/PSEN2/OMA1/TRAPPC12/PIDD1
BP,GO:1990138,neuron projection extension,0.8855055966609752,4,0.6652099266267446,0.8722899970884841,PAK1/ZFYVE27/CDK5/CYFIP1
BP,GO:0008154,actin polymerization or depolymerization,0.8897424655445204,5,0.6655077363379903,0.8722899970884841,CAPZA1/DIAPH1/MICAL2/MYO1C/CYFIP1
BP,GO:0032496,response to lipopolysaccharide,0.9016056984184473,8,0.6661123279683138,0.8722899970884841,CDK4/BCL10/DUSP10/CLDN1/TNIP2/HNRNPA0/LDOC1/PDE4B
CC,GO:0045177,apical part of cell,0.9043389187866927,9,0.6668499100092758,0.8556999029338496,UPK2/VAMP7/MYO1B/ANO1/STK26/PSEN2/MARVELD2/CLDN1/NHS
BP,GO:0030072,peptide hormone secretion,0.892589641434263,6,0.6672187603753372,0.8722899970884841,ACVR2B/ANO1/CAPN10/MPC2/MYO5A/RASL10B
BP,GO:0007517,muscle organ development,0.907103294140511,10,0.667512503291197,0.8722899970884841,CYP26B1/TGFBR1/CD164/PAK1/CDK5/FRS2/RBPJ/MTM1/NUPR1/MYL6B
BP,GO:0035270,endocrine system development,0.8785331116478966,3,0.6677179745888476,0.8722899970884841,CDK6/TGFBR1/RBPJ
BP,GO:0099024,plasma membrane invagination,0.8785331116478966,3,0.6677179745888476,0.8722899970884841,VAMP7/APPL2/ARHGAP12
CC,GO:0046540,U4/U6 x U5 tri-snRNP complex,0.9186935047991799,1,0.6684642235970764,0.8556999029338496,LSM7
CC,GO:0097526,spliceosomal tri-snRNP complex,0.9186935047991799,1,0.6684642235970764,0.8556999029338496,LSM7
CC,GO:0099738,cell cortex region,0.9186935047991799,1,0.6684642235970764,0.8556999029338496,CLASP2
CC,GO:1990391,DNA repair complex,0.9186935047991799,1,0.6684642235970764,0.8556999029338496,ERCC5
BP,GO:0045666,positive regulation of neuron differentiation,0.9022132494281634,9,0.6697034352567803,0.8722899970884841,SS18L2/ITGA6/NDRG4/ANKRD27/VAMP7/PAK1/ZFYVE27/CYB5D2/CYFIP1
BP,GO:0015698,inorganic anion transport,0.8802659185742238,4,0.6697461366402115,0.8722899970884841,CLCC1/ANO1/PIDD1/LRRC8B
BP,GO:0048660,regulation of smooth muscle cell proliferation,0.8802659185742238,4,0.6697461366402115,0.8722899970884841,NDRG4/CDKN1A/PAK1/APOD
BP,GO:0009798,axis specification,0.8750878837590813,2,0.6705291290547762,0.8722899970884841,FRS2/LDB1
BP,GO:0014031,mesenchymal cell development,0.8750878837590813,2,0.6705291290547762,0.8722899970884841,TAPT1/PDCD6
BP,GO:0048864,stem cell development,0.8750878837590813,2,0.6705291290547762,0.8722899970884841,TAPT1/PDCD6
BP,GO:1901532,regulation of hematopoietic progenitor cell differentiation,0.8750878837590813,2,0.6705291290547762,0.8722899970884841,CDK6/LDB1
BP,GO:1904705,regulation of vascular smooth muscle cell proliferation,0.8750878837590813,2,0.6705291290547762,0.8722899970884841,CDKN1A/PAK1
BP,GO:1990874,vascular smooth muscle cell proliferation,0.8750878837590813,2,0.6705291290547762,0.8722899970884841,CDKN1A/PAK1
BP,GO:0021537,telencephalon development,0.8890335074046443,6,0.6709568669878809,0.8722899970884841,PHLPP2/CSNK2A2/BAX/CDK6/C12orf57/CDK5
BP,GO:0045637,regulation of myeloid cell differentiation,0.8890335074046443,6,0.6709568669878809,0.8722899970884841,CDK6/AGO4/ARNT/GABPA/TOB2/LDB1
MF,GO:0003678,DNA helicase activity,0.8739259259259259,2,0.6714508547843485,0.8342264348398134,INO80/RAD54L2
MF,GO:0004527,exonuclease activity,0.8739259259259259,2,0.6714508547843485,0.8342264348398134,CNOT6/CNOT7
BP,GO:0009855,determination of bilateral symmetry,0.8716695717131474,3,0.6728868022991463,0.8722899970884841,NDRG4/ACVR2B/MICAL2
BP,GO:0010595,positive regulation of endothelial cell migration,0.8716695717131474,3,0.6728868022991463,0.8722899970884841,SRPX2/MET/PDCD6
BP,GO:0032606,type I interferon production,0.8716695717131474,3,0.6728868022991463,0.8722899970884841,POLR3F/POLR3C/ZCCHC3
BP,GO:0034763,negative regulation of transmembrane transport,0.8716695717131474,3,0.6728868022991463,0.8722899970884841,NEDD4/ISCU/APPL2
BP,GO:0051282,regulation of sequestering of calcium ion,0.8716695717131474,3,0.6728868022991463,0.8722899970884841,BAX/DIAPH1/MYO5A
BP,GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,RTP4
BP,GO:0006308,DNA catabolic process,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,BAX
BP,GO:0006458,'de novo' protein folding,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,ENTPD5
BP,GO:0007520,myoblast fusion,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,DYRK1B
BP,GO:0010664,negative regulation of striated muscle cell apoptotic process,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,NUPR1
BP,GO:0030835,negative regulation of actin filament depolymerization,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,CAPZA1
BP,GO:0040019,positive regulation of embryonic development,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,CLASP2
BP,GO:0042572,retinol metabolic process,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,AKR1C3
BP,GO:0044743,protein transmembrane import into intracellular organelle,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,TOMM20
BP,GO:0045616,regulation of keratinocyte differentiation,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,VDR
BP,GO:0048286,lung alveolus development,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,RC3H2
BP,GO:0090279,regulation of calcium ion import,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,PSEN2
BP,GO:0150077,regulation of neuroinflammatory response,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,NUPR1
BP,GO:1900117,regulation of execution phase of apoptosis,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,BAX
BP,GO:1903053,regulation of extracellular matrix organization,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,CLASP2
BP,GO:1905209,positive regulation of cardiocyte differentiation,0.9071032941405112,1,0.6733015218431269,0.8722899970884841,RBPJ
MF,GO:0008536,Ran GTPase binding,0.9075384615384616,1,0.6733827768994753,0.8342264348398134,RCC1
MF,GO:0016409,palmitoyltransferase activity,0.9075384615384616,1,0.6733827768994753,0.8342264348398134,ZDHHC18
MF,GO:0061980,regulatory RNA binding,0.9075384615384616,1,0.6733827768994753,0.8342264348398134,AGO4
CC,GO:0036064,ciliary basal body,0.8703412150729073,3,0.6737368771857921,0.8581964830788386,WRAP73/WDR11/TAPT1
BP,GO:0043433,negative regulation of DNA-binding transcription factor activity,0.8750878837590813,4,0.6742400163977511,0.8732277576268869,G3BP2/PRMT2/BTRC/NUPR1
BP,GO:0015849,organic acid transport,0.8934831245588218,8,0.6758865013387557,0.8748031458625701,CTNS/PLA2G3/PRKAG2/SLC36A1/SLC7A1/MPC2/PRKAA2/PRAF2
BP,GO:0046942,carboxylic acid transport,0.8934831245588218,8,0.6758865013387557,0.8748031458625701,CTNS/PLA2G3/PRKAG2/SLC36A1/SLC7A1/MPC2/PRKAA2/PRAF2
BP,GO:0006303,double-strand break repair via nonhomologous end joining,0.8649124432502548,2,0.6767670512045227,0.875107553814367,DTX3L/RNF168
BP,GO:0006890,"retrograde vesicle-mediated transport, Golgi to ER",0.8649124432502548,2,0.6767670512045227,0.875107553814367,COPE/NBAS
BP,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,0.8649124432502548,2,0.6767670512045227,0.875107553814367,RAB7A/NUP62
CC,GO:0000152,nuclear ubiquitin ligase complex,0.897328539571292,1,0.6770748859473634,0.8581964830788386,CDC26
CC,GO:0005891,voltage-gated calcium channel complex,0.897328539571292,1,0.6770748859473634,0.8581964830788386,PDE4B
CC,GO:0016235,aggresome,0.897328539571292,1,0.6770748859473634,0.8581964830788386,EDEM1
BP,GO:0071219,cellular response to molecule of bacterial origin,0.877151770277381,5,0.6776588762682036,0.8755838758755614,CDK4/BCL10/TNIP2/LDOC1/PDE4B
MF,GO:0008013,beta-catenin binding,0.8632682926829268,2,0.6779926653987591,0.8384428869255117,BTRC/TBL1XR1
BP,GO:0003206,cardiac chamber morphogenesis,0.8649124432502548,3,0.6779963640629347,0.8755838758755614,TGFBR1/RBPJ/PARVA
BP,GO:0009799,specification of symmetry,0.8649124432502548,3,0.6779963640629347,0.8755838758755614,NDRG4/ACVR2B/MICAL2
BP,GO:0050853,B cell receptor signaling pathway,0.8649124432502548,3,0.6779963640629347,0.8755838758755614,BAX/PLEKHA1/CMTM3
CC,GO:0043204,perikaryon,0.8638461313783333,3,0.6786505777897918,0.8581964830788386,WDFY3/CDK5/NSMF
BP,GO:0048659,smooth muscle cell proliferation,0.8699704107546422,4,0.6786914810286586,0.8759254266575454,NDRG4/CDKN1A/PAK1/APOD
BP,GO:0060401,cytosolic calcium ion transport,0.8699704107546422,4,0.6786914810286586,0.8759254266575454,BAX/DIAPH1/PSEN2/MYO5A
BP,GO:1902749,regulation of cell cycle G2/M phase transition,0.8730336868488486,5,0.6816434036859047,0.8761615777743694,MAPRE1/VPS4A/TAOK3/CDK4/CCNB3
BP,GO:0051924,regulation of calcium ion transport,0.8785331116478966,6,0.6820103644210798,0.8761615777743694,BAX/DIAPH1/PSEN2/STAC/PDE4B/MYO5A
BP,GO:0006284,base-excision repair,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,MBD4
BP,GO:0006509,membrane protein ectodomain proteolysis,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,PSEN2
BP,GO:0010470,regulation of gastrulation,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,CLASP2
BP,GO:0010559,regulation of glycoprotein biosynthetic process,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,ITM2B
BP,GO:0010677,negative regulation of cellular carbohydrate metabolic process,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,NUPR1
BP,GO:0010907,positive regulation of glucose metabolic process,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,EPM2AIP1
BP,GO:0017145,stem cell division,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,DOCK7
BP,GO:0021983,pituitary gland development,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,RBPJ
BP,GO:0030517,negative regulation of axon extension,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,CDK5
BP,GO:0031057,negative regulation of histone modification,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,KDM3A
BP,GO:0032958,inositol phosphate biosynthetic process,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,PLCD4
BP,GO:0097028,dendritic cell differentiation,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,RBPJ
BP,GO:2001222,regulation of neuron migration,0.8855055966609752,1,0.6821051417923865,0.8761615777743694,NSMF
MF,GO:0001784,phosphotyrosine residue binding,0.8848499999999999,1,0.6826311975331971,0.8411856068893121,YES1
MF,GO:0042287,MHC protein binding,0.8848499999999999,1,0.6826311975331971,0.8411856068893121,FAM49B
BP,GO:0001892,embryonic placenta development,0.854970920914045,2,0.6829085557482273,0.876333231072322,ARNT/RBPJ
BP,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,0.854970920914045,2,0.6829085557482273,0.876333231072322,NEDD4/PIK3CA
BP,GO:0051781,positive regulation of cell division,0.854970920914045,2,0.6829085557482273,0.876333231072322,PKN2/NUP62
BP,GO:0030324,lung development,0.8649124432502548,4,0.6831004610939855,0.876333231072322,RC3H2/TAB1/ACVR2B/RBPJ
BP,GO:0030099,myeloid cell differentiation,0.894020073551946,10,0.684975544565209,0.8774683475508572,THOC5/CDK6/AGO4/ARNT/LBR/PIP4K2A/GABPA/RBPJ/TOB2/LDB1
BP,GO:1904951,positive regulation of establishment of protein localization,0.8971569860907249,11,0.6854126721399814,0.8774683475508572,CSNK2A2/ANO1/XPO4/EDEM1/CAPN10/MPC2/PAK1/CDK5/IL1RAP/MYO18A/MYO1C
BP,GO:0001818,negative regulation of cytokine production,0.8795224507375902,7,0.6867998600084275,0.8774683475508572,ARG2/ADCY7/APPL2/MAPKBP1/RPS6KA4/GBA/APOD
CC,GO:0031091,platelet alpha granule,0.84802477366078155,2,0.6870636139137856,0.8604344214725557,VAMP7/FAM49B
CC,GO:0035578,azurophil granule lumen,0.84802477366078155,2,0.6870636139137856,0.8604344214725557,FTL/C6orf120
CC,GO:0035579,specific granule membrane,0.84802477366078155,2,0.6870636139137856,0.8604344214725557,PTPRB/RAP2B
CC,GO:0060170,ciliary membrane,0.84802477366078155,2,0.6870636139137856,0.8604344214725557,PHLPP2/PCDHB13
BP,GO:0003018,vascular process in circulatory system,0.8599129493586347,4,0.6874669022068427,0.8774683475508572,GCLM/ACTA2/DOCK5/YES1
BP,GO:0030183,B cell differentiation,0.8517076731242967,3,0.6880379156795322,0.8774683475508572,BAX/RBPJ/CARD11
BP,GO:0051208,sequestering of calcium ion,0.8517076731242967,3,0.6880379156795322,0.8774683475508572,BAX/DIAPH1/MYO5A
BP,GO:0055076,transition metal ion homeostasis,0.8517076731242967,3,0.6880379156795322,0.8774683475508572,FTL/ISCU/TMEM199
BP,GO:0032088,negative regulation of NF-kappaB transcription factor activity,0.8452553422672945,2,0.6889543064404398,0.8774683475508572,G3BP2/PRMT2
BP,GO:0034103,regulation of tissue remodeling,0.8452553422672945,2,0.6889543064404398,0.8774683475508572,BAX/VDR
BP,GO:0048644,muscle organ morphogenesis,0.8452553422672945,2,0.6889543064404398,0.8774683475508572,TGFBR1/RBPJ
BP,GO:0061097,regulation of protein tyrosine kinase activity,0.8452553422672945,2,0.6889543064404398,0.8774683475508572,RAP2B/PTPN1
BP,GO:0097194,execution phase of apoptosis,0.8452553422672945,2,0.6889543064404398,0.8774683475508572,BAX/CAPN10
BP,GO:1902476,chloride transmembrane transport,0.8452553422672945,2,0.6889543064404398,0.8774683475508572,CLCC1/ANO1
BP,GO:0042254,ribosome biogenesis,0.8765610956846017,7,0.6901496866690333,0.8774683475508572,ZNHIT6/FCF1/WDR55/RSL24D1/BTRC/TRMT112/C1D
BP,GO:0000096,sulfur amino acid metabolic process,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,GCLM
BP,GO:0000959,mitochondrial RNA metabolic process,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,HSD17B10
BP,GO:0006692,prostanoid metabolic process,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,AKR1C3
BP,GO:0006693,prostaglandin metabolic process,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,AKR1C3
BP,GO:0006904,vesicle docking involved in exocytosis,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,RAB15
BP,GO:0021795,cerebral cortex cell migration,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,CDK5
BP,GO:0032881,regulation of polysaccharide metabolic process,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,EPM2AIP1
BP,GO:0034383,low-density lipoprotein particle clearance,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,CNPY2
BP,GO:0043616,keratinocyte proliferation,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,VDR
BP,GO:0046461,neutral lipid catabolic process,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,DDHD2
BP,GO:0046464,acylglycerol catabolic process,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,DDHD2
BP,GO:0071364,cellular response to epidermal growth factor stimulus,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,PDE8A
BP,GO:0072348,sulfur compound transport,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,CTNS
BP,GO:0086004,regulation of cardiac muscle cell contraction,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,PDE4B
BP,GO:0099054,presynapse assembly,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,IL1RAP
BP,GO:1901658,glycosyl compound catabolic process,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,GBA
BP,GO:1904646,cellular response to amyloid-beta,0.8649124432502548,1,0.6906719884114663,0.8774683475508572,CDK5
MF,GO:0043177,organic acid binding,0.8632682926829268,5,0.6912938153704553,0.8503525693494981,CYP26B1/SESN1/PYGL/VDR/EGLN3
BP,GO:2001252,positive regulation of chromosome organization,0.854970920914045,4,0.6917907646554832,0.8786153077172979,RTF1/HMBOX1/HNRNPU/RPS6KA4
BP,GO:0042177,negative regulation of protein catabolic process,0.8452553422672945,3,0.6929700766322529,0.8792895420274499,CSNK2A2/RYBP/MTM1
BP,GO:0042552,myelination,0.8452553422672945,3,0.6929700766322529,0.8792895420274499,GNPAT/SBF2/MYO5A
BP,GO:0045598,regulation of fat cell differentiation,0.8452553422672945,3,0.6929700766322529,0.8792895420274499,DUSP10/ASXL2/HNRNPU
CC,GO:0008287,protein serine/threonine phosphatase complex,0.8574472711459014,1,0.6936323551218299,0.8604344214725557,PPP1CC
CC,GO:0031304,intrinsic component of mitochondrial inner membrane,0.8574472711459014,1,0.6936323551218299,0.8604344214725557,MPC2
CC,GO:0031305,integral component of mitochondrial inner membrane,0.8574472711459014,1,0.6936323551218299,0.8604344214725557,MPC2
CC,GO:1903293,phosphatase complex,0.8574472711459014,1,0.6936323551218299,0.8604344214725557,PPP1CC
BP,GO:0032602,chemokine production,0.8357580912305833,2,0.6949050010524911,0.8805207295503431,ARG2/APOD
BP,GO:0010921,regulation of phosphatase activity,0.8500853727945361,4,0.6960720230293528,0.8805207295503431,ELL/BOD1/PPP1R14A/PPP1R14C
BP,GO:0032200,telomere organization,0.8500853727945361,4,0.6960720230293528,0.8805207295503431,SMG6/TERF2/HMBOX1/HNRNPU
BP,GO:0036294,cellular response to decreased oxygen levels,0.856940899994492,5,0.6972498702052687,0.8805207295503431,HP1BP3/EGLN3/ARNT/RBPJ/P4HB
BP,GO:0009581,detection of external stimulus,0.8389000389419765,3,0.6978433121436136,0.8805207295503431,ANO1/NMT2/CDS1
BP,GO:0003416,endochondral bone growth,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,SCARA3
BP,GO:0007007,inner mitochondrial membrane organization,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,OMA1
BP,GO:0007019,microtubule depolymerization,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,CLASP2
BP,GO:0010828,positive regulation of glucose transmembrane transport,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,CAPN10
BP,GO:0014002,astrocyte development,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,CDK6
BP,GO:0018023,peptidyl-lysine trimethylation,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,RTF1
BP,GO:0035850,epithelial cell differentiation involved in kidney development,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,ACTA2
BP,GO:0038084,vascular endothelial growth factor signaling pathway,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,MYO1C
BP,GO:0042987,amyloid precursor protein catabolic process,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,PSEN2
BP,GO:0045910,negative regulation of DNA recombination,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,TERF2
BP,GO:0061001,regulation of dendritic spine morphogenesis,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,CDK5
BP,GO:0070897,transcription preinitiation complex assembly,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,TBP
BP,GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,STARD13
BP,GO:0090382,phagosome maturation,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,RAB7A
BP,GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,BAX
BP,GO:1903214,regulation of protein targeting to mitochondrion,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,CSNK2A2
BP,GO:1903573,negative regulation of response to endoplasmic reticulum stress,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,PTPN1
BP,GO:2000404,regulation of T cell migration,0.8452553422672945,1,0.6990084173488929,0.8805207295503431,APOD
BP,GO:0030900,forebrain development,0.8785331116478967,9,0.699760378167275,0.8805207295503431,PHLPP2/CSNK2A2/BAX/CDK6/C12orf57/DOCK7/CDK5/FRS2/RBPJ
BP,GO:0003007,heart morphogenesis,0.8615730129674353,6,0.6998909842630017,0.8805207295503431,TAB1/NDRG4/TGFBR1/MICAL2/RBPJ/PARVA
BP,GO:0030323,respiratory tube development,0.8452553422672945,4,0.7003106658482932,0.8805207295503431,RC3H2/TAB1/ACVR2B/RBPJ
MF,GO:0019894,kinesin binding,0.8427142857142857,1,0.7003513090381732,0.8569439432773422,NUP62
MF,GO:0030331,estrogen receptor binding,0.8427142857142857,1,0.7003513090381732,0.8569439432773422,PRMT2
MF,GO:0043028,cysteine-type endopeptidase regulator activity involved in apoptotic process,0.8427142857142857,1,0.7003513090381732,0.8569439432773422,RPS6KA1
BP,GO:0001843,neural tube closure,0.8264718902169101,2,0.700761369071365,0.8805207295503431,MTHFD1L/BCL10
BP,GO:0014033,neural crest cell differentiation,0.8264718902169101,2,0.700761369071365,0.8805207295503431,TAPT1/PDCD6
BP,GO:0031058,positive regulation of histone modification,0.8264718902169101,2,0.700761369071365,0.8805207295503431,RTF1/RPS6KA4
BP,GO:0045778,positive regulation of ossification,0.8264718902169101,2,0.700761369071365,0.8805207295503431,ACVR2B/TOB2
BP,GO:0051304,chromosome separation,0.8264718902169101,2,0.700761369071365,0.8805207295503431,CSNK2A2/CDC26
BP,GO:0050807,regulation of synapse organization,0.8530099784348844,5,0.7010682421363716,0.8805207295503431,NEDD4/SRPX2/CDK5/IL1RAP/CYFIP1
BP,GO:0007599,hemostasis,0.8725216436307556,8,0.701083245578555,0.8805207295503431,CBX5/PRKAR2A/CAPZA1/PIK3CA/RBSN/ANXA7/RAP2B/ACTG1
BP,GO:0023061,signal release,0.8855055966609752,11,0.7015937200703122,0.8808898929771697,SNX4/ACVR2B/VAMP7/ANO1/CAPN10/MPC2/SNAPIN/ADCY1/CDK5/MYO5A/RASL10B
BP,GO:0007006,mitochondrial membrane organization,0.8326395908901707,3,0.7026577621157435,0.8811380321476092,BAX/OMA1/TOMM20
BP,GO:0007272,ensheathment of neurons,0.8326395908901707,3,0.7026577621157435,0.8811380321476092,GNPAT/SBF2/MYO5A
BP,GO:0008366,axon ensheathment,0.8326395908901707,3,0.7026577621157435,0.8811380321476092,GNPAT/SBF2/MYO5A
BP,GO:0048565,digestive tract development,0.8326395908901707,3,0.7026577621157435,0.8811380321476092,ITGA6/ACVR2B/CDKN1A
MF,GO:0016209,antioxidant activity,0.8231162790697674,2,0.7031032561704622,0.8572925667341601,SESN1/UBIAD1
MF,GO:0030165,PDZ domain binding,0.8231162790697674,2,0.7031032561704622,0.8572925667341601,PLEKHA1/LNX2
BP,GO:0001959,regulation of cytokine-mediated signaling pathway,0.8404798883561797,4,0.7045066951950578,0.8813961625726231,TRIM44/YTHDF3/PTPN1/CNOT7
BP,GO:0007584,response to nutrient,0.8491149557023049,5,0.7048532162417045,0.8813961625726231,CYP26B1/GCLM/VDR/GNPAT/AKR1C3
BP,GO:0009952,anterior/posterior pattern specification,0.8491149557023049,5,0.7048532162417045,0.8813961625726231,TGFBR1/ACVR2B/FRS2/RBPJ/LDB1
BP,GO:0001578,microtubule bundle formation,0.8173897815332078,2,0.7065241694972859,0.8813961625726231,CAPN6/PLA2G3
BP,GO:0060606,tube closure,0.8173897815332078,2,0.7065241694972859,0.8813961625726231,MTHFD1L/BCL10
BP,GO:1901992,positive regulation of mitotic cell cycle phase transition,0.8173897815332078,2,0.7065241694972859,0.8813961625726231,CCND3/CDK4
BP,GO:1904063,negative regulation of cation transmembrane transport,0.8173897815332078,2,0.7065241694972859,0.8813961625726231,NEDD4/ISCU
BP,GO:0001819,positive regulation of cytokine production,0.8816887621926089,11,0.7068722186245874,0.8813961625726231,POLR3F/MAP3K7/BCL10/ARNT/FAM49B/PDE4B/POLR3C/CARD9/IL1RAP/CARD11/ZCCHC3
BP,GO:0002833,positive regulation of response to biotic stimulus,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,ZCCHC3
BP,GO:0014014,negative regulation of gliogenesis,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,DUSP10
BP,GO:0031018,endocrine pancreas development,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,CDK6
BP,GO:0032309,icosanoid secretion,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,PLA2G3
BP,GO:0035987,endodermal cell differentiation,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,RTF1
BP,GO:0045581,negative regulation of T cell differentiation,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,RC3H2
BP,GO:0048538,thymus development,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,TGFBR1
BP,GO:0050913,sensory perception of bitter taste,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,RTP4
BP,GO:0051932,"synaptic transmission, GABAergic",0.8264718902169101,1,0.7071206139821397,0.8813961625726231,USP46
BP,GO:1900271,regulation of long-term synaptic potentiation,0.8264718902169101,1,0.7071206139821397,0.8813961625726231,ADCY1
BP,GO:0032956,regulation of actin cytoskeleton organization,0.8674340538719756,8,0.7071818349629186,0.8813961625726231,MET/TGFBR1/CAPZA1/PAK1/CLASP2/CDK5/MYO1C/CYFIP1
BP,GO:0043484,regulation of RNA splicing,0.8264718902169101,3,0.707413586725569,0.8813961625726231,CIRBP/CELF1/HNRNPU
BP,GO:0060359,response to ammonium ion,0.8264718902169101,3,0.707413586725569,0.8813961625726231,DIAPH1/GABPA/CDK5
BP,GO:0051271,negative regulation of cellular component movement,0.8716695717131475,9,0.7084332557709063,0.8823963516460646,NDRG4/RAP2A/STARD13/STK26/DUSP10/CLASP2/RAP2B/APOD/CSNK2B
MF,GO:0001221,transcription cofactor binding,0.8231162790697674,1,0.708837536479743,0.8601896413562545,VGLL4
MF,GO:0015932,nucleobase-containing compound transmembrane transporter activity,0.8231162790697674,1,0.708837536479743,0.8601896413562545,SLC35E3
MF,GO:0008509,anion transmembrane transporter activity,0.865908256880734,8,0.7091923230174588,0.8601896413562545,CTNS/CLCC1/SLC36A1/ANO1/SLC7A1/MPC2/PIDD1/LRRC8B
CC,GO:0005604,basement membrane,0.8123184674013801,2,0.7095911843810252,0.8781401592933826,ITGA6/SMOC1
BP,GO:0052548,regulation of endopeptidase activity,0.8750878837590813,10,0.710112470187086,0.8842171805084377,BAX/RPS6KA1/EGLN3/BCL10/CRADD/TRIAP1/PIDD1/CARD9/ASPH/PDCD6
BP,GO:0009582,detection of abiotic stimulus,0.8203948910241388,3,0.7121109656366227,0.8851732758805546,ANO1/NMT2/CDS1
BP,GO:0035710,"CD4-positive, alpha-beta T cell activation",0.8085051099948034,2,0.7121941887364033,0.8851732758805546,RC3H2/ARG2
BP,GO:1904894,positive regulation of STAT cascade,0.8085051099948034,2,0.7121941887364033,0.8851732758805546,IL7R/CRLF3
BP,GO:2000117,negative regulation of cysteine-type endopeptidase activity,0.8085051099948034,2,0.7121941887364033,0.8851732758805546,RPS6KA1/TRIAP1
BP,GO:0048771,tissue remodeling,0.8310890516147699,4,0.7127709874372293,0.8851732758805546,BAX/VDR/ACVR2B/RBPJ
BP,GO:0002067,glandular epithelial cell differentiation,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,CDK6
BP,GO:0002437,inflammatory response to antigenic stimulus,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,RBPJ
BP,GO:0007129,synapsis,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,AGO4
BP,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,CD164
BP,GO:0010883,regulation of lipid storage,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,FITM2
BP,GO:0014075,response to amine,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,RGS17
BP,GO:0022602,ovulation cycle process,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,PLEKHA1
BP,GO:0032527,protein exit from endoplasmic reticulum,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,EDEM1
BP,GO:0035196,production of miRNAs involved in gene silencing by miRNA,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,AGO4
BP,GO:0044003,modification by symbiont of host morphology or physiology,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,KPNA5
BP,GO:0050706,regulation of interleukin-1 beta secretion,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,ARG2
BP,GO:0051339,regulation of lyase activity,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,ISCU
BP,GO:0051646,mitochondrion localization,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,MTM1
BP,GO:0060711,labyrinthine layer development,0.8085051099948034,1,0.7150145979703793,0.8851732758805546,RBPJ
BP,GO:0046425,regulation of JAK-STAT cascade,0.8144066071480501,3,0.716750097227727,0.8863214513794359,CDK5/CRLF3/CNOT7
BP,GO:0071346,cellular response to interferon-gamma,0.8264718902169101,4,0.7168393190549136,0.8863214513794359,KIF16B/CLDN1/ACTG1/MYO1C
BP,GO:0071466,cellular response to xenobiotic stimulus,0.8264718902169101,4,0.7168393190549136,0.8863214513794359,CYP26B1/ARNT/CMBL/ARNT2
MF,GO:1901505,carbohydrate derivative transmembrane transporter activity,0.804409090909091,1,0.7170838960447214,0.8682461807510129,SLC35E3
BP,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,0.7998115066615259,2,0.7177722385850598,0.8863214513794359,VPS4A/TAOK3
BP,GO:0033273,response to vitamin,0.7998115066615259,2,0.7177722385850598,0.8863214513794359,CYP26B1/VDR
BP,GO:0035249,"synaptic transmission, glutamatergic",0.7998115066615259,2,0.7177722385850598,0.8863214513794359,ALS2/CDK5
BP,GO:0046634,regulation of alpha-beta T cell activation,0.7998115066615259,2,0.7177722385850598,0.8863214513794359,RC3H2/ARG2
BP,GO:0048704,embryonic skeletal system morphogenesis,0.7998115066615259,2,0.7177722385850598,0.8863214513794359,TGFBR1/MTHFD1L
BP,GO:0045444,fat cell differentiation,0.8338841941650438,5,0.7196585940253653,0.8863214513794359,ITGA6/DUSP10/ASXL2/HNRNPU/TBL1XR1
BP,GO:0032970,regulation of actin filament-based process,0.8626832874686821,9,0.7197452073866518,0.8863214513794359,MET/TGFBR1/CAPZA1/PAK1/CLASP2/CDK5/PDE4B/MYO1C/CYFIP1
MF,GO:0005319,lipid transporter activity,0.8105496183206108,3,0.7199485887512445,0.8697764683551821,TRIAP1/OSBP2/APOD
CC,GO:0016324,apical plasma membrane,0.8493581459464116,7,0.7206868338197246,0.886409967585818,UPK2/ANO1/STK26/PSEN2/MARVELD2/CLDN1/NHS
MF,GO:0072341,modified amino acid binding,0.795370786516854,2,0.7208507133418487,0.8697764683551821,LANCL1/APPL2
BP,GO:0046631,alpha-beta T cell activation,0.8085051099948034,3,0.7213311978384953,0.8863214513794359,RC3H2/ARG2/ELF4
CC,GO:0030136,clathrin-coated vesicle,0.8209601532247991,4,0.7215379762164471,0.886409967585818,SPG21/VAMP4/VAMP7/IL7R
BP,GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,RNF168
BP,GO:0002208,somatic diversification of immunoglobulins involved in immune response,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,RNF168
BP,GO:0010799,regulation of peptidyl-threonine phosphorylation,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,PRKAG2
BP,GO:0018198,peptidyl-cysteine modification,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,ZDHHC18
BP,GO:0030261,chromosome condensation,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,BANF1
BP,GO:0030574,collagen catabolic process,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,ADAMTS14
BP,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",0.7913028736119352,1,0.7226962276857396,0.8863214513794359,RC3H2
BP,GO:0045058,T cell selection,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,CARD11
BP,GO:0045190,isotype switching,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,RNF168
BP,GO:0048806,genitalia development,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,BAX
BP,GO:0050435,amyloid-beta metabolic process,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,PSEN2
BP,GO:0050912,detection of chemical stimulus involved in sensory perception of taste,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,RTP4
BP,GO:0060351,cartilage development involved in endochondral bone morphogenesis,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,SCARA3
BP,GO:0070169,positive regulation of biomineral tissue development,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,ACVR2B
BP,GO:0070849,response to epidermal growth factor,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,PDE8A
BP,GO:0098868,bone growth,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,SCARA3
BP,GO:1900744,regulation of p38MAPK cascade,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,DUSP10
BP,GO:1901068,guanosine-containing compound metabolic process,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,CARD11
BP,GO:1903115,regulation of actin filament-based movement,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,PDE4B
BP,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,0.7913028736119352,1,0.7226962276857396,0.8863214513794359,MCL1
BP,GO:0000726,non-recombinational repair,0.7913028736119352,2,0.7232591543022605,0.8864773244054222,DTX3L/RNF168
BP,GO:0070167,regulation of biomineral tissue development,0.7913028736119352,2,0.7232591543022605,0.8864773244054222,ACVR2B/BMP2K
BP,GO:0046883,regulation of hormone secretion,0.8389000389419765,6,0.7237715840082881,0.8868381938993121,SNX4/VAMP7/ANO1/CAPN10/MPC2/RASL10B
CC,GO:0001917,photoreceptor inner segment,0.7874515755421542,1,0.7242484351602162,0.886409967585818,PHLPP2
CC,GO:0043209,myelin sheath,0.7874515755421542,1,0.7242484351602162,0.886409967585818,MARVELD2
BP,GO:0030041,actin filament polymerization,0.8173897815332078,4,0.7248486165911094,0.8878904463392452,CAPZA1/DIAPH1/MYO1C/CYFIP1
MF,GO:0048156,tau protein binding,0.7865333333333334,1,0.7250971545264322,0.8733839209633802,CDK5
BP,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,0.8026885264696609,3,0.7258545010315929,0.8888549398544612,ADCY7/ADCY9/ADCY1
MF,GO:0008080,N-acetyltransferase activity,0.7865333333333334,2,0.726564748257304,0.8736375433197687,KANSL3/TADA3
BP,GO:0002702,positive regulation of production of molecular mediator of immune response,0.7829733696791781,2,0.728655792767078,0.8903035076277979,MAP3K7/BCL10
BP,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,0.7829733696791781,2,0.728655792767078,0.8903035076277979,FBXL12/BTRC
BP,GO:0042116,macrophage activation,0.7829733696791781,2,0.728655792767078,0.8903035076277979,TNIP2/MYO18A
BP,GO:0038061,NIK/NF-kappaB signaling,0.8129231707051574,4,0.7287897229689495,0.8903035076277979,RC3H2/MAP3K7/BTRC/TRIM44
BP,GO:0050770,regulation of axonogenesis,0.8129231707051574,4,0.7287897229689495,0.8903035076277979,PAK1/ZFYVE27/CDK5/CYFIP1
MF,GO:0035326,enhancer binding,0.798360902255639,3,0.729431385012369,0.8751010069948689,ARNT/RBBP4/LDB1
CC,GO:0034774,secretory granule lumen,0.8414202193487815,7,0.7295972094456595,0.886409967585818,PPIE/FTL/PYGL/FAM49B/C6orf120/CSNK2B/CYFIP1
BP,GO:0007595,lactation,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,VDR
BP,GO:0030850,prostate gland development,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,FRS2
BP,GO:0043039,tRNA aminoacylation,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,GATC
BP,GO:0043628,ncRNA 3'-end processing,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,HSD17B10
BP,GO:0044764,multi-organism cellular process,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,ZCCHC3
BP,GO:0045912,negative regulation of carbohydrate metabolic process,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,NUPR1
BP,GO:0055023,positive regulation of cardiac muscle tissue growth,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,RBPJ
BP,GO:0061647,histone H3-K9 modification,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,KDM3A
BP,GO:0072604,interleukin-6 secretion,0.7748173970783533,1,0.7301712045263002,0.8903035076277979,IL1RAP
MF,GO:0008168,methyltransferase activity,0.8231162790697675,5,0.7303148733599728,0.8751010069948689,METTL22/TRMT2A/PRMT2/TRMT112/TRMT2B
BP,GO:0097553,calcium ion transmembrane import into cytosol,0.7969550369948777,3,0.730320256871672,0.8903035076277979,BAX/DIAPH1/MYO5A
CC,GO:0005903,brush border,0.7794975192235465,2,0.73074792354616,0.886409967585818,MYO1B/MYO1C
CC,GO:0097525,spliceosomal snRNP complex,0.7794975192235465,2,0.73074792354616,0.886409967585818,HTATSF1/LSM7
CC,GO:0099061,integral component of postsynaptic density membrane,0.7717025440313112,1,0.7314128163699545,0.886409967585818,ADCY1
BP,GO:0042113,B cell activation,0.8398020819946022,7,0.7315784388214324,0.8915701285576952,BAX/CDKN1A/RNF168/RBPJ/IL7R/TNIP2/CARD11
BP,GO:0050769,positive regulation of neurogenesis,0.8630877334543682,11,0.7323836378058303,0.8922841085936261,SS18L2/ITGA6/NDRG4/ANKRD27/VAMP7/PAK1/ZFYVE27/NSMF/CYB5D2/PPP1CC/CYFIP1
MF,GO:0004715,non-membrane spanning protein tyrosine kinase activity,0.7694347826086956,1,0.7328838881960891,0.8751010069948689,YES1
MF,GO:0032813,tumor necrosis factor receptor superfamily binding,0.7694347826086956,1,0.7328838881960891,0.8751010069948689,PIDD1
BP,GO:1902903,regulation of supramolecular fiber organization,0.8452553422672945,8,0.733615113906718,0.8925471689428731,MAPRE1/MET/TGFBR1/CAPZA1/PAK1/CLASP2/MYO1C/CYFIP1
BP,GO:0050803,regulation of synapse structure or activity,0.819190199554206,5,0.7339284826892867,0.8925471689428731,NEDD4/SRPX2/CDK5/IL1RAP/CYFIP1
BP,GO:0032755,positive regulation of interleukin-6 production,0.7748173970783533,2,0.7339630307178235,0.8925471689428731,CARD9/IL1RAP
MF,GO:0004713,protein tyrosine kinase activity,0.7924029850746269,3,0.7340775353640411,0.8751010069948689,DYRK1B/MET/YES1
CC,GO:0044438,microbody part,0.7717025440313112,2,0.7358285412463081,0.886409967585818,AGPS/GNPAT
CC,GO:0044439,peroxisomal part,0.7717025440313112,2,0.7358285412463081,0.886409967585818,AGPS/GNPAT
BP,GO:1903708,positive regulation of hemopoiesis,0.8041348121029396,4,0.7365452858235513,0.8925471689428731,ARNT/DUSP10/IL7R/TOX
BP,GO:0045165,cell fate commitment,0.8264718902169101,6,0.7368097808027845,0.8925471689428731,CYP26B1/TGFBR1/DOCK7/RTF1/MCL1/RBPJ
BP,GO:0051054,positive regulation of DNA metabolic process,0.8155972600824771,5,0.7374123984954727,0.8925471689428731,BAX/INO80/HMBOX1/DTX3L/RNF168
BP,GO:0002686,negative regulation of leukocyte migration,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,APOD
BP,GO:0002704,negative regulation of leukocyte mediated immunity,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,IL7R
BP,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,RASL10B
BP,GO:0003254,regulation of membrane depolarization,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,GCLM
BP,GO:0008347,glial cell migration,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,CDK5
BP,GO:0032757,positive regulation of interleukin-8 production,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,BCL10
BP,GO:0043038,amino acid activation,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,GATC
BP,GO:0045010,actin nucleation,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,CYFIP1
BP,GO:0048546,digestive tract morphogenesis,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,ACVR2B
BP,GO:0060042,retina morphogenesis in camera-type eye,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,ZHX2
BP,GO:0071715,icosanoid transport,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,PLA2G3
BP,GO:1901571,fatty acid derivative transport,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,PLA2G3
BP,GO:1903018,regulation of glycoprotein metabolic process,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,ITM2B
BP,GO:1904707,positive regulation of vascular smooth muscle cell proliferation,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,PAK1
BP,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,0.7590047971379787,1,0.7374450771139811,0.8925471689428731,BCL10
MF,GO:0015238,drug transmembrane transporter activity,0.7694347826086956,2,0.7376961604061532,0.8764082589440623,SLC36A1/SLC7A1
MF,GO:0035258,steroid hormone receptor binding,0.7694347826086956,2,0.7376961604061532,0.8764082589440623,KDM3A/PRMT2
CC,GO:0005771,multivesicular body,0.7565711215993246,1,0.7383914125378983,0.886409967585818,CHMP1B
CC,GO:0016469,proton-transporting two-sector ATPase complex,0.7565711215993246,1,0.7383914125378983,0.886409967585818,TMEM199
CC,GO:0043195,terminal bouton,0.7565711215993246,1,0.7383914125378983,0.886409967585818,CYFIP1
BP,GO:0050871,positive regulation of B cell activation,0.7857303181639639,3,0.7390802050508627,0.8925471689428731,CDKN1A/TNIP2/CARD11
BP,GO:0001657,ureteric bud development,0.7668295888610507,2,0.7391817630699458,0.8925471689428731,ARG2/SDC1
BP,GO:0006942,regulation of striated muscle contraction,0.7668295888610507,2,0.7391817630699458,0.8925471689428731,C12orf57/PDE4B
BP,GO:0010596,negative regulation of endothelial cell migration,0.7668295888610507,2,0.7391817630699458,0.8925471689428731,STARD13/CSNK2B
BP,GO:0014020,primary neural tube formation,0.7668295888610507,2,0.7391817630699458,0.8925471689428731,MTHFD1L/BCL10
BP,GO:0042775,mitochondrial ATP synthesis coupled electron transport,0.7668295888610507,2,0.7391817630699458,0.8925471689428731,ISCU/SDHAF2
BP,GO:0048709,oligodendrocyte differentiation,0.7668295888610507,2,0.7391817630699458,0.8925471689428731,DUSP10/CDK5
BP,GO:0090630,activation of GTPase activity,0.7668295888610507,2,0.7391817630699458,0.8925471689428731,TBC1D22B/DOCK7
BP,GO:2001022,positive regulation of response to DNA damage stimulus,0.7668295888610507,2,0.7391817630699458,0.8925471689428731,DTX3L/RNF168
MF,GO:0016860,intramolecular oxidoreductase activity,0.7530638297872341,1,0.7404504881565422,0.8781793332232029,P4HB
BP,GO:0010594,regulation of endothelial cell migration,0.8120356999947806,5,0.7408629612066502,0.8926379493685302,SRPX2/MET/STARD13/CSNK2B/PDCD6
BP,GO:0040013,negative regulation of locomotion,0.8452553422672946,9,0.7414958855290499,0.8926379493685302,NDRG4/RAP2A/STARD13/STK26/DUSP10/CLASP2/RAP2B/APOD/CSNK2B
BP,GO:0035296,regulation of tube diameter,0.7802357005544257,3,0.7433749737710454,0.8926379493685302,GCLM/ACTA2/DOCK5
BP,GO:0044344,cellular response to fibroblast growth factor stimulus,0.7802357005544257,3,0.7433749737710454,0.8926379493685302,GCLM/KIF16B/FRS2
BP,GO:0050880,regulation of blood vessel size,0.7802357005544257,3,0.7433749737710454,0.8926379493685302,GCLM/ACTA2/DOCK5
BP,GO:0097746,regulation of blood vessel diameter,0.7802357005544257,3,0.7433749737710454,0.8926379493685302,GCLM/ACTA2/DOCK5
BP,GO:0048167,regulation of synaptic plasticity,0.7955344397809829,4,0.7441326859722723,0.8926379493685302,ADCY1/CDK5/NSMF/RIN1
BP,GO:0002042,cell migration involved in sprouting angiogenesis,0.7590047971379787,2,0.7443129013097021,0.8926379493685302,SRPX2/STARD13
BP,GO:0009119,ribonucleoside metabolic process,0.7590047971379787,2,0.7443129013097021,0.8926379493685302,CMPK1/CARD11
BP,GO:0031341,regulation of cell killing,0.7590047971379787,2,0.7443129013097021,0.8926379493685302,FAM49B/IL7R
BP,GO:0042773,ATP synthesis coupled electron transport,0.7590047971379787,2,0.7443129013097021,0.8926379493685302,ISCU/SDHAF2
BP,GO:0050764,regulation of phagocytosis,0.7590047971379787,2,0.7443129013097021,0.8926379493685302,APPL2/MYO18A
BP,GO:0072163,mesonephric epithelium development,0.7590047971379787,2,0.7443129013097021,0.8926379493685302,ARG2/SDC1
BP,GO:0072164,mesonephric tubule development,0.7590047971379787,2,0.7443129013097021,0.8926379493685302,ARG2/SDC1
BP,GO:0099175,regulation of postsynapse organization,0.7590047971379787,2,0.7443129013097021,0.8926379493685302,CDK5/IL1RAP
BP,GO:0001706,endoderm formation,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,RTF1
BP,GO:0001961,positive regulation of cytokine-mediated signaling pathway,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,TRIM44
BP,GO:0010718,positive regulation of epithelial to mesenchymal transition,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,TGFBR1
BP,GO:0014009,glial cell proliferation,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,PPP1CC
BP,GO:0045540,regulation of cholesterol biosynthetic process,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,MBTPS1
BP,GO:0097035,regulation of membrane lipid distribution,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,TRIAP1
BP,GO:0106118,regulation of sterol biosynthetic process,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,MBTPS1
BP,GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,CCND3
BP,GO:1903793,positive regulation of anion transport,0.7438247011952192,1,0.7445232453803892,0.8926379493685302,TRIAP1
CC,GO:0030315,T-tubule,0.7420216769531838,1,0.7451890321958425,0.8871672961095299,STAC
CC,GO:0032420,stereocilium,0.7420216769531838,1,0.7451890321958425,0.8871672961095299,MYO1C
CC,GO:0005796,Golgi lumen,0.7565711215993246,2,0.7457450811952304,0.8871672961095299,IMPAD1/SDC1
CC,GO:0097730,non-motile cilium,0.7768817557362193,3,0.7458335426026375,0.8871672961095299,PHLPP2/PCDHB13/MYO5A
BP,GO:0070588,calcium ion transmembrane transport,0.8264718902169101,7,0.7464533638241329,0.8946883571115417,BAX/TRPM7/DIAPH1/PSEN2/STAC/PDE4B/MYO5A
BP,GO:0035150,regulation of tube size,0.7748173970783533,3,0.7476133465732111,0.8952873399646225,GCLM/ACTA2/DOCK5
BP,GO:0060041,retina development in camera-type eye,0.7748173970783533,3,0.7476133465732111,0.8952873399646225,BAX/ACVR2B/ZHX2
BP,GO:1902107,positive regulation of leukocyte differentiation,0.7748173970783533,3,0.7476133465732111,0.8952873399646225,DUSP10/IL7R/TOX
MF,GO:0005245,voltage-gated calcium channel activity,0.7373750000000001,1,0.747803165545875,0.8838829932897672,CDK5
MF,GO:1990841,promoter-specific chromatin binding,0.7373750000000001,1,0.747803165545875,0.8838829932897672,HNRNPU
BP,GO:0030838,positive regulation of actin filament polymerization,0.7513380820153729,2,0.7493573719607594,0.8964046345347149,MYO1C/CYFIP1
BP,GO:0001954,positive regulation of cell-matrix adhesion,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,CDK6
BP,GO:0007566,embryo implantation,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,VMP1
BP,GO:0019369,arachidonic acid metabolic process,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,AKR1C3
BP,GO:0030071,regulation of mitotic metaphase/anaphase transition,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,CDC26
BP,GO:0030834,regulation of actin filament depolymerization,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,CAPZA1
BP,GO:0031050,dsRNA processing,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,AGO4
BP,GO:0031103,axon regeneration,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,APOD
BP,GO:0032206,positive regulation of telomere maintenance,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,HMBOX1
BP,GO:0045668,negative regulation of osteoblast differentiation,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,CDK6
BP,GO:0050999,regulation of nitric-oxide synthase activity,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,TERF2
BP,GO:0070918,production of small RNA involved in gene silencing by RNA,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,AGO4
BP,GO:0097366,response to bronchodilator,0.7292399031325678,1,0.7514109645436032,0.8964046345347149,RGS17
CC,GO:0099146,intrinsic component of postsynaptic density membrane,0.7280212679540671,1,0.7518103596582342,0.8922396295716174,ADCY1
MF,GO:0019842,vitamin binding,0.7694347826086956,3,0.7520349025532008,0.887375649022877,PYGL/VDR/EGLN3
BP,GO:0070838,divalent metal ion transport,0.8470053533278893,11,0.7540685401665593,0.8985528422583166,BAX/TRPM7/VDR/DIAPH1/ISCU/PSEN2/STAC/CNNM4/CDK5/PDE4B/MYO5A
BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.7438247011952192,2,0.7543161151209811,0.8985528422583166,MAP3K7/FAM49B
BP,GO:0030301,cholesterol transport,0.7438247011952192,2,0.7543161151209811,0.8985528422583166,STX12/VPS4A
BP,GO:0034446,substrate adhesion-dependent cell spreading,0.7438247011952192,2,0.7543161151209811,0.8985528422583166,DOCK5/PARVA
BP,GO:0035282,segmentation,0.7438247011952192,2,0.7543161151209811,0.8985528422583166,FRS2/RBPJ
BP,GO:0060759,regulation of response to cytokine stimulus,0.7829733696791781,4,0.7552006777435969,0.8993431958609346,TRIM44/YTHDF3/PTPN1/CNOT7
BP,GO:0055123,digestive system development,0.7642034601320744,3,0.7559222062817863,0.8999389918508359,ITGA6/ACVR2B/CDKN1A
MF,GO:0008237,metallopeptidase activity,0.7821878453038674,4,0.7560957073214649,0.8899395893158079,ERMP1/COPS5/ADAMTS14/OMA1
BP,GO:0048588,developmental cell growth,0.7946845098239521,5,0.7576173932762738,0.9004394463199409,PAK1/ZFYVE27/PRMT2/CDK5/CYFIP1
BP,GO:0016447,somatic recombination of immunoglobulin gene segments,0.7152160588415568,1,0.7581133489788097,0.9004394463199409,RNF168
BP,GO:0032330,regulation of chondrocyte differentiation,0.7152160588415568,1,0.7581133489788097,0.9004394463199409,TGFBR1
BP,GO:0048168,regulation of neuronal synaptic plasticity,0.7152160588415568,1,0.7581133489788097,0.9004394463199409,NSMF
BP,GO:0051438,regulation of ubiquitin-protein transferase activity,0.7152160588415568,1,0.7581133489788097,0.9004394463199409,DTX3L
BP,GO:0060421,positive regulation of heart growth,0.7152160588415568,1,0.7581133489788097,0.9004394463199409,RBPJ
BP,GO:1900024,regulation of substrate adhesion-dependent cell spreading,0.7152160588415568,1,0.7581133489788097,0.9004394463199409,DOCK5
BP,GO:2000649,regulation of sodium ion transmembrane transporter activity,0.7152160588415568,1,0.7581133489788097,0.9004394463199409,NEDD4
MF,GO:0004896,cytokine receptor activity,0.7373750000000001,2,0.758801967791845,0.8899395893158079,IL7R/IL1RAP
MF,GO:0008170,N-methyltransferase activity,0.7373750000000001,2,0.758801967791845,0.8899395893158079,METTL22/PRMT2
BP,GO:0000018,regulation of DNA recombination,0.7364601001932862,2,0.7591900830667395,0.9006664502524049,TERF2/IL7R
BP,GO:0016073,snRNA metabolic process,0.7364601001932862,2,0.7591900830667395,0.9006664502524049,ELL/TBP
BP,GO:0032649,regulation of interferon-gamma production,0.7364601001932862,2,0.7591900830667395,0.9006664502524049,FAM49B/PDE4B
BP,GO:1903426,regulation of reactive oxygen species biosynthetic process,0.7364601001932862,2,0.7591900830667395,0.9006664502524049,CTNS/ARG2
BP,GO:0061351,neural precursor cell proliferation,0.7590047971379786,3,0.7599933748081846,0.9013565739707566,DOCK7/APPL2/FRS2
CC,GO:0030532,small nuclear ribonucleoprotein complex,0.7349548038393439,2,0.7600206295981028,0.8999335182286626,HTATSF1/LSM7
CC,GO:0044441,ciliary part,0.8351759134537999,10,0.7618143024175166,0.9000119082982453,PHLPP2/CDKL1/CEP128/PRKAR2A/WRAP73/WDR11/TAPT1/GABARAP/PCDHB13/MYO5A
MF,GO:0008028,monocarboxylic acid transmembrane transporter activity,0.7078800000000001,1,0.7618907275437491,0.8899395893158079,MPC2
MF,GO:0008188,neuropeptide receptor activity,0.7078800000000001,1,0.7618907275437491,0.8899395893158079,NPBWR1
MF,GO:0098632,cell-cell adhesion mediator activity,0.7078800000000001,1,0.7618907275437491,0.8899395893158079,PKP3
BP,GO:0007565,female pregnancy,0.7748173970783533,4,0.7623723094829132,0.9016048433360776,VMP1/VDR/ADCY7/LDOC1
BP,GO:0007389,pattern specification process,0.8338841941650438,10,0.7636432571596359,0.9016048433360776,CYP26B1/NDRG4/TGFBR1/ACVR2B/MICAL2/FRS2/RBPJ/RFNG/ASPH/LDB1
BP,GO:0001823,mesonephros development,0.7292399031325678,2,0.763980238922199,0.9016048433360776,ARG2/SDC1
BP,GO:0002367,cytokine production involved in immune response,0.7292399031325678,2,0.763980238922199,0.9016048433360776,MAP3K7/BCL10
BP,GO:0098869,cellular oxidant detoxification,0.7292399031325678,2,0.763980238922199,0.9016048433360776,SESN1/UBIAD1
BP,GO:2000379,positive regulation of reactive oxygen species metabolic process,0.7292399031325678,2,0.763980238922199,0.9016048433360776,CDKN1A/AKR1C3
BP,GO:0061041,regulation of wound healing,0.7538763863465059,3,0.7640095094565946,0.9016048433360776,CDKN1A/DUSP10/CLASP2
BP,GO:0071216,cellular response to biotic stimulus,0.7879498953339186,5,0.7640878950149035,0.9016048433360776,CDK4/BCL10/TNIP2/LDOC1/PDE4B
BP,GO:0006376,mRNA splice site selection,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,CELF1
BP,GO:0006968,cellular defense response,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,BCL10
BP,GO:0031638,zymogen activation,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,ASPH
BP,GO:0032715,negative regulation of interleukin-6 production,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,GBA
BP,GO:0036297,interstrand cross-link repair,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,RNF168
BP,GO:0038066,p38MAPK cascade,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,DUSP10
BP,GO:0045214,sarcomere organization,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,ACTG1
BP,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,MET
BP,GO:0050702,interleukin-1 beta secretion,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,ARG2
BP,GO:0050704,regulation of interleukin-1 secretion,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,ARG2
BP,GO:0060563,neuroepithelial cell differentiation,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,RBPJ
BP,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,0.7017214162219049,1,0.7646353759856116,0.9016048433360776,CDC26
BP,GO:0051224,negative regulation of protein transport,0.7708027991660301,4,0.7658965084263114,0.9028301930681643,ARG2/MAPKBP1/CDK5/APOD
BP,GO:0072511,divalent inorganic cation transport,0.8366126496060747,11,0.7678466028632538,0.9030677587970006,BAX/TRPM7/VDR/DIAPH1/ISCU/PSEN2/STAC/CNNM4/CDK5/PDE4B/MYO5A
BP,GO:0002706,regulation of lymphocyte mediated immunity,0.7488168132837776,3,0.7679709790550233,0.9030677587970006,MAP3K7/FAM49B/IL7R
MF,GO:0003743,translation initiation factor activity,0.6940000000000001,1,0.7686371794181827,0.893315785444209,COPS5
MF,GO:0005044,scavenger receptor activity,0.6940000000000001,1,0.7686371794181827,0.893315785444209,SCARA3
MF,GO:0005326,neurotransmitter transporter activity,0.6940000000000001,1,0.7686371794181827,0.893315785444209,SLC36A1
BP,GO:0032091,negative regulation of protein binding,0.7221599040730283,2,0.7686875553910931,0.9030677587970006,BAX/MET
BP,GO:0034766,negative regulation of ion transmembrane transport,0.7221599040730283,2,0.7686875553910931,0.9030677587970006,NEDD4/ISCU
BP,GO:1905269,positive regulation of chromatin organization,0.7221599040730283,2,0.7686875553910931,0.9030677587970006,RTF1/RPS6KA4
CC,GO:0005766,primary lysosome,0.7468089135786882,3,0.7693768742834463,0.9048427799134887,FTL/VAMP7/C6orf120
CC,GO:0042582,azurophil granule,0.7468089135786882,3,0.7693768742834463,0.9048427799134887,FTL/VAMP7/C6orf120
BP,GO:0030100,regulation of endocytosis,0.7941188980731876,6,0.7703876727695608,0.9030677587970006,EHD4/USP46/VAMP4/APPL2/PTPN1/MYO18A
BP,GO:0046578,regulation of Ras protein signal transduction,0.7813284676420369,5,0.7704272744354264,0.9030677587970006,ALS2/MET/CYTH1/MAPKAP1/NUP62
MF,GO:0044389,ubiquitin-like protein ligase binding,0.804409090909091,7,0.7709638048378648,0.8945239471824975,PRKAR2A/CDKN1A/BCL10/DTX3L/ANKRA2/GABARAP/ACTG1
BP,GO:0006584,catecholamine metabolic process,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,RNF180
BP,GO:0006636,unsaturated fatty acid biosynthetic process,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,AKR1C3
BP,GO:0007091,metaphase/anaphase transition of mitotic cell cycle,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,CDC26
BP,GO:0009712,catechol-containing compound metabolic process,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,RNF180
BP,GO:0010524,positive regulation of calcium ion transport into cytosol,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,BAX
BP,GO:0032655,regulation of interleukin-12 production,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,MAST2
BP,GO:0035384,thioester biosynthetic process,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,MPC2
BP,GO:0046164,alcohol catabolic process,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,AKR1C3
BP,GO:0050994,regulation of lipid catabolic process,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,CDK4
BP,GO:0051290,protein heterotetramerization,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,RCC1
BP,GO:0061005,cell differentiation involved in kidney development,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,ACTA2
BP,GO:0061512,protein localization to cilium,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,LZTFL1
BP,GO:0071616,acyl-CoA biosynthetic process,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,MPC2
BP,GO:0097345,mitochondrial outer membrane permeabilization,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,BAX
BP,GO:1904645,response to amyloid-beta,0.6887265751807584,1,0.7709818894547648,0.9030677587970006,CDK5
BP,GO:0071774,response to fibroblast growth factor,0.7438247011952192,3,0.7718781626125477,0.9038573303131388,GCLM/KIF16B/FRS2
BP,GO:2000377,regulation of reactive oxygen species metabolic process,0.7628971294309939,4,0.7728225734989214,0.9047027997103919,CTNS/ARG2/CDKN1A/AKR1C3
MF,GO:0005070,SH3/SH2 adaptor activity,0.6806538461538462,1,0.7751928526750629,0.8964376582515287,SH2D3A
MF,GO:0005548,phospholipid transporter activity,0.6806538461538462,1,0.7751928526750629,0.8964376582515287,TRIAP1
CC,GO:0060205,cytoplasmic vesicle lumen,0.7991002674880441,7,0.7763653401209599,0.9072201775265326,PPIE/FTL/PYGL/FAM49B/C6orf120/CSNK2B/CYFIP1
CC,GO:0032421,stereocilium bundle,0.6769320561678167,1,0.776622263295266,0.9072201775265326,MYO1C
CC,GO:0032589,neuron projection membrane,0.6769320561678167,1,0.776622263295266,0.9072201775265326,MYO1C
BP,GO:0050663,cytokine secretion,0.7748173970783533,5,0.7766363519407272,0.905904587368823,ARG2/MAPKBP1/RBPJ/IL1RAP/CARD11
BP,GO:0001541,ovarian follicle development,0.6762042738138355,1,0.7771576034370222,0.905904587368823,BAX
BP,GO:0002090,regulation of receptor internalization,0.6762042738138355,1,0.7771576034370222,0.905904587368823,USP46
BP,GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",0.6762042738138355,1,0.7771576034370222,0.905904587368823,ISCU
BP,GO:0042220,response to cocaine,0.6762042738138355,1,0.7771576034370222,0.905904587368823,CDK5
BP,GO:0043113,receptor clustering,0.6762042738138355,1,0.7771576034370222,0.905904587368823,CDK5
BP,GO:0043954,cellular component maintenance,0.6762042738138355,1,0.7771576034370222,0.905904587368823,RASSF8
BP,GO:0044273,sulfur compound catabolic process,0.6762042738138355,1,0.7771576034370222,0.905904587368823,IDUA
BP,GO:0045620,negative regulation of lymphocyte differentiation,0.6762042738138355,1,0.7771576034370222,0.905904587368823,RC3H2
BP,GO:0046456,icosanoid biosynthetic process,0.6762042738138355,1,0.7771576034370222,0.905904587368823,AKR1C3
BP,GO:0061098,positive regulation of protein tyrosine kinase activity,0.6762042738138355,1,0.7771576034370222,0.905904587368823,PTPN1
BP,GO:0098900,regulation of action potential,0.6762042738138355,1,0.7771576034370222,0.905904587368823,GBA
BP,GO:0052547,regulation of peptidase activity,0.82281493495046365,10,0.7775982722452075,0.905904587368823,BAX/RPS6KA1/EGLN3/BCL10/CRADD/TRIAP1/PIDD1/CARD9/ASPH/PDCD6
BP,GO:0001841,neural tube formation,0.7084044773287801,2,0.7778576016910764,0.905904587368823,MTHFD1L/BCL10
BP,GO:0002708,positive regulation of lymphocyte mediated immunity,0.7084044773287801,2,0.7778576016910764,0.905904587368823,MAP3K7/FAM49B
BP,GO:0002821,positive regulation of adaptive immune response,0.7084044773287801,2,0.7778576016910764,0.905904587368823,MAP3K7/FAM49B
BP,GO:0008593,regulation of Notch signaling pathway,0.7084044773287801,2,0.7778576016910764,0.905904587368823,RBPJ/RFNG
BP,GO:1902750,negative regulation of cell cycle G2/M phase transition,0.7084044773287801,2,0.7778576016910764,0.905904587368823,VPS4A/TAOK3
MF,GO:0015108,chloride transmembrane transporter activity,0.7078800000000001,2,0.7784238963029366,0.8986787507151843,CLCC1/ANO1
CC,GO:0031983,vesicle lumen,0.7967430395603508,7,0.778920107846275,0.9078688505322355,PPIE/FTL/PYGL/FAM49B/C6orf120/CSNK2B/CYFIP1
BP,GO:0021700,developmental maturation,0.7857303181639639,6,0.7789703124323465,0.9065077135191206,ANKRD27/CDKN1A/SNAPIN/RBPJ/BLOC1S5/MYO5A
BP,GO:0072593,reactive oxygen species metabolic process,0.7857303181639639,6,0.7789703124323465,0.9065077135191206,CTNS/SESN1/ARG2/CDKN1A/RFK/AKR1C3
BP,GO:0032675,regulation of interleukin-6 production,0.7340375340742294,3,0.7795312352816328,0.9065077135191206,GBA/CARD9/IL1RAP
BP,GO:1904950,negative regulation of establishment of protein localization,0.7551519809088518,4,0.7795868174966956,0.9065077135191206,ARG2/MAPKBP1/CDK5/APOD
MF,GO:0030246,carbohydrate binding,0.7836309963099631,6,0.7813090195777258,0.8993151929503883,PYGL/UAP1/LGALSL/EGLN3/GALNT1/SCARA3
MF,GO:0005544,calcium-dependent phospholipid binding,0.667811320754717,1,0.7815631317151577,0.8993151929503883,ANXA7
BP,GO:0051963,regulation of synapse assembly,0.7017214162219049,2,0.7823223142412302,0.9065077135191206,SRPX2/IL1RAP
BP,GO:1901989,positive regulation of cell cycle phase transition,0.7017214162219049,2,0.7823223142412302,0.9065077135191206,CCND3/CDK4
CC,GO:0035577,azurophil granule membrane,0.6652608138200957,1,0.7824282665229424,0.9078956054753965,VAMP7
CC,GO:0035861,site of double-strand break,0.6652608138200957,1,0.7824282665229424,0.9078956054753965,RNF168
BP,GO:0007626,locomotory behavior,0.7513380820153729,4,0.7829087666830175,0.9065077135191206,ALS2/CTNS/DDHD2/MYO5A
BP,GO:0060541,respiratory system development,0.7513380820153729,4,0.7829087666830175,0.9065077135191206,RC3H2/TAB1/ACVR2B/RBPJ
BP,GO:0000768,syncytium formation by plasma membrane fusion,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,DYRK1B
BP,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,FAM49B
BP,GO:0002381,immunoglobulin production involved in immunoglobulin mediated immune response,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,RNF168
BP,GO:0022029,telencephalon cell migration,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,CDK5
BP,GO:0032615,interleukin-12 production,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,MAST2
BP,GO:0044784,metaphase/anaphase transition of cell cycle,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,CDC26
BP,GO:0045292,"mRNA cis splicing, via spliceosome",0.6641291974957314,1,0.7831671056166956,0.9065077135191206,CWC15
BP,GO:0060113,inner ear receptor cell differentiation,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,RBPJ
BP,GO:0140253,cell-cell fusion,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,DYRK1B
BP,GO:1903078,positive regulation of protein localization to plasma membrane,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,STAC
BP,GO:1905515,non-motile cilium assembly,0.6641291974957314,1,0.7831671056166956,0.9065077135191206,WRAP73
BP,GO:0006261,DNA-dependent DNA replication,0.7292399031325677,3,0.7832779284709215,0.9065077135191206,STAG2/INO80/TERF2
BP,GO:0030168,platelet activation,0.7292399031325677,3,0.7832779284709215,0.9065077135191206,PIK3CA/RAP2B/ACTG1
BP,GO:0050729,positive regulation of inflammatory response,0.7292399031325677,3,0.7832779284709215,0.9065077135191206,SNX4/VAMP7/NUPR1
BP,GO:0034341,response to interferon-gamma,0.7475625137640393,4,0.7861908861224571,0.9095780742876195,KIF16B/CLDN1/ACTG1/MYO1C
BP,GO:0006790,sulfur compound metabolic process,0.7998115066615259,8,0.7863780942157221,0.9095780742876195,GCLM/CTNS/NUBP2/IMPAD1/IDUA/MICAL2/ISCU/MPC2
BP,GO:0043502,regulation of muscle adaptation,0.6951632721450646,2,0.7867081507069107,0.9097011816588155,PAK1/GTF2IRD2
BP,GO:0055067,monovalent inorganic cation homeostasis,0.7245045790862524,3,0.7869719427546795,0.909747616688274,RAB7A/SNAPIN/TMEM199
CC,GO:0042581,specific granule,0.7234711350293541,3,0.7876118618665775,0.9100488630155841,PTPRB/RAP2B/CYFIP1
MF,GO:0005200,structural constituent of cytoskeleton,0.6940000000000001,2,0.7877011776840337,0.901958003694956,TUBAL3/ACTG1
MF,GO:0030170,pyridoxal phosphate binding,0.6554444444444445,1,0.787753249270271,0.901958003694956,PYGL
MF,GO:0070279,vitamin B6 binding,0.6554444444444445,1,0.787753249270271,0.901958003694956,PYGL
CC,GO:0030667,secretory granule membrane,0.7768817557362193,6,0.7877774226871946,0.9100488630155841,RAB7A/VAMP7/PTPRB/DIAPH1/ANXA7/RAP2B
BP,GO:0010665,regulation of cardiac muscle cell apoptotic process,0.6524778080659817,1,0.7890148606924673,0.9100403893668718,NUPR1
BP,GO:0010965,regulation of mitotic sister chromatid separation,0.6524778080659817,1,0.7890148606924673,0.9100403893668718,CDC26
BP,GO:0014888,striated muscle adaptation,0.6524778080659817,1,0.7890148606924673,0.9100403893668718,GTF2IRD2
BP,GO:0033344,cholesterol efflux,0.6524778080659817,1,0.7890148606924673,0.9100403893668718,STX12
BP,GO:0042743,hydrogen peroxide metabolic process,0.6524778080659817,1,0.7890148606924673,0.9100403893668718,CTNS
BP,GO:0045143,homologous chromosome segregation,0.6524778080659817,1,0.7890148606924673,0.9100403893668718,AGO4
BP,GO:0051055,negative regulation of lipid biosynthetic process,0.6524778080659817,1,0.7890148606924673,0.9100403893668718,AKR1C3
BP,GO:0060760,positive regulation of response to cytokine stimulus,0.6524778080659817,1,0.7890148606924673,0.9100403893668718,TRIM44
BP,GO:0002793,positive regulation of peptide secretion,0.7748173970783533,6,0.7900357963429008,0.9109596427219162,ANO1/CAPN10/MPC2/IL1RAP/MYO18A/RASL10B
CC,GO:0022626,cytosolic ribosome,0.6890201285993849,2,0.7906545174696415,0.9113517778798302,RSL24D1/APOD
BP,GO:0006821,chloride transport,0.6887265751807584,2,0.7910161146911174,0.9110570652784444,CLCC1/ANO1
BP,GO:0009062,fatty acid catabolic process,0.6887265751807584,2,0.7910161146911174,0.9110570652784444,LPIN3/ACAD11
BP,GO:0015696,ammonium transport,0.6887265751807584,2,0.7910161146911174,0.9110570652784444,SNX4/VAMP7
BP,GO:0032526,response to retinoic acid,0.6887265751807584,2,0.7910161146911174,0.9110570652784444,CYP26B1/YES1
BP,GO:0007259,JAK-STAT cascade,0.7152160588415568,3,0.7942036297566275,0.9124642419421846,CRLF3/PTPN1/CNOT7
BP,GO:0043535,regulation of blood vessel endothelial cell migration,0.7152160588415568,3,0.7942036297566275,0.9124642419421846,SRPX2/STARD13/CSNK2B
BP,GO:0006949,syncytium formation,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,DYRK1B
BP,GO:0019229,regulation of vasoconstriction,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,DOCK5
BP,GO:0030837,negative regulation of actin filament polymerization,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,CAPZA1
BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,BCL10
BP,GO:0042093,T-helper cell differentiation,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,RC3H2
BP,GO:0055081,anion homeostasis,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,PRKAA2
BP,GO:0060997,dendritic spine morphogenesis,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,CDK5
BP,GO:0071385,cellular response to glucocorticoid stimulus,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,HNRNPU
BP,GO:1903749,positive regulation of establishment of protein localization to mitochondrion,0.6412281906855337,1,0.7947052136679351,0.9124642419421846,CSNK2A2
BP,GO:0001676,long-chain fatty acid metabolic process,0.6824079827479075,2,0.7952472129514245,0.9128289114803597,AKR1C3/MYO5A
CC,GO:0101003,ficolin-1-rich granule membrane,0.6325430688781238,1,0.798958048372978,0.918889940843977,DIAPH1
BP,GO:0006939,smooth muscle contraction,0.6762042738138355,2,0.7994024545068237,0.9159780683581376,ACTA2/DOCK5
BP,GO:0098739,import across plasma membrane,0.6762042738138355,2,0.7994024545068237,0.9159780683581376,ISCU/SLC7A1
MF,GO:0003707,steroid hormone receptor activity,0.6320357142857143,1,0.7996131979716596,0.911034709164432,VDR
MF,GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",0.6320357142857143,1,0.7996131979716596,0.911034709164432,SESN1
MF,GO:0016836,hydro-lyase activity,0.6320357142857143,1,0.7996131979716596,0.911034709164432,PCBD1
BP,GO:0010518,positive regulation of phospholipase activity,0.6303599162671348,1,0.8002423930542824,0.9159780683581376,ARL1
BP,GO:0010656,negative regulation of muscle cell apoptotic process,0.6303599162671348,1,0.8002423930542824,0.9159780683581376,NUPR1
BP,GO:0010662,regulation of striated muscle cell apoptotic process,0.6303599162671348,1,0.8002423930542824,0.9159780683581376,NUPR1
BP,GO:0021885,forebrain cell migration,0.6303599162671348,1,0.8002423930542824,0.9159780683581376,CDK5
BP,GO:0031102,neuron projection regeneration,0.6303599162671348,1,0.8002423930542824,0.9159780683581376,APOD
BP,GO:0042130,negative regulation of T cell proliferation,0.6303599162671348,1,0.8002423930542824,0.9159780683581376,ARG2
BP,GO:0045071,negative regulation of viral genome replication,0.6303599162671348,1,0.8002423930542824,0.9159780683581376,BANF1
BP,GO:0097755,positive regulation of blood vessel diameter,0.6303599162671348,1,0.8002423930542824,0.9159780683581376,DOCK5
BP,GO:0006310,DNA recombination,0.7642034601320744,6,0.8006742560854863,0.9162145917737717,INO80/TERF2/KIN/RNF168/IL7R/PGBD5
BP,GO:0060402,calcium ion transport into cytosol,0.7061626910081195,3,0.8012297550279902,0.9165924194189718,BAX/DIAPH1/MYO5A
BP,GO:0007596,blood coagulation,0.7748173970783533,7,0.8025164065750884,0.91780622489386,CBX5/PRKAR2A/CAPZA1/PIK3CA/RBSN/RAP2B/ACTG1
CC,GO:0098978,glutamatergic synapse,0.7739137261058994,7,0.8032876291013715,0.9208355144315686,USP46/ADCY1/CDK5/YES1/PPP1CC/IL1RAP/MYO5A
BP,GO:0098661,inorganic anion transmembrane transport,0.6701123434191163,2,0.8034828497901381,0.9186532414126705,CLCC1/ANO1
BP,GO:0008544,epidermis development,0.8015352383569172,10,0.8037272047176593,0.9186744222510363,CYP26B1/VDR/FOXQ1/RBPJ/BNC1/CALML5/PKP3/AKR1C3/MYO5A/LDB1
CC,GO:0035580,specific granule lumen,0.6223407613155735,1,0.8041845663461876,0.9208355144315686,CYFIP1
MF,GO:0042054,histone methyltransferase activity,0.6209473684210527,1,0.8052927740169048,0.9160040555511437,PRMT2
BP,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.6198539176626826,1,0.8056305139874269,0.9193001208698043,RC3H2
BP,GO:0010659,cardiac muscle cell apoptotic process,0.6198539176626826,1,0.8056305139874269,0.9193001208698043,NUPR1
BP,GO:0042267,natural killer cell mediated cytotoxicity,0.6198539176626826,1,0.8056305139874269,0.9193001208698043,VAMP7
BP,GO:0051306,mitotic sister chromatid separation,0.6198539176626826,1,0.8056305139874269,0.9193001208698043,CDC26
BP,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,0.6198539176626826,1,0.8056305139874269,0.9193001208698043,BAX
BP,GO:1902808,positive regulation of cell cycle G1/S phase transition,0.6198539176626826,1,0.8056305139874269,0.9193001208698043,CCND3
CC,GO:0120114,Sm-like protein family complex,0.6652608138200957,2,0.8065688845101228,0.9215403263810833,HTATSF1/LSM7
BP,GO:0051056,regulation of small GTPase mediated signal transduction,0.7702326787524457,7,0.8073247317284308,0.9198731221636002,ALS2/MET/CYTH1/MAPKAP1/STARD13/ARHGAP12/NUP62
BP,GO:0000041,transition metal ion transport,0.6641291974957314,2,0.8074894098442026,0.9198731221636002,FTL/ISCU
BP,GO:0014902,myotube differentiation,0.6641291974957314,2,0.8074894098442026,0.9198731221636002,CYP26B1/DYRK1B
BP,GO:0050868,negative regulation of T cell activation,0.6641291974957314,2,0.8074894098442026,0.9198731221636002,RC3H2/ARG2
BP,GO:0070268,cornification,0.6641291974957314,2,0.8074894098442026,0.9198731221636002,CYP26B1/PKP3
BP,GO:1990748,cellular detoxification,0.6641291974957314,2,0.8074894098442026,0.9198731221636002,SESN1/UBIAD1
BP,GO:0050768,negative regulation of neurogenesis,0.7564318995205618,6,0.8083766456991801,0.9206260343516979,APPL2/HMG20A/DUSP10/SNAPIN/CDK5/ZHX2
CC,GO:0022625,cytosolic large ribosomal subunit,0.6124623365327866,1,0.8092754687423769,0.9226094512358389,RSL24D1
MF,GO:0001786,phosphatidylserine binding,0.6102413793103448,1,0.8108116863180128,0.9192726296753979,APPL2
MF,GO:0004869,cysteine-type endopeptidase inhibitor activity,0.6102413793103448,1,0.8108116863180128,0.9192726296753979,RPS6KA1
BP,GO:0002287,alpha-beta T cell activation involved in immune response,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,RC3H2
BP,GO:0002293,alpha-beta T cell differentiation involved in immune response,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,RC3H2
BP,GO:0003170,heart valve development,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,RBPJ
BP,GO:0016266,O-glycan processing,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,GALNT1
BP,GO:0032370,positive regulation of lipid transport,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,TRIAP1
BP,GO:0034113,heterotypic cell-cell adhesion,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,PARVA
BP,GO:0042490,mechanoreceptor differentiation,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,RBPJ
BP,GO:0045604,regulation of epidermal cell differentiation,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,VDR
BP,GO:0050701,interleukin-1 secretion,0.6096923780288681,1,0.8108735812619197,0.9211487653095475,ARG2
CC,GO:0030666,endocytic vesicle membrane,0.6931459976329142,3,0.8111184644861296,0.9226915283783264,RAB7A/VAMP7/APPL2
BP,GO:0032609,interferon-gamma production,0.6582519479603709,2,0.811423145560086,0.9215157331486404,FAM49B/PDE4B
BP,GO:0007409,axonogenesis,0.7946845098239521,10,0.8119147722153863,0.9215403394254786,ALS2/C12orf57/DOCK7/PIK3CA/PAK1/ZFYVE27/ADCY1/CDK5/FRS2/CYFIP1
BP,GO:2000027,regulation of animal organ morphogenesis,0.7350046454498212,5,0.8138895800148456,0.9215403394254786,BAX/TGFBR1/VDR/FRS2/RBPJ
BP,GO:0090276,regulation of peptide hormone secretion,0.7152160588415568,4,0.81397612571412,0.9215403394254786,ANO1/CAPN10/MPC2/RASL10B
BP,GO:0030833,regulation of actin filament polymerization,0.6887265751807584,3,0.8146796390243017,0.9215403394254786,CAPZA1/MYO1C/CYFIP1
CC,GO:0005788,endoplasmic reticulum lumen,0.7492257709041855,6,0.8152716435499494,0.925395482112252,CALU/MBTPS1/SUMF1/ARSK/ARSJ/P4HB
BP,GO:0006690,icosanoid metabolic process,0.6524778080659817,2,0.8152850669556765,0.9215403394254786,PLA2G3/AKR1C3
BP,GO:0008543,fibroblast growth factor receptor signaling pathway,0.6524778080659817,2,0.8152850669556765,0.9215403394254786,KIF16B/FRS2
BP,GO:0030282,bone mineralization,0.6524778080659817,2,0.8152850669556765,0.9215403394254786,ACVR2B/BMP2K
BP,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,RNF168
BP,GO:0003407,neural retina development,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,ZHX2
BP,GO:0009584,detection of visible light,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,NMT2
BP,GO:0009880,embryonic pattern specification,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,FRS2
BP,GO:0010658,striated muscle cell apoptotic process,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,NUPR1
BP,GO:0010676,positive regulation of cellular carbohydrate metabolic process,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,EPM2AIP1
BP,GO:0010830,regulation of myotube differentiation,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,CYP26B1
BP,GO:0016444,somatic cell DNA recombination,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,RNF168
BP,GO:0032835,glomerulus development,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,ACTA2
BP,GO:0035082,axoneme assembly,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,PLA2G3
BP,GO:0055025,positive regulation of cardiac muscle tissue development,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,RBPJ
BP,GO:1902305,regulation of sodium ion transmembrane transport,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,NEDD4
BP,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,0.5998586299961445,1,0.8159754922838185,0.9215403394254786,BAX
MF,GO:0005507,copper ion binding,0.5998983050847458,1,0.8161744708772847,0.9193537394808962,SUMF1
MF,GO:0016597,amino acid binding,0.5998983050847458,1,0.8161744708772847,0.9193537394808962,SESN1
MF,GO:0097110,scaffold protein binding,0.5998983050847458,1,0.8161744708772847,0.9193537394808962,MAP3K7
MF,GO:0098631,cell adhesion mediator activity,0.5998983050847458,1,0.8161744708772847,0.9193537394808962,PKP3
BP,GO:0050817,coagulation,0.7612241094103119,7,0.8166716457810277,0.922042077786148,CBX5/PRKAR2A/CAPZA1/PIK3CA/RBSN/RAP2B/ACTG1
BP,GO:0051216,cartilage development,0.7117939724356164,4,0.8168730698970692,0.922042077786148,IMPAD1/TGFBR1/SCARA3/TAPT1
CC,GO:0043679,axon terminus,0.6484895327994211,2,0.8177896013522121,0.9256671246054713,ACTG1/CYFIP1
BP,GO:0031214,biomineral tissue development,0.6845012587686065,3,0.817919294347728,0.9227109510278863,ACVR2B/BMP2K/CNNM4
BP,GO:0099173,postsynapse organization,0.6845012587686065,3,0.817919294347728,0.9227109510278863,CDK5/ACTG1/IL1RAP
CC,GO:0001533,cornified envelope,0.593617341562547,1,0.819064384727682,0.9256671246054713,PKP3
BP,GO:0031646,positive regulation of neurological system process,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,GBA
BP,GO:0034394,protein localization to cell surface,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,RIC3
BP,GO:0042255,ribosome assembly,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,RSL24D1
BP,GO:0046622,positive regulation of organ growth,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,RBPJ
BP,GO:0046637,regulation of alpha-beta T cell differentiation,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,RC3H2
BP,GO:0046686,response to cadmium ion,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,AKR1C3
BP,GO:0090181,regulation of cholesterol metabolic process,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,MBTPS1
BP,GO:1904377,positive regulation of protein localization to cell periphery,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,STAC
BP,GO:2000401,regulation of lymphocyte migration,0.59033706444065015,1,0.8209400399446913,0.9238130242033207,APOD
BP,GO:0010721,negative regulation of cell development,0.7567983878439729,7,0.821211626976101,0.9238630803481136,APPL2/HMG20A/DUSP10/SNAPIN/PAK1/CDK5/ZHX2
MF,GO:0000049,tRNA binding,0.5899,1,0.8213855358824641,0.9207466894166331,HSD17B10
MF,GO:0016279,protein-lysine N-methyltransferase activity,0.5899,1,0.8213855358824641,0.9207466894166331,METTL22
MF,GO:0016655,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",0.5899,1,0.8213855358824641,0.9207466894166331,AKR1C3
BP,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,0.7263913097609562,5,0.8217435699229473,0.9239504816049059,EHD4/YES1/RAP2B/PTPN1/CNOT7
BP,GO:0090596,sensory organ morphogenesis,0.7263913097609562,5,0.8217435699229473,0.9239504816049059,CYP26B1/BAX/C12orf57/FRS2/ZHX2
BP,GO:0006304,DNA modification,0.6412281906855337,2,0.8227974984328684,0.9246243711671018,PIK3CA/MBD4
BP,GO:0021782,glial cell development,0.6412281906855337,2,0.8227974984328684,0.9246243711671018,CDK6/CDK5
CC,GO:0034704,calcium channel complex,0.58462313941766,1,0.8237691526599105,0.9289691093848773,PDE4B
BP,GO:0071695,anatomical structure maturation,0.6762042738138355,3,0.8242545059802067,0.9248998028424843,CDKN1A/RBPJ/MYO5A
BP,GO:0002228,natural killer cell mediated immunity,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,VAMP7
BP,GO:0016445,somatic diversification of immunoglobulins,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,RNF168
BP,GO:0030032,lamellipodium assembly,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,CYFIP1
BP,GO:0035794,positive regulation of mitochondrial membrane permeability,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,BAX
BP,GO:0043550,regulation of lipid kinase activity,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,NRBF2
BP,GO:0045669,positive regulation of osteoblast differentiation,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,ACVR2B
BP,GO:0045670,regulation of osteoclast differentiation,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,TOB2
BP,GO:0046503,glycerolipid catabolic process,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,DDHD2
BP,GO:0046579,positive regulation of Ras protein signal transduction,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,ALS2
BP,GO:1903672,positive regulation of sprouting angiogenesis,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,SRPX2
BP,GO:2000378,negative regulation of reactive oxygen species metabolic process,0.5811130478087649,1,0.8257709154188552,0.9248998028424843,CTNS
MF,GO:0016278,lysine N-methyltransferase activity,0.5802295081967214,1,0.8264491653012298,0.924931030409589,METTL22
BP,GO:0002761,regulation of myeloid leukocyte differentiation,0.6357476078591616,2,0.8264500182248955,0.9251509835274834,CDK6/TOB2
BP,GO:0022904,respiratory electron transport chain,0.6357476078591616,2,0.8264500182248955,0.9251509835274834,ISCU/SDHAF2
BP,GO:0002244,hematopoietic progenitor cell differentiation,0.6721307540920655,3,0.8273510134258002,0.925904793016824,CDK6/PRRC2C/LDB1
CC,GO:0031093,platelet alpha granule lumen,0.5758974209188888,1,0.828351818325311,0.9321194327159548,FAM49B
BP,GO:0006816,calcium ion transport,0.7712468099950429,9,0.8288574174050471,0.9273355264036667,BAX/TRPM7/VDR/DIAPH1/PSEN2/STAC/CDK5/PDE4B/MYO5A
BP,GO:0090257,regulation of muscle system process,0.717977510806196,5,0.829328666969236,0.9276076484000143,C12orf57/DOCK5/PAK1/PDE4B/GTF2IRD2
BP,GO:0006940,regulation of smooth muscle contraction,0.5721728470732454,1,0.8304717108858946,0.9276109060636516,DOCK5
BP,GO:0051187,cofactor catabolic process,0.5721728470732454,1,0.8304717108858946,0.9276109060636516,ALDH1L1
BP,GO:0070192,chromosome organization involved in meiotic cell cycle,0.5721728470732454,1,0.8304717108858946,0.9276109060636516,AGO4
BP,GO:0072678,T cell migration,0.5721728470732454,1,0.8304717108858946,0.9276109060636516,APOD
BP,GO:1901016,regulation of potassium ion transmembrane transporter activity,0.5721728470732454,1,0.8304717108858946,0.9276109060636516,NEDD4
BP,GO:0015893,drug transport,0.6951632721450646,4,0.8308068889523458,0.9277305584019057,SLC36A1/SLC7A1/CLDN1/PRAF2
MF,GO:0004714,transmembrane receptor protein tyrosine kinase activity,0.5708709677419355,1,0.8313695223747944,0.9276018611309593,MET
MF,GO:0031625,ubiquitin protein ligase binding,0.7322896551724138,6,0.8319545005754784,0.9276018611309593,PRKAR2A/CDKN1A/BCL10/ANKRA2/GABARAP/ACTG1
BP,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,0.7459560040639733,7,0.8321783214252284,0.9290069735339815,TAB1/TGFBR1/ACVR2B/MAP3K7/APPL2/RBPJ/CSNK2B
CC,GO:0005801,cis-Golgi network,0.5674283411994935,1,0.832815544576495,0.9351226265611075,TMED5
MF,GO:0008238,exopeptidase activity,0.6264424778761062,2,0.8328396566125448,0.9276018611309593,PGPEP1/PM20D2
BP,GO:0001906,cell killing,0.6641291974957314,3,0.8334042305729743,0.9296759388034265,VAMP7/FAM49B/IL7R
BP,GO:0071706,tumor necrosis factor superfamily cytokine production,0.6641291974957314,3,0.8334042305729743,0.9296759388034265,ARG2/BCL10/CARD9
BP,GO:0019935,cyclic-nucleotide-mediated signaling,0.6919299546002038,4,0.833485443931923,0.9296759388034265,PRKAR2A/ADCY7/ADCY9/ADCY1
BP,GO:0060249,anatomical structure homeostasis,0.7659522094687612,9,0.8346589921405585,0.9296759388034265,SMG6/BAX/TERF2/HMBOX1/HNRNPU/CDK5/MTM1/ACTG1/LDB1
BP,GO:0015800,acidic amino acid transport,0.5635035615115297,1,0.8350459221804541,0.9296759388034265,PRAF2
BP,GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,0.5635035615115297,1,0.8350459221804541,0.9296759388034265,USP46
BP,GO:1901607,alpha-amino acid biosynthetic process,0.5635035615115297,1,0.8350459221804541,0.9296759388034265,SEPHS2
BP,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,0.5635035615115297,1,0.8350459221804541,0.9296759388034265,BAX
BP,GO:1905710,positive regulation of membrane permeability,0.5635035615115297,1,0.8350459221804541,0.9296759388034265,BAX
BP,GO:0010959,regulation of metal ion transport,0.7551519809088518,8,0.8350629007836088,0.9296759388034265,NEDD4/BAX/DIAPH1/ISCU/PSEN2/STAC/PDE4B/MYO5A
BP,GO:0007269,neurotransmitter secretion,0.6601994389306678,3,0.8363619069693494,0.9308673700550789,SNAPIN/ADCY1/CDK5
BP,GO:0099643,signal release from synapse,0.656315912819311,3,0.8392742762610546,0.9333352277065349,SNAPIN/ADCY1/CDK5
BP,GO:0030858,positive regulation of epithelial cell differentiation,0.5550930605934471,1,0.8394969513712417,0.9333352277065349,VDR
BP,GO:0050909,sensory perception of taste,0.5550930605934471,1,0.8394969513712417,0.9333352277065349,RTP4
BP,GO:2000573,positive regulation of DNA biosynthetic process,0.5550930605934471,1,0.8394969513712417,0.9333352277065349,HMBOX1
BP,GO:0001704,formation of primary germ layer,0.6147311580125778,2,0.8403920752017051,0.9340751262077968,KIF16B/RTF1
BP,GO:0006937,regulation of muscle contraction,0.6524778080659817,3,0.842141826175919,0.9348291798788018,C12orf57/DOCK5/PDE4B
BP,GO:0043901,negative regulation of multi-organism process,0.6524778080659817,3,0.842141826175919,0.9348291798788018,ARG2/MAPKBP1/BANF1
MF,GO:0004386,helicase activity,0.6514233128834357,3,0.8431239790997378,0.9365866177934787,INO80/DHX34/RAD54L2
MF,GO:0042277,peptide binding,0.7198779661016949,6,0.8436017593362845,0.9365866177934787,PPIE/LANCL1/ITM2B/TOMM20/NPBWR1/KPNA5
BP,GO:0043500,muscle adaptation,0.6096923780288681,2,0.8437155291293912,0.9348291798788018,PAK1/GTF2IRD2
BP,GO:1903409,reactive oxygen species biosynthetic process,0.6096923780288681,2,0.8437155291293912,0.9348291798788018,CTNS/ARG2
BP,GO:0002292,T cell differentiation involved in immune response,0.5469299273494258,1,0.8438281092711307,0.9348291798788018,RC3H2
BP,GO:0019915,lipid storage,0.5469299273494258,1,0.8438281092711307,0.9348291798788018,FITM2
BP,GO:0031343,positive regulation of cell killing,0.5469299273494258,1,0.8438281092711307,0.9348291798788018,FAM49B
BP,GO:0033866,nucleoside bisphosphate biosynthetic process,0.5469299273494258,1,0.8438281092711307,0.9348291798788018,MPC2
BP,GO:0034030,ribonucleoside bisphosphate biosynthetic process,0.5469299273494258,1,0.8438281092711307,0.9348291798788018,MPC2
BP,GO:0034033,purine nucleoside bisphosphate biosynthetic process,0.5469299273494258,1,0.8438281092711307,0.9348291798788018,MPC2
BP,GO:0035924,cellular response to vascular endothelial growth factor stimulus,0.5469299273494258,1,0.8438281092711307,0.9348291798788018,MYO1C
BP,GO:0050918,positive chemotaxis,0.5469299273494258,1,0.8438281092711307,0.9348291798788018,MET
CC,GO:0048786,presynaptic active zone,0.543452495796698,1,0.8455235014035879,0.9473499875941275,PNISR
BP,GO:0051928,positive regulation of calcium ion transport,0.6047355294270074,2,0.8469761185722834,0.9380612170846852,BAX/STAC
BP,GO:0034381,plasma lipoprotein particle clearance,0.5390034066632022,1,0.8480426178801992,0.9382206607388225,CNPY2
BP,GO:0050771,negative regulation of axonogenesis,0.5390034066632022,1,0.8480426178801992,0.9382206607388225,CDK5
BP,GO:0051865,protein autoubiquitination,0.5390034066632022,1,0.8480426178801992,0.9382206607388225,DTX3L
BP,GO:0086003,cardiac muscle cell contraction,0.5390034066632022,1,0.8480426178801992,0.9382206607388225,PDE4B
BP,GO:0001838,embryonic epithelial tube formation,0.5998586299961445,2,0.8501748129367706,0.9394363730953628,MTHFD1L/BCL10
BP,GO:0014013,regulation of gliogenesis,0.5998586299961445,2,0.8501748129367706,0.9394363730953628,DUSP10/PPP1CC
BP,GO:0050714,positive regulation of protein secretion,0.6938663257418088,5,0.8505222784390174,0.9394363730953628,ANO1/CAPN10/MPC2/IL1RAP/MYO18A
MF,GO:0008514,organic anion transmembrane transporter activity,0.6709763033175355,4,0.8507602906921197,0.9430277544354436,CTNS/SLC36A1/SLC7A1/MPC2
BP,GO:0044706,multi-multicellular organism process,0.6701123434191163,4,0.8512607384775133,0.9394363730953628,VMP1/VDR/ADCY7/LDOC1
BP,GO:0001756,somitogenesis,0.5313033579965851,1,0.8521436127634927,0.9394363730953628,RBPJ
BP,GO:0010517,regulation of phospholipase activity,0.5313033579965851,1,0.8521436127634927,0.9394363730953628,ARL1
BP,GO:0032720,negative regulation of tumor necrosis factor production,0.5313033579965851,1,0.8521436127634927,0.9394363730953628,ARG2
BP,GO:0034121,regulation of toll-like receptor signaling pathway,0.5313033579965851,1,0.8521436127634927,0.9394363730953628,APPL2
BP,GO:0051966,"regulation of synaptic transmission, glutamatergic",0.5313033579965851,1,0.8521436127634927,0.9394363730953628,CDK5
BP,GO:0060395,SMAD protein signal transduction,0.5313033579965851,1,0.8521436127634927,0.9394363730953628,TGFBR1
BP,GO:0061515,myeloid cell development,0.5313033579965851,1,0.8521436127634927,0.9394363730953628,PIP4K2A
BP,GO:0072091,regulation of stem cell proliferation,0.5313033579965851,1,0.8521436127634927,0.9394363730953628,HNRNPU
BP,GO:2001259,positive regulation of cation channel activity,0.5313033579965851,1,0.8521436127634927,0.9394363730953628,STAC
BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,0.6375640295959021,3,0.8531736241041029,0.9403170693187457,RAB7A/CAPZA1/DCTN4
CC,GO:0099056,integral component of presynaptic membrane,0.5285633863228159,1,0.8534551771043559,0.9541848653892049,PSEN2
MF,GO:0001158,enhancer sequence-specific DNA binding,0.5948571428571429,2,0.8536385589261343,0.9435646010040584,RBBP4/LDB1
BP,GO:0051961,negative regulation of nervous system development,0.7084044773287801,6,0.8539210886269103,0.9408859665585783,APPL2/HMG20A/DUSP10/SNAPIN/CDK5/ZHX2
MF,GO:0005518,collagen binding,0.5282686567164179,1,0.8539599050813708,0.9435646010040584,PAK1
BP,GO:0001936,regulation of endothelial cell proliferation,0.6339415067004709,3,0.8558244268484234,0.9424725956739,TGFBR1/ARNT/PDCD6
BP,GO:0050796,regulation of insulin secretion,0.6339415067004709,3,0.8558244268484234,0.9424725956739,ANO1/CAPN10/MPC2
BP,GO:0051057,positive regulation of small GTPase mediated signal transduction,0.5238202121093093,1,0.8561341453652522,0.9425585124075362,ALS2
CC,GO:0098839,postsynaptic density membrane,0.5214206378589941,1,0.8572672522672391,0.954350936818871,ADCY1
CC,GO:0099060,integral component of postsynaptic specialization membrane,0.5214206378589941,1,0.8572672522672391,0.954350936818871,ADCY1
BP,GO:0045665,negative regulation of neuron differentiation,0.661177512173528,4,0.8583731281862574,0.9445920325456505,HMG20A/SNAPIN/CDK5/ZHX2
BP,GO:0006305,DNA alkylation,0.5165449313855688,1,0.8600171852613027,0.9445920325456505,PIK3CA
BP,GO:0006306,DNA methylation,0.5165449313855688,1,0.8600171852613027,0.9445920325456505,PIK3CA
BP,GO:0006635,fatty acid beta-oxidation,0.5165449313855688,1,0.8600171852613027,0.9445920325456505,ACAD11
BP,GO:0019226,transmission of nerve impulse,0.5165449313855688,1,0.8600171852613027,0.9445920325456505,GBA
BP,GO:0060193,positive regulation of lipase activity,0.5165449313855688,1,0.8600171852613027,0.9445920325456505,ARL1
BP,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,0.5165449313855688,1,0.8600171852613027,0.9445920325456505,ARG2
BP,GO:1903747,regulation of establishment of protein localization to mitochondrion,0.5165449313855688,1,0.8600171852613027,0.9445920325456505,CSNK2A2
BP,GO:0018108,peptidyl-tyrosine phosphorylation,0.7171863510146741,7,0.8600710148842402,0.9445920325456505,EHD4/DYRK1B/MET/YES1/RAP2B/PTPN1/CNOT7
BP,GO:2001257,regulation of cation channel activity,0.6268185684229375,3,0.8610008942888959,0.9453580669277271,STAC/PDE4B/MYO5A
BP,GO:0008064,regulation of actin polymerization or depolymerization,0.6233167887110774,3,0.8635275404284133,0.9458736451480168,CAPZA1/MYO1C/CYFIP1
BP,GO:1903034,regulation of response to wounding,0.6233167887110774,3,0.8635275404284133,0.9458736451480168,CDKN1A/DUSP10/CLASP2
BP,GO:0002312,B cell activation involved in immune response,0.509468973421383,1,0.8637956223512493,0.9458736451480168,RNF168
BP,GO:0009988,cell-cell recognition,0.509468973421383,1,0.8637956223512493,0.9458736451480168,ST6GALNAC6
BP,GO:0030239,myofibril assembly,0.509468973421383,1,0.8637956223512493,0.9458736451480168,ACTG1
BP,GO:0032945,negative regulation of mononuclear cell proliferation,0.509468973421383,1,0.8637956223512493,0.9458736451480168,ARG2
BP,GO:0043627,response to estrogen,0.509468973421383,1,0.8637956223512493,0.9458736451480168,GBA
BP,GO:0045685,regulation of glial cell differentiation,0.509468973421383,1,0.8637956223512493,0.9458736451480168,DUSP10
BP,GO:0046128,purine ribonucleoside metabolic process,0.509468973421383,1,0.8637956223512493,0.9458736451480168,CARD11
BP,GO:0050672,negative regulation of lymphocyte proliferation,0.509468973421383,1,0.8637956223512493,0.9458736451480168,ARG2
CC,GO:0031594,neuromuscular junction,0.5076990421258626,1,0.8645970435665772,0.9602769167302887,CDK5
BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,0.5766082955001699,2,0.865273309277948,0.9465872291469455,RC3H2/ARG2
BP,GO:0043270,positive regulation of ion transport,0.6762042738138355,5,0.8654588195914502,0.9465872291469455,BAX/SNX4/VAMP7/STAC/TRIAP1
BP,GO:0018212,peptidyl-tyrosine modification,0.7113077743670128,7,0.8655300716231946,0.9465872291469455,EHD4/DYRK1B/MET/YES1/RAP2B/PTPN1/CNOT7
BP,GO:0030832,regulation of actin filament length,0.6198539176626826,3,0.8660137814686419,0.9465872291469455,CAPZA1/MYO1C/CYFIP1
BP,GO:0043534,blood vessel endothelial cell migration,0.6198539176626826,3,0.8660137814686419,0.9465872291469455,SRPX2/STARD13/CSNK2B
MF,GO:0005262,calcium channel activity,0.5755121951219513,2,0.86616522979681565,0.9555314836647412,TRPM7/CDK5
BP,GO:0001895,retina homeostasis,0.5025842575643372,1,0.8674722689920877,0.9465872291469455,ACTG1
BP,GO:0014015,positive regulation of gliogenesis,0.5025842575643372,1,0.8674722689920877,0.9465872291469455,PPP1CC
BP,GO:0031670,cellular response to nutrient,0.5025842575643372,1,0.8674722689920877,0.9465872291469455,VDR
BP,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",0.5025842575643372,1,0.8674722689920877,0.9465872291469455,RC3H2
BP,GO:0060998,regulation of dendritic spine development,0.5025842575643372,1,0.8674722689920877,0.9465872291469455,CDK5
BP,GO:0099601,regulation of neurotransmitter receptor activity,0.5025842575643372,1,0.8674722689920877,0.9465872291469455,CDK5
BP,GO:1900182,positive regulation of protein localization to nucleus,0.5025842575643372,1,0.8674722689920877,0.9465872291469455,DTX3L
BP,GO:1903671,negative regulation of sprouting angiogenesis,0.5025842575643372,1,0.8674722689920877,0.9465872291469455,STARD13
CC,GO:0005743,mitochondrial inner membrane,0.7341778960128752,9,0.867601034411115,0.9602769167302887,SLC25A43/PTPMT1/MPC2/OMA1/TMEM65/C15orf48/UCP2/DNAJC30/ACAD11
CC,GO:0098948,intrinsic component of postsynaptic specialization membrane,0.5011055480722799,1,0.8681198229941766,0.9602769167302887,ADCY1
BP,GO:0050671,positive regulation of lymphocyte proliferation,0.5721728470732454,2,0.8681205998844281,0.9470406544193761,CDKN1A/CARD11
BP,GO:0002285,lymphocyte activation involved in immune response,0.6164293103827783,3,0.8684601063147039,0.9471570274767334,RC3H2/VAMP7/RNF168
MF,GO:0017022,myosin binding,0.49850704225352116,1,0.8698368666877018,0.9580612081584037,TRPM7
BP,GO:0019884,antigen processing and presentation of exogenous antigen,0.6130423361499059,3,0.8708670027905182,0.9484557920022093,RAB7A/CAPZA1/DCTN4
BP,GO:0032946,positive regulation of mononuclear cell proliferation,0.5678051154161978,2,0.8709125794845041,0.9484557920022093,CDKN1A/CARD11
BP,GO:0098754,detoxification,0.5678051154161978,2,0.8709125794845041,0.9484557920022093,SESN1/UBIAD1
BP,GO:0002200,somatic diversification of immune receptors,0.49588313413014606,1,0.8710498620747921,0.9484557920022093,RNF168
BP,GO:0010611,regulation of cardiac muscle hypertrophy,0.49588313413014606,1,0.8710498620747921,0.9484557920022093,PAK1
BP,GO:0015914,phospholipid transport,0.49588313413014606,1,0.8710498620747921,0.9484557920022093,TRIAP1
BP,GO:0002040,sprouting angiogenesis,0.6096923780288681,3,0.8732349574542112,0.9503263260898156,SRPX2/STARD13/PARVA
BP,GO:0021953,central nervous system neuron differentiation,0.6096923780288681,3,0.8732349574542112,0.9503263260898156,C12orf57/CDK5/LDB1
BP,GO:0072175,epithelial tube formation,0.5635035615115297,2,0.8736501564514619,0.9504655016309611,MTHFD1L/BCL10
BP,GO:0001937,negative regulation of endothelial cell proliferation,0.48935835604948624,1,0.8745310650454,0.9504655016309611,TGFBR1
BP,GO:0042278,purine nucleoside metabolic process,0.48935835604948624,1,0.8745310650454,0.9504655016309611,CARD11
BP,GO:0046902,regulation of mitochondrial membrane permeability,0.48935835604948624,1,0.8745310650454,0.9504655016309611,BAX
BP,GO:1901264,carbohydrate derivative transport,0.48935835604948624,1,0.8745310650454,0.9504655016309611,SLC35E3
CC,GO:0005758,mitochondrial intermembrane space,0.48841933166538676,1,0.8748933203360774,0.9651510758554317,TRIAP1
BP,GO:0050864,regulation of B cell activation,0.6063788324961026,3,0.8755644554212049,0.9513344563711168,CDKN1A/TNIP2/CARD11
CC,GO:0044306,neuron projection terminus,0.5592047420516747,2,0.8762312070626088,0.9651510758554317,ACTG1/CYFIP1
BP,GO:0007224,smoothened signaling pathway,0.5592666926279843,2,0.8763342304103603,0.9519165952761937,WDR11/BTRC
BP,GO:0006809,nitric oxide biosynthetic process,0.48300305272416827,1,0.8779184698720759,0.9528741556669169,ARG2
BP,GO:0008344,adult locomotory behavior,0.48300305272416827,1,0.8779184698720759,0.9528741556669169,CTNS
BP,GO:2000779,regulation of double-strand break repair,0.48300305272416827,1,0.8779184698720759,0.9528741556669169,DTX3L
BP,GO:0032355,response to estradiol,0.5550930605934471,2,0.8789656920511879,0.9537563177551966,MBD4/ARNT2
BP,GO:0060560,developmental growth involved in morphogenesis,0.6330422988895481,4,0.8800233317038919,0.954649310232382,PAK1/ZFYVE27/CDK5/CYFIP1
MF,GO:0002020,protease binding,0.55303125,2,0.8804394321195408,0.9666752058816442,BCL10/CRADD
MF,GO:0019955,cytokine binding,0.55303125,2,0.8804394321195408,0.9666752058816442,TGFBR1/COPS5
BP,GO:0014743,regulation of muscle hypertrophy,0.47681070589437125,1,0.8812145989595936,0.9546687053442415,PAK1
BP,GO:0030433,ubiquitin-dependent ERAD pathway,0.47681070589437125,1,0.8812145989595936,0.9546687053442415,EDEM1
BP,GO:0032413,negative regulation of ion transmembrane transporter activity,0.47681070589437125,1,0.8812145989595936,0.9546687053442415,NEDD4
BP,GO:0070664,negative regulation of leukocyte proliferation,0.47681070589437125,1,0.8812145989595936,0.9546687053442415,ARG2
BP,GO:0072347,response to anesthetic,0.47681070589437125,1,0.8812145989595936,0.9546687053442415,CDK5
BP,GO:0007498,mesoderm development,0.5509812601446068,2,0.88154542295834,0.9547728382839529,ACVR2B/LDB1
BP,GO:0019933,cAMP-mediated signaling,0.5966508298357373,3,0.8823270351485378,0.9553650196923746,ADCY7/ADCY9/ADCY1
BP,GO:0043062,extracellular structure organization,0.7050471101376484,8,0.8839396675765621,0.9566148146044748,ITGA6/HAS3/TGFBR1/SDC1/PLAGL2/ADAMTS14/CLASP2/P4HB
MF,GO:0016835,carbon-oxygen lyase activity,0.47192,1,0.8839908156411996,0.9675175068828878,PCBD1
MF,GO:0019905,syntaxin binding,0.47192,1,0.8839908156411996,0.9675175068828878,VAMP7
BP,GO:0007292,female gamete generation,0.5469299273494258,2,0.8840742954556791,0.9566148146044748,DIAPH2/TOB2
CC,GO:0098889,intrinsic component of presynaptic membrane,0.47055033172640925,1,0.8844080655072197,0.9721025361376825,PSEN2
BP,GO:0043536,positive regulation of blood vessel endothelial cell migration,0.47077512733874627,1,0.8844219070126424,0.9566148146044748,SRPX2
BP,GO:1900034,regulation of cellular response to heat,0.47077512733874627,1,0.8844219070126424,0.9566148146044748,NUP62
MF,GO:0017124,SH3 domain binding,0.544523076923077,2,0.8857453511682162,0.9679135519841356,LANCL1/INPPL1
BP,GO:0002440,production of molecular mediator of immune response,0.650196417128688,5,0.8863861536420243,0.9580080056305688,MAP3K7/BCL10/RNF168/IL7R/CARD11
BP,GO:0060048,cardiac muscle contraction,0.5429377380987,2,0.8865531724664637,0.9580080056305688,PIK3CA/PDE4B
BP,GO:1903670,regulation of sprouting angiogenesis,0.5429377380987,2,0.8865531724664637,0.9580080056305688,SRPX2/STARD13
BP,GO:0048002,antigen processing and presentation of peptide antigen,0.59033706444065,3,0.8866519521138375,0.9580080056305688,RAB7A/CAPZA1/DCTN4
CC,GO:0005902,microvillus,0.4648810506212718,1,0.8874163404512387,0.9721460154651654,MYO1C
BP,GO:0022617,extracellular matrix disassembly,0.46489043824701193,1,0.8875427828493191,0.9584613858855934,CLASP2
BP,GO:0097061,dendritic spine organization,0.46489043824701193,1,0.8875427828493191,0.9584613858855934,CDK5
MF,GO:0051082,unfolded protein binding,0.5403664122137405,2,0.8883158436087895,0.9688675295689542,PPIE/TOMM20
BP,GO:0048562,embryonic organ morphogenesis,0.6456811642319611,5,0.8898761683780515,0.9600118168785762,NDRG4/TGFBR1/MTHFD1L/MICAL2/FRS2
BP,GO:0060070,canonical Wnt signaling pathway,0.6661116727121364,6,0.8902067916996714,0.9600118168785762,SDC1/PYGO2/BTRC/SDHAF2/RBPJ/TBL1XR1
BP,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,0.4591510501205056,1,0.8905795511661367,0.9600118168785762,TGFBR1
BP,GO:0031145,anaphase-promoting complex-dependent catabolic process,0.4591510501205056,1,0.8905795511661367,0.9600118168785762,CDC26
BP,GO:0048708,astrocyte differentiation,0.4591510501205056,1,0.8905795511661367,0.9600118168785762,CDK6
CC,GO:0099572,postsynaptic specialization,0.6652608138200957,6,0.89073604995125,0.9721460154651654,ALS2/ADCY1/CDK5/NSMF/YES1/PDE4B
MF,GO:0005178,integrin binding,0.5362727272727272,2,0.8908326744672737,0.9688675295689542,ANXA7/P4HB
BP,GO:0001935,endothelial cell proliferation,0.5841555244988631,3,0.8908345254396752,0.9600118168785762,TGFBR1/ARNT/PDCD6
BP,GO:0002700,regulation of production of molecular mediator of immune response,0.5351256843131073,2,0.8913643439765999,0.9600118168785762,MAP3K7/BCL10
BP,GO:0070665,positive regulation of leukocyte proliferation,0.5351256843131073,2,0.8913643439765999,0.9600118168785762,CDKN1A/CARD11
BP,GO:0007162,negative regulation of cell adhesion,0.6434469733522656,5,0.8915863964772719,0.9600118168785762,RC3H2/ARG2/CD164/CLASP2/APOD
BP,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.617281909705576,4,0.8915884822625478,0.9600118168785762,TGFBR1/ACVR2B/RBPJ/CSNK2B
BP,GO:0048568,embryonic organ development,0.6951632721450646,8,0.8926878834539796,0.9600118168785762,THOC5/NDRG4/TGFBR1/MTHFD1L/MICAL2/ARNT/FRS2/RBPJ
BP,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,0.5811130478087649,3,0.8928736082326398,0.9600118168785762,EHD4/YES1/PTPN1
CC,GO:0098803,respiratory chain complex,0.4539426729595948,1,0.8932004932284504,0.9721460154651654,C15orf48
MF,GO:0015078,proton transmembrane transporter activity,0.5322406015037594,2,0.8932968162910127,0.9688675295689542,SLC36A1/C15orf48
CC,GO:0034702,ion channel complex,0.6409489568366371,5,0.8933354735648321,0.9721460154651654,CLCC1/ANO1/PIDD1/PDE4B/LRRC8B
BP,GO:0046209,nitric oxide metabolic process,0.4535516470702556,1,0.8935344742558456,0.9600118168785762,ARG2
BP,GO:0055117,regulation of cardiac muscle contraction,0.4535516470702556,1,0.8935344742558456,0.9600118168785762,PDE4B
MF,GO:0001540,amyloid-beta binding,0.4537692307692308,1,0.8935886136024456,0.9688675295689542,ITM2B
MF,GO:0003724,RNA helicase activity,0.4537692307692308,1,0.8935886136024456,0.9688675295689542,DHX34
BP,GO:0033865,nucleoside bisphosphate metabolic process,0.5313033579965851,2,0.8936983162534828,0.9600118168785762,IMPAD1/MPC2
BP,GO:0033875,ribonucleoside bisphosphate metabolic process,0.5313033579965851,2,0.8936983162534828,0.9600118168785762,IMPAD1/MPC2
BP,GO:0034032,purine nucleoside bisphosphate metabolic process,0.5313033579965851,2,0.8936983162534828,0.9600118168785762,IMPAD1/MPC2
BP,GO:0035023,regulation of Rho protein signal transduction,0.5313033579965851,2,0.8936983162534828,0.9600118168785762,ALS2/MET
BP,GO:0035725,sodium ion transmembrane transport,0.5313033579965851,2,0.8936983162534828,0.9600118168785762,NEDD4/CNNM4
BP,GO:0072073,kidney epithelium development,0.5313033579965851,2,0.8936983162534828,0.9600118168785762,ARG2/SDC1
CC,GO:0098984,neuron to neuron synapse,0.6614593234554095,6,0.8937772387865917,0.9721460154651654,ALS2/VAMP7/ADCY1/CDK5/NSMF/PDE4B
BP,GO:0002377,immunoglobulin production,0.5781020993745226,3,0.8948785098085291,0.9607721768015562,RNF168/IL7R/CARD11
BP,GO:0006413,translational initiation,0.5781020993745226,3,0.8948785098085291,0.9607721768015562,PAIP2/COPS5/YTHDF3
BP,GO:0050709,negative regulation of protein secretion,0.5275352490746235,2,0.8959856484122253,0.9608945659993358,ARG2/MAPKBP1
BP,GO:0008652,cellular amino acid biosynthetic process,0.4480871693947103,1,0.8964097536793213,0.9608945659993358,SEPHS2
BP,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,0.4480871693947103,1,0.8964097536793213,0.9608945659993358,CNOT7
BP,GO:0098659,inorganic cation import across plasma membrane,0.4480871693947103,1,0.8964097536793213,0.9608945659993358,ISCU
BP,GO:0099587,inorganic ion import across plasma membrane,0.4480871693947103,1,0.8964097536793213,0.9608945659993358,ISCU
BP,GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,0.4480871693947103,1,0.8964097536793213,0.9608945659993358,TGFBR1
MF,GO:0005089,Rho guanyl-nucleotide exchange factor activity,0.44802531645569615,1,0.8966084043509999,0.9701797574611642,ALS2
MF,GO:0020037,heme binding,0.5243555555555556,2,0.8980708629788094,0.9701797574611642,CYP26B1/CYB5D2
BP,GO:0010675,regulation of cellular carbohydrate metabolic process,0.5238202121093093,2,0.8982271547459592,0.9625890583526243,NUPR1/EPM2AIP1
BP,GO:0000245,spliceosomal complex assembly,0.4427527983304876,1,0.899207531892749,0.9628787153829174,CELF1
BP,GO:0046889,positive regulation of lipid biosynthetic process,0.4427527983304876,1,0.899207531892749,0.9628787153829174,LPGAT1
BP,GO:0050886,endocrine process,0.4427527983304876,1,0.899207531892749,0.9628787153829174,RASL10B
MF,GO:0051117,ATPase binding,0.44242499999999996,1,0.8995426646430024,0.9701797574611642,ZNHIT6
MF,GO:0052689,carboxylic ester hydrolase activity,0.5205000000000001,2,0.9003826526078431,0.9701797574611642,DDHD2/PLA2G3
CC,GO:0005746,mitochondrial respiratory chain,0.4384673545632449,1,0.9013253393255598,0.9750079516643226,C15orf48
CC,GO:0031970,organelle envelope lumen,0.4384673545632449,1,0.9013253393255598,0.9750079516643226,TRIAP1
BP,GO:0002028,regulation of sodium ion transport,0.43754394187954065,1,0.9019298938312963,0.9645243975041308,NEDD4
BP,GO:0034308,primary alcohol metabolic process,0.43754394187954065,1,0.9019298938312963,0.9645243975041308,AKR1C3
BP,GO:0045682,regulation of epidermis development,0.43754394187954065,1,0.9019298938312963,0.9645243975041308,VDR
BP,GO:1903901,negative regulation of viral life cycle,0.43754394187954065,1,0.9019298938312963,0.9645243975041308,BANF1
BP,GO:2001057,reactive nitrogen species metabolic process,0.43754394187954065,1,0.9019298938312963,0.9645243975041308,ARG2
BP,GO:1904064,positive regulation of cation transmembrane transport,0.5165449313855688,2,0.9025758972305007,0.964961563714501,BAX/STAC
CC,GO:0098862,cluster of actin-based cell projections,0.5144683626875407,2,0.9036792970291849,0.9750079516643226,MYO1B/MYO1C
CC,GO:1905368,peptidase complex,0.43354075507377027,1,0.9038941279344872,0.9750079516643226,TADA3
BP,GO:0015711,organic anion transport,0.694442148418773,9,0.904467787774465,0.9656933634624444,CTNS/PLA2G3/PRKAG2/SLC36A1/SLC7A1/MPC2/PRKAA2/TRIAP1/PRAF2
BP,GO:0007260,tyrosine phosphorylation of STAT protein,0.4324562216251274,1,0.9045788684504348,0.9656933634624444,CNOT7
BP,GO:0032760,positive regulation of tumor necrosis factor production,0.4324562216251274,1,0.9045788684504348,0.9656933634624444,CARD9
BP,GO:0060291,long-term synaptic potentiation,0.4324562216251274,1,0.9045788684504348,0.9656933634624444,ADCY1
BP,GO:0090559,regulation of membrane permeability,0.4324562216251274,1,0.9045788684504348,0.9656933634624444,BAX
BP,GO:0007605,sensory perception of sound,0.512982552548427,2,0.9046847119359331,0.9656933634624444,DIAPH1/MARVELD2
BP,GO:0051321,meiotic cell cycle,0.5974495591929471,4,0.9054850832134251,0.9662542411317135,CYP26B1/STAG2/AGO4/CCNB3
BP,GO:0034765,regulation of ion transmembrane transport,0.6930043799955458,9,0.9056852068424837,0.9662542411317135,NEDD4/BAX/DIAPH1/ISCU/PSEN2/STAC/DNAJC30/PDE4B/MYO5A
CC,GO:0030864,cortical actin cytoskeleton,0.4287236355729507,1,0.9063961709661501,0.9750341234454251,CAPZA1
BP,GO:0051250,negative regulation of lymphocyte activation,0.509468973421383,2,0.9067508578477963,0.966556406013499,RC3H2/ARG2
BP,GO:0061337,cardiac conduction,0.509468973421383,2,0.9067508578477963,0.966556406013499,TMEM65/ASPH
MF,GO:0015085,calcium ion transmembrane transporter activity,0.5092661870503598,2,0.9070281381907808,0.9758274861340444,TRPM7/CDK5
BP,GO:0030317,flagellated sperm motility,0.4274854604570225,1,0.907156430226042,0.966556406013499,PLA2G3
BP,GO:0048477,oogenesis,0.4274854604570225,1,0.907156430226042,0.966556406013499,DIAPH2
BP,GO:0097722,sperm motility,0.4274854604570225,1,0.907156430226042,0.966556406013499,PLA2G3
CC,GO:0099699,integral component of synaptic membrane,0.5076990421258626,2,0.9076613241286586,0.9750341234454251,PSEN2/ADCY1
BP,GO:0070972,protein localization to endoplasmic reticulum,0.5060031980919858,2,0.9087750989931704,0.9674549512416488,SEC62/TAPT1
BP,GO:0090263,positive regulation of canonical Wnt signaling pathway,0.5060031980919858,2,0.9087750989931704,0.9674549512416488,RBPJ/TBL1XR1
BP,GO:0070372,regulation of ERK1 and ERK2 cascade,0.6198539176626826,5,0.908937244300842,0.9674549512416488,PDE8A/NDRG4/DUSP10/FRS2/PTPN1
BP,GO:0106027,neuron projection organization,0.42262767113364724,1,0.9096645006143822,0.9674549512416488,CDK5
BP,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,0.42262767113364724,1,0.9096645006143822,0.9674549512416488,CARD9
BP,GO:1903725,regulation of phospholipid metabolic process,0.42262767113364724,1,0.9096645006143822,0.9674549512416488,MTMR3
BP,GO:2000177,regulation of neural precursor cell proliferation,0.42262767113364724,1,0.9096645006143822,0.9674549512416488,APPL2
MF,GO:0005126,cytokine receptor binding,0.6187762237762238,5,0.9098579307905612,0.9773589828430295,TGFBR1/ACVR2B/FRS2/PIDD1/IL1RAP
BP,GO:0002792,negative regulation of peptide secretion,0.5025842575643372,2,0.9107581892607947,0.9678590161736973,ARG2/MAPKBP1
BP,GO:0035148,tube formation,0.5025842575643372,2,0.9107581892607947,0.9678590161736973,MTHFD1L/BCL10
BP,GO:0051668,localization within membrane,0.5025842575643372,2,0.9107581892607947,0.9678590161736973,USP46/CDK5
CC,GO:0098798,mitochondrial protein complex,0.5890859114742834,4,0.9109732890023499,0.9765783612556055,HSD17B10/BAX/C15orf48/TOMM20
BP,GO:0006094,gluconeogenesis,0.41787904561529166,1,0.91210494947304,0.9680258112330621,PGM1
BP,GO:0032410,negative regulation of transporter activity,0.41787904561529166,1,0.91210494947304,0.9680258112330621,NEDD4
BP,GO:0046427,positive regulation of JAK-STAT cascade,0.41787904561529166,1,0.91210494947304,0.9680258112330621,CRLF3
BP,GO:0061053,somite development,0.41787904561529166,1,0.91210494947304,0.9680258112330621,RBPJ
BP,GO:0070126,mitochondrial translational termination,0.41787904561529166,1,0.91210494947304,0.9680258112330621,MTRF1L
BP,GO:0008277,regulation of G protein-coupled receptor signaling pathway,0.4992112088558517,2,0.9127008723928459,0.9683666276147671,MET/NMT2
MF,GO:0015297,antiporter activity,0.4164,1,0.9130132843304861,0.9777260903076853,SLC35E3
MF,GO:0038024,cargo receptor activity,0.4164,1,0.9130132843304861,0.9777260903076853,SCARA3
BP,GO:0003002,regionalization,0.6357476078591616,6,0.9134485582225175,0.9683666276147671,CYP26B1/TGFBR1/ACVR2B/FRS2/RBPJ/LDB1
CC,GO:0036126,sperm flagellum,0.414893840877049,1,0.9135189133072226,0.9772964144416078,GABARAP
BP,GO:0032651,regulation of interleukin-1 beta production,0.41323594510845507,1,0.9144795964438452,0.9683666276147671,ARG2
BP,GO:0045132,meiotic chromosome segregation,0.41323594510845507,1,0.9144795964438452,0.9683666276147671,AGO4
BP,GO:1901379,regulation of potassium ion transmembrane transport,0.41323594510845507,1,0.9144795964438452,0.9683666276147671,NEDD4
BP,GO:0016331,morphogenesis of embryonic epithelium,0.49588313413014606,2,0.9146038819844715,0.9683666276147671,MTHFD1L/BCL10
BP,GO:0035567,non-canonical Wnt signaling pathway,0.49588313413014606,2,0.9146038819844715,0.9683666276147671,AGO4/MAP3K7
BP,GO:0002449,lymphocyte mediated immunity,0.6339415067004709,6,0.9147482514209422,0.9683666276147671,VAMP7/MAP3K7/BCL10/FAM49B/RNF168/IL7R
BP,GO:0034764,positive regulation of transmembrane transport,0.5469299273494258,3,0.9148065265298795,0.9683666276147671,BAX/CAPN10/STAC
BP,GO:0035637,multicellular organismal signaling,0.5469299273494258,3,0.9148065265298795,0.9683666276147671,TMEM65/GBA/ASPH
BP,GO:0030216,keratinocyte differentiation,0.6096923780288682,5,0.9159882150856613,0.9692054531267016,CYP26B1/VDR/RBPJ/PKP3/AKR1C3
BP,GO:0055088,lipid homeostasis,0.4925991398643835,2,0.9164679414906698,0.9692054531267016,PRKAA2/FITM2
BP,GO:0030510,regulation of BMP signaling pathway,0.4086948907666039,1,0.9167902122988072,0.9692054531267016,RBPJ
BP,GO:0045639,positive regulation of myeloid cell differentiation,0.4086948907666039,1,0.9167902122988072,0.9692054531267016,ARNT
BP,GO:0051899,membrane depolarization,0.4086948907666039,1,0.9167902122988072,0.9692054531267016,GCLM
BP,GO:0072503,cellular divalent inorganic cation homeostasis,0.678947496019977,9,0.917157456204437,0.9693417853571447,BAX/TRPM7/VDR/DIAPH1/ANXA7/CDK5/PDZD8/RIC3/MYO5A
BP,GO:0050679,positive regulation of epithelial cell proliferation,0.5416199280547712,3,0.9180379014271989,0.9700203072742454,TGFBR1/ARNT/PDCD6
BP,GO:0019319,hexose biosynthetic process,0.4042525549974017,1,0.9190385202500423,0.9708254220662611,PGM1
MF,GO:0046906,tetrapyrrole binding,0.4881931034482759,2,0.9190941865926043,0.9827237841259384,CYP26B1/CYB5D2
BP,GO:0042133,neurotransmitter metabolic process,0.4861599354217118,2,0.9200820534556099,0.971118986864453,ARG2/RNF180
BP,GO:0045807,positive regulation of endocytosis,0.4861599354217118,2,0.9200820534556099,0.971118986864453,APPL2/MYO18A
BP,GO:0050670,regulation of lymphocyte proliferation,0.5364120441311676,3,0.9211572549838637,0.971118986864453,ARG2/CDKN1A/CARD11
BP,GO:0003073,regulation of systemic arterial blood pressure,0.39990575333076295,1,0.9212261972246618,0.971118986864453,RASL10B
BP,GO:0007589,body fluid secretion,0.39990575333076295,1,0.9212261972246618,0.971118986864453,VDR
BP,GO:0035278,miRNA mediated inhibition of translation,0.39990575333076295,1,0.9212261972246618,0.971118986864453,AGO4
BP,GO:0040033,"negative regulation of translation, ncRNA-mediated",0.39990575333076295,1,0.9212261972246618,0.971118986864453,AGO4
BP,GO:0045974,"regulation of translation, ncRNA-mediated",0.39990575333076295,1,0.9212261972246618,0.971118986864453,AGO4
BP,GO:0032412,regulation of ion transmembrane transporter activity,0.5721728470732454,4,0.9220130147977109,0.9716966176676395,NEDD4/STAC/PDE4B/MYO5A
BP,GO:0032944,regulation of mononuclear cell proliferation,0.5338454793267122,3,0.9226759567084287,0.9721434322429133,ARG2/CDKN1A/CARD11
BP,GO:0044728,DNA methylation or demethylation,0.3956514368059676,1,0.9233548751055477,0.9725592785986664,PIK3CA
BP,GO:0010977,negative regulation of neuron projection development,0.4798869039969155,2,0.9235487938118605,0.9725592785986664,SNAPIN/CDK5
BP,GO:0009612,response to mechanical stimulus,0.5313033579965851,3,0.9241678848176709,0.9725606938075039,BCL10/STRBP/CRADD
BP,GO:0050707,regulation of cytokine secretion,0.5313033579965851,3,0.9241678848176709,0.9725606938075039,ARG2/MAPKBP1/IL1RAP
CC,GO:0097729,9+2 motile cilium,0.3937257877710771,1,0.9242082659519365,0.9788252185644065,GABARAP
BP,GO:0034767,positive regulation of ion transmembrane transport,0.47681070589437125,2,0.925228601137253,0.9725606938075039,BAX/STAC
BP,GO:0042129,regulation of T cell proliferation,0.47681070589437125,2,0.925228601137253,0.9725606938075039,ARG2/CARD11
CC,GO:0014069,postsynaptic density,0.5954494938513204,5,0.9252855212602906,0.9788252185644065,ALS2/ADCY1/CDK5/NSMF/PDE4B
CC,GO:1902495,transmembrane transporter complex,0.5954494938513204,5,0.9252855212602906,0.9788252185644065,CLCC1/ANO1/PIDD1/PDE4B/LRRC8B
BP,GO:0042102,positive regulation of T cell proliferation,0.39148668483958904,1,0.9254261419389357,0.9725606938075039,CARD11
BP,GO:0044070,regulation of anion transport,0.39148668483958904,1,0.9254261419389357,0.9725606938075039,TRIAP1
BP,GO:0097711,ciliary basal body-plasma membrane docking,0.39148668483958904,1,0.9254261419389357,0.9725606938075039,MAPRE1
BP,GO:1903531,negative regulation of secretion by cell,0.5287853326032363,3,0.9256334416770238,0.9725606938075039,RAB7A/ARG2/MAPKBP1
BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.6181368707993511,6,0.9257018206545367,0.9725606938075039,RC3H2/MAP3K7/BCL10/FAM49B/RNF168/IL7R
CC,GO:0000794,condensed nuclear chromosome,0.38974875961177324,1,0.926182351078526,0.9788252185644065,RCC1
BP,GO:0030509,BMP signaling pathway,0.47377369502880196,2,0.9268735873791908,0.9728809173208344,ACVR2B/RBPJ
BP,GO:0043271,negative regulation of ion transport,0.47377369502880196,2,0.9268735873791908,0.9728809173208344,NEDD4/ISCU
BP,GO:1905952,regulation of lipid localization,0.47377369502880196,2,0.9268735873791908,0.9728809173208344,TRIAP1/FITM2
BP,GO:0006835,dicarboxylic acid transport,0.38740869853917664,1,0.9274415431096843,0.9728809173208344,PRAF2
BP,GO:0010660,regulation of muscle cell apoptotic process,0.38740869853917664,1,0.9274415431096843,0.9728809173208344,NUPR1
BP,GO:0033108,mitochondrial respiratory chain complex assembly,0.38740869853917664,1,0.9274415431096843,0.9728809173208344,SDHAF2
BP,GO:0045861,negative regulation of proteolysis,0.6147311580125777,6,0.927961449549055,0.9731753484829997,CSNK2A2/RPS6KA1/RYBP/CDK5/TRIAP1/MTM1
CC,GO:0070469,respiratory chain,0.3858512720156556,1,0.928105116834407,0.9788252185644065,C15orf48
CC,GO:0099240,intrinsic component of synaptic membrane,0.47055033172640925,2,0.9284948147697163,0.9788252185644065,PSEN2/ADCY1
BP,GO:0006874,cellular calcium ion homeostasis,0.6496285599958245,8,0.9285665457523982,0.9731813913898016,BAX/VDR/DIAPH1/ANXA7/CDK5/PDZD8/RIC3/MYO5A
BP,GO:0010771,negative regulation of cell morphogenesis involved in differentiation,0.38341479443052534,1,0.9294025824850982,0.9731813913898016,CDK5
BP,GO:0030316,osteoclast differentiation,0.38341479443052534,1,0.9294025824850982,0.9731813913898016,TOB2
BP,GO:0043255,regulation of carbohydrate biosynthetic process,0.38341479443052534,1,0.9294025824850982,0.9731813913898016,EPM2AIP1
BP,GO:0051591,response to cAMP,0.38341479443052534,1,0.9294025824850982,0.9731813913898016,SDC1
BP,GO:0060996,dendritic spine development,0.38341479443052534,1,0.9294025824850982,0.9731813913898016,CDK5
CC,GO:0032279,asymmetric synapse,0.5881879146580116,5,0.9298825190904025,0.9788252185644065,ALS2/ADCY1/CDK5/NSMF/PDE4B
CC,GO:0099634,postsynaptic specialization membrane,0.38203096239173817,1,0.9299778947972769,0.9788252185644065,ADCY1
BP,GO:0070371,ERK1 and ERK2 cascade,0.5866125403747785,5,0.9309848662970663,0.9739844832985659,PDE8A/NDRG4/DUSP10/FRS2/PTPN1
BP,GO:0046364,monosaccharide biosynthetic process,0.3795023985689894,1,0.9313107235281435,0.9739844832985659,PGM1
BP,GO:0050848,regulation of calcium-mediated signaling,0.3795023985689894,1,0.9313107235281435,0.9739844832985659,MYO5A
BP,GO:0060191,regulation of lipase activity,0.3795023985689894,1,0.9313107235281435,0.9739844832985659,ARL1
BP,GO:0021915,neural tube development,0.46489043824701193,2,0.9316061023880825,0.9739844832985659,MTHFD1L/BCL10
BP,GO:0032680,regulation of tumor necrosis factor production,0.46489043824701193,2,0.9316061023880825,0.9739844832985659,ARG2/CARD9
BP,GO:0022898,regulation of transmembrane transporter activity,0.5550930605934471,4,0.932355510193613,0.9744389905081959,NEDD4/STAC/PDE4B/MYO5A
BP,GO:0001708,cell fate specification,0.37566904100768644,1,0.9331673903808719,0.9744389905081959,RBPJ
BP,GO:0048525,negative regulation of viral process,0.37566904100768644,1,0.9331673903808719,0.9744389905081959,BANF1
BP,GO:1901570,fatty acid derivative biosynthetic process,0.37566904100768644,1,0.9331673903808719,0.9744389905081959,AKR1C3
BP,GO:0007204,positive regulation of cytosolic calcium ion concentration,0.5829347188050307,5,0.9332385218829723,0.9744389905081959,BAX/DIAPH1/CDK5/RIC3/MYO5A
CC,GO:1990351,transporter complex,0.5811013132765898,5,0.9342261575003539,0.9813141694711377,CLCC1/ANO1/PIDD1/PDE4B/LRRC8B
BP,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,0.3719123505976096,1,0.9349739689188505,0.9748337155380783,ANO1
BP,GO:0010657,muscle cell apoptotic process,0.3719123505976096,1,0.9349739689188505,0.9748337155380783,NUPR1
BP,GO:0022600,digestive system process,0.3719123505976096,1,0.9349739689188505,0.9748337155380783,VDR
BP,GO:0036503,ERAD pathway,0.3719123505976096,1,0.9349739689188505,0.9748337155380783,EDEM1
BP,GO:0060079,excitatory postsynaptic potential,0.3719123505976096,1,0.9349739689188505,0.9748337155380783,CDK5
BP,GO:0010001,glial cell differentiation,0.5118059870609306,3,0.9351868974325518,0.9748337155380783,CDK6/DUSP10/CDK5
BP,GO:0032640,tumor necrosis factor production,0.4563341725124043,2,0.936048154341197,0.9748337155380783,ARG2/CARD9
BP,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,0.4563341725124043,2,0.936048154341197,0.9748337155380783,ARG2/CARD9
BP,GO:0007631,feeding behavior,0.3682300500966431,1,0.9367318077773716,0.9748337155380783,USP46
BP,GO:0032611,interleukin-1 beta production,0.3682300500966431,1,0.9367318077773716,0.9748337155380783,ARG2
BP,GO:0046632,alpha-beta T cell differentiation,0.3682300500966431,1,0.9367318077773716,0.9748337155380783,RC3H2
BP,GO:0048661,positive regulation of smooth muscle cell proliferation,0.3682300500966431,1,0.9367318077773716,0.9748337155380783,PAK1
BP,GO:0050830,defense response to Gram-positive bacterium,0.3682300500966431,1,0.9367318077773716,0.9748337155380783,CARD9
BP,GO:0032103,positive regulation of response to external stimulus,0.5757157129993956,5,0.9375497227218705,0.9754353636911942,MET/SNX4/VAMP7/NUPR1/ZCCHC3
CC,GO:0044455,mitochondrial membrane part,0.5054820157410335,3,0.9384858741933444,0.9829283623566184,MPC2/C15orf48/TOMM20
BP,GO:0050954,sensory perception of mechanical stimulus,0.45080284920922364,2,0.9388562465416173,0.9763659860712689,DIAPH1/MARVELD2
BP,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,0.504858394476393,3,0.9389242225936096,0.9763659860712689,ADCY7/ADCY9/ADCY1
MF,GO:0033218,amide binding,0.5965280898876405,6,0.9395462553426099,0.9999991752923971,PPIE/LANCL1/ITM2B/TOMM20/NPBWR1/KPNA5
BP,GO:0007229,integrin-mediated signaling pathway,0.36107995203651416,1,0.9401064807615589,0.9764250547024639,ITGA6
BP,GO:0032652,regulation of interleukin-1 production,0.36107995203651416,1,0.9401064807615589,0.9764250547024639,ARG2
BP,GO:0048259,regulation of receptor-mediated endocytosis,0.36107995203651416,1,0.9401064807615589,0.9764250547024639,USP46
BP,GO:0070663,regulation of leukocyte proliferation,0.5025842575643372,3,0.9401250922390356,0.9764250547024639,ARG2/CDKN1A/CARD11
CC,GO:0000786,nucleosome,0.3606086654351921,1,0.9402351526644053,0.9829283623566184,HP1BP3
BP,GO:0055074,calcium ion homeostasis,0.6316982600384027,8,0.9405601613669206,0.9764250547024639,BAX/VDR/DIAPH1/ANXA7/CDK5/PDZD8/RIC3/MYO5A
BP,GO:0007411,axon guidance,0.5390034066632022,4,0.9414428282954581,0.9764250547024639,PIK3CA/CDK5/FRS2/CYFIP1
BP,GO:1901568,fatty acid derivative metabolic process,0.44540401269174795,2,0.9415471610709731,0.9764250547024639,PLA2G3/AKR1C3
BP,GO:0007218,neuropeptide signaling pathway,0.3576080294207784,1,0.9417258348121701,0.9764250547024639,NPBWR1
BP,GO:0030593,neutrophil chemotaxis,0.3576080294207784,1,0.9417258348121701,0.9764250547024639,PDE4B
BP,GO:0032414,positive regulation of ion transmembrane transporter activity,0.3576080294207784,1,0.9417258348121701,0.9764250547024639,STAC
CC,GO:0001669,acrosomal vesicle,0.35726969631079214,1,0.9417925130411766,0.9829283623566184,CSNK2A2
MF,GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,0.3575151515151515,1,0.9418865499290453,0.9999991752923971,RBBP4
BP,GO:0097485,neuron projection guidance,0.5370575459893279,4,0.9424970943243667,0.9764250547024639,PIK3CA/CDK5/FRS2/CYFIP1
BP,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,0.4427527983304876,2,0.942850087944443,0.9764250547024639,CDH20/PCDHB13
BP,GO:0050806,positive regulation of synaptic transmission,0.4427527983304876,2,0.942850087944443,0.9764250547024639,ADCY1/CDK5
BP,GO:0006637,acyl-CoA metabolic process,0.35420223866439005,1,0.9433014908998729,0.9764250547024639,MPC2
BP,GO:0007009,plasma membrane organization,0.35420223866439005,1,0.9433014908998729,0.9764250547024639,FNBP1L
BP,GO:0015748,organophosphate ester transport,0.35420223866439005,1,0.9433014908998729,0.9764250547024639,TRIAP1
BP,GO:0035383,thioester metabolic process,0.35420223866439005,1,0.9433014908998729,0.9764250547024639,MPC2
BP,GO:0043266,regulation of potassium ion transport,0.35420223866439005,1,0.9433014908998729,0.9764250547024639,NEDD4
CC,GO:0044853,plasma membrane raft,0.3539919926749134,1,0.943309368864317,0.9829283623566184,PRKAR2A
BP,GO:0051100,negative regulation of binding,0.4401329592871119,2,0.9441253955010309,0.9767693159402652,BAX/MET
BP,GO:0019882,antigen processing and presentation,0.4936889609702782,3,0.9447134340301961,0.9767693159402652,RAB7A/CAPZA1/DCTN4
BP,GO:0002286,T cell activation involved in immune response,0.35086070811095244,1,0.9448346259156695,0.9767693159402652,RC3H2
BP,GO:0003300,cardiac muscle hypertrophy,0.35086070811095244,1,0.9448346259156695,0.9767693159402652,PAK1
BP,GO:0042136,neurotransmitter biosynthetic process,0.35086070811095244,1,0.9448346259156695,0.9767693159402652,ARG2
BP,GO:0071772,response to BMP,0.43754394187954065,2,0.9453736231110307,0.9767714002901908,ACVR2B/RBPJ
BP,GO:0071773,cellular response to BMP stimulus,0.43754394187954065,2,0.9453736231110307,0.9767714002901908,ACVR2B/RBPJ
BP,GO:0060047,heart contraction,0.5313033579965851,4,0.9455569750105141,0.9767714002901908,PIK3CA/TMEM65/PDE4B/ASPH
BP,GO:0001894,tissue homeostasis,0.4915141197325236,3,0.9458084492667035,0.9767831357240288,BAX/ACTG1/LDB1
BP,GO:0050905,neuromuscular process,0.3475816360725323,1,0.9463263851157522,0.9770699834139289,POMK
MF,GO:0015294,solute:cation symporter activity,0.34700000000000003,1,0.9467008243316237,0.9999991752923971,SLC36A1
MF,GO:0042562,hormone binding,0.34700000000000003,1,0.9467008243316237,0.9999991752923971,VDR
MF,GO:0051087,chaperone binding,0.34700000000000003,1,0.9467008243316237,0.9999991752923971,BAX
MF,GO:0015267,channel activity,0.6209473684210527,8,0.94727401943136,0.9999991752923971,BAX/TRPM7/CLCC1/ANO1/MTMR6/CDK5/PIDD1/LRRC8B
CC,GO:1990204,oxidoreductase complex,0.34451006429969244,1,0.947627287998779,0.9854567206534208,P4HB
BP,GO:0099565,"chemical synaptic transmission, postsynaptic",0.3443632875903792,1,0.947777882970188,0.9780856391854268,CDK5
BP,GO:0140013,meiotic nuclear division,0.4324562216251274,2,0.9477909512460552,0.9780856391854268,CYP26B1/AGO4
MF,GO:0022803,passive transmembrane transporter activity,0.6195886214442013,8,0.9480731872248338,0.9999991752923971,BAX/TRPM7/CLCC1/ANO1/MTMR6/CDK5/PIDD1/LRRC8B
BP,GO:0032409,regulation of transporter activity,0.5256711669224163,4,0.948467501682416,0.9785355812437404,NEDD4/STAC/PDE4B/MYO5A
BP,GO:0010469,regulation of signaling receptor activity,0.42995647467931736,2,0.9489610860597308,0.9785366826727737,CDK5/LDOC1
BP,GO:0006613,cotranslational protein targeting to membrane,0.34120399137395374,1,0.9491902039888803,0.9785366826727737,SEC62
BP,GO:0014897,striated muscle hypertrophy,0.34120399137395374,1,0.9491902039888803,0.9785366826727737,PAK1
BP,GO:0033559,unsaturated fatty acid metabolic process,0.33810213690691776,1,0.9505644035254128,0.9793463168486385,AKR1C3
BP,GO:0050804,modulation of chemical synaptic transmission,0.597106984904419,7,0.950772046552183,0.9793463168486385,USP46/SNAPIN/ADCY1/CDK5/NSMF/RIN1/CYFIP1
BP,GO:0002695,negative regulation of leukocyte activation,0.42504268639726805,2,0.9512268176165146,0.9793463168486385,RC3H2/ARG2
BP,GO:0060828,regulation of canonical Wnt signaling pathway,0.5201571337029505,4,0.9512349732522715,0.9793463168486385,BTRC/SDHAF2/RBPJ/TBL1XR1
BP,GO:0050727,regulation of inflammatory response,0.6134636710888406,8,0.9514654853207257,0.9793463168486385,SNX4/ADCY7/VAMP7/APPL2/DUSP10/NUPR1/GBA/APOD
BP,GO:0099177,regulation of trans-synaptic signaling,0.595740607364592,7,0.9515208562126525,0.9793463168486385,USP46/SNAPIN/ADCY1/CDK5/NSMF/RIN1/CYFIP1
CC,GO:0044815,DNA packaging complex,0.33552284523100484,1,0.9516169213338195,0.9876342948504381,HP1BP3
MF,GO:0005216,ion channel activity,0.5955721153846154,7,0.9517309424517337,0.9999991752923971,TRPM7/CLCC1/ANO1/MTMR6/CDK5/PIDD1/LRRC8B
BP,GO:0014896,muscle hypertrophy,0.33505617170955815,1,0.9519015085593698,0.9793463168486385,PAK1
BP,GO:0072676,lymphocyte migration,0.33505617170955815,1,0.9519015085593698,0.9793463168486385,APOD
BP,GO:0032411,positive regulation of transporter activity,0.3320645987478657,1,0.9532025184577048,0.9799413305751687,STAC
BP,GO:0043279,response to alkaloid,0.3320645987478657,1,0.9532025184577048,0.9799413305751687,CDK5
BP,GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,0.3320645987478657,1,0.9532025184577048,0.9799413305751687,KPNA5
CC,GO:0099055,integral component of postsynaptic membrane,0.32978741197919276,1,0.9541066783518874,0.9882496608774023,ADCY1
BP,GO:0060964,regulation of gene silencing by miRNA,0.32912597398018545,1,0.9544684057157192,0.9807505607789936,NUP62
BP,GO:0003015,heart process,0.512982552548427,4,0.9547129352715866,0.9807505607789936,PIK3CA/TMEM65/PDE4B/ASPH
BP,GO:0042063,gliogenesis,0.512982552548427,4,0.9547129352715866,0.9807505607789936,CDK6/DUSP10/CDK5/PPP1CC
BP,GO:0030177,positive regulation of Wnt signaling pathway,0.41554452580738493,2,0.9554737065781548,0.9812690748730205,RBPJ/TBL1XR1
BP,GO:0007127,meiosis I,0.32623890403299083,1,0.9557001166781975,0.9812690748730205,AGO4
BP,GO:0051048,negative regulation of secretion,0.4687970805852221,3,0.956593463707708,0.9817562148492571,RAB7A/ARG2/MAPKBP1
BP,GO:0032612,interleukin-1 production,0.3234020439979214,1,0.9568985722412253,0.9817562148492571,ARG2
BP,GO:0032963,collagen metabolic process,0.3234020439979214,1,0.9568985722412253,0.9817562148492571,ADAMTS14
BP,GO:0022408,negative regulation of cell-cell adhesion,0.41095287358851884,2,0.9574623241973699,0.9820869225504036,RC3H2/ARG2
BP,GO:0051604,protein maturation,0.5620841570744729,6,0.9581064632409328,0.9823307743417714,DOHH/SNAPIN/PSEN2/OMA1/PIDD1/ASPH
BP,GO:0008217,regulation of blood pressure,0.4086948907666039,2,0.9584244944352238,0.9823307743417714,ACTA2/RASL10B
BP,GO:0009566,fertilization,0.4086948907666039,2,0.9584244944352238,0.9823307743417714,BAX/PLCD4
CC,GO:0015934,large ribosomal subunit,0.3188853487732691,1,0.9587090990521321,0.9887672599178601,RSL24D1
BP,GO:0010906,regulation of glucose metabolic process,0.3178738039295808,1,0.9591992775896103,0.9823823417005375,EPM2AIP1
BP,GO:0060147,regulation of posttranscriptional gene silencing,0.3178738039295808,1,0.9591992775896103,0.9823823417005375,NUP62
BP,GO:0060966,regulation of gene silencing by RNA,0.3178738039295808,1,0.9591992775896103,0.9823823417005375,NUP62
CC,GO:0098936,intrinsic component of postsynaptic membrane,0.3162715344390619,1,0.9597858315681742,0.9887672599178601,ADCY1
BP,GO:1903522,regulation of blood circulation,0.5008920546769152,4,0.9602551100819198,0.9827707201967316,DOCK5/TMEM65/PDE4B/ASPH
CC,GO:0097223,sperm part,0.40403274556613145,2,0.9602998723962326,0.9887672599178601,CSNK2A2/GABARAP
BP,GO:0045047,protein targeting to ER,0.3151799581335674,1,0.9603032479798446,0.9827707201967316,SEC62
BP,GO:1990266,neutrophil migration,0.3151799581335674,1,0.9603032479798446,0.9827707201967316,PDE4B
MF,GO:0022838,substrate-specific channel activity,0.578873831775701,7,0.9603083059998478,0.9999991752923971,TRPM7/CLCC1/ANO1/MTMR6/CDK5/PIDD1/LRRC8B
BP,GO:0002791,regulation of peptide secretion,0.5950597609561753,8,0.9611438128622865,0.9833752289159221,ARG2/ANO1/MAPKBP1/CAPN10/MPC2/IL1RAP/MYO18A/RASL10B
BP,GO:0061982,meiosis I cell cycle process,0.31253138705681477,1,0.9613774054568884,0.9833752289159221,AGO4
BP,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,0.3099269588313413,1,0.9624225535599902,0.9841968194776369,TGFBR1
BP,GO:0001505,regulation of neurotransmitter levels,0.5252999302226123,5,0.9633368314416499,0.9848363402545288,ARG2/SNAPIN/RNF180/ADCY1/CDK5
BP,GO:0031345,negative regulation of cell projection organization,0.3956514368059676,2,0.9637742061340411,0.9848363402545288,SNAPIN/CDK5
BP,GO:1903046,meiotic cell cycle process,0.3956514368059676,2,0.9637742061340411,0.9848363402545288,CYP26B1/AGO4
BP,GO:0072599,establishment of protein localization to endoplasmic reticulum,0.30484618901443405,1,0.9644289283045758,0.9849619314072259,SEC62
BP,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,0.30484618901443405,1,0.9644289283045758,0.9849619314072259,TGFBR1
BP,GO:0006302,double-strand break repair,0.44989397249710833,3,0.9646234844460146,0.9849619314072259,INO80/DTX3L/RNF168
BP,GO:0051480,regulation of cytosolic calcium ion concentration,0.5208856450946913,5,0.9652257665881081,0.9852516953432069,BAX/DIAPH1/CDK5/RIC3/MYO5A
BP,GO:0071621,granulocyte chemotaxis,0.3023677647135037,1,0.9653916562532012,0.9852516953432069,PDE4B
BP,GO:0009913,epidermal cell differentiation,0.5194306572592312,5,0.9658352552021738,0.9854571904094414,CYP26B1/VDR/RBPJ/PKP3/AKR1C3
BP,GO:0046717,acid secretion,0.29992931499807224,1,0.9663283785565868,0.9854659924713449,PLA2G3
BP,GO:0051101,regulation of DNA binding,0.29992931499807224,1,0.9663283785565868,0.9854659924713449,CSNK2B
MF,GO:0099106,ion channel regulator activity,0.2999491525423729,1,0.9664021758884618,0.9999991752923971,NEDD4
BP,GO:0008016,regulation of heart contraction,0.44451675370232213,3,0.9667457625964655,0.9856228370193123,TMEM65/PDE4B/ASPH
BP,GO:0044272,sulfur compound biosynthetic process,0.38740869853917664,2,0.9669667508712083,0.9856228370193123,GCLM/MPC2
BP,GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.2951685322203251,1,0.9681265918103381,0.9865578595902944,TGFBR1
BP,GO:0032368,regulation of lipid transport,0.29284437054929885,1,0.9689894288957139,0.9871898313918769,TRIAP1
BP,GO:0051346,negative regulation of hydrolase activity,0.5586666210693706,7,0.9692466292598136,0.9872046289005814,ELL/RPS6KA1/TERF2/BOD1/PPP1R14A/TRIAP1/PPP1R14C
CC,GO:0097060,synaptic membrane,0.5359045444661882,6,0.9695765789308255,0.9931939736830241,SRPX2/PSEN2/ADCY1/CDK5/NSMF/PCDHB13
CC,GO:0045211,postsynaptic membrane,0.4778343925890472,4,0.9696235108035756,0.9931939736830241,ADCY1/CDK5/NSMF/PCDHB13
BP,GO:0002576,platelet degranulation,0.29055652390438247,1,0.9698289536055426,0.987496298880971,FAM49B
BP,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",0.4358347858565737,3,0.9700184882813078,0.987496298880971,ADCY7/ADCY9/ADCY1
MF,GO:0005267,potassium channel activity,0.28775609756097564,1,0.970916593048433,0.9999991752923971,MTMR6
MF,GO:0015405,P-P-bond-hydrolysis-driven transmembrane transporter activity,0.28775609756097564,1,0.970916593048433,0.9999991752923971,TOMM20
BP,GO:0030198,extracellular matrix organization,0.5053156937467521,5,0.9714113451467017,0.9886668381428028,ITGA6/HAS3/TGFBR1/ADAMTS14/CLASP2
CC,GO:0098800,inner mitochondrial membrane protein complex,0.2858157570486337,1,0.9714801915840201,0.9931939736830241,C15orf48
BP,GO:0050866,negative regulation of cell activation,0.37378125688201963,2,0.9719139093086948,0.9888206195157422,RC3H2/ARG2
BP,GO:0050708,regulation of protein secretion,0.551564926733743,7,0.9720792982438256,0.9888206195157422,ARG2/ANO1/MAPKBP1/CAPN10/MPC2/IL1RAP/MYO18A
CC,GO:0042383,sarcolemma,0.28371417059974674,1,0.9722244272137088,0.9931939736830241,STAC
BP,GO:0006898,receptor-mediated endocytosis,0.47077512733874627,4,0.9722916612740828,0.9888206195157422,SNX1/NEDD4/USP46/FNBP1L
MF,GO:0015399,primary active transmembrane transporter activity,0.283152,1,0.972548007817185,0.9999991752923971,TOMM20
BP,GO:0045995,regulation of embryonic development,0.28175178075576485,1,0.9729662503637563,0.9892073530489011,CLASP2
BP,GO:0015850,organic hydroxy compound transport,0.42585383656214837,3,0.9735442999630013,0.9892073530489011,STX12/VPS4A/OSBP2
BP,GO:0001508,action potential,0.27963334631399217,1,0.9736983111209789,0.9892073530489011,GBA
BP,GO:0006414,translational elongation,0.27963334631399217,1,0.9736983111209789,0.9892073530489011,EIF5A2
BP,GO:0000724,double-strand break repair via homologous recombination,0.27754653029672355,1,0.9744105864523308,0.9892073530489011,INO80
BP,GO:0046683,response to organophosphorus,0.27754653029672355,1,0.9744105864523308,0.9892073530489011,SDC1
BP,GO:0007266,Rho protein signal transduction,0.3664161089631621,2,0.9744117919962796,0.9892073530489011,ALS2/MET
BP,GO:0045766,positive regulation of angiogenesis,0.3646199515662839,2,0.9750019431395112,0.9892073530489011,SRPX2/PDCD6
BP,GO:0000725,recombinational repair,0.2754906300723034,1,0.9751036100604948,0.9892073530489011,INO80
BP,GO:0050921,positive regulation of chemotaxis,0.2754906300723034,1,0.9751036100604948,0.9892073530489011,MET
CC,GO:0005882,intermediate filament,0.3606086654351921,2,0.9762370666636877,0.9953415102383196,VMAC/MYO5A
BP,GO:0031644,regulation of neurological system process,0.27146886904935,1,0.9764339654622407,0.9903099904014946,GBA
MF,GO:0005244,voltage-gated ion channel activity,0.3593299492385787,2,0.9767629595897672,0.9999991752923971,ANO1/CDK5
MF,GO:0022832,voltage-gated channel activity,0.3593299492385787,2,0.9767629595897672,0.9999991752923971,ANO1/CDK5
BP,GO:0042391,regulation of membrane potential,0.5141645399966952,6,0.9775360972904161,0.9908461920152004,GCLM/CTNS/NEDD4/BAX/CDK5/GBA
BP,GO:0007586,digestion,0.2675628421565536,1,0.9776933664574765,0.9908461920152004,VDR
BP,GO:0050715,positive regulation of cytokine secretion,0.2675628421565536,1,0.9776933664574765,0.9908461920152004,IL1RAP
BP,GO:0016485,protein processing,0.4535516470702556,4,0.9780371395774501,0.9909477170114738,PSEN2/OMA1/PIDD1/ASPH
BP,GO:0060078,regulation of postsynaptic membrane potential,0.26565167899829256,1,0.9782976473941959,0.9909648480078658,CDK5
BP,GO:0042742,defense response to bacterium,0.45080284920922364,4,0.9788783387870621,0.9910668444780649,ARG2/MAPKBP1/RBPJ/CARD9
BP,GO:0097530,granulocyte migration,0.26376762453731173,1,0.9788855902440671,0.9910668444780649,PDE4B
CC,GO:0072562,blood microparticle,0.2624838585140514,1,0.9792363162170992,0.9956372955073857,ACTG1
BP,GO:0019932,second-messenger-mediated signaling,0.5083084518418354,6,0.9794004934041685,0.9911526524337888,PRKAR2A/ADCY7/ADCY9/ADCY1/CALML5/MYO5A
BP,GO:0072006,nephron development,0.26191010605465465,1,0.9794576358858976,0.9911526524337888,ACTA2
BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,0.3459649773001019,2,0.9806843241811858,0.9915084499256118,PDE8A/NDRG4
MF,GO:0005261,cation channel activity,0.4438119122257053,4,0.9809865448716527,0.9999991752923971,TRPM7/ANO1/MTMR6/CDK5
CC,GO:0062023,collagen-containing extracellular matrix,0.47518629558578274,5,0.9812510360897176,0.9956372955073857,ITGA6/SRPX2/ANXA7/SCARA3/SMOC1
BP,GO:0071804,cellular potassium ion transport,0.3427763599977968,2,0.981573333901173,0.9915084499256118,NEDD4/MTMR6
BP,GO:0071805,potassium ion transmembrane transport,0.3427763599977968,2,0.981573333901173,0.9915084499256118,NEDD4/MTMR6
BP,GO:0045834,positive regulation of lipid metabolic process,0.2547344867106915,1,0.9815952550072916,0.9915084499256118,LPGAT1
BP,GO:2000241,regulation of reproductive process,0.2547344867106915,1,0.9815952550072916,0.9915084499256118,NUPR1
BP,GO:0006814,sodium ion transport,0.34120399137395374,2,0.9820028379425492,0.9915084499256118,NEDD4/CNNM4
BP,GO:0007601,visual perception,0.34120399137395374,2,0.9820028379425492,0.9915084499256118,CNNM4/MYO5A
BP,GO:0016064,immunoglobulin mediated immune response,0.34120399137395374,2,0.9820028379425492,0.9915084499256118,BCL10/RNF168
BP,GO:0019722,calcium-mediated signaling,0.34120399137395374,2,0.9820028379425492,0.9915084499256118,CALML5/MYO5A
BP,GO:0014074,response to purine-containing compound,0.24960560442792584,1,0.9830514525255778,0.9921621104645452,SDC1
MF,GO:0022843,voltage-gated cation channel activity,0.24925352112676058,1,0.9831984291510736,0.9999991752923971,CDK5
BP,GO:0019724,B cell mediated immunity,0.336572262984262,2,0.9832339107705372,0.9921621104645452,BCL10/RNF168
CC,GO:0098802,plasma membrane receptor complex,0.3923911240837175,3,0.9834672625248864,0.9956372955073857,ITGA6/TGFBR1/ACVR2B
BP,GO:0007338,single fertilization,0.24794156706507303,1,0.983510832193639,0.9921621104645452,PLCD4
BP,GO:0050953,sensory perception of light stimulus,0.33505617170955815,2,0.9836258091208236,0.9921621104645452,CNNM4/MYO5A
MF,GO:0015293,symporter activity,0.24579166666666669,1,0.9841419076665213,0.9999991752923971,SLC36A1
MF,GO:0016247,channel regulator activity,0.24579166666666669,1,0.9841419076665213,0.9999991752923971,NEDD4
BP,GO:0031424,keratinization,0.3320645987478657,2,0.9843831102120204,0.9926798444081554,CYP26B1/PKP3
MF,GO:0008528,G protein-coupled peptide receptor activity,0.2424246575342466,1,0.9850325059157565,0.9999991752923971,NPBWR1
CC,GO:0042734,presynaptic membrane,0.23965917516500349,1,0.9856655769405792,0.9956372955073857,PSEN2
BP,GO:0030856,regulation of epithelial cell differentiation,0.23840535294718562,1,0.9860175737584774,0.9940816580048293,VDR
MF,GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",0.48374487471526195,6,0.9861427984205542,0.9999991752923971,ELF4/PLAGL2/GABPA/RBPJ/ARNT2/NHLH2
MF,GO:0015081,sodium ion transmembrane transporter activity,0.23754362416107383,1,0.9862756785137208,0.9999991752923971,CNNM4
BP,GO:1904018,positive regulation of vasculature development,0.3234020439979214,2,0.9864565119029441,0.9942777726514312,SRPX2/PDCD6
MF,GO:0001653,peptide receptor activity,0.23285526315789473,1,0.9874157847613354,0.9999991752923971,NPBWR1
CC,GO:0031225,anchored component of membrane,0.2269713364797974,1,0.9887054925486493,0.9956372955073857,VNN2
BP,GO:0035821,modification of morphology or physiology of other organism,0.2267758235351278,1,0.9887783257482513,0.9961886871155923,KPNA5
BP,GO:0030111,regulation of Wnt signaling pathway,0.4098207720083852,4,0.9890482531310212,0.9961886871155923,BTRC/SDHAF2/RBPJ/TBL1XR1
BP,GO:0060326,cell chemotaxis,0.3670187670371147,3,0.9892169778530031,0.9961886871155923,MET/PDE4B/PARVA
BP,GO:0006813,potassium ion transport,0.3099269588313413,2,0.9893319311570778,0.9961886871155923,NEDD4/MTMR6
MF,GO:0015079,potassium ion transmembrane transporter activity,0.22260377358490566,1,0.9897218176911231,0.9999991752923971,MTMR6
MF,GO:0003823,antigen binding,0.22121249999999998,1,0.9900148437576324,0.9999991752923971,IL7R
MF,GO:0004252,serine-type endopeptidase activity,0.22121249999999998,1,0.9900148437576324,0.9999991752923971,MBTPS1
MF,GO:0005201,extracellular matrix structural constituent,0.21714110429447855,1,0.9908448355745438,0.9999991752923971,SRPX2
CC,GO:0031514,motile cilium,0.21555936984114835,1,0.9911017200003276,0.9956372955073857,GABARAP
BP,GO:0016525,negative regulation of angiogenesis,0.21497823733965868,1,0.9912392333676476,0.997415905067396,STARD13
MF,GO:0015291,secondary active transmembrane transporter activity,0.29868354430379745,2,0.9914434819838898,0.9999991752923971,SLC36A1/SLC35E3
BP,GO:0010951,negative regulation of endopeptidase activity,0.29752988047808765,2,0.9916091521348515,0.997415905067396,RPS6KA1/TRIAP1
BP,GO:0006956,complement activation,0.21252134319863403,1,0.9917083193774948,0.997415905067396,SCARA3
BP,GO:2000181,negative regulation of blood vessel morphogenesis,0.21252134319863403,1,0.9917083193774948,0.997415905067396,STARD13
CC,GO:0009897,external side of plasma membrane,0.3927239409828555,4,0.992035403190614,0.9956372955073857,ITGA6/SDC1/IL7R/P4HB
BP,GO:0019083,viral transcription,0.21011997208904493,1,0.9921523360220678,0.997415905067396,NUP62
BP,GO:0048469,cell maturation,0.21011997208904493,1,0.9921523360220678,0.997415905067396,CDKN1A
BP,GO:0090090,negative regulation of canonical Wnt signaling pathway,0.20893952280764583,1,0.9923653640498038,0.997415905067396,SDHAF2
MF,GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",0.29251239669421486,2,0.9924620693061621,0.9999991752923971,HMBOX1/FOXQ1
BP,GO:0045765,regulation of angiogenesis,0.38842020950141987,4,0.9927213901773789,0.997415905067396,SRPX2/HTATIP2/STARD13/PDCD6
BP,GO:1905330,regulation of morphogenesis of an epithelium,0.20661797255422754,1,0.992774261593104,0.997415905067396,CLASP2
BP,GO:0050900,leukocyte migration,0.4471891991153622,6,0.9930025603547084,0.997415905067396,ITGA6/SDC1/PIK3CA/YES1/PDE4B/APOD
CC,GO:0044391,ribosomal subunit,0.20307961685034503,1,0.9933523895168048,0.9956372955073857,RSL24D1
MF,GO:0004866,endopeptidase inhibitor activity,0.20225142857142858,1,0.9935308707068846,0.9999991752923971,RPS6KA1
BP,GO:0010466,negative regulation of peptidase activity,0.2839025577080989,2,0.9937210639875126,0.997891209158529,RPS6KA1/TRIAP1
CC,GO:0005840,ribosome,0.28371417059974674,2,0.9937262834238783,0.9956372955073857,RSL24D1/APOD
MF,GO:1901681,sulfur compound binding,0.283152,2,0.9938503732928505,0.9999991752923971,LANCL1/RCC1
BP,GO:1901343,negative regulation of vasculature development,0.19888360994524573,1,0.9940407687280319,0.9979659050310055,STARD13
BP,GO:0019080,viral gene expression,0.19471850816628772,1,0.9946623288476759,0.9982427789990964,NUP62
MF,GO:0008236,serine-type peptidase activity,0.19447252747252747,1,0.9947177505138992,0.9999991752923971,MBTPS1
MF,GO:0030414,peptidase inhibitor activity,0.19447252747252747,1,0.9947177505138992,0.9999991752923971,RPS6KA1
MF,GO:0061135,endopeptidase regulator activity,0.19447252747252747,1,0.9947177505138992,0.9999991752923971,RPS6KA1
BP,GO:0048839,inner ear development,0.19370434926958832,1,0.9948073318737307,0.9982427789990964,RBPJ
MF,GO:0015077,monovalent inorganic cation transmembrane transporter activity,0.37061780104712044,4,0.9950553329166929,0.9999991752923971,SLC36A1/MTMR6/CNNM4/C15orf48
MF,GO:0017171,serine hydrolase activity,0.19029032258064515,1,0.9952956266156971,0.9999991752923971,MBTPS1
BP,GO:0002685,regulation of leukocyte migration,0.1897511992844947,1,0.9953490784424119,0.998540086585384,APOD
BP,GO:0072376,protein activation cascade,0.18783452050384322,1,0.9955984129089338,0.9985439703435756,SCARA3
MF,GO:0022839,ion gated channel activity,0.31791017964071855,3,0.9962120278291191,0.9999991752923971,ANO1/MTMR6/CDK5
BP,GO:1901342,regulation of vasculature development,0.3525235550688242,4,0.9967837152837808,0.9985819026068556,SRPX2/HTATIP2/STARD13/PDCD6
BP,GO:0030178,negative regulation of Wnt signaling pathway,0.17710111933219502,1,0.9968378984038051,0.9985819026068556,SDHAF2
BP,GO:0097529,myeloid leukocyte migration,0.17710111933219502,1,0.9968378984038051,0.9985819026068556,PDE4B
BP,GO:0071356,cellular response to tumor necrosis factor,0.25560986295368354,2,0.9969069595198865,0.9985819026068556,CLDN1/GBA
MF,GO:0022836,gated channel activity,0.30956851311953354,3,0.9969419865173488,0.9999991752923971,ANO1/MTMR6/CDK5
CC,GO:0034703,cation channel complex,0.175386941825298,1,0.9970014272343232,0.9970014272343232,PDE4B
MF,GO:0003735,structural constituent of ribosome,0.17521782178217823,1,0.9970411932595653,0.9999991752923971,RSL24D1
MF,GO:0001664,G protein-coupled receptor binding,0.2528142857142857,2,0.9971555134078312,0.9999991752923971,NEDD4/RTP4
BP,GO:0008037,cell recognition,0.17298248865005095,1,0.9972451332683185,0.9985819026068556,ST6GALNAC6
BP,GO:0050920,regulation of chemotaxis,0.1713881799988984,1,0.9973929707784457,0.9985819026068556,MET
BP,GO:0043583,ear development,0.16982299114046098,1,0.997532889672661,0.9985819026068556,RBPJ
BP,GO:0002526,acute inflammatory response,0.16905106845345888,1,0.9976000128304477,0.9985819026068556,NUPR1
BP,GO:0030595,leukocyte chemotaxis,0.16603229937393285,1,0.9978507658597832,0.9985871870891999,PDE4B
MF,GO:0022804,active transmembrane transporter activity,0.2933204419889503,3,0.9980617056985082,0.9999991752923971,SLC36A1/TOMM20/SLC35E3
BP,GO:0034612,response to tumor necrosis factor,0.23840535294718562,2,0.9981584020187522,0.9986493800817225,CLDN1/GBA
MF,GO:0061134,peptidase regulator activity,0.1616164383561644,1,0.9981930755820445,0.9999991752923971,RPS6KA1
MF,GO:0005125,cytokine activity,0.16088181818181818,1,0.9982447669774547,0.9999991752923971,CMTM3
MF,GO:0046873,metal ion transmembrane transporter activity,0.3232328767123288,4,0.9985963753840112,0.9999991752923971,TRPM7/MTMR6/CNNM4/CDK5
BP,GO:0006959,humoral immune response,0.20893952280764583,2,0.9993869534416993,0.9996326841900254,SCARA3/RBPJ
BP,GO:0050907,detection of chemical stimulus involved in sensory perception,0.07796904624687832,1,0.9999980971453744,0.9999980971453744,RTP4
MF,GO:0048018,receptor ligand activity,0.07343153526970955,1,0.9999991752923971,0.9999991752923971,CMTM3
